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Walter Hines Page 11(1915-1999)
Walter Hines Page II, whose home looked down on Cold Spring Harbor and out toward
Long Island Sound, died on January 8,1999 at the age of 83. A considerate, wise, and
effective leader, he spent his entire working life as a banker. Following education at St.
Bernard's, Milton Academy, and Harvard University, he joined J.P. Morgan & Co. After
wartime service as a naval officer on a submarine chaser in the Atlantic, he steadily
moved up Morgan's ranks, becoming a vice president in 1953 and vice chairman of the
board in 1968. The latter role reflected his many major successes during the 1960s as
head of the company's rapidly expanding international division. In 1971, Walter was pro-
moted to Morgan's presidency and was chairman of its board when he retired at the end
of 1979.
Walter's life was also closely associated with the Cold Spring Harbor Laboratory.
Beginning in 1957, he was president of its parent body, the Long Island Biological
Association, and starting in 1963, he served several long intervals on its Board of Trustees.
Following his retirement from J.P. Morgan, he was for six years (1980-1986) our very able
chairman.
Walter's roots on Long Island date to his distinguished North Carolina-born grandfa-
ther and namesake, Walter Hines Page (1855-1918). A journalist and editor, he founded
with Frank Doubleday the publishing house Doubleday-Page, which in 1910 they located
in Garden City, New York. Earlier in Boston, the first Walter Hines Page rose to become
editor of The Atlantic Monthly and an adviser to the publishers Houghton Mifflin.
Doubleday-Page achieved renown when it published Theodore Dreiser's novel Sister
Carrie. The decision to publish this novel was made by Walter's grandfather, with Frank
Doubleday later wanting to revoke the agreement. But its publication went ahead, albeit
in a less sexually explicit form orchestrated by Dreiser's wife at the time, Sara. Soon after,
Walter Hines Page founded The World's Work, a monthly magazine that placed great
emphasis on the public responsibility of big business. He and Frank Doubleday also start-
ed Country Life in America, more immediately a financial success.
Walter's father, Arthur Wilson Page, joined the family firm in 1905 following his gradu-
ation from Harvard. He became its vice president in 1913, when his father was appoint-
ed American Ambassador to the Court of St. James by President Wilson. An extraordi-
narily well-liked ambassador, Walter Hines Page was to remain in London for the duration
of World War I, dying just at its conclusion.
While with Doubleday-Page, Arthur Wilson Page bought an old homestead called
County Line Farm in West Hills, several miles south of Cold Spring Harbor. The farm was
adjacent to the estate of the distinguished New York lawyer Henry L. Stimson, who served
as Secretary of State during both the first and second World Wars and as secretary of
state during Herbert Hoover's administration. Walter's attachment to the Cold Spring
Harbor region thus began in his boyhood years. Then he acquired his love of sailing boats,
and it was from the Cold Spring Harbor Beach Club, which his father helped found, that
he raced with children from the families whose estates dominated the lands around Cold
Spring Harbor until the end of World War II. Among them was Jane Nichols, three years
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Walter's junior, whose family's land looked down onto the lower mill pond and St. John's
Church.
In January 1942, just after the United States entered World War II, Walter and Jane
married. During the next six years, their three children were born-Jane Norton in 1943,
Walter Hines, Jr. in 1945, and Mark Nichols in 1948.
As a youth, Walter learned from his father about the Biological Laboratory, which had
been established in 1890 through gifts from Long Island's then preeminent family, the
Joneses. Sited next to the Laboratory, along Cold Spring Harbor's inner harbor, were the
turn of the century buildings of the Department of Genetics of the Carnegie Institute of
Washington. The Department's mission was to broadly extend the applicability of the then
newly rediscovered Mendelian laws of heredity. While the Department of Genetics labs
had stable financial backing from the Institute, the Biological Laboratory was habitually
underfunded and periodically faced extinction. Enlightened philanthropy from the owners
of nearby Gold Coast estates came to the rescue in 1924 with the formation of the Long
Island Biological Association (LIBA). The association's purpose was not only to keep the
Biological Laboratory alive, but to expand its activities to include research as well as
teaching. Arthur Page was LIBA's first treasurer, and in 1928, he became its president. By
that time, his association with the Doubledays had ceased, and he was using his formi-
dable personal qualities and great wisdom in behalf of AT&T, where he was vice president
of public relations. He soon became a member of AT&T's board and remained in that
position until just before his death at age 74.
In his role as LIBA's president, Arthur Page guided the Biological Laboratory through
the difficult years of the Depression (at its depth, he secured a $1 donation from a then
assistant secretary of the U.S. Treasury!). His most important contribution was in 1940,
when the flames of World War II were soon to engulf the United States, Entirely on his
own, he secured the agreement of Carnegie Institute officials to coordinate the efforts of
the Biological Laboratory with those of the Department of Genetics. A Carnegie geneti-
cist, Milislav Demerec, was appointed director of both institutions, leading to a period of
20 highly fruitful years. During that time, Cold Spring Harbor acquired worldwide renown
through the Nobel Prize-winning research on maize by Barbara McClintock and on bac-
terial viruses by Alfred Hershey, Salvador Luria, and Max Delbruck.
A new period of great institutional instability arose at Milislav Demerec's retirement in
1960. Unable to find a suitable successor, the Carnegie Institute made the decision to
gradually withdraw its support of science at Cold Spring Harbor. Fortunately, by this time,
Walter Page had assumed the LIBA presidential mantle long held by his father. In this
capacity, he helped bring into existence the Cold Spring Harbor Laboratory (CSHL), under
whose organizational framework all science activities at Cold Spring Harbor would be
managed. To help fill the financial gap created by the Carnegie Institute's withdrawal,
Walter secured $25,000 pledges from several major universities and medical research
institutions. In turn, representatives of these groups were appointed to a newly formed
Board of Trustees. Walter Page, as LIBA's president, and several other prominent com-
munity members were also members of the Board.
During the next several years, Walter's responsibilities at J.P. Morgan increasingly lim-
ited the time he could devote either to CSHL or to LIBA in its new, nonoperational role as
a mobilizer of community support. Seeing the need for a talented person to help him,
Walter wisely chose Edward Pulling to take over as LIBA's Board chairman. Pulling would
replace Nevil Ford, a banker who had held the position for many years. Having just retired
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Walter H, Page, upon retiring as chairman of the
CSHL Board of Trustees, 1986
Ed Pulling, Jane and Walter Page, Joe Sambrook, David Livingston
at the Sambrook Laboratory dedication, 1985
0 0
Walter, Claire Landau, 1986
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as headmaster of the Millbrook School, Ed was living on nearby land inherited from his
wife's father, Russell Leffingwell, a banker who was Morgan's chairman between 1948
and 1950. Under Ed, LIBA became effectively led by its chairman, not its president. In the
capacity of chairman, Ed assumed the place on our Board held for the previous five years
by Walter Page.
Walter returned to the Board in 1972, when Charles S. Robertson, owner of a large
Lloyd Harbor estate fronting on Cold Spring Harbor, was searching for an institute to
which he could gift his estate. In contemplating an even larger second gift that would be
designated for research support, Robertson wanted the assurance that Walter Page's
financial acumen would be at the Lab's side if the proposed Robertson gifts became final-
ized. Happily, Walter agreed to come back onto our Board, and Charles Robertson, now
at ease, provided $8 million for the creation of the Robertson Research Fund. Today,
thanks in part to wise spending guidelines set in 1973 by Charles Robertson and Walter
Page, the Robertson Research Fund totals some $80 million.
Several years later, Walter persuaded the Carnegie Institute to sell to CSHL at a very
reasonable price 20 acres of land it had long ago purchased from Jones family members.
This was an asset that Carnegie had initially held back from the newly formed Cold Spring
Harbor Laboratory, believing that it might soon bite the dust. Now that our long-term sur-
vival was assured by Charles Robertson's great generosity, Walter informed the Carnegie
management that we wanted to resolve the land question because we would soon need
a portion of it for construction of a new building for our cancer research. Walter, who had
once been on the Carnegie Board, went to Washington to see embryologist Jim Ebert,
Carnegie's newly installed president. To our great relief, the visit was a complete success.
Carnegie's asking price, which Walter immediately accepted, was $200,000, payable
over five years with no interest. Acquiring the needed Carnegie land would in no way
decrease the forward momentum of our cancer research.
Walter's negotiating skills again proved crucial to our long-term betterment when the
Village of Laurel Hollow, seeing that the Lab's financial health was no longer precarious,
asked us to cover village service costs that, as a tax exempt body, we were not legally
bound to pay. Walter had the good sense to know that our community relations could
only profit by our seeing that Laboratory activities did not prompt an increase in village
taxes. On the other hand, he was firm in saying that we should never pay more than our
village services actually cost. Luckily, common sense and good will prevailed, and both
the village officers and CSHL officials were pleased with the final agreement.
The stage was thus set for the Laboratory to commence construction of several new
buildings needed to maintain our preeminence in research and education. I shall always
remember Walter telling me that every successful organization, be it a bank or a research
institution, had to expand. Either we would get bigger or go into decline. This rule most
certainly held for our Cold Spring Harbor Symposium, which continued to grow. If we
could not provide a larger, better-equipped meeting site, our June Symposium and its
attendant intellectual excitement would be forced to move elsewhere. Happily, Ed Pulling
was soon to find a major donor who agreed to support the construction of a 360 seat
brick-covered auditorium that would replace our 200-seat Bush Lecture Hall. The donor
was Oliver Grace, newly moved into the community and a true capitalist, known as a
tough, buccaneering business negotiator. In the past, he and Walter had pitted their skills
against each other, but this was the time to make peace. Oliver was asked to join our
Board, and just before Walter retired as chairman, the Oliver and Lorraine Grace
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Auditorium was dedicated at the opening of our 1986 Symposium on Human Genetics.
Walter's support also proved crucial to Cold Spring Harbor's return to a major role in
plant genetics research. The famous field, next to the library, on which George Shull had
discovered improved yields from hybrid corn in 1908 and which Barbara McClintock had
used to show the existence of jumping genes in maize 40 years later, was no longer suit-
able for agricultural purposes. To use the powerful new recombinant-DNA techniques to
exploit Barbara's jumping-gene concept, we needed a new plot of good agricultural land
that we could yearly count on. Walter led the negotiations that let us purchase for
$700,000, 10 acres of land and assorted buildings on the Uplands Farm property, just
recently deeded by his wife's mother to the Nature Conservancy.
With good field plots now assured, the time had come to construct a building specif-
ically for plant research. Since the Page Motel, built in 1953 and named for Arthur's father,
was to be soon torn down to make way for construction of the Beckman Laboratory, our
new plant biology building, dedicated in 1987, was appropriately named the Arthur and
Walter Page Laboratory.
To Walter, the many personal advantages of being the scion of an important, landed
family demanded that he in turn be an enlightened public servant. His lifelong devotion to
our Laboratory was only part of his effort to keep our civilization moving forward. He knew
that J.P. Morgan Bank's great prominence meant that it also must work for the benefit of
New York City's less-advantaged men and women. He was a strong backer of the Urban
Coalition and made sure that significant Morgan Guaranty philanthropy was directed
toward the education of minority students. He was also personally involved in seeing that
educated minority members entered the banking community.
In so doing, Walter recognized that the social fabric of the United States had been
changed for the better by World War II. To him, the promise of a productive future did not
necessarily belong to those born well but to those who possessed inherent talents and
were willing to work hard and effectively. He believed that talent should be encouraged,
wherever it lies.
Even as Morgan's chairman, Walter took the 7:46 a.m. Long Island Railroad from
Cold Spring Harbor each day into New York City. The Pages' home, located across from
the Lab, and their Murray Hill townhouse reflected their view that money was best spent
on simple comforts. Only through his long-beloved sloop, the Barn Swallow, could Walter
be marked as more than a simple fisherman who knew when the blues were running.
Never far from his heart were the waters of Cold Spring Harbor. That its inner harbor was
not dredged to become another pleasure-boat-clogged Huntington Harbor and that
Robert Moses never built a massive causeway along its eastern shore to Marshall Field's
former lands owe much to Walter's gritty determination. We will long miss the many sen-
sible ways he used his privileges and connections to our great betterment.
James D. Watson
Walter and Jane Page, 1958
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Jane Norton Page (1918-1998)
Jane Norton Page's death on December 15,1998, preceded that of her husband, Walter,
by only 25 days. They had been together for 56 cherished years, having married just after
Walter went on active duty as a naval officer in World War II. Jane's no-nonsense, yet
always caring, manner complemented well that of her husband, whose tactful conversa-
tional openings often masked strong personal convictions. And when civic duty called,
Jane and Walter could always be counted on to lead.
Born in 1918, Jane, like Walter, was the product of an intelligent, landed family with
roots early into our country's history. Her father's family, the Nichols, had lived in
Massachusetts since the 17th century. A distant forebear, Susanna Martin, a Quaker
widow, was in 1692 convicted of witchcraft and hanged on Gallows Hill in Salem. During
the Revolutionary War, Ichabod Nichols, who had captained a ship to St. Petersburg and
the court of Catherine II, was expelled from their Quaker meeting for privateering against
British shipping. Late in the 19th century, Jane's grandfather, John White Treadwell
Nichols (1852-1920), who owned a textile mill, moved to New York and bought lands bor-
dering the road from Cold Spring Harbor to Syosset. This land continued to be farmed by
his descendants until after World War II.
Jane's father, George Nichols, carried on the family textile business. A prominent
yachtsman, he maintained the family farming tradition at Uplands Farm, an estate off
Lawrence Hill Road, where he and his family moved in 1924. Uplands Farm had been
given to his wife by her father, the financier J.P. Morgan (1867-1943), whose Long Island
estate was on Matinecock Point in Glen Cove. Morgan's summers were generally spent
in England, to the north of London in Hertfordshire. There Jane Page, as a young girl,
experienced the pleasures of the English country house life that New York's great wealth
was trying to emulate, if not better, on Long Island's North Shore. In the summer of 1939,
Morgan's chauffeur, in a casual conversation with a Lab scientist, gave assurances that
war was not imminent because Mr. Morgan was still in England.
Jane Page's strong sense of civic responsibility was also present in her mother, from
whom she took her first names. Jane Norton Morgan Nichols had two main interests in
her later life-social welfare and land preservation. In her early 50s, she enrolled in the
New York School of Social Work. Her certification from this program allowed her to be a
better liaison between professional social workers and the boards of their community
organizations. Later, following her husband's death, she became president of the
Huntington Family Service League. It was her long residency at Uplands Farm, where she
maintained a prize herd of Guernsey cows until the early 1960s, that led her to become
concerned about the increasing pressures of development on open land. As she grew
older, she derived great pleasure from the fact that the Nature Conservancy would later
take possession of her estate and keep her beloved fields and forests perpetually free of
development.
During the 1960s, Jane Page very much followed in her mother's steps, becoming a
member of the Board of the Long Island Chapter of the Nature Conservancy and even-
tually serving as its president. In particular, Jane helped spearhead our local Nature
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Summer of 1920
Jane Nichols (lower right) and her cousins with their grandmother in the summer of 1920.
Top: Jim Estabrook, Floyd Nichols, Mary Blake Nichols holding Nancy Taylor, Mollie Nichols, John Nichols
Bottom: David Nichols, John Estabrook, Laura Estabrook, Olivia Taylor, Jane Nichols
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Conservancy's chapter in its acquisitions of selective, small parcels of woodland and open
land that would serve as buffers between tracts of up-market family homes. Toward that
end, she gave to the Conservancy the land across from St. John's Cemetery, on which
her stable stood, to serve as a sanctuary. Later, she strongly opposed decisions made in
the Conservancy's Washington office to discontinue acceptance of local lands that could
not be part of much larger land parcels. Saddened, Jane realized that this decision meant
that even more of her local community would be lost to suburban sprawl.
While her children were still in local schools, Jane began to champion community
causes. In 1950, she became director of the Long Island Biological Association (LIBA).
Two years later, she became the group's vice president, a position she held for six years.
She effectively ran the committee that raised the funds that would permit the LIBA-owned
James Lab to have a second floor.
Feeling it tactful to have only one Page as a LIBA officer, she left the Board in 1958,
when her husband became LIBA's president. But she very much continued in our camp,
hosting one of our annual Symposium dinner parties. I, like previous Lab directors, always
took care to direct to their party several of the more lively symposium speakers. Over the
past decade, the rebirth of plant genetics at Cold Spring Harbor Laboratory brought her
much pleasure because she again could see Uplands Farm as a site for successful agri-
culture.
Outside our community, Jane's most cherished philanthropy was the Robert College
of Istanbul in Turkey. During her college years at Bryn Mawr, she became fascinated by
classical archeology, an interest heightened 'when she sailed to Turkey on a boat built for
their family friend Paul Hammond, who, like her father, was an experienced yachtsman.
Excited by the opportunities Robert College and the American College for Girls offered for
high-level secondary education, Jane soon became a member of its Board of Trustees.
Later, she also became actively involved with the Near East College Association.
In addition to sailing, a pleasure that took her and Walter to Maine's waters virtually
every summer, Jane loved horseback riding. Unfortunately, as had been true for her moth-
er, arthritis would dominate her later years. Never one to complain, Jane valiantly persist-
ed in attending Robert College Board meetings, despite obvious periods of physical pain.
The cruel stroke suffered by Walter in 1986, when they were sailing on Puget Sound,
sadly meant they could not continue to be forceful community leaders. But even then,
they remained strong backers of our local Whaling Museum, with Walter taking on its
presidency.
The New Year's Day party that the Pages annually held for their friends in the com-
munity was a cherished event, bringing together individuals whose commitments to
excellence on all fronts made them and their families important players in our nation's cul-
tural and business fabric for almost a century. To our sorrow, Jane and Walter are now
gone. So we must strive ever harder to see that the values they so long worked for stay
with us.
James D. Watson
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PRESIDENT'S
ESSAY
For now more than 50 years, the postgraduate courses at the Cold Spring Harbor
Laboratory have been without equal. The first one, the famous Phage Course, offered for 26
consecutive years, was initiated and taught in the waning days of World War II by the
German-born theoretical-physicist-turned-biologist Max Delbruck. He saw his course-
offered for three weeks during the summer-as a lifeboat for his six talented students, aca-
demic scientists who might otherwise begin to grow stale. The course gave them the oppor-
tunity to use bacterial viruses (phages) to come to grips with the essence of what was then
still very mysterious: the gene. Although no long-term converts emerged from the first-year
class, the Phage Course in subsequent years had many real payoffs. The summer of 1948,
for example, saw Seymour Benzer and Gunther Stent doing their first phage experiments,
and they never went back to their respective past worlds of physics and chemistry.
Encouraged by the teaching triumphs of the Phage Course, then-Director Milislav
Demerec, in 1950, started a second course, on bacterial genetics. No one then could have
imagined that we would be celebrating its 50th consecutive offering this year. Its success, in
turn, inspired the creation in 1958 of our third course on animal cells and viruses. Equally influ-
ential, its early students included Purnell Choppin, later long to serve as the president of the
Howard Hughes Medical Institute; growth factor discoverer and Nobel prize winner Stanley
Cohen, and the clever Swiss interferon cloner, Charles Weissman. Today, our yearly course
offerings, ranging from Yeast Genetics to Neurobiology, total 25, with the number bound to
increase as biology grows ever more relevant to human life during the next century.
We always aim to teach ideas and experimental techniques that are not yet part of the
academic teaching scene even in the best of universities. We therefore recruit teachers who
have actually generated new ideas and techniques, and they choose the students from the
respective applicant pools. To ensure that their choices are not influenced by financial cir-
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cumstances, our student fees are low, covering only a small percentage of the true teaching
costs. And when a given student has no means to cover even such reduced fees, we usu-
ally provide scholarship support. As a result, we are constantly seeking governmental and
foundation monies to cover most of our true teaching costs.
Next fall, we shall be taking on an equally important academic challenge. Our long-
dreamed-for opportunity of offering our own Ph.D. degrees is now a reality. Late last
September, we received formal permission from the New York State Department of
Education to create a degree-granting School of Biological Sciences. Although we have long
served as a site for extensive Ph.D. thesis research, the actual degrees have been awarded
by nearby universities-for the most part, by the State University of New York (SUNY) at
Stony Brook. With large numbers of most valuable Stony Brook students continuing to do
their thesis research here, an increasing number of students will have all aspects of their
Ph.D. education take place here.
In helping plan our new Ph.D.-granting program, I have naturally looked back on my own
education to try to pinpoint the crucial elements that led to my future success as a scientist.
Not surprisingly, I see the very powerful influence of my parents. They both strongly encour-
aged my studies, seeing knowledge and its creation as the key factor that liberates human
beings from much of illness, poverty, and superstition. To them, ultimate truth came from
observation and experiments, never from personal revelations. Scholarly and cultural pur-
suits were the ways our Depression-limited family's money was most enthusiastically spent.
At Christmas, books were increasingly favored over toys, starting with the child-oriented
Travelling with Birds, given to me by my uncle and aunt on my eighth Christmas. It was
instantly a cherished gift, with its focus on bird migration kindling an interest in biology that
increasingly dominated my intellectual aspirations as I moved through adolescence.
Even before high school, I wanted to master the basic laws of nature, and I found
Darwin's Theory of Evolution by Natural Selection a powerful liberating force in facing up to
the extraordinary diversity of living forms that now inhabit the earth. Its importance to me
steadily increased as I went through the University of Chicago and, with little hesitation, early
on chose zoology as my major. That I had matriculated when just 15 in no way indicated
unusual childhood precocity. Instead, it was a reflection of President Robert Maynard
Hutchins' belief that the last two years of American high schools served no useful purpose.
In particular, he faulted them for not successfully challenging human minds to think as
opposed to learn facts, a task best left to trade schools. To prove his point, he created a
program that let a small number of students enter the university after only two years of high
school. I was one of those so chosen, most likely because I was a keen reader with much
better than ordinary memory.
Not until my third year in college did I as a student feel at ease, knowing by then that it
was the ideas, not the facts of the past, that led to good grades in Hutchins' College. Only
with ideas in place could facts be prioritized. I was thus ready for intellectual zapping by the
famous Austrian physicist Erwin Schrodinger, through his little, elegantly written, wartime
book, What is Life? Here he posed the key question that had attracted me to biology but
whose previous answers had left me wanting. Schrodinger's message was that the essence
of life was its ability to pass genetic information from parental to daughter cells. Most impor-
tantly, this information must reflect the precise arrangement of atoms within the molecules of
heredity located on chromosomes. To truly understand life, we must pursue genetics at the
molecular level.
Suddenly, birds seemed objectives for outdoor fun, not for serious science, and I began
anticipating going on to a graduate school that would broaden my education to include
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chemistry as well as physics. But my first choice, Caltech, did not find me up to their stan-
dards, being apprised from my transcript that I was a straight-A student only in ecology
courses. Happily, Indiana University only wanted to be sure that my main intellectual objec-
tive was no longer birds, and so in the fall of 1947, I was off to its main campus at
Bloomington.
My two and a half years there as a graduate student were to transform me from a stu-
dent into a scientist. Crucial to this process were Indiana's splendid courses. They gave me
a sense not only of topics then currently exciting, but also of key earlier experiments that had
put the gene at the center of heredity. Particularly inspirational during my first term were lec-
tures on advanced genetics by the recent Nobel prize winner Herman J. Muller. They, in
effect, were the story of his pursuit of the gene, starting with his undergraduate days at
Columbia University. A year later, I took Felix Haurowitz's course on proteins and nucleic
acids, the molecules most likely to carry genetic information. From him I learned that their
highly complex structures were likely too complex for current X-ray crystallographic methods
to soon give any meaningful take-home lessons for genetics. Instead, this was the time for
me to master the ways of the phage world first introduced to me by Salvador Luria's fall 1947
virus course at Indiana University. By the time its final exam was over, I was totally hooked
on phages and the possibility that in studying how they multiply, we were in essence study-
ing how genes were copied. Although my resulting Ph.D. thesis, which Luria suggested I do
on X-ray-inactivated phage, eventually went nowhere, I frequently went to the lab hoping my
next experiment might have a real intellectual payoff.
By the spring of 1950, when I wrote up my thesis, I had mastered all the key phage pub-
lications of the past decade, by then knowing their factual details to a greater depth than did
either Luria or his long-close, then Caltech-dominated, collaborator, Max DelbrOck. Equally
important, I felt myself a bona fide member of the phage group by having spent two long
summers with it-first at Cold Spring Harbor (1948) and then at Caltech (1949). I also
immensely profited from many school-year microbial genetics gatherings in Chicago hosted
by Leo Szilard, the legendary developer with Enrico Fermi of the first atomic reactor. When I
did not understand an argument or experiment, I had the courage to say so. By my last year
with Luria, I was effectively on my own, generating several new ideas on how X-rays inacti-
vate phages. Although all of those ideas soon proved to be off-base, I was having fun.
Intellectual torture only came from having to write up minor results. Happily, Luria, in effect,
wrote most of my thesis, enjoying his position as an immigrant in control of the English lan-
guage. Later, I found I could write well when I had a message of importance.
By the time my graduate student days came to a close, I more than subconsciously knew
that even the most elegant phage experiments were unlikely to reveal the gene at the cru-
cial molecular level. Somehow, I had to move closer toward the chemistry of DNA. I thus
applied for (and received) a National Research Council postdoctoral fellowship that would
take me to the Copenhagen lab of Max Delbruck's biochemist friend Herman Kalckar. But
soon after my arrival, I feared I had made a bad move. Herman's interests were enzymatic,
and there was no way his experiments on how DNA precursors are made could help deter-
mine the structure of the gene. Soon I reverted to doing phage experiments in the
Copenhagen lab of Ole Maaloe. My intellectual course only truly changed after a meeting on
macromolecules that I attended with Kalckar in Naples. There, Maurice Wilkins presented his
newly obtained X-ray diffraction diagram of the crystalline "A" form of DNA. Conceivably,
within its myriad details were the clues to cracking the mystery of the gene. Learning soon
of my change of heart, Salva Luria arranged for me to move to the small but powerful group
of protein crystallographers at Cambridge University led by Sir Lawrence Bragg and Max
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Perutz. Only 18 more months were to pass before Francis Crick and I found the extraordi-
narily informative double-helical structure of DNA. The basic structure of the gene was far
simpler than we or anyone else could have predicted.
Looking back, I see my first graduate school years as teaching me the values of science
and how experiments should be planned, executed, and interpreted. Most importantly, my
days were not narrowly focused, and I spent much time learning how others were trying to
approach the gene. To his great credit, Luria never saw my experiments as a means to fur-
ther advance his own career and would not have put his name on my thesis publications
even if they had proved major scientific announcements. Nor did he ever express displea-
sure when I stopped following his research suggestions and went in directions that he
thought unlikely to succeed. He saw my need to move forward or backward on my own
terms.
That I was then given such independence owed much to my tough undergraduate days
at the University of Chicago. I now look back at it as an officers' training school of intellec-
tuals. There, the utterance of an illogical argument inevitably resulted in verbal face slaps that
seldom elicited the sympathy of others. No other biology student at Indiana had been so
tested over such a hard intellectual obstacle course, and students there found it hard to
accept that so much of the science around them would never yield meaningful answers to
important questions.
After I joined the Harvard faculty, I tried as much as possible to handle my Ph.D. students
as I had been looked after by Salva Luria and Max Delbruck. My students' inherent intelli-
gence was a big plus in my being able to let them run at their own pace. By the time they
were in the lab, they had listened to sufficient numbers of my lectures to know what I thought
were the big problems to be solved over the next several years. They also knew what fields
I thought had no effective chance of soon moving forward. Until the late 1960s, I gave an
annual lecture on why developmental biology should be avoided until the basic facts about
genes and their expression were better known.
For thesis topics, I tried to start my graduate students out on problems bound to yield
sufficient data for a thesis but that nonetheless had potential big payoffs. I never intentional-
ly assigned a topic that I thought had a low probability of success. Occasionally, I guessed
wrong, suggesting to Volker Vogt, for example, that he purify the enzyme that removes
formyl groups from the amino-terminal end of growing bacterial polypeptide chains. It proved
an intractable objective, but he nevertheless received an on-time Ph.D. I did not see then,
nor do I now, that the primary purpose of a Ph.D. is to pull off difficult science. Of course,
both I and my students always hoped that their thesis research would lead to big concep-
tual breakthroughs. This, in fact, happened sufficiently often to keep most everyone's morale
high. Although my first graduate student, Bob Risebrough, interrupted his studies for a year
on an oceanographic ship, he returned to do extraordinarily important experiments during
the late winter of 1960 that demonstrated the existence of messenger RNA.
By sharing my lab and its intellectual objectives with one or more already accomplished
scientists, my students always had at least two mentors they could turn to for advice. For
my first five years, both I and my students greatly profited from the many talents of the Swiss
biochemist Alfred Tissieres, then waiting for a senior professorship to open up in Geneva.
Upon his departure, his lab space was taken over by Wally Gilbert, then makng the transi-
tion from theoretical physics to molecular biology. Upon Wally's promotion to tenure in bio-
physics, we continued to share growing lab space, and when one of us was otherwise
involved or away for sabbatical periods, our students were not lacking for advice when they
wished it.
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My students always knew they were working primarily to advance their own careers, not
those of Alfred, Wally, or me. Except for review-like papers, only our students' names deco-
rated their manuscripts. Of course, Wally's and my applications for funds benefited heavily
from showing how well our students had used our existing grant monies. It is my hope that
this same atmosphere will prevail in our new graduate school, despite the many changes in
the ethos of science since I left Harvard. While I was a professor there, the number of sci-
entists was much smaller, and I spent little emotional time worrying whether my next grant
would be funded. My main anxieties always related to whether our science was going well.
Today, there are many, many more scientists, and the funding process is less personal and
more undependable-even for good scientists. Anxieties about money are at least equal to
those about whether our science is original or derivative.
Too frequently, predoctoral students are now seen as necessary cogs in the machinery of
getting grants. With their salaries more often than not paid out of grants, they sense all too
clearly that their respective mentors' grant objectives must succeed. It is thus essential that
significant new endowment funds be raised for use by our School of Biological Sciences.
Only when such funds are ensured will our students sense the freedom to move where their
new knowledge tells them to go. I feel confident that these monies will be raised and that not
too many years will pass before students from our school are seen helping lead biology to
further improve the quality of human life.
April 1999 James D. Watson
5
DIRECTOR'S
REPORT
This year, Cold Spring Harbor Laboratory witnessed one of the most significant events in its
history: the establishment of our own School of Biological Sciences. With the ability to grant
the degree of Doctor of Philosophy (Ph.D.), we expect to attract some of the world's brightest
young people to the shores of Cold Spring Harbor for an experience that will change their lives
and, we expect, ours. As we enter into a new era, the Watson School of Biological Sciences
will have a broad impact on the future of the Laboratory, much like other new educational pro-
grams have in the past.
For much of its existence, CSHL has played two overlapping roles in biological science.
One stems from the need in the late nineteenth century for a gathering place for people-pri-
marily teachers-to practice and teach biology. Biology was at that time predominantly devot-
ed to the study of the organism and its environment, so the bountiful resources of the shore of
Cold Spring Harbor were a distinct attraction. With the help of the local philanthropic commu-
nity, the Laboratory evolved into a center for both visiting researchers and year-round investi-
gators, particularly with the addition of the Carnegie Institution of Washington laboratories in
1904, where genetics became the primary focus of research. Thus, the Laboratory became a
place for teachers to learn during their summer breaks and for researchers to work year-round.
In addition, local school-age children could come to the Laboratory to participate in a summer
nature study program, making the most of the shores of Cold Spring Harbor, its surrounding
springs, creeks, and fields, a program that still exists today.
During the height of the classical genetics period, the year-round research effort was com-
plemented by the introduction of a formal meetings program (1933) and soon after the Second
World War, with an advanced laboratory course (1945). Both of these programs set a new direc-
tion for the Laboratory, and it is these programs that greatly influence our current activities and
make the Laboratory a wonderfully unique place. Principal among the modern benefits is the
constant flow of visiting scientists who attend meetings and demonstrate and lecture in our
advanced courses, thereby keeping us up to date with the latest results and technologies. In
1998, approximately 7000 scientists visited CSHL to attend 1 of the 20 meetings at our main
campus, study in 1 of our 25 courses, or work in our labs as visiting scientists. We have thus
long existed as a dynamic center for science by combining a focused and productive research
program with a vibrant and world-renowned academic program.
There are many times when the two endeavors have dovetailed, with each program influ-
encing the other. The animal cells and viruses courses that started in 1958 preceded the high-
ly productive era of research at CSHL aimed at understanding how DNA tumor viruses induce
cancer. Tumor virus research at CSHL in turn helped focus attention on the molecular biology
of animal cells and led to major insights into how genes are expressed, how they replicate, and
how the tumor viruses intersect with the host cell's division-control machinery to promote tumor
growth. Similarly, the introduction of the neurobiology courses in the early 1970s promoted an
environment in which we could no longer resist starting year-round research on learning and
memory, a program that is currently under significant expansion due to its great success.
Forty years ago, the introduction of a summer Undergraduate Research Program broad-
ened our educational program. With the goal of providing research opportunities to under-
graduate students from throughout the United States and abroad, this program has brought
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some of the brightest students to Cold Spring Harbor to experience both the research and the
summer's advanced educational programs. This year, we had more than 400 applications and
accepted 22 students, who then studied with our best researchers.
Learning about science is not just for the young; it is a life-long undertaking that will never
escape the productive scientist: Attending research meetings is a form of continuing education
that enables active scientists to keep apace with the rapid developments in research. In addi-
tion to the meetings on our main campus, we have a complementary program of smaller meet-
ings at our Banbury Conference Center. It was very fortunate that we were graced with the
addition of Charles Robertson's Banbury estate in 1976, where we were able to establish the
Banbury Conference Center. Functioning as a biological think tank, the Center brings scientists
together to discuss research, policy, funding, and ethics, as well as to learn about fields of biol-
ogy unfamiliar to them. Today the Banbury Center facilitates the continuing education of scien-
tists in a remarkably beautiful setting.
In the mid 1980s, the DNA Learning Center (DNALC) arose because of the need to reach
out to high school students and their teachers and inform them of the exciting developments
in DNA research. Biological discovery is moving at an unparalleled pace and has had, and will
have, a broad impact on society as a whole. The DNALC therefore fulfills three essential goals:
First, to educate young students in modern genetics so that the next generation can under-
stand how modern biology can improve their lives; second, to expose talented students to bio-
logical research at an early age, so that some will be inspired to pursue a career in biological
science or medical research; and third, to make it possible for teachers to use the DNALC and
its resources to keep abreast of developments in biology, so that they are teaching relevant biol-
ogy to their students. The DNALC is another one of the Laboratory's educational success sto-
ries, and it serves as a model for similar centers throughout the United States and abroad. As
a recent part of this effort, an exciting genetics Internet site, inspired by Jim Watson in collab-
oration with David Miklos, Jan Witkowski, and John Kruper, and with funds from the Josiah
Macy, Jr., Foundation, saw significant development in 1998. The first sections on genetics were
released in January 1999 (http: / /vector.cshl.org /dnaftb). This site is for everyone who wishes to
learn about biology, not just high school students.
With the extensive teaching opportunities we have offered in the past, CSHL has in a very
unique way emerged as a powerhouse of science education. The establishment at the end of
1998 of the School of Biological Sciences represents another significant milestone and a major
addition to our educational mission and soon will have an impact that will be as prominent as
the other educational activities. We now maintain an almost continuous educational slate, rang-
ing from early school years to the most advanced biology for active scientists. Importantly, the
graduate school will establish a more intimate connection between our research program and
its scientists and our educational program.
When Jim Watson arrived as Director in 1968, he brought along a few students to do their the-
sis research at CSHL, contributing to the successful DNA Tumor Virus program. But they were for-
mally aligned with universities such as Harvard, Columbia, and New York University. Beginning in
the mid 1970s, students from the nearby State University of New York at Stony Brook began work-
ing at CSHL. The first arrival was Jim Manley, who graduated in 1978 and is now chair of the
Department of Biological Sciences at Columbia University. The number of students coming from
Stony Brook increased steadily, initially through our strong relationship with the Stony Brook
Department of Microbiology, which was then headed by Arnold Levine, a former Laboratory trustee
and now president of the Rockefeller University, and more recently by Eckard Wimmer, also a for-
mer CSHL trustee. With the establishment of the multi-institutional graduate program in genetics in
the early 1980s, which brought together scientists at Stony Brook, CSHL, and the Brookhaven
National Laboratory, there were even more opportunities for students to work at CSHL.
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A particularly important event in the evolution of the interactions between Stony Brook and
CSHL was the collaboration between Stony Brook's Nicholas Muzyczka, director of Stony
Brook's Genetics Graduate Program, and Winship Herr, who spearheaded the involvement of
CSHL scientists in the recruiting and teaching students. The interactions between Stony Brook
and CSHL flourished and expanded to include students from the graduate programs in molecu-
lar and cellular biology, pharmacology, and, most recently, neurobiology. CSHL scientists are
also members of the Medical Scientist Training Program that trains M.D./Ph.D. students at Stony
Brook. In 1998, we had 57 graduate students from Stony Brook working at the Laboratory, mak-
ing up a sizable fraction of our total research scientists. As we established our own graduate
school, maintaining and even strengthening the interactions between Stony Brook and CSHL
were of the utmost importance. These interactions not only promote the training of graduate
students, but they are the basis of the relationship between our two institutions and thereby
broaden the intellectual environment on Long Island, a highly desirable goal for all involved.
Throughout this period, there had often been discussions about whether CSHL should estab-
lish its own graduate program, but they were usually tabled because we were busy venturing into
new research fields. In addition, many people quite rightly questioned whether our own program
might change the nature of the Laboratory. This was a very appropriate question to ask.
Eventually, however, the notion that we start a graduate school at CSHL emerged as one of the
principal topics for discussion, encouraged by the Board of Trustees under the strong and enthu-
siastic leadership of David Luke. As a result, we embarked on a journey that, I believe, will have
as much of an impact on the Laboratory as the starting of the postgraduate courses did in 1945.
CSHL has always enjoyed the ability to be flexible in its programs and not having to follow
what people elsewhere have done. This key thread was woven into the plans for the new grad-
uate program. Beginning from scratch, Winship Herr again took on a major new challenge to
lead the design of a graduate program with CSHL faculty that was appropriate for the modern
era of biology and that would serve us well far into the future. He also had to guide our appli-
cation through the New York State Board of Regents' stringent approval process while not
compromising on our desire to be innovative. In both of these, he and the Laboratory were
spectacularly successful.
Incorporating the experiences of our diverse faculty who have studied in many different coun-
tries and graduate programs, the design of our graduate school took shape. Several important
principles emerged that guided the thinking behind the design process and that became part of
the graduate school curriculum. Many graduate students in the United States spend far too long
in graduate school (up to seven years in some cases), so the program was designed to take about
four to four and a half years. For the highly motivated students we expect to attract, this time
frame should be more than adequate to embark on a life-long journey as a scientist. (I was fortu-
nate to have completed a successful Ph.D. degree in three years and thus come to Cold Spring
Harbor as a postdoctoral fellow having just turned 25. But I was trained well enough to appreci-
ate all that CSHL had to offer.)
To ensure that our students can maximally benefit from the exciting environment at CSHL,
we have incorporated a two-tier mentoring system. Students will have an academic mentor
from the faculty, who will guide their intellectual and individual development, in addition to a
research mentor to guide their thesis research. The relationship between a student and a
research advisor is particularly unique and affects both people and their careers in significant
ways. Indeed, it is a very special relationship that develops. But there are potential conflicts
because the research advisor's research goals often have little to do with the education of a
student. Moreover, the very nature of graduate thesis research focuses the student on a very
narrow, albeit important problem. The addition of a second mentor for each student who will
meet with and guide the student in all aspects of science should counter these possible con-
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flicts. That mentor will guide the overall education of the student, particularly inareas of science
not related to the research thesis.
Together, the student and academic mentor will discuss science and address problems
that might arise. Although such discourse may also come from the research mentor (and I hope
it will), the academic mentor will provide another point of view. I was aided greatly by having a
marvelous thesis advisor in Alan Bel lett, but also a second mentor, Ban Younghusband, who
gave me the good advice to come to CSHL from Australia, against the advice of others. Ban
urged me to come here because we got to know each other very well, and he therefore knew
what would be good for my future. He turned out to be right.
The shorter training period necessitates a way of teaching that is more intense and differ-
ent from what many graduate programs use, where students spend one to one and a halfyears
in formal course work. It is my observation that following this, students often think that they do
not have to continue to learn about science outside their thesis field. But those who take this
attitude are doomed to mediocre science.
The innovative curriculum of the new school was designed to teach students in an initial
14-week course how to learn, think, and expand their own horizons. By exposing students to
what they need to know in the first semester, we do not expect them to become experts in all
subjects. Rather, we expect that the course will open doors and that they will then seek out
more information on their own, with their mentors' guidance. To reinforce the concept of con-
tinuing education, short courses over the entire four years of the program will provide opportu-
nities for students to learn about new areas, particularly taking advantage of the CSHL
advanced courses. There, scientists do not become instant experts in the field taught in a
course, but they are exposed to what is currently possible, enabling them to continue the learn-
ing process when they return to their own laboratories.
The graduate program involves a significant commitment on behalf of our faculty and the stu-
dents, so we have initially limited student numbers to approximately five per year. But the small
number will also allow us to address other important aspects of the program. First, because we
seek high-quality students who will bring a vital energy to the program, recruiting must be highly
selective. Second, so as to not have a negative impact on the current research budget, we will
endow the graduate school with sufficient funds so that every student will have a guaranteed
stipend, in addition to coverage of research costs and other expenses. This will have the added
advantage that the students will have more flexibility in selecting the topics for their thesis research
because they will not have to rely solely on funds from research grants that have other aims.
There was an obvious choice for the name of the school. Jim Watson has made pioneer-
ing contributions to research and to CSHL, but he has also made many significant contribu-
tions to education. As a teacher at Harvard, he developed perhaps the most influential textbook
in modern biology, Molecular Biology of the Gene. This book greatly influenced later texts,
including the popular Molecular Biology of the Cell, which Jim also helped write. He was a dri-
ving force in the establishment of the DNA Learning Center and its programs, and greatly
expanded the postgraduate courses at CSHL during his tenure as director. Jim has been
uncompromising on quality, innovation, and enthusiasm as a leader in education. I was there-
fore most pleased that when David Luke and I asked Jim whether we might name the school
the Watson School of Biological Sciences, he said yes, although somewhat reluctantly.
None of this would be possible if it had not been for the dedication and very hard work of
Winship Herr. He has guided the development of the curriculum, organized the faculty, and set
a high standard for the graduate school. The Laboratory owes him a great debt. It is therefore
most appropriate that Winship was named the first Dean of the Watson School of Biological
Sciences at the November meeting of the Board of trustees.
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HIGHLIGHTS OF THE YEAR
Each of the existing divisions of the Laboratory had a busy and successful year with exciting
developments on many fronts, and expansion of our research and education efforts into new
arenas. In addition to the formation of the new Watson School of Biological Sciences, new
research initiatives in neurobiology were under way. We also began an expansion of our
research facilities on our main campus and at a nearby technology center, and we worked with
New York State to develop a nearby Biotechnology Park. Coupled with our existing activities,
these initiatives will ensure that the Laboratory remains at the forefront of research and educa-
tion as we enter the next millennium.
Research Highlights
The research program at Cold Spring Harbor Laboratory continues to be strong and produc-
tive. Advances have occurred in cancer research; the neuroscience program has continued to
grow; and plant biology has persisted as a powerful cornerstone of research. The bioinformat-
ics initiative reported last year has proven to be an invaluable asset to the Laboratory and has
been expanded, in terms of its scientific staff and the development of advanced courses on the
use of computers to solve biological problems. There also continues to be important research
on basic cell biology that advances our knowledge of the most fundamental aspects of life.
Cell Biology
Last year, Tatsuya Hirano and his colleagues reported the discovery of condensins, protein
complexes that work to physically compact chromosomes in preparation for cell division. This
year, Hirano and his colleagues reported the identification of cohesins, other protein complex-
es that keep together the two parts of newly replicated DNA (sister chromatids) until they are
split and transported into two daughter cells during mitosis. Condensins and cohesins both
contain a subset of related components called the SMC (structural maintenance of chromo-
somes) proteins. The two SMC protein complexes help to ensure that the
genetic information encoded in DNA that has been replicated segregates
evenly during cell division. Not surprisingly, these proteins are conserved in
bacteria and eukaryotes, which include human cells, and it is remarkable
that such important proteins have, until recently, eluded cell biologists.
During the period between one cell division and the next, cells perform
essential functions as part of tissue. One of the most important functions is
the process of controlling which genes are expressed and which are
silenced. This was the topic of this year's Symposium (described below).
Nouria Hernandez studies how a particular class of genes within the
genome is transcribed into small nuclear RNA molecules (snRNAs). The
snRNAs play several roles in the cell, but their main job is to organize and
participate in the complex machinery that processes the RNA that is tran-
scribed from other genes to produce the messenger RNA (mRNA) that will
then produce proteins. Like regulatory mechanisms for all genes, many pro-N. Hernandez
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teins bind to each snRNA gene promoter (the regulatory region of a gene), thereby controlling
the expression of the snRNA genes.
In her studies on the mechanisms of gene control in human cells, Nouria and her collabo-
rators have characterized SNAP, a molecular complex made of five protein subunits that helps
to direct transcription of genes that encode snRNAs. Recent results have demonstrated that
SNAPS cannot bind to the promoter in the absence of an activator protein that binds to DNA
adjacent to the SNAPS binding site. SNAPS and the activator cooperate to trigger gene tran-
scription by direct protein-protein interactions. The activator is a protein called Oct-1, an acti-
vator of other genes-including those in the herpes simplex virus family-and the subject of
research in Winship Herr's laboratory. The observation that SNAP and the activator cooperate
was striking because Nouria had shown previously that SNAP also binds to another protein
that binds to gene promoters, the TBP protein, and the two cooperate to activate gene tran-
scription. The protein-protein interactions between Oct-1 and SNAPS and between SNAPS and
TBP both involve the inactivation of regions of the proteins that prevent promoter DNA recog-
nition. Thus, Nouria and her colleagues may have uncovered one of the mechanisms-if not the
mechanism-of how activators of gene transcription cooperate to control the expression of
genes in cells.
Cancer
The breast cancer tumor suppressor gene PTEN, identified in 1997 by Michael Wigler's lab at
CSHL in collaboration with Ramon Parsons of Columbia-Presbyterian Medical Center, has now
been shown to be involved in many types of cancer. From the sequence of the protein, it was
suspected that the gene product would prove to be involved in removal of phosphate groups
from substrate proteins. A collaboration between Mike Wigler's lab and Nick Tonks' lab, then,
was a natural.
Nick studies protein phosphorylation and its role in signal transduction, the process where-
by extracellular signals are transmitted into the cell to control all manner of events. In fact, Nick
helped pioneer studies of dephosphorylation, the removal of phosphate groups on tyrosine
residues in proteins. A protein's condition (phosphorylated or dephosphorylated) helps to deter-
mine whether it is active or inactive. Phosphorylation and dephosphorylation regulate approxi-
mately one third of all proteins in a cell.
To pursue the function of the PTEN protein, Tonks and postdoctoral fellow Mike Myers col-
laborated with Javor Stolarov of the Wig ler lab and Peter Downes of the University of Dundee
to determine that the PTEN gene does encode a regulator of phosphorylation. But it turned out
to be a poor enzyme that used proteins containing phosphates. After much investigation, its
key target for tumor suppression was found not to be a phosphoprotein, but rather a membrane
phospholipid called PIP,. PIP, functions in a variety of cellular responses related to cancer,
including signaling from cell surface receptors to control whether a cell survives or undergoes
cell death, or apoptosis. Apoptosis is the cellular equivalent of a suicide mechanism that, when
triggered by serious DNA damage or external signals, causes a cell to self-destruct. Apoptosis
is a natural self-defense mechanism against cancer; it rids the body of abnormal cells and pre-
vents their replication.
The finding that the PTEN protein dephosphorylates PIP, is the first to indicate that muta-
tions in a gene encoding a lipid phosphatase are directly linked to cancer. Mutations in PTEN
occur in breast cancer, glioblastoma, prostate cancer, and endometrial cancer. In addition,
mutations in PTEN are found in several disorders predisposing to cancer, including Cowden's
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Syndrome, Lhermitte-Duclos disease, and Bannayan-Zonana syndrome, all of which are char-
acterized by the formation of multiple benign tumors and an increased incidence of malignant
tumors.
Several labs at Cold Spring Harbor continue to study apoptosis. Because apoptosis is a
natural defense against cancer and causes the death of cells with serious genetic defects, it has
become clear that the deregulation of apoptosis contributes to cancer. Yuri Lazebnik's lab is
studying the molecular machinery that effects apoptosis and the signals that trigger it. His goal
is to determine how this cell death mechanism-present in all cells-can be selectively reacti-
vated to destroy cancer cells.
Yuri is following up on the observation that expression of certain oncogenes can either
induce apoptosis or sensitize cells to the stimuli that cause apoptosis. It intrigues him that some
of the cellular events that cause cancer may also be used to kill cancer cells.
All cells have the apoptotic machinery, but healthy cells lack the signals to trigger it.
Oncogene expression naturally generates a signal that can activate apoptosis. When this signal
is interrupted and fails to reach the apoptotic machinery, cancer cells can survive and become
resistant to chemotherapeutic drugs. Yuri's plan is to develop a way to recouple the oncogenic
signal and the apoptotic machinery in order to kill the otherwise apoptosis-resistant cells.
To understand the molecular mechanisms that link oncogene-induced signals and the
apoptotic machinery, Yuri studies caspases. This family of cysteine proteases-enzymes that
cleave, or cut, other proteins-comprise an essential component of the apoptotic machinery.
Caspases are activated at the onset of apoptosis and they cause cell death by cleaving sever-
al proteins in a coordinated manner. Yuri's objective was to determine how oncogenic transfor-
mation triggers apoptosis, specifically to identify which caspases become activated.
Yuri's lab developed a cell-free system to study the apoptotic machinery and its activation
by oncogenes. Through the use of this system, Yuri's lab has identified the caspase that is acti-
vated by oncogenes, caspase-9. What occurs in tumor cells, however, is that other mutations
somehow prevent or bypass the activation of caspase-9.
Scott Lowe also studies apoptosis and has made significant contributions to the field with
his work on the tumor-suppressor gene p53 and its role in programmed cell death. Scott and
CSHL adjunct investigator David Beach have identified another way in which tumor-suppressor
genes, such as p16 and p53, can prevent cancer. The p53 protein has long been recognized
as an important tumor suppressor, because it plays a vital role in programmed cell death. When
cells lack active p53, programmed cell death (including oncogene-dependent apoptosis) does
not occur and cells are robbed of an important defense mechanism against cancer. In their
recent studies, Scott and David discovered that cells carrying the normal forms of the tumor
suppressor genes p16 and p53, as well as the oncogene ras, are prevented from becoming
tumor cells by another mechanism. They found that the proteins p16 and p53 can also induce
cell senescence-a state in which cells cease to divide but do not die.
Then in July, Scott, in collaboration with Charles "Chuck" Sherr, a Howard Hughes Medical
Institute researcher at St. Jude's Children's Research Hospital in Memphis, Tennessee, report-
ed that another gene, p19 (art), also functions like a tumor suppressor. p19 (art) plays an impor-
tant role in the pathways that lead to programmed cell death and senescence, the same path-
ways that are triggered by the normal p53 gene. Together, Scott's recent studies indicate that
two genes, p16 and p19 (which are physically overlapping in the genome of a cell), defend
against cancer in different ways. p16 works with p53 (art) to induce cell senescence, and p19
(art) works with p53 to induce programmed cell death as well as senescence. Both pathways
can prevent tumor growth, and the loss of either pathway can promote tumor progression.
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In recent studies, Scott and his colleagues have shown that APAF-1 and caspase-9 are
downstream from the p53 gene in the p53-dependent apoptosis pathway. Thus, loss of p53,
which occurs in more than half of all cancers, or of p19 (ar0, which is mutated in many of the
other cancers, eliminates a major signaling pathway to the cell death machinery in tumor cells.
This may explain why these tumor cells eventually become resistant to chemotherapeutic drugs
that are used to treat cancer by inducing cell death. Tumor cells lacking the proteins encoded
by these genes cannot signal the cell death machinery to kill the cells; thus, the tumor contin-
ues to grow. It now seems clear that we now must find ways around this defect in tumor cells.
Greg Hannon's laboratory studies another aspect of oncogene-dependent cell death. He is
looking for mutations that might inactivate this defense mechanism and
allow the formation of a tumor and has developed a method for identifying
such genes. A visiting scientist in Greg's lab, Roberta Maestro from the CRO
in Aviano, Italy, identified a gene called twist using the screening method that
Greg developed. The Twist protein may help to regulate diverse develop-
mental processes; it was already known that mouse embryos lacking the
twist gene die before birth. In 1998, Greg's lab found that Twist protects cells
in culture from apoptosis. Because of these observations, Greg suspected
that the twist gene might be a part of the p53 pathway. Indeed, a variety of
experiments confirmed that the Twist protein could interfere with activities of
p53 that are essential for tumor suppression.
The observation that the Twist protein might affect the p53 tumor sup-
pressor pathway prompted Greg and his collaborators to search for muta-
tions in the twist gene in human cancers. They found that twist is frequent-
ly expressed in rhabdomyosarcomas, a cancer of the bone, soft tissues, or
connective tissue (e.g., tendon or cartilage) that is the most common soft-tissue cancer in chil-
dren. It begins in the soft tissues of muscle and is thought to derive from skeletal muscle pre-
cursor cells that fail to complete terminal differentiation. The twist gene is not expressed in dif-
ferentiated muscle cells, but in 50% of rhabdomyosarcomas, they found that twist expression
is maintained.
In collaboration with Larry Kedes of UCLA, Greg and Roberta have demonstrated a likely
role for Twist in this tragic childhood disease. The Twist protein interacts with a component of
the p53 pathway, called p300, a gene transcription regulator. They also have provided the first
evidence that Twist can disable cells' ability to commit programmed cell death, thus promoting
the development of cancerous growth.
G. Hannon
DNA Microarray Technology
One of the most powerful new techniques in modern biology, called DNA microarrays, or DNA
chip arrays, emerged from recent studies on yeast at Stanford University. During the past year,
we have been working to merge this method with techniques developed at the Laboratory that
were designed to identify mutations in human cancers. Mike Wig ler has entered into a collabo-
ration with Larry Norton, M.D., of Memorial Sloan-Kettering Cancer Center in New York City, to
use DNA chip technology to look for genes that are mutated in breast cancer.
To use chip technology, researchers place fragments of different DNA samples on a glass
microscope slide in a grid of very high density. They expose the slide to labeled DNA, or a com-
plementary DNA (cDNA) copy of mRNA, which hybridizes with the DNA on the glass slide, and
then analyze the amount of hybridization in each spot on the slide. The results are color-coded,
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so that the most active genes (with the greatest degree of hybridization) are colored red, and
genes that are repressed (hybridized the least) are colored green. Alternatively, the experiment
can be set up so that genes that are overrepresented in cancer cells are labeled red and genes
that are missing in the tumor cells are labeled green. Mike and his associates are using the
method to compare the genes in healthy versus cancerous breast tissue and at various stages
of breast cancer progression.
This year, thanks to a $300,000 grant from the Lillian Goldman Charitable Trust through The
Breast Cancer Research Foundation in New York City, Mike installed state-of-the-art microar-
ray equipment in his Demerec Laboratory. His lab will now be able to analyze tremendous num-
bers of DNA samples from breast cancer tissue. The emerging DNA chip technology should
make possible the development of better methods for the diagnosis and treatment of breast
cancer, because it will allow researchers to design treatment aimed at the specific mutations
present in each patient.
Just as Mike uses the microarray technology to study gene activity at various points in dis-
ease progression, Bruce Futcher is using it to locate and characterize genes whose activity is
determined by the stages of the cell division cycle in yeast.
Bruce is collaborating with David Botstein and Patrick Brown of the Stanford University
School of Medicine. In 1998, they used DNA microarray technology to find, characterize, and
analyze yeast genes whose activity is regulated by the cell division cycle. In just four months,
the two labs located and characterized about 800 yeast cell-cycle-regulated genes. During the
past 15 years, many scientists had identified and characterized only 103 cell cycle(regulated
genes in yeast, revealing the power of the new technology.
Microarray technology has yielded an unprecedented increase in the rate of accumulation
of data. The microarrays used in Bruce's cell cycle experiments contained 6000 discrete DNA
fragments, each of which represents one of the approximately 6000 genes in yeast. Michael
Zhang, one of our bioinformatics experts, is using the power of computational analysis to sift
through the enormous amounts of data.
Knowing the set of 800 yeast genes that are regulated by the cell cycle has provided a
wealth of information that is contributing to a more complete understanding of cell division. For
example, researchers now have an overview of the different kinds of biochemical processes
that change with cell division. They can study the clusters of dozens or hundreds of coregulat-
ed genes that cooperate in these processes and probe the molecular mechanisms that allow
the different clusters of genes to be turned on one after another in an orderly way. Researchers
can begin to identify the functions of uncharacterized genes by analyzing the known functions
of genes in the same coregulated cluster. The combination of biochemical studies and microar-
ray analysis is destined to lead to an ever-greater understanding of the vital cell process of cell
division in yeast-and in higher organisms.
Through the acquisition of a small campus in nearby Woodbury-a building of 60,000
square feet located on 12 acres-the Laboratory has positioned itself to further exploit and
develop microarray technology. The property was previously owned by the American Institute
of Physics and will provide the Laboratory with much-needed space for expansion of high-tech-
nology research, such as genome sequencing and microarray research.
In structural biology, Leemor Joshua-Tor is continuing her studies of the three-dimensional
structure and activity of the enzyme bleomycin hydrolase (BH), which is similar in humans and
yeast. (Researchers discovered human bleomycin hydrolase [hB1-1) in the 1970s when they real-
ized that it detoxifies the anticancer drug bleomycin and causes resistance to the drug.) Learner
has found that yeast BH interacts with its substrate (the bleomycin molecule) in an unusual way.
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Six molecules of BH come together to form a barrel-shaped structure with a channel in the cen-
ter. One end of each molecule of the enzyme projects toward the central channel and into the
active site region of the enzyme. This spatial configuration allows theenzyme to interact specif-
ically with bleomycin.
Leemor, in collaboration with Stephen Johnston of the University of Texas-Southwestern
Medical Center, recently solved the three-dimensional structure of hBH, in its wild type and a
mutant form. Knowing the three-dimensional structure of a molecule often provides important
clues about its function. Although the structure of hBH was predictably similar to that of yeast
BH, Leemor's lab found a striking difference in the human molecule's electrostatic charge: The
inner channel of the yeast BH has a strong positive charge, but the same region of the human
enzyme has a slight negative charge.
Like the enzymes that Yuri studies, bleomycin hydrolase is a protease-an enzyme that
cleaves other proteins. BH deactivates bleomycin, the anticancer drug, by cutting each
bleomycin molecule at a particular place. Although most proteases determine the cleavage site
on their targets (usually proteins) by finding a specific point in the target molecule's amino acid
sequence, Leemor found that the point at which BH cleaves its target is determined not by an
amino acid sequence, but by the relative positions of the negative and positively charged ends
of the substrate. The protease acts like PacMan, eating the substrate protein away from its end.
Neuroscience
Surprisingly, in 1998, several labs reported a possible link between bleomycin hydrolase and
Alzheimer's disease. A group led by Robert Ferrell and John Lazo at the University of Pittsburgh
found that individuals with two copies of a particular allele (type) of the BH gene were four times
more likely than the average person to develop sporadic Alzheimer's disease. Then, Carmela
Abraham of Boston University and her collaborators purified BH from the brains of individuals
with Alzheimer's disease while looking for amyloid precursor protein (APP), a protein that is
processed to yield 13-amyloid, a component of the plaques that occur in the brains of
Alzheimer's patients.
Leemor's lab is currently studying the connection between BH and APP processing, specif-
ically the relevance of a BH polymorphism suspected of playing a role in this process. In addi-
tion, her lab is continuing its studies of the protease's effect on the anticancer drug bleomycin
and ways to ameliorate the resulting drug resistance in order to preserve the drug's anticancer
activity.
Roberto Malinow, a senior neurobiologist who was recently appointed by the Board of
Trustees to the Harrison Chair of Neuroscience, has also discovered a possible link between his
research and Alzheimer's disease.
Scientists at other institutions have shown that mutations in the presenilin 1 gene (PS1) are
associated with the most common cause of familial Alzheimer's disease. Roberto's lab is study-
ing mice that carry a mutant form of the PS1 gene-the same mutation that some human
Alzheimer's patients carry. These mice provide an experimental model for studying certain mol-
ecular aspects of Alzheimer's disease. (Although the mice do not display the behavioral
changes characteristic of Alzheimer's patients, this is not unexpected, as the same mutation in
humans is present at birth, yet 30 or more years typically pass before the onset of the behav-
ioral manifestations of the disease.)
Roberto's lab studies long-term and short-term potentiation (LTP and STP)-a strengthen-
ing of synaptic communication between neurons that occurs when neurons are repeatedly
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stimulated at high frequency. Roberto's lab found that LTP and STP are notably-and unex-
pectedly-elevated in brain cells of the PS1 mutant mice. Surprisingly, synaptic inhibition, which
suppresses LTP and STP as well as the firing of electrical impulses, was also enhanced in the
mutant mice. This increased synaptic inhibition may represent a compensatory homeostatic
response to the increased ability to produce LTP and STP. Roberto's lab then further inhibited
synaptic activity in these PS1 mutant brain cells by applying the drug benzodiazapine, which
returned synaptic potentiation (LTP and STP) to normal levels.
Coincidentally, clinicians in Sweden recently reported that the regular use of the benzodi-
azapines Xanax and Valium correlated with a markedly reduced incidence of Alzheimer's dis-
ease in the patients studied. Although the mechanism of the drugs' action is known as it relates
to their traditionally prescribed use as anti-anxiety agents, it was not clear how these drugs
affected the likelihood of developing Alzheimer's disease. Roberto's studies of the relationship
between the molecular biology of the PS1 gene and the activity of the bezodiazepines may
reveal a greater understanding of ways to prevent or treat Alzheimer's disease.
Roberto's lab is also continuing to study factors involved in neuronal plasticity, i.e., the ways
in which neurons change their activity or shape during development or as a result of learning,
trauma, or other events. The researchers have developed improved tools for studying the activ-
ity of brain cells and the connections between them, called synapses. One new method devel-
oped by the Malinow lab involves the introduction, using a viral vector, of recombinant proteins
whose movement in cells and at synapses can be monitored by electrophysiology and imaging
techniques. By attaching these proteins to specific molecules important for learning and the for-
mation of memories, Roberto can track the movement and activity of important nerve cell fac-
tors. The studies also utilize the sophisticated two-photon laser-scanning imaging system that
Karel Svoboda brought to CSHL in 1997, as well as high-resolution electron microscopy, to
track the movement of other important proteins in the brain during learning.
Karel, in collaboration with Roberto and postdoctoral fellow Mirjana Maletic-Savatic, used
the new imaging system to observe and document the effect of synaptic stimulation on the
shape of brain neurons. Karel custom-built a two-photon laser-scanning microscope to study
living nerve cells in brain slices from rat hippocampus, a region of the brain that is important for
the formation of memories. The researchers stimulated axons from one group of nerve cells that
form synapses on a small dendritic branch of a neighboring cell-a strong but highly localized
stimulus. They found that the stimulus triggers the growth of new dendritic protrusions called
filopodia. Growth of filopodia begins within 20 minutes after the stimulation and continues for at
least 40 minutes more. The new filopodia may ultimately form new synapses, an important phe-
nomenon during development and learning and memory. By comparing stimulated and unstim-
ulated dendritic regions, the researchers found that growth of filopodia evoked by strong elec-
trical stimulation was limited to regions of the dendritic tree close to stimulated synapses.
Mirjana, Roberto, and Karel also found that the growth of dendritic filopodia requires acti-
vation of N-methyl-D-aspartate (NMDA) neurotransmitter receptors at the synapses under
study. Other studies had shown that activation of these receptors is required for the formation
of memories and for normal brain development. In the recent experiments, the blockade of
NMDA receptors prevented stimulation-induced growth. Thus, synaptic transmission, and acti-
vation of NMDA receptors in particular, is required to produce this kind of dendritic growth.
In the cells affected by the synaptic stimulation, the growth of filopodia subsided about 45
minutes after the stimulus ended, but the filopodia remained, and some formed bulb-like tips
which suggests that they may become functional synapses. Karel and Roberto will continue to
study the structure of the outgrowths, as well as their signal transduction properties.
16
Meanwhile, Jerry Yin and postdoctoral fellow Marcia Belvin at the University of California at
Berkeley have made a fascinating observation that suggests how and when memories are
formed. Neuroscientists have long suspected that important brain functions take place while
people are sleeping. Jerry and Marcia found that the activity of CREB, a protein that Tim Tully
and Jerry Yin previously showed is important in memory formation, displays circadian, or 24-
hour cyclical, patterns of activity. The Yin lab is trying to determine the functional connection
between the nighttime peak in CREB activity and memory formation. Given what is known
about memory formation in mammals, it is likely that some aspect of memory consolidation
occurs at night, probably during sleep.
Advanced Neuroscience Imaging
In an exciting expansion of the Laboratory's neuroscience program, close on the heels of the
establishment of the Beckman Neuroscience Center in 1992, an advanced neuroscience imag-
ing facility is being constructed on the main campus just west of James Laboratory. The new
building, named the Nancy and Edwin Marks Building, will house advanced imaging facilities for
use in studies of the living brain-a great advance for neurobiology research. Karel Svoboda will
use and further develop state-of-the-art laser-scanning microscopy to extend his ongoing stud-
ies of neuronal activity and synaptic plasticity in individual neurons in functioning brains of live
animals. In addition, scientists from around the world will take courses in the Marks Building to
learn how to use this sophisticated new technology. The imaging facility is scheduled to open
in August 1999.
In another expansion of existing neuroscience facilities, the Laboratory is replacing the old
visitors' cabins just north of the Beckman Neuroscience Center with a small building dedicated
to computational neuroscience. The new facility, made possible by Laboratory Trustee William
Murray, will be known as the Samuel Freeman Building. There scientists will use the latest com-
puterized tools to model how the brain works.
Plant Biology and Plant Genetics
In April, Ueli Grossniklaus and his colleagues reported that MEDEA, a gene in the widely stud-
ied model plant Arabidopsis, is important for the maternal control of plant embryo development.
If a plant embryo (in a seed) has inherited one mutant copy of the MEDEA gene from the moth-
er plant, cells in the embryo grow excessively and the embryo dies. But if the embryo inherits
one mutant MEDEA gene from the father plant, it lives and functions normally. Because of this
difference, researchers call MEDEA a "maternal-effect gene," meaning that it dictates certain
behavior (in this case, cell division and embryo development) only if the gene comes from the
female parent. Ueli found that the function of the MEDEA gene product in plants resembles the
Polycomb group of genes in animals, which are important for controlling cell proliferation and
for mediating the expression of traits inherited from one parent.
Also in plant genetics, the Laboratory's role in the global Arabidopsis Genome Sequencing
Project continues to go well. Dick McCombie's sequencing expertise and Rob Martienssen's
work with the gene traps he developed with Sundaresan Venkatesan have proved to be an
invaluable contribution not only to the sequencing effort, but also to the determination of gene
function in this small, flowering plant. Rob continues to do research on other aspects of plant
genetics as well, and he recently made an important discovery about the movement of intra-
cellular proteins across cell membranes.
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The May 1998 Genome meeting occurred in the wake of Craig Venter's surprising
announcement of plans to complete the sequence of the human genome on an accelerated
schedule. (Venter now heads the Celera Corporation in Rockville, Maryland.) Most of the lead-
ers in human genome research were in attendance, which resulted in lively discussions about-
and considerable media interest in-Craig's plan. The Laboratory's goal in these efforts is to
produce a timely, accurate body of data that is made available to all researchers.
The Laboratory also plans to expand its genomics research program. A significant portion
of the recently acquired building in high technology center in nearby Woodbury will be dedicat-
ed to genome sequencing projects. This expansion of the existing program will enable CSHL to
more quickly play a role in other sequencing projects.
Broadhollow Bioscience Park
The long quest to establish a suitable biotechnology park within close proximity to the
Laboratory has finally been fulfilled. The new facility will allow start-up biotech companies based
on CSHL research as well as research from other academic centers and companies to locate
nearby and to maintain easy scientific interactions and collaboration. John Cleary, who has
been a member and president of the CSHL Association and a member of the Laboratory's
Board of Trustees, was instrumental in securing substantial backing for the park from Governor
George Pataki and New York State, as well as the support of many local business and political
leaders.
The park is located on 20 acres of land adjacent to the State University of New York (SUNY)
Farmingdale campus on nearby Route 110 in Farmingdale. The Broadhollow Bioscience Park
will be supervised by a separate not-for-profit organization that will be controlled by Cold Spring
Harbor Laboratory and SUNY Farmingdale. Completion of the facility will enhance the transfer
of innovations and discoveries in basic research to the private and public business sectors, and
thereby enhance the utility of our research efforts.
Watson School of Biological Sciences
As described above, another long-standing initiative came to fruition in 1998 when the New
York State Board of Regents voted in November to approve accreditation of Cold Spring Harbor
Laboratory as a Ph.D.-granting institution. The Laboratory is now in the process of raising funds
to endow the school.
In the initial application for accreditation, the school was named the Cold Spring Harbor
Laboratory School of Biological Sciences. In January, the state approved the new name for the
graduate school at Cold Spring Harbor: The Watson School of Biological Sciences, named for
the Laboratory's long-time Director and now President James D. Watson.
To supplement housing for Watson School students, the Laboratory recently purchased a
grand old house on land adjacent to Laboratory property on Route 25A, facing the inner har-
bor. The house was constructed in the 1700s, and it once served as the general store and post
office for Cold Spring Harbor. The house was also home to many generations of the illustrious
Long Island Jones family, including Jones descendant and former CSHL Trustee Townsend
Knight. The building, located at 222 Main Street in Cold Spring Harbor, was recently named the
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Knight House
Knight House in honor of Townie and will serve as housing for graduate students attending the
Watson School of Biological Sciences. But due to its considerably run-down condition, the
house will first undergo considerable restoration.
Symposium LXIII
Transcription, the copying of one strand of DNA into a complementary RNA sequence, was the
topic of the 63rd CSHL Symposium, Mechanisms of Transcription. For five days, from June 3
to June 8, Grace Auditorium was filled with talk of promoters, transcription factors, and chro-
mosome structure. In attendance were the best-known scientists in the field, as well as many
younger ones.
On Sunday evening, as is customary, the Laboratory welcomed neighbors and friends for
the annual public Dorcas Cummings Lecture. Ronald M. Evans, a Howard Hughes Medical
Institute investigator at the Salk Institute, discussed "The Molecular Biology of Fat: Weighing the
Risks," a subject of broad interest to a general audience.
Dr. Evans described the role of hormones, the signaling molecules secreted by glands and
other tissues. Hormones coordinate the activities of organs and tissues by regulating gene
activity. His group discovered a hormone called 15-deoxy-412,14-prostaglandin J2, which
directs muscle and fibroblast cells to become fat cells. This hormone is now being used to treat
type II diabetes. Evans advocated a diet with fewer saturated fats, such as a Mediterranean-
style diet which is rich in legumes and grains.
Jim and Liz Watson invited Australian artist Lewis Miller to attend the annual Symposium
as artist-in-residence. Miller sketched visiting scientists at meeting sessions, breaks, and at the
Symposium picnic. A collection of his marvelous framed sketches now appears along the stair-
case in Blackford Hall.
19
Sketch by Lewis Miller in Grace Auditorium during the Symposium
Jim Watson's CSHL Anniversaries
In addition to a milestone birthday, 1998 marked two special anniversaries for Jim Watson. It
has been 50 years since his first visit to Cold Spring Harbor Laboratory as a graduate student
doing summertime research, and 30 years since he became director of the Laboratory. To com-
memorate these events, the Laboratory held a special late-winter conference called Pathways
to Cancer. CSHL alumnus and Trustee Ed Harlow, of Massachusetts General Hospital and
Harvard University, Jan Witkowski, and I, were coorganizers.
The meeting included sessions entitled "Cancer Genetic Pathways," "Cancer Cell Growth
Controls," and "Cancer Pathways"-a discussion of research from the cell to the clinic. But the
highlight of the meeting came on Thursday evening when the BBC film Life Story was shown in
Grace Auditorium. What an extraordinary experience it was to see Jim Watson stand before us
offering offered his thoughtful comments on the movie that was based upon his 1968 best-sell-
ing book The Double Helix. The showing of the movie in the context of a modern meeting on
biology highlighted how far we have come since those exciting days in 1953.
Banbury Center
From Molecules to Brains-The J.P. Morgan Meeting
The unusually broad topic of the 1998 annual Executives' Seminar weekend, sponsored by J.P.
Morgan, was Imaging: From Molecules to Brains. Carlos Bustamante described his work using
the atomic force microscope with which he images single molecules and tries to "see" how a
DNA molecule is synthesized. Paul Sigler described his X-ray crystallography studies of the
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Banbury meeting participants watch cells in three dimensions.
structures of large protein assemblies, and Mark Ellisman showed some remarkable three-
dimensional pictures of cells taken with a powerful electron microscope. Bruce Rosen and John
Gabrieli discussed their studies of the brain. We are indebted to Sandy Warner and David
Deming for their continuing support of this unique occasion.
Horse Genetics and the Performance of Thoroughbreds
The 1998 Banbury Center meeting on horse genetics was stimulated by CSHL Trustee and race
horse owner Charles Harris. It was his belief that the performance of racing thoroughbreds has
fallen and that this decline might be related to inbreeding. Horse geneticists, scientists who
study horses and humans, and thoroughbred owners and breeders considered this question
and offered an in-depth analysis of the current state of the genetic map of the horse as well as
ways to promote genetics research on the horse. Such policy issues have been raised at pre-
vious Banbury meetings and have been influential in stimulating funding of research in this area.
Finding Individual Differences in Human Disease Genes
One of the most important advances in human geneticscame in 1980 with the development of
a new method for identifying individual differences in human genes that are linked to specific
diseases. The new strategy, based on small but common variations called single nucleotide
polymorphisms (SNPs), has generated a great deal of excitement. Many unresolved issues
remain, however, and the Banbury meeting, Large-scale Discovery & Genetic Applications of
SNPs, tackled some of them: how to find these variations, how many will be needed for effec-
tive mapping, and how to use them. The group also discussed interesting and controversial
questions of intellectual property.
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Robertson Research Fund
Since 1973, the Robertson Research Fund has supported Cold Spring Harbor Laboratory's sci-
entific program. Its balance is now almost $80 million, up from approximately $8 million in 1973.
Once again this year, Robertson funds supported labs in each of our primary fields of
research-cancer, neurobiology, and plant genetics.
In 1998, Robertson funds supported cancer research by providing start-up support for new
bioinformatics investigators Andy Neuwald, Andy Reiner, and Lincoln Stein and research pro-
gram support for established scientists David Helfman, Michael Hengartner, Nouria Hernandez,
Tatsuya Hirano, Scott Lowe, Ryuji Kobayashi, Adrian Krainer, Jacek Skowronski, David Spector,
Nick Tonks, and Rui Ming Xu. In neurobiology, the fund supported research in the labs of Karel
Svoboda, Holly Cline, Grisha Enikolopov, Alcino Silva, Jerry Yin, and Yi Zhong, and furthered
plant research by Erich Grotewold, Hong Ma, Rob Martienssen, and David Jackson.
The Robertson Research Fund also helps to support many postdoctoral researchers, grad-
uate students, and scientific seminars.
In addition, the Marie H. Robertson Memorial Fund, dedicated to neuroscience, gave sup-
port to Grisha Enikolopov and Yi Zhong.
Board of Trustees
David L. Luke III completed a more than 12-year tenure with the Board of Trustees, and the
Laboratory remains deeply indebted to him for his outstanding leadership during a time of sig-
nificant growth and improvement. Very few people have devoted as much time and effort to the
Laboratory as has David. His guidance has ensured that we remain a dynamic and growing
institution, and the generosity of David and his wife, Fanny, has reflected their love of the
Laboratory. I am most pleased that David has agreed to continue to serve the Laboratory as
chair of the campaign to endow the Watson School. In November 1998, David retired as
Chairman of the Board and was elected Honorary Trustee. In April 1999, he was feted at a din-
ner in his honor.
It is our great fortune that William Miller has stepped into David's shoes as our new
Chairman of the Board. Bill, retired Vice Chair of Bristol Myers Squibb and Co., served as
David's deputy and has already made major contributions to the Laboratory.
The following members of the Board of Trustees also completed their terms in 1998: John
R. Reese, Arnold J. Levine, J. Anthony Movshon, and Joan A. Steitz. David H. Koch complet-
ed his term on the Board as well, and to him we are indebted for a Watson School of Biological
Sciences fellowship that will endow one student per year. Thomas A. Saunders III stepped
down from the Board due to other commitments, and John Cleary completed his term on the
Board as he completed his term as President of the CSHL Association. During John's tenure
as Association President, the organization expanded considerably and increased its support of
the Laboratory's programs. John was also very helpful in the creation of the Graduate School
and Broadhollow Bioscience Park and is still making major contributions as Broadhollow's
chairman. The Laboratory is grateful for the guidance and input of every Trustee.
We are pleased to welcome the following individuals, who joined the Board in 1998: Charles
E. Harris, chairman and CEO of the public venture capital firm Harris & Harris Group, Inc.; Leslie
C. Quick, cofounder of one of the first and largest discount stock brokerage firms, Quick and
Reilly, Inc.; Howard Solomon, president and CEO of the pharmaceutical company Forest
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Laboratories; Susan Hockfield, professor of neurobiology at Yale University School of Medicine
and dean of the Yale University Graduate School of Arts and Sciences; Rudolf Jaenisch, M.D.,
member of the Whitehead Institute for Biomedical Research and professor of Biology at
Massachusetts Institute of Technology; Charles J. Sherr, M.D., Ph.D., Howard Hughes Medical
Institute investigator and professor at St. Jude's Children's Research Hospital; and James
Spingarn, senior vice president of investments at Gruntal & Co. located in Great Neck, New
York, and president of the CSHL Association.
At the November 7 meeting of the Board of Trustees, the playground of the Mary D. Lindsay
Child Care Center was dedicated to Honorary Trustee Wendy Vander Poel Russell. Mrs. Russell
has a long and rich history with CSHL; in fact, as a small child she participated in the Lab's
Nature Study program. More recently she was instrumental in securing on-site child care for
CSHL.
A champion fund-raiser at the Laboratory, Wendy has been tireless in her devotion to vari-
ous projects over the years, including those for Grace Auditorium, the Beckman Neuroscience
building, and the Mary D. Lindsay Child Care Center. She was instrumental in establishing the
Corporate Advisory Board as a supporting body for the DNA Learning Center and has been a
consistent and ardent supporter of the CSHL Association Annual Fund. She began serving on
the Board of Trustees in 1984 and has since served four 3-year terms including those as
Secretary in 1985-1987 and 1992-1997. She has served on the Board's Development,
Executive, Finance & Investment, Banbury, Building, and DNA Learning
Center committees and has been a long-time member of the CSHL
Association.
It was our honor to name the playground for her. What more cheerful
recognition could we have offered to such an upbeat and dynamic lady?
Sadly, one of the newer members of the Board-and a long-time mem-
ber of the CSHL Association-passed away in July. Mrs. Vernon L. Merrill,
who assumed the position of president of the CSHL Association in
February, had been an active and generous supporter of the Laboratory
since 1985. She, too, was an ardent proponent of the Laboratory's initiative
to establish on-site child care, and served on the Building, Development,
and Executive committees for the Board of Trustees. Mrs. Merrill lost her
long and valiant battle with breast cancer on July 13. Her enthusiastic
involvement will be deeply missed, and the Laboratory extends deepest
condolences to her husband, Robert, and their family.
CSHL Association
V.L. Merrill
Following the death of Mrs. Merrill, CSHL Association member James Spingarn assumed the
role of acting president of the Association. He has since been elected President. Jim has been
a most enthusiastic supporter of the Laboratory's research programs and public education
efforts.
On February 1, the CSHL Association held its Annual Meeting and hosted Judah Folkman
as its keynote speaker. Dr. Folkman is a senior associate in surgery and the director of the
Surgical Research Laboratory at Boston's Children's Hospital and Harvard Medical School. His
research on anti-angiogenic factors has attracted much attention during the past year. His work
is directed at stopping the development of new blood vessels (angiogenesis) in tumors as a way
to shrink and eradicate them. His proposed therapy, using compounds such as endostatin and
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Dr. Folkman
angiostatin, has proven successful in controlling tumors in
mice. Dr. Folkman's talk was entitled "Anti-angiogenic Therapy."
On April 18, the Association hosted the Blue Hill Troupe
musical group for a most successful fund-raiser. The group
performed a variety of Gilbert and Sullivan operettas and joined
concertgoers for a spectacular dinner in Blackford Hall follow-
ing the performance.
Association members Jim and Carol Large hosted an
enjoyable cocktail party at their home in Locust Valley in
October in honor of the Association's major donors. Thanks to
the warm evening weather and a beautiful backyard patio,
much of the mingling and conversation between scientists and
Laboratory supporters took place outdoors.
Everyone at the Laboratory was saddened to learn of the
death of a cherished Association member and friend of the
Laboratory, Mrs. Edna Davenport. Edna became involved with
Cold Spring Harbor Laboratory in early 1970 when she and
her husband, retired Pfizer Pharmaceutical executive John
Davenport, donated generously to the Laboratory with the
intention of helping initiate the tumor virus research program in
James Laboratory. Their initial gift enabled the Laboratory to
execute a much-needed expansion of James Lab, and after
John passed away in 1988, Edna's continued generosity
became a cornerstone of support for the Laboratory's young
scientists through the CSHL Association. While we sense a
terrible loss in Edna's passing, we are even more sympathetic
to her son Peter and daughter Linda Spire and their families for
their loss.
The Blue Hill Troupe musical group
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DNA Learning Center
The DNA Learning Center experienced record growth in 1998, with income increasing by 59%,
to $1,393,100. The greatest single source of growth in 1998 was funding from the Josiah Macy,
Jr., Foundation to create "DNA from the Beginning," an online, animated primer on genetics.
Targeted at the level of a bright teenager, the site uses a number of multimedia elements and
tools-animation, video clips of scientists and historians, archival photographs, audio glossary,
interactive quizzes, and powerful navigation tools-to let users master genetics at their own
pace and according to their own learning style. The first installment of DNA from the Beginning
was a resounding success, with more than 10,000 log-ins during its first eight weeks on the
World Wide Web. Four additional releases are planned in 1999-2000.
Cold Spring Harbor Laboratory Press
In 1997, the productivity of CSHL Press was improved through management restructuring and
investment in technology. These gains were consolidated in 1998 and resulted in improved
financial performance.
The journals, Genes & Development (G&D), Genome Research, and Learning & Memory,
all improved in several ways. Scientists submitted more and better manuscripts for publication
and each journal published more pages than ever before. G&D led the way with a 30% increase
in the number of submitted manuscripts. G&D continues to rank in the top ten of all journals in
the life sciences, in terms of the number of citations reported by the Institute for Scientific
Information. All three CSHL journals are published online as well as in print, and online users
now have access to several improved services, including E-mail alerting services. The three
journals either maintained or improved their subscription base, a significant achievement in a
period of continued change in library purchasing habits and increased electronic distribution of
information.
The CSHL Press published 14 new books in 1998. The most widely anticipated was Using
Antibodies, a techniques manual by Laboratory alumni Ed Harlow (currently a Trustee) and
David Lane. A complete update of their 1988 Antibodies: A Laboratory Manual, the new book,
with its innovative design and improved binding, seems likely to attain the classic status of its
predecessor. Two other former Laboratory staff also revised a highly successful book: Ray
Gesteland and John Atkins, in collaboration with Nobel prize winner Tom Cech, edited a sec-
ond edition of the influential monograph The RNA World. A collection of essays by Max Perutz,
entitled I Wish I'd Made You Angry Earlier, attracted glowing reviews and brisk sales and is now
being translated into several languages. Other strong titles included At The Bench, a quirky
introduction to life in the laboratory by Kathy Barker, and the 1997 Symposium volume Pattern
Formation during Development, which brought together excellent science from widely differing
areas of investigation. These lead titles, and a high-quality backlist, increased book sales by
25% over the previous year.
The Laboratory's well-established publishing activities for professional scientists expanded
in 1998 to incorporate an ambitious new program for creating undergraduate textbooks.
Opportunities to reshape university teaching in a variety of fields have been identified, and, led
by newly appointed Senior Editor Alex Gann, teams of talented, innovative authors have begun
work on these projects. The acquisition of the Meier House in Lloyd Harbor, and its conversion
for use as a writing center by textbook authors, has provided an extraordinary asset in building
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this program, which has potentially far-reaching consequences for the future growth of the
Press.
For several years, that growth has been hampered by space limitations and by the distrib-
ution of the staff at three sites: Urey Cottage and the Library on the main campus, and a ware-
house in Plainview. The pending renovation of the Woodbury property should allow the Press
to consolidate many of its activities while retaining a base of editorial activities at the
Laboratory's main campus.
Major Gifts
Private support has been a cornerstone of the Laboratory's research program for many years, but
it is particularly important for special projects like building construction and renovations or the cre-
ation of graduate school. Government grants for such initiatives, regardless of their worthiness,
are scarce.
The initial campaign to endow the Watson School of Biological Sciences was quite suc-
cessful. Contributions received in 1998 included $5,068,568 from a donor who wishes to
remain anonymous, $885,000 from Mr. and Mrs. Leslie C. Quick, Jr., and $548,748 from Mr.
and Mrs. David L. Luke III. The William Stamps Farish Foundation gave $350,000 and the
Seraph Foundation gave $50,000. Additional gifts came in after the new year, and the public
phase of the capital campaign will begin in April 1999.
The Nancy and Edwin Marks Building will house our new brain imaging program and allow
for expansion of the Laboratory's strong neuroscience program, including creating space for
more teaching labs. This project has also received substantial support. The Marks Family
Foundation gave $1,261,531; the Booth Ferris Foundation gave $100,000; The Weezie
Foundation donated $100,000; the Estate of Sophie Rubenfield gave $57,731; the Fairchild
Martindale Foundation gave $50,000; and Mary D. Lindsay made a gift of $50,000. We have
added previous gifts from Thomas Saunders and David Koch to this project.
In support of neuroscience research, the Lita Annenberg Hazen Foundation gave $200,000
to the Lita Annenberg Hazen Fund for Neurobiology, and Mr. and Mrs. William L. Matheson
gave an additional $50,220 in support of their previous gifts that established the Matheson Fund
for Neuroscience. The Seraph Foundation gave $27,000 for neuroscience research in Grisha
Enikolopov's lab, as well as $23,000 for cancer research in Yuri Lazebnik's lab.
Support from breast cancer advocacy groups has continued to be quite helpful to our can-
cer research program. In 1998, Mike Wigler's lab received a $300,000 grant from The Lillian
Goldman Charitable Trust through the Breast Cancer Research Foundation and our long-time
supporter, 1 in 9: the Long Island Breast Cancer Action Coalition, donated $100,000 to the
Michael Scott Barish Human Cancer Fund. Both donations, along with $25,000 from the
Huntington Breast Cancer Action Coalition and $4,600 from the Long Island Foundation for the
Elimination of Breast Cancer, will be applied to the development of the DNA microarray facility.
The renovation of the old Power House and Carpentry Shed, to make room for the
Laboratory's growing Public Affairs, Development, and Human Resources departments, was
subsidized in part by a $200,000 gift from the William and Maude Pritchard Charitable Trust and
a $200,000 gift from the Estate of Vernon L. Merrill. The Development conference room will be
named for Mrs. Merrill, and the building will be named in honor of former Chairman of the Board
of Trustees, and now Honorary Trustee, David L. Luke III and his wife Fanny.
The Stone Foundation gave $60,000 in support of the Mary D. Lindsay Child Care Center;
the Gladys Brooks Foundation donated $57,000 for the purchase of microfilm equipment for
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the Library; and the Joseph G. Goldring Foundation continued support to Bruce Stillman's lab-
oratory through a gift of $50,000 for two postdoctoral fellows. In addition, Alan and Edith
Seligson once again gave $35,000 in support of one postdoctoral researcher, as they have
since 1990. The Goldring support went to Kate Simpson and Bill Henry and the Seligson fel-
lowship supported Howard Fearnhead in his final year as a postdoc.
President's Council
The President's Council was formed five years ago in an effort to bring together a small group
of leaders from business, research, and biotechnology who are interested in science and in the
work at Cold Spring Harbor Laboratory. Members of the President's Council contribute $25,000
or more to support research and educational programs at the Laboratory. The funding helps
the Laboratory attract top young scientists fresh from their Ph.D. or M.D. studies. The fellow-
ships allow promising young researchers to pursue their own high-level, independent research,
rather than assisting in the laboratory of an established scientist.
The 1998 meeting of the President's Council, held May 15-16, focused on the topic of
human evolution and began with lunch on Friday at the President's House. The luncheon was
followed by an afternoon lecture by CSHL scientist Karel Svoboda on imaging neuronal func-
tion in the intact brain. The keynote speaker, Dr. Roger Lewin, a member of the science and
engineering technology development company AEA Technology in Oxfordshire, U.K., and a col-
laborator of renowned Kenyan anthropologist and conservationist, Richard Leakey, described
what archaeology is able to tell us about evolution. The speakers on Saturday were Dr. Sean
Carroll of the University of Wisconsin, Dr. Mark Stoneking of Pennsylvania State University and
Dr. Michael Hammer from the University of Arizona.
The following are members of the 1998 President's Council:
Abraham Appel, Appel Consultants, Inc.
Peter Bloom, General Atlantic Partners, LLC
James Conneen, A. T. Hudson & Co.
Theodore N. Danforth, Oxford Bioscience
Michel David-Weill, Lazard Freres & Co.
Stefan Englehorn M.D.
Leo A. Guthart, ADEMCO
Charles E. Harris, Harris & Harris Group, Inc.
Walter B. Kissinger, WBK Associates
Thomas J. McGrath, Simpson Thacher & Bartlett
Donald A. Pels, Pelsco, Inc.
George B. Rathmann, ICOS Corporation
Hubert J. P. Schoemaker, Centocor, Inc.
James H. Simons, Renaissance Technologies Corporation
Sigi Ziering, Diagnostic Products Corporation
Gavin Borden Visiting Fellow Lecture
This annual event was initiated in 1995 to honor scientific textbook publisher Gavin Borden,
who died in 1991 of salivary gland cancer, in an effort to carry on the mission that was so dear
to him-the education of graduate students. Each year, the visiting Gavin Borden Fellow gives
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M.W. Kirschner, B. Stillman
a lecture to students and spends time dining and talking with them about science and careers
in science.
The Gavin Borden Fellow in 1998 was Marc W. Kirschner, chair of the Department of Cell
Biology at Harvard Medical School and a prominent contributor to science policy issues. His
talk on March 23 was entitled "Proteolysis Control of the Mitotic Cycle."
Building Projects
Construction of the Nancy and Edwin Marks Building, on the hill to the north of James
Laboratory, began in early 1998. It will contain a state-of-the-art brain imaging and research
facility, together with a new teaching laboratory. The building is scheduled to be in operation by
the fall of 1999.
Nancy and Edwin Marks Building site
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Power House renovations
Renovation of the Laboratory's old Power House, built on the waterfront in 1913, and the
adjacent former Carpentry Shed began in 1998. By the sping of 1999, the buildings were con-
verted into office space for the Departments of Public Affairs, Development, and Human
Resources. The new complex is called the David and Fanny Luke Building in honor of long-time
Laboratory supporter and retired Chairman of the Board, David L. Luke III and his wife.
In November, members of the facilities staff removed the old guest cabins north of the
Beckman Neuroscience Center to make room for the construction of the new Samuel Freeman
Building. The new building will house facilities for computational neuroscience, an important
component in the further expansion of neuroscience program. We were saddened to see the
historic (albeit utilitarian) cabins come down, but it was not possible to preserve them for relo-
cation due to their extensive deterioration.
Historic Guest Cabins
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Undergraduate Research Program (URPs)
The 1998 summer Undergraduate Research Program, through which students live and work at
the Laboratory for 10 weeks during the summer, consisted of 23 students (12 men and 11
women) from nine countries. They were chosen from among 459 applicants from 39 countries.
The students receive room and board on Laboratory grounds as well as a stipend.
The objectives of the program are to provide students with a greater understanding of the
principles of biology, to instill in them an awareness of major topics of investigation, to help them
develop intellectual tools necessary in modern research, to expose them to the process of
research, and to allow them to meet people involved in that research.
The URP program received support this year from the C. Bliss Memorial Fund, the
Burroughs Wellcome Fund, the Jephson Educational Trust, the National Science Foundation,
the Dorcas Cummings Fund, and the URP endowment (which includes proceeds from the
Emanual Ax Fund, the Garfield Fund, the Glass Fund, the Libby Fund, the Olney Fellowship, the
Shakespeare Fellowship, and the Von Stade Fellowship).
Partners for the Future (PFF)
Each year, the Laboratory selects several outstanding high school seniors to work on original
research projects in a laboratory under the supervision of a scientist-mentor. The students are
expected to spend a minimum of ten hours per week at the Lab, beginning in October, and to
present scientific summaries to an audience of scientists, teachers, parents, and Laboratory
administrators at the conclusion of the program in March. They gain valuable research experi-
ence and are paid a small stipend for their efforts.
The participants for the 1998-1999 school year were Francis Browne of Cold Spring
Harbor, Cold Spring Harbor High School (mentor: Michael Hengartner); Mariza Daras of
Manhasset Hills, Herricks High School (mentor: Michael Weinreich); Peter Hal lock of Holtsville,
Sachem High School North (mentor: Jean-Philippe Vielle Calzada); Rachael Neumann of
Woodbury, Syosset High School (mentor: Grigori Enikolopov); Allison Scheff of Islip, Islip High
School (mentor: Robert Filipkowski); Diane St. Fleur of Brentwood, Brentwood High School
(mentor: Guy Birkenmeier).
Outreach
Outreach initiatives through the Department of Development include the Next Generation
Initiative (NGI), a series of talks and tours designed to inspire an interest in basic research among
individuals in their 30s and 40s. The Young President's Organization provides similar experiences
for young leaders of industry and companies, and the Harbor Society is a small group of
Laboratory supporters who have contributed to the Laboratory's planned giving program.
The Harbor Society
The Harbor Society gained six new members (or member couples) in 1998: Jim and Jan
Eisenman, Lois Learned, Ed and Betty Palmer, Sam and Ann Parkinson, John and Joyce
Phelan, John and Hope Reese, and one who wishes to remain anonymous. The Harbor Society
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is a group of distinguished individuals, now numbering 44 (see report in the Financial Section)
who have included the Laboratory in their estate planning. We are most grateful to these indi-
viduals and families for their generosity.
Public Education
The Laboratory continues to participate in Project WISE, a program to promote the entry of
women into science and engineering. The program is run by SUNY Stony Brook and is
designed to benefit high school students.
Once again, for the fourth year, the Laboratory hosted a group of Japanese exchange stu-
dents and their teachers who were visiting Cold Spring Harbor High School in July. The
Laboratory also continues to host the West Side School Science Nights, which are now open
to all local elementary schools. Lectures this year included of Leemor Joshua-Tor talking about
"Proteins in 3-D" in January; Michael Hengartner discussing "A Matter of Life and Death: How
Cells Die, and Why That's A Good Thing" in March; and Jean Philippe Vielle-Calzada on
"Fertilization Tales: Doing It With or Without Tails" in May.
The "Great Moments in DNA Science" lecture series is still a big hit with high school audi-
ences. In April, Linda Van Aelst talked about "The Role of Cell Signaling in Cancer." In May, Jan
Witkowski spoke on "Ian Had a Little Lamb: The Cloning of Dolly," and Karel Svoboda pre-
sented "Imaging Neurons in Action."
Breast Cancer Support
Our long-time supporter 1 in 9: The Long Island Breast Cancer Action Coalition donated
$100,000 to the Laboratory for breast cancer research at its annual gala in October. The money
was applied toward the new DNA microarray facility being developed by Michael Wig ler. Also
at the gala, 1 in 9 presented the Laboratory with an Olympus BX-40 microscope, which was
donated by Dan Biandi, a vice president at Olympus America, through a breast cancer research
fund-raiser held by Chameleon Hair Design in Port Jefferson.
The Laboratory also gained the support in 1998 of three other breast cancer activist
groups: the Huntington Breast Cancer Action Coalition, the Breast Cancer Research
Foundation, and the Long Island Foundation for the Elimination of Breast Cancer.
Huntington Breast Cancer Action Coalition founder and president Karen Joy Miller and vice
president Marcy Usdan-Hyman made a $25,000 donation to Mike Wig ler's lab at the Coalition's
annual gala in October for use in the development of the DNA microarray technology. This was
the group's first major research grant award and we are quite honored to have been the recipient.
Mike Wigler's breast cancer research program also received a $300,000 grant from The
Lillian Goldman Charitable Trust through the Breast Cancer Research Foundation, a New York
City-based organization led by president Evelyn H. Lauder. This major grant enabled the Wig ler
lab to purchase the expensive equipment necessary for the development of the DNA microar-
ray technology. This technology is being used to search for new genes that are mutated in
breast cancer.
The Long Island Foundation for the Elimination of Breast Cancer became a CSHL sup-
porter in 1998 with gifts totaling $4,600. The Laboratory is pleased to have the support of this
local grass-roots organization and looks forward to cultivating this and other new relationships
with local activists who are so vital to raising funds and awareness for this important issue.
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Special Events
Grace Auditorium was put to good use in 1998 not only for scientific conferences, but also for
a host of cultural events. In March, Cablevision held the New York premier of the award-win-
ning HBO mini-series "From the Earth to the Moon." Participants included astronaut Buzz
Aldrin; actor Bryan Cranston, who played Aldrin in the HBO production (and is now famous for
his role in "Saving Private Ryan"); Andrew Chaikin, author of the book on which the HBO pro-
duction was based; Cablevision executives; and retired Grumman Aerospace engineers who
designed and built the Apollo aircraft.
Also in March, Patrick Cunningham, Professor of Animal Genetics at Trinity College in
Dublin, Ireland, gave a public lecture on horse genetics and the history of horse breeding. All of
today's thoroughbred horses descend from a handful of stallions imported to England from
North Africa and the Middle East back in the 1600s. In fact, about one third of the genes in cur-
rent thoroughbreds can be traced to three top stallions of that century, and a full half of the
genes in today's thoroughbred horses can be traced to ten seventeenth-century stallions. Dr.
Cunningham, who was attending a Banbury Conference, has been studying genetics and ani-
mal breeding for more than 20 years. He initiated studies of thoroughbred breeding in the
1970s.
In May, Laboratory staff and visitors enjoyed a poetry reading entitled "the single secret," a
phrase borrowed from an e.e. cummings poem. Performers Jane Lapotaire and Paul Jesson of
England's Royal Shakespeare Company were in New York City for a series of performances of
Shakespeare's "Henry VIII" at the Brooklyn Academy of Music. Their show for the Laboratory
included an entertaining assortment of poetry by British and American writers including William
Shakespeare, John Donne, Dorothy Parker, and e.e. cummings.
In October, during the meeting on Gametogenesis, several visiting scientists participated in
a public forum about cloning. Moderator Dr. Anne McLaren, principal research fellow of the
Institute of Cancer and Developmental Biology at the Wellcome CRC Institute, in Cambridge,
England, led panel members Dr. Brigid Hogan, investigator at Howard Hughes Medical Institute
and professor of Cell Biology at Vanderbilt University Medical School in Nashville, Tennessee;
News 12's Doug Geed interviewing astronaut Buzz Aldrin
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Paul Jesson and Jane Lapotaire, in the Single Secret
Dr. Ryuzo Yanagimachi, professor in the Department of Anatomy and Reproductive Biology at
the University of Hawaii Medical School (who had recently reported the production of 50 cloned
mice); and Dr. Anthony Mahowald, professor and chairman of the Department of Molecular
Genetics and Cell Biology and chairman of the Committee on Developmental Biology at the
University of Chicago in Illinois.
Then, in November, Alan Kay, fellow and vice president of Research and Development at
Walt Disney Company, discussed "Origins of the Personal Computer-and Beyond." Dr. Kay's
"Dynabook" is considered to be the forerunner of the personal computer. He also invented the
forerunner of today's Macintosh and Windows interfaces, and led one of several groups that
together developed modern workstations,
the Smalltalk programming language, and
the Ether Net-the technology used today by
the Internet. He was a member of the
University of Utah Advanced Research
Project Agency (ARPA), a federal Depart-
ment of Defense research team that devel-
oped three-dimensional graphics, and he
participated in the development of ARPANet,
which became the Internet in the 1970s.
Before joining the Walt Disney Company, Dr.
Kay also worked for Xerox Palo Alto
Research Center, Atari, and Apple.
Concerts in Grace this year included the
following: May 9, Mary Phillips, mezzo sopra-
no and Ted Taylor, pianist; May 23, Alex
Velinzon, violinist and Inessa Zaretsky, pianist;
May 30, Dmitri Berlinsky, violinist, and Elena
Baksht, pianist; June 8, Irina Muresanu and
Mark Ptashne, violinists; August 22, David Mark Ptashne and Irina Muresanu
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Korevaar, pianist; August 29, the Harold Betters Jazz Quartet; September 5, Jennifer Fratuschi,
violinist, and Benjamin Loeb, pianist; September 12, Anton Barachovsky, violinist, and Sonya
Ovrutsky, pianist; and September 26, Bion Tsang, cellist, and Benjamin Loeb, pianist.
The Banbury Center also served as a forum for public events. In February, Lloyd Harbor
resident Dick Opsahl talked to community members about "Running on Everest: A Personal
Account of a Marathon Starting at Everest Base Camp," and in November the Laboratory
offered a Tax & Estate Planning Seminar at Banbury.
Long-term Service
On July 9, several employees celebrated long-term anniversaries with the Laboratory at a pool-
side dinner at Robertson House on the grounds of the Banbury Center. Jim and Liz Watson cel-
ebrated the 30 years that have passed since Jim became the Laboratory's director in 1968. I
presented Jim with a beautiful, abstract lead crystal sculpture engraved with the image of
Ballybung and "With Deep Appreciation, 30 Years of Dedicated Service, 1998." In addition, he
received a three-tiered, custom-made base for the sculpture created by Long Island sculptor
John Roper. Liz was presented with a framed print of the collage of dedication booklet covers
that appeared in the tribute to Jack Richards that Liz edited in 1997. The calligraphy inscription
read "30 Years of Dedication, Our Sincerest Gratitude, 1998." Liz's advice about the adaptive
re-use and historic preservation of Laboratory buildings, and her 1991 book, Houses for
Science, are enduring and most valuable contributions to Cold Spring Harbor Laboratory.
(Back row) W. Herr, C. Schneider, B. Stillman
(2nd row) M. Simkins, J. Wiggins, J. Watson, M. Wigler, P. Wendel
(3rd row) D. Jusino, M. Falkowski, J. Ebert, C. McEvoy, M. McBride
(Front row) P. Maroney, B. Toliver, L. Hyman
34
Laura Hyman joined the Library 25 years ago as a part-time library assistant when the
Library staff consisted only of Susan Cooper and her volunteers. Since that time, Laura has
become business manager for three departments-Development, Public Affairs, and the
Library-as well as the Laboratory's art curator. Laura has selected, obtained, framed, arranged
and supervised the hanging of most artwork in the Laboratory's many buildings.
Senior scientist and cancer researcher Michael Wig ler celebrated his 20-year anniversary
with the Laboratory. Mike came to Cold Spring Harbor in 1978, and three years later he codis-
covered the first human oncogene, ras, now the object of much study at CSHL and elsewhere.
Laboratory technician Jeanne Wiggins, Banbury administrative assistant Beatrice To liver,
Banbury grounds foreman Christopher McEvoy, Facilities' draftsperson/estimator Charles
Schneider, and payroll administrator Patricia Maroney also celebrated 20-year anniversaries.
Assistant Director and Dean of the Watson School of Biological Sciences Winship Herr cel-
ebrated his 15-year anniversary with the Laboratory. Winship came to Cold Spring Harbor
Laboratory in 1983 as a postdoc in Joe Sambrook's lab. The following people also celebrated
15-year anniversaries: CSHL Press project coordinator Joan Ebert, laboratory technician
Margaret Falkowski, shipping and receiving foreman Daniel Jusino, meetings registrar Michaela
McBride, personnel manager Merilyn Simkins, and laboratory technician Patricia Wendel.
Connie Hallaran, who has been running the Laboratory's bookstore since its inception, also cel-
ebrated a 15-year anniversary. She now works under the auspices of Barnes & Noble.
Administrative Staff Changes
In April, W. Dillaway Ayres joined the Laboratory as associate administrative director. Dill earned
a B.A. from Princeton University, where he majored in English literature, and an M.B.A. in finance
from Columbia University Graduate School of Business Administration. He gained extensive
experience in corporate planning and finance at several companies, including Capital
Cities/ABC Inc. and American Express Company, and was an investment banker at Veronis,
Suhler & Associates Inc., which specializes in television and radio broadcasting. Most recently,
he was cofounder, executive vice president, and chief financial officer of Business and Trade
Network (BATNET), which provides Internet services to national and international associations.
In July, after working for several months as a consultant, Deborah Barnes became director
of Public Affairs. Deborah earned a Ph.D. in biology from Georgetown University and did post-
doctoral research at the Children's Hospital at Harvard Medical School. She taught high school
biology for five years, was a news writer for the journal Science, taught science writing for the
Johns Hopkins University Graduate Program, and for seven years was editor of The Journal of
NIH Research. Deborah has initiated a public lecture series about cancer and the production of
a video about CSHL tentatively entitled "A Year in the Life of the Lab."
Late in 1998, soon after the Watson School of Biological Sciences became a formal entity,
Lilian Gann was recruited as Assistant Dean. Lilian received her Ph.D. from the University of St.
Andrews in Scotland for her research on adenovirus transcriptional regulation. After postdoc-
toral studies at Memorial Sloan Kettering Cancer Center, Harvard Medical School, and the
Imperial Cancer Research Fund (ICRF) in London, she became administration manager at the
ICRF and earned an M.B.A. In her role as administration manager, she helped direct the grad-
uate student and postdoctoral programs. Most recently, Lilian was director of cancer support
services at CancerBACUP, a U.K. charity that helps people with cancer. Lilian, too, worked as
a consultant before assuming her full-time position in early March 1999.
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Changes in Scientific Staff
Departures
Hong Ma left to become an associate professor at Pennsylvania State University in College
Park. Akila Mayeda accepted an appointment as assistant professor at the University of Miami
School of Medicine, in the Department of Biochemistry and Molecular Biology. El ly Nedivi left
our neuroscience program to accept a position as assistant professor in Brain and Cognitive
Sciences at the Massachusetts Institute of Technology, in Cambridge. Alcino Silva is now an
associate professor in the Department of Neurobiology, Psychiatry, and Psychology at
University of California, Los Angeles, and Erich Grotewold went on to become an assistant pro-
fessor in the Department of Plant Biology at Ohio State University.
New Arrivals
Shivinder "Shiv" Grewal, who studies chromosome dynamics and epigenetic control of gene
expression, was recruited to CSHL as an assistant investigator. Shiv comes from the National
Cancer Institute's Frederick Cancer Research and Development Center. Lincoln Stein was
recruited as an assistant investigator in bioinformatics. Lincoln specializes in database integra-
tion and management as it applies to biological data accessible via the Internet. He was for-
merly the director of bioinformatics at the Whitehead Institute for Biomedical Research/MIT
Center for Genome Research.
We also have two new research scholars this year. Both were students at Eton College in
Windsor, U.K., and are now living at Ballybung with the Watson family while they get experience
working in the laboratory. Robin Holden is studying transcription in Winship Herr's lab, and
Indraneil "Neil" Mahapatra is working in the lab of Holly Cline. Neil is cloning a family of genes
encoding proteins that are involved in axon pathfinding in the developing brain.
CSHL Fellow
Marja Timmermans joined the Laboratory in June as a CSHL Fellow. The CSHL Fellow program
provides an outstanding opportunity for talented scientists who have recently received their
Ph.D. or M.D. degrees to establish strong independent research programs. Each CSHL Fellow
has a lab and technician, as well as access to all of the resources of Cold Spring Harbor
Laboratory.
Marja earned her Ph.D. in the lab of Jo Messing, at the Waksman Institute at Rutgers
University in Piscataway, New Jersey. Marja is a maize geneticist who has focused on discov-
ering and understanding the genes involved in maize leaf development. She has studied two
such genes, /eafbladeless 1 and rough sheath 2, which are required for leaves to grow into their
proper shapes.
Promotions
Hollis Cline was promoted to investigator. Holly came to the Laboratory in 1994 as part of our
developing neuroscience initiative, and since that time, her work in neuronal development has
been outstanding. Investigator is the highest research position at the Laboratory, comparable to
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full professor status at an academic institution. Rather than tenure, though, the investigator
appointment provides "Rolling 5" status-the contract is renewed each year for five years.
Michael Hengartner, Tatsuya Hirano, Yuri Lazebnik, Scott Lowe, and Linda Van Aelst were
each promoted to associate investigator.
Masaaki Hamaguchi, of Mike Wigler's lab, was promoted to assistant investigator. Masaaki,
who was formerly a gastrointestinal surgeon in Japan, came to do postdoctoral research in the
Wig ler lab after deciding to make the change from clinical medicine to basic research.
Visiting Scientists
Seven visiting scientists joined us this year: Yoshitaka Azumi of Nagoya University in Japan
spent time in Hong Ma's lab; Simona Ceccarelli of the University of Milan was working in Peter
Nestler's lab; Jyoti Raychaudhura of Lincoln Hospital in the Bronx and Winthrop University
Hospital in Mineola, New York, joined Yuri Lazebnik's lab; Shern Chew of the University of
Cambridge worked in Adrian Krainer's lab; Jyotsna Dhawan of Boston University spent time in
David Helfman's lab; Costaicis Frangou of the University of Portsmouth in the United Kingdom
worked in Greg Hannon's lab; and Benjamin Horwitz of the Technion Israel Institute of
Technology spent three weeks in Hong Ma's lab as part of an ongoing collaboration.
Several other visiting scientists also wrapped up their stays at the Laboratory. Paula
Enrietto, who was working with Tom Marr, returned to a staff scientist position with Tom's com-
pany, Genomica, in Boulder, Colorado. Eli Hatchwell completed his studies in Mike Wig ler's lab
and returned to his clinical work at Southampton University in the United Kingdom; and Mirjana
Maletic-Savatic left Roberto Malinow's lab to finish her residency at SUNY Stony Brook School
of Medicine's Department of Neurology.
Postdoctoral Departures
The Laboratory has long been a springboard from which many scientists launch their research
and academic careers. In 1998, the tradition continued with the following postdoctoral
researchers moving on to other positions.
Concurrent with Alcino Silva's move to UCLA, many of his lab members accepted new
positions as well. Nikolai Fedorov is now an assistant researcher with Alcino in the Department
of Neurobiology at UCLA; Masuo Ohno is a visiting assistant professor there. Three of Alcino's
CSHL postdocs have relocated to parallel positions at UCLA as well: Ype Elgersma, Paul
Frank land, and Jeffrey Kogan. Karl Peter Giese, of Alcino's lab, accepted a position as lecturer
at University College in London.
Three postdoctoral researchers from Hong Ma's lab moved with Hong to the Pennsylvania
State University Biotech Institute. Hiroyasu Onaka, Yixing Wang, and Ming Yang will all contin-
ue their postdoctoral research there.
From Nick Tonks' lab, Anton Bennett accepted a position as assistant professor at Yale
University School of Medicine; Michael Gutch became a manager at Electronic Publishing
Company in New York City; and Andrew Garton is now a senior scientist at OSI
Pharmaceuticals in Uniondale, New York.
From the Stillman lab, Chun Liang accepted a position as assistant professor at the Hong
Kong University of Science and Technology, and Alain Verreault went on to become a lab head
at the Imperial Cancer Research Fund Clare Hall Laboratories in Potters Bar, United Kingdom.
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Jianzhong Ding and Yu Liu both moved on from Rui Ming Xu's lab-Jianzhong to become an
engineer with Aeroflex Laboratory Inc., in Setauket, New York, and Yu as a postdoctoral
researcher at the Hong Kong University of Science and Technology.
Andrea Doseff from Yuri Lazebnik's lab accepted a position as research scientist at Ohio
State University in Columbus; Jeffrey Dickinson from Tim Tully's lab went on to become a pro-
grammer at Zeneca Pharmaceuticals in Wilmington, Delaware; Cameron Gray of Karel
Svoboda's lab went to Philadelphia to pursue other interests; and Fei Guo from Erich
Grotewold's lab is continuing his postdoctoral research in Erich's new lab at Ohio State
University's Department of Plant Biology.
Ruiping Liu moved from Peter Nestler's lab to a position as research scientist with 3-D
Pharmaceuticals, Inc., in Exton, Pennsylvania; Yi Liu went from Winship Herr's lab to the posi-
tion of Research assistant professor at the University of Southern California School of Medicine;
Martin Lock moved from Jacek Skowronski's lab to continue his postdoctoral studies at the
University of Pennsylvania, Bensalem; and Tom Misteli moved from David Spector's lab to the
National Cancer Institute to become a principal investigator there.
Indrani Rajan from Holly Cline's lab is continuing her postdoctoral research in the
Department of Pathology at the University of Washington in Seattle; Brandt Schneider moved
from Bruce Futcher's lab to become an assistant professor at Texas Tech Medical School in
Lubbock; Yung-Chih (Judy) Wang went from David Helfman's lab to the Ferring Research
Institute, Inc., in California as a research scientist; Bill Henry finished up in Nouria Hernandez's
lab and moved on to a position as assistant professor at Michigan State University; and Mark
Curtis completed his Ph.D. in Rob Martienssen's lab, and, after a brief period as a postdoctor-
al fellow at CSHL, moved to the United Kingdom to pursue research in private industry.
Graduate Students
Eleven graduate students completed their Ph.D. degrees at the Laboratory this year. From
Alcino Silva's lab, Ofelia Carvalho is now a staff research scientist with Alcino at UCLA
Department of Neurobiology, and Pin (Adele) Chen is continuing her graduate studies in the
Silva lab at UCLA (although she is expected to receive her degree from SUNY Stony Brook).
From Nouria Hernandez's lab, Ethan Ford went on to do postdoctoral research in the
Department of Biochemistry and Molecular Biology at Oregon Health Sciences University in
Lagunitas, California, and Debra Morrison went on to do postdoctoral research at Mount Sinai
Ruttenberg Cancer Center in New York City. Craig Hinkley completed his studies and went to
embark on postdoctoral studies in Bill Henry's lab at Michigan State.
Degui (Charlie) Chen from David Helfman's lab went on to do postdoctoral research at
UCLA; Richard Freiman went from Winship Herr's lab to do postdoctoral research with former
staff scientist Bob Tjian of the University of California at Berkeley; Anthony (John) lafrate com-
pleted his Ph.D. in Jacek Skowronski's lab and went on to complete clinical training for his M.D.
at SUNY Stony Brook; and Kenneth La Montagne went from Nick Tonks' lab to do postdoctor-
al research with Judah Folkman at the Children's Hospital in Boston.
Peter Rubinelli finished up in Hong Ma's lab and went on to do postdoctoral research at
Ohio State University in the Department of Biochemistry and Plant Biology; Hua Tu went from
Mike Wig ler's lab to a postdoctoral research position at Tularik, Inc., in San Francisco; and
Qiang Wu of Adrian Krainer's lab left to do postdoctoral research at Harvard University's
Department of Molecular and Cell Biology.
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Twenty Years at CSHL
At the time of writing, it has been 20 years since I came to Cold Spring Harbor Laboratory from
Australia, initially as a postdoctoral fellow for two years. Much has changed during those years,
yet the Laboratory remains a vibrant and exciting place to work. I am pleased to have been wel-
comed into this marvelous community with such warmth.
This year happens to be one of the busiest on record, and all the staff at the Laboratory
must be congratulated for their efficiency and dedication. Because of the combined effort of all
our staff, CSHL remains one of the most exciting addresses in science, making my life inter-
esting every day.
On a personal note, I was most happy to learn at the end of the year that in the 1999
Australia Day honors list (January 26th), I was named as having received the Order of Australia
(AO). This high national honor from my homeland is particularly pleasing as it recognizes the
contributions to science and humanity at large by an Australian scientist who happens to be
working in the United States, emphasizing the international nature of modern biomedical
research.
May 1999 Bruce Stillman
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MEETINGS & COURSE PARTICIPANTS
ADMINISTRATION
With much anticipation, the Laboratory in 1998 advanced a broad series of initiatives in edu-
cation and research that will shape our institution in the 21st century.
Foremost among these is the Watson School of Biological Sciences, which received
approval in October from the New York State Board of Regents and by year end was recruit-
ing its first class of Ph.D. candidates. We also established new courses at the postgraduate
level and continued to expand the program of scientific meetings held on the main campus
and at Banbury Center. The DNA Learning Center introduced a remarkable new genetics
Internet site, DNA from the Beginning. Designed initially for high school students, the site will
be further developed for the general public. The Cold Spring Harbor Press launched a new
venture in textbook publishing at the college freshman level.
In research, the Laboratory began programs in neural imaging, bioinformatics, gene
sequencing and function, and DNA microarray technology. All are designed to augment our
traditional focus on cancer, neuroscience, and plant research.
Construction of new buildings for imaging and bioinformatics began on the main cam-
pus and will be completed this summer. A major renovation of the old powerhouse and car-
pentry shop is under way. When completed, it will provide office space for our expanding
Human Resources, Development, and Public Affairs Departments. We purchased an historic
Cold Spring Harbor residence across the harbor and are renovating it for use by our first
class of graduate students, who will arrive in the fall. In Cold Spring Harbor Village, the DNA
Learning Center completed plans for a badly needed expansion of its laboratory and com-
puter teaching space.
A few minutes' drive to the south in Woodbury, the Lab purchased an 11-acre site and
a 60,000-square-foot building from the American Institute of Physics. It will be renovated as
a new home for the Cold Spring Harbor Laboratory Press and as a high-technology center
for research on gene sequencing and function and DNA microarray technology. Space will
also be available there for behavior studies and housing of new mouse lines.
During 1998, New York State approved $15 million in funding for a new biotechnology
park, which will be located on State University of New York (SUNY) land in Farmingdale, just
south of Woodbury. This will be the home for young biotechnology companies that are devel-
oping commercial applications for new technology developed at the Laboratory and other
institutions. Because of the lack of appropriate facilities on Long Island, such companies
have located in states such as Massachusetts, South Carolina, California, and Washington,
which have aggressively encouraged biotechnology clusters near academic institutions.
Now such companies will have the opportunity to locate in close proximity to the center of
academic excellence represented by Cold Spring Harbor Laboratory, SUNY Stony Brook,
and Brookhaven National Laboratory.
The park will be managed by a new nonprofit corporation, Broad Hollow Bioscience
Park, Inc. A majority of the corporation's directors will be appointed by CSHL, the remain-
der, by SUNY Farmingdale. John Cleary, who in 1997 completed terms as president of the
CSHL Association and as a trustee of the Laboratory, is Chairman of the Board of the new
corporation. Construction will begin this spring and should be completed in 2000.
Strong finances are an important foundation from which to launch new initiatives, and,
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therefore, it is pleasing to report that Cold Spring Harbor Laboratory had its best financial
year ever in 1998. Revenues, at $53,639,000, were 10% larger than in 1997, while expens-
es increased by 8%, to $48,970,000. There was a surplus of $476,000 after depreciation of
$3,443,000 and establishment of a reserve of $750,000 for the coming start-up costs of our
new imaging and bioinformatics programs. These results are much better than had been
anticipated in our annual budget. All major areas of operations-the main Lab, the CSHL
Press, Banbury Center, and the DNA Learning Center-achieved break-even or better
results, thus reaching a key goal established at the beginning of the year. There was a pos-
itive cash flow from operations of $4,669,700, which, as in the past, will be used to main-
tain and modernize our capital plant, purchase scientific equipment, and support new pro-
grams.
Our strong financial position was primarily due to our scientists' success in obtaining
federal grants; the strength of our meetings, courses, and other educational programs; high-
er royalty and investment income; improved operations at the CSHL Press; and very careful
cost control by administrative departments. The strong financial status of the Laboratory
was recognized at year-end with a high A+1 rating from Standard & Poor's, which enabled
us in early 1999 to issue $42.2 million of tax-exempt Civic Facility Refunding and
Improvement Bonds through the Nassau County Industrial Development Agency.
Underwritten by J.P. Morgan Securities Inc., the bonds provide $15.2 million for the new
Woodbury High Technology Center and $27 million to refinance outstanding debt. The A+1
rating permits the new issue to be backed by a liquidity facility from Morgan Guaranty Bank
at half the cost of the previously needed letter of credit.
Despite the great volatility experienced in financial markets during 1998, the
Laboratory's endowment again increased substantially as a result of good market return and
new additions. The endowment consists of the Robertson Research Fund and the Cold
Spring Harbor Fund; the latter now includes the funds being raised for our new graduate
school. At year-end, the market value of the endowment was $167,044,000, a 12-month
increase of nearly $23 million, or about 16%. The funds, which continue to be invested in a
balanced mix of equities, fixed-income and short-term instruments, are managed by a team
of investment professionals-Essex Investment Management Company, LLC; Miller
Anderson & Sherrerd (now a subsidiary of Morgan Stanley Dean Witter); U.S. Trust
Company; and the Vanguard PRIMECAP Fund. In a year in which it was extremely difficult
for managers to exceed benchmark indices, Vanguard and Essex were able to do so-in the
case of Essex, by a very handsome margin. Over many years, the Laboratory's conservative
policy, under which it draws 4% per annum from the endowment, has played an important
role in the remarkable growth of the funds. The 4% drawdown is based on an average of the
market value of the endowment at the end of each of the past three years. In consideration
of the extraordinary strength of recent equity markets, the drawdown was held even below
the 4% target in 1998 and 1999.
In 1992, the Board of Trustees established the Science Fund as the component of the
endowment into which we place all equity positions and a portion of the royalties we receive
for intellectual property licensed to new companies founded in whole or in part on the basis
of CSHL technology. The Science Fund is intended for the future support of science, and no
drawdown is currently being taken in order to encourage its growth. At year-end, the
Science Fund was valued at $7,456,000, with a number of its equity positions very conser-
vatively stated. In mid-2000, an important patent will expire, royalties from which have been
providing significant funding for Lab research. The Science Fund will be helpful in bridging
any temporary period while new sources of funding develop.
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During 1998, our administrative departments successfully managed an extraordinary
array of new projects with skill and good humor, despite tight budgets, staff limitations, and
a shortage of working space.
John Maroney, director of Technology Transfer, and his department facilitate the transfer
of cutting-edge basic research at the Laboratory to the commercial sector. Last year, two
new companies, Genetica and Orion, were formed to pursue gene discovery in the fields of
cancer and plant research. The Lab has equity participations in both companies. The
Technology Transfer Department has also been instrumental-with New York State and
SUNY Farmingdale-in planning and organizing the Broad Hollow Bioscience Park until a
full-time manager can be recruited. In the meantime, preliminary discussions have been con-
ducted with prospective tenants who have already spoken for more than half the initial space
to be available.
The Facilities Department, led by Art Brings, manages each year to meet the heavy
demands of schedules and budgets for construction, renovations, and maintenance while
keeping the Lab productive and ensuring that it is also a showcase of style and natural beau-
ty. Our grounds, under the care of Dan Miller, have never looked better. Grants Management,
Human Resources, and Purchasing, managed by Susan Schultz, Cheryl Sinclair, and Phil
Lembo, respectively, can be counted on to cope well with constantly increasing demands on
their departments. Roberta Salant, administrative assistant to John Maroney and me, is of
great help to both of us and meets the often-complex needs of our Board of Trustees and
its committees with efficiency and grace.
No area of the Laboratory has been growing faster than the need for information ser-
vices. Its requirements permeate everything we do in science, education, and administration.
Virtually all the buildings on our main campus and our six remote locations are now part of
the Lab-wide computer network. Gerry Latter, director of Information Services, and his staff
deserve great credit for bringing the Lab to the cutting edge of data management.
Very important to the smooth functioning of the Laboratory is our financial infrastructure,
which is headed by Controller Bill Keen and Assistant Controller Lari Russo. "Best-ever"
financial years are the result of the efforts of many people, but they also are very dependent
on good planning and budget control. We can count on Bill and Lari to provide such ser-
vices. Equally important is their ability to successfully take on and complete time-consuming
major projects such as the Lab's recent $42-million bond issue.
A priority of the past few years has been to add a new depth of professionalism to
administrative areas that will be particularly important to the Laboratory in the years ahead.
We have made substantial progress in this regard.
The Lab's Development Department is currently challenged with raising some $67 mil-
lion to help fund our new initiatives and to substantially increase the level of annual support
for research. Rick Cosnotti, our chief development officer for 18 months, is making remark-
able progress on this task. More than half the $32 million endowment planned for the
Graduate School has been raised, and in 1998, both of the Laboratory's annual funds-the
Association and the DNA Learning Center Corporate Advisory Board-established new
records.
Deborah Barnes, our director of Public Affairs for nearly a year, is producing a new video
encompassing a year in the life of the Lab. It will be an effective tool for development and for
recruiting graduate students. In cooperation with Newsday, Deborah has introduced a new
public lecture series on cancer. The first lecture, given in March by Richard Klausner, direc-
tor of the National Cancer Institute, was a cautiously optimistic explanation of the current sta-
tus of cancer research. The Laboratory's scientists, and Dr. Watson in particular, have been
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featured broadly in the national media. Deborah and chief science writer Wendy Goldstein
are making good progress on their mission to make Cold Spring Harbor Laboratory and its
science more visible nationally and internationally.
At the close of 1998, Margaret Henderson, director of the Library, left the Laboratory due
to her husband's new job responsibilities and two growing children at home. We miss her
and hope she will visit often. Margaret's replacement, Ludmila Tsytlenok-Pollock (Mila), joined
us in early April. Mila has a master's degree in library science, 19 years of experience in the
field, and seemingly boundless energy. Before coming to the United States in 1993, she was
head of the Reference Department of the State Central Scientific Medical Library in Moscow,
Russia. Since 1993, she had been director of the Medical Library at South Nassau
Community Hospital on Long Island. Now she will be dealing with the space limitations of the
Lab's 94-year-old Carnegie Library, keeping abreast of the changes brought about by elec-
tronic publishing, and meeting the needs of our new graduate students. She will plan the
organization and preservation of the personal archives of Dr. Watson and the voluminous
records of the 110-year existence of the Laboratory, which encompass much of the history
of molecular biology and genetics.
W. Dillaway Ayres will soon complete his first year as associate administrative director.
Dill has been deeply involved with me in the planning of our new initiatives and has been of
much help with many of the Lab's day-to-day concerns. Working closely with Gerry Latter
and all the department heads, he has been instrumental in guiding a major capital project
that entails the purchase and installation of new, Lab-wide business-management software
and accompanying hardware. The new system, being purchased from Lawson Software, will
change most of the accounting, reporting, approval, and operational methodology at the
Lab. It should greatly improve our productivity and be a solid foundation for future operations.
Dill is also chairman of our Year is well along in ensuring that the
Laboratory will not be seriously affected by any technical problems associated with the arrival
of the new century.
As noted elsewhere in this report, the annual meeting of the Board of Trustees this past
November marked the retirement of David L. Luke III as chairman of the Board and John R.
Reese as treasurer. Each had completed the maximum number of years in office permitted
by our by-laws. Their guidance and leadership in matters of finance and many other areas of
Laboratory activity have been invaluable. Fortunately, in their respective successors, William
R. Miller and Lola N. Grace, we have two individuals in whom we have a similar level of con-
fidence.
Looking ahead to the fast-approaching millennium, we are reminded that it is challenges
and opportunities such as those described in this report that make Cold Spring Harbor
Laboratory such an exciting place for all who come in contact with it-our employees, sup-
porters, and the world of science. The future looks every bit as promising as the past.
May 1999 G. Morgan Browne
Administrative Director
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TUMOR VIRUSES
The investigators in the Tumor Viruses Section are unified by the shared use of viruses to probe cell func-
tion and to understand cell transformation. The viruses used include adenovirus, human and bovine papil-
lomaviruses, SV40, herpes simplex virus, and human and simian immunodeficiency viruses. A reading of
the reports in this section reveals a robust research program.
Arne Stenlund and Bruce Stillman study DNA replication of papillomavirus and SV40, respectively. The
Stillman laboratory complements studies of SV40 DNA replication with studies of cellular DNA repli-
cation in human and yeast cells.
Winship Herr and Adrian Krainer study the control of gene expression, particularly the control of gene
transcription and pre-mRNA splicing.
William Tansey, new to the section in 1997, has added to this section a new dimension in the study of
gene expression control. His laboratory is studying how protein stability is regulated, using the Myc
oncoprotein as a model.
Yuri Lazebnik and Scott Lowe focus their research on the cellular defenses against cancer, including
programmed cell death or apoptosis and senescence.
Jacek Skowronski studies how the human and simian immunodeficiency viruses disrupt signal trans-
duction and the expression of cell surface receptors in infected T cells.
James Laboratory Entrance
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TRANSCRIPTIONAL REGULATION
W. Herr D. Aufiero Y. Liu T. Tubon
R. Babb V. Meschan K. Wu
C. Hinkley J. Reader J. Wysocka
R. Holden P. Reilly X. Zhao
S. Lee
We are interested in the mechanisms of transcriptional
control in human cells. We use the human herpes sim-
plex virus (HSV) as a probe to uncover these mecha-
nisms and to study virushost cell interactions.
Viruses provide simple regulatory networks in which
the cellular transcriptional machinery is altered to
achieve the goals of virus infection. In a cell infected
by HSV, the virus can grow lytically or remain latent
for many years. In the lytic cycle, HSV gene expres-
sion is initiated by a viral transcription factor called
VP16, which is carried in the infecting virion. Before
activating transcription, VP16 forms a multiprotein-
DNA complex-the VP16-induced complex-on viral
immediate-early promoters with two cellular proteins:
HCF, a protein that regulates cell proliferation, and
Oct-1, a POU-homeodomain transcription factor.
Once the VP16-induced complex is assembled, VP16
initiates viral gene transcription through a potent tran-
scriptional activation domain.
Our research is focused on three principal issues:
(1) How do transcriptional regulators activate the basal
transcriptional machinery? (2) How do transcription
factors, as in the VP16-induced complex, modify their
transcriptional activity through selective protein-pro-
tein and protein-DNA interactions? (3) What are the
natural cellular roles of HCF and Oct-1, and how do
they influence HSV infection?
Enhancer Function
C. Hinkley, T. Tubon, X. Zhao
Our current studies on how transcriptional regulators
activate the basal transcriptional machinery focus on
two areas: (1) the response of the basal transcriptional
machinery to activators, and (2) how transcriptional
activation domains discriminate among basal tran-
scriptional machineries bound to different core pro-
moter elements. In the first line of investigation, we
continue to study the function of basal transcription
factors in vivo through the use of altered-specificity
interactions among these factors, which allows us to
circumvent the endogenous transcriptional machinery
and thus study the activity of mutant basal factors in
vivo. In the second line of investigation, we study tran-
scription in vitro to dissect how transcriptional activa-
tion domains can distinguish among basal factors
bound to different core promoter elements.
For the latter studies, we use two types of promot-
ers: (1) promoters that direct the synthesis of mRNAs
by RNA polymerase II and contain a TATA box core
promoter element and (2) promoters that direct the
synthesis of small nuclear RNAs (snRNAs) by either
RNA polymerase II as in the case of the U2 snRNA or
RNA polymerase III as in the case of the U6 snRNA.
snRNAs are involved in RNA processing and their
corresponding promoters contain a dedicated core pro-
moter element called the PSE. The TATA box of the
mRNA-type promoters binds the basal transcription
factor complex TFIID, whereas the PSE element of
snRNA gene promoters binds the basal transcription
factor complex SNAP, studied by the Hernandez lab-
oratory. We study how transcriptional activation
domains discriminate between the mRNA- and
snRNA-type promoters.
Some years ago, Dr. Carol Greider, formerly of
Cold Spring Harbor Laboratory, and her collaborators
isolated a novel "small-nuclear-RNA" gene that is not
involved in RNA processing, but instead is involved in
chromosome telomere maintenance-this is the RNA
component of telomerase. Together with the Greider
laboratory and Dr. Villeponteau and colleagues of
Geron Corporation, we have characterized the struc-
ture of the promoter for this gene to determine whether
it has an "mRNA-" or "snRNA-" type structure.
Owing to the mechanism by which DNA is repli-
cated, the ends of chromosomes would become pro-
gressively shorter during successive rounds of replica-
tion if they were not actively maintained. One way
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chromosomal ends are maintained is by de novo addi-
tion of short G-rich repeats to their 3' ends by telom-
erase. Telomerase contains a single RNA molecule and
multiple protein components, which are essential for
activity. In organisms as diverse as ciliates, yeast, and
vertebrates, the telomerase RNA sequence contains a
"template" region complementary to the sequence of
the telomeric repeats. It is responsible for both align-
ing the telomere end and serving as a template for
addition of the telomeric repeats. In all organisms ana-
lyzed prior to our studies, this template region was
embedded in the telomerase RNA sequence.
In ciliates, the telomerase RNA gene is transcribed
by RNA polymerase III and contains a promoter rem-
iniscent of U6 snRNA genes. To characterize verte-
brate telomerase RNA gene transcription, we mapped
the mouse telomerase RNA 5' terminus and deter-
mined the sequence of the human and mouse telom-
erase RNA gene promoter sequences flanking the
telomerase RNA transcriptional start site. The human
and mouse telomerase RNA gene sequences are relat-
ed, but, in contrast to the ciliate genes, they reveal
sequence elements typical of RNA polymerase II
mRNA-type promoters-they contain TATA and
CCAAT box sequences-and not a PSE element typi-
cal of the promoters of genes encoding the snRNAs
involved in RNA processing.
Further to our surprise, although humans and
mice are closely related, our studies showed that the
position of the transcriptional start site relative to the
template-encoding sequence is very different in
humans and mice: Whereas the human transcription-
al start site lies 45 by upstream of template-encoding
sequence, the mouse transcriptional start site lies
only 2 by upstream of the template-encoding
sequence. Thus, the mouse telomerase RNA is
unusual among all telomerase RNAs analyzed in that
the template sequence is located very near the 5' end
of the RNA.
These results suggest that the mammalian telom-
erase RNA sequences 5' of the template sequence are
not essential for telomerase function. They may, how-
ever, be important to modulate the function of telom-
erase. In vitro, human telomerase is more processive
than mouse telomerase. Perhaps, the sequences 5' of
the template sequence in the human telomerase RNA
help stabilize the correct folding of the telomerase
RNA or aid in interactions either with other telom-
erase components or with the chromosome substrate.
Such interactions may afford greater processivity to
the human enzyme.
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Viral Trans-activation
C. Huang, R. Babb, L.K. Wu
We continue to study the structure and function of
VP16 and members of the VP16-induced complex. In
collaboration with Drs. Y. Liu, W. Gong, and X.
Cheng, formerly of Cold Spring Harbor Laboratory,
we have determined the three-dimensional crystal
structure of the core region of VP16 that is sufficient
for VP16-induced complex assembly.
VP16 has multiple roles during the HSV infection
cycle. It is synthesized late during infection where it is
incorporated into the tegument of the virion with other
viral proteins. Upon de novo infection, VP16 is
released into the cell where it associates with HCF and
Oct-1 on HSV immediate-early promoters. Thus,
VP16 is a multifaceted protein that, at different times
during the HSV infection cycle, interacts with either
viral proteins, as in the virion, or cellular proteins, as
in the VP16-induced complex.
VP16 is a modular protein of 490 amino acids. Its
potent transcriptional activation domain is located
within the carboxy-terminal 80 amino acids, whereas
sequences sufficient for VP16-induced complex
assembly encompass much of the remainder of the
protein. Comparison of the HSV VP16 sequence with
those of the related proteins from other herpesviruses
reveals that the region sufficient for VP16-induced
complex assembly is conserved, whereas the sequence
of the transcriptional activation domain is not con-
served. The X-ray crystal structure of the free form of
the conserved VP16-induced complex-forming region
reveals a novel, seat-like protein structure. Sequences
involved in DNA-sequence recognition and productive
virion assembly are structured, but sequences involved
in associating with HCF and Oct-1 are disordered,
suggesting that VP16 undergoes conformational
changes during VP16-induced complex assembly.
Cellular Functions of HCF
Y. Liu, S. Lee, R Reilly, J. Wysocka
HSV must maintain an intimate relationship with the
host cell to remain latent for many years and yet retain
the ability to grow lytically. Because VP16 associates
with the cellular proteins HCF and Oct-1 to initiate
HSV gene expression during lytic infection, we
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FIGURE 1 C. elegans HCF displays uneven sequence similarity to human HCF. Schematic structure comparison of human and C.
elegans HCF. Conservation represents the percentage of identical residues between C. elegans and human HCF in the regions indi-
cated. Charged/WYF is the region enriched in charged and large hydrophobic residues.
hypothesize that HCF and Oct-1 are key regulators of
which mode of infection-latent or lytic-HSV
enters. We are therefore interested in the natural cellu-
lar roles of HCF and Oct-1, and how these roles may
influence HSV infection. We focus primarily on the
cellular functions of HCF because HCF has been high-
ly conserved during evolution and is involved in cell
proliferation.
Human HCF is synthesized as a large approxi-
mately 2000-amino-acid precursor protein, which is
proteolytically cleaved to generate a family of associ-
ated amino- and carboxy-terminal polypeptides. Only
the amino-terminal 380 residues of HCF, however, are
required to associate with VP16 and to stabilize VP16-
induced complex formation. This region of HCF is not
only involved in interaction with VP16, but also nec-
essary to promote cell proliferation.
This past year, in collaboration with M.
Hengartner at Cold Spring Harbor Laboratory, we
reported that HCF has been conserved during meta-
zoan evolution. Extracts from insect cells and the
worm Caenorhabditis elegans, but not from yeast, can
stabilize VP16 association with human Oct-1. We
showed that C. elegans expresses a functional
homolog of human HCF that can associate with and
activate VP16. As illustrated in Figure 1, however, the
pattern of sequence conservation between human and
worm HCF is uneven. Amino-terminal sequences
involved in cell proliferation and interaction with
VP16 and carboxy-terminal sequences of unknown
function are conserved, but sequences required for
mammalian HCF processing are not present in C. ele-
gans HCF. These results suggest that HCF possesses
a highly conserved role in metazoan cell proliferation
which is targeted by VP16 to regulate HSV infection.
The precise mechanisms, however, by which HCF
functions in mammals and worms appear to differ.
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RNA SPLICING
A.R. Krainer L. Carlegni L. Manche T.-L. Tseng
S. Chew A. Mayeda Q. Wu
M. Hastings M. Murray J. Zhu
H.-X. Liu
MECHANISMS OF CONSTITUTIVE
AND ALTERNATIVE PRE-mRNA SPLICING
RNA splicing is an essential step for the expression of
most eukaryotic protein-coding genes. The selection
and pairing of authentic splice sites within the spliceo-
some occur with a very high degree of fidelity, which
requires precise interpretation of limited and dispersed
sequence information present throughout introns and
exons. The expression of many cellular and viral genes
occurs via alternative splicing, which involves sub-
stantial flexibility in the choice of splice sites, allow-
ing the expression of multiple protein isoforms from
individual genes. The choice of alternative splice sites
is commonly regulated to alter gene expression, either
tissue-specifically or in response to a developmental
program or to extracellular signals. Both constitutive
and alternative splicing mechanisms involve multiple
protein components, as well as RNA components that
are part of small nuclear ribonucleoprotein (snRNP)
particles. Our laboratory has focused on the identifi-
cation, purification, and molecular characterization of
protein factors that are necessary for the catalysis of
splicing and/or for the regulation of alternative splice
site selection.
CHARACTERIZATION OF HUMAN SR PROTEINS
The SR proteins constitute a large family of nuclear
phosphoproteins required for constitutive pre-mRNA
splicing and for the recognition of splicing enhancers
present on at least some exons. These factors also have
global, concentration-dependent effects on alternative
splicing regulation, and this activity is antagonized by
members of the heterogeneous nuclear RNP ( hnRNP)
A/B family of proteins. The SR proteins have a modu-
lar structure that consists of one or two RNA-recogni-
tion motifs (RRMs) and a carboxy-terminal RS
domain. We recently demonstrated that a subset of SR
proteins shuttles rapidly and continuously between the
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nucleus and the cytoplasm, although at steady state,
only the nuclear population is detected by immuno-
fluorescence. The difference between shuttling and
nonshuttling SR proteins is due to the RS domain,
although shuttling also requires RNA binding mediat-
ed by one or more RRMs. Shuttling SR proteins appar-
ently exit the nucleus bound to the exons of spliced
mRNAs. Differential modulation of hnRNP A/B and
SR protein shuttling by kinases may serve to regulate
alternative splicing in response to signal transduction
pathways. The finding that some but not all SR pro-
teins shuttle suggests that these proteins may have
roles not only in nuclear pre-mRNA splicing, but also
in mRNA transport, in cytoplasmic events, and/or in
processes that involve communication between the
nucleus and the cytoplasm. One of these events is
mRNA decay triggered by premature nonsense
codons, a process that is somehow linked to the posi-
tion of the in-frame nonsense codons relative to the
introns. When the mature transcripts are translated in
the cytoplasm, protein tags may indicate the positions
of the spliced exon junctions, and we have proposed
that shuttling SR proteins could be the tags. J. Zhu is
currently investigating this hypothesis.
We have continued the functional characteriza-
tion of SR proteins with respect to their roles in
enhancer-dependent splicing and in alternative splic-
ing regulation. H.-X. Liu developed a randomization
and iterative selection protocol based on biochemical
complementation with single SR proteins to define
the types of sequences that can function as exonic
splicing enhancers in the presence of each of three
different SR proteins. In collaboration with M. Zhang
here at the Laboratory, short consensus sequences
corresponding to enhancers specific for each SR pro-
tein were defined. These studies defined new classes
of splicing enhancers, of which the well-studied
purine-rich elements are only a small subset. In col-
laboration with G. Screaton (John Radcliffe Hospital,
Oxford), A. Mayeda mapped natural enhancer ele-
ments specific either for SF2/ASF or for SC35 with-
in exons of human immunodeficiency virus (HIV)
and IgM pre-mRNAs. This study demonstrated the
presence of enhancers in constitutive exons and also
revealed the existence of an exon silencer in HIV that
suppresses the action of SC35 but not of SF2/ASF.
In collaboration with X.-D. Fu (University of
California, San Diego), we showed that the individ-
ual RRM modules of SR proteins appear to be
responsible for the specific recognition of individual
enhancer and silencer elements by each SR protein,
whereas their RS domains can be interchanged with-
out affecting substrate specificity. S. Chew obtained
evidence suggesting a role of enhancer elements and
SR proteins in the second catalytic step of splicing.
This was seen both by observing a kinetic effect on
both steps of splicing of an enhancer-dependent pre-
mRNA and by use of a bimolecular exon ligation
assay, in which second-step trans-splicing required a
3' exon containing an enhancer.
STRUCTURE AND FUNCTION OF
hnRNP A/B PROTEINS
hnRNP A/B proteins, exemplified by hnRNP A1,
antagonize SR proteins to promote exon skipping and
distal alternative 5' splice site use. These proteins con-
sist of two RRMs and a carboxy-terminal glycine-rich
domain. A proteolytic fragment of hnRNP Al lacking
the carboxy-terminal domain is known as UP1. The
crystal structure of human UP1 was determined here
at the Laboratory by R.-M. Xu in collaboration with
our group, and simultaneously by a team at Yale.
Recently, B. Chabot (University of Sherbrooke)
showed that UP1 and/or hnRNP Al is also involved in
telomere length regulation in vivo and that this effect
is likely direct, involving binding of the protein to sin-
gle-stranded telomere overhangs. R.-M. Xu has now
solved the crystal structure of UP 1 bound to single-
stranded telomeric DNA. A. Mayeda and L. Manche
have continued our efforts, in collaboration with R.-M.
Xu and with S. Munroe (Marquette University), to
investigate the mechanism of action of hnRNP Al
using functional assays with Al variants bearing muta-
tions designed on the basis of the structure and of phy-
logenetic conservation data. The observed functional
cooperativity between the RRMs is borne out by the
structure, as is the more critical role of RRM2, which
can function when duplicated to replace RRM1.
Although RRM1 and RRM2 fold almost identically,
their nonequivalent roles may be due to a few differ-
ences in surface residues, to residues involved in inter-
actions between the RRMs, and/or to residues involved
in dimerization induced by nucleic acid binding. These
possibilities are now being investigated.
ROLE OF THE TYPE-2C PROTEIN PHOSPHATASE
PP2Cy IN PRE-mRNA SPLICING
To identify activities involved in human pre-mRNA
splicing, M. Murray developed a procedure to separate
HeLa cell nuclear extract into five complementing
fractions. One of these fractions was extensively puri-
fied by assaying for reconstitution of splicing in the
presence of the remaining four fractions (Fig. 1). The
purification yielded PP2Cy, a type-2C Ser/Thr phos-
phatase of previously unknown function. Previous
work suggested that dephosphorylation of splicing
factors may be important for catalysis after spliceo-
some assembly, although the identities of the specific
phosphatases involved remained unclear. We showed
that human PP2Cy is physically associated with the
spliceosome in vitro throughout the splicing reaction
but is first required during the early stages of spliceo-
some assembly for efficient formation of the A com-
plex. An active-site mutant not
support spliceosome assembly, demonstrating that
phosphatase activity is required for the splicing func-
tion of PP2Cy. The requirement for PP2Cy is highly
specific, as seen by the fact that the closely related
phosphatase PP2Ca could not substitute for PP2Cy.
Consistent with a role in splicing, PP2Cy localized to
the nucleus in vivo. Therefore, at least one specific
dephosphorylation event catalyzed by PP2Cy is
required for formation of the spliceosome. Current
experiments are aimed at identifying the relevant sub-
strates of PP2Cy in splicing, determining the basis for
its physical association with the spliceosome, and
understanding the mechanistic consequences of the
specific dephosphorylation events.
THE AT-AC INTRON SPLICING PATHWAY
We have continued to study the mechanisms of AT-AC
pre-mRNA splicing, which is a minor pathway for pro-
cessing approximately 0.1% of metazoan introns. We
previously developed an in vitro splicing system using
a sodium channel minigene transcript with an AT-AC
intron. Q. Wu demonstrated that purine-rich exonic
enhancers can stimulate AT-AC splicing in vitro, there-
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FIGURE 1 Human PP2Cy, a SeriThr protein phosphatase, is a pre-mRNA splicing factor. (A) In vitro splic-
ing complementation assay. Nuclear extract competent for in vitro splicing was separated into four crude
chromatographic fractions (I through IV) plus purified SR proteins. The indicated combinations of fractions
were incubated with labeled P-globin pre-mRNA under splicing conditions and the RNAs were analyzed by
denaturing PAGE. None of the individual fractions can splice p-globin pre-mRNA, but activity is restored
when all five fractions are added in combination. The assay shown demonstrates the dependence on frac-
tion IV for the first catalytic step of splicing. Extensive purification of this fraction yielded human PP2Cy. (8)
Spliceosome assembly assay. Prespliceosomal and spliceosomal p-globin pre-mRNA complexes assem-
bled in nuclear extract or in complementation reactions were assayed by native PAGE. In the absence of
fraction IV or PP2Cy, only a low level of the prespliceosomal complex A is formed. Addition of either partial-
ly purified fraction IV or recombinant PP2Cy expressed in baculovirus or bacteria greatly stimulates A-com-
plex formation. Mutant PP2Cy containing an active-site point mutation does not stimulate A-complex for-
mation in this assay nor does a related type-2C phosphatase, PP2Ca. As a control, the complexes formed
in a 30-min incubation with crude nuclear extract are also shown. (C) Nuclear localization of PP2Cy. The
intracellular localization of PP2Cy in HeLa cells was determined using anti-PP2Cy monoclonal antibody and
FITC-conjugated secondary antibody. SC35 localization is included as a positive control and as a marker for
the speckle region of the nucleus. Bar, 10 pm. (D) Stable association of PP2Cy with the spliceosome.
Splicing reactions in nuclear extract with p-globin pre-mRNA were immunoprecipitated after a 1-hr incuba-
tion. Radioactively labeled RNA was recovered from the immunoprecipitates and analyzed by denaturing
PAGE. The amount of input RNA shown is equivalent to 10% of the amount used for each immunoprecipi-
tation. Anti-Sm and anti-trimethyl guanosine (TMG) immunoprecipitations were included as positive controls,
and an anti-maltose-binding protein (MalE) antibody served as a negative control.
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by extending the parallels between the major and
minor pathways. Taking advantage of the unique
snRNA requirements for this pathway, he showed that
enhancer function does not require intact Ul or other
major snRNAs. The lack of a Ul requirement distin-
guishes the mechanisms of splicing activation by an
exonic enhancer and by a downstream 5' splice site,
both of which are thought to contribute to exon defin-
ition. This finding is probably also applicable to the
major splicing pathway. The lack of a polypyrimidine
tract for binding by U2AF and the close proximity
between the branch site and 3' splice site in these
introns make it unlikely that U2AF is involved in AT-
AC splicing stimulation by downstream 5' splice site
or enhancer elements, in contrast to current models for
splicing enhancement of the major pathway. M.
Hastings is now pursuing these findings by investigat-
ing the protein factors involved in basal AT-AC splic-
ing and in activation of this pathway by downstream
enhancers or conventional 5' splice sites.
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REGULATION OF APOPTOSIS IN CANCER CELLS
Y. Lazebnik H. Fearnhead L. Faleiro
J. Rodriguez M. Elgersma
Apoptosis is a fundamental biological process critical
for maintaining tissue homeostasis. Consequently,
deregulation of apoptosis contributes to cancer. Our
laboratory is investigating how the apoptotic machin-
ery can be used to kill cancer cells. The main problem
is to find out how to kill cancer cells selectively, and
we are trying to understand how to achieve this goal.
An essential component of the apoptotic machin-
ery is the caspases, a family of cysteine proteases.
Caspases are activated at the onset of apoptosis and
cause death by cleaving a number of proteins in a
coordinated manner. If caspase activation is prevented,
a cell can become drug-resistant. We study which cas-
pases are involved in apoptosis, how they are activat-
ed, how this activation leads to cell death, and what
prevents this activation in drug-resistant cells. The
ultimate goal is to understand how caspases can be
activated selectively in cancer cells.
ONCOGENE-DEPENDENT APOPTOSIS
IS MEDIATED BY CASPASE-9
The answer to selective killing of cancer cells may lie
in the observation that the expression of oncogenes
that deregulate the cell cycle can either induce apopto-
sis or sensitize cells to pro-apoptotic stimuli. An impli-
cation of this observation is that oncogene expression
generates a pro-apoptotic signal that is present in
transformed cells but absent in normal cells. When
this signal is uncoupled from the apoptotic machinery
transformed cells can survive and become resistant to
chemotherapeutic drugs. In principle, restoring the
link between the signal and the apoptotic machinery
should selectively kill transformed cells because
although untransformed cells have the machinery, they
lack the signal. Understanding how the apoptotic
machinery is regulated by oncogenic transformation is
the first step in testing this hypothesis.
A central component of the apoptotic machinery is
a family of cysteine proteases called caspases that are
expressed as inactive precursors which are activated by
proteolytic processing. According to the current model,
two classes of caspases, initiators and effectors, are
involved in apoptosis. Pro-apoptotic signals activate
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initiator caspases. This activation is autocatalytic and
requires the binding of specific cofactors. Activated
initiator caspases process effector caspases, which in
turn cause cell collapse by cleaving a specific set of
substrates. It appears that each initiator caspase is acti-
vated in response to a subset of signals, indicating that
a prerequisite for understanding how a specific signal
activates apoptosis is linking this signal to a particular
initiator caspase. The initiator caspase that mediates
oncogene-dependent apoptosis is elusive.
To investigate how the apoptotic machinery is reg-
ulated by oncogene expression, we previously devel-
oped a cell-free system that mimics oncogene-depen-
dent apoptosis. This system is based on the observation
that extracts from cells transformed with the adenovi-
ral oncogene EIA ("transformed extracts") sponta-
neously activated caspases, whereas extracts from
untransformed cells ("untransformed extracts") did
not, an observation consistent with the pro-apoptotic
effect of this oncogene in cells. We suggested that the
activity that triggered caspase activation is induced by
expression of EIA, and we called this activity OGA
(oncogene-generated activity). OGA partially purified
from 293 cells (a transformed human epithelial kidney
cell line that expresses the E1A and ElB oncogenes)
activated caspases when added to untransformed
extracts, thus mimicking the effects of EIA expression
in cells. Therefore, we suggested that OGA is a link
between oncogene expression and the apoptotic
machinery.
We have purified OGA to apparent homogeneity
and have identified it as APAF-I (apoptotic protease
activating factor I), a cofactor required for caspase-9
activation. We found that caspase-9 was indeed
required for caspase activation in our cell-free system,
as was cytochrome c, a second caspase-9 cofactor.
These observations predicted that caspase-9 is the ini-
tiator caspase that mediates oncogene-dependent
apoptosis in cells and that expression of oncogenes
sensitizes the cells to apoptosis by facilitating activa-
tion of this caspase. To test these predictions, we used
human primary fibroblasts (IMR90) that were sensi-
tized to drug-induced apoptosis by expression of ade-
noviral oncogene E1A. Consistent with the results
from the cell-free system, a caspase-9 dominant-nega-
tive mutant blocked drug- induced apoptosis in cells
expressing E1A. This finding led us to investigate how
E1A expression controlled caspase-9 activation. We
conclude that this control is achieved through several
mechanisms, one of which is regulating cytochrome c
release from mitochondria.
Because our results indicated that caspase-9 is
involved in E1A- dependent apoptosis and because
cytochrome c is required for caspase-9 activation, we
asked whether E1A sensitizes cells to drug-induced
apoptosis by facilitating cytochrome c release. We
found that although etoposide induced cytochrome c
release in cells expressing ElA irrespective of other
manifestations of apoptosis, it did not have this effect
in normal IMR90 cells, except in the small fraction
that underwent apoptosis following etoposide treat-
ment (<5% of the whole population). Thus, it appears
that E1A controls drug-induced apoptosis, at least in
part, by regulating cytochrome c release and thereby
facilitating caspase-9 activation. This facilitation may
be a biochemical mechanism underlying oncogene-
induced sensitization of cells to apoptosis.
How ElA regulates the release of cytochrome c
remains to be elucidated. One way can be through
induction of proteins that release cytochrome c such as
Bax. Considering that E/A -dependent Bax expression
is controlled by p53, a tumor suppressor, it is a rea-
sonable speculation that the function of p53 in onco-
gene-dependent apoptosis is to induce proteins
required for cytochrome c release.
Although E1A can control caspase-9 activation by
facilitating cytochrome c release, our findings in vitro
suggest that additional mechanisms are involved. In
the cell-free system, transformed and untransformed
extracts have similar concentrations of cytochrome c,
because breaking mitochondria during extract prepa-
ration bypasses any mechanism that regulates
cytochrome c release in cells. However, caspases
become active only in transformed extracts, which led
us to propose that an activity, OGA, accounts for the
difference. Yet, OGA, which was identified here as
APAF-I, is also present in both extracts, as is caspase-
9. Our hypothesis is that oncogenic transformation not
only affects cytochrome c release, but also somehow
"activates" other components required for caspase-9
activation.
LOCALIZATION OF CASPASES
INVOLVED IN APOPTOSIS
Where are the components of the apoptotic machinery
in a cell is one of the many mysteries of apoptosis. Not
knowing where these components are makes it difficult
to devise a viable model of cell death. Indeed, a signifi-
cant part of our knowledge, as well as many assump-
tions, about the mechanisms of apoptosis comes from
studies on cell-free systems, which are made of a homo-
geneous cell extract and isolated nuclei. Therefore, dur-
ing the last year, we continued to analyze systematical-
ly the intracellular localization of caspases.
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REGULATION OF APOPTOSIS AND SENESCENCE
S. Lowe G. Ferbeyre A. Samuelson
A. Lin C. Schmitt
M. McCurrach E. de Stanchina
J. Polyakova M. Soengas
Apoptosis is a genetically controlled form of cell death
that is important in normal development and in main-
taining tissue homeostasis. Senescence produces
"genetic death" in that senescent cells permanently
arrest and are incapable of further genome propaga-
tion. Both processes are frequently disrupted in cancer
cells, implying that each can limit tumor development.
Moreover, radiation and many chemotherapeutic
agents can induce apoptosis or senescence, raising the
possibility that the integrity of these programmed
responses influences the outcome of cancer therapy in
patients. The goal of our research is to understand how
cancer genes control apoptosis and senescence in nor-
mal cells and how mutations that disrupt these
processes impact tumor development and therapy. Our
approach is genetic, and we typically exploit simple
cellular systems to study cancer gene function. We
often use viral oncogenes to probe cellular processes
involved in normal growth control but have more
recently extended our studies to cellular oncogenes.
Finally, we are currently developing animal models to
confirm the relevance of our simple systems for mul-
tistep carcinogenesis and cancer therapy.
Activation of p53 by E1A
E. de Stanchina, M. McCurrach, A. Samuelson
[in collaboration with C. Prives, Columbia University,
and C. Sherr and M. Roussel, St. Jude Children's
Research Hospital]
Much of our previous work focused on the p53 tumor
suppressor, the most frequently mutated gene in
human cancer. p53 promotes cell cycle arrest or apo-
ptosis in response to DNA damage, hypoxia, and mito-
genic oncogenes. Following DNA damage, signaling
to p53 is mediated, at least in part, by a kinase that
phosphorylates p53 on Ser-15, thereby stabilizing the
protein by preventing its association with Mdm2.
Mitogenic oncogenes can also activate p53, leading to
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increased apoptosis or premature senescence. This
year, we demonstrated that the adenovirus E1A onco-
gene activates p53 through a mechanism independent
of DNA damage, which involves inactivation of
retinoblastoma protein (RB) and activation of the ARF
tumor suppressor (de Stanchina et al. 1998). Hence,
the stabilized p53 in E1A-expressing cells lacks
detectable Ser-15 phosphate, and E1A is unable to
induce p53 or its transcriptional targets in ARF-null
mouse embryonic fibroblasts (MEFs). Moreover,
ARF-null MEFs expressing E1A are resistant to apo-
ptosis following serum depletion, irradiation, or adri-
amycin treatment. Reintroduction of ARF restores
both p53 accumulation and apoptosis. Of note, the
functions of E1A that induce pl9A' and p53 and pro-
mote apoptosis are precisely those required for E1A's
oncogenic potential, implying that these processes are
tightly coupled. These effects are not unique to E1A,
as other mitogenic oncogenes that activate p53 also
induce p 19^'F and require ARF to elicit their antipro-
liferative effects (see Sherr, Genes Dev. 12: 2984
[1998]). These data imply that pl9A" functions as part
of a p53-dependent fail-safe mechanism designed to
counter uncontrolled proliferation and that this path-
way is distinct from that induced by DNA damage.
The involvement of bona fide tumor suppressors (RB
and ARF) in oncogene-mediated signaling to p53
underscores the role of the ARF-p53 pathway in tumor
surveillance (see Lowe 1999).
E1A and Chemosensitivity
M. McCurrach, E. de Stanchina,
J. Polyakova, A. Samuelson
E1A has the remarkable property of making cells
extremely sensitive to the cytotoxic effects of radiation
and many chemotherapeutic drugs, and we continue to
use E1A as a tool to understand factors that modulate
cellular radio- and chemosensitivity. This year, we
demonstrated that a major component of this effect
results from the ability of E1A to induce p19ARF. ARF
can stabilize p53 in response to oncogenes, but it does
not activate p53 in response to DNA damage (see
above). However, in the presence of an oncogenic
stimulus, we demonstrated that pl9ARF can synergize
with DNA damage to activate p53 and promote apo-
ptosis (de Stanchina et al. 1998). Hence, ARF-null
cells expressing E1A display attenuated apoptosis in
response to radiation or adriamycin treatment com-
pared to their normal counterparts, and reintroduction
of ARF into ARF-null cells expressing E1A produces
massive increases in p53 protein and radio- and
chemosensitivity. Of note, since p19ARF targets p53,
reintroduction of ARF into p53-null cells has no effect
on radio- or chemosensitivity. These data imply that
activation of p53 by DNA-damaging agents can be
markedly influenced by peripheral signals affecting
p53 function. Moreover, if similar processes occur in
human cancer, therapeutic strategies to exploit pl9ARF
activation may enhance the radiosensitivity or
chemosensitivity of p53-expressing tumors.
Other studies from our laboratory indicate that the
ability of E1A to induce ARF cannot fully explain its
ability to enhance anticancer agent-induced apoptosis.
Therefore, we are performing extensive structure-
function analysis on E1A to identify (ultimately) the
cellular factors and processes underlying these alter-
native mechanisms. In addition, we continue to collab-
orate with Y. Lazebnik here at the Laboratory to
explore how E1A can ultimately potentiate activation
of the apoptotic machinery. We hope that a better
understanding of this phenomenon may ultimately
suggest cellular targets for novel therapies to enhance
the radiosensitivity and/or chemosensitivity of human
tumors.
p53-dependent and
p53-independent
Apoptotic Pathways
M. Soengas, M. McCurrach [in collaboration
with T. Mak, Amgen Institute]
We continue to compare and contrast p53-dependent
and p53-independent apoptotic programs in cells
expressing E 1 A. E1A sensitizes cells to apoptosis
induced by serum depletion, ionizing radiation,
chemotherapeutic agents, hypoxia, and tumor necrosis
factor (TNF). By introducing E1A into fibroblasts
from normal and "knockout" mice, we can determine
whether the deleted gene is involved in the above forms
of apoptosis. For example, p534- cells expressing E1A
are less sensitive to most anticancer agents than their
p53+'4" counterparts, yet display similar sensitivities to
TNF. Using knockout MEFs expressing E1A, we
assessed the requirement for pl9ARF, p53, Bax, cas-
pase-3 (Casp3), caspase-9 (Casp9), Fas-associated
death domain protein (FADD), and Apafl during apo-
ptosis following adriamycin (p53-dependent) and TNF
(p53-independent) treatment. To varying degrees, we
see that inactivation of ARF (de Stanchina et al. 1998),
Bax, Casp9 (Hakem et al. 1998), and Apafl (M.
Soengas and S. Lowe, unpubl.) suppress cell death
induced by ADR but not THE In contrast, FADD inac-
tivation prevents TNF-induced death but not ADR (Yeh
et al. 1998). Finally, inactivation of Casp3 attenuates
cell death leading to an aberrant form of apoptosis fol-
lowing treatment with either agent (Woo et al. 1998),
implying that the p53-dependent and p53-independent
pathways ultimately converge.
The studies defined from the simple genetic sys-
tem clearly define at least two apoptotic pathways in
oncogene-expressing cells. Since we hypothesize that
the p53 pathway acts to suppress transformation, a
clear prediction of our model is that disruption of the
downstream components of the p53 apoptotic path-
way should facilitate oncogenic transformation even
in the presence of normal p53. Preliminary studies
suggest this is the case (M. Soengas and S. Lowe,
unpubl.).
Induction of Cellular
Senescence by
Oncogenic Ras
A. Lin, G. Ferbeyre [in collaboration with
L. Van Aelst, Cold Spring Harbor Laboratory]
We also examined the Ras signaling pathway(s)
responsible for p53 activation and premature senes-
cence of nonimmortal human and mouse fibroblasts.
Known Ras effectors include Raf-1 and components of
the MAPK cascade, PI3-kinase (PI3K), Akt, c-Jun-N-
terminal kinase (JNK), Rac the Rho proteins, and NF-
KB. In normal cells, Ras induces premature senescence
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through activation of the MAPK cascade, the same
pathway important for Ras-induced mitogenesis in
immortal cells (Lin et al. 1998). In human fibro-blasts,
Ras "effector loop" mutants that retain their ability to
bind Raf-1 promote premature senescence, and among
a series of Ras downstream components examined, only
activated Raf-1 and MEK induce p53, p16, and features
of senescence. Moreover, a MEK inhibitor (PD98059)
prevents Ras-induced cell cycle arrest and senescence.
In primary murine fibroblasts, activated MEK arrests
wild-type MEFs but forces uncontrolled mitogenesis
and transformation when expressed at comparable lev-
els in p53 -1- or INK4a"24- MEFs. The precisely opposite
response of normal and functionally immortal cells to
constitutive MAPK activation implies that premature
senescence acts as a fail-safe mechanism to limit the
transforming potential of excessive Ras mitogenic sig-
naling. Thus, constitutive MAPK signaling activates
p53 and p16 as tumor suppressors. More recently, we
demonstrated that, like El A, oncogenic ras activates
p53 through p 19A' (G. Ferbeyre, A. Lin, D. de
Stanchina, and S. Lowe, unpubl.).
In addition to their relevance for understanding
multistep carcinogenesis, we believe our data provide
new insights into the process of cellular senescence.
Senescence was originally defined by the observation
that primary cells have a genetically determined limit
to their proliferative potential in cell culture, after
which they permanently arrest with characteristic fea-
tures. Because of the "end-replication problem," telo-
meres shorten during each cell division unless telom-
erase is expressed, and it has been proposed that some
aspect of excessive telomere shortening activates cell
cycle arrest and other characteristics of senescence.
Our data demonstrate that senescence can be activated
in response to deregulated MAPK activation (Lin et al.
1998). Although it remains possible that telomere
shortening or some other cell-doubling-sensitive mech-
anism activates senescence through MAPK signaling,
our hypothesis is that senescence can be activated by
diverse stimuli leading to engagement of a common cell
cycle arrest program. In this view, the process of senes-
cence is conceptually related to apoptosis, a genetically
controlled program carried out by a common cell-death
machinery. Diverse stimuli and signaling pathways feed
into this machinery, allowing regulation of cell death to
be highly versatile. Consequently, the biological roles
of cellular senescence may go well beyond the control
of cellular or organismal aging, acting as a global
antiproliferative response to a variety of cellular stress-
es.
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In Vivo Models of Drug
Sensitivity and Resistance
C. Schmitt, M. McCurrach
Our research is based on the premise that apoptosis
provides a natural defense against tumor development
and contributes to the cytotoxicity of most current
anticancer agents. If true, then mutations that disrupt
apoptosis should produce drug resistance. Although
this appears to be true in at least some settings, the
relationship between apoptosis and therapy is contro-
versial. Thus, not all studies see an impact of specific
anti-apoptotic changes on clonogenic survival of cul-
tured cells nor correlate apoptotic mutations with drug
resistance in patients. The picture is further clouded by
the fact that cellular context can influence the results
of clonogenic survival assays, and most commonly
studied human tumor lines are derived from patients
who received chemotherapy and have been further
selected for growth in culture; hence, the response of
these cells to anticancer agents may differ substantial-
ly from primary human tumor cells.
Since cancer occurs in whole animals, cell culture
models may not recapitulate in vivo processes.
Nevertheless, studies in human patients are complicat-
ed by extreme genetic heterogeneity and ethical issues.
Mouse models provide an attractive alternative, since
(1) large numbers of genetically identical individuals
can be analyzed, (2) transgenic and knockout strains
can be used to produce tumors with specific genetic
alterations, and (3) samples can be isolated from ani-
mals undergoing therapy. To this end, our laboratory is
studying the molecular genetics of drug sensitivity and
resistance in the Eg-myc transgenic mouse developed
by Adams et al. (Nature 318: 533 [1985]). These ani-
mals constitutively express c-Myc in the B-cell lineage
and typically succumb to pre-B or B-cell lymphoma at
4-6 months of age, many with associated leukemia.
We hypothesized that the Eg-myc transgenic mouse
would be a tractable model for studying factors
involved in therapy-induced cell death, since (1) tumor
burden can be easily monitored by lymph node palpa-
tion or blood smears, (2) lymphomas are detectable
long before the animal dies, so animals can be treated
early, (3) large numbers of pure tumor cells can be iso-
lated from mice undergoing therapy, (4) therapy is per-
formed in immunocompetent mice, and (5) lymphoma
cells readily adapt to culture and can be transplanted
into syngeneic mice.
We have characterized the response of Ept-myc
lymphomas to several anticancer drugs and have
developed methods to facilitate the analysis of genetic
factors involved in drug sensitivity and resistance. In
addition, we have shown that Eli-myc lymphomas typ-
ically retain p53 function and are highly responsive to
DNA damaging agents such as adriamycin and ioniz-
ing radiation, which produce massive p53 induction
and apoptosis shortly after treatment. In contrast, Eli-
myc lymphomas lacking functional p53 (generated by
crossing to the p53 knockout mouse) display reduced
apoptosis and are typically resistant to these same
therapies. Although p53 mutations are relatively rare
in primary human leukemias or lymphomas, patients
harboring these tumors rarely respond to cancer thera-
py. Therefore, the behavior of Ep,-Inye lymphomas
recapitulates the behavior of human tumors and
strongly suggests that this model will be useful for
identifying additional factors relevant to drug sensitiv-
ity and resistance in human cancer.
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CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski Y.-N. Chang
M.E. Greenberg
B. Hill
A.J. Jafrate
A. Janardhan
M. Lock
N. Shohdy
T. Swigut
Our interest is in understanding the molecular mech-
anisms underlying the pathogenesis of AIDS and, in
particular, in understanding the functional conse-
quences of the interactions between viral proteins and
the cellular regulatory machinery. The focus of our
research is to understand the function of Nef, a regu-
latory protein of human and simian immunodeficen-
cy viruses (HIV and SIV), which is an important
determinant of viral pathogenicity. Nef is likely an
attractive potential target for the development of new
drugs for AIDS treatment because viral replication is
low and AIDS is attenuated in humans and animal
models of AIDS. In addition, deleting the nef gene is
a common promising strategy to attenuate immunod-
eficiency viruses for use as live attenuated vaccines.
Natural Nef proteins have several conserved
effects on signal transduction and protein-sorting
machineries that probably enhance viral virulence in
vivo. One effect of Nef is to down-regulate expression
of the CD4 molecule, an essential component of the
cellular receptor for HIV and SIV virions and a com-
ponent of the antigen receptor on class II major histo-
compatibility complex (MHC)-restricted T lympho-
cytes, from the cell surface. Nef also down-regulates
expression of class I MHC from the cell surface, and,
through this effect, Nef can probably help infected
cells evade the immune response in the infected host.
During the last year, we focused on the mechanism of
down-regulation of class I MHC by Nef. We also con-
tinued our studies of the mechanism of Nef-induced
down-regulation of CD4 expression and, in collabora-
tion with Dr. Tom Kirchhausen (Harvard University),
obtained evidence suggesting that Nef interacts direct-
ly with the AP-2 adaptor protein complex. Finally, we
initiated the studies of the role of class I MHC down-
regulation by Nef for the development of AIDS.
NEF INDUCES THE ACCUMULATION OF CLASS I
MHC IN THE TRANS-GOLGI
Experiments were performed to address the fate of
class I MHC in cells expressing HIV-1 Nef. Using flu-
orescence microscopy, we found a dramatic accumula-
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tion of assembled class I MHC in the Golgi of Nef-
expressing cells. Colocalization experiments with pro-
teins known to reside in various subcompartments of
the Golgi revealed that class I MHC accumulates in
the trans-Golgi compartment that also contains the
AP-1 clathrin adaptor complex, found in the trans-
Golgi and in transport vesicles linking the trans-Golgi
with the endocytotic pathway. In contrast, very little if
any class I MHC is found at this location in the
absence of Nef.
Class I MHCs are normally transported to the plas-
ma membrane by the default exocytotic pathway.
Since the trans-Golgi is a late-sorting station for the
protein traffic to and from the plasma membrane, class
I MHC molecules that accumulate in the trans-Golgi
could be sorted to this location directly from the exo-
cytotic pathway, or following endocytosis from the
plasma membrane, or by both of these mechanisms.
We addressed these possibilities and found that class I
MHC that are internalized from the plasma membrane
accumulate in trans-Golgi in cells that express Nef.
These and other observations indicate that Nef pro-
motes class I MHC internalization from the cell sur-
face to the trans-Golgi. Many viruses are known to
interfere with the normal expression of class I MHC at
the cell surface. They usually do so by disrupting the
biogenesis and/or transport of the class I MHCs along
the exocytotic pathway. Therefore, the mechanism
whereby Nef promotes the internalization of class I
MHC molecules to the trans-Golgi, likely followed by
transport to the endosome-lysomal pathway and
degradation, is a novel mechanism for down-regulat-
ing class I MHC expression by a viral protein. Our
current experiments address the possibility that Nef
alters additional events in the assembly and/or trans-
port of class I MHC.
SEPARATE FUNCTIONS OF NEF DOWN-REGULATE
CD4 AND CLASS I MHC EXPRESSION
Involvement of endocytosis with both the down-reg-
ulation of CD4 and class I MHC expression by Nef
suggested that these effects may involve similar
mechanisms. Since we know that the ability of Nef to
down-regulate CD4 involves its colocalization with
the AP-2 clathrin adaptor, we were interested in
whether this interaction is also required for down-
regulation of the class I MHC. Interestingly, we
found that the mutations in Nef disrupting the inter-
action with AP-2 on class I MHC down-regulation
had no effect on down-regulation of class I MHC.
These observations indicate that Nef down-regulates
class I MHC and CD4 molecules via different inter-
actions, with possibly different components of the
protein-sorting machinery.
DOWN-REGULATION OF CLASS I MHC
LIKELY INVOLVES NEF INTERACTION
WITH AN SH-3 DOMAIN-CONTAINING
PROTEIN
We asked whether the down-regulation of class I MHC
maps to surfaces in Nef with other known functional
roles. Using a panel of previously characterized
mutant Nef proteins, we found that mutations that dis-
rupt the SH3-domain-binding surface of Nef also dis-
rupt class I MHC down-regulation. The mutations
included substitutions disrupting the PPII helix in Nef
and the canonical SH3 ligand-binding motif, as well as
those disrupting other aspects of the SH3-domain-
binding surface of Nef. These observations suggest
that down-regulation of class I MHC expression prob-
ably involves an interaction of Nef with an SH3 -
domain- containing protein.
The ability of Nef to down-regulate class I MHC
expression also requires a cluster of acidic amino acid
residues conserved in HIV-1 Nef. This acidic element
is not known to be a part of the surface of Nef that
mediates interactions with SH3 domain ligands, sug-
gesting that interactions of Nef with a non -SH3-
domain- containing protein are also important for the
down-regulation of class I MHC expression. Although
we do not yet have a candidate protein for this interac-
tion, the acidic element in Nef may function as a sort-
ing signal because a similar cluster of acidic amino
acids are part of trans-Golgi retrieval signals found in
cytoplasmic domains of proteins that reside in the
trans-Golgi. Interestingly, the acidic region and the
PPII helix of Nef are also important for the ability of
Nef to block CD3-initiated signaling in T cells, thus
linking the sorting and signal transduction machiner-
ies in the regulation of class I MHC expression by Nef.
HIV-1 NEF BINDS AP-2 TO DOWN-REGULATE
THE CD4 MOLECULES FROM THE CELL
SURFACE
We previously found that HIV-1 Nef colocalizes in the
cell with AP-2 clathrin adaptor complex and with
CD4. The AP-2 adaptor mediates clathrin-dependent
endocytosis by linking sorting signals in cytoplasmic
domains of integral membrane proteins to clathrin in
clathrin-coated pits at the plasma membrane.
Furthermore, our observations that mutations which
disrupt colocalization of Nef with AP-2 also disrupt
the ability of Nef to down-regulate CD4 expression
indicated that Nef down-regulates CD4 endocytosis by
recruiting CD4 to clathrin-coated pits at the plasma
membrane and accelerating CD4 endocytosis via this
route; these observations also suggested that Nef may
interact directly with the AP-2 adaptor complex.
During the last year, experiments were performed
to further characterize the putative direct interaction
between HIV-1 Nef and AP-2. First, in collaboration
with Tom Kirchhausen (Harvard University), we iden-
tified a sequence in the carboxy-terminal disordered
region in Nef that is essential for down-regulation of
CD4. This sequence has the characteristics of the
dileucine motif, one of two well-characterized sorting
signals identified in other systems as being required
for targeting membrane proteins to clathrin-coated
membranes. The dileucine-containing Nef peptide
binds directly and specifically to the 13-subunit of the
clathrin-adaptor complexes AP-1 and AP-2. In contrast
to wild-type Nef, a Nef mutant that lacks this motif
does not colocalize with AP-2 in vivo and does not
down-regulate CD4 expression. These findings sup-
port the possibility that HIV-1 Nef binds directly to
AP-2 via its acceptor site for dileucine-based sorting
signals and that this interaction is likely critical for its
ability to down-regulate CD4, possibly by promoting
the recruitment of CD4 to AP-2. Current experiments
are aimed toward understanding the interactions of
Nef resulting in the recruitment of CD4.
ROLE OF CLASS I MHC RESTRICTED
ANTIVIRAL RESPONSES IN THE
DEVELOPMENT OF AIDS
Cytotoxic-T-cell responses directed toward viral anti-
gens presented by class I MHC molecules by virally
infected cells provide the fundamental mechanism for
the antiviral responses of the host. Down-regulation of
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class I MHC on the cell surface by Nef provides a pos-
sible mechanism through which immunodeficiency
viruses could evade the defenses of the infected host
and thereby permit the establishment of progressive
infection. This effect of Nef could be very important
for the development of AIDS, but little is known about
its role for viral replication in vivo or about the role of
the cytotoxic-T-cell response in HIV/SIV infection.
To address these questions, we initiated experi-
ments in collaboration with R.C. Desrosiers (Harvard
University) to assess the role of class I MHC down-
regulation by Nef for SIV replication and development
of AIDS in rhesus macaques, the best currently avail-
able animal model of AIDS. As a first step, we identi-
fied a number of point mutations in the carboxy-ter-
minal region of SIV Nef that disrupt class I MHC
down-regulation but have little effect on other known
Nef functions. We are currently developing mutant
Nef proteins with deletions in those regions that would
selectively disrupt class I MHC down-regulation. We
hope that it will be more difficult for such mutations
to revert in vivo and that we will be able to measure the
effect of this Nef function on SIV replication in the
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context of a functional immune system and for disease
progression.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund C. Sanders G. Chen
E. Gillitzer A. Lee
The papillomaviruses infect and transform the basal
epithelium of their hosts, inducing proliferation of the
cells at the site of infection. The resulting tumors are
in most cases benign and will usually regress after
some time, but certain types of human papillo-
maviruses (HPVs) give rise to tumors that are prone to
progress toward malignancy, especially frequently cer-
vical carcinoma. In total, HPV DNA can now be found
in biopsies from approximately 80% of all cervical
carcinomas.
A key impediment to the study of papillomavirus-
es has been an inability to define simple in vitro cell
culture systems for HPVs, largely because these virus-
es normally require specialized differentiating cells
that only with great difficulty can be generated in cell
culture. Therefore, a bovine papillomavirus (BPV-1)
has become the prototype virus for the papillomavirus
group largely because a convenient cell culture system
exists for this virus. In this cell culture system, viral
gene expression, oncogenic transformation, and viral
DNA replication can be studied. The DNA replication
properties of papillomaviruses show some unique and
interesting characteristics. As a part of their normal
life cycle, these viruses can exist in a state of latency
which is characterized by maintenance of the viral
DNA as a multicopy plasmid in the infected cells. The
copy number of the viral DNA appears to be tightly
controlled, and the viral DNA is stably inherited under
these conditions. This system therefore provides a
unique opportunity to study plasmid replication in
mammalian cells.
In previous years, we have reported the characteri-
zation of the papillomavirus replicon and the identifi-
cation of the viral components required for viral DNA
replication. More recently, we have directed our atten-
tion toward detailed biochemical analysis of the repli-
cation process. We are studying the biochemical prop-
erties of the virus-encoded El and E2 proteins that are
required for viral DNA replication. We are also study-
ing how these two proteins interact with the ori and
with each other to generate initiation complexes. From
these studies, we now have a relatively clear picture of
the roles of the El and E2 proteins in replication. El
has all the characteristics of an initiator protein,
including ori recognition, DNA-dependent ATPase
activity, and DNA helicase activity. El can also func-
tion to unwind a supercoiled plasmid that contains the
on sequence. The E2 polypeptide, whose function has
remained more elusive, appears to serve largely as a
specificity factor for El. Through physical interac-
tions with both El and the ori, E2 can provide
sequence specificity in the formation of the initiation
complex.
Our attention has now turned toward elucidation of
the precise biochemical events that precede initiation
of replication at the origin of replication, i.e., binding
of the initiator to the ori, the initial opening of the
DNA helix, and the assembly and loading of the El
replication helicase at the replication fork. Our studies
indicate that initiation of DNA replication is an
ordered multistep process involving the sequential
assembly of El onto the ori to generate different com-
plexes that in turn serve to recognize the ori, to desta-
bilize the double helix at the ori, and to function as a
replication helicase.
DNA Binding by the
Initiator Protein El
G. Chen
The initiator protein El has a poorly characterized
DNA-binding activity that serves to recognize the
papillomavirus origin of DNA replication and thus
determines where DNA replication initiates. We have
previously established that El can form several differ-
ent complexes with ori DNA. To understand how these
forms are generated and how they function in replica-
tion, we are interested in determining the stoichiome-
try of binding as well as defining the sequences that
constitute specific recognition sequences for El. We
have identified and isolated a minimal domain from
El that is capable of binding specifically to the ori.
This domain, which consists of the sequences between
amino acids 142 and 308 in El, can form several dif-
ferent complexes with the ori as judged from gel-shift
analysis and can also bind cooperatively with the E2
protein. To determine the stoichiometry of binding, we
performed mixing experiments using two DNA-bind-
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ing domain fragments of different sizes. The results
from these studies demonstrated that the El DNA-
binding domain, which is monomeric in solution, can
bind to the on as one to four monomers. Interference
analysis in combination with mutational analysis
demonstrated that each monomer of El recognizes a
hexanucleotide sequence which exists in six copies in
the on sequence. In the presence of E2, El binds as
two monomers, which is also the form of El that
cooperates with the E2 protein for binding. Binding of
El is primarily in the major groove where bases from
both strands are recognized.
Interactions between the
DNA-binding Domains of the
El and E2 Proteins
G. Chen
In most eukaryotic replicons that have been studied,
binding sites for transcription factors constitute a part
of the cis-acting sequences required for replication
activity. In the majority of cases, including, for exam-
ple, SV40, polyomavirus, and ARS elements from
Saccharomyces cerevisiae, this auxiliary activity can
be supplied by various transcriptional trans-activators
with little apparent specificity. A similar requirement
exists also for papillomavirus replicons; however, only
the virus-encoded transcription factor E2 can serve as
an auxiliary factor for DNA replication. The involve-
ment of E2 in replication of BPV extends beyond a
mere requirement for E2 bound to the ori: A physical
interaction with El is also required. This interaction
can be detected as cooperative binding of the two pro-
teins to the ori. The interaction between the El and E2
proteins appears to take place in a two-step process
where an initial weak physical interaction between El
and the E2 DNA-binding domain allows a productive
interaction to occur between El and the activation
domain of E2. We have used site-directed mutagenesis
to identify the specific residues in the E2 DNA-bind-
ing domain that are required for the interaction with
El. These studies have mapped two small patches of
hydrophobic residues in the DNA-binding domain of
E2 that are important for the interaction with El, ver-
ifying the specificity of this interaction and allowing
us to address the importance of this protein-protein
interaction in the viral life cycle. Mutations in these
residues abolish the cooperative binding between El
and E2 DNA-binding domains. Furthermore, these
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point mutations in the E2 DNA-binding domain result
in a severe defect in the interactions between the full-
length E 1 and E2 proteins, indicating that, indeed, the
interaction between the two DNA-binding domains is
a prerequisite for the interaction beween the E2 activa-
tion domain and El. Interestingly, these same muta-
tions, when introduced into the viral genome, result in
a severe defect in transformation. When replication of
the viral genome is measured, the mutant viral DNA
fails to accumulate, demonstrating a defect in viral
DNA replication. Thus, most likely, the defect in trans-
formation is caused by the defect in replication of the
viral genome.
Cooperative Binding of El
and E2 Induces Structural
Changes in the on
E. Gillitzer
As discussed above, cooperative binding of the El and
E2 proteins is required for DNA replication in vivo. We
have previously demonstrated that this interaction has
two separate components. The DNA-binding domains
of the two proteins interact, and the activation domain
of E2 interacts with the helicase domain of the El pro-
tein. As mentioned above, the interaction between the
activation domain of E2 and El is the productive inter-
action, whereas the interaction between the two DNA-
binding domains serves to facilitate this interaction. To
determine how the physical interaction between the
two DNA-binding domains triggers the productive
interaction, we have analyzed the structure of the ori in
response to binding of the two DNA-binding domains.
Both the El and E2 proteins individually generate
modest bends upon binding. However, when the two
proteins are bound cooperatively, a much sharper bend
centered between the two binding sites results. This
sharp bend (which approaches 901 could result either
from the combined intrinsic bends contributed by the
individual proteins or from the interaction between the
two proteins. To distinguish between these possibilities,
we utilized the E2 DNA-binding domain mutants
described above that fail to interact with the El DNA-
binding domain. Interestingly, although the intrinsic
bend generated by the mutant E2 DNA-binding
domains was of a magnitude similar to that generated
by the wild-type E2 DNA-binding domain, the mutant
E2 DNA-binding domains failed to generate a sharp
bend in combination with the E1 DNA-binding
domain. These results suggest that when the El and E2
DNA-binding domains interact physically, the result is
the generation of a bend of the sequences between the
two sites. This bend, in turn, appears to facilitate the
interaction between the trans-activation domain of E2
and the helicase domain in El.
Assembly of Initiator Complexes
C. Sanders
An intriguing aspect of viral initiator proteins is their
ability to perform several different, seemingly unrelat-
ed biochemical functions. The El protein is known to
be a sequence-specific DNA-binding protein, but it
can also distort the ori and serve as a DNA helicase.
One model to explain how these activities can reside in
one single polypeptide is that different oligomeric
forms of the protein may have different activities. Our
previous genetic and biochemical studies have indicat-
ed that both of the two specific El-containing com-
plexes that we can detect on the ori are important for
initiation of DNA replication. These two complexes,
which we have termed the E1E2-ori complex and the
El-ori complex, differ in that E2 is present in one of
the complexes and also that a larger number of El
molecules are present in the El -ori complex. However,
the complexes are clearly related, and the El mole-
cules bound in the E1E2-ori complex constitute a sub-
set of the El molecules bound in the El-ori complex.
To address whether these two complexes represent
stages in an assembly pathway, we have analyzed their
biochemical properties as well as their relation to each
other. These studies have revealed a very interesting
relationship, consistent with a role for both complexes
in the ordered assembly of an initiator complex on the
BPV ori. The E1E2-ori complex binds to the ori with
very high affinity and specificity, whereas the El -ori
complex shows limited sequence specificity. By using
an epitope tagging technique to follow the fate of the
El molecules from one particular complex, we have
been able to demonstrate that the El E2-ori complex is
a preferred substrate for the formation of the El -ori
complex. In a reaction that requires hydrolysis of ATP,
the E1E2-ori complex can be converted into the El -ori
complex. As a consequence of this reaction, E2 is dis-
placed from its binding site and additional El mole-
cules are added to the complex. Because the El-ori
complex formed from the E1E2-ori complex appears
to be identical to the El-ori complex formed in the
absence of E2, these results identify a role for the viral
transcription factor E2 as a factor required transiently
and catalytically for the assembly of the initiator com-
plex. One clear implication of these results is that a
crucial function for E2 in DNA replication is to form
a cooperative complex with El, increasing the speci-
ficity and affinity of El binding. Thus, this pathway
identifies a strategy for depositing a complex with
limited sequence specificity (the El -ori complex) onto
a specific site. This is accomplished through the initial
formation of the sequence-specific E1E2-ori complex
which subsequently is converted to the less sequence-
specific El-ori complex. This process shows interest-
ing parallels to loading of both prokaryotic and
eukaryotic replication factors such as, for example,
proliferating cell nuclear antigen (PCNA) and Dna B.
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Our research continues to focus on the mechanism and
regulation of DNA replication and the mechanisms
that ensure inheritance of chromatin structures in pro-
liferating eukaryotic cells. During the past year, con-
siderable progress has been made toward these goals.
Furthermore, we have become increasingly more
interested in how epigenetically determined states of
chromatin are inherited. In particular, we have uncov-
ered interactions between the DNA replication protein
machinery and the machinery that facilitates chro-
matin assembly. In addition to these studies, we have
continued to investigate how initiation of DNA repli-
cation occurs and how this process is controlled by cell
cycle events.
THE INITIATION OF DNA REPLICATION
Characterization of the DNA elements that constitute
a functional origin of DNA replication and identifica-
tion of the origin recognition complex (ORC) that
binds to these origins have proved to be significant
advances. The origin-bound ORC is the focus of a
series of protein-protein interactions that determine
how initiation of DNA replication occurs and how it is
controlled. Our studies since these two discoveries
have been directed toward understanding how ORC
functions as an origin-specific landing pad for other
proteins that eventually cause the initiation of DNA
replication at each origin during the S phase of the cell
cycle.
ORC was originally discovered in the yeast
Saccharomyces cerevisiae as a six-subunit protein
complex that bound to autonomously replicating
sequences (ARS) in an ATP-dependent manner. We
had previously identified the ORC1 and ORC2 sub-
units from human cells and other species, suggesting
that ORC is conserved. This may have seemed rather
obvious, but the DNA sequences within origins of
DNA replication have not been conserved, even
among the fungi. Thus, it was not obvious that the
mechanism of initiation involving ORC would be con-
served. In the last year we have, in collaboration with
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Tim Hunt's laboratory (Imperial Cancer Research
Laboratories, United Kingdom), purified and
sequenced subunits of ORC from Xenopus, identified
cDNAs encoding the Xenopus ORC3 and ORC5 sub-
units, and cloned cDNAs encoding the human ORC3,
ORC4, and ORC5 subunits. Combined with the
sequences of the yeast orthologs, we realized that the
ORC1, ORC4, and ORC5 subunits are structurally
related to each other, belonging to a class of predicted
ATP-binding proteins. Andy Neuwald's group here at
the Laboratory independently identified these three
ORC subunits as belonging to a large superfamily of
known and putative ATPases called the AAA' protein
family. Also belonging to this family of proteins are
the Cdc6 and the six minichromosome maintenance
(MCM) proteins, both of which cooperate with ORC
to initiate DNA replication. Thus, one challenge has
been to determine how ATP controls the functions of
these proteins. Steve Bell's laboratory (Massachusetts
Institute of Technology) has characterized the ATP
dependence of ORC interaction with the origins of
DNA replication.
To further characterize the function of the initia-
tion proteins, we have performed structure-function
analysis of yeast Cdc6p from S. cerevisiae.
Mutagenesis studies suggest that ATP binding, but not
ATP hydrolysis, is required for Cdc6p-dependent
loading of the Mcm proteins on to chromatin to form
the prereplication complex (pre-RC). Furthermore, we
and others have demonstrated that Cdc6p in yeast is
loaded on to chromatin as cells exit mitosis and is then
removed from chromatin as cells enter S phase, after
the activation of the S-phase-specific cyclin-depen-
dent protein kinases (CDKs). In contrast, the Mcm
proteins are loaded on to chromatin soon after the
Cdc6p, but in contrast to Cdc6p, they are removed
from chromatin gradually during S phase. Similar
findings on Cdc6p and Mcm protein binding to chro-
matin have emerged from the laboratories of Steve
Bell, Kim Nasmyth, and John Diffley.
In recent years, the genomes of several species of
Archaea have been completely sequenced, and open
reading frames with high sequence similarity to the
Orc 1/Cdc6p sequences and the Mcm protein
sequences have been identified. The Archaea are a
newly recognized group of organisms that are believed
to bridge the differences between bacteria and eukary-
otic species. The Mcm proteins are essential for initia-
tion of DNA replication in yeast and form part of the
pre-RC at origins of DNA replication prior to S phase.
Like Orclp and Cdc6p, sequences related to the Mcm
protein have been identified in Archaea. To study the
structure and function of these putative initiation pro-
teins, we have cloned the Mcm and Orc 1 /Cdc6-related
proteins from a number of Archaea species and, in col-
laboration with the Rui-Ming Xu laboratory, are bio-
chemically and structurally characterizing these pro-
teins. We anticipate that these studies will complement
similar studies with the yeast proteins.
In the previous year, we reported that Cdc45p is
loaded on to chromatin just prior to S phase in a man-
ner that was dependent on the CLB-CDKs. These
CDKs are essential for initiation of DNA replication
and act to trigger formation of a preinitiation complex
(pre-IC). In the past year, we have characterized anoth-
er protein kinase that is essential for initiation of DNA
replication, the Cdc7-Dbf4p kinase. Recombinant ver-
sions of this kinase have been purified to homogeneity,
and using this enzyme, we have demonstrated that the
kinase autophosphorylates the Dbf4p subunit, Mcm2p,
Mcm3p, Mcm4p, Mcm6p, and Mcm7p, and the largest
subunit of DNA polymerase a primase. Interestingly,
Mcm5p appears not to be a substrate, yet it is known
that mutations in the gene encoding this protein bypass
the need for Cdc7-Dbf4p kinase in mitotically dividing
cells. We have also shown that the Dbf4p subunit is
cell-cycle-regulated in its abundance and is loaded onto
chromatin at the Gi to S phase transition, about the
same time as Ccd45p, and is removed as cells enter into
mitosis. At this time, Dbf4p is degraded in a manner
dependent on functional anaphase-promoting complex
(APC), a protein complex that facilitates ubiquitin-
mediated protein degradation by the 26S proteosome.
How both protein kinases act to trigger entry into S
phase is under further investigation.
DNA-REPLICATION-DEPENDENT
CHROMATIN ASSEMBLY
Previous studies using the SV40 DNA replication sys-
tem have uncovered a DNA replication-dependent
chromatin assembly mechanism. A central component
of this mechanism is the chromatin assembly factor-1
(CAF-1), a three-subunit protein that can mediate
assembly of nucleosomes during DNA replication and
DNA repair. We have shown that elimination of CAF-1
from yeast leads to sensitivity of the yeast strains to UV
light and to reduced silencing of the epigenetically
determined transcriptional state of reporter genes that
are placed adjacent to telomeric heterochromatin. In a
population of CAF-1-defective yeast cells, the
silenced state is inefficiently maintained and the gene
expression is variegated.
We have long wondered why the CAF-1-dependent
nucleosome assembly occurred preferentially on DNA
that was replicated or had undergone DNA repair. In
the last year, we have shown that the replicated DNA
becomes marked with a noncovalent imprint during
DNA replication and that the marked, completely repli-
cated DNA can be isolated and used for chromatin
assembly. Removal of this mark on the replicated DNA
caused the DNA to become incompetent for chromatin
assembly. Analysis of the nature of the noncovalent
mark on the DNA resulted in the demonstration that the
proliferating cell nuclear antigen (PCNA), a protein we
have shown previously to be a DNA polymerase clamp
protein, remained linked to the DNA after DNA repli-
cation. Removal of PCNA from the DNA by the clamp
unloader protein, replication factor C (RFC), removed
the imprint and prevented chromatin assembly on the
replicated DNA. We further showed that PCNA direct-
ly bound to PCNA via the p150 subunit of CAF-1.
These studies show that PCNA is necessary for a DNA-
replication (and DNA-repair)-dependent mark on the
DNA that facilitates CAF-1-dependent chromatin
assembly (Fig. 1). Because of the asymmetric nature of
the DNA replication process and the consequent asym-
metry of PCNA on leading and lagging strands at the
DNA replication fork, we suggest that PCNA may be
part of a mechanism that allows asymmetric inheri-
tance of chromatin structures to daughter cells during
development (Fig. 1).
It is known that PCNA also binds to the [cytosine-
5] methyltransferase, suggesting that PCNA left on
DNA after DNA replication and repair may mediate
DNA methylation. Thus, PCNA may well be a mark on
replicated DNA for the stable inheritance of epigenet-
ically determined chromosomal states, be they nonco-
valent protein or covalent modifications such as cyto-
sine methylation. Consistent with this observation, it is
known that mutations in the gene encoding Drosophila
PCNA cause suppression of position effect variegation
and sensitivity to DNA-damaging agents, phenotypes
remarkably similar to those displayed by yeast strains
that lack CAF-1.
We suggest that CAF-1 and PCNA are components
of a system to ensure the stable propagation of chro-
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FIGURE 1 Model for PCNA-mediated inheritance of chromatin
on replicated DNA. PCNA binds to CAF-1 and mediates DNA-
replication-coupled chromatin assembly. In A, the nucleosomes
are assembled concomitant with passage of the DNA replica-
tion fork, and a similar chromatin structure is formed on both
leading and lagging strands. In B, the asymmetric distribution of
PCNA on the leading strand versus the lagging strand could
promote asymmetric chromatin states on the two sister chro-
matids that then could be distributed to the two daughter cells,
creating phenotypic differences between them.
mosomal complexes in eukaryotic cells. Current
efforts are to test this hypothesis further and to char-
acterize other proteins that are essential for this
process.
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ONCOPROTEIN DESTRUCTION
W. Tansey A. Herbst S. Salghetti
S.Y. Kim K. Tworkowski
M. Muratani
The maintenance of normal cellular growth and differ-
entiation ultimately depends on mechanisms which reg-
ulate cell cycle progression. Two of the most important
of these regulatory mechanisms are transcriptional acti-
vation and proteolytic destruction, which together con-
trol the appropriate appearance and disappearance of
key cell cycle players. Work in our laboratory explores
the intersection between these two processes to under-
stand how oncogene transcription factors are regulated
at the level of their own destruction.
As a paradigm for transcription factor destruction,
we study Myc. Myc is a basic helix-loop-helix tran-
scription factor that features prominently in the regu-
lation of cell proliferation and in cancer. Consistent
with its potent growth-promoting properties, the
expression and activity of Myc are tightly regulated at
many levels, including transcription, mRNA stability,
translation, and protein stability. Indeed, Myc-like
many of the transcription factors that regulate cell
growth-is a highly unstable protein, with a typical
half-life of about 30 minutes. The extreme instability
of Myc and these other regulators helps keep their
intracellular levels low and maintains tight control
over cell proliferation, a role which is underscored by
the fact that some viral oncogenic transcription factors
escape degradation and accumulate to higher levels
than their cellular counterparts.
Work in our laboratory has demonstrated that Myc
is unstable because it is destroyed by a process known
as ubiquitin-mediated proteolysis. In this process, the
covalent attachment of Myc to the protein ubiquitin
signals Myc destruction by the 26S proteasome, a
large complex with several proteolytic activities.
Protein ubiquitylation is a highly specific multistep
process, which begins when an element within the tar-
get protein, termed a degron, is recognized by the cel-
lular ubiquitylation machinery. After the degron has
been recognized and bound, ubiquitin is then trans-
ferred to a lysine residue within the target protein. This
process is then repeated many times to produce a high-
ly ubiquitylated substrate that is rapidly destroyed by
the proteasome. Because proteasomal destruction
depends on prior substrate ubiquitylation, selectivity
in degron recognition by the ubiquitylation machin-
ery-and regulation of this process-is central to the
control of ubiquitin-mediated proteolysis.
In the last year, we have made considerable progress
in understanding how Myc is targeted for destruction
and how loss of control of this process relates to human
cancer. First, using a reverse genetic approach, we have
defined regions in the Myc protein that determine its
stability in human cells. We have found that the Myc
degron resides within the amino-terminal 128 residues
of the protein, a region that overlaps closely with the
transcriptional activation domain (TAD) of Myc.
Indeed, despite our best efforts, we have been unable to
separate genetically the transcriptional activation func-
tion of this region from its degron function, implying
that it is the TAD per se that signals Myc destruction. In
contrast to the amino-terminal degron, we have also
identified an element in the carboxyl terminus of Myc
that promotes Myc stability. This element appears to
function by association with the POZ domain transcrip-
tion factor Miz-1, a protein that binds to Myc and converts
it from a transcriptional activator to a transcriptional
repressor. The significance of Miz-induced stabilization
of Myc is unclear at this stage, but it may allow the for-
mation of stable Miz-Myc repressor complexes that can
efficiently repress gene transcription. We are currently
exploring this possibility.
Second, we have explored the ubiquitin-mediated
destruction of Myc in yeast. We reasoned that as the Myc
TAD activates transcription in the yeast Saccharomyces
cerevisiae, it may also function as a degron in this
species. This is indeed the case. We have found that Myc
is a highly unstable protein in yeast, with a typical
half-life of approximately 5 minutes. Removal of the
Myc TAD or genetic disruption of the proteasome sta-
bilizes Myc, demonstrating that the Myc TAD signals
ubiquitin-mediated Myc turnover in yeast, as it does in
mammalian cells. This result not only demonstrates an
extraordinary conservation of proteolytic targeting
mechanisms, but also provides an opportunity to dis-
sect genetically Myc destruction in yeast, and we have
devised a number of screening strategies to identify
genes required for Myc destruction.
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Finally, we have asked whether Myc destruction is
changed in human malignancy. Missense mutations
within the first 130 amino acid residues of Myc are
commonly found in a variety of lymphomas. Because
these mutations lie within the Myc degron, we asked
whether they alter Myc stability. As shown in Figure
1, four out of five mutant forms of Myc that we tested
were more stable than wild-type Myc and accumulat-
ed to higher steady-state levels (not shown). In one
case, a single point mutation, Thr-58 to Ala-58,
increased the stability of Myc from 35 minutes to
approximately 2 hours: This mutation occurs at a
major site of growth-regulated Myc phosphorylation
and has been shown to increase the transforming
potential of Myc in vitro. Thus, cancer-associated and
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FIGURE 1 Lymphoma-associated and transforming mutations
stabilize Myc. Human U2OS cells were transiently transfected with
expression constructs encoding wild-type human Myc (WT) or the
indicated mutant Myc alleles. Protein stability was determined by
pulse-chase analysis. The alleles shown represent a cross section
of different mutations. The T58A mutation is found in several viral
Myc proteins and has been shown to enhance the transforming
potential of Myc in vitro; residue 58 is also one of the major muta-
tional hot spots within the Myc-coding sequence. Allele A21 is a
complex mutation (S71Y, L82H, A115-120) identified in a tumor
sample from a patient suffering from an aggressive, AIDS-associ-
ated, lymphoma. The A44V mutation has been found in a patient
with Burkitt's lymphoma and in a separately derived Burkitt's lym-
phoma cell line. The P57S mutation was identified in a Burkitt's
lymphoma patient, whereas allele D4 (mutations: N127D and
1129L) was identified in a tumor sample from a patient suffering
from a non-AIDS-associated lymphoma.
transforming mutations disrupt Myc degron function,
demonstrating that the rapid destruction of Myc is sub-
verted in cancer. These data provide one of the first
examples of how a defect in ubiquitin-mediated prote-
olysis can be a mechanism of cellular oncogene activa-
tion. Given the frequent occurrence of mutations with-
in the Myc degron in cancer, we speculate that
enhanced protein stability is a common mechanism
contributing to oncogenic transformation by Myc.
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MOLECULAR GENETICS
The section on molecular genetics covers many diverse problems, from organisms from three different
kingdoms of life, and from biological phenomena as diverse as cancer, cell cycle, programmed cell
death, growth and differentiation, and intercellular communication. The scientific groups are united only
in their adoption of genetic approaches to the study of their problems.
Dr. Wigler's group studies tumor suppressors and is developing new genetic tools for the study of
human disease. These tools, based on representational difference analysis, identify the somatic
mutations that underlie human cancer and the germ-line mutations that underlie sporadic heredi-
tary diseases. Part of this effort is directed at developing new applications of micro-arrayed DNA
probes for the analysis of genomic changes.
Dr. Hamaguchi's group is isolating tumor suppressor genes by applying newly developed technolo-
gies in positional cloning.
Dr. Beach and Dr. Hannon's group have developed new technology for the genetic manipulation of
mammalian cells, using highly modified retroviral tools. This technology is expected to increase both
speed and accuracy of the elucidation of genes involved in disease, their functions, and the asso-
ciated genetic pathways.
Dr. Hengartner's group uses the nematode C. elegans to study conserved biological processes,
with an emphasis on apoptosis (programmed cell death) and developmental neurobiology.
Dr. Futcher's laboratory studies the control of cell division, with special emphasis on cyclin-depen-
dent kinases and their substrates. This year, microarray technology allowed all the cell cycle regu-
lated genes of yeast to be identified and placed in the cell cycle transcriptional loop. The laborato-
ry also works on telomeres and their relationship to aging.
Dr. Grossniklaus' group studies the genetic and molecular basis of sexual plant reproduction and
apomixis, focusing on the development and function of the haploid female gametophyte. They also
explore how the female gametophyte controls subsequent events during seed formation and found
that epigenetic mechanisms such as genomic imprinting play a crucial role.
Dr. Jackson's group studies a novel mechanism of cell-to-cell communication in plants involving the
intercellular trafficking of regulatory proteins. They are also characterizing novel mutants of maize
that affect fundamental aspects of plant growth such as the pattern of leaf initiation and the control
of stem cell proliferation.
Dr. Grotewold's group has significantly contributed to understanding the evolution of plant tran-
scription factors containing the conserved Myb DNA-binding domain and to elucidating the mech-
anisms by which they control gene expression. They also explored successfully the possibility of
manipulating plant metabolism by ectopically expressing transcription factors in cultured maize
cells.
Dr. Ma's laboratory continues to identify new mutants using the gene trap transposon mutagenesis
system developed at Cold Spring Harbor Laboratory. Several new mutants with defects in floral
organ development and male meiosis have been identified, and their characterization should uncov-
er new genes regulating reproductive development in plants.
Dr. Martienssen's laboratory continues to do research on other aspects of plant genetics as well,
and he recently made an important discovery about the movement of intracellular proteins across
cell membranes. They have shown that a gene, hcf106, codes for a membrane protein that resem-
bles certain bacterial proteins and is vital to protein translocation in maize and bacteria.
71
EUKARYOTIC CELL CYCLE CONTROL
D. Beach J. Chen P. Sun
D. Conklin J. Wang
During the course of the year, Susan Allan accepted a
position at Mitotix in Cambridge, Massachusetts, and
Pedro de Campos Lima took up a fellowship at the
Institute of Child Health in London.
MDM2 Overexpression May
Contribute to TGF-I3
Resistance in Tumors
P. Sun
Transforming growth factor-0 (TGF-(3) is a multifunc-
tional cytokine that inhibits the growth of cells of
epithelial, lymphoid, and neuroectodermal origin.
TGF-P sensitivity often declines during the progres-
sion of tumors derived from these cells. In several
types
lates with malignancy. These observations implicate
the involvement of TGF-P in tumorigenesis. Currently,
the mechanisms of TGF-P resistance in tumor cells are
not well understood. Some tumors may become TGF -
13- resistant following c-Myc overexpression or inacti-
vation of essential components of the TGF-P signaling
pathway (e.g., loss of TGF-(3 receptor function and
mutations in Smad2 and Smad4 genes), or through
deletion of the p 1 5mK4B locus. However, such alter-
ations cannot account for the majority of cases in
which TGF-P responsiveness is lost. Therefore, TGF -
3 resistance must also be achieved by mechanisms that
are as yet unknown.
To search for additional genetic alterations leading
to TGF-P resistance in tumors, we performed a screen
to identify genes that overcome the TGF-P sensitivity
of mink lung epithelial (Mv1Lu) cells. We found that
overexpression of an oncoprotein, MDM2, rescued the
TGF-P-sensitive phenotype of Mv1Lu cells. MDM2
was previously shown to associate with and inactivate
the p53 tumor suppressor protein. However, the capac-
ity of MDM2 to bypass TGF-P-induced growth arrest
was independent of its ability to inactivate p53,
because two dominant negative p53 alleles
(p53Va1135 and p53-175H) did not confer TGF-P
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resistance, although they could interfere with the func-
tion of endogenous, wild-type p53 in Mv1Lu cells.
Moreover, an MDM2 mutant which could no longer
bind to p53 also conferred TGF-P resistance in Mv1Lu
cells. We further demonstrated that MDM2 overcomes
TGF-P through interference with the retinoblastoma
(RB)/E2F pathway. More specifically, MDM2 pre-
vented the dephosphorylation of RB and down-regula-
tion of E2F-1 expression induced by TGF-P.
TGF-P induces growth arrest in normal human
lymphocytes, melanocytes, and breast epithelial cells.
However, cells from human leukemia, lymphomas,
melanomas, and breast carcinomas are often TGF-13-
resistant. Coincidentally, MDM2 is commonly overex-
pressed in these tumors (e.g., 73% in human breast
carcinomas). We found that enforced expression of
MDM2 alone in primary human mammary epithelial
cells (HMEC) was sufficient to convert these TGF-P-
sensitive cells to a resistant phenotype. These
tions raised the possibility that increased MDM2
expression might contribute to TGF-P resistance in
tumors.
We therefore examined the correlation between
MDM2 expression levels and TGF-13 responsiveness
in seven human breast tumor cell lines. T-47D, ZR-75-
1, and HTB20 cells expressed MDM2 at levels com-
parable to those observed in cells (HMEC and
Mv1Lu) that had been made TGF-P-resistant by infec-
tion with MDM2 retroviral vectors. These three cell
lines were completely resistant to TGF-p-induced
growth arrest. The two cell lines (MCF-7 and BT549)
that were most sensitive to TGF-Pi treatment had very
low MDM2 levels, similar to those seen in TGF-P-sen-
sitive, normal HMECs. Thus, in several tumor cell
lines, increased MDM2 expression strictly correlated
with the ability to escape TGF-P-induced growth inhi-
bition. Two other breast carcinoma cell lines (HBL100
and MDA-MB-468) exhibited partial resistance to
TGF-P despite low levels of MDM2 expression, con-
firming that other mechanisms (e g c-myc overex-
pression and receptor mutation) must also contribute
to TGF-P-resistance.
Our data therefore suggest that overexpression of
MDM2 is a potential mechanism leading to TGF-P
insensitivity in tumors and that MDM2 can con-
tribute to tumorigensis by antagonizing both p53 and
RB tumor suppressor pathways, functioning in many
respects as a cellular version of SV40 large T anti-
gen.
Genetic Investigation of
Calcium Regulation of
Cellular Proliferation
D. Conklin
Although calcium ion is arguably the most important
second messenger in excitable cell signaling, a consid-
erable amount of work has indicated an important role
for Ca-FE signaling in the regulation of proliferation in
nonexcitable cells. Calcium ion is necessary and suffi-
cient for cell cycle progression during the maturation
of oocytes and marine eggs. Calcium has been identi-
fied in genetic studies as an important regulator of cell
cycle progression at Gi/S and at mitosis in lower
eukaryotes. Direct observation of mammalian cells
with calcium indicators and imaging techniques has
determined that Ca++ transients occur at several points
in the cell cycle including Go/G1, Gi/S, S, and M. At
present, both the mechanisms of calcium release and
the downstream effects during the cell cycle are poor-
ly understood. The importance of these signals to cel-
lular proliferation, however, is underscored by the abil-
ity of calcium channel antagonists to inhibit both the
transients and the subsequent cell cycle progression in
a number of cell types.
In an effort to identify gene products involved in
the calcium regulation of cell proliferation, retroviral
cDNA libraries have been screened for genes that,
when overexpressed, allow cells to escape calcium
channel antagonist-induced growth arrest. Several
known genes involved in signal transduction have
been isolated in these screens, including ras, jun, a G-
protein-coupled serpentine receptor, and a calcium-
binding protein.
One gene selected for the ability to confer resis-
tance to the inorganic calcium channel blocker cobalt
also conferred resistance to the 1,4-dihydropyridine
calcium channel antagonist, nifedipine. Since this gene
confers resistance to two structurally unrelated com-
pounds that both function as calcium channel blockers,
it was named CCBRI. Overexpression of CCBRI does
not confer increased resistance to several other drugs
that inhibit proliferation. Overexpression of the human
p-glycoprotein (MDR1), which is responsible for the
detoxification of a number of toxic substances, does
not confer resistance to nifedipine. Collectively, these
results indicate that the resistance conferred by CCBRI
does not result from increased general stress response
or drug detoxification and that CCBRI is likely to be
related to some aspect of calcium biology.
Sequence analysis indicates that the CCBRI gene
encodes a previously unknown member of a family of
proteins involved in both cell proliferation and trans-
port, recently identified as light chains of the activa-
tion antigen CD98. CD98 is a heterodimeric surface
glycoprotein initially isolated on activated T lympho-
cytes; however, it has subsequently been found on a
number of rapidly proliferating cells including most
tumor cells. The heavy chain has been implicated in a
variety of cell functions including integrin action,
human immunodeficiency virus (HIV) gp160-induced
cell fusion, and amino acid transport.
CD98 has also been implicated in Ca++ homeosta-
sis in cardiac smooth muscle cells and T cells. Current
studies are focused on the effects of overexpression of
CCBRI and the other calcium channel blocker resis-
tance genes on intracellular calcium levels.
Immortalization of Human
Primary Cells
J. Wang
The c-myc gene was identified as the cellular homolog
of the v-myc oncogene found in several transforming
retroviruses. It is expressed at elevated levels in a vari-
ety of human tumors, indicating that its deregulation
may be an important component in tumorigenicity. c-
myc has been shown to have a dual function in mam-
malian cells. On the one hand, it acts as a central reg-
ulator of cellular function, involved in the regulation
of proliferation, mitogenesis, and differentiation. On
the other hand, c-myc appears to be involved in the
regulation of apoptotic cell death.
The ras genes are also critical regulators of numer-
ous physiological functions, including cell growth and
differentiation. Activated or oncogenic ras genes have
been implicated in many types of human cancers.
Although increased expression of normal ras proto-
oncogenes can induce certain manifestations of the
malignant phenotype, ras oncogenes activated by sin-
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gle point mutations displayed more efficient trans-
forming ability.
Immortalization is a critical step during tumorige-
nesis. Oncogenic ras efficiently transforms most
immortal rodent cell lines but not primary cells.
However, ras cooperates with certain other oncogenic
alterations to transform primary rodent cells. Similarly,
deregulated myc expression alone is insufficient to elic-
it a transformed phenotype. It is well established that
myc can cooperate with an activated ras oncogene to
transform primary rat fibroblasts, rat embryo cells, and
pre-B cells.
Although myc and ras behave very similarly in
many aspects, they act in a totally opposite way in
senescence control. Oncogenic ras has been shown to
provoke premature cell senescence in primary human
or rodent cells. We have recently reported that myc can
bypass replicative senescence through activating
telomerase in human primary epithelial cells and
fibroblasts. Furthermore, we found that myc or hEST2
can immortalize human primary cells through a telo-
mere maintenance mechanism. The myc or hEST2-
infected HMEC and IMR-90 cells have bypassed the
normal senescence point (>150 population doublings)
and still grow well. Their telomere length remains sta-
ble even after hundreds of population doublings. On
the other hand, activated rasV12 can overcome myc or
hEST2 to induce cellular senescence in HMECs. It is
not through inactivating telomerase or shortening
telomere in those cells. However, the mechanism is
unknown. We suggest that rasV12 induces senescence
through a mechanism different from natural replicative
senescence.
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In addition, we have characterized the myc and
hEST2 cells by comparing the expression levels of sev-
eral cell cycle regulatory proteins including p16, p21,
and p53.
Western blots showed that p21 decreased signifi-
cantly in HMEC/myc and/or hEST2 cells compared
with vector cells, whereas p53 stayed unchanged, and
that both p16 and p21 decreased dramatically in IMR-
90/myc or hEST2 cells compared with vector control
cells, whereas p53 did not. These results indicate that
loss of p16 and/or p21 but not p53 contributes to
immortalization of HMEC and IMR-90 cells.
Human primary cells HMEC and IMR-90 can be
immortalized by a single step: overexpression ofmyc
or hEST2. This is through maintaining or elongating
telomere length by activation of telomerase. However,
oncogenic rasV12 can overcome the effects of myc
and hEST2 and prevent immortalization by arresting
myc or hEST2 cell growth. This growth arrest has been
characterized to be senescence by several criteria.
RasV12-induced senescence is telomere-length-inde-
pendent. The mechanism of this senescence is
unknown.
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CELL CYCLE CONTROL IN SACCHAROMYCES CEREVISIAE
B. Futcher J. Donovan S. Honey T. Volpe
N. Edgington B. Schneider H. Wijnen
F. Ferrezuelo G. Sherlock J. Zhou
Our main interest is the regulation of Start and mitosis
in Saccharomyces cerevisae. We are most interested in
the tethering of division to cell growth and in the gen-
eration of basic cell cycle oscillation. Many key cell
cycle events are regulated by protein kinase complex-
es formed between Cdc28p and one of nine cyclins.
These fall into two broad groups: the G, cyclins
including Clnlp, Cln2p, and Cln3p that regulate Start
and the mitotic B-type cyclins Clblp, Clb2p, Clb3p,
and Clb4p. Two other cyclins, ClbSp and C1b6p, are
very important for DNA replication, but they also have
roles at Start and perhaps also in early mitosis.
A second interest is yeast and human telomerase,
and how telomere length relates to cell senescence.
A Network for Exit
from Mitosis
J. Donovan
High Cdc28p kinase activity is required for mitosis. At
the end of anaphase, the Cdc28p kinase must be inac-
tivated to allow the mitotic spindle to dissolve. This
inactivation can be thought of as consisting of two
steps: (1) a signaling step, in which the completion of
anaphase triggers some unknown signal, and (2) an
inactivation step, in which the Cdc28p kinase is inac-
tivated by destruction of cyclins, production of the
Cdk inhibitor Sic 1p, and possibly by other mecha-
nisms. A network of genes is required for this signal-
ing and inactivation pathway. The typical loss-of-Rine-
tion phenotype is a large budded cell with divided
nuclei and a long mitotic spindle.
One gene involved in exit from mitosis is SDB24.
Sdb24p has no close homologs, but it has six potential
sites for phosphorylation by Cdc28p, and it has a clear
coiled-coil domain. The transcript is cell-cycle-regu-
lated, with a peak in S phase. The sdb24 null mutant is
viable but is synthetically lethal with dbf2 and with
cdc23. The synthetic lethality of dbfl sdb24 can be
rescued by overexpression of the mitotic exit genes
CDC5, SIC1, and SP012, but not CDC15 or TEMJ.
GAL-CLB2 and GAL-CLB5 are lethal in an sdb24
background.
Sdb24p also has connections to early spindle
events. The protein is found in early spindles and is
apparently at kinetochores. The sdb24 mutation is syn-
thetically lethal with mutations in the kinesin-like
motor proteins Cin 8p and Kip 1p, both of which are
important for forming the mitotic spindle.
All of these results are consistent with the general
idea that Sdb24p is important for spindle formation
and function. We speculate that because of a slightly
aberrant spindle, sbd24 mutants have difficulty sig-
naling the end of anaphase and so have difficulty
inactivating Cdc28p at the end of mitosis. In short,
Sdb24p is one of the proteins comprising a check-
point that allows inactivation and exit from
mitosis.
Dissection of Nuclear
and Cytoplasmic Roles
of Cyclins
N. Edgington
Nine different yeast cyclins bind to and activate the
Cdc28p kinase. Although the enzymatic properties of
the nine different cyclin-Cdc28p complexes are simi-
lar, these nine complexes have very different biologi-
cal roles. We asked how many of these differences
could be accounted for by differences in location. We
have created "forced localization" tags, which, when
appended to a protein, force it to be either cytoplas-
mic or nuclear. Using such tagged proteins, we have
found that nuclear Cln3p, but not cytoplasmic Cln3p,
can complement all Cln3p functions, suggesting the
Cln3p is solely nuclear. On the other hand, most func-
tions of Cln2p are complemented only by cytoplasmic
Cln2p. Most functions of C1b2p are complemented
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only by nuclear C1b2p, and yet nuclear Clb2p is not
entirely wild type, suggesting that it may have a cyto-
plasmic role or may need to transit through the cyto-
plasm.
Affinity Purification
Tags
S. Honey, B. Schneider
We have been interested in identifying the components
of various protein complexes, such as cyclin-Cdk
complexes. To aid in this, we have developed new
methods for rapid purification. We have made a Nod
cassette carrying six histidines (allowing binding to
nickel columns and elution with imidizole), a calmod-
ulin-binding peptide (allowing binding to calmodulin
and elution with EGTA), and a triple hemagglutinin
epitope (allowing immunoprecipitation with mono-
clonal antibody 12CA5). This tag has allowed us to
purify Clb2p and associated proteins to homogeneity
in 1 day. Tandem mass spectrometry identified
Cdc28p, Sic 1p, and Ckslp as C1b2-associated pro-
teins. We are currently expanding these methods to
other complexes.
Gene Arrays for Analysis
of Cell Cycle Gene
Expression
G. Sherlock [in collaboratoin with P. Spellman,
D. Botstein, P Brown, M. Zhang, and others]
The laboratories of Pat Brown and David Botstein
have arrayed all 6000 yeast genes on glass slides, such
that the relative level of expression of each gene can
be assayed by hybridization. We have used these
microarrays to analyze the pattern of gene expression
in yeast through synchronous cell cycles. We syn-
chronized yeast in G, phase with a factor, or in late
mitosis with cdc15-2, or in G, phase by elutriation.
These three cultures were then allowed to progress
through several synchronous cycles. Samples were
taken frequently, and the level of mRNA for all 6000
genes was assayed by hybridization to a microarray;
about 400,000 pieces of data were generated in this
way. By doing extensive statistical analysis, including
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fitting results for each gene to a sine wave, we were
able to identify 800 genes (-13% of the total genes)
whose transcripts oscillated in abundance in a cell-
cycle-dependent way.
The 800 genes were further analyzed using a clus-
tering algorithm that grouped genes which behaved
similarly. This established ten groups containing about
400 genes. For each group, we identified a common
promoter element, and for most of these promoter ele-
ments, we were able to identify a transcription factor
that bound. Thus, we are able to explain at least 400
cell-cycle-regulated genes in terms of upstream ele-
ments and transcription factors.
For one important group of genes, the "CLB2"
cluster, we defined an upstream element, but no tran-
scription factor was known for this element. We
guessed that the responsible transcription factor(s)
might itself be cell-cycle-regulated. Thus, we looked
on the list of cell-cycle-regulated genes for putative
transcription factors of unknown function. There were
only a few. Furthermore, other workers have previous-
ly used genetic screens to try to find the regulator of
CLB2 and other genes in the CLB2 cluster without
success. This failure suggested to us that two or more
genes might redundantly encode the transcription fac-
tor. Our list of cell-cycle-regulated putative transcrip-
tion factors contained one pair of homologs, FKH1
and FKH2. We therefore examined mutants in these
genes (will) the help of T. Davis, Seattle). We found
that the fkhl fich2 double mutant was defective in cell-
cycle-regulated expression of CLB2, SWI5, and other
genes in the CLB2 cluster. Instead, these genes were
now expressed at a constitutively low level. Thus, we
believe we have identified a new cell cycle transcrip-
tion factor. Interestingly, Fkh2p contains many con-
sensus Cdc28p phosphorylation sites, suggesting it
may be under the direct control of Cdc28p. In addi-
tion, the fkhl fkh2 double mutant has a constitutive
pseudohyphal growth phenotype, suggesting that we
may have identified the pathway, and the effector
genes, for pseudohyphal growth.
Analysis of WHI3,
a New Size Control Gene
T. Volpe
The whi3 mutation was isolated some years ago by
Rob Nash, and we are continuing its characteriza-
tion. It contains an RNA-binding motif, and we have
recently shown that this RNA-binding motif is essen-
tial for Whi3p function. Like other whi mutants, it
gives a small cell phenotype, which seems to be the
reason whi3 mutants overexpress CLNI and CLN2
Gi cyclins. Overexpression of WHI3 turns off CLN1
and CLN2 and is lethal. Presumably, then, the normal
role of WHI3 is to somehow repress CLN1,2 expres-
sion.
The level at which WHI3 interferes with CLN
expression, however, has been unclear. WHI3 does not
interfere with CLN1 or CLN2 expression from a GAL
promoter, so WHI3 probably does not act directly on
the CLN1,2 mRNAs. CLN1 and CLN2 transcription
depends on the transcription factors Swi4p and
Swi6p, and these are somehow activated by CLN3. We
asked whether WHI3 might interfere with the activa-
tion of Swi4p/Swi6p by CLN3. The answer may be
yes, because (1) a whi3 mutation cannot reduce the
size of a cln3 mutant (i.e., cln3 is epistatic to whi3),
and (2) a carboxy-terminally truncated Swi4p, which
does not depend on activation by CLN3, can promote
CLN2 transcription even in the presence of excess
Whi3p.
Presumably, Whi3p binds some RNA or RNAs. We
immunoprecipitated Whi3p, and then carried out
Northern analysis on the immunoprecipiates to deter-
mine whether CLN3 or any other relevant mRNA was
coprecipitated. So far, no such RNA has been found.
Recently, RNAs coimmunoprecipitated with Whi3p
have been sent for microarray analysis to determine if
any RNAs can be identified.
Mechanisms of Transcriptional
Activation by Cyclin-Cdc28p
Complexes
H. Wijnen
One effect of the C1n3-Cdc28p complex-perhaps the
only effect-is to induce transcription of a large fam-
ily of genes involved in the G1 /S transition. We are
trying to discover the mechanism of induction. The
promoters of the CLN3-inducible genes all include
binding sites for the Swi4p transcription factor or for
its close relative Mbplp. The Swi4p and Mbplp
DNA-binding proteins each forms a complex with
another protein called Swi6p; these two complexes
are called the SBF or MBF transcription factors,
respectively. We have found that swi6 mutants are
completely defective for CLN3-induced transcription,
and this argues that Swi6p is the direct or indirect tar-
get for Cln3p.
One model for activation of SBF/MBF by Cln3p is
that Cln3p/Cdc28p phosphorylates SBF/MBF. This
does not seem to be the case, because mutants lacking
all consensus Cdc28p phosphorylation sites in SBF
are wild type for activation by Cln3p. Another model
is that Cln3p joins the SBF/MBF complex and acts rel-
atively directly on transcription. This also does not
seem to be correct, because (1) cln3 mutants with an
appended VP16 transcriptional activation domain do
not hyperinduce transcription and (2) cln3 mutants
with an appended TUP1 repression domain still
induce transcription normally. Finally, it does not
appear that CLN3 activates an activator of SBF/MBF,
because no such activator could be identified in a sat-
urating high-copy screen.
A remaining model is that CLN3 inhibits an
inhibitor of SBF/MBF. This would be parallel to the
system in mammalian cells, where cyclin D /CDK4
(analogous to Cln3p/Cdc28p) inhibits retinoblastoma
(RB), an inhibitor of E2F (analogous to SBF). To look
at this model, we have selected for mutants in which
SBF is active even in the absence of CLN3. Several
such mutants have been found. One is in a gene encod-
ing a component of a histone deacetylase, and the
human homolog of this gene is a known RB-binding
protein.
Finally, we have looked for mutants of Swi6p that
can activate transcription even in the absence of CLN3.
Alleles of Swi6p lacking the leucine zipper behave in
this way, suggesting that the leucine zipper might be
the binding site of the putative inhibitor of SBF.
New Telomere Maintenance
Mutants
F. Ferrezuelo
We have done a screen to identify new yeast telomere
maintenance mutants. Several mutants have been
obtained, and these include two new alleles of est2,
showing that the screen works. Another mutant was
recently identified as mtr10, a karyopherin i3 involved
in nuclear import. It may be important for import of
Est 2p, Tlclp (the telomerase RNA), or the Est 2p/
Tlclp complex. We still have several unidentified
mutants, which produce short telomeres.
Analysis of an RNA-binding
Motif in the Telomerase
Component Esti p
J. Zhou
The telomerase component Estlp has a homolog we
call EstlOp. Whereas estl mutants have a senescent
phenotype ("ever shorter telomeres," leading to senes-
cence and death), the est10 mutant has only a short
telomere phenotype. We noted a clear RNA-binding
motif in Estl Op, and a less clear RNA-binding motif in
Estlp and found that these motifs were at the center of
the most highly conserved region of the two proteins.
This suggested that the role of Estlp/EstlOp might be
to bind the Tlclp telomerase RNA and help form the
complex with the catalytic subunit, Est2p. We
destroyed the RNA-binding motif in Estlp by site-
directed mutagenesis and found that this gave a domi-
nant-lethal allele, consistent with the model.
Furthermore, when the RNA-binding site was recon-
structed, but with different amino acids, EST1 function
was restored. Immunoprecipitation of Estlp and estl
mutants, followed by Northern analysis, showed that
Tlclp coprecipitated with Estlp, and with Estlp with
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a reconstructed RNA-binding site, but did not copre-
cipitate with the estl mutant lacking the RNA-binding
site. This coprecipitation did not require the presence
of Est2p (the catalytic reverse transcriptase), suggest-
ing that the interaction of Estlp with Tlclp is direct.
Finally, it has been proposed that Estlp acts as a sin-
gle-stranded DNA-binding protein. We could detect
very little single-stranded DNA-binding activity, but
such activity as was present was not affected by the
RNA-binding site mutations.
In summary, we conclude that Estlp is likely an
RNA-binding protein that binds Tlclp, and in this way
helps form the Est2p-Tlclp complex. Other telomer-
ases also contain RNA-binding proteins, although they
are not homologous to Estlp.
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DEVELOPMENTAL GENETICS OF PLANT REPRODUCTION
U. Grossniklaus R. Baskar I. Siddiqi Y. Red ler J. Parkey
P. Hal lock A. Coluccio J. Thomas C. Spillane
P. Pultorak J. Moore K. Gremski J.-P. Vielle-Calzada
We use genetic and molecular approaches to character-
ize the developmental control of plant reproduction.
We focus on the events that lead to the formation of the
female gametes, the molecular and genetic basis of
which is largely unknown. Unlike in animals, where the
meiotic products differentiate directly into gametes, the
spores of plants give rise to multicellular haploid
organisms that produce the gametes later in their devel-
opment. The key events in female gametogenesis occur
within ovules, which are specialized reproductive
structures of sporophytic origin that harbor the female
gametophyte. The highly polar nature and simple orga-
nization of ovule and megagametophyte make it an
ideal system to study fundamental aspects of plant
development. The long-term goal of our research is to
elucidate the role of cell lineage, positional informa-
tion, and cell-cell communication in plant morphogen-
esis and cellular differentiation.
In addition to yielding important insights into fun-
damental concepts of plant development, a better under-
standing of the mechanisms controlling plant reproduc-
tion will also provide tools to manipulate the reproduc-
tive system. We are particularly interested in engineer-
ing components of apomixis, a natural form of asexual
reproduction through seeds. The introduction of
apomixis into crops promises economic and social ben-
efits exceeding those of the green revolution. We are
using the tools we generate in our basic research for a
biotechnological manipulation of the sexual system
toward apomixis in Arabidopsis. In addition, we also
use genetic strategies to isolate mutants displaying
apomictic traits in maize and, in collaboration with R.
Pruitt (Harvard University), in Arabidopsis.
A collection of over 4000 transposants forms the
basis for our analysis of female gametogenesis in
Arabidopsis. Enhancer detection allows the identification
of genes based on their pattern of expression. We are
using the enhancer/gene trap system developed here at
the Laboratory by V. Sundaresan, R. Martienssen, and co-
workers (Sundaresan et al., Genes Dev. 9: 1810 [1995]).
Our transposant collection was subjected to four inde-
pendent screens to identify genes involved in ovule mor-
phogenesis, megasporogenesis, female gametophyte
development, and fertilization.
Alterations of Megasporogenesis and
Induction of Apomixis in Arabidopsis
J.-P. Vielle-Calzada, U. Grossniklaus
Megasporogenesis is initiated as a single hypodermal
cell in the ovule primordium differentiates into the
megaspore mother cell (MMC). The MMC undergoes
meiosis to produce four haploid megaspores. Only one
of the megaspores survives, divides three times, and
ultimately gives rise to a functional megagametophyte.
Whereas most flowering plants including Arabidopsis
reproduce sexually, some species can form embryos
that are genetically identical to the maternal parent
through apomixis. Apomictic embryos arise from a cell
lineage lacking both meiosis and fertilization, leading to
the formation of clonal seeds. Apomixis is genetically
controlled, but the molecular mechanisms and genetic
basis of its regulation are largely unknown. The deter-
mination of apomictic initial cells occurs during megas-
porogenesis. It is likely that some of the genes regulat-
ing sexual development are also responsible for the
induction of apomixis.
To test this hypothesis, we are isolating genes that
act during early ovule development in Arabidopsis. By
screening reporter gene expression in over 1100 trans-
posants, we identified 27 lines that show expression in
the developing ovule. In most, expression can be
traced back to the onset of MMC differentiation. Some
of the genomic sequences flanking the insertions show
similarity to genes with important roles in plant and
animal development (e.g., cell cycle regulators, recep-
tor kinases, MAP kinase kinases, and chromatin
remodeling factors). Three lines show expression pat-
terns that are of particular interest to megasporogene-
sis and the induction of apomixis: In the first one, a
few cells in the nucellus that might correspond to a
group of cells with the potential to differentiate into a
MMC express the reporter gene. In the second line,
expression is restricted to the MMC itself, whereas in
the third line, only the surviving megaspore stains.
Regulatory sequences controlling nucellar and MMC-
specific expression will serve as important tools to
alter determination and cellular interactions during
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megasporogenesis and to manipulate the reproductive
potential of sexual plants toward apomixis.
Genetic Analysis of dyad, a Mutation
Affecting Female Meiosis in Arabidopsis
I. Siddiqi, U. Grossniklaus
The dyad mutant of Arabidopsis causes female sterili-
ty by affecting the division of the MMC. The mutant
was isolated at the Centre for Cellular and Molecular
Biology, Hyderabad, India, and the experiments
described below were conducted during a sabbatical
visit here at the Laboratory. In the dyad mutant, nor-
mal meiosis is altered such that the MMC undergoes a
single division giving rise to a dyad instead of a tetrad,
which then arrests. Understanding the function of the
dyad gene is of particular interest with respect to
processes that are unique to female meiosis and
megasporogenesis. What type of division does the
MMC undergo in the dyad mutant? The mutant phe-
notype could be due to an arrest at the end of meiosis
I, or, alternatively, it could be that the MMC undergoes
a mitotic division instead of a meiotic one. We had
prior evidence in support of the first explanation based
on the appearance of a cytological marker (callose)
that is expressed during meiosis in the MMC.
At Cold Spring Harbor, we further addressed the
issue of whether the MMC in dyad divides meiotical-
ly or mitotically by examining the expression of the
meiosis-specific gene AtDMC1 by RNA in situ
hybridization using protocols developed by J.-P.
Vielle-Calzada. We also examined chromosome segre-
gation during the division using confocal microscopy.
In addition, ultrastructural studies were carried out by
transmission electron microscopy. The results from all
three approaches indicated that the MMC in dyad
undergoes meiosis I but arrests before meiosis II. This
suggests that the dyad gene is specifically required
during female meiosis for entry into meiosis II. We are
continuing this collaboration by examining the expres-
sion of ovule- and megagametophyte-specific markers
in the dyad mutant.
Characterization of tlazolteotl, a Mutant
Affecting Ovule Morphogenesis
J.-P. Vielle-Calzada, K. Gremski (URP Program),
P. Hallock (Partner for the Future), U. Grossniklaus
We have made substantial progress in the characteri-
zation of one of the female sterile mutants we identi-
fied. Ovules of this mutant have shorter integuments,
80
a dense region of proliferating cells at the chalaza, and
abnormal embryo sacs often protruding through the
micropyle (Fig. 1). After fertilization, a few viable
seeds are formed. The GUS expression pattern in this
transposant correlates with the tissues affected in the
mutant. We named it tlazolteotl (tlz), after the Aztec
goddess of fertility who is often represented as giving
birth through the mouth. Complementation analysis
has shown that tlz is not allelic to previously charac-
terized mutants (ant, bel, ino, sin, and exc). Reversion
analysis showed that the single Ds element present in
this line is responsible for the mutant phenotype. The
sequence flanking the insertion site shows strong
homology with a hypothetical protein with domains
often found in transcription factors. We are currently
focusing on the isolation of a TLZ cDNA, the determi-
nation of the pattern of TLZ mRNA localization, and
the investigation of genetic interactions of tlz with
other genes controlling ovule development.
Characterization of Mutants
Disrupting Megagametogenesis
J. Moore, J. Parkey, P. Pultorak, U. Grossniklaus
During megagametogenesis, the mature female gameto-
phyte consisting of seven cells (1 egg cell, 2 synergids, 3
FIGURE 1 Morphological comparison of wild-type 0,B) and
tlazolteotl (tlz) ovules (C,D). Fixed specimens were either gold-
coated and observed with a scanning electron microscope
(4,C) or cleared in Herr's solution and observed with Nomarski
optics (B,D). In contrast to wild-type, t/z ovules have short
integuments, a dense region of proliferating cells at the proxi-
mal pole (arrowheads in D), and abnormal embryo sacs often
protruding through the micropyle (D).
antipodals, and 1 binucleate central cell) is formed.
After double fertilization of both the egg and the central
cell, the ovule develops into a seed. Despite the impor-
tance of this process for plant reproduction, only a small
number of mutants affecting megagametogenesis have
been described. We identified about 50 mutants affect-
ing the gametophytic phase of the plant life cycle and
characterized 14 of these at the genetic and morpholog-
ical level. Of the 14 mutants, 12 have been mapped and
were shown to represent independent loci distributed
over all chromosomes. The transmission efficiency of
the Ds elements associated with these mutations
through male and female gametophytes was deter-
mined. All but two mutants were found to affect the
female, but most also affected the male to various
degrees. A morphological characterization of male
gametophyte development in mutants with reduced
male transmission has been performed in collaboration
with D. Twell (University of Leicester). We also thank
Nikhil Laud and Sean Kass (both from Roslyn High
School), who helped with reversion analyses and the
characterization of pollen tube guidance in these
mutants, respectively.
Based on morphological defects, the mutants can
be grouped into four classes: (1) mitotic division
cycles are abnormal, (2) nuclear fusion of polar and/or
sperm nuclei is affected, (3) abnormal degeneration
processes occur, and (4) the megagametophyte devel-
ops to maturity, but fertilization is not properly effect-
ed. The phenotype of one member of each class is
described as an example. In haumea (hma), named
after a Polynesian-Hawaiian goddess of fertility, the
regulation of the mitotic division cycles is disturbed,
resulting in mitotic arrests, asynchronous nuclear divi-
sions, or sometimes in additional division cycles such
that megagametophytes with up to 22 nuclei have been
observed. In jumis (jum), named after a Latvian god of
fertility, karyogamy is disrupted, and the polar nuclei
in the central cell do not fuse nor do the sperm nuclei
fuse with their targets. In anat (ana), which honors a
Canaanite fertility goddess, the antipodals and syn-
ergids, which usually degenerate, often persist. The
megagametophytes offeronia (fer), named in honor of
the Etruscan goddess of fertility and fire, develop nor-
mally and attract pollen tubes, but seed development is
not initiated, suggesting that double fertilization or the
activation of seed development is disrupted. To date,
we have obtained sequences flanking the insertion site
for 12 of these mutants. As expected, some of these
have similarities with proteins involved in basic cellu-
lar processes, whereas others appear to have regulato-
ry functions.
Cell Specification in the
Female Gametophyte
R. Baskar, J. Moore, J.-P. Vielle-Calzada, U. Grossniklaus
Although the seven cells of the megagametophyte are clon-
ally derived, they develop along four alternative develop-
mental pathways, making it an ideal system to study cell
specification. We have screened over 2300 transposants for
reporter gene expression in mature ovules. Among the
enhancer detector transposants, about 5% show expression
in the female gametophyte. Whereas some of these show
expression in all cells of the megagametophyte, others are
specific to a subset of cells or to individual cell types. We are
particularly interested in the specification and function of the
egg cell. The egg-cell-specific expression of the two tran-
scription units we identified was verified by in situ
hybridization, and genomic phages spanning the insertion
sites were isolated. Reporter gene constructs containing up
to 4 kb of 5' sequences of one of these genes are being ana-
lyzed by Agrobacterium-mediated transformation. Once
identified, egg-cell-specific promoters will be used for
genetic cell ablation and misexpression of putative regulato-
ry genes involved in egg activation. This will allow us to
investigate cellular interactions between the cells of the
megagametophyte and to probe the potential of the egg cell
for autonomous activation, an important component of
apomictic reproduction.
The medea Locus Is Regulated
by Genomic Imprinting
J.-P. Vielle-Calzada, J. Thomas, U. Grossniklaus
We have previously shown that the Arabidopsis mutant
medea (mea) displays a gametophytic maternal effect.
Seeds derived from megagametophytes carrying a mutant
mea allele abort after delayed morphogenesis with exces-
sive cell proliferation in the embryo and reduced free
nuclear divisions in the endosperm. MEA encodes a SET
domain protein of the Polycomb and trithorax group,
which are believed to maintain repressed or active states of
gene expression during development by modulating high-
er-order chromatin structure. During the last year, we elu-
cidated the nature of the mea maternal effect. Because the
endosperm inherits two maternal copies but only one
paternal copy of the genome, mea could affect a dosage-
sensitive gene required for endosperm development.
Alternatively, the mutation could disrupt a maternally pro-
duced gene product stored in the egg and/or central cell,
which is required for seed development. As a third possi-
bility, the mutation could affect an imprinted gene that is
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only transcribed from the maternally inherited allele.
Using duplex tetraploid plants (mea/mea/MEA/MEA)
that produce endosperm carrying from 0 to 6 mutant mea
alleles, we could exclude gene dosage as the cause for the
mea maternal effect. The latter two possibilities were dis-
tinguished using in situ hybridization and reverse tran-
scription (RT)-PCR. MEA is expressed prior to fertiliza-
tion in the megagametophyte, but also after fertilization
in the embryo and endosperm. The high level of MEA
transcript detected several days after fertilization suggests
that MEA is transcribed not only maternally, but also
zygotically. In the endosperm, we could directly visualize
zygotic transcription of the mea locus by a sensitive in
situ hybridization protocol that allows the detection of
nuclear dots representing nascent transcripts. In triploid
endosperm nuclei, only two nuclear dots are visible, sug-
gesting that only two of the three mea loci are actively
transcribed after fertilization. Using PCR conditions that
allow a distinction between various mea alleles, we could
independently confirm that paternally inherited MEA
alleles are not transcribed in either fertilization product.
Thus, the mea locus is regulated by genomic imprinting
in both the embryo and endosperm.
Regulation of Genomic
Imprinting in Plants
C. Spillane, A. Coluccio, J. Thomas, U. Grossniklaus
Genomic imprinting, where individual genes are
expressed depending on their parental origin, has only
been described in mammals and plants. This may have its
evolutionary origin in a shared strategy to produce off-
spring (placental habit) that led to a parental conflict over
the allocation of nutrients from the mother to her off-
spring (Haig and Westoby, Am. Nat. 143: 147 [1989]).
Only a few imprinted genes have been described in
plants. MEA is the first one that shares many features
with imprinted genes in mammals: MEA is the only
known imprinted plant gene that affects morphogenesis
and where imprinting is not allele-specific. Despite its
importance in development and disease, the regulation of
imprinting is still poorly understood. Using mea as a tool,
we try to elucidate the regulation of imprinting using
molecular and genetic approaches. Several constructs
have been made to identify the cis-regulating sequences
that control parent-of-origin-specific expression of MEA.
In addition, we use the powerful genetics of Arabidopsis to
identify trans-acting factors involved in imprinting. To this
aim, we use chemical mutagenesis to isolate mutants that
modify the mea seed abortion phenotype. To date, we have
identified several mutations that alter the frequency of seed
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abortion in a heterozygous mea plant, some of which may
be regulators of genomic imprinting. As an alternative to
isolating new mutations that modify the mea phenotype, we
are screening the natural variation in different Arabidopsis
ecotypes for modifier loci. We are also analyzing genetic
interactions with mutants that have a known effect on trans-
gene silencing or DNA methylation which were isolated in
other laboratories. A better understanding of imprinting in
plants will be essential for the engineering of apomixis in
sexual crops. These are usually highly sensitive to imbal-
ances in the ratio of maternal to paternal genomes in the
endosperm as occurs if a reduced sperm fertilizes a nonre-
duced central cell. Imprinting is also thought to be an obsta-
cle to wide crosses that have a great potential for plant
breeding.
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PLANT GENETICS
E. Grotewold E.L. Braun P.D. Rabinowicz
M.J. Hernandez G.M. Sosa
M. Pizzirusso
Evolution of Plant Myb
Domain Proteins
P.D. Rabinowicz, E.L. Braun (Ohio State University),
E. Grotewold
Transcription factors containing the Myb homologous
DNA-binding domain are widely found in eukaryotes.
In plants, R2R3 Myb domain proteins are involved in
the control of form and metabolism. The Arabidopsis
genome harbors more than 100 R2R3 myb genes, but
few have been found in monocots, animals, and fungi.
Using reverse transcriptase-polymerase chain reaction
(RT-PCR) from different maize organs, we cloned 480
fragments corresponding to a 42-44-residue-long
sequence spanning the region between the conserved
DNA-recognition helices (MybBRH) of the R2R3 myb
domains. We determined that maize expresses more
than 80 different R2R3 myb genes. Evolutionary dis-
tance analyses among maize Mybsas sequences indi-
cate that most of the amplification of the R2R3 myb
gene family occurred within the past 550 million
years, possibly after the origin of land plants, but prior
to the separation of the two main groups of flowering
plants. Interestingly, particular classes of R2R3 myb
genes have suffered a dramatic amplification within
the past 30 million years within the grasses, adding
support to the idea that expansion of this gene gamily
has occurred in conjunction with the development of
novel cellular functions.
Cloning and Characterization of a
Maize WD40 Protein That Has High
Homology with Regulators of
Anthocyanin Accumulation and
Trichome Formation
M. Pizzirusso (Partners for the future student 1997),
M.J. Hernandez (Ohio State University), G.M. Sosa
(Ohio State University), E. Grotewold
The Anll protein of Petunia controls anthocyanin accu-
mulation, probably by modulating the function of the
Myb domain protein An2. Using degenerate primers
derived from conserved regions of the Anll gene, a PCR
fragment was generated from cDNA obtained from
maize seedling poly(A)* RNA. After cloning and
sequencing, the PCR fragment was used as a probe to
screen maize cDNA and genomic libraries. Sequence
analysis of the corresponding genomic and cDNA
clones revealed a gene without introns with an open
reading frame (ORF) about 410 amino acids long encod-
ing an MP1 protein of 45 kD. The MP1 protein contains
conserved WD40 repeats and has a very high identity to
Anl 1 and TTG. Northern analysis indicated that MPI is
expressed in all maize organs investigated including
silks, seedlings, roots, tassels, and immature ears. This is
similar to what has been previously observed for Anl 1.
Mapping experiments positioned MP1 to the short arm
of chromosome 5, close to the recently identified pale
aleurone colorl (pad) maize mutant.
The MP1 protein was expressed in Escherichia coli
as a histidine-tagged fusion (N6His-MP1), affinity-puri-
fied, and injected into rabbits. Polyclonal antibodies will
be used to determine whether the subcellular localization
of MP1 is cytoplasmic, as observed for Anl 1. Purified
N6His-MP1 protein was utilized in in vitro kinase assays
together with total protein extracts from maize aleurones
and pericarps in the presence of [y- 32P]ATP. A phosphor-
ylated band of the correct molecular weight in PAGE-
SDS gels was identified in reactions containing MP1,
but absent in control reactions. These preliminary find-
ings suggest that MP1 can be phosphorylated by a pro-
tein kinase in maize extracts and provide additional sup-
port to the idea that MP1, TTG, and Anl 1 are part of a
signal transduction cascade.
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CANCER GENETICS
M. Hamaguchi B. O'Connor
J. Troge
We are interested in the genes responsible for carcino-
genesis and metastasis. The analysis of cancer genes is
the first step in elucidating the molecular mechanisms
of the development of cancer. For this purpose, we
have applied and developed genetic tools, including
representational difference analysis (RDA), rapid iso-
lation of cDNAs by hybridization (RICH), and exon
trapping. Genetic lesions were first discovered by
RDA. A transcript map was constructed by utilization
of RICH, a new technique, as well as other available
methods including exon trapping, database searches,
and sequencing. We are also trying to develop a muta-
tion detection system based on RDA.
New Technology for Positional
Cloning
M. Hamaguchi, B. O'Connor [in collaboration with
R. McCombie and M. Wig ler, Cold Spring Harbor
Laboratory]
Powerful methods facilitate the localization of disease
genes to chromosomal regions. We have applied posi-
tional cloning to discover these genes. The regions cov-
ered by contigs of large genomic clones (yeast artificial
chromosomes or YACs, bacterial artificial chromo-
somes or BACs, and Pls) must be analyzed to identify
transcribed sequences. Candidate genes are winnowed
out from the transcripts in the region by mutation
analyses.
The rate-limiting step in positional cloning is the
search for transcribed sequences in a given genomic
region. This problem has been approached in a number
of ways: exon trapping, computational analysis after
DNA sequencing, and direct hybridization selection.
Exon trapping is effective when the splice sites of the
genes in question are recognized accurately by the host
cells, but cryptic splice sites cause a background of
false positives. DNA sequencing is still costly and time
consuming. Direct hybridization selection is useful in
some cases, but it diminishes in usefulness when the tar-
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get genes are rare messages. This method also suffers
from background problems created by repetitive
sequences.
We have developed RICH, a new method of isolat-
ing cDNAs that have sequences in common with large
genomic clones. RICH is meant to complement the
isolation of transcribed sequences by exon trapping
and DNA sequencing. The ends of cDNA fragments
are modified so that they can be selected only when
they hybridize to fragments derived from large genom-
ic clones covering the regions of interest. We have
demonstrated that RICH is a powerful tool when
applied to amplified loci such as the c-myc locus. We
have also demonstrated that RICH works on the sup-
pressor locus PTEN (phosphatase and tensin
homolog). The yield of PTEN fragments was less sat-
isfactory than that of c-myc, we believe, due to a
reduced level of expression of PTEN. An additional
products, however, is helpful for
subsequent cloning.
We have also introduced a variation in our method:
selectively amplifying genomic DNA fragments that
have homology with cDNAs, i.e., RICH in reverse.
This method is called rapid isolation of genes by
hybridization to transcripts (RIGHT). The RIGHT
products are all genomic fragments and therefore are
ready to be used for polymerase chain reaction (PCR)-
based analysis such as radiation hybrid mapping and
deletion mapping by quantitative PCR (Q-PCR).
Utilization of both methods may facilitate the confir-
mation of cDNAs and aid in the determination of
intron-exon boundaries.
Loci Deleted in Breast
Cancer
M. Hamaguchi, J. Troge, B. O'Connor [in collaboration
with R. McCombie and M. Wigler, Cold Spring
Harbor Laboratory]
Loss of heterozygosity (LOH) has reportedly occurred
in more than half of breast cancers. RDA has identi-
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fied two homozygous deletions of 8p22 and 8p23.
These facts imply the presence of tumor suppressor
genes at 8p22 and 8p23. Our efforts have been direct-
ed at cloning these suppressor genes.
First, RDA probes were localized by radiation
hybrid mapping. The radiation hybrids are rodent
cells containing fragments of human genomic DNA
generated by irradiation. The relative distance
between known sequence tagged site (STS) markers
and the probe in question is obtained by comparison
of the presence of the marker and the probe in each
radiation hybrid. One RDA probe was mapped to
8p23 and the other to 8p22. Second, physical maps
of these regions were constructed. Library screening
and database searches generated 20 YACs, 9 BACs,
and 2 P1 s. STSs around the original RDA probes
were isolated by database searches, subcloning of
genomic clones, and sequencing of P 1 s. These STSs
were further mapped by radiation hybrids and ana-
lyzed by PCR against genomic clones to determine
their physical order. Subsequently, deletion mapping
was carried out by Q-PCR on 87 breast tumors using
16 STSs.
Figure 1 demonstrates two distinctive deletion epi-
centers that are mapped to 8p22 and 8p23. The size of
each deletion is estimated at 1 Mb. A transcript map was
then constructed by database searches, RICH, exon
trapping, and sequencing. This procedure has provided
32 candidate sequences including 19 expressed
sequence tags (ESTs), 7 RICH products, 2 trapped
exons, and 4 exons predicted by computational analysis.
Reverse transcriptase PCR analysis showed that 7 out of
32 fragments are expressed in normal mammary glands.
Among them, three sequences have detected positive
clones in cDNA libraries from normal breast tissues.
These candidate genes are being analyzed further.
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FIGURE 1 Deletion map of the short arm of
chromosome 8. Double arrowheads indicate
approximately 1 Mb. The letters represent STSs
used for deletion analysis. The deletion numbers
are listed under the corresponding STS markers
and represented by the height of the columns.
(Gray circles) Localization of ESTs found in the
databases; (gray squares) RICH products. Two
deletion peaks are demonstrated in the figure.
One epicenter is mapped to 8p23 (B) and the
other to 8p22 (L).
Identification of Mutations in Tumors
M. Hamaguchi, J. Troge [in collaboration with
S. Lowe and M. Wigler, Cold Spring Harbor Laboratory]
We recently commenced a project utilizing a modified
RDA technique to detect mutations with LOH.
Homozygous deletions identified by conventional
RDA are generally large, and laborious deletion analy-
sis is unavoidable in narrowing down the commonly
deleted region. Moreover, tumor suppressor genes are
frequently inactivated by mutations accompanied by
LOH. We believe that isolation of mutant genes in the
LOH region is directly linked to the discovery of
tumor suppressor genes. We are now exploring the
possibility of improving the protocols of cDNA-RDA
for this purpose. When genomic alterations are accom-
panied by functional LOH, i.e., any suppression of
transcription such as physical LOH, genomic imprint-
ing, and repression, only the mutants exist in the
cDNA representation. If the mutations alter recogni-
tion sites of frequent cutters, modified RDA with
restriction enzyme digestion will detect these muta-
tions as well as basic differences in the transcripts of
two tumors. In contrast, conventional cDNA-RDA
identifies only basic differences. Mutations of the
genes in the LOH region will be identified by com-
parison of the products from both modified and con-
ventional RDA procedures. We are testing this idea by
examining mouse tumors.
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GROWTH CONTROL IN ANIMAL CELLS
G. Hannon P. Dong
C. Frangou
The long-standing goal of our laboratory remains an
understanding of the mechanisms that contribute to
tumorigenesis. Normal cells are protected from onco-
genic transformation by homeostatic responses that
prevent cell proliferation in the face of potentially
oncogenic alterations. These oversight mechanisms
require well-known tumor suppressor pathways such
as p53 and p16. During the past year, we have focused
our efforts on two processes that have a clear relation-
ship to neoplastic transformation:cellular mortality
control and oncogene-dependent apoptosis.
PROTECTION FROM ONCOGENE-DEPENDENT
APOPTOSIS
During the past several years, it has become clear that
normal cells respond to oncogene activation in a sur-
prising way. For example, normal cells that are forced
to express activated ras senesce. Upon expression of
oncogenes such as myc or EDI, normal cells are sensi-
tized to programmed cell death. These responses are
likely to be key tumor suppressive mechanisms.
Since oncogenes such as myc predispose normal
cells to apoptosis, additional genetic alterations must
occur during tumorigenesis that counteract the pro-
apoptotic effects of oncogenes. During her stint as a
Visiting Scientist here at the Laboratory, Roberta
Maestro (now at the CRO, Aviano, Italy) devised a
genetic screen to identify genes that could protect nor-
mal cells from oncogene-dependent cell death. One of
the genes isolated through this approach was a devel-
opmentally regulated transcription factor, Twist.
Twist is a basic helix-loop-helix protein that has
been implicated in the control of diverse developmen-
tal processes. Mice specifically lacking the twist gene
die at day 9.5 p.c. and show massive apoptosis in the
developing somites, a site of embryonic twist expres-
sion. We found that in cell culture, ectopic twist expres-
sion protected from the predisposition to apoptosis that
occurs upon expression of both cellular (c-myc) and
viral (E 1A) oncogenes.
Oncogene-dependent apoptosis proceeds largely
through a mechanism that requires an intact p53 tumor
suppressor protein. Twist could interfere with p53-
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dependent apoptosis in MEF (mouse embryonic fibro-
blast) cells that had been transformed with EU plus ras,
a system originally characterized by Scott Lowe here at
the Laboratory. Twist could also interfere with other p53
activities. MEF cells that have been engineered to
express a temperature-sensitive version of p53 arrest
upon shift to the permissive temperature. However, in
the presence of Twist, this arrest is suppressed.
Since Twist interfered with oncogene-dependent
apoptosis and with the activity of a known tumor sup-
pressor, we sought to determine whether inappropriate
Twist expression might contribute to tumorigenesis.
We surveyed a number of tumor types and found fre-
quent Twist expression in rhabdomyosarcomas.
Rhabdomyosarcoma is the most common sarcoma
in children. This tumor is thought to derive from skele-
tal muscle precursor cells that fail to complete termi-
nal differentiation.' Twist is generally excluded from
differentiating muscle cells, but in 50% of rhab-
domyosarcomas, Twist expression is maintained.
Inappropriate expression of Twist in rhab-
domyosarcomas is interesting from several stand-
points. First, enforced Twist expression had previous-
ly been shown to block myogenic differentiation,
although the precise mechanism was unclear. We have
shown that Twist can protect from programmed cell
death and antagonize a tumor suppressor. Thus, twist
may contribute to the formation of rhabdomyosarco-
mas through multiple routes.
The diverse effects of twist may have a single
underlying biochemical basis. In collaboration with
Larry Kedes' group (University of California, Los
Angeles), we have shown that Twist can interact phys-
ically with a promiscuous coactivator, p300. Recently,
p300 has been shown to promote transcriptional acti-
vation by p53. The p300 protein is an acetyltrans-
ferase that can modify histones and thus affect chro-
matin structure. p53 itself is also acetylated by p300,
and this modification may affect both DNA binding
and transcriptional activation. It has recently been
shown that Twist can inhibit p300 acetyltransferase
activity. Since p300 serves as a coactivator for diverse
transcription factors (including myogenic proteins),
the interaction between Twist and p300 provides a
potential biochemical mechanism for the effects that
we see on p53 function and for additional effects of
twist on myogenic differentiation and other diverse
developmental processes.
CELLULAR MORTALITY CONTROL
Normal human cells have a limited replicative life
span. When placed in culture, these cells can execute
only a predetermined number of cell divisions before
entering an irreversible state of growth arrest termed
cellular senescence. Tumor cells often escape from
these life-span limitations, thus becoming capable of
indefinite proliferation. It is likely that inactivation of
mortality controls and release from proliferative limits
are essential for tumorigenesis, particularly for the for-
mation of metastases.
The consumption of proliferative potential by a
normal cell in culture is measured by loss of telo-
meres. Telomeres are simple, repetitive sequences that
cap the ends of chromosomes. At each cell division,
these repeats are progressively lost due to the inability
of the DNA replication machinery to completely
reproduce a linear DNA molecule. As these repeat
arrays become critically short, an as yet mysterious
signaling mechanism triggers senescence.
In immortal cells, such as germ-line and tumor
cells, telomeres are maintained by the action of telom-
erase, an enzyme that adds repeats to chomosome
ends. At the end of last year, we showed, in collabora-
tion with Jenny Wang and David Beach (CSHL, The
Institute of Child Health, London), that the life span of
a normal cell could be extended by artificially activat-
ing telomerase in an otherwise mortal cell. We have
now demonstrated that telomerase activation is suffi-
cient to immortalize these cells, which have now been
passed continuously in culture for more than 1 year.
Although telomerase is activated in a high per-
centage of human cancers, the underlying mechanism
of this activation was unknown. We found that expres-
sion of the limiting subunit of telomerase, hTERT, was
regulated by a human oncogene, c-myc, that shows
increased activity in a broad spectrum of human
tumors. This provided an explanation for telomerase
activation in transformed cells and added at least one
piece to the puzzle of how myc activation contributes
to tumorigenesis.
Despite the fact that we could immortalize some
cultured human cells through a single genetic alter-
ation, it is unlikely that telomerase activation is suffi-
cient to allow continuous propagation of any primary
human cell. In fact, one of the "normal" cell lines used
in our studies had already silenced the p 1 6iNK4a tumor
suppressor prior to our introduction of telomerase. In
the other cell type, normal human fibroblasts, we find
that extended life-span populations are under continu-
ous pressure to extinguish p16 expression. This is con-
sistent with recent work that has defined a second
mortality control point that uses p16 as an effector but
that is telomere-independent. Current efforts are
aimed at defining the spectrum of molecular events
that are required to allow unlimited propagation of a
truly normal human cell in culture. Through a defini-
tion of these events, we may devise methods for the
expansion of normal human cells in a way that does
not select for populations that contain potentially
oncogenic alterations.
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CAENORHABDITIS ELEGANS DEVELOPMENTAL GENETICS
M. Hengartner S. Desnoyers T. Gumienny S. Milstein
R. Dodes (URP) D. Hoeppner M. Spector
A. Fraser J. Keller S. Tharin
A. Gartner Q. Liu
Ever since its introduction to the research community
by Sydney Brenner, the small nematode Caenorhabditis
elegans has been used extensively as a model organism
for the study of complex biological phenomena, includ-
ing developmental and signal transduction pathways,
neurobiology, and aging. The value of C. elegans for
such studies derives in part from its great simplicity at
the anatomical and developmental levels, from its pow-
erful genetics and ease of maintenance, and from the
availability of powerful reverse genetic tools (gene
knockout, RNA-mediated interference). The comple-
tion of the worm genome at the end of this year has
made C. elegans ready for the next generation of mole-
cular and developmental biologists.
Despite its great simplicity, one should not lose
sight of the fact that C. elegans is a metazoan-a mul-
ticellular animal-and as such shares with humans
many fundamental molecular and cellular programs. It
is this similarity at the level of genes and biochemical
pathways that allows the nematode worm to be used as
a useful model system. Our laboratory uses C. elegans
to study two basic biological problems: programmed
cell death (apoptosis) and nervous system development
and function.
PROGRAMMED CELL DEATH
Programmed cell death (PCD), or apoptosis, is a high-
ly regulated program of cell suicide. Apoptosis is
employed in many key biological processes, from the
removal of unnecessary cells during development to
the maintenance of cell populations and the deletion of
potentially dangerous (e.g., cancer-prone) cells in
adults. Defects in cell death also have a central role in
the pathogenesis of many human diseases including
AIDS, various neurodegenerative diseases, and cancer.
An understanding of the underlying molecular mecha-
nisms of both the regulation and execution of cell death
may thus allow significant improvement in therapeutic
design to treat these diseases.
More than 12 genes have been identified that func-
tion in programmed cell death in C. elegans. These
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genes divide the process into three distinct steps: exe-
cution of the death sentence, engulfment of dying cells,
and degradation of dead engulfed cells. The proximal
cause of apoptosis in C. elegans is the activation of the
caspase homolog CED-3 from the inactive zymogen
(proCED-3) into the mature protease. This activation is
mediated by the Apaf-1 homolog CED-4. In cells that
should survive, CED-3 and CED-4 are antagonized by
the Bcl -2 family member CED-9. CED-9 has been pro-
posed to prevent death by sequestering CED-4 and
proCED-3 in an inactive ternary complex, the apopto-
some. In cells fated to die, CED-9 is in turn inactivated
by the pro-apoptotic BH3 domain-containing protein
EGL-1. The structural and functional conservation of
cell death genes between nematodes and mammals
strongly suggests that the apoptotic program is ancient
in origin and that all metazoans share a common mech-
anism of apoptotic cell killing.
Physiological Cell Death in the
C. elegans Germ Line
T. Gumienny, S. Milstein
How is the apoptosome regulated? The answer to this
question is likely to be complex, as even a single cell
might need to integrate multiple signals to determine
whether it should activate the death pathway or keep
on living. To address this question in C. elegans, we
have set out to determine how specific cell types
decide between life and death.
One of the cell types that we chose to focus on is
the germ cell. PCD plays a major part in the adult her-
maphrodite germ line. Our previous studies have
shown that a majority of the germ cells that differenti-
ate along the oogenic pathway undergo PCD (Fig. 1).
We suspect that these deaths serve a homeostatic func-
tion and are needed to regulate the number of cells that
are allowed to differentiate into oocytes. Indeed, loss
of germ cell death results in germ line hyperplasia,
which likely accounts for the lower fertility of ced-3
and ced-4 mutants.
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FIGURE 1 Germ cell apoptosis. (a) Schematic diagram of an adult hermaphrodite C. elegans gonad. (b-d) Apoptotic germ cells
(arrows) can readily be distinguished from their surviving sisters (arrowheads) by DIC light microscopy (b), Hoechst nuclear staining
(c), and SYT012 vital dye staining (d). Bar, 10 turn.
The CED-9/CED-4/CED-3 apoptosome appears to
be regulated differently in the germ line than in the
soma. Loss of egl-1 function or gain of ced-9 function
prevents most, if not all, developmental deaths. In con-
trast, these mutations have no effect on germ cell
death, suggesting that perhaps another BH3 domain
protein inhibits CED-9 in the germ line.
To further decipher how germ cells make the deci-
sion between life and death, we have screened for
mutations that specifically affect PCD in the germ
line. We have thus far isolated more than two dozen
mutations that result in excessive germ cell death. We
are now in the process of genetically characterizing
and classifying these mutations, as a prelude to posi-
tional cloning.
DNA-damage-induced
Apoptosis in C. elegans
A. Gartner, S. Milstein
During our studies of the regulation of germ cell
death, we noticed that ionizing radiation, as well as
chemical mutagens, can induce germ cell death and
germ cell proliferation arrest. Both responses require
the function of the rad-5 gene. Interestingly, although
egl-1 is not involved in physiological germ cell death,
loss of egl-1 function significantly reduces (but does
not abrogate) radiation-induced germ cell death. Thus,
at least three distinct pathways can lead to apoptosome
activation in C. elegans.
Genes Involved in the
Engulfment of Dying Cells
T. Gumienny, Q. Liu
Once a cell activates the apoptotic machinery, a num-
ber of downstream "subprograms" are activated, with
the goal of rapidly breaking down the cell and remov-
ing it from the body. One important subprogram
results in the generation of signals that promote recog-
nition and phagocytosis of the dying cell by other
cells.
Six genes have previously been shown to function
in this process in C. elegans. In the past year, we have
reported our cloning and molecular characterization of
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one of these six genes, ced-6. CED-6 contains a phos-
photyrosine-binding (PTB) domain and a number of
potential SH3-binding sites, suggesting that CED-6
might act in a signal transduction cascade activated
once a cell recognizes that one of its neighbors is
undergoing PCD. Interestingly, overexpression of
CED-6 can partially rescue the engulfment defect of
ced-1 and ced-7 mutants, suggesting that ced-6 might
act downstream from these genes to promote cell
engulfment.
NERVOUS SYSTEM FUNCTION
AND DEVELOPMENT
A second area under investigation in the lab is the ner-
vous system in C. elegans. The small size and relative
simplicity of the nematode nervous system allow us to
readily address complex questions at the genetic and
molecular levels.
Axonal Guidance and
Outgrowth
S. Tharin in collaboration with B. Wightman,
Muhlenberg College, Pennsylvania; G. Garriga,
University of California, Berkeley; E. Hartwieg,
and R. Horvitz, HHMI/Massachusetts Institute
of Technology]
C. elegans has proven to be a useful system to identi-
fy conserved genes that function in nervous system
development. We have recently found that the unc-69
gene is required for axonal guidance, outgrowth, and
fasciculation in C. elegans. We have cloned the unc-69
gene and found that it encodes a small novel protein
with a predicted coiled-coil motif near its carboxyl ter-
minus. Rescuing unc-69::gfp fusion constructs are
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expressed throughout development in the nervous sys-
tem, predominantly in axons, suggesting that the unc-
69 gene acts cell autonomously to promote axonal
guidance and outgrowth. Our current data are consis-
tent with a model where unc-69 participates in a signal
transduction pathway that relays external guidance
cues to the axonal cytoskeleton.
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PLANT DEVELOPMENT
D. Jackson J.M. Arroyo G. Sabino
G. Birkenmeier D. St. Fleu
Z. Khalfan Z. Yuan
Our goal is to understand the molecular and genetic
mechanisms controlling plant development. Plants
have unique developmental capabilities because they
possess pools of stem cells, called meristems, that
enable them to initiate new organs throughout their
life cycle. For example, the shoot apical meristem
gives rise to the shoot organs such as leaves and flow-
ers. The fate of any given cell during plant develop-
ment depends mainly on its position with respect to
surrounding cells, rather than its developmental his-
tory or lineage. The cytoplasmic connections
between neighboring cells, called plasmodesmata,
are likely to be one route through which cells
exchange positional information. This is supported
by a growing body of evidence which indicates that
macromolecules of viral and plant origin traffic
through plasmodesmata.
Perhaps the best known example of a plant devel-
opmental gene that acts nonautonomously is knottedl
(kn 1) from maize. The knl gene was first identified by
dominant mutations that cause ectopic growths, called
knots, on the leaves. When Knl is expressed only in
the middle mesophyll layers of the leaf, this is suffi-
cient to induce the extra cell divisions in all cell layers,
leading to knot formation. The discovery that KN1
protein can be detected outside the domain of
detectable transcript accumulation in the meristem as
well as in knotted leaves suggested that intercellular
movement of KN1 protein may account for the non-
cell-autonomous behavior of Knl . Previously, we
showed that like viral movement proteins, fluorescent-
ly labeled KN1 protein rapidly moves from cell to cell
when microinjected into maize or tobacco leaf meso-
phyll cells. knl is a member of a small family of
homeobox genes, and therefore our data supporting
the intercellular trafficking of a putative transcription
factor suggest a novel mechanism by which plant cells
communicate during development.
The data supporting intercellular movement of the
KN1 protein are compelling, but there is still no direct
evidence that KN1 protein moves in the shoot meri-
stem, where it is normally required, nor whether move-
ment of KN1 is important for knl gene function. Also,
little is known about the mechanism by which macro-
molecules are targeted to and traffic through plasmod-
esmata.
HIGH-RESOLUTION IMAGING OF KN1
Cell-to-cell trafficking of viral and plant gene products
has been evidenced, in part, by performing high-resolu-
tion localization experiments to demonstrate that these
molecules are associated with plasmodesmata in planta.
Recently, we were able to show that KN1 protein is
detected in the plasmodesmata (Fig. 1) and nuclei (data
not shown) in the maize inflorescence meristem. The
level of labeling is weak compared to viral movement
proteins, suggesting that the level of expression or the
mechanism of trafficking may differ. Our results sup-
port the idea that the route for intercellular trafficking of
FIGURE 1 Sections of maize inflorescence meristem were
incubated with a control preimmune serum (A) or anti-KN1
polyclonal antibodies (8) followed by incubation with protein A
gold. Gold particles (black dots) are visible in plasmodesmata
farrowed) in B, but not in A.
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KN1 is through the plasmodesmata. We have improved
the specimen preparation procedure to look at the sur-
face layers of the meristem, which were not well pre-
served in the procedures that we used initially.
IN VIVO IMAGING OF KN1 CELL-TO-CELL
TRAFFICKING
Our current understanding of cell-to-cell trafficking of
plant proteins is limited by the accessibility of tissues to
microinjection. We are therefore developing new sys-
tems to visualize cell-to-cell trafficking of KN1 and
other proteins in different tissues of intact plants.
Several fusion proteins between KN1 and the green flu-
orescent protein (GFP) have been created. The GFP
gene was isolated from jellyfish and encodes a protein
that is naturally fluorescent. Using microprojectile bom-
bardment to introduce the KN1-GFP fusion constructs
into single epidermal cells, we have succeeded in
demonstrating cell-to-cell trafficking of the fusion pro-
tein. The KN1-GFP fusion clone has also been
expressed in stable transgenic Arabidopsis plants to fol-
low trafficking in different tissues of the plant, using
several approaches. First, we have grafted nontransgenic
stems (the scion) onto plants that express the KN1-GFP
fusion and have observed trafficking of the fusion pro-
tein into the stem of the nontransgenic scion. This exper-
iment demonstrates the cell-to-cell trafficking of the
KN1-GFP fusion but does not allow us to determine the
extent of trafficking in a wide range of cell types.
Second, we are using the Cre-/oxP site-specific recom-
bination system of bacteriophage P1 to create mosaic
sectors of GFP-KN1 in Arabidopsis. The sector bound-
aries are marked with a different form of GFP that is tar-
geted to a specific subcellular compartment, such as the
mitochondria or chloroplasts. Transgenic plants harbor-
ing the /oxP/GFP-KN1 constructs have been made and
will be crossed to plants carrying the cre recombinase
gene under the control of a heat shock promoter. Upon
the application of a heat shock, cre expression will be
induced and lead to the production of sectors that
express KN1-GFP and lack the subcellular marker GFP.
Imaging of the boundary between cells that express
KN1 -GFP and cells that do not will allow us to deter-
mine in which tissues and how far the KN1 protein can
move in vivo. As a third approach, we are using a Ga14-
based enhancer trap-trans-activation system developed
by Dr. Jim Haseloff to express KN1-GFP in specific tis-
sue and cell types. We have generated more than 100
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enhancer trap lines that express GFP in specific cell or
tissue types during development. These lines will be
crossed to plants that carry the KN1-GFP fusion under
the control of the Gal4UAS, so that the transgene will be
activated in the specific cell or tissue types revealed by
the enhancer trap expression pattern. These approaches
will allow us to determine when and where during
development the KN1 protein is able to traffic between
plant cells.
MAIZE MUTANTS AFFECTING MERISTEM
DEVELOPMENT AND PHYLLOTAXY
Plant architecture has a major impact on agricultural
yield; for example, the introduction of dwarfing genes
into wheat helped increase yields from 0.75 tons/
hectare to up to 8 tons/hectare. Architecture is the end-
product of morphogenesis, which in plants, as in ani-
mals, commences during embryogenesis with the
development of distinct organ and tissue types. In
plants, however, new organs are initiated throughout
the life cycle from populations of stem cells in the
meristems. The shoot organs such as leaves, axillary
meristems, and flowers are initiated by the shoot apical
meristem (SAM), usually in regular and defined pat-
terns. SAMs show remarkable abilities to self-regulate
their size during development, by balancing their own
growth with the incorporation of cells into new pri-
mordia. We are investigating the mechanism of SAM
size regulation through the molecular and phenotypic
analyses of mutants in maize that cause enlargement or
fasciation of the ear inflorescence SAM.
We have identified several spontaneous and trans-
poson-induced mutants that have a fasciated pheno-
type, leading to enlarged and fasciated ears. Allelism
tests indicate that the mutations correspond to several
different genes and also suggest that certain of the gene
products may interact directly. One of the mutants, fas-
ciated earl (fae2), was isolated in a nondirected
Mutator (Mu) transposon screen conducted at Dekalb.
We identified a Mu transposon that cosegregates with
the fae2 mutation in approximately 80 mutant individ-
uals and have cloned a genomic DNA fragment con-
taining the Mu element as well as flanking DNA that
may contain the fae2 gene. By analysis of RNA expres-
sion, we identified a region of the genomic clone that
encodes a transcript which is preferentially expressed
in ear primordia and is absent in fae2 mutant ears, mak-
ing this a good candidate for the fae2 gene.
Experiments to definitively show whether the cloned
sequence corresponds to fae2 are in progress. We are
also trying to determine whether this mutation directly
affects the proliferation of stem cells in the meristem or
whether it acts by an alternative mechanism.
An aspect of meristem function that has been dif-
ficult to address is how regular patterns of leaf initia-
tion are generated. These patterns, known as phyl-
lotaxies, have been studied for decades, but the mole-
cular mechanisms involved are largely unknown. We
have been characterizing a new recessive mutant of
maize, abphyll (abphl), that initiates leaves in oppo-
site pairs rather than singly, as is typical for the grass-
es. The abphl mutation leads to the initiation of a larg-
er shoot meristem domain in the embryo and an
altered phyllotactic pattern. There are two possible
models to explain the mechanism of action for the
abphl mutation: (1) The mutation might affect the
axial growth of the embryo, causing the initiation of a
broader shoot meristem that initiates more primordia
due to an increased morphogenetic field within which
the primordia are specified or (2) the mutation could
function by directly specifying extra primordia. In this
case, the larger meristem domain would be a conse-
quence of having extra primordia. Isolation of the
abphl gene should allow testing of these models by
determining when and where the gene is expressed.
We therefore initiated a directed tagging experiment
by crossing abphl mutant plants onto Mu active plants
and screening in the F, generation for rare putative
new alleles. Last winter in the greenhouse, we found
several candidates, and since then, we have been able
to show that at least two are heritable. We have now
generated the families to start to look for cosegregat-
ing Mu transposons that would allow us to isolate the
abphl gene and determine how it acts to control the
phyllotaxy of the maize plant.
Understanding these fundamental aspects of plant
development could provide a means to control the
number, pattern, and size of organs produced during
development and could therefore enhance crop plant
productivity.
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ARABIDOPSIS FLOWER AND POLLEN DEVELOPMENT
H. Ma Y. Azumi
A. Debrowski
J. Ellstein
B. Horwitz
Y. Hu
E. Katz H. Onaka
B. Laulicht P. Rubinelli
D. Liu S. Vi rani
S. Luo Y. Wang
S. Moran M. Yang
Our research continues to focus on the functional
analysis of genes important for plant reproductive
development in Arabidopsis. Our recent endeavor has
been to isolate mutants defective in flower develop-
ment and pollen development and to clone the affect-
ed genes, using the gene/enhancer trap system devel-
oped here at CSHL by Drs. V. Sundaresan and R.
Martienssen.
In 1998, Peter Rubinelli, a graduate student of the
SUNY, Stony Brook MCB program, completed his
research project here at the Laboratory, successfully
defended his thesis, and received his Ph.D. degree. For
his postdoctoral training, he has chosen to work at
Ohio State University. In addition, we welcomed sev-
eral new members. Drs. Yixing Wang from Jinan
University, China, and Hiroyasu Onaka from the
University of Tokyo, Japan, joined our laboratory as
postdoctoral associates. They have started experiments
designed to gain further insights into the function of
the floral regulatory gene AGAMOUS. Dr. Yoshitaka
Azumi came from Kanagawa University, Japan, for his
sabbatical leave. He has been learning the gene-trap
system step by step and has participated in the analy-
sis of a newly identified male meiosis gene. Dr.
Benjamin Horwitz came for a short stay from The
Technion Institute in Israel, working on constructing
cDNA libraries as a part of a 3-year collaboration
between our two laboratories. Shujin Luo, an URP
from Peking University, performed studies on
enhancer-trap lines with floral expression patterns.
Elisa Katz, our Partner for the Future, completed her
project with Ming Yang, a postdoctoral fellow in the
laboratory, on the characterization of an Arabidopsis
gene required for male meiosis. Finally, high school
students Brian Laulicht, Sienna Moran, Amy
Debrowski, and Joshua Ellstein continued their pro-
jects in the gene-trap effort. As always, we greatly
appreciate the assistance by the Uplands Farm manag-
er Tim Mulligan and his assistant Stan Schwarz.
In August, my laboratory concluded more than 8
years of research at CSHL, and we moved to the
Pennsylvania State University Department of Biology,
94
where I have started a position as an associate professor.
I am fortunate that most of the full-time members in my
laboratory have moved with me, including postdoctoral
fellows Ming Yang, Yixing Wang, and Hiroyasu Onaka,
visiting scientist Yoshitaka Azumi, and technicianYi Hu.
Because of family reasons, postdoc Dehua Liu stayed at
CSHL, working with Dr. Martienssen.
Characterization of a
Ds-tagged Locus, SKL1
M. Yang, Y. Hu, H. Ma [in collaboration with
M. Lodhi and R. McCombie, Cold Spring
Harbor Laboratory]
We previously reported the isolation of a putative Ds-
tagged mutant defective in male meiosis from a Ds
insertional line called ET5223. Subsequent genetic
studies have recovered several revertant sectors in
mutant plants carrying an Ac element, presumably as
the result of Ac-dependent transposition of the Ds ele-
ment. Sequence analysis indicates that the Ds-disrupt-
ed locus is completely restored to the wild-type
sequence in 12 revertants. Furthermore, in two other
revertants at the site of Ds insertion, the Ds element is
no longer present, but six nucleotide insertions remain
and are capable of encoding two additional amino acid
residues. These results provide direct evidence for the
idea that the mutant phenotype is caused by the Ds
insertion and suggest that the corresponding protein
product can still function with these extra residues.
Portions of the sequences flanking the Ds element
match perfectly cDNA sequences of an expressed
sequence tag (EST) clone that is highly similar to a
yeast gene and a human cDNA encoding the SKP1 pro-
teins. These results indicate that the gene disrupted by
the Ds element is a likely homolog of the yeast and
human SKP1 genes; thus, we have named the gene
SKL1, for SKP 1 -LIKE/ , and the Ds insertional mutant
allele skll -1. The Ds insertion in the mutant and the
extra amino acid residues are in a nonconserved linker
region between two conserved domains, consistent with
the fact that these additional amino acids do not disrupt
the SKL1 function. The SKL1 gene is expressed
throughout plant development, in all organs tested,
including both vegetative and reproductive organs. In
particular, RNA in situ hybridization revealed that SKI'
is expressed in male meiotic cells. Analysis of RNA
samples from the sk11-1 mutant plants indicates that the
SKL1 message is not detectable.
Characterization of the
Male Meiotic Defect in
the skI1-1 Mutant
M. Yang, E. Katz, B.B. Laulicht, Y. Hu, H. Ma
Normal Arabidopsis male meiosis in a microspore
mother cell produces a tetrad containing four equal-
sized spores. Our previous studies indicate that the All-
] mutant exhibits defects during male meiosis, resulting
in abnormal "tetrads" with a variable number of spores
that are uneven in size. Our further analysis indicates
that the mutant fails to separate homologous chromo-
somes during meiosis I in the microspore mother cell.
Proper chromosomal association and subsequent segre-
gation are essential for normal passage of genetic infor-
mation through cell divisions. However, little is known
about the association and separation of homologous
chromosomes during meiosis. Using fluorescence
microscopy, we found that chromosomal condensation
at metaphase I appeared to be similar between wild-type
and sk11-1 mutant male meiosis, but the mutant chro-
mosomal materials were abnormally extended during
anaphase I. Furthermore, fluorescence in situ hybridiza-
tion analysis of chromosome 2 using rDNA as a probe
revealed that the rDNA region is localized to the central
portion of the extended DNA materials. These results
strongly suggest that homologous chromosomes in the
mutant fail to separate following metaphase I, and the
region of association is small. In particular, the region
of attachment on chromosome 2 may be near or overlap
with the rDNA region. As reported above, the SKL1
gene product is a member of a highly conserved family
that includes the human and yeast SKP1 proteins. The
yeast SKP1 protein targets specific proteins for degra-
dation by ubiquitin-mediated proteolysis or for phos-
phorylation in the kinetochore. We propose that the
Arabidopsis SKP1 protein controls homolog separation
during male meiosis I by degrading or otherwise remov-
ing a protein complex that holds homologs together
prior to anaphase I.
Genetic Studies of a
Possible Interaction
between SKL1 and UFO
M. Yang, B. Laulicht, H. Ma
Molecular genetic studies have identified a number of
genes whose functions are specifically required for
controlling floral organ identity. At the same time, it is
likely that other genes with more pleiotropic functions
also contribute to the regulation of floral organ identi-
ty. While studying the male-sterile mutant sk11-1, we
noticed that in addition to its defects in male meiosis,
it also has abnormalities during vegetative and flower
development. We have begun to characterize these
abnormalities. In the skI1-1 mutant, rosette leaf
growth is reduced, resulting in slightly smaller than
normal rosette leaves throughout vegetative develop-
ment. After flowering, the mutant has less internode
elongation than wild type. Although some mutant
flowers have four normal-sized petals, many flowers
have one or more petals that are reduced in size. The
filaments are more uniformly shortened, and there are
slightly fewer petals and stamens. In addition,
petal/stamen chimeric organs are found in many flow-
ers. These results indicate that the SKL1 gene affects
the size of vegetative and floral organs.
The skll floral phenotype resembles, but is not as
severe as, that of the Arabidopsis ufo mutants; we
therefore have initiated experiments to test for possible
interactions by examining the ufo-2 sk11-1 double
mutant. Crosses were carried out between sk11-1 and
ufo-2 mutant plants. In addition, other crosses were
performed to generate double mutants to investigate
potential interactions between SKLI and other floral
regulatory genes. Analysis of these double mutants
should uncover genetic interactions and provide
insight about how SKLI functions in the regulation of
flower development.
Preliminary Characterization
of Putative Mutants
D. Liu, Y. Azumi, Y. Hu, S. Moran, H. Ma
We have screened our Ds insertional lines for visible
developmental phenotypes in the flower. In addition to
several mutants similar to known mutants, we also
found a number of mutants that have novel floral phe-
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notypes. These include mutants that have abnormal
floral organ sizes and/or shape. In particular, several
mutants have short filaments; some of these produce a
large number of functional pollen grains but have
reduced fertility because the pollen grains are not effi-
ciently delivered to the stigma.
From among several new male sterile mutants, we
have characterized in some detail one mutant from
transposant ET2292 that has a defect in male meiosis.
This mutant produced tetrads with four to six spores,
and thus the mutant phenotype is different from that of
the meiotic mutant from ET5223 or from those of sev-
eral published mutants. Our results from pollination
using normal pollen indicate that the ET2292 mutant
is female fertile. Previously, we reported that we had
obtained several revertant sectors among mutant
plants carrying an Ac element. Further analysis indi-
cated that the ET2292 mutant carries a single Ds inser-
tion, and the revertant alleles have lost this Ds ele-
ment. In particular, DNA sequences of the regions
flanking the Ds element in the mutant and the corre-
sponding regions from the wild-type and several rever-
tants support the hypothesis that the Ds insertion is
responsible for the mutant phenotype. We are in the
process of isolating the cDNA and genomic clones.
Preliminary analysis of mutant meiosis using
DAPI staining suggests that the homologous chromo-
somes fail to pair properly during meiosis I.
Consequently, at metaphase I, ten univalents (single
unpaired chromosomes) were observed in the mutant
cells, as opposed to the five bivalents (pairs of homol-
ogous chromosomes) seen in the wild-type cells.
Further investigation is in progress.
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Screening Enhancer and Gene-trap
Transposants for Addition Mutants
A. Debrowski, J. Ellstein, Y. Hu, H. Ma [in collaboration with
Jean-Philippe Vielle Calzada and Ueli Grossniklaus, Cold
Spring Harbor Laboratory]
To identify new genes regulating Arabidopsis flower
development, we have continued to generate enhancer
trap/gene trap transposon insertional lines. At the same
time, we have screened for new mutants among Ds
insertional lines. A number of new putative mutants
were identified, and will be characterized in the near
future. In particular, in collaboratoin with Jean-
Philippe Vielle Calzada and Ueli Grossniklaus, we
have screened for sterile or low-fertility mutants.
Initial microscopic examinations suggest that three
sterile mutants may have defects in male meiosis,
whereas others have abnormal pollen development at
later stages. We expect that further analysis should
reveal the abnormalities more precisely.
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PLANT DEVELOPMENTAL GENETICS AND
FUNCTIONAL GENOMICS
R. Martienssen M. Byrne B. May M. Dunham [URIP] R. Shen
M. Curtis P. Rabinowicz A.M. Settles J. Simorowski
C. Kidner E. Vollbrecht J.-M. Arroyo C. Yordan
A. Groover
We are using plant developmental genetics to study
fundamental questions of patterning and differentia-
tion during development. Currently, these studies are
focused on the Arabidopsis leaf and in the maize inflo-
rescence. Our primary tools in this work are function-
al genomics and gene trap transposon mutagenesis. In
collaboration with Dick McCombie's laboratory at
Cold Spring Harbor, we have also embarked on a
sequence analysis of the Arabidopsis genome and have
developed methods for sequencing maize and rice. The
ability to examine complete sets of genes at the struc-
tural and functional levels across species barriers is
leading to a revolution in our understanding of plant
form and function and of how this relates to similar
processes in animals and microbes.
Dorsoventral Axis Specification
in the Arabidopsis Leaf
C. Kidner, R. Martienssen
The leaf is the ground-state organ of plants, and asym-
metry in the dorsoventral axis is vital for producing the
flattened blade that characterizes most leaves and leaf-
like organs such as petals. We found that an
Arabidopsis gene (DANDELION [DND]), which is
required for proper formation of the dorsoventral axis,
is a member of a large and evolutionary well-con-
served gene family, with representatives in humans,
insects, nematodes, and yeast as well as other plants.
Analysis of the function of DND in Arabidopsis is
aided by an allelic series. The original dandelion muta-
tion (dndl-1) was isolated by A. Bhatt and C. Dean, and
a similar mutant, dndl -2, was recovered from our
enhancer trap collection. These plants produce radial
leaves and no flowers, and one out of five dies in the first
week of growth. This phenotype is similar to another
mutant, argonaute (agol), that has recently been cloned
molecularly (Bohmert et al., EMBO 17: 170 [1998]) and
proved to be allelic. The gene trap lines also yielded a
much weaker allele, dndl -3. These plants have radial
first leaves and floral organs, but subsequent leaves have
some dorsoventral asymmetry. Scott Poethig (University
of Pennsylvania) provided us with a similar mutant that
proved to be an additional allele, dndl -4, that is similar
to dndl -3 but has trumpet-shaped leaves and a more
severe floral phenotype. None of the alleles recovered
from the enhancer trap lines were associated with a
transposon insertion, but reverse transcriptase-poly-
merase chain reaction (RT-PCR) shows that dndl -3 and
dndl -4 produce aberrant DND mRNAs of various sizes,
the predominant size being about 50 by smaller than
wild type. This points to a partial splicing defect.
Using the allelic series and gene trap and enhancer
trap expression patterns, we have found a number of
genes in the same developmental pathway as DND.
Enhancer traps have identified several genes that are
misexpressed in a dnd background, including a gene
with similarity to teosinte branched, a member of a
large gene family controlling lateral organ growth in
maize and its relatives.
Proximodistal Axis Specification
in the Arabidopsis Leaf
M. Byrne, M. Dunham (URP), M. Curtis,
R. Martienssen
Assymetric leafl (as 1) is a classical mutant of
Arabidopsis first isolated in the 1940s. Leaf shape is
progressively altered in this mutant, with round, buck-
led rosette leaves being gradually replaced with lobed
leaves and then dissected cauline leaves later in devel-
opment. By examining a number of spatially restricted
enhancer and gene trap reporter gene expression pat-
terns, we have established that the mutant phenotype
reflects the presence of multiple proximodistal axes
and may have a partial alteration in dorsoventral polar-
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ity. The as1 gene maps to chromosome 2, and we have
been isolating recombinants with flanking markers in
a "chromosome landing" experiment designed to posi-
tionally clone the as1 gene. We have narrowed the as1
region to less than 50 kb and have identified a number
of candidate genes in the region. These genes are being
fine-mapped and tested for their ability to complement
the mutant phenotype in transgenic plants.
Plant Vascular Differentiation
A. Groover, R. Martienssen
Vascular plants represent the most important group of
terrestial plants in evolution, and the highly ordered
and polar arrangement of veins within leaves is a strik-
ing example of spacing differentiation in plant devel-
opment. Cells must assess their position relative to
other cells within the tissue and to differentiate at the
appropriate stage. This process underlies secondary
growth in plants (the formation of wood).
We are using Arabidopsis gene traps to study sig-
naling mechanisms controlling vascular development
by (1) identifying secreted signaling proteins using a
functional genomics approach and (2) identifying reg-
ulatory genes expressed in a specific vascular cell
type, the tracheary element. Tracheary elements syn-
thesize an elaborate secondary cell wall, and then
undergo a process of programmed cell death. We are
systematically identifying genes expressed within this
cell type using gene traps. We have also developed a
"secretion trap" screen that identifies secreted signal-
ing proteins based on functional properties of the gene
trap fusion protein. Preliminary results from this
screen include the tagging of several membrane-bound
and -secreted receptor-like molecules, as well as a
number of novel genes.
Characterization of the iojap Gene
in Maize and Bacteria
M. Byrne, R. Martienssen
The iojap mutant of maize was first characterized in
the 1920s and 1940s and has a pattern of green and
white stripes on its leaves. Green sectors have cells
with normal chloroplasts, whereas white sectors have
cells where plastids fail to differentiate. These mutant
plastids, when transmitted through the female gameto-
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phyte, do not recover even in the presence of the wild-
type Iojap (Ij) gene.
Biochemical evidence suggests that the Ij protein
interacts with the 50S ribosomal subunit, and
sequences homologous to Ij have been found in all
eubacteria for which the complete genome sequence is
available (except for mycoplasmas). The Escherichia
coli homolog, ybeB, is the first gene in an operon of
four genes, two of which (pbpA and rodA) encode
gene products required for cell wall formation.
Disruption of pbp2 is conditionally lethal, but an E.
coli strain carrying a chromosomal deletion in ybeB
has normal growth rate compared with wild type. The
morphology of mutant cells also appears to be unal-
tered, except for occasional colonies that exhibit fila-
mentous growth. We are currently comparing the
growth of the wild type and mutant under specific
growth conditions such as limiting nutrients, and we
are making double mutants with ribosome assembly
and other relevant mutants.
We have used a His-tagged Ij fusion protein to gen-
erate both polyclonal antibodies and a collection of 20
monoclonal antibodies specific for Ij. These are being
used in immunoprecipitation experiments to isolate
proteins interacting with Ij.
Redundancy and Suppression
in the Control of Chloroplast
Protein Translocation by the
hcf106 Gene in Maize
M. Settles, R. Martienssen [in collaboration with A. Barkan,
University of Oregon]
The hcf106 gene on maize chromsome 2S is required
for targeting and localization of a subset of thylakoid
proteins in the chloroplast (Settles et al., Science
278(5342): 1467 [1998]). A homologous gene family
in prokaryotes and another conserved membrane pro-
tein are required for similar protein targeting in E. coll.
The hcf106 secretion pathway is posttranslational and
may tolerate tertiary structure, allowing tightly associ-
ated proteins to translocate as a single unit.
In maize, a second gene 88% identical to hcf106
encodes a protein closely related to HCF106
(HCF106C) that is not expressed in hcf106 mutant
seedlings and maps close to a genetic factor required
for the hcf106 phenotype on chromosome 10L. We
sequenced the hcf106C locus of both wild-type and
mutant plants and found a 7-bp direct repeat in the
mutant hcf106C locus that causes a nonfunctional pro-
tein to be produced. Using this polymorphism, we
have shown that the mutated hcf106C gene cosegre-
gates with the hcf106 phenotype.
The unlinked hcf106C mutation complicates
genetic studies of double mutants. The thal mutation
of maize disrupts chloroplast SecA of the Sec post-
translational targeting pathway. We have made triple
mutants with hcf106, hcf106C, and thal which
demonstrate that the HCF106 and SecA pathways are
independent of each other, implying that the hcf106
pathway does not share essential components with the
Sec pathway. In the process of making this triple
mutant, we found that the thal mutation is epigeneti-
cally regulated by the activity state of Robertson's
Mutator transposons. The thal mutation contains a
Mu/ insertion in an intron. Intron Mu insertions are
not generally thought to be epigenetically regulated,
but we have confirmed that the hcf106-mum4 allele,
which also has an insertion in an intron, is also epige-
netically regulated.
Exploring Lethality and Redundancy
in the Arabidopsis Genome with
Systematic Gene Trap Sequencing
J. Simorowski, C. Yordan, R. Shen, Q. Gu (University
of Tennessee), P. Springer (University of California
at Riverside), C. Kidner, M. Curtis, A. Groover,
R. Martienssen [in collaboration with J. Healy,
A. Reiner, and W.R. McCombie, Cold Spring Harbor
Laboratory]
The genome ofArabidopsis thaliana has approximate-
ly 20,000 genes, of which only 10% encode essential
functions. Reverse genetic studies have revealed that
only a small proportion of the remaining genes have
obvious roles in growth and development, even when
they are known to be expressed. One explanation is
that most genes have closely related homologs else-
where in the genome that encode redundant functions.
To address redundancy and lethality in functional
genomics, we are using a gene trap approach. The
transposon system that we have devised is uniquely
suited to this as it generates single, random insertions
in the Arabidopsis genome via positive-negative selec-
tion for unlinked transpositions. We are generating
thousands of gene trap and enhancer trap insertions
and amplifying, sequencing, and staining each one to
simultaneously determine allelic structure, gene
expression, and genetic function. So far, 800 lines
have been successfully sequenced.
A relational database of gene expression patterns
and insertion site sequences has been established that
allows gene expression, mutant phenotype, map posi-
tion, and gene disruption data to be searched using
sophisticated Web-based applications. In this way, dis-
ruptions in gene family members that are expressed in
the same cells can be genetically combined to reveal
redundancy.
The expression patterns of lethal genes can also be
examined in viable heterozygotes, revealing clues to
function. prolifera was the first lethal insertion to be
recovered, and it proved to disrupt an essential cellular
function, namely, DNA replication. We have now
recovered many more lethals by systematically screen-
ing transposants for similar phenotypes as they are iso-
lated. Lethal mutations in translation, transcription,
and cell cycle function have been recovered. Most of
these mutants have variable and occasionally mater-
nally inherited phenotypes, including semisterility and
embryonic lethality. These phenotypes are highly rem-
iniscent of similar mutants in yeast, Drosophila, and
Caenorhabditis elegans which cause early develop-
mental arrest and maternal effects.
Genetically Filtered Shotgun
Sequencing of the Maize Genome
P. Rabinowicz, C. Yordan, R. Martienssen
[in collaboration with K. Schultz, N. Dedhia,
L. Parnell, L Stein, and R. McCombie,
Cold Spring Harbor Laboratory]
The genomes of higher plants and animals are highly
differentiated, comprising a relatively small number of
genes and a large fraction of repetitive DNA. Recently,
it has been shown that the bulk of this repetitive DNA
constitutes transposable, and especially retrotranspos-
able, elements. It has been hypothesized that most of
these elements are heavily methylated relative to genes
and that this methylation might serve to sequester
transposons and other repeats from transcriptional
complexes in the nucleus. However, the evidence for
this is anecdotal and controversial.
We analyzed a random sample of a few hundred
clones from maize genomic libraries using two kinds
of hosts: mcr (defective restriction-modification sys-
tems), which should include any sequence present in
the maize genome, and mcr+ (called genetically fil-
tered libraries), which should restrict methylated
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DNA. By judicious use of insert sizes less than the size
of genes, we reasoned that genes should be preferen-
tially represented in these libraries if methylation were
restricted to repeats. 90% of the mcr clones contained
repetitive DNA (mainly retrotransposons), as previous
studies predicted. In contrast, almost 80% of the
genetically filtered clones were low-copy DNA, and
only 10% had high-copy repeats. By comparison with
databases, most of the low-copy DNA in the geneti-
cally filtered libraries could be accounted for by genes
and genic regions.
EST (expressed sequence tag) sequencing largely
avoids intergenic and noncoding DNA, but many genes
are also absent or underrepresented even in normalized
cDNA libraries. Genomic sequencing approaches do
not suffer these limitations, and relatively low-quality
sequence from a genome of interest and its comparison
to the complete and highly accurate sequence of a relat-
ed genome would yield most of the information sought.
The difficulty with such an approach for plant and
mammalian genomes has always been the high density
of repetitive sequences that consume sequencing
capacity and prohibit assembly. The use of genetically
filtered libraries could overcome this difficulty.
Mutator-targeted Mutagenesis
in Maize
B. May, E. Vollbrecht, P. Rabinowicz, J.-M. Arroyo,
R. Martienssen [in collaboration with M. Freeling,
University of California at Berkeley; L. Senior,
D. Alexander, Novartis Seeds; and L. Stein,
Cold Spring Harbor Laboratory]
The availability of large amounts of DNA sequence
information in plants allows a systematic approach to
be taken to determine gene function. This approach,
pioneered in animal genomes such as Drosophila and
C. elegans, involves first constructing a library of
thousands of organisms, each of which has a different
spectrum of insertions or deletions. This library is then
screened with a target sequence to identify plants that
carry mutations in a given gene. Robertson's Mutator
transposable elements are uniquely suited for this pur-
pose, and we have previously developed a strategy
allowing large populations of plants to be screened for
mutations in pools (Das and Martienssen, Plant Cell
7: 287 [1995]). This strategy involves crossing active
lines with a strain that inhibits Mutator activity, so that
F, plants carry germinal but no somatic mutations
(Martienssen and Baron, Genetics 136: 1157 [1994]).
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A background of somatic mutations has proven to be
problematic in a similar system, now known as
"TUSC," which was developed by Pioneer Hi-bred at
around the same time (Bensen et al., Plant Cell 7: 75
[1995]).
As part of the new Plant Genome Initiative, we are
establishing a library of 40,000 F, plants. So far, more
than half of these plants have been self-pollinated and
the seeds collected. DNA samples are being extracted
from tissue samples and pooled using bar codes. A
preliminary screen for kernel phenotypes has been
used to estimate the mutation frequency. PCR can be
performed on DNA pools derived from this population
so that seeds corresponding to mutations in a given
gene can be readily identified. Individual geneticists
from the maize community will be able to send in
sequence information for targeted disruption of genes
of interest to them. The information will be entered
into a database, and the seed corresponding to the
mutation will be distributed to interested researchers
to allow them to determine the function of each gene
chosen in this way. The Mutator-targeted mutagenesis
(MTM) system will thus be used to build up a database
of gene function in maize.
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MAMMALIAN CELL GENETICS
M. Wig ler C. Yen D. Esposito
M. Hamaguchi E. Hatchwell
M. Nakamura D. Dong
R. Lucito J. Stolarov
L. Serina
H. Tu
J. West
L. Rodgers
M. Riggs
Our overall research program is only modestly modi-
fied from last year's. Our general aims remain the
same: to define the mutations that result in cancer and
other human diseases; to understand the mechanisms
by which these mutations cause disease; and to devel-
op strategies to modify the course of disease. Our
effort is specifically focused in three areas: combina-
torial chemistry, in which we are trying to develop a
general methodology that will enable us to manipu-
late the biochemical pathways involved in cancer;
signal transduction, in which we study the pathways
of intracellular communication that become deranged
in cancer cells; and genomics, in which we apply and
develop tools for the genetic analysis of human dis-
ease.
The combinatorial program (Dennis Dong), con-
ducted in collaboration with Peter Nest ler and col-
leagues here at the Laboratory, has demonstrated the
feasibility of finding small branched peptidic mole-
cules that recognize the peptide epitopes of proteins
and alter their biochemical interactions.
Our signal transduction studies are focused in
two areas: cellular pathways that relate to the onco-
genic Ras proteins (Hua Tu and Dennis Dong) and
the analysis of the PTEN tumor suppressor (Javor
Stolarov, Ken Chang, and Dennis Dong, in collab-
oration with Mike Myers and Nick Tonks at
CSHL).
Our genomic studies are now divided into three
parts. First, we are searching for cancer genes at the
many loci that we have discovered by the application
of representational difference analysis, or RDA. We
are seeking tumor suppressor genes at six of the loci
that are commonly deleted in cancer (Clifford Yen,
Masaaki Yamaguchi, Robert Lucito, and Diane
Esposito, in collaboration with Dick McCombie and
Larry Pamell at CSHL). The PTEN tumor suppressor
was found this way. In collaboration with Scott Powers
and colleagues at Tularik, we are also seeking onco-
genes in the regions that are commonly amplified in
J. Troge M. Katari
B. O'Conner D. Almanzar
V. Tu J. Brodsky
A. Bug lino J. Douglas
cancer (Clifford Yen and Mariko Nakamura). In the
second part, we are expanding the use of genomic rep-
resentations and microarrays to develop "genomic
chips" (Robert Lucito and Joe West, in collaboration
with Andy Reiner at CSHL). We expect to develop
thereby a vastly more powerful engine for the discov-
ery of genes mutated in cancer. Additionally, we hope
that genomic chips will provide a method for rapidly
genotyping clinical human cancers, leading to
improvements in the diagnosis and the selection of
therapies. The cancer genomics studies are conducted
in collaboration with Larry Norton of the Sloan
Kettering Memorial Cancer Institute. In the third part,
we are adapting the techniques of representational
analysis to find spontaneous mutations that cause
germ-line transmission of sporadic hereditary diseases
(Eli Hatchwell and Lidia Serina).
Combinatorial
Chemistry
D. Dong
In collaboration with Peter Nestler's lab here at the
Laboratory, we are investigating the binding capacity
of a class of branched peptidic molecules, or molecu-
lar "forceps." These "forceps" have been generated as
members of encoded combinatorial libraries, a method
developed in collaboration with C. Still's laboratory at
Columbia University (Ohlmeyer et al., Proc. Natl.
Acad. Sci. 90: 10922 [1993]). As targets, we have cho-
sen the carboxyl end of H-RAS, because it is the sub-
strate of famesyl transferase, the first step in the
essential processing of RAS proteins (Gibbs, Cell 65:
1 [1991]), and because this end is predicted by crys-
tallographic studies to be an exposed peptide. Several
forceps libraries were screened against both H-RAS
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protein and H-RAS terminal peptides using "on-bead"
assays. Several members of this forceps library thus
found were shown to bind specifically to the carboxy-
terminal sequences of H-RAS and to recognize these
sequences when they are fused to other proteins. At
high concentrations, these forceps block the enzymat-
ic farnesylation of H-RAS, in a manner strongly sug-
gesting competition with enzyme for substrate bind-
ing. These results (Dong et al. 1999) suggest that
branched peptidic molecules have the general capacity
to recognize peptides and could, in principle, be used
to modulate biological systems. However, improve-
ments in the chemical backbone and binding affinities
are clearly necessary before this end can be achieved.
Our current efforts are now focused on screening more
selective libraries and validating the strategy of specif-
ically blocking H-RAS maturation as a way to modu-
late tumor growth.
Studies of MAP Kinase
Cascades
H. Tu,
The MAP protein kinase cascade, consisting of com-
ponents from the MEKK, MEK, and MAPK protein
kinase families, is a conserved triad found in all
eukaryotic organisms and is under the control of Ras
proteins in multiple species from diverse phyla. Our
first encounter with the triad was in the sexual differ-
entiation pathway in the yeast Schizosaccharomyces
pombe. In that organism, Rasl acts directly on Byr2,
an MEKK, by binding to its regulatory domain. We
have conducted many studies of the integration and
control of this pathway during the past years, and in
previous years demonstrated that Shkl, a conserved
protein kinase, activates Byr2 by "opening" its confor-
mation. Shkl is a member of the PAK family of pro-
tein kinases. Like the MEKK kinases, these kinases
also have a carboxy-terminal catalytic domain and an
amino-terminal regulatory domain that contains the
binding site for certain RHO proteins, members of the
Ras superfamily of GTPases. We have demonstrated
that the tools for analyzing the regulatory components
of Byr2 can be used for the study of the PAK family of
kinases (Tu and Wigler 1999). In particular, the RHO
proteins bind the regulatory domain of Shk 1 , and this
domain of Shjk 1 binds the catalytic domain.
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Moreover, mutations in the Shkl regulatory region
that abolish binding to the catalytic region open the
conformation of Shkl and activate it.
The PTEN Tumor
Suppressor
J. Stolarov, K. Chang, C. Yen, D. Dong
The use of RDA led to the identification of a region on
chromosome 10 deleted in a variety of human cancers,
including breast, prostate, and brain cancers. We there-
fore suspected that this region harbored a tumor sup-
pressor gene. In a collaboration with Ramon Parsons of
Columbia University, a gene from this region, PTEN,
was identified and found to be mutated in many cancers
(Li et al., Science 275: 1943 [1997]). Parsons and col-
laborators found that the PTEN gene is mutated in the
germ line of patients with Cowdens syndrome, an inher-
ited predisposition to multiple neoplasms (Liaw et al.,
Nat. Genet. 16: 64 [1997]; Marsh et al., Nat. Genet. 16:
333 [1997]). More recently, other investigators have
shown that transgenic mice hemizygous for PTEN are
cancer prone, completing the evidence that PTEN is a
tumor suppressor.
In a collaboration with Mike Myers and Nick
Tonks here at the Laboratory, we showed that PTEN is
a protein tyrosine phosphatase with a somewhat atyp-
ical substrate preference (Myers et al., Proc. Natl.
Acad. Sci. 90: 10922 [1997]). More recently, we have
shown that PTEN has a lipid phosphatase activity, spe-
cific for phosphatidylinositol -3,4,5 phosphate, PIP3,
(Myers et al. 1998). In fact, one of the mutations in
Cowdens syndrome destroys lipid phosphatase activi-
ty, leaving the protein phosphatase activity apparently
untouched, suggesting that the lipid phosphatase activ-
ity is essential for PTEN function. This hypothesis is
made more plausible because PIP3 is a second mes-
senger that has been previously implicated in the
growth and survival of cancer cells.
We are pursuing two lines of investigation into the
biology of PTEN. First, we have expressed the PTEN
protein in cultured human tumor cells that lack a func-
tional PTEN gene. Constitutive expression of PTEN
appears to slow the growth and flatten these cells, and
significantly suppresses tumorigenicity of these cells
in experimental animals. Our current efforts are direct-
ed at constructing an inducible expression system for
PTEN in cultured cells, so that these effects can be
examined more accurately. Second, we are studying
the PTEN homologs in the yeasts Saccharomyces
cerevisiae and S. pombe. As yet, no phenotype is
apparent in S. cerevisiae when the PTEN homolog,
Tep 1 , is deleted or overexpressed. We are just initiat-
ing similar experiments in S. pombe.
Loci Deleted or Amplified
in Breast Cancer
C. Yen, M. Hamaguchi, R. Lucito, Y. Han,
D. Esposito, M. Nakamura
Many loci that are homozygously deleted or amplified
in breast cancer have now been identified by RDA.
These loci are presumed to carry tumor suppressor
genes or oncogenes, respectively. Among the loci we
have found deleted are those encoding the PTEN gene
and the p16/ARF (alternate reading frame) tumor sup-
pressors. Virtually all of the loci known to be ampli-
fied in breast cancer have also been identified by
RDA, including ErbB2, c-Myc, and the cyclin D loci.
Six deletion loci and an equal number of amplified
loci remain that are uncharacterized and in which we
are searching for genes.
Unfortunately, the regions of homozygous deletion
and amplification are quite large, often greater than a
megabase upon initial characterization. Therefore, the
first step in characterizing these loci entails "epicen-
ter" mapping, a process that delineates the minimum
region that is commonly deleted in cancers. To achieve
this, it is necessary to search through large archives of
stored breast cancer biopsies. For this purpose, we
have developed a technique for "immortalizing" and
amplifying the DNA from small tumor samples
(Lucito et al. 1998). The immortalized DNAs can then
be analyzed for gene copy gains or loss, which we cur-
rently do by quantitative polymerase chain reaction
(Q-PCR).
Once the epicenter has been determined, a variety
of techniques will be employed for searching for
genes, including exon trapping, mining the existing
databases for expressed sequences, and a new method
for hybridization screening that we have developed
called rapid isolation of cDNAs by hybridization
(RICH). In the latter procedure, cDNAs from libraries
are identified by their ability to hybridize to a given
large-insert chromosomal vector such as a BAC (bac-
terial artificial chromosome) or YAC (yeast artificial
chromosome) (Hamaguchi et al. 1998).
Another method for gene searching entails DNA
sequencing and sequence analysis. In a collaboration
with Richard McCombie's lab at CSHL we have fin-
ished the sequencing of the PTEN locus. PTEN
appears to arise from a gene-poor region of the
genome. Nevertheless, we are using these studies to
model methods for gene finding from large contiguous
tracts of genomic sequence.
Genomic
Microarrays
R. Lucito, J. West
Although RDA was an advance over existing methods
for finding lesions in cancer cells, we need to acceler-
ate the pace of cancer gene discovery. Several oppor-
tunities have moved our genomic studies into the arena
of microarrays. DNA microarrays are spatially orga-
nized collections of probes on a surface ("chip") that
are used for measuring DNA concentrations of com-
plementary sequences by hybridization (DeRisi et al.,
Nat. Genet. 14: 457 [1996]; Chee et al., Science 274:
610 [1996]). We are beginning to use this technology
to perform RDA on a chip. Eventually, we expect that
this approach will allow us to scan the genome for
amplifications and deletions more thoroughly, vastly
more rapidly, and in a more quantitative manner than
ever before. This application of microarrays to
genomics is made feasible by the successful imple-
mentation of representations, which allows us to sam-
ple the genome reproducibly, yielding DNA popula-
tions with reduced nucleotide complexity and hence
improved hybridization kinetics. With the help of Raju
Kucherlapati, Geoffery Childs, and Aldo Massimi,
from the Albert Einstein School of Medicine, we have
constructed and hybridized our first pilot chips. Andy
Reiner of CSHL's Bioinformatics division is directing
the software development needed to interpret and ana-
lyze the data. We expect that the genomic chips we
develop will also have application to cancer and genet-
ic clinical diagnosis.
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Applications of RDA
to Spontaneous
Genetic Disease
L. Serina, E. Hatchwell
In principle, RDA can be used to detect genetic
rearrangements. Such events occur in cancer, but
they also sometimes occur as spontaneous genetic
lesions in the germ line of a parent. When these
germ-line mutations are transmitted to offspring,
"sporadic" genetic disease, such as some forms of
neurofibromatosis, Duchenne's muscular dystrophy,
William's Syndrome, and a host of other apparent
anomalies such as autisms may result. We have
begun to apply RDA to families of children with sus-
pected sporadic genetic disease. Success could open
a new chapter in the study of human genetic disor-
ders.
Although we have encountered rearranged
regions with RDA in cancers, the method was not
optimized for that task. We are now testing a variety
of improved methods for the "corepresentation" of
progeny and parental DNAs that are designed to find
restriction endonuclease fragments in the progeny
that are not present in either parent. In principle,
such differences should arise predominantly by
spontaneous mutation. At present, we have been
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tackling technical obstacles that are formidable but
can be overcome.
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CELL BIOLOGY
This section comprises labs studying a diverse set of interests including signal transduction events that
regulate gene expression and ultimately growth in normal and cancer cells.
David Helfman's laboratory studies how specific actin assemblies are organized and regulated and
how alterations in actin filament assembly contribute to aberrant cell growth. They are interested in
understanding how the assembly of different cytoskeletal structures is regulated by extracellular sig-
nals and how cellular contractility contributes to signaling cascades that lead to focal adhesion for-
mation and the regulation of adhesion-dependent signal transduction.
Now-is Hernandez and her colleagues work on basal mechanisms of transcription using two sys-
tems, the human snRNA genes and the HIV-1 LTR. The snRNA promoters assemble RNA poly-
merases II and III transcription initiation complexes with many of the same transcription factors; one
interest in this system is to identify the determinants that ensure recruitment of the correct RNA poly-
merase. The HIV-1 promoter directs the synthesis of full-length transcripts and, in addition, short
transcripts. In this case, their main interest is to understand the biochemical mechanisms that gov-
ern the formation of short transcripts.
Shiv Grewal's group focuses on the epigenetic control of transcription and recombination. They
have shown that an epigenetic imprint controlling transcriptional repression in the fission yeast is
stable not only during mitosis, but also during meiosis, and is chromosomally inherited. In addition,
their work suggests that propogation of the repressed state occurs through the self-templated
assembly of chromatin during DNA replication.
Tatsuya Hirano's laboratory continues to take biochemical approaches to the study of mitotic chromo-
some condensations and segregation. They have revealed a mechanism by which the chromosome con-
densation machinery is activated by the master mitotic kinase cdc2. In addition, a eukaryotic complex
required for sister chromatid cohesion and a bacterial version of condensation protein have been purified
and characterized to reveal insights into the evolution of chromosome architecture and dynamics.
David Spector's group focuses on structural and function organization of the mammalian cell nucleus.
During the past year, they have demonstrated that the carboxy-terminal domain of the large subunit of
RNA polymerase II is involved in the targeting of pre-mRNA splicing factors to active sites of transcrip-
tion. In addition, they have purified and biochemically characterized interchromatin granule clusters
(ICGs), a nuclear structure enriched in 75 proteins including pre-mRNA splicing factors. By utilizing a
novel mass spectrometry strategy and peptide microsequencing, 33 known proteins, many linked to
pre-mRNA splicing, and several uncharacterized proteins have been identified in the ICG fraction.
Nick Tonks' laboratory studies the physiological function of the protein tyrosine phosphatase (PTP)
family of signal transducing enzymes. They developed "substrate-trapping" mutant forms of these
enzymes, which form stable complexes with target substrates in a cellular context, and used them
to identify physiological substrates of several members of the PTP family. This has revealed that,
contrary to popular belief, the PTPs display exquisite substrate selectivity in a cellular context and
thus may be specific regulators of cellular signaling events. In addition, they have shown that PTEN,
the tumor suppressor from human chromosome 10q23, is a phosphatase that dephosphorylates
the lipid second messenger phosphatidylinositol 3,4,5-trisphosphate (PIP3). It is the ability to recog-
nise PIP3 as substrate that is essential for the tumor suppressor function of PTEN.
Linda Van Aelst and her colleagues focus on the identification of signaling pathways mediating the
effects of Has and Rac on cell adhesion, invasiveness, and metastasis. They have shown that the
effector pathways mediating the tumodgenic and metastatic functions of Ras can be segregated and
that the activation of the Raf/Mek/MAPK pathway is essential for the acquisition of the metastatic phe-
notype. They have demonstrated a role for Rac in the cytoskeletal rearrangements associated with
invasiveness and in T-cell adhesion. Finally, they have been characterizing the Ras-binding protein AF-
6 and have found that it interacts with profilin, a G-actin-binding protein that regulates actin filament
assembly. This interaction may provide a link between cell junctions and the actin cytoskeleton.
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EPIGENETIC CONTROL OF GENE EXPRESSION
S. Grewal R. Krimper
Research in our laboratory focuses on the fundamen-
tal question of how differentiated cells establish and
maintain stable patterns of gene expression. Although
gene-specific control mechanisms participate in this
process, heritable changes in transcription are often
suggested to occur via epigenetic (heritable changes
without alterations in DNA) modifications such as
DNA methylation or stable changes in the architecture
of the chromosomes. In addition to creating distinct
metastable transcriptional domains, these epigenetic
alterations can also influence interchromosomal or
intrachromosomal recombination, avoiding potentially
deleterious effects on the integrity of the genome. The
underlying mechanisms by which differentiated cells
establish and maintain stable states of gene expression
are not clear. To address these fundamental questions
of cellular differentiation and genome integrity, we
study the mating-type switching system of the fission
yeast Schizosaccharomyces pombe, where sophisticat-
ed tools of biology can be applied. Fission
a gene repression mechanism known as "silencing" to
maintain the cell identity. Mating-type loci mat2 and
mat3, which serve as donors for matl alleles during
mating-type switching, are silenced even though they
contain genetic information identical to that of the
expressed matl-P or matl-M alleles, respectively. In
addition, silencing also extends to adjoining areas,
including an interval between the donor loci, called the
K-region. The K-region, which shares homology with
centromeric repeats, also exhibits severe recombination
suppression. We recently found that transcriptional
silencing, recombination suppression, and efficiency of
mating-type switching are mechanistically related and
controlled by an epigenetic mechanism. In our strains,
which carry replacement of a part of the K-region with
the ura4+ marker gene (KA::ura4+), ura4+ expression,
recombination, and mating-type switching are variegat-
ed. The Ura efficiently switching (ura4-on) and Um+
inefficiently switching (ura4-on) epigenetic states are
chromosomally inherited during mitosis and meiosis.
Recent observations suggest that the ura4 -off and ura4-
on states represent "closed" and "open" chromatin
structures, respectively, at the mat2/3 region. Although
several of the cis- and trans-acting factors that affect
stability of the epigenetic states have been identified,
106
almost nothing is known about the nature of the epi-
genetic "imprint" governing propagation of the
silenced state. In addition, the question of how chro-
mosomal structures acting as imprints are duplicated
at a replication fork remains unanswered. Through
analysis of the transcriptionally repressed domain in
the mating-type region, we are addressing the follow-
ing questions: (1) What are the key molecular events
that occur during conversion of the expressed state
into the silenced state and vice versa? (2) What are the
requirements (trans and/or cis) for the inheritance of a
gene expression state? (3) Is assembly or disassembly
of the silenced state restricted to a particular phase(s)
of the cell cycle?
MECHANISM OF INHERITANCE OF
THE EPIGENETIC STATES
During the last year, we continued the experiments ini-
National Cancer Institute in Frederick, and together
we have made significant progress in understanding
the nature of epigenetic imprint regulating propagation
of the silenced state. By using a combination of genet-
ics and molecular biology techniques, we have shown
that propagation of each state is likely to occur by the
self-templated assembly of the chromatin in the mat-
ing-type region. The transient presence of multiple
copies of swi6, which encodes a chromodomain (a
motif found in proteins associated with chromatin
organization) protein, altered the imprint at the mat
locus and resulted in heritable conversion of the ura4-
on state to the ura4-off state. Our results suggest that
Swi6 may be a dosage-critical component essential for
resetting the epigenetic memory.
Evidence from other laboratories suggests that his-
tone deacetylation leads to assembly of "compact"
chromatin, which prevents access to transcription fac-
tors, whereas acetylation makes "open" chromatin,
allowing access to the transcription machinery. In this
regard, analysis of the status of histone acetylation at
the KA::ura4+ gene showed that histones are acetylat-
ed in ura4-on cells but not in ura4-off cells.
Remarkably, the Swi6-induced transition from ura4-
on to ura4-off is associated with a heritable change in
the acetylation status. Thus, the effect of Swi6 is like-
ly to be linked to heritable changes in chromatin struc-
ture at the silent mating-type region. Consistent with
this idea, we find that mutations in two histone
deacetylase homologs, clr3 and clr6, disrupt the stable
propagation of the epigenetic states.
The role of Swi6 in establishment of the imprint at
matt /3 was confirmed by using a strain with three
copies of swi6 (swi6+-333 allele). The ura4-off cells of
this strain, whose mat locus is marked with a mutation
in the tightly linked his2 gene, were crossed to anoth-
er ura4-on strain (his2+; one copy of swi6) and sub-
jected to tetrad analysis. Of the four different segrega-
tion patterns shown in Figure 1, we found that classes
II through IV were novel and are not observed in sim-
ilar crosses using standard swi6+-containing strains.
When swi6+-333 cosegregates with his2, the usual 2
Ure:2 Ura- segregation was seen (class I). However,
in tetrads in which swi6±-333 cosegregates with his2+
(which originally marked the ura4-on epiallele), non-
Mendelian segregation patterns were observed: 1
Ura+:3 Ura- (class II) or 0 Ura+:4 Ura (class III; Fig.
1). The gain of an imprint in classes II and III suggests
that expression of multiple swi6 copies converts ura4-
on to ura4-off by changing the imprint at the mat
locus. The effect of swi6 multiple copies can also
assert itself prior to meiosis during diploid mitotic
growth (class IV). These data led us to conclude that
Class
Is
IIIIV MUD
the imprinting event and a self-replicating chromatin
structure are one and the same. Therefore, the unit of
inheritance in this system is composed of DNA plus
the associated epigenetic set of chromatin structure.
We are continuing to work on the Swi6-induced
change in the imprint and addressing the following key
questions: (1) Does the Swi6-induced ura4-on to ura4-
off transition occur only during a specific phase of the
cell cycle? (2) Is the change in the imprint associated
with alteration in timing of replication, spatial prox-
imity of sequences and complexes, or both? (3) What
are the other requirements (trans and/or cis) for the
establishment and propagation of the imprint?
IDENTIFICATION AND CHARACTERIZATION
OF NOVEL FACTORS AFFECTING
PROPAGATION OF EPIGENETIC STATES
The linkage groups previously implicated in silencing
(clrl -clr4, clr6, swi6, and rikl) either were identified
in indirect searches designed to uncover mutants defi-
cient in mating-type switching or were isolated as
mutations affecting silencing of donor mating-type
loci. On the basis of our observation that swi6+-333
induced an increase in the ura4-on to ura4-off transi-
tion rate, we have designed and carried out a more
direct scheme to systematically identify genes that
might affect the establishment as well as propagation
SPG51 ura4÷
X
SPG97 KA:: ura4+ his2- swi6+-333
KA:: ura4+
Expression
"on"
"off"
YEA
0
0
AA-HIS AA-LEU AA-URA FOA
Iodine
Staining
Light
Dark
PMA+
FIGURE 1 The presence of multiple copies of swi6 causes novel non-Mendelian segregation of
KA,:ura4* epialleles in genetic crosses. Two copies of the LEU2-based plasmid containing swi6 were inte-
grated in tandem at the swi6* locus (swi6' -333 allele) of the ura4-on strain. The resultant ura4-off strain
(SPG97) was crossed to the ura4-on derivative of SPG51 to construct diploids. Diploids were sporulat-
ed and subjected to tetrad analysis. Segregation of the swi6 -333 allele was followed by its linkage to
LEU2. Similarly, segregation of KA,:ura4* epialleles was followed by their linkage to the respective his2
marker. Examples of the different segregation patterns obtained are shown. Growth on AA-URA or FOA
indicates K4::ura4+ expression, and intensity of iodine staining (PMA* panel) indicates efficiency of mat-
ing-type switching.
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of the epistates. This approach ensures identification
of essential genes that might not have been identified
previously. The ura4-on cells spontaneously change to
ura4-off at a low rate of 8.1 x 10-4 per cell division. A
fission yeast genomic library cloned in the pWH5 vec-
tor (-3-4 copies/cell) was transformed into ura4-on
cells, and colonies showing an increased rate of con-
version to the ura4-off state were sought. By using this
approach, we have identified at least four new genes of
unknown functions. Genetic and biochemical analyses
of these genes and their functions will undoubtedly be
helpful in understanding the mechanism of epigenetic
inheritance.
In another effort to identify factors specifically
affecting the inheritance of epigenetic states, we
searched for mutants that could establish and maintain
transcriptional repression yet displayed a reduction in
the heritability of the repressed state. Colonies were
selected that showed an increased rate of ura4-off to
ura4-on transition, rather than complete derepression
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of ura4+. Nine isolates that unambiguously showed
increased papillation on uracil-lacking medium were
selected for further study. The effect of the mutations
seems likely to be epigenetic, as no rearrangements of
the mating-type region were observed. Two of the nine
mutations had a temperature-sensitive phenotype as
well. We are in the process of dividing these mutants
into different complementation groups. Taken together
with the previously described genes, this class is
expected to fill in many gaps left in the present picture
which is composed almost entirely of genes that are
strongly required for both mitotic propagation and
interphase stability of the imprint.
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THE CYTOSKELETON IN NORMAL AND TRANSFORMED CELLS
D.M. Helfman C. Berthier M. Selvakumar
C. Chen A. Vaahtokari
J. Grossman Y.-C. Wang
A.J. Rai
We are interested in understanding how specific actin
assemblies are organized and regulated and how alter-
ations in actin filament assembly contribute to aber-
rant cell growth. Actin filaments have an important
role in muscle contraction, cell movements, cell divi-
sion, intracellular transport, regulation of cell shape,
adhesion, and adhesion-mediated signaling. In partic-
ular, we are studying dynamic and stable macromolec-
ular assemblies of distinct actin structures that are
characteristic of specific cell types, e.g., stress fibers,
lamellipodia, filopodia, and the contractile ring in
fibroblasts or sarcomeres in skeletal muscle, in order
to determine what proteins are required for the assem-
bly and regulation of specific structures. We are also
interested in understanding how the assembly of dif-
ferent cytoskeletal structures is regulated by extracel-
lular signals, and how cellular contractility contributes
to signaling cascades that lead to focal adhesion for-
mation and regulation of adhesion-dependent signal
transduction. Below is a description of our studies dur-
ing the past year.
Regulation and Role of
Cell Contractility in
Adhesion-dependent Signaling
D. Helfman, C. Berthier [in collaboration with
A. Bershadsky, Weizmann Institute of Science,
Rehovot, Israel]
Contractility of nonmuscle cells has been hypothe-
sized to be intimately associated with adhesion and
adhesion-dependent signaling, leading to the forma-
tion of focal contacts, tyrosine phosphorylation, and
signals required for cell growth and survival. To inves-
tigate the role of cell contractility in adhesion-depen-
dent signaling, we have studied the effects of nonmus-
caldesmon on cellular contractility, actin
cytoskeleton organization, and focal adhesion forma-
tion in fibroblasts. Caldesmon is an actin-, myosin-,
tropomyosin-, and Ca'-calmodulin-binding protein
known to inhibit the actin-activated ATPase activity by
phosphorylated myosin II, and it can block myosin-II-
driven motility. Transient transfection of nonmuscle
caldesmon prevents myosin-II-dependent cell con-
tractility, induces disruption of stress fibers, and
decreases the number and size of tyrosine-phosphory-
lated focal adhesions. In addition, expression of
caldesmon interferes wih Rho-induced formation of
stress fibers and focal adhesions, as well as with focal
adhesion induction by microtubule disruption. These
results demonstrate a role for nonmuscle caldesmon
in the physiological regulation of actomyosin contrac-
tility and adhesion-dependent signaling, and they fur-
ther demonstrate the involvement of contractility in
focal adhesion formation and signal transduction.
Disruption of adhesion-dependent signaling is a char-
acteristic feature of neoplastic transformation; such
cells often display anchorage-independence, growing
and dividing extracellular
matrix contact. On the basis of our results demon-
strating an ability of caldesmon to regulate adhesion-
dependent signaling, we suggest that its interaction
with specific tropomyosins could be important in
maintaining the normal signaling function in the cell.
Studies are in progress to determine how contractility
leads to enhanced focal adhesion formation and what
roles tropomyosin and caldesmon play in the signal-
ing cascades associated with adhesion-mediated sig-
nal transduction events.
Dynamic Distribution of
Tropomyosin Isoforms in
Fibroblasts
C. Berthier
Nonmuscle tropomyosin (TM) isoforms belong to a
conserved family of cytoskeletal proteins that are
thought to have a role in the stabilization of filamen-
tous actin and to act in cooperation with caldesmon to
regulate actomyosin-based contractility. Our studies
focus on the specific localization and role of TM iso-
forms in fibroblasts. The dynamic distribution of
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fibroblast TM isoforms was investigated using stable
cell lines of NIH-3T3 fibroblasts expressing fusion
proteins of TM isoforms and green fluorescent protein
(GFP) by time-lapse recordings and confocal analysis.
Our results show that distinct actin-containing struc-
tures such as stress fibers, the contractile ring, and
filopodia exhibit preferential incorporation of differ-
ent isoforms. All isoforms incorporate into actin stress
fibers. However, the low-molecular-weight TM-4 is
preferentially present in filopodia. During cytokinesis,
TM-4 and TM-5 associate with the contractile ring
throughout the cell division process, whereas TM-1
and TM-2 are present only at the late stages. The
results of these studies demonstrate that TM isoforms
show specific localization to dynamic structures and
suggest that they have specific roles in the regulation
of actomyosin contractility.
Identification and Characterization
of a Novel Conserved Phosphoprotein
Involved in Intracellular Vesicle Transport
A.J. Rai
We have identified a novel protein from human non-
muscle cells. The cDNA sequence predicts a protein of
136 amino acids containing a transmembrane domain
and a coiled-coil region. Computer database searches
identified homologs in rodents, zebrafish, and
Drosophila. Antibodies raised to the protein reveal a
punctate cytoplasmic localization, as well as a strong
juxtanuclear concentration. This staining pattern is
characteristic of vesicles that emanate from the Golgi
complex. Furthermore, the protein is phosphorylated,
and perturbations in signal transduction pathways
appear to alter its phosphorylation state and subcellu-
lar distribution. Work is in progress to delineate the
identity of the vesicular subcompartment and its role
in intracellular transport.
Binding of hnRNP H to an Exonic
Splicing Silencer Is Involved in the
Regulation of Alternative Splicing
of the Rat p-TM Gene
C. Chen
In the rat I3-tropomyosin 03-TM) gene, exons 6 and 7
are alternatively spliced in a mutually exclusive man-
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ner. Exon 6 is included in mRNA encoding nonmuscle
TM-1, whereas exon 7 is used in mRNA encoding
skeletal muscle 13-TM. Previously, we demonstrated
that a six-nucleotide mutation at the 5' end of exon 7,
designated as ex -1, activated exon 7 splicing in non-
muscle cells. In this study, we showed that the activat-
ing effect of this mutation is not the result of creating
an exonic splicing enhancer (ESE) or disrupting a
putative secondary structure. The sequence in exon 7
acts as a bona fide exonic splicing silencer (ESS),
which is specifically bound by a trans-acting factor.
Isolation and peptide sequencing revealed that this
factor is heterogeneous nuclear ribonucleoprotein H
(hnRNP H), a member of the hnRNP family. Binding
of hnRNP H correlates with the ESS activity.
Furthermore, addition of antibodies that specifically
recognize hnRNP H to the splicing reactions or partial
depletion of hnRNP H from nuclear extract activates
exon 7 splicing in vitro, and this effect can be reversed
by addition of purified recombinant hnRNP H. These
results indicate that hnRNP H participates in exclusion
of exon 7 in nonmuscle cells. The involvement of
hnRNP H in the activity of an ESS may represent a
prototype for the regulation of tissue- and develop-
mental-specific alternative splicing.
Exonic Splicing Enhancers
Contribute to the Use of Both
3" and 5' Splice Site Usage
of Rat (3 -TM Pre-mRNA
M. Selvakumar
The rat I3-TM gene encodes two tissue-specific iso-
forms that contain the internal mutually exclusive
exons 6 (nonmuscle/smooth muscle) and 7 (skeletal
muscle). We previously demonstrated that the 3' splice
site of exon 6 can be activated by introducing a nine-
nucleotide polyuridine tract at its 3' splice site, or by
strengthening the 5' splice site to a Ul consensus
binding site, or by joining exon 6 to the downstream
common exon 8. Examination of sequences within
exons 6 and 8 revealed the presence of two purine-rich
motifs in exon 6 and three purine-rich motifs in exon
8 that could potentially represent ESEs. In this report,
we carried out substitution mutagenesis of these ele-
ments and showed that some of them have a critical
role in splice site usage of exon 6 in vitro and in vivo.
Using UV cross-linking, we have identified SF2/ASF
as one of the cellular factors that bind to these motifs.
Furthermore, we show that substrates which have
mutated ESEs are blocked prior to A complex forma-
tion, supporting a role for SF2/ASF binding to the
ESEs during the commitment step in splicing. Using
pre-mRNA substrates containing exons 5 through 8, we
showed that the ESEs within exon 6 also play a part in
cooperation between the 3' and 5' splice sites flanking
this exon. The splicing of exon 6 to 8 (i.e., 5' splice site
usage of exon 6) was enhanced with pre-mRNAs con-
taining either the polyuridine tract in the 3' splice site
or the consensus sequence in the 5' splice site around
exon 6. We showed that the ESEs in exon 6 are required
for this effect. However, the ESEs are not required
when both the polyuridine and consensus splice site
sequences around exon 6 were present in the same pre-
mRNA. These results support and extend the exon def-
inition hypothesis and demonstrate that sequences at
the 3' splice site can facilitate use of a downstream 5'
splice site. In addition, the data support the hypothesis
that ESEs can compensate for weak splice sites, such as
those found in alternatively spliced exons, thereby pro-
viding a target for regulation.
Characterization of an Activity in
Myogenic Cells That Stimulates
Splicing of f3-TM Exon 7
V.-C. Wang
Exons 6 and 7 of rat p-TM pre-mRNA are alternative-
ly spliced in a tissue-specific manner. Exon 7 is
included in mature mRNA only in skeletal muscle
cells. Previous studies suggested that the 3' splice site
of exon 7 is repressed in nonmuscle cells. We have
developed an in vitro splicing complementation assay
to study how muscle cells activate the 3' splice site of
exon 7. Nuclear extracts prepared from mouse myo-
genic cells, including BC3H1 and C2C12 cells, can
complement a human 293 cell (nonmuscle) nuclear
extract to activate exon 7, whereas nuclear extracts
from mouse or human nonmuscle cells cannot.
Addition of HeLa cell SR proteins to BC3H1 (but not
293 cell nuclear extract) stimulates the splicing of
exons 5-7. This muscle-specific activity can be sepa-
rated from known SR proteins by ammonium sulfate
precipitation. Fractionation of the whole BC3H1
nuclear extract through a CsC1 density gradient reveals
a peak of stimulatory activity for exon 5-7 splicing.
Besides this muscle-specific stimulatory activity, the
results also suggest a possible involvement of two SR
proteins, SRp30 and SRp20, in activating the 3' splice
site of exon 7. Collectively, these data demonstrate the
presence of an activator in myogenic cells that pro-
motes the inclusion of a muscle-specific exon in 13-TM
pre-mRNA.
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INITIATION AND TERMINATION OF TRANSCRIPTION IN
HUMAN snRNA GENES AND HIV-1
N. Hernandez T.L. Kuhlman V. Mittal
E. Ford D.J. Morrison
R.W. Henry P.S. Pendergrast
B. Ma L.M. Schramm
S. Sepehri
Y. Sun
X. Zhao
We work on RNA polymerase II and III transcription
in two model systems, the human small nuclear RNA
(snRNA) genes and the HIV-1 long terminal repeat.
The human snRNA genes have very similar promot-
ers, but some of them are transcribed by RNA poly-
merase II and others are transcribed by RNA poly-
mer-ase III. Both the RNA polymerase II and III
snRNA promoters contain an enhancer referred to as
the distal sequence element (DSE), which is charac-
terized by the presence of an octamer sequence
responsible for recruiting the widely expressed POU
domain transcription factor Oct-1. Both types of pro-
moters also contain a common basal promoter ele-
ment referred to as the proximal sequence element
(PSE), which is responsible for recruiting a multi-
subunit complex we call SNAP The RNA poly-
merase III snRNA promoters contain a second basal
element, namely, a TATA box, which is responsible
for recruiting the TATA-box-binding protein (TBP).
The TATA box is absent in the RNA polymerase II
snRNA promoters, and indeed in the context of the
PSE, the TATA box determines RNA polymerase III
specificity.
The human immunodeficiency virus type-1 (HIV-
1) promoter directs the synthesis of two types of RNA
molecules: full-length transcripts, whose synthesis is
activated by the viral trans-activator Tat, and short
transcripts, whose synthesis is activated by a DNA
element called the inducer of short transcripts (IST).
The synthesis of short transcripts does not require any
viral factors, but the cellular factors required have not
been identified. A candidate for a cellular factor
involved in the synthesis of short transcripts is FBI-1,
because FBI-1 binds to wild-type IST but not to
mutated ISTs that are unable to direct the synthesis of
short transcripts.
We want to understand how snRNA promoters
assemble RNA polymerase II and III initiation
complexes, and in particular how RNA polymerase
specificity is determined. We are also interested in
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the mechanisms by which Oct-1, and more particu-
larly the Oct-1 POU domain, mediates transcription
activation of snRNA promoters. In addition, we
want to understand how IST functions, and what
part FBI-1 might play for short transcript formation
or HIV-1 transcription in general. In the last year,
we have assembled a functional SNAPS from
recombinant subunits. This recombinant SNAP
constitutes an invaluable tool to understand how a
multisubunit complex mediates the protein-protein
interactions required to (1) recruit members of both
the RNA polymerase II and RNA polymerase III
general transcription machinery and (2) respond to
transcription activators. Indeed, as described below,
by generating recombinant SNAPcs bearing single-
amino-acid changes, we have been able to identify
the target for activation by the Oct-1 POU domain
within SNAP.
Assembly of a Functional Core
Promoter Complex (SNAP) Shared
by RNA Polymerases II and Ill
R. W. Henry, V Mittal, B. Ma, R. Kobayashi,
N. Hernandez
In coimmunoprecipitations of in-vitro-translated pro-
teins, we had previously found that SNAP190 associ-
ates with SNAP45 and that SNAP50 associates with
SNAP43. We were, however, unable to detect associ-
ation between the two pairs of proteins. This suggest-
ed that we might be missing a SNAP subunit. Indeed,
we have now isolated cDNAs encoding SNAP19, the
last subunit of SNAP. Inclusion of in-vitro-translat-
ed SNAP19 with the other in-vitro-translated SNAP
subunits results in the formation of a complex con-
taining all five subunits. In addition, we could gener-
ate a recombinant SNAP, capable of binding specifi-
cally to the PSE by coinfection of insect cells with five
recombinant baculoviruses expressing each of the
SNAPc subunits.
The availability of recombinant SNAP, allowed us
to determine whether the very same SNAP, can func-
tion for RNA polymerase II and III transcription.
Depletion of a transcription extract with anti-SNAP43
antibodies inhibited snRNA gene transcription.
Significantly, transcription by both RNA polymerases
II and III could then be regained by addition of recom-
binant SNAP,. Thus, the same complex mediates the
assembly of two types of transcription initiation com-
plexes, namely, RNA polymerase II and RNA poly-
merase III initiation complexes.
Protein-Protein Interactions
among SNAPS Subunits
B. Ma, N. Hernandez
To understand the architecture of SNAP we are
defining which parts of the various SNAP, subunits
interact with other members of SNAP as determined
by coimmunoprecipitation of in-vitro-, translated pro-
teins. Such information will allow us to build a "min-
imal" SNAP, lacking sequences dispensable for the
integrity of the complex, which will be tested for DNA
binding and transcription activity.
Characterization of
Partial SNAPcs
V. Mittal, N. Hernandez
Basal promoter elements in RNA polymerase I, II, and
III promoters recruit multisubunit complexes. This is
probably because such complexes can support multi-
ple and flexible interactions with other players of the
transcription machinery, including activators, repres-
sors, and other members of the general transcription
machinery. Because we can reconstitute SNAP, from
recombinant subunits, and because it mediates the
assembly of both RNA polymerase II and III initiation
complexes, SNAP, constitutes an invaluable system to
study how a multisubunit complex coordinates the
assembly of two different initiation complexes, and
how it responds to activators such as Oct-1.
To study this question, we are using the bac-
ulovirus expression system. Infection of insect cells
with various subsets of SNAP, subunits allows the
reconstitution of partial SNAP s, which are then tested
for RNA polymerase II and III basal and activated
transcription.
The Oct-1 POU Domain Activates
snRNA Gene Transcription by
Contacting a Region in the SNAP
Largest Subunit That Bears
Sequence Similarities to the
Oct-1 Coactivator OBF-1
E. Ford, N. Hernandez [collaboration with
M. Strubin, University of Geneva, Switzerland]
We had previously shown that Oct-1 and SNAP° bind
cooperatively to probes containing an octamer motif
and a PSE and that this cooperative binding results in
transcription activation in vitro. We had also shown
that the largest subunit of SNAP, SNAP190, is capa-
ble of associating with Oct-1 POU bound to an
octamer motif and that this association is sensitive to
the same single-amino-acid substitution in Oct-1 POU
(E7R) that affects cooperative binding of Oct-1 POU
and SNAP, to probes containing both an octamer
motif and a PSE. This raised the possibility that
SNAP190 constitutes the target for transcription acti-
vation by the Oct-1 POU domain.
Although it is clear that one mechanism by which
activators effect transcription activation is through
recruitment of the basal transcription machinery, it has
been difficult to identify with certainty the natural tar-
gets of various activators. It is therefore of consider-
able interest to define the target of the Oct-1 POU
domain within the basal transcription machinery of
snRNA genes in molecular detail. For this purpose, we
first narrowed down the SNAP190 region required for
interaction with octamer-bound Oct-1 POU to a small
44-amino-acid region. In so doing, we developed a
generally applicable method involving in vivo selec-
tion in yeast to identify, with near single-amino-acid
resolution, the borders of the domain required for
interaction.
We changed several basic amino acids within the
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minimal SNAP190 domain capable of interacting with
octamer-bound Oct-1 POU to glutamic acids and
assembled mutant recombinant SNAP s. These were
then tested for cooperative binding with wild-type Oct-
1 POU on probes containing an octamer motif and a
PSE and for transcription activation. Strikingly, the
SNAP, mutant K900E was unable to bind cooperatively
with Oct-1 POU and could not sustain transcription acti-
vation, even though it was capable of sustaining basal
transcription. Thus, a single-amino-acid change within
the largest subunit of SNAP, debilitated transcription
activation but had no effect on basal transcription.
Protein-protein interactions are best demonstrated
by the generation of altered specificity interactions, in
which a mutation in one partner that disrupts the inter-
action can be compensated for by a second mutation in
the other partner that restores the interaction.
Remarkably, SNAP190 K900E was capable of binding
cooperatively with Oct-1 POU carrying the E7R muta-
tion. As described above, E7R disrupts the interaction
of Oct-1 POU with wild-type SNAP190. Together,
these results identify a direct target for activation by
the Oct-1 POU domain and show that activation is
mediated by a protein-protein interaction.
OBF-1 is a B-cell-specific coactivator that associ-
ates with Oct-1 bound to an octamer motif and increas-
es transcription from immunoglobulin promoters.
Remarkably, although a comparison with the BLAST
program of full-length SNAP190 with sequences in the
databases failed to identify any related sequence in
OBF-1, a direct comparison of the minimal SNAP190
region required for association with octamer-bound
Oct-1 POU revealed a striking region of similarity with
the first 60 amino acids of OBF-1, which are known to
be required for interaction with octamer-bound Oct-1.
Apart from the Oct-1 POU interacting regions, OBF-1
and SNAP190 do not share any obvious sequence simi-
larity, nor are they known to share any functional role.
Thus, two proteins that differ in their tissue distribution,
their function, and their primary structure nevertheless
share a common Oct-1 POU-binding domain.
Characterization of a Human
RNA Polymerase III Holoenzyme
S. Sepehri, N. Hernandez
RNA polymerase II is known to exist in the cell as part
of very large complexes. Some of these complexes
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contain a number of general transcription factors as
well as factors required to mediate response to an acti-
vator. The same is true for RNA polymerase III. We
are purifying this complex to determine its composi-
tion.
Factors Required for snRNA
Transcription by RNA
Polymerase Ill
L Schramm, N. Hernandez
Basal RNA polymerase III transcription of the human
snRNA genes requires SNAP,, TBP, RNA polymerase
III, and other, unidentified, components. The goal of
this project is to identify new factors involved in RNA
polymerase III transcription of snRNA genes.
Transcription from Chromatin
Templates
X. Zhao, N. Hernandez
We are studying the transcription of snRNA genes
wrapped into chromatin templates. We are especially
interested in determining whether chromatin allows
transcription activation by the Oct-1 POU domain and
cooperative binding of SNAP, and Oct-1 POU to their
natural targets in the human U6 promoter.
Factors Required for
snRNA Transcription by
RNA Polymerase II
T.L. Kuhlman, N. Hernandez [in collaboration
with H. Cho and D. Reinberg, the Howard Hughes
Medical Institute and the University of Medicine
and Dentistry of New Jersey, Piscataway]
The general transcription factors required for RNA
polymerase II transcription from a typical TATA-box-
containing mRNA promoter such as the adenovirus 2
major late promoter have all been purified to near
homogeneity, and most of them have been cloned.
RNA polymerase II transcription from snRNA pro-
moters requires SNAP, but surprisingly nothing is
known about which of the general transcription factors
are required.
We performed depletion experiments using anti-
bodies directed against the various general transcrip-
tion factors. In cases where we observed a reduction in
transcription, we then tested whether complementation
of the depleted extract with the missing recombinant
factor restored transcription. Our results indicate that
most of the general transcription factors are required
for RNA polymerase II transcription of snRNA genes.
Thus, although the factors that recognize the core ele-
ments of RNA polymerase II mRNA and snRNA-type
promoters differ, they mediate the recruitment of many
common general transcription factors.
Isolation of cDNAs Corresponding
to FBI-1
D.J. Morrison, P.S. Pendergrast,
R. Kobayashi, N. Hernandez
We have obtained cDNAs encoding FBI-1 and have
characterized the DNA-binding properties of this pro-
tein. FBI-1 contains a POZ domain at its amino ter-
minus and four Kriippel-type zinc fingers at its car-
boxyl terminus. The carboxyl terminus is sufficient
for specific binding, and FBI-1 can form homomers
through its POZ domain and, in vivo, through its zinc
finger domain as well. In addition, FBI-1 associates
with Tat, suggesting that this interaction may have a
role in Tat activation or in Tat repression of the short
transcripts.
Function of FBI-1
P.S. Pendergrast, N. Hernandez
We are continuing our effort to define directly the
function of FBI-1, both by in vivo transcription assays
and protein-protein interaction assays.
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HIGHER-ORDER CHROMOSOME DYNAMICS
T. Hirano M. Hirano A. Losada
K. Kimura T. Yokochi
The assembly of mitotic chromosomes is a fundamen-
tal process that ensures the faithful segregation of
genetic information during eukaryotic cell division.
Our laboratory is interested in understanding the mol-
ecular mechanisms underlying this dynamic structural
change of chromosomes. Recent studies have shown
that members of a unique class of chromosomal
ATPases, known as SMC (structural maintenance of
chromosome) proteins, have central roles in this
process. By using a cell-free extract derived from
Xenopus laevis eggs, we have identified two distinct
SMC protein complexes, 13S condensin and 14S
cohesin, which are key players in chromosome con-
densation and sister chromatid cohesion, respectively.
Our efforts are now being focused on the structural
and functional characterization of these two eukaryot-
ic SMC protein complexes. SMC proteins are also
conserved in bacteria and archaea and appear to fulfill
similar cellular functions. To understand the evolu-
tionarily conserved mechanism of SMC action, we are
also working on a "primitive" SMC protein from the
bacterium Bacillus subtilis. During the past year, great
advances have been made in all three areas of research
in our laboratory.
Condensin Regulation
K. Kimura, M. Hirano, T. Hirano [in collaboration
with R. Kobayashi, Cold Spring Harbor Laboratory]
13S condensin is a chromosome condensation protein
complex that we originally identified and purified
from X laevis egg extracts. 13S condensin is a five-
subunit protein complex that consists of two different
SMC subunits (XCAP-C and -E) and three non-SMC
subunits (XCAP-D2, -G, and -H). When purified
from mitotic extracts, 13S condensin can introduce
positive supercoils into relaxed circular DNA in the
presence of ATP and topoisomerase I. During the past
year, we have obtained evidence that the positive
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supercoiling activity of 13S condensin is regulated by
mitosis-specific phosphorylation of the XCAP-D2
and XCAP-H subunits. The phosphorylation of these
two "regulatory" subunits is under the control of
Cdc2 which governs the initiation of mitosis, as
judged from immunodepletion and add-back experi-
ments. Furthermore, in vitro phosphorylation and
peptide-mapping experiments indicated that Cdc2 is
likely to be the physiological kinase that directly
phosphorylates and activates the condensin complex.
By using phosphoepitope-specific antibodies, we
were able to map three phosphorylation sites by Cdc2
in the carboxy-terminal domain of XCAP-D2. Our
results provide for the first time a direct functional
link between Cdc2 and one of its major downstream
events, chromosome condensation.
Condensin Mechanism
K. Kimura, T. Hirano [in collaboration with
N. Cozzarelli, University of California, Berkeley]
The energy-dependent positive supercoiling in the
presence of topoisomerase I is likely to be an impor-
tant activity of the chromosome condensation protein
complex. We still do not know, however, how this reac-
tion works or how this activity contributes to the com-
paction of chromatin fibers. To get further insight into
the mechanism of condensin action, we set up a new
functional assay in collaboration with Nick
Cozzarelli's group. We found that when 13S condensin
was incubated with a nicked circular DNA in the pres-
ence of a type II topoisomerase, a specific type of knot
(i.e., positive trefoil knot) was generated. The knotting
reaction, like the supercoiling reaction, required ATP
hydrolysis and mitosis-specific phosphorylation of
condensin subunits. These results suggest that 13S
condensin actively compacts and organizes DNA by
introducing a global positive writhe, rather than by a
local overwinding or wrapping of DNA.
Cohesin and Sister Chromatid Mechanics of a Prokaryotic
Cohesion SMC Protein
A. Losada, T. Yokochi, M. 1- 'Kano
T. Hirano
Sister chromatid cohesion is another important
process for the faithful segregation of chromosomes in
mitosis. The linkage between duplicated sister chro-
matids is established during S phase and maintained
throughout the G2 phase of the cell cycle. We have
found that an SMC protein complex distinct from 13S
condensin plays a crucial part in sister chromatid
cohesion. This complex (termed 14S cohesin) consists
of two SMC subunits (SMC1 and SMC3 types) and at
least three additional subunits. One of the non-SMC
subunits was identified to be the Xenopus homolog of
budding yeast Scclp/Mcdlp implicated genetically in
sister chromatid cohesion. In the cell-free extracts,
14S cohesin associated with interphase chromatin dur-
ing S phase, but most of the complex dissociated from
chromatin at the onset of mitosis. Immunodepletion of
14S cohesin during interphase caused defects in sister
chromatid cohesion in subsequent mitosis, whereas
condensation was unaffected. We hypothesize that the
cohesin complex is primarily involved in interphase-
specific cohesion that holds sister chromatids together
along their entire length. Upon entry in mitosis, the
cohesin complex is released from the chromatids and
mitosis-specific cohesion may be reestablished at the
centromeric regions by a mechanism that remains to
be determined.
We found that human tissue culture cell extracts
also contain a protein complex whose size and sub-
unit composition are very similar to those of the
Xenopus 14S cohesin complex. We have established
a purification scheme of this human cohesin complex
and are currently trying to identify biochemical
activities associated with this cohesion machine.
Comparing and contrasting activities of 14S cohesin
and 13S condensin should provide us with an inte-
grated molecular picture of how higher-order chro-
mosome dynamics are regulated throughout the
eukaryotic cell cycle. These studies should also
reveal a common molecular mechanism that might
underlie the two apparently distinct processes: cohe-
sion and condensation.
M. Hirano, T. Hirano
Evolutionary conservation of SMC proteins among bac-
terial and archaeal species reflects their fundamental
function in DNA dynamics. To understand the "basics"
of SMC action, we have purified a prokaryotic SMC
protein from the gram-positive bacterium B. subtilis.
Unlike eukaryotic versions, the B. subtilis SMC protein
(BsSMC) is a simple homodimer with no associated
subunits. We found to our surprise that it binds prefer-
entially to single-stranded DNA (ssDNA). The ATPase
activity of BsSMC was stimulated by ssDNA more effi-
ciently than by double-stranded DNA. A DNA spin-
down assay revealed that in the presence of ATP,
BsSMC forms large nucleoprotein aggregates in an
ssDNA-specific manner. We also found that BsSMC
undergoes conformational changes upon binding to
ATP and ssDNA as judged from limited proteolysis
experiments. Taking these results together with recent
genetic data, we propose that the energy-dependent
aggregation of ssDNA might represent a primitive type
of chromosome condensation that occurs during segre-
gation of bacterial chromosomes. We anticipate that
comparative studies of the bacterial and eukaryotic
SMC proteins will provide deep insights into the evolu-
tion of higher-order chromosome architecture as well as
the evolution of SMC proteins per se.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector T. Misteli
P. Mintz
T. Howard
Studies in our laboratory are focused on the structur-
al-functional organization of the mammalian cell
nucleus. Our research program evolves around under-
standing the nuclear organization of factors associated
with pre-mRNA splicing and the RNA substrates with
which these factors interact. The microscopy core
facility has been used extensively during the past year,
and numerous collaborations are under way with the
excellent technical expertise of Tamara Howard.
RNA Polymerase II Mediates
Targeting of Splicing Factors to
Transcription Sites In Vivo
T. Misteli, D.L. Spector
In by a large
RNA polymerase II holoenzyme containing the large
subunit of RNA polymerase II and accessory tran-
scription factors. In mammalian cells, the large sub-
unit of RNA polymerase II contains a carboxy-termi-
nal domain (CTD) consisting of 52 heptad repeats of
the sequence YSPTSPS. Biochemical evidence has
indicated that splicing factors as well as other RNA
processing factors physically interact with the CTD of
the large subunit of RNA polymerase II. During the
past year, we have used live-cell microscopy to inves-
tigate the cell biological role of the CTD in the target-
ing of splicing components to transcription sites in
intact nuclei. We find that the CTD mediates the
recruitment and targeting of pre-mRNA splicing fac-
tors to transcription sites in vivo. Deletion of the CTD
prevents the accumulation of splicing factors at a
newly formed site of transcription and blocks pre-
mRNA splicing. The inhibitory effect was general
since deletion of the CTD resulted in the failure of not
only SR proteins, but also core Sm proteins and the
small nuclear RNAs (snRNAs) to accumulate at the
site of transcription (Fig. 1). The presence of the CTD
is crucial for targeting of splicing factors to sites of
transcription since in CTD-less cells, splicing factors
failed to accumulate at the transcription site despite
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the fact that they contained a level of RNA similar to
that of cells expressing the large subunit with the wild-
type CTD. This indicates that the mere presence of
RNA is not sufficient for the targeting and accumula-
tion of splicing factors to nascent RNA and that the
CTD of the large subunit of RNA polymerase II is
instrumental in the recruitment process. We have also
mapped the domains of SR proteins that are required
for the interaction with the large subunit of RNA poly-
merase II. We find that the RS domain is required for
the interaction in several SR proteins and that the
interaction of all SR proteins tested with the large sub-
unit is independent of transcriptional activation of the
cell. In the case of SF2/ASF-ARS, which has been
shown to bind RNA with the same affinity as
SF2/ASF-WT, but does not bind the CTD efficiently,
this mutant protein did not accumulate at the site of
transcription. These results argue that the CTD of
RNA polymerase II is involved in the targeting of pre-
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FIGURE 1 HeLa cells expressing pem RNA were examined for
their ability to recruit splicing factors to the site of pem RNA
transcription in the presence or absence of the RNA poly-
merase II CTD. In cells expressing the wild-type CTD or in mock
transfected cells, splicing factors were recruited nearly 100% of
the time to the transcription site. However, in cells expressing a
CTD with only five heptapeptide repeats, splicing factors were
recruited to the site of transcription only 25-30% of the time.
BmRNA splicing factors to active sites of transcription.
The general effect on splicing is consistent with the
possibility that splicing components are present in the
nucleus as complexes rather than single proteins, and
it is thus tempting to speculate that the CTD is associ-
ated with prespliceosomal complexes or with spliceo-
somal subunits.
Purification and Biochemical
Characterization of
Nuclear Speckles
P. Mintz, D.L. Spector [in collaboration
with S. Patterson, Amgen Inc.]
The mammalian cell nucleus is a highly organized
structure that contains many internal nuclear domains
including the nucleolus, interchromatin granule clus-
ters, perichromatin fibrils, coiled bodies, PML bodies,
and gems. Immunocytochemical studies have shown
that pre-mRNA splicing factors are localized in a speck-
led nuclear pattern that corresponds to interchromatin
granule clusters (IGCs) and perichromatin fibrils (PFs).
Although PFs are thought to represent RNA transcripts,
little to no transcription is associated with the majority
of IGCs. One function of IGCs is to provide pre-mRNA
splicing factors to sites of transcription. To elucidate
additional roles of IGCs in nuclear function, we have
developed a biochemical cell fractionation procedure to
purify the IGCs from mouse liver nuclei. Samples have
been taken from each stage in the biochemical fraction-
ation and examined by electron microscopy for purity
and morphological characterization. The purified inter-
chromatin granules measured 18-27 um in diameter,
similar to their in situ counterparts. Immunogold label-
ing was performed on the IGC fraction with monoclon-
al antibody 3C5, which recognizes a family of SR pro-
teins, to verify that it contained splicing factors. The
immunogold particles labeled the IGCs. The protein
FIGURE 2 HeLa cells transiently expressing a
plenty-of-proline'sNFP fusion protein (4) show
the protein to be colocalized with an endoge-
nous pre-mRNA splicing factor (8, lower nucleus)
in a speckled nuclear distribution pattern. The
upper cell in 8 was not transfected.
composition of the purified IGCs was analyzed by one-
and two-dimensional gel electrophoresis. We have iden-
tified approximately 300 proteins in the purified IGC
fraction by two-dimensional gel electrophoresis; 75
proteins are enriched in this fraction. The IGC fraction
was further immunopurified with the anti-3C5 mono-
clonal antibody. Immunoblotting was performed on the
purified IGC fraction in order to identify known mark-
er proteins. Several splicing and nonsplicing factors
including U2AF65 , U2AF35 , and the five SR proteins
(SRp20, SRp30a/b, SRp40, SRp55, SRp75) were
enriched within the IGC fraction. The purified IGCs
were analyzed by mass spectrometry in order to identi-
fy all of its constituents. Thus far, we have identified 27
known proteins and several expressed sequence tags.
Using one of the peptide sequences, we identified a full-
length cDNA encoding a protein called plenty-of-pro-
line's. When this cDNA was fused to green fluorescent
protein and transiently expressed in cells, the fusion
protein localized to speckles (Fig. 2). We are currently
in the process of developing monoclonal and polyclon-
al antibodies to the purified IGC fraction and the
enriched proteins. By biochemically characterizing the
IGCs, we hope to elucidate the biological roles of this
nuclear compartment.
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PROTEIN TYROSINE PHOSPHATASES AND THE
CONTROL OF CELLULAR SIGNALING RESPONSES
N.K. Tonks A.M. Bennett K.R. La Montagne H.L. Palka
R.L. Del Vecchio J.P. Liu K.A. Pennino
A.J. Garton M.P. Myers A.A. Samatar
M.J. Gutch
The phosphorylation of tyrosyl residues in proteins is a
key component of the regulation of signaling pathways
that control many fundamental physiological processes
including cell proliferation or differentiation. Protein
phosphorylation is a reversible, dynamic process in
which the net level of phosphate observed in a target
substrate reflects not only the activity of the kinases that
phosphorylate it, but also the competing action of pro-
tein phosphatases that catalyze the dephosphorylation
reaction. We study the expanding family of protein tyro-
sine phosphatases (PTPs) which, like the kinases, com-
prise both transmembrane receptor-linked forms and
nontransmembrane cytosolic species and represent a
major family of signaling enzymes. The structures of
the PTPs indicate important roles in the control of key
cellular functions. We are utilizing a variety of strategies
to characterize the normal physiological function of
several members of the PTP family. Disruption of nor-
mal patterns of tyrosine phosphorylation has been
implicated as a contributor to several human diseases.
Therefore, insights into the mechanisms involved in
modulating PTP function may ultimately yield impor-
tant information to help counter such diseases.
During the last year, Anton Bennett, Mike Gutch,
and Andy Garton completed their postdoctoral studies.
Anton Bennett took up a faculty position in the
Department of Pharmacology, Yale University, Mike
Gutch joined EPS, Inc., a scientific publication com-
pany, as Manager of Science and Medical Projects,
and Andy accepted a position as a Senior Research
Scientist at OSI Pharmaceuticals, Inc., New York. In
addition, Ken LaMontagne completed his Ph.D. and
joined the laboratory of Dr. Judah Folkman at
Children's Hospital, Boston, to perform postdoctoral
studies. We were joined by Helena Palka, Yu Shen, and
Lifang Zhang as postdocs and J.P. Liu worked as a
technician in our laboratory during the year.
IDENTIFICATION OF PTP SUBSTRATES: DEVELOPMENT
OF "SUBSTRATE-TRAPPING" MUTANT PTPs
The identification of substrates of PTPs is an essential
step toward a complete understanding of the physiolog-
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Y. Shen
L. Zhang
S.H. Zhang
ical function of members of this enzyme family. In
1995, in collaboration with David Barford (Oxford
University), we determined the crystal structure of
PTP1B in a complex with a phosphotyrosyl peptide
substrate. Using this structure to drive an analysis by
site-directed mutagenesis, we generated a form of
PTP1B that maintains a high affinity for substrate but
does not catalyze dephosphorylation effectively, i.e., we
converted an extremely active enzyme into a "substrate
trap." Furthermore, the residue that is mutated to gener-
ate the substrate-trapping mutant is the invariant cat-
alytic acid (Asp-181 in PTP1B) that is conserved in all
members of the PTP family. Therefore, this has afford-
ed us a unique approach to identification of physiologi-
cal substrates of PTPs in general. Following expression,
the mutant PTP binds to its physiological substrates in
the cell, but, because it is unable to dephosphorylate the
target efficiently, the mutant and substrate become
locked in a stable, "dead-end" complex. Potential sub-
strates can be identified by immunoblotting lysates of
cells expressing the mutant PTP with antibodies to pTyr
to reveal proteins whose phosphorylation state is altered
as a consequence of expression of the mutant. In addi-
tion, the complex between the mutant PTP and the pTyr
substrate can be isolated by immunoprecipitation, and
associated proteins can be identified by immunoblotting
or, on a larger scale, by primary sequence determina-
tion. We have now initiated such an approach to sub-
strate identification with intriguing results. The major
take-home message from this work is that members of
the PTP family display exquisite substrate specificity in
a cellular context.
PTP-PEST
Previously, we had shown that the cytosolic protein
tyrosine phosphatase PTP-PEST displays a remark-
able degree of selectivity for tyrosine-phosphorylated
p130'as as a substrate, both in vitro and in intact cells.
We demonstrated that the highly specific nature of the
interaction between PTP-PEST and p130'a8 appears to
result from a combination of two distinct substrate
recognition mechanisms; the catalytic domain of PTP-
PEST contributes specificity to the interaction with
p130cas, whereas the SH3 domain-mediated associa-
tion of p130c" and PTP-PEST dramatically increases
the efficiency of the interaction. We have developed
the study further by investigating the physiological
role of PTP-PEST using Ratl fibroblast-derived stable
cell lines which we have engineered to overexpress
PTP-PEST. These cell lines exhibit normal levels of
tyrosine phosphorylation of the majority of proteins,
but they have significantly lower levels of tyrosine
phosphorylation of p130cas than control cells. Initial
cellular events occurring following integrin-mediated
attachment to fibronectin (cell attachment and spread-
ing) are essentially unchanged in cells overexpressing
PTP-PEST; similarly, the extent and time course of
MAP kinase activation in response to integrin engage-
ment are unchanged. In contrast, the reduced phos-
phorylation state of p130cas is associated with a con-
siderably reduced rate of cell migration and a failure
of cells overexpressing PTP-PEST to accomplish the
normally observed redistribution of p130"' to the lead-
ing edge of migrating cells. Furthermore, cells overex-
pressing PTP-PEST demonstrate significantly reduced
levels of association of p130's with the Crk adaptor
protein. Our results suggest that one physiological role
of PTP-PEST is to dephosphorylate p130cas, thereby
controlling tyrosine-phosphorylation-dependent sig-
naling events downstream from p130e's and regulating
cell migration.
PTPH1
PTPH1, which was first characterized in my laboratory,
features a long noncatalytic amino-terminal segment
characterized by the presence of a domain that has
homology with band 4.1. PTPH1 is mostly associated
with membrane structures in cells, and this association
is mediated by the amino-terminal segment of the mol-
ecule. Furthermore, we have shown previously that the
amino-terminal segment of PTPH1 exerts an inhibitory
effect on activity of the enzyme in vitro, suggesting the
potential for direct modulation of activity at defined
locations in the cell. In addition, we had observed that
up to 50% of PTPH1 is complexed with the 14-3-3
adaptor protein in cells in a manner that is dependent on
phosphorylation of serine residues in PTPH1 and is reg-
ulated by mitogenic signals. However, the biological
function of PTPH1 remained unclear.
When we expressed PTPH1 in NIH-3T3 cells under
the control of a tetracycline-repressible promoter, we
observed that the wild-type enzyme dramatically inhib-
ited cell growth, whereas a catalytically impaired mutant
showed no effect. To identify the direct target of PTPH1
in the cell, we applied our strategy of expression of a
substrate-trapping mutant form of the enzyme, in which
the invariant general acid aspartate residue is changed to
alanine (D811A in PTPH1). The PTPH1-D811A mutant
specifically trapped a 97-1(D tyrosine-phosphorylated
protein, which was determined to be valosin-containing
protein (VCP, also named p97 or yeast CDC48) from
various cell lysates in vitro. However, when expressed in
mammalian cells, the D811A mutant was observed to
contain high levels of pTyr and did not trap substrates.
The recovery of pTyr in the DA mutant appeared to be
dependent on catalytic activity, since the inactive CAS
mutant, in which the essential nucleophilic cysteine
residue is mutated, did not incorporate phosphate. We
focused our attention on the tyrosine residue (Y676) that
forms one side of the active site cleft. Mutation of Y676
to phenylalanine (Y676F) in the PTPH1-D811A mutant
led to a marked reduction in pTyr content. Furthermore,
this double mutant specifically trapped VCP in vitro.
Like wild-type PTPH1, this double mutant also inhibit-
ed cell proliferation. Moreover, induction of wild-type
PTPH1 resulted in specific dephosphorylation of VCP
without changing the overall phosphotyrosine profile of
the cells. VCP is a member of a family of proteins that
have been implicated in endoplasmic reticulum
(ER)/Golgi membrane fusion, vesicle trafficking,
organelle biogenesis, and cell cycle control. VCP has
been found to be tyrosine-phosphorylated during mitosis
and upon T-cell activation. Furthermore, in yeast, muta-
tion of the tyrosine residue in CDC48 which is equiva-
lent to the major phosphorylation site of VCP results in
growth defects. Our data suggest that PTPH1 may exert
its effects on cell proliferation via dephosphorylation of
VCP as substrate, thus implicating tyrosine phosphory-
lation as an important regulator of VCP function.
Furthermore, these studies reveal an important refine-
ment to our strategy for identifying physiological sub-
strates of the PTPs. Upon expression of several members
of the PTP family, the D -*A mutants are recovered in a
form that contains high levels of pTyr and in which sub-
strate trapping is impaired. We anticipate that the combi-
nation of the D->A mutation with conversion of the
active site tyrosine residue to phenyl-alanine will yield
effective substrate-trapping mutant forms of all of these
PTPs and thus expand the scope of this approach.
PTEN
Since their initial characterization 10 years ago, many
PTPs have been linked to the inhibition of cell prolifer-
ation. This led to the proposal that these enzymes may
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function as tumor suppressors. However, it was not
until 1997 that the identification ofPTEN revealed the
first clear-cut example of a tumor suppressor PTP.
PTEN is one of the most frequently deleted tumor sup-
pressor genes, especially in prostate cancer, endometri-
al cancer, melanomas, and glioblastomas. In addition to
playing a part in sporadic cancers, germ-line transmis-
sion ofPTEN mutations gives rise to a variety of famil-
ial cancer syndromes, such as Cowden Disease. These
disorders are characterized by the formation of multi-
ple, benign tumors and an increased susceptibility to
malignant cancers. The frequent loss of PTEN in dif-
ferent types of malignancies indicates that it has a crit-
ical role in cancer surveillance in a wide variety of tis-
sues. Therefore, the study of PTEN is expected to
reveal important insights into the complex process of
tumorigenesis and may lead to the discovery of new or
improved treatments for a variety of cancers.
Previously, we had shown that PTEN possesses
intrinsic phosphatase activity and displays selectivity
for highly acidic substrates. Furthermore, mutations in
PTEN, identified in primary tumors, tumor cell lines,
and tissue explants from patients with Cowden
Disease, result in the ablation of phosphatase activity
in vitro, suggesting that phosphatase activity is
required for PTEN to function as a tumor suppressor.
One exception to this rule is a mutation that was iso-
lated from two independent Cowden Disease kindreds.
This mutation, in which a glycine in the conserved cat-
alytic signature motif is mutated to a glutamate
(G129E), did not significantly ablate the phosphatase
activity of PTEN in vitro. Although it retained phos-
phatase activity using artificial substrates, this muta-
tion must ablate the tumor suppressor function of
PTEN as it is the causative ablation in a cancer predis-
position syndrome. Therefore, this mutation becomes
a powerful tool with which to ascertain which activi-
ties ascribed to PTEN are important for its tumor sup-
pressor function (Fig. 1).
We have extended our analysis of this important
enzyme to identify its physiological substrates. Despite
the precedents showing that the PTPs recognize protein
targets, our observations led to the proposal that the
physiological substrates of PTENmay actually be non-
proteinaceous and focused our attention on the inositol
phospholipids. Inositol phospholipids were attractive
candidates because, in addition to their highly acidic
nature, they function as second messengers that regu-
late the morphological and hyperproliferative respons-
es that underlie cellular transformation. Additionally,
these lipids have also been shown to inhibit apoptosis,
a naturally occurring form of cell death that is often
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triggered by, and counteracts, the effects of hyperpro-
liferative stimuli. In fact, we discovered that PTEN
dephosphorylates a specific inositol phospholipid,
phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 is
normally produced by the activation of PI3-kinase in
response to a variety of stimuli, including most growth
and survival factors, and functions to activate a wide
variety of signaling pathways by recruiting signaling
molecules, such as the protein kinase PKB/Akt, to the
plasma membrane. PTEN exhibited exquisite selectiv-
ity for PIP3 to the point of dephosphorylating only a
single site in the inositol ring-the site phosphorylated
by PI3-kinase. Importantly, the G129E Cowden
Disease mutation resulted in the specific loss of the
ability of PTEN to dephosphorylate PIP3. Since this
mutation, which ablates the tumor suppressor function
of PTEN, retained activity against proteinaceous sub-
strates, it was clear that the lipid phosphatase activity
ofPTEN, rather than its protein phosphatase activity, is
required for its function as a tumor suppressor.
Additionally, tumor cell lines, which have lost PTEN
expression through mutation or deletion of the endoge-
nous alleles, have increased levels of PIP, and of acti-
vated PKB/Akt. Reconstitution ofPTEN expression in
these cells lowered both the levels of PIP, and of acti-
vated PKB/Akt, indicating that PTEN also functions as
PIP, phosphatase in intact cells. Most importantly,
reconstitution of PTEN expression in prostate cancer
cell lines resulted in the inhibition of PIP3-dependent
survival signals and the induction of apoptosis in these
cells. Significantly, the lipid-phosphatase-deficient
mutant of PTEN did not induce apoptosis in these
cells, further emphasizing the requirement of the lipid
phosphatase activity ofPTEN to inhibit the tumor-pro-
moting signals emanating from PIP3. These data
demonstrate that the lipid phosphatase activity of
PTEN is required for it to function as a tumor suppres-
sor and provide a molecular basis for Cowden Disease,
as loss of the lipid phosphatase activity ofPTEN leads
to the accumulation of the products of PI3-kinase and
results in the neoplastic pathology characteristic of the
disease.
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FIGURE 1 The lipid phosphatase activity of PTEN is required for it
to function as a tumor suppressor. (4) Recombinant PTEN was
incubated with radiolabeled polyGluTyr and Ptdlns(3,4,5)P3 and
the release of 321=p1 was measured. PTEN recognized
PtclIns(3,4,5)P3 as substrate, whereas cdc14, the closest homolog
of PTEN, did not. Furthermore, a point mutant of PTEN isolated
from Cowden Disease (G129E) revealed that the lipid phos-
phatase activity of this enzyme is important for its tumor suppres-
sor function. (8) Expression of PTEN induces apoptosis in LnCaP
cells. PTEN, PTENC124S, or PTENG129E were cotransfected
with a green fluorescent protein (GFP) expression vector into
LnCaP cells. The cotransfections also included either expression
vector for a constitutively active form of PKB/Akt (black bars) or a control empty vector (striped bars). Expression of PTEN resulted
in a decrease in the number of viable cells recovered, and this loss could be rescued by coexpression of the activated form of
PKB/Akt. This indicates that PTEN inhibits the PKB/Akt-dependent survival signals. Significantly, the lipid phosphatase-defective
mutant (G129E) did not effect cell viability, indicating that the lipid phosphatase activity of PTEN is required for this effect. Transfected
cells were identified as GFP-positive cells or by immunofluorescence microscopy following staining with antibodies to the transfect-
ed PTEN. Transfection efficiency was assessed by determining the percentage of GFP/PTEN-positive cells (total number of cells was
determined by counting nuclei [stained with DAPI[). Data are expressed as the mean transfection efficiency (±s.o. n = 3). (C) Model
of PTEN function in antagonizing the growth/survival signals stimulated by PI 3-kinase.
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SIGNAL TRANSDUCTION
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M. McDonough
A. Schmitz
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M. Zhao
R. Packer
Our research interest is the study of the signal trans-
duction pathways involved in cell growth control and
morphogenesis. In particular, one major research pro-
ject is to investigate the role of the Ras and Rac pro-
teins in signal transduction. Ras and Rac are members
of the Ras and Rho subfamilies of small GTPases
which function as molecular switches cycling between
an inactive guanine nucleotide diphosphate (GDP) -
bound state and an active guanine nucleotide triphos-
phate (GTP)-bound state. These proteins have been
shown to have a central role in the signal transduction
pathways that mediate important biological phenome-
na such as transformation, senescence, adhesion, inva-
siveness, metastasis, and development. Our major
objective is to uncover the molecular mechanisms by
which the Ras and Rac proteins exert these effects.
Another project ongoing in our laboratory is the func-
tional characterization of p62"k, a constitutively tyro-
sine phosphorylated, Ras-GAP-associated protein,
detected in chronic myelogenous leukemia (CML)
progenitor cells.
Ras SIGNALING PATHWAYS
Ras proteins have a crucial role in the ethiology of
human cancers. Activating mutations in ras genes are
commonly found in a variety of human tumors, and, in
addition, oncogenic mutants of Ras confer both tumori-
genic and metastatic properties to rodent cells in culture,
providing a system for determining the molecular events
necessary for tumor progression. Abundant evidence
suggests a crucial role for the Raf-MEK-MAPK (mito-
gen-activated protein kinase) pathway in Ras-mediated
transformation; however, more recent studies have
implicated Raf-independent pathways which contribute
to mammalian cell transformation. These include the
PI3-kinase/Rac and RaIGDS/Ral (Ral guanine nucleo-
tide dissociation stimulator) pathways. Less clear are the
Ras-mediated signaling pathways key to the acquisition
of the metastatic phenotype. To gain more information,
we tested effector domain mutants of oncogenic ras
(which are deficient in specific effector function and
therefore unable to activate specific downstream signal-
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ing) for their abilities to mediate tumorigenic and
metastatic phenotypes in athymic nude mice when
expressed in NIH-3T3 cells. The use of these Ras effec-
tor loop mutants (RasV12S35, RasV12G37, and
RasV12C40) showed that all mutants displayed compa-
rable tumorigenic properties, but that only the mutant
which retained its ability to activate the Raf/MEK/
MAPK pathway, RasV12S35, induced tumors in the
experimental metastasis assay. Furthermore, we found
that direct activation of the MEK/MAPK pathway, using
either a constitutively active mutant of MEK or the onco-
gene mos, which is a potent activator of MEK, was suf-
ficient to induce metastasis, whereas R-Ras, which is
able to activate PI3-kinase but not MAPK was tumori-
genic but nonmetastatic. Finally, we observed that the
subcutaneous tumors and lung metastases derived from
RasV12S35-transformed cells displayed an increased
level of MAPK activity as compared to parental cells,
whereas cells explanted from RasV12G37- and
RasV12C40-induced tumors did not show any changes
in MAPK activity. Taken together, these results indicate
that whereas Ras-mediated tumorigenicity can arise
independently from MAPK activation, experimental
metastasis requires constitutive activation of the MAPK
pathway, and that the Ras effector pathways mediating
the tumorigenic and metastatic activities can be segre-
gated. We cannot, however, exclude that in addition to
Raf, other effectors differentially regulated by the above-
described Ras effector loop mutants may contribute to
the metastatic phenotype. In addition, since an experi-
mental metastasis assay was used, the metastatic pheno-
type relates to later stages of metastasis (e.g., extravasa-
tion and establishment and/or secondary growth) and not
to the early steps (e.g., intravasation) in which the Rho-
GTPases are likely to play a part (see below). These stud-
ies have been performed in collaboration with G. Webb
and G. Vande Woude (National Cancer Institute).
In addition to the above-mentioned Ras effectors,
we identified AF-6 as a novel Ras-binding protein. AF-
6 has been previously described as a fusion partner for
ALL1 in acute lymphoblastic leukemias. The AF-6
protein contains a combination of interesting homolo-
gy regions. At its very amino terminus reside two puta-
tive Ras-binding motifs, which we proved to be essen-
tial for Ras binding. These are followed by U104 and
DIL motifs, domains that are found in the head por-
tions of actin and microtubule-based motor proteins.
Located further to the carboxyl terminus is a PDZ
domain. Recent studies showed that AF-6 interacts
with members of the Eph receptor tyrosine kinases
through its PDZ domain. Furthermore, the carboxy-ter-
minal remainder of AF-6 harbors several proline-rich
clusters that may also function as docking sites for
other molecules. Although the biochemical function of
AF-6 remains to be defined, a picture is emerging that
suggests a role for AF-6 in the establishment and/or
maintenance of cell-cell contacts. In epithelial cells,
AF-6 colocalizes with the cell adhesion component
ZO-1 at tight junctions, whereas in cells lacking tight
junctions, the two proteins colocalize with adherens
junctions. Furthermore, AF-6 has been reported to
interact directly with ZO-1. We recently found that the
carboxy-terminal portion of AF-6 interacts with profil-
in, a G-actin-binding protein that regulates actin fila-
ment assembly. It is thus an intriguing possibility that
AF-6 serves as a multi-adaptor protein linking compo-
nents of tight junctions and/or adherens junctions with
the actin cytoskeleton. At present, the functional rela-
tionship between Ras and AF-6 remains to be unrav-
eled. To address this question in a more comprehensive
system, we took refuge to Drosophila as a model sys-
tem. A Drosophila homolog of AF-6 known as Canoe
was first identified in a genetic search for unknown
components of Notch signaling, a pathway that in a
multitude of developmental processes determines vari-
ous cell fates. Notably, the Canoe protein harbors the
same homology regions in the same order as AF-6. In
fact, we found that the domain containing the predict-
ed Ras-binding motifs in Canoe is sufficient to bind to
Ras. In collaboration with Ulrike Gaul (Rockefeller,
New York), we recently observed that expression of
Canoe under GMRGAL4 control (which drives expres-
sion in all cells posterior to the morphogenetic furrow
in the developing eye) leads to excessive neural deter-
mination of precursor cells in the eye disc and that
Canoe appears to influence eye differentiation in a
dose-dependent manner. Further studies are under way
to assess the relationship between Ras and Canoe.
RAC SIGNALING PATHWAYS
During the past years, it has become clear that the Rho
family member, Rac, participates in a wide variety of
biological activities, including cytoskeletal organiza-
tion, transcriptional activation, and proliferation, and
more recently adhesion, invasiveness, and neuronal
development. Depending on the cell type and the
extracellular matrix, Rac can promote either cell adhe-
sion or cell migration. We recently showed that expres-
sion of a constitutively activated mutant form of Rac,
RacV12, triggers the adherens of a Jurkat T-cell line on
immobilized fibronectin in an integrin-dependent
manner and that adhesion is associated with dramatic
cell spreading, cytoskeletal rearrangements, and inte-
grin clustering. Expression of RacV12, however, does
not alter the expression level nor activation state of the
integrins, indicating that the contribution of Rac to T-
cell adhesion involves events following receptor occu-
pancy, such as cell spreading and integrin clustering,
rather than alterations of integrin affinity or cell sur-
face expression.
A major challenge has been the identification of
downstream effector pathways by which Rac mediates
the above activities. We have taken three different
approaches to obtain more insight in the signaling
pathways mediating these effects. As a first approach,
we made use of the yeast two-hybrid system to isolate
Rae-interacting proteins. We succeeded in the isola-
tion of three novel Rac-interacting proteins and pro-
vided evidence for a role of one of them, designated
PORI, in cytoskeletal rearrangements. The other pro-
teins are currently under investigation. Second, we
devised a system to dissect genetically the different
functions of Rac. This was accomplished through the
use of Rac effector domain mutants, which we
obtained in a yeast two-hybrid screen for mutant forms
of Rac which are differentially impaired in their abili-
ty to bind different Rac effector proteins. These results
indicate that the growth-promoting activity of Rac is
not dependent on signals contributed by the Jun N-ter-
minal kinase (JNK) MAP kinase or SRF pathways.
Activation of JNK and SRF (serum response factor) is
also not essential for Rac's effect on T-cell adhesion;
the latter is, however, dependent on the short-term
cytoskeletal rearrangements triggered by Rac and
appears to involve a lipid kinase. As a third approach
to identify targets of Rac-in particular those underly-
ing invasiveness-we intend to perform cDNA-RDA
(representational difference analysis) on pairs of
cDNAs obtained from a breast carcinoma cell line
(T47D) expressing RacV12 under an inducible pro-
moter. The choice of this particular cell line is based
on the fact that activation of RacV12 in T47D cells
was previously shown to confer an invasive potential
to these cells. RDA is a polymerase chain reaction
(PCR)-based subtractive hybridization technique
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which selectively amplifies the differences between
two DNA populations. We will be performing RDA on
the cDNAs obtained from T47D cells induced and not
induced for RacV12 expression to isolate the cDNAs
that are differentially expressed. These experiments
will be performed in collaboration with Rob Lucito
and M. Wig ler here at the Laboratory.
FUNCTIONAL CHARACTERIZATION OF p62.'K
Another research project ongoing in our laboratory is the
functional characterization of p62"k, a protein that was
observed to be constitutively phosphorylated on tyrosine
in primary lin- Ph+ chronic-phase CML blasts. CML is
characterized by the presence of the fusion protein
p2101'"-"1 which has an elevated tyrosine kinase activity
relative to normal c-Abl. Furthermore, p62d" was found
to form an in vivo complex with p120 Ras-GAP. It is an
intriguing possibility that p62a" is a critical immediate
substrate of p210"' "I and that its constitutive phospho-
rylation plays a part in a complex physiological disorder
manifested in the chronic phase of CML.
We obtained further evidence that p62d" is a direct
substrate of p210b"."' and interacts directly with the
SH2-SH3-SH2 domain of Ras-GAP. R. Kobayashi
the tyro-
sine sites on p62d" responsible for GAP binding. To
obtain more information on the function of p62d" and
its relative contribution to the p210kr-"1- induced aber-
rant phenotype in hematopoietic cells, we searched for
p62d°k-interacting proteins and constructed a variety of
truncation mutants with the goal to obtain dominant-
negative mutants of p62d" that may interfere with
p210b'''-"1 signaling. Our coimmunoprecipitation
experiments using antibodies raised against p62d" and
Mo7/p210''''M cells revealed the presence of at least
five additional proteins with molecular masses of 64,
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66, 68, 120, and 210 kD. The 120- and 210-kD bands
were identified as Ras-GAP and p210b"-"d, respective-
ly. The identity of the other proteins remains to be
defined; we do know, however, that these proteins are
not Zap70, Slp76, Lck, or Syk components in T-cell
signaling. We intend to purify these proteins and clone
their respective cDNAs. Additionally, we are currently
assessing the effects of p62 truncation mutants on
p210b"-"rinduced proliferation and differentiation in
hematopoietic cell lines as well as the growth proper-
ties of p62-1- cells (which we retrieved from P.
Pandolfi, Memorial Sloan-Kettering Cancer Center,
New York) and potential altered signaling in these
cells. These studies are being performed in collabora-
tion with R. Kobayashi and N. Tonks (CSHL) and B.
Clarkson and P. Pandolfi.
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STRUCTURE AND GENOMICS
The Structure and Genomics Section continued to expand its activities and interactions with other
CSHL scientists. This group continues its work to apply both classical experimental approaches and
computational approaches toward a new understanding of the correlation between structure and func-
tion in both proteins and nucleic acids.
The Structural area has seen several important advances.
Rui-Ming Xi's lab has made considerable advances in understanding the structure of the proteins
in the splicing complex.
Leemor Joshua-Tor's lab has determined the structure of bleomycin hydrolase, and this has led
to a new understanding of the function of this protein.
Peter Nestler's lab showed the potential of screening combinatorial libraries with peptide epitopes
to isolate binding regions.
The Kobayashi lab, in collaboration with Yuri Lazebnick, used mass spectrometry to identify a
protein identified with oncogene activity as being the apoptotic protease activity factor I.
Andy Neuwald's lab, using a computational approach to protein structure, has developed new
algorithms to better compare protein sequences and has used this to study a group of ATPases.
The Genomics area has expanded with the addition of Dr. Lincoln Stein.
Lincoln Stein has been developing tools to allow the display of complex genome databases to
biologists via the World Wide Web. His first use of these tools has been to display the database
ACEDB, which contains the complete genome sequence of Caenorhabditis elegans, the first ani-
mal to be completely sequenced.
The Zhang lab has expanded their efforts in predicting genes from genome sequence and has
also begun efforts to find other types of signals in sequences, such as promoters.
The McCombie lab has continued its genome analysis efforts, sequencing more than 2 million
bases of DNA, including parts of Arabidopsis and the region encoding the human tumor sup-
presser PTEN.
DNA Sequencing Lab entrance at Hershey
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STRUCTURAL BIOLOGY
L. Joshua-Tor T. Messick D. van Aalten
P. O'Farrell D. Vaughn
J. Rosenbaum C. Chong (URP)
We study the molecular basis of cell regulatory
processes by combining the tools of structural biology
and biochemistry to examine the molecular interac-
tions associated with these processes. X-ray crystallog-
raphy enables us to obtain the three-dimensional struc-
tures of individual proteins and their complexes with
other molecules. We use biochemistry to characterize
properties that can be correlated to protein structure
and information from molecular biology and genetics
in a collaborative effort to study protein function.
Our current efforts center around two distinct
themes. The first is the study of an evolutionarily con-
served family of oligomeric self-compartmentalizing
intracellular proteases, the bleomycin hydrolases (cyli-
nases). The second theme involves structural studies of
protein complexes involved in gene expression. We are
also looking at the effect of molecular motions on var-
ious biological processes.
During the last year, Tom Malone, who has been
the Crystallographic Systems Manager for both struc-
ture groups, departed the Laboratory. Ming Wang has
taken his place and now runs the X-ray and computer
facilities for the Structural Biology Center.
Bleomycin Hydrolases
Bleomycin hydrolase (BH) is a 300-kD cysteine pro-
tease with unusual structural and biological features. It
was discovered because of its ability to deactivate the
glycopeptide antibiotic, bleomycin, which is used as a
therapeutic agent in the treatment of a number of dif-
ferent forms of cancer. The clinical use of bleomycin
is limited due to drug resistance and dose-dependent
production of pulmonary fibrosis. The endogenous
enzyme, BH, is overexpressed in some tumor cells and
is thought to be a major cause of tumor cell resistance
to bleomycin therapy. It was shown that both in yeast
and in mammalian cells, BH is the only enzyme with
bleomycin deamidation activity. Interest in its clinical
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relevance was heightened by a recent report of the
genetic linkage of an allelic variant to the nonfamilial
form of Alzheimer's disease. BH was also found to
bind amyloid precursor protein (APP).
Since mammals rarely encounter bleomycin,
bleomycin hydrolysis is probably not the normal func-
tion of the enzyme. On the basis of studies with BH
knockout mice, it was shown that BH is important for
neonatal survival. BH is widely distributed throughout
nature; homologs exist in bacteria, yeast, birds, and
mammals, with high sequence identity among the dif-
ferent forms. The yeast form negatively regulates the
galactose metabolism system and also binds single-
stranded DNA and RNA with high affinity. Nucleic-
acid-binding activity was also reported for other mem-
bers of the family.
Previously, we determined the crystal structure of
the yeast BH, Ga16. The structure reveals several
unique features of these proteases. It is a hexameric
ring-barrel structure with the active sites embedded
in a central cavity. This cavity is 22 A wide at the
openings on either end, and widens to 45 A in the
interior of the protein. The only access to the active
sites is through the cavity, and thus a protein sub-
strate would need to be at least partially unfolded or
degraded in order to reach them. BH has little sub-
strate specificity so it is reasonable to assume that
this sequestration of the active sites is necessary to
prevent indiscriminate proteolysis. This places BH in
the class of "self-compartmentalizing proteases"
with, for example, the proteasome and the tricorn
protease. The carboxyl terminus of BH lies in the
active site, in much the same position as that taken
by inhibitors complexed with papain. Our recent
work on the yeast BH, Ga16, has shown that it acts as
a carboxypeptidase on its carboxyl terminus to con-
vert itself to an aminopeptidase and peptide ligase.
The carboxyl terminus anchors the substrate into the
active site and confers "positional" specificity. This
model also serves to explain the unique ability of
BH/Ga16 to inactivate bleomycin.
Human Bleomycin Hydro lase
P. O'Farrell, L. Joshua-Tor [in collaboration with
F. Gonzalez, W. Zheng, and S.A. Johnston,
University of Texas-Southwestern Medical Centerl
In an effort to understand the mechanism of action of
the enzyme, and with the long-term goal of designing
an effective inhibitor and a cleavage-resistant
bleomycin, we have determined the crystal structure of
wild-type human bleomycin hydrolase (hBH) at 2.6 A
resolution and of an active site mutant C73S at 1.85 A.
As expected from sequence identity, the structure of
hBH is very similar to the structure of the yeast BH,
Ga16. However, there is a striking difference between
the two forms. The central channel, which has a very
prominent positive charge in the yeast enzyme, is
slightly negative in the human protein (Fig. 1). We have
also determined that hBH does not have the strong sin-
gle-stranded DNA- or RNA-binding activity of the
yeast protein. This may reflect a somewhat different, or
perhaps altered, role in their respective biological func-
tions. As mentioned, the clinical relevance of hBH has
recently been augmented by its possible association
with Alzheimer's disease. The structure suggests that
the location of the putative disease-linked variant could
affect interactions with another protein, which in turn
may modulate the peptidase activity of hBH by reposi-
tioning the carboxyl terminus.
If indeed there is an involvement of hBH in some
Alzheimer's disease pathology, the structural and func-
tional similarities and differences between the yeast
and human forms may prove useful in delineating the
disease mechanism. In addition, the human structure
may now serve as the basis for a rational design of
inhibitors of BH activity to augment the effectiveness
of bleomycin in cancer treatment.
FIGURE 1 The central channel in hBH is close to neutral in charge, whereas the yeast BH,
Gal6, has a very prominent positive charge as shown by the darker surface. (Top) hBH; (bottom)
Ga16. (Left panels) Top view down the threefold axis, (right panels) a slice through the protein,
highlighting the difference in charge between the interiors of the human and yeast proteins.
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A Structural Snapshot
of Base Pair
Opening in DNA
D.M.F. van Aalten, L. Joshua-Tor [in collaboration
with G. Verdine, Harvard University]
The response of double-helical DNA to torsional
stress may be a driving force for many processes act-
ing on DNA. The 1.55-A crystal structure of a duplex
DNA oligonucleotide d(CCAGGCCTGG)2 with an
engineered cross-link in the minor groove between the
central guanine bases depicts how the duplex can
accommodate such torsional stress. We have captured
in the same crystal two very different conformational
states. One duplex (A) contains a strained cross-link
that is stabilized by calcium ion binding in the major
groove, directly opposite the cross-link. This strain
results from an eclipsed bond for one of the ethano
bridges in the tether that forms the ethyldisulfide
cross-link and very tight packing of the cross-link in
the minor groove. In the other duplex (B), the strain in
the cross-link is relieved as both ethano bridges are in
a staggered conformation and the cross-link is loosely
packed in the groove. The net result is that in going
from molecule A to B, the tether is elongated and
thrust forward in the direction of the bases by approx-
imately 2.5 A. Thus, the entire disulfide cross-link in
molecule B is fully extended. This pushes the guanine
at the end of the cross-link into the major groove.
However, because the far end of this guanine base
remains attached to the DNA backbone, the base is
constrained to swivel rather than slide forward. The
cytosine swivels the other way, partially flipping out
from the helix, with a partial rupture of the base pair,
retaining only one hydrogen bond. This conformation
is subsequently trapped by a stabilizing hydrogen-
bonding interaction with a neighboring molecule. The
consequence of this is therefore partial extrusion of a
cytosine accompanied by helix bending. The sequence
used is the target sequence for the HaeIII methylase,
and this partially flipped cytosine is the same
nucleotide targeted for extrusion by the enzyme.
Molecular dynamics simulations of these structures
show an increased mobility for the partially flipped-
out cytosine.
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Crystal Structure of Carboxypeptidase
A Complexed with D-Cysteine
D.M.F. van Aalten, C.R. Chong, L. Joshua-Tor
n- Penicillamine is used as a treatment for Wilson's
disease and arthritis. Recent experiments have shown
that it is a potent inhibitor of zinc proteases, such as
carboxypeptidase A. It appears to inhibit carboxypep-
tidase by causing the active site zinc to dissociate from
the protease. D-cysteine, which differs from n- penicil-
lamine by removal of two methyl groups on the 0-car-
bon, inhibits carboxypeptidase by formation of a
ternary complex in which the zinc ion remains bound
in the active site. We solved the crystal structure of
carboxypeptidase A complexed to D-cysteine at 1.75 A
resolution. This is the first structure of a thiol inhibitor
bound to carboxypeptidase. The thiolate of D-cysteine
has replaced the active site water to coordinate the
zinc ion. In addition to the zinc-sulfur bond, the
inhibitor is tethered to the active site by eight hydro-
gen bonds, five of which are protein residues. In con-
trast, L-cysteine would not be capable of forming all of
these interactions concurrently, which may explain its
reduced affinity. In addition, the two additional methyl
groups of D-penicillamine would result in steric clash-
es with primary and secondary zinc ligands. This may
explain why this drug acts presumably by extracting
zinc from the active site rather than simply blocking
substrate access to the active site.
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PROTEIN CHEMISTRY
R. Kobayashi N. Kashige
N. Poppito
K. Wanat
The Human Genome Project is well on its way to com-
pletion, and thus we are focusing more and more on
studying protein function. To do so, we are developing
all kinds of methods for microcharacterization of pro-
tein, including protein sequencing and posttranslational
modification analysis.
Oncogene-dependent Apoptosis
Is Mediated by Caspase-9
R. Kobayashi, N. Poppito, K. Wanat [in collaboration
with Y. Lazebnik, Cold Spring Harbor Laboratory]
Collaboration with other scientists at Cold Spring
Harbor Laboratory continues to be a major activity in
214nm
295nm
HPLC peptide map of OGA
our laboratory. We use the matrix-assisted laser de-
sorption ionization time-of-flight mass spectrometer
(MALDI-TOF-MS) for identification of proteins in a
database. Dr. Yuri Lazebnik's group here at the
Laboratory studies apoptosis, and they have purified
an oncogene-generated activity (OGA). The OGA was
purified from a cell line that expresses the E1A onco-
genes, and when added to the untransformed extract, it
activated caspases, thus mimicking the effects of E1A
expression in cells. It was therefore suggested that
OGA is a link between oncogene expression and the
apoptotic machinery. To determine the function of
OGA, we use our in-gel digestion protocol, followed
by regular chemical sequencing and mass mapping
using MALDI-TOF-MS. About 15 pmoles of the OGA
Mass mapping with MALDI-MS
Peptide fragments identified by Edman degradation
DNDSYVSFYNALLHEGYKDLAALLHDGIPWSSSS
YVVPVESSLGK
SFRYYLHDLQ
LLEIK
QFFLNLEDPQEDMEVIVK
TVWHIQFTADEK
VWNIITGNK
IHVSPDFK
Peptide fragments identified by mass spectrometry
mass
Sequence Found Expected
DYYTDLSILQK 1359.34 1359.52
GLEILSLFVNMK 1380.52 1380.69
KADLPEQAHSIIK 1450.52 1450.68
QEVDNGMLYLEWINK 1867.03 1869.11
VRNEPTQQQRAAMLIK 1900.05 1900.22
DNDSYVSFYNALLHEGYK 2136.22 2136.29
TSYIMDHMISDGFLTISEEEK 2479.47 2479.75
SSSYDYEALDEAMSISVEMLREDIK 2914.88 2915.18
FIGURE 1 Two methods to identify OGA.
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was purified and digested by lysylendopeptidase. For
analysis, the digest was divided for high-performance
liquid chromatography peptide mapping (95%) and
mass spectrometry mass mapping (5%). Both methods
were able to identify the OGA as apoptotic protease
activating factor I (APAF-I) (Fig. 1).
Biochemical Characterization of
p62d°k, a Constitutively
Tyrosine-phosphorylated
Protein in CML
N. Kashige
We continue to study the tyrosine-phosphorylated
p62d" in chronic myelogenous leukemia (CML) in the
presence of p210b"-"' tyrosine kinase. Human CML is
characterized by the Philadelphia chromosome, a
translocation in which the breakpoint cluster region
(bcr) gene on chromosome 22 becomes fused to the
abl tyrosine kinase proto-oncogene on chromosome 9.
As a result, a chimeric 210-kD Bcr-Abl protein is pro-
duced. In CML, p62d" is constitutively tyrosine-phos-
phorylated by p210bc'-dbi and only tyrosine phosphory-
lated p62d°k binds to Ras-GAP. Since Ras-GAP is a
negative regulator of Ras, p62d" may have an impor-
tant role in the Ras signaling pathway. We continued
tyrosine phosphorylation site analysis of p62d" and
identified five essential phosphotyrosine residues for
Ras-GAP association.
We are currently analyzing the effect of p62d" and
its mutants on the Ras-GAP activity in vitro.
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SEQUENCE-BASED ANALYSIS OF COMPLEX GENOMES
W.R. McCombie M. de la Bastide
K. Habermann
L. Gnoj
E. Ning Huang
L. Spiegel R. Shah M. Shekher
R. Preston I. Swaby L. Parnell
K. Schutz A. Matero N. Dedhia
M.D. Vil M. Rodriguez A. O'Shaughnessy
For several years, we have been building an infra-
structure that will allow us to use high-throughput
DNA sequencing to analyze large genomic regions.
In 1998, we made significant progress and reached
several milestones. With our sample tracking soft-
ware in place, and a reorganization of our laboratory
to maximize efficiency, we have continued to greatly
increase our sequencing capacity.
In the area of production sequencing, we expand-
ed our capacity in 1998 by adding a second shift of
production sequencing. This has allowed us to more
fully utilize our laboratory space and sequencing
instruments, and thus to increase our production from
about 800 reactions per week run on gels at the end
of 1997 to about 3500 per week by the end of 1998.
In addition, we were able to increase our success rate
slightly during this scale-up. This
impact in our production of finished, highly accurate
sequence to GenBank.
Figure 1 shows the amount of finished sequence
we have submitted to GenBank from 1996 to 1998. In
calendar year 1997, we submitted just over 700 kb of
finished sequence to GenBank. In calendar year
1998, we submitted more than 2 million bases of fin-
ished sequence. This increase in finished sequence
coupled with that in our raw sequence generation has
MB Submitted to GeuIleuk
two ISM
FIGURE 1 Output of finished sequence submitted to
GenBank.
allowed us to extend our contribution to projects not
requiring finished sequence.
The net effect of this rise in capacity has been the
simultaneous increase of our contribution to several
projects. We have substantially increased our
Arabidopsis genomic sequencing. Most of our
increased output in 1998 was directed at this project.
In late 1998, we also began to scale up two human
sequencing projects. One project in association with
the Wigler lab is to sequence regions of the human
genome deleted in breast and other types of cancers.
The second is a pilot project to sequence a region
of human chromosome 18. This infrastructure has
allowed us to carry out both of these major new pro-
jects, as well as to continue several smaller projects in
a very efficient manner.
Arabidopsis Genome
Sequencing
M. de la Bastide, K. Habermann, L. Gnoj, E. Ning Huang,
L. Spiegel, R. Preston, K. Schutz, M.D. Vil, R. Shah,
I. Swaby, A. Matero, M. Rodriguez, M. Shekher,
A. O'Shaughnessy, L. Parnell, N. Dedhia, W.R. McCombie
[in collaboration with R. Martienssen, CSHL, R.K. Wilson
and M. Marra, Washington University School of Medicine,
and E. Chen, PE Applied Biosystems]
Our maps of sequence-ready clones for the region of
the Arabidopsis genome that we targeted for sequenc-
ing were completed in 1998. This allowed us to ramp-
up our sequence production both here at CSHL and in
the laboratory of our collaborators at the Washington
University Genome Sequencing center.
In 1998, our consortium produced 4.5 million bases
of finished Arabidopsis genomic sequence. Of this
amount, our group at CSHL produced about 1.7 Mb.
Much of this sequence is present in a highly contiguous
region of chromosome IV. The status of this project can
be found on our Web page at the URL www.cshl.org/pro-
torah.
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Arabidopsis Sequence
Annotation
L. Parnell, W.R. McCombie [in collaboration with R.
Martienssen, CSHL, C.M.E. Schuster, H.-W. Mewes
and K.F.X. Mayer, Munich Institute of Protein Science]
As we have increased the rate of sequence annotation,
we have found it necessary to modify the way in which
we analyze and annotate the sequence we generate.
This change has been most acute in the way we ana-
lyze our Arabidopsis sequence. We are continuing to
work with our collaborators at the Munich Institute for
Protein Science to develop approaches to annotation
that are both informative and scaleable to keep pace
with the increase in sequencing rates.
As an example, we had been using as many as
seven different gene prediction programs and compar-
ing the results of these programs with those of data-
base searches to predict the presence and boundaries
of genes. It has become impossible to keep up with the
rate of sequencing using this annotation strategy. We
have, however, learned from the use of all these meth-
ods a considerable amount about the strengths and
weaknesses of the programs. Comparing predictions
with known or experimentally presumptive structures
based on cDNA or EST data enabled us to minimize
the number of programs employed. Although it does
not provide as much accuracy as when we use all of
the programs, it does allow us to approximate the qual-
ity of the annotation in a time frame that is reasonable
given our sequencing rate.
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As the amount of sequence has increased, we have
been able to begin carrying out statistical analyses on
the results of our analysis. While this is ongoing, sev-
eral interesting points can be made. Figure 2 shows the
comparison of the genomic sequence to the current
Arabidopsis EST database. Interestingly, although not
surprisingly, a large percentage of the genes predicted
from genomics sequence are not found in the EST
database. Some of these are almost certainly false-pos-
itive predictions. However, it is likely that the great
majority of them represent real genes not in the EST
database. For instance, many are similar to known
genes from other species. Interestingly, a few of the
predicted genes each matches many ESTs.
We can also begin to break down the genes found
according to function. This is shown in Figure 3. Many
of the genes are involved in so-called housekeeping
functions, such as metabolism. However, a large per-
centage are involved in fairly specialized complex func-
tions such as signal transduction. There is clearly much
remaining in the Arabidopsis genome to sequence and
analyze. This initial sample is large enough that it will
not likely change in any major way as far as the repre-
sentation of types of gene functions found.
We are in the final stages of completing chromo-
somes IV and V. Chromosome IV will likely be the
first chromosome to be sequenced from a plant. The
entire genome is slated for completion by the end of
the year 2000. This sequence, coupled with the large-
scale functional analyses being done in a variety of
labs, including Rob Martienssen's lab, will dramatical-
ly change the way Arabidopsis research is conducted,
FIGURE 2 Comparison of genomic sequence to the currentArabidopsis EST database.
Most genes have no EST counterpart.
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FIGURE 3 Breakdown of genes according to function.
as well as our understanding of the complex patterns
of growth, development, and regulation that higher
plants exhibit.
Gene Trap Sequencing
K. Schutz, L. Gnoj, W.R. McCombie [in collaboration
with R. Martienssen, Cold Spring Harbor Laboratory]
In addition to determining the structure of the
Arabidopsis genome, it is important that we use this
information to advance our understanding of the func-
tion of the genes in this plant. One way that this is
being carried out is through the systematic generation
of transposon insertions in the Arabidopsis genome
and the sequencing of the sites of insertion of those
transposons.
The Martienssen laboratory is generating inser-
tions in Arabidopsis on a large scale, and in a collab-
oration with them, we are sequencing those insertion
sites. In 1998, we sequenced about 2100 insertion
sites and will continue to sequence these insertions in
1999. These data are being used to create a database
of transposon insertions. The completion of the
Arabidopsis genome sequence will allow precise
mapping of the position of any of these insertions
within the genome.
Development of a Method to Filter
Repetitive DNA from Libraries
Generated from Plant Genomes
K. Schutz, L. Parnell, N. Dedhia, W.R. McCombie
[in collaboration with P. Rabinowicz and R. Martienssen,
Cold Spring Harbor Laboratory]
The genomes of most higher eukaryotes, especially
higher plants, contain a large amount of repetitive
DNA. In fact, the genomes of higher plants are com-
posed mostly of these repetitive DNA sequences. In
model genomes such as those of Arabidopsis and rice,
efforts are under way to sequence the entire genome.
In larger genomes, such as corn and wheat (about 20-
fold and 100-fold larger than Arabidopsis, respective-
ly), this is not possible. However, it might be possible
to obtain much of the sequence information using var-
ious "skimming" or partial sequencing strategies,
without completely sequencing the genome. We have
explored these strategies in the past for human
genome analysis, and they are even more relevant for
plant genome analysis. The difficulty even more than
with the human genome is that much of the effort in
skimming plant genomes would go into sequencing
repetitive DNA. We have been testing a method that
would remove most of the repetitive DNA from
libraries made from plant genomic DNA. The
libraries were plated in the Martienssen lab on
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Escherichia coli, which restricts methylated DNA.
Since most of the repetitive DNA is highly methylat-
ed, it is not grown on this host. As a control, the same
libraries were plated on E. coli strains containing
mutations in the methylation restriction lines. Our lab
sequenced several hundred clones isolated from each
of the E. coli host strains and worked with the
Martienssen lab to analyze these sequences for their
gene content and repetitive element content. The
results showed that plating on the appropriate host
could reduce the number of clones containing repeats
by 10-20-fold over controls. This approach has con-
siderable promise for sequence-based gene detection
by skimming in plant genomes.
Sequencing of Tumor Suppressor
Deletion Loci
M. de Is Bastide, K. Habermann, L Gnoj, E. Ning Huang,
L. Spiegel, R. Preston, K. Schutz, M.D. Vil, R. Shah,
I. Swaby, A. Matero, M. Rodriguez, M. Shekher, A.
O'Shaughnessy, L. Parnell, N. Dedhia, W.R. McCombie
[in collaboration with R. Lucito, M. Hamaguchi, and
M. Wig ler, Cold Spring Harbor Laboratory]
There are a sizable number of genes whose deletion or
damage creates tumors or modifies their progression.
Many of these are unknown. We have joined an ongo-
ing effort with the Wigler lab to identify and charac-
terize these genes. Using RDA, the Wigler lab has
been mapping these loci in the human genome. We
have begun using our high-throughput DNA sequenc-
ing to assist in identifying and characterizing these
genes. This is being done in several ways depending
on the size of the loci and the other available informa-
tion. In areas where the loci are relatively large, we are
using sequence skimming at low redundancy. This will
potentially identify genes in the area as well as gener-
136
ate sequence data that can be used to further identify
probes from the region to facilitate more precise local-
ization of the region of interest. In better-defined
areas, we are carrying out more complete, finished
sequence. This information then undergoes compre-
hensive analysis to identify genes in the area. Potential
tumor suppressors can then be identified and con-
firmed.
In 1998, we completed the sequencing and analy-
sis of the first of these regions. The tumor suppresser
in this region had been previously identified as PTEN
(Li et al., Science 275: 1943 [1997]). Sequencing of
this region enabled us to obtain the complete genomic
sequence of the PTEN gene. The region sequenced is
about 200 kb. The coding region of PTEN is composed
of nine exons spread over about 110,000 bases. In
addition, there are several other genetic features found
within this region. We are using the region to test
methods for finding genes in genomic sequence at var-
ious levels of sequence coverage. For instance, we
have tested what percentage of the PTEN exons are
found by various computational gene-finding pro-
grams and are testing how those results are effected by
reducing the amount of sequence data available (to
simulate skimming of the region). This will allow us to
implement strategies for the most rapid and efficient
ways to screen large regions of genomic DNA for
putative tumor suppressors.
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COMBINATORIAL LIBRARIES
H.P. Nest ler R. Liu
R. Sherlock
W. Cui (URP)
Combinatorial "One-beadOne-structure" libraries
have opened a new dimension for the study of interac-
tions of small molecules with chemical and biological
ligands. We are employing such encoded combinatori-
al libraries to identify molecules that specifically inter-
fere with the biological function of proteins of physio-
logical importance at specific functional sites. Hereby,
we pursue an approach that outlines a new paradigm
for molecular biology, as we will attempt to prevent a
biological process not by inhibiting the enzyme con-
nected with this process, but by masking the substrate
with a synthetic molecule. The second aspect of our
research is the identification of substrates and subse-
quently of inhibitors of enzymes, especially proteases
and kinases. Binding studies of proteins with mole-
cules in combinatorial libraries are rather straightfor-
ward, but the identification of enzyme substrates is dif-
ficult because of the deactivation of enzymes on most
library supports. Finding new substrates for enzymes
will not only open ways to design compounds inhibit-
ing these enzymes, but also help to elucidate the path-
ways these enzymes are involved in.
Molecular Forceps from
Combinatorial Libraries
That Bind Ras Proteins
R. Liu, R. Sherlock, H.P. Nestler [in collaboration
with D.L. Dong and M.H. Wigler, Cold Spring Harbor
Laboratory]
Our initial studies have shown that simple molecules
displaying two or more short peptide or peptide-like
chains (which we termed "molecular forceps") can
provide reasonable affinities and selectivities toward
peptide substrates. We are using libraries of molecular
forceps to identify molecules that are able to bind to
the carboxyl terminus of Ras proteins (also termed
"CaaX box") and prevent its farnesylation. The fame-
sylation of Ras has been shown to be a crucial step in
the activation of Ras as a signal transduction protein,
and pharmaceutical trials have shown that molecules
which inhibit the farnesyl transferase (FTase), the far-
nesylating enzyme, are able to stop tumor growth. The
approach we follow outlines a new paradigm for mo-
lecular biology, as we will attempt to prevent a biolog-
ical process not by inhibiting the enzyme connected
with this process, but by masking the substrate with a
synthetic molecule. To efficiently target our molecular
forceps toward the carboxyl terminus of Ras, we use
the isolated peptide sequence instead of the whole pro-
tein as substrate for the screening of our libraries. The
molecules selected against the peptide epitope should
bind Ras site-specifically at the CaaX box. Although
precedence exists that antibodies can be raised against
peptide epitopes in this fashion, it is unclear whether
this approach is suitable for the selection of synthetic
molecules. The carboxyl terminus of Ras is a suitable
test case for this novel approach as it is conformation-
ally not restricted and should therefore be readily
accessible for the molecular forceps we intend to gen-
erate.
In our assays of a library that contained two-
armed and four-armed molecular forceps with the
octapeptide derived from the CaaX box of Ras and the
whole Ras protein, we observed molecular forceps
with four peptide arms as interacting molecules. Each
of the molecules that had been selected against the
peptide binds with micromolar affinities selectively to
the Ha-Ras protein, with some specificity over other
proteins such as ovalbumin or bovine serum albumin,
supporting our assumption that we can screen
libraries with isolated peptide epitopes to identify for-
ceps binding to the full-length protein. Furthermore,
two of the peptide binders not only bind to the Ras
protein, but also slow down the farnesylation of Ha-
Ras with IC50 values of 100 gm and 400 ium. None of
the protein binders or of nonbinding forceps prevent
the farnesylation in the micromolar range. These find-
ings suggest that some molecular forceps-although
not all of them-selected for binding to peptide epi-
topes recognize this epitope on the full-length protein,
whereas forceps selected against the protein bind at
other locations of the protein surface. Beyond that,
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the retardation of farnesylation by the stronger acting
forceps is sensitive to the peptide used as substrate for
the FTase: The farnesylation of a peptide derived
from the CaaX box of Ras is inhibited with an IC50 of
100 gm, whereas the farnesylation of a peptide
derived from Ki-Ras B is inhibited with an IC5o
greater than 1 mm (75% farnesylation efficiency at a
concentration of 1 mM) and the farnesylation of a
hybrid peptide is inhibited with an IC50 of approxi-
mately 500 p.m. The farnesylation of a peptide derived
from the carboxyl terminus of lamin B is not affected
at concentrations of up to 1 mM. The same selectivity
pattern is observed using protein substrates for the
farnesylation: The farnesylation of the Ha-Ras pep-
tide is significantly inhibited, whereas the farnesyla-
tion of other substrates is only slightly affected.
These patterns, the correlation of inhibitory activ-
ity with binding strength, and the fact that our forceps
molecules do not bind to the FTase prove that the inhi-
bition is not achieved through inhibition of the
enzyme, but through trapping of the substrate. This
mode of action by a synthetic molecule is without
precedence in the literature and may suggest a new
approach to modulate enzymatic transformations.
nesylation reaction, farnesyl pyrophosphate (FPP) and
the CaaX-containing proteins. Although compounds
that compete with FPP have been used to inhibit
FTase, peptides and peptide mimics that compete with
the protein in the CaaX-box-binding site show more
potential for inhibitory activity and tuning of selectiv-
ity. Structural investigations of substrates and
inhibitors suggest an active conformation containing a
peptide turn. In the course of studies on factors deter-
mining the conformation of peptides, we investigated
peptide-turn-inducing bicyclic lactams. It was our
expectation that the incorporation of the reverse-turn
mimics into an FTase substrate sequence could lead to
potent FTase inhibitors.
When we incorporated the bicyclic lactams as
building blocks into the farnesylation substrate
sequence, we found that molecules with a free amino-
terminal site did not have the expected activity, where-
as molecules carrying a lipophilic group at this site
had activities one order of magnitude weaker than
commercially available inhibitors. Appropriate modi-
fication of the side chains displayed on the lactam
skeleton should allow us to improve the activity of our
inhibitors.
Inhibitors of Ras
Farnesylation
R. Liu, R. Sherlock, H.P. Nestler [in collaboration with
A. Mielgo, C. Scolastico, and C. Gennari, University
di Milano, Italy, and D.L. Dong, Cold Spring Harbor
Laboratory]
Ras proteins have a central role in normal cellular
physiology and pathophysiology and are commonly
found in human tumors. Ras proteins are initially syn-
thesized in the cytoplasm where they undergo a series
of posttranslational modifications at their carboxy-ter-
minal sequence. The processed proteins become local-
ized to the cell membrane, a step that is essential to
their functioning. The farnesylation cascade has been
considered to be a logical target for the development
of cancer therapeutics. In fact, inhibitors of the FTase
can induce morphological reversion of cells trans-
formed by Ras at concentrations that do not arrest nor-
mal cell growth.
Structural studies on the FTase revealed that the
enzyme has two substrate recognition pockets in its
active site to bring together the two partners of the far-
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Substrates and Inhibitors
for Proteases and Kinases
R. Liu, W. Cui, H.P. Nestler [in collaboration with
S. Ressel, U. Piarulli, and C. Gennari, University di
Milano, Italy, and P. Chan and Todd Miller, SUNY,
Stony Brook]
In recent years, the importance of cysteine proteases
for physiological events and the determination of cell
fate have become of major interest. The quest for new
mechanism-based inhibitors of these enzymes yielded
a variety of new structural elements. We have been
investigating a class of peptide analogs, vinylogous
sulfonamides, that contain a functional moiety suitable
for inhibition of cysteine proteases. When we incorpo-
rated these analogs into short peptides, we observed
weak inhibition of cathepsin L, a protease involved in
inflammatory processes. We are now using combina-
torial libraries to find peptide sequences that are pre-
ferred substrates of cathepsin L. Incorporating our
vinylogous sulfonamides into such sequences should
yield potent inhibitors.
Although binding studies of proteins with mole-
cules in combinatorial libraries are rather straightfor-
ward, the identification of enzyme substrates is quite
difficult because of the deactivation of enzymes on
most library supports. Although we observe the bind-
ing of proteins to peptides on commonly used plastic
supports, the proteins seem to precipitate on these sup-
ports and thus are deactivated. Our search for a suitable
support for enzymatic assays led us to controlled pore
glass (CPG) beads, the same material that is used for
oligonucleotide synthesis. We have developed a fluo-
rescence-based assay to identify protease substrates in
encoded "One-bead-One-structure" libraries. We are
also using libraries on the same CPG support to find
substrates for physiologically important tyrosine kinas-
es. For the screening of these libraries, we use an
automicroradiographic screening that we established a
few years ago. The knowledge of the sequence speci-
ficity for these kinases should help to elucidate the cel-
lular substrates by sequence homology.
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SEQUENCED-BASED PREDICTION OF PROTEIN
STRUCTURE AND FUNCTION
A.F. Neuwald A. Poleksic
Our work focuses on the development and application
of computational methods for predicting protein struc-
ture and function from multiple sequence data.
Specifically, this involves the development and opti-
mization of statistical models representing particular
protein families, and the design of procedures based
on these models to detect and align distantly related
sequences. Because the goal of our research is to dis-
cover important biological features of protein
sequences, the development of new methods is close-
ly linked to the analysis of specific protein families or
superfamilies.
Modeling, Detection, and Alignment
of Protein Families
A.F. Neuwald, A. Poleksic
The detection and alignment of structurally and func-
tionally related proteins require a biologically mean-
ingful statistical model of the specific family under
investigation. Conversely, developing such a model
requires an understanding of both the similarities and
the differences between related proteins. For this rea-
son, the design of statistical models has been closely
linked to the study of structural and sequence diver-
gence in various protein superfamilies, such as the
a,(3-hydrolase-fold superfamily, for which about 2000
highly diverse sequences and about 20 distinct struc-
tures are available. This has led to improvements in
database search sensitivity, in multiple sequence align-
ment procedures, and in related methods that aid inter-
pretation of sequence and structural similarities.
Several approaches have been taken to improve the
database search sensitivity of our programs. These
include the incorporation of weighting schemes to
adjust for sequence redundancy, modified log-likeli-
hood scores that model insertions and deletions with-
in and between conserved regions of an alignment, and
the application of a jackknife test for statistical signif-
icance. The jackknife test is important for detecting
and eliminating false positives from an evolving align-
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ment model during automated iterative database
searches (as are used by the PROBE and PSI-BLAST
programs). Measures of statistical significance for
modified log-likelihood scores were devised in collab-
oration with J.L. Spouge at the National Center for
Biotechnology Information (NCBI). To better under-
stand fundamental principles involved in the detection
of distant relationships, an information theoretical
analysis of database search problems was conducted in
collaboration with W.J. Wilbur at the NCBI. This
analysis has led to a measure of statistical significance
for aggregate scores obtained by combining several
individual scores reflecting distinct properties.
Many of the improvements in multiple sequence
alignment procedures involve the design of new Gibbs
sampling operations. Some of these operations are
linked to fundamental changes in the underlying sta-
tistical model. These include sampling of single or
multiple domains within a single polypeptide chain,
sampling of short insertions and deletions within con-
served regions (earlier methods only aligned contigu-
ous sequence blocks), and incorporation of residue
substitution matrices. Other operations help speed up
convergence to an optimal alignment (as defined by
the underlying statistical model) by facilitating escape
from suboptimal alignments. These operations
include, for instance, operations to split and fuse
aligned regions and more efficient recombination
operations within the genetic algorithm component of
Gibbs sampling. These operations function in a man-
ner analogous to that of chemical catalysts, which
drive a reaction to thermodynamic equilibrium by
facilitating escape from kinetic traps.
Other approaches for speeding up the Gibbs sam-
pling procedures were also devised. For example,
"simulated annealing" is now applied after conver-
gence to locate the optimal alignment and, conse-
quently, to better detect subtly conserved patterns in
the sequences. Similarly, machine learning procedures
were implemented to help the program apply the cor-
rect number and sequence of particular sampling oper-
ations. Better assessment of convergence has been
obtained through incorporation of routines to measure
the "distance" between independently generated mul-
tiple alignments. This is needed, given the stochastic
nature of Gibbs sampling procedures, to find the opti-
mum alignment and, consequently, to detect struc-
turally accurate, biologically meaningful sequence
similarities such as described in the example below.
The interpretation of multiple sequence alignment
data was facilitated through development of a statisti-
cally based method for detecting and highlighting con-
served residues within an alignment. This facilitates
identification of patterns having important functional
and structural significance.
The methods described here, although currently
implemented only within our own programs, can also
be incorporated into other procedures. In particular,
we are collaborating with the NCBI to incorporate
related improvements into the PSI-BLAST program.
Thus, although these methods are currently unavail-
able to the biological community, they will eventually
be made available through our own programs (which
have not yet been published or released) and through
the services provided by the NCBI.
Analysis of a Class of
Chaperone-like ATPases
A. Neuwald [in collaboration with
L. Aravind and E.V. Koonin, National
Center for Biotechnology Information, NH]
The methods described in the previous section were
applied (in combination with other computational
approaches) to an analysis of replication factor C
(RFC)-related proteins, which function in the initia-
tion of DNA replication. Included among these is one
protein of known structure, the Escherichia coli DNA
polymerase III 8' subunit (pollIl 6'), which provides
structural information relevant to the family as a
whole. Starting from these proteins, our analysis
resulted in the detection and alignment of many other
distantly related ATPases, collectively designated the
AAA+ class. These include members of the AAA fam-
ily ( ATPases associated with a variety of cellular
activities), whose activities include signal transduc-
tion, cytoskeletal interactions, mitotic spindle forma-
tion, cell cycle control, peroxisome biogenesis, assem-
bly of mitochondrial membrane proteins, protein
degradation by the 26S proteasome, and transcription.
Fortunately, the three-dimensional structure of the
hexameric complex for one of the AAA proteins, the
D2 ATPase module of N-ethylmaleimide-sensitive fac-
tor (NSF), was recently determined, which allowed us
to glean further structural and functional insights into
this class. Our analysis indicates that polIII 8' and
NSF-D2 are structurally related to ATPases involved
in the initiation of DNA replication and transcription,
to Lon and Clp family chaperones, and to other
ATPases (some of which are described below) per-
forming diverse functions.
Many of the AAA+ proteins are known to function
as chaperones and others, although not known to be
chaperones, are nevertheless involved in the assembly
or remodeling of protein complexes. These include,
for example, subunits of the origin recognition com-
plex (ORC), Cdc6, MCM (minichromosome mainte-
nance) DNA licensing factors, and RFC subunits, all
of which are involved in successive steps in the initia-
tion of DNA replication. It is feasible that these pro-
teins possess chaperone-like remodeling activities
considering that known AAA+ chaperones have been
found to be involved in the assembly or initiation of
protein-DNA complexes. For example, the ClpA chap-
erone facilitates binding of the bacteriophage replica-
tion initiator protein RepA to DNA, and the C1pX
chaperone is involved in the initiation of bacterio-
phage Mu DNA replication. Similarly, AAA+ proteins
are also associated with the initiation of transcription.
For example, the bacterial AAA+ protein NtrC activates
transcription from a distant enhancer by remodeling the
closed complex between promoter DNA and RNA poly-
merase to an open complex. Known AAA+ chaperones
have also been associated with transcription.
The functions of other AAA+ proteins are also like-
ly to involve chaperone-like remodeling. For example,
Rubisco activate, which couples ATP hydrolysis to the
release of inhibitory sugar phosphates bound to
Rubisco-active sites, appears to function as a chaper-
one. The dynein motor protein, which transports mem-
branous organelles along microtubules, contains six
AAA+ ATPase modules. This suggests that it may form
an assemblage resembling the NSF D2 hexamer and
that it functions via chaperone-like remodeling.
Our improved procedures allowed construction of
a structurally meaningful sequence alignment of this
diverse class of ATPases. This is illustrated in Figure 1,
which shows our alignment of NSF-D2 versus polIII
8' (Fig. 1A) and the corresponding locations of these
aligned regions in the structures (Fig. 1B). These
regions correspond to two distinct structural compo-
nents: an amino-terminal a,(3 -fold that is generally
similar to other P-loop ATP-binding domains and car-
boxy-terminal structural elements that appear to be
directly associated with chaperone activity (Fig. 1C).
On the basis of the location of bound ATP relative to
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the chaperone-specific component, it appears that
ATP binding or hydrolysis leads to coordinated con-
formational changes required for substrate remodel-
ing. Furthermore, the spiral appearance of the chaper-
one-specific component (center image in Fig. 1C)
suggests that these conformational changes may
involve an inward, twisting motion. Possible mecha-
nisms of action are suggested by comparing con-
served positions in the alignment with residue loca-
tions in the NSF-D2 and polIII 8" structures. This
reveals several highly conserved residue positions that
may function to directly link binding or hydrolysis of
ATP to coordinated conformational changes.
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FIGURE 1 (4) Sequence alignment of the NSF
D2 ATPase module (NSF_CRIGR) with the DNA
polymerase Ill 8' subunit (1A5TX). (8) Locations
of aligned regions in the corresponding struc-
tures. (C) Basic structural components of the
NSF-D2 module. The image on the left corre-
sponds to the a,[3-fold P-loop domain. The cen-
ter image corresponds to chaperone-specific
structural components. The image on the right
corresponds to the complete NSF D2 hexamer-
ic complex.
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STRUCTURAL BIOLOGY
R.-M. Xu J. Jiang H. Shi
M. Hayashi Y. Zhang
K. Hendren (URP)
Our laboratory is concerned with understanding the
molecular mechanism of protein-RNA interactions in
pre-mRNA splicing and the molecular assembly of
multiprotein complexes in DNA replication and cell
cycle regulation. We use X-ray crystallography as our
principal approach to address these questions.
PROTEIN-RNA INTERACTIONS
IN PRE-mRNA SPLICING
Most eukaryotic genes are interrupted by introns. The
primary transcript must be processed to remove the
introns and to join the coding sequence into a contigu-
ous mRNA molecule. Splicing of pre-mRNA involves
an ordered assembly of components, including hetero-
geneous nuclear ribonucleoproteins (hnRNPs), small
nuclear ribonuclear particles (snRNPs), and additional
protein-splicing factors. The current focus in our labo-
ratory is to determine the crystal structure of individ-
ual splicing factors. Our research activities during
1998 are described below.
Structural Studies of hnRNP Al. Human hnRNP Al is
a versatile nucleic-acid-binding protein that has been
shown to be important in various aspects of mRNA
metabolism and in telomere length regulation. We
have previously determined the crystal structure of the
amino-terminal RNA-binding domain of hnRNP Al
(UP1) alone and in complex with telomeric DNA.
These structural studies revealed several unexpected
features: (1) The two RNA-recognition motifs (RRMs)
are antiparallel and held together in a rigid structure
by two salt bridges and (2) specific protein-protein
interaction may be important for sequence-specific
recognition of telomeric DNA. Implication of these
structural findings in pre-mRNA splicing is being
investigated in collaboration with Adrian Krainer here
at the Laboratory. Further structural studies aimed at
understanding the structure and function of the car-
boxy-terminal region of hnRNP Al are currently
being pursued.
SF2-associated Protein p32. We have solved the crys-
tal structure of human p32 at 2.25 A resolution. p32
was originally isolated by copurification with the
nuclear pre-mRNA splicing factor SF2/ASF, with
which it appeared to be associated, although no evi-
dence of a splicing function was obtained. Since the
original study, it has become apparent that p32 is an
evolutionarily conserved eukaryotic protein. In addi-
tion to its ability to bind to SF2/ASF in vitro, many
additional properties or apparent functions of p32 have
been reported. In particular, it can interact with many
viral proteins, including human immunodeficiency
virus type-1 (HIV-1) Tat and Rev, EBNA-1 of Epstein-
Barr virus, ORF P of herpes simplex virus, and core
protein V of adenovirus. Unexpectedly, immunofluo-
rescence and subcellular fractionation studies have
shown that p32 and its yeast homolog localize pre-
dominantly in the mitochondrial matrix. It has been
reported that p32 functions in the maintenance of
mitochondrial oxidative phosphorylation. There is
some evidence that a small fraction of p32 protein
localizes in the nucleus. Furthermore, the distribution
of p32 appears to be altered upon adenovirus infection,
with p32 migrating to the nucleus together with a viral
core protein. These observations suggest that p32 has
a bridging role in nucleus-mitochondrion interactions.
In addition to trying to understand the structure and
function of p32, we are also attempting to use p32 as a
vehicle for the crystallization of pre-mRNA splicing
factor SF2/ASF.
The crystal structure shows that p32 forms a
doughnut-shaped trimer (Fig. 1), with an outer diame-
ter of approximately 75 A, an average inner diameter
of about 20 A, and a thickness of about 30 A.
Interestingly, the protein monombr has a novel fold!
p32 is a very acidic protein: 23% of its residues are
aspartic and glutamic acids. A dramatic feature of the
p32 trimer is that the charge distribution on the protein
surface is highly asymmetric, with a high negative
charge distribution on one side of the doughnut sur-
face and inside the channel. This polarity in charge
distribution clearly suggests asymmetric functional
roles for the two sides of the protein. On the basis of
the structural findings, we propose that p32 may serve
as a high-capacity divalent cation storage protein to
modulate mitochondrial matrix cation concentration.
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Yeast Splicing Factor Prpl8p. Splicing of pre-mRNA
proceeds in two sequential steps. The first step
involves the excision of the 5' exon and the formation
of a lariat intermediate. In the second step, the intron
is cleaved at the 3' splice site and two exons are ligat-
ed together. Both steps require the participation of a
large assembly of RNP particles and protein factors.
Prp 18p from Saccharomyces cerevisiae is associated
with the U5/snRNP and is required for the second step
of the splicing reaction.
We have isolated a large fragment of yeast Prpl8p
by controlled proteolysis. This proteolytic fragment
corresponds to an 79-residue deletion at the amino
terminus of the full-length Prpl8p. The splicing activ-
ity of this fragment is nearly indistinguishable from
the wild-type protein, judging from its ability to
recover splicing activity in Prp 1 8p-depleted yeast
extract. This Prp l8p fragment can readily be crystal-
lized. The recombinant form of this fragment, termed
Prpl8479, crystallized in space group C222, with cell
dimensions of a = 49.94 A, b = 79.17 A, and c =
171.20 A. There are two Prp18479 molecules per
asymmetric unit.
The crystal structure of Prp18479 was solved
using a single Os derivative, and it has been refined to
2.15 A resolution. The refined structure has an R fac-
tor of 20.3% (R-free = 25.2%) and good stereochem-
istry. Prpl8479 forms a compact all-helical structure.
The core of the structure consists of five a helices
packed close together in a way dissimilar to other
structures. Detailed structural analysis is still on-
going, but it is already clear that conserved residues
form a distinct region on the protein surface that are
likely to be important for protein-protein interactions
in pre-mRNA splicing.
MULTIPROTEIN COMPLEXES IN CELL CYCLE
CONTROL OF DNA REPLICATION
Initiation of DNA replication in eukaryotes is a tight-
ly regulated process. Cell-cycle-dependent assembly
of the prereplicative complex (pre-RC) coordinates the
initiation of chromosomal replication with cell cycle
progression. Many essential components of the pre-
RC have been identified and characterized, including
the origin recognition complex (ORC), the minichro-
144
FIGURE 1 Ribbon representation of the p32 trimer, looking
down the noncrystallographic threefold axis. The dotted lines
show disordered segments in the structure. The three
monomers that make up the trimer are colored in different
shades of gray.
mosome maintenance (MCM) complex, and Cdc6p
and Cdc45p. Both ORC and MCM are six-subunit
protein complexes. To understand the molecular mech-
anism of origin recognition and pre-RC formation, we
are pursuing structural studies of several of the pre-RC
components, in collaboration with the Stillman labora-
tory here at Cold Spring Harbor.
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COMMUNITY ACCESS TO GENOME RESOURCES
L.D. Stein
The Human Genome Project and its related model
organism sequencing projects are producing unprece-
dented amounts of information regarding the contents,
structure, and function of the genome. However, with-
out good software tools for storing, analyzing, and
accessing this information, much of it is beyond the
reach of the biological community.
My laboratory is actively developing tools to put
these data at the fingertips of the community, by mak-
ing it accessible via the World Wide Web and by pro-
viding software tools for manipulating and analyzing
the information. Our major achievement during 1998
was the development and release of two interface
libraries for the popular ACEDB database, one written
for the Perl programming language and the other in
Java. Use of these interfaces makes it possible for biol-
ogists to directly access genome data stored in ACEDB
databases, including the complete genomes of yeast and
Caenorhabditis elegans, as well as portions of the
human genome. Genome sequencing and mapping
information from multiple plant crops are also available
in this form, including maize, millet, rice, and barley.
Fortuitously, the completion of the Perl interface
library came just as the sequence of the C. elegans
nematode genome was being completed. In collabora-
tion with the C. elegans sequencing consortium, my
laboratory created a series of Web sites that allows the
community to query, browse, and display this rich data
resource (see URLs http://stein.cshl.org/elegans.html
and http://wormsrvl.sanger.ac.uldcgi-bin/ace/simple/
worm/). These Web pages were made available con-
comitantly with the publication of the paper announc-
ing the completion of the C. elegans sequence in
December 1998. In the first month of use, the pages
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FIGURE 1 Web Browser screen shot of the C. elegans database.
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saw over 60,000 accesses. Figure 1 shows a screen
shot of the database as seen in a Web browser.
During 1999, this work will be extended to create
a community annotation system for the C. elegans
genome and other genomes maintained in ACEDB.
This system will allow interested laboratories to add
comments, corrections, and new information to the C.
elegans sequence, allowing this information to be
shared immediately with the community in electronic
form. We will also be expanding our suite of free
genome analysis tools, which currently includes tools
for building genome maps and for comparing the
genomes of related species.
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COMPUTATIONAL GENOMICS
M.Q. Zhang R. Bari B. Chan
J. Feng J. Tabaska
I. loschikhes J. Zhu
Z. loschikhes
Our research interest continues to be the identifica-
tion and characterization of genetic elements in nucle-
ic acid sequences by computational means. As the
Human Genome Project entered its large-scale
sequencing phase, the development of efficient com-
putational methods for identification of genes and
their control/regulatory elements has become
extremely important. Knowing the organization of a
gene often becomes the prerequisite for further func-
tional studies. We have previously studied statistical
characteristics of exons and introns in protein-coding
regions and developed coding-exon prediction pro-
grams by applying multivariate statistical pattern-
recognition techniques. This year, we began to focus
on splicing enhancers, promoters, and transcriptional
start site and polyadenylation site regions in order to
develop new computational methods for identifica-
tion of these functional elements. In addition to struc-
tural genomics, we have also started looking into
functional genomics where genome-wide expression
data analysis has become our new challenge.
B. Chan returned to Harvard to continue work on
his Ph.D. thesis in Tom Maniatis' laboratory, and J.
Feng found a job at the American Physical Society. J.
Zhu joined our laboratory from Georgia Tech., and R.
Bari moved over from Holly Cline's laboratory as a
part-time student; she has been helping all of the post-
doctoral fellows with their research projects.
Continuation of Spi and CCAAT
Site-containing Promoter
Data Collection
I. loshikhes, J. Feng, M.O. Zhang
This approach to promoter analysis is based on study-
ing experimentally obtained distributions of promoter
sequence elements. Since collection and annotation of
the complete 5" sequence database are very labor-
intensive, we decided to begin by collecting smaller
databases that are structurally homogeneous (promot-
ers containing certain transcription factor elements
[TFEs] simultaneously). We extended the analysis of
the promoters containing the E2F /Sp 1 transcription
factor pair to other transcription factors, such as
Sp 1 /NF-Y or, in a more general case, Sp 1 /CCAAT
motifs. A database for a specific family of promoters is
being built to facilitate statistical analysis. The data-
base is close to completion and will be presented at our
group Web site. We are currently completing a full
annotation and will be making an exhaustive analysis
of this database. We will use the neural network and
other approaches for its analysis. Our goal is to use sig-
nificant spatial correlation of specific transcription fac-
tor sites as a robust criterion for identification of func-
tional promoters and for screening new genes under
similar regulatory pathways. The database is accessible
from http://www.cshl.org/mzhanglab/.
Periodical Distribution of
Transcription Factor Sites in
Promoter Regions and Connection
with Chromatin Structure
I. loshikhes, M.Q. Zhang [in collaboration
with E.N. Trifonov, Weizmann Institute]
Nucleosomes regulate transcriptional initiation when
positioned in the promoter area. This may require cor-
relation of transcription factor (TF) sites with nucleo-
some positions and phasing on the nucleosome surface.
If this is the case, a periodic distribution of TF sites
would be expected in the vicinity of promoters, with a
nucleosomal period of 10.1-10.5 bp. We examined the
distributions of putative binding sites of 323 different
TFs on 1057 sequences of the Eukaryotic Promoter
Database (EPD) (release 50) (Perier et al., Nucleic Acids
Res. 26: 353 [1998]) and of 218 TFs on 673 sequences
of the Lead Exon Database (LEDB) of human promot-
er sequences (Zhang 1998). We obtained a statistically
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significant overrepresentation of TF sites distributed
with a main period of 10.1-10.5 by in the region 50 to
+120 around the transcription start site and in a few
locations nearby. Correlation of the positioning of TF
sites with the nucleosomes is further reinforced by
sequence-directed mapping of the nucleosomes, a
method developed previously (Ioshikhes et al., J. Mol.
Biol. 262: 129 [1996]).
Computational Identification of the
Polyadenylation Site and the
Last Exon of Human Genes
J. Tabaska, M.Q. Zhang
To expand the MZEF internal coding exon-finding
program into a complete gene prediction system, we
are developing a 3 "-terminal exon detection module.
As an intermediate step toward this goal, we have
compiled a database of human poly(A) signal regions
and have produced a program for prediction of human
poly(A) signals. Stand-alone 3 "-terminal exon recog-
nition presents some special challenges, especially
with regard to detection of the 3' end of the gene. Most
gene-finding programs-which generally attempt to
simultaneously predict all of the exons in a gene-
simply define the 3' end as the first stop codon in the
reading frame that extends through the predicted
exons. When trying to find the 3 '-terminal exon alone,
as we are trying to do, there is generally too little cod-
ing information present to accurately determine the
location of the stop codon. We are therefore using
poly(A) signals, rather than stop codons, as markers
for gene 3' ends. The potential advantage is that our
predicted genes will include information about mRNA
3 '-untranslated regions, which are known to contain
posttranscriptional regulatory signals.
Development of our 3 "-terminal exon finder thus
began with a study of poly(A) signals. To ensure that
we were using the best possible data, we collected
polyadenylated human expressed sequence tag (EST)
sequences and matched them with known gene
sequences. The resulting database of genes with
known poly(A) sites was then used to train quadratic
discriminant functions (QDFs) for poly(A) signal
detection. These QDFs are implemented in our pro-
gram, polyadq. In tests, polyadq substantially outper-
forms other poly(A) signal-finding programs.
Work is now under way to combine the poly(A)
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signal capablities of polyadq with a splice acceptor
site QDF to produce a 3 "-terminal exon-finding pro-
gram. We are also compiling data on mouse 3 '-termi-
nal exons to produce poly(A) signal and terminal
exon-finding programs for this organism.
SCPD: A Promoter Database of Yeast
Saccharomyces cerevisiae
J. Zhu, M.O. Zhang
To facilitate the study of yeast S. cerevisiae promoters
on a genome scale, we have developed a yeast promot-
er database (SCPD), which collects two types of infor-
mation, the experimentally mapped transcriptional fac-
tors' binding sites (TF) and transcriptional start sites
(TSS). It also contains information on binding affinity
and gene expression. Currently, SCPD contains 580 TF
sites and 500 TSS. In addition, it provides a variety of
computational tools: Retrieve promoter sequences,
Search existing motif, Search putative regulatory ele-
ments, Group genes according to their function cate-
gories, K-tuple relative information, and Motif distribu-
tion. All programs work with multiple sequences. SCPD
is accessible at http://www.cshl.org/mzhanglab/
Identification of Cell-cycle-regulated
Genes and Promoter Elements
in Yeast S. cerevisiae
M.O. Zhang [in collaboration with the Futcher Lab,
Cold Spring Harbor Laboratory, and the Brown/Botstein
Labs, Stanford]
We wanted to create a comprehensive catalog of yeast
genes whose transcript levels vary periodically within
the cell cycle. We used DNA microarrays and samples
from yeast cultures synchronized by three independent
methods: a-factor arrest, elutriation, and arrest of a
cdc15 temperature-sensitive mutant. Using periodicity
and correlation algorithms, we identified 800 genes that
meet an objective minimum criterion for cell cycle reg-
ulation. In separate experiments designed to examine
the effects of inducing either the G1 cyclin Cln3p or the
B-type cyclin C1b2p, we found that the mRNA levels of
more than half of these 800 genes respond to one or both
of these cyclins. Furthermore, we analyzed our set of
cell-cycle-regulated genes for known and novel promot-
er elements and showed that several elements (or varia-
tions thereof) contain information predictive of cell
cycle regulation. A full description and complete data
sets are available at http: / /wwwcshl.org /mzhanglab /.
Computational Analysis
of Intronic Elements Involved
in Alternative Splicing
B. Chan, M.Q. Zhang
Alternative splicing allows various isoforms of a gene
to be produced from the same pre-mRNA transcript,
and it is often associated with suboptimal splice sites;
the reduced affinity of these sites for the splicing
machinery allows neighboring splice sites to compete.
Alternative splicing is regulated by a number of splic-
ing factors that bind to specific RNA sequences
known as enhancers. Splicing enhancers are found in
both exons and introns. The majority of existing
research has focused on the exons, but intronic ele-
ments have recently been emphasized as well, and
enhancers located in introns are not restrained like
their exonic counterparts by a need to avoid disrupting
a protein-coding sequence. This study focused on
intronic splicing enhancers. After the compilation, a
dual approach was followed: We first searched for new
instances of a published element using (1) the weight
matrix method and (2) the repeat detection method and
then we identified putative novel splicing enhancer
elements in Genbank. This work will be continued as
a Ph.D. thesis project in Tom Maniatis' laboratory at
Harvard; the computer program developed is still
being tested, and some putative enhancer elements will
be followed up by experimental verification.
Identification of Functional Exonic
Splicing Enhancer Motifs Recognized
by Individual SR Proteins
M.Q. Zhang [in collaboration with H.-X. Liu and
A.R. Krainer, at Cold Spring Harbor Laboratory]
Using an in vitro randomization and functional selec-
tion procedure, we have identified three novel classes
of exonic splicing enhancers (ESEs) recognized by
human SF2/ASF, SRp40, and SRp55, respectively.
These ESEs are functional in splicing and are highly
specific. For SF2/ASF and SRp55, in most cases, only
the cognate SR protein efficiently recognizes an ESE
and activates splicing. In contrast, the SRp40-selected
ESEs function with either SRp40 or SRp55, but not
with SF2/ASF. UV cross-linking/competition and
immunoprecipitation experiments showed that SR pro-
teins recognize their cognate ESEs in a nuclear extract
by direct and specific binding. A motif search algo-
rithm was used to derive consensus sequences for
ESEs recognized by these SR proteins. Each SR pro-
tein yielded a distinct five- to seven-nucleotide degen-
erate consensus. These three consensus sequences
occur at higher frequencies in exons than in introns
and may thus help define exon-intron boundaries; they
occur in clusters within regions corresponding to nat-
urally occurring mapped ESEs. We conclude that a
remarkably diverse set of sequences can function as
ESEs. The degeneracy of these motifs is consistent
with the fact that exonic enhancers evolved within
extremely diverse protein-coding sequences and are
recognized by a small number of SR proteins that bind
RNA with limited sequence specificity.
Construction of the Web
Service for Multiple DNA
Sequence Alignment Tools
Z. loschikhes, M.Q. Zhang
To support our group as well as CSHL scientists for
multiple DNA sequence alignment needs, a suite of
computer programs is provided on the Internet which
may be accessed at http://www.cshl.org/mzhanglab/.
The following three programs are implemented on our
local machine: (1) neural networks for multiple align-
ment of binding sites (Heumann et al., Intelligent Sys.
Mol. Biol. 2: 1884 [1994]); (2) Original Gibbs Motif
and Sites Samplers (the Gibbs Sampler stochastically
examines candidate alignments in an effort to find the
best alignment as measured by the maximum a poste-
riori log-likelihood ratio); and (3) Consensus and
WConsensus programs (see Hertz, Comput. AppL
Biosci. 6: 81 [1990]). A fourth program, MIME
(Bailey and Elkan, Mach. Learn. 21: 51 [1990]), is
provided as a hot link. These programs determine con-
149
sensus patterns in unaligned sequences. The algorithm
is based on a matrix representation of a consensus pat-
tern.
GibbsDNA Sites and Motif Samplers for DNA
sequence analysis have been developed on the basis of
the original program, taking into account specific
sequence features of DNA that differ from protein
sequences. These features have been reflected in the
following program options:
1. Including both strands of DNA as a single sequence
allows searching for a common pattern on either
direct or reverse complementary DNA strands.
2. Including both strands of DNA as separate
sequences allows searching for common pattern on
both the strands simultaneously.
3. Aligning motifs that cannot contain words allows
excluding certain words (oligonucleotide motifs)
from the pattern being searched.
4. Aligning motifs that must contain a word allows
searching only for those motifs that are including
certain word.
5. Assuming that the pattern is symmetrical is a fea-
ture designed specifically for search of palindrome
motifs only.
6. Setting distance (or distance range) between two
motifs allows simultaneous search of two motifs
separated by a certain distance.
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NEUROSCIENCE
Over the last half century, neuroscience research has been dominated by cellular studies. Technical
advances in electrophysiological recording and cellular imaging have yielded important biological
insights to developmental programs, synaptic transmission, neurotransmitter receptors, ion channels,
action potentials, intracellular signaling pathways, and gene regulation. Most of the major discoveries,
in fact, have been made.
The next frontier of neuroscience lies in integrative approaches: Gene function must be integrated
with cells, cellular function with circuits, circuit function with neural systems, system function with
behavior. How can this be accomplished? One approach is via genetic analysis. By manipulating
genetic variants experimentally as independent variables, causal inferences can be drawn to depen-
dent measures at various levels of analysis. Such a "vertical integration" allows us to "connect the dots"
from gene function to biochemistry, cell biology, neuroanatomy and behavior-at any developmental
stage.
As cellular neuroscientists become interested in the biological bases of learning and memory, they
have focused on the study of molecular mechanisms of synaptic plasticity. From a neurogenetic per-
spective, however, a broader question can be asked. What genes in the human genome, when mutat-
ed, give rise to learning/memory disabilities? An adequate answer to this question wit include the iden-
tification of (1) genes involved in cellular mechanisms of synaptic plasticity, (2) genes involved in the
development of underlying neuronal architecture, and (3) genes involved in both neurodevelopment
and neuronal function.
At the heart of this neurogenetic perspective is gene discovery, which now is driven with increasing
force by the genome project(s) and the use of genetically amenable model systems. For the next few
years, much of this effort will appear factory-like. Brute force will be required to identify genes and to
connect them to particular biological functions. As more and more genes are "put on the table," how-
ever, vertical integration will accelerate and Kuhnian insight will emerge. With such comprehensive
knowledge of brain function, an understanding of the biological bases of cognitive dysfunction will be
within our grasp and effective therapies will emerge.
Neuroscience Entrance
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ACTIVITY-DEPENDENT NEURONAL DEVELOPMENT
H.T. Cline K. Bronson A. Javaherian
I. Cantallops J. Jay
I. Cohen Z. Li
L. Foa I. Mahapatra
K. Haas (Eton Student)
E. Nedivi
J. Newman
I. Rajan
D. Rosa
The role of neuronal activity in shaping circuits
within the brain has been apparent since the pio-
neering work of Hubei and Weisel, who demonstrat-
ed that visual experience governs the formation of
synaptic connections within the mammalian visual
cortex. Despite the widespread recognition that the
developing brain can be influenced by activity, we
have little understanding of how neurons translate
"experience" into modified neuronal structure or
changes in synaptic strength. The focus of my labo-
ratory is to determine the cellular mechanisms by
which neuronal activity controls central nervous sys-
tem (CNS) development and plasticity. We address
this question using the retinotectal projection of the
frog. We have applied several analytical approaches
to the retinotectal system that allow us to assess and
manipulate the coordinated development of neuronal
morphology and synaptic function in the CNS. One
approach is to use in vivo imaging during periods of
up to 5 days of retinal axons or tectal neurons
labeled with a fluorescent lipophilic dye, DiI. A sec-
ond approach is to use a whole-brain preparation to
take patch-clamp recordings from optic tectal neu-
rons at different stages of maturation. A third
approach is to use viral vectors to deliver genes of
interest into postmitotic frog neurons.
Control of Visual System
Plasticity by CaMKII
G.-Y. Wu, D.J. Zou, D. Rosa, E. Ruthazer,
K. Bronson, H.T. Cline
Developing neurons coordinate their morphological
and functional development. We showed previously
that calcium/calmodulin protein kinase type II
(CaMKII) activity is sufficient to promote the matu-
ration of retinotectal glutamatergic synapses in
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E. Ruthazer
W.C. Sin
G.-Y. Wu
D.-J. Zou
Xenopus. G.-Y. Wu tested whether CaMKII activity
also controls morphological maturation of optic tectal
neurons using in vivo time-lapse imaging of single
neurons during periods of up to 5 days. We divided
morphological development of tectal cells into three
stages: Stage 1 neurons are newly differentiated, and
they undergo axonogenesis with little elaboration of
the dendritic arbor. Stage 2 neurons are in a phase of
rapid dendritic growth. Stage 3 is a period of slower
dendritic arbor growth. Short-interval observation
indicates that stage-2 neurons are more dynamic than
more mature stage-3 neurons.
CaMKII expression in tectal neurons correlates
with the transition from rapidly growing stage-2 neu-
rons to more stable stage-3 neurons. Elevating
CaMKII activity in young neurons by viral expres-
sion of constitutively active CaMKII slowed dendrit-
ic growth to a rate comparable to that of mature neu-
rons. CaMKII overexpression stabilized dendritic
structure in more mature neurons, whereas pharma-
cological CaMKII inhibition increased their dendrit-
ic growth.
D.-J. Zou tested whether endogenous CaMKII
activity in postsynaptic tectal cells regulates the elab-
oration of neuronal processes in the Xenopus tadpole
retinotectal projection. He selectively infected post-
synaptic tectal cells with recombinant vaccinia virus-
es that express CaMKII-specific inhibitory peptides.
Using in vivo time-lapse imaging, he found that
expression of CaMKII inhibitor peptides in postsy-
naptic tectal cells increased the elaboration of both
tectal cell processes and presynaptic retinotectal axon
arbors. The results suggest that endogenous postsy-
naptic CaMKII activity regulates the coordinated
development of pre- and postsynaptic arbor struc-
tures.
To test the role of CaMKII in brain plasticity fur-
ther, E. Ruthazer will determine whether CaMKII is
necessary and sufficient for the development and
maintenance of the retinotopic map within the optic
tectum.
Role of Glutamate Receptor
Activity in the Development of
Tectal Cell Dendrites In Vivo
I. Rajan, K. Bronson, H.T. Cline
Glutamatergic retinotectal inputs mediated principally
by N-methyl-p-aspartate (NMDA) receptors can be
recorded from optic tectal neurons early during their
morphological development in Xenopus tadpoles. As
tectal cell dendrites elaborate, retinotectal synaptic
responses acquire an a-amino-3-hydroxy-5-methyl-4-
isoxazole (AMPA)-receptor-mediated synaptic com-
ponent in addition to the NMDA component. I. Rajan
tested whether glutamatergic activity was required for
the elaboration of dendritic arbors in Xenopus optic
tectal neurons. Using in vivo time-lapse imaging of
single DiI-labeled neurons, she showed that the
NMDA receptor (NMDA-R) antagonist, amino phos-
phono valeric acid (APV), blocked the early develop-
ment of the tectal cell dendritic arbor, whereas the
AMPA receptor (AMPA-R) antagonist, CNQX, or the
sodium channel blocker, TTX, did not. The decreased
dendritic development is due to failure to add new
branches and extend preexisting branches. These
observations indicate that NMDA-type glutamatergic
activity promotes the initial development of the den-
dritic arbor. At later stages of tectal neuron develop-
ment, when AMPA-R-mediated synaptic transmission
is strong, both APV and CNQX decrease dendritic
arbor branch length, consistent with a role for gluta-
matergic synaptic transmission in maintaining dendrit-
ic arbor structure. These results indicate that AMPA-R
and NMDA-R can differentially influence dendritic
growth at different stages of neuronal development,
correlating with changes in the relative contribution of
the receptor subtype to synaptic transmission.
Role of Glutamate Receptor Activity
in the Development of Tectal
Cell Dendrites and Retinal
Axons In Vivo
I. Rajan, K. Bronson, H.T. Cline
Previous studies suggested that blocking retinotectal
synaptic activity might increase the elaboration of
retinal axon arbors, whereas the experiments men-
tioned above indicate that blocking rectinotectal
synaptic activity can limit elaboration of the dendritic
arbor. I. Rajan investigated the role of NMDA-R
activity in the formation of both the presynaptic axon
arbor and postsynaptic dendritic arbors in vivo by tak-
ing time-lapse confocal images of single DiI-labeled
Xenopus retinotectal axons and optic tectal neurons in
the presence and absence of the NMDA-R antagonist,
APV. Retinotectal axons or tectal neurons were
imaged at 30-minute intervals over 2 hours or twice
during a 24-hour period. Retinal axons in animals
exposed to APV in rearing solution show an increase
in rates of branch additions and a decrease in branch
lifetimes compared to untreated axons. Under the
same experimental conditions, tectal neurons show a
decreased rate of branchtip additions and retractions
and a decrease in branch lifetimes. APV treatment
over 24 hours had no apparent effect on axon arbor
morphology, but it did decrease tectal cell dendritic
development. These observations indicate that
NMDA-R activity in postsynaptic neurons promotes
the initial development of the dendritic arbor and sta-
bilizes presynaptic axon arbor morphology.
Regulation of Dendritic
Morphology by RhoA GTPases
Z. Li, W.C. Sin, H.T. Cline [in collaboration with
L Van Aelst, Cold Spring Harbor Laboratory]
The Rho family of small GTPases regulates actin
cytoskeletal structure. To test whether this family of
proteins affects neuronal structure during brain devel-
opment in vivo, Z. Li and W.C. Sin have expressed
dominant negative and constitutively active forms of
the Rho GTPases in tectal neurons using vaccinia
virus. In vivo imaging of single neurons shows that the
three GTPases, Rac, Rho, and Cdc42, all affect neu-
ronal structure in distinct ways. We will continue these
studies to determine the signaling pathways control-
ling neuronal structural plasticity.
Candidate Plasticity
Genes
I. Cantallops, L. Foa, K. Haas, J. Jay, E. Nedivi,
J. Newman, I. Rajan, H.T. Cline, K. Bronson,
G.-Y. Wu [in collaboration with P. Worley,
Johns Hopkins University]
Our experiments have demonstrated the important role
of synaptic activity in promoting the development of
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the brain. One potential effect of synaptic activity is to
induce gene transcription. The activity-induced genes
may then promote the further development of the
brain. We have begun to investigate the potential func-
tion of two activity-induced genes cpg15 and homer in
brain development.
CPG15, a GPI-linked Signaling
Molecule Induced by Synaptic
Activity, Promotes Dendritic
Growth In Vivo
E. Nedivi, G.-Y. Wu, K. Bronson, H.T. Cline
During CNS development, intricate connections
between neurons are established with remarkable
accuracy. Activity-independent and activity-depen-
dent processes work in concert to guide afferent and
efferent processes to their appropriate synaptic part-
ners. E. Nedivi and G.-T. Wu showed that CPG15, a
novel protein identified in a differential screen for
genes regulated by synaptic activity, functions as a
new growth factor. Using time-lapse imaging and
virally mediated gene transfer, they demonstrated that
CPG15 promotes dendritic arbor growth in vivo.
CPG15 accelerates the growth of projection neurons,
but has no effect on the growth rate of interneurons.
They further showed that CPG15, a GPI-linked pro-
tein, controls growth of neighboring neurons through
an intercellular signaling mechanism. Thus, CPG15 is
a signaling molecule capable of translating neuronal
activity into structural changes. Our findings posit the
existence of a new class of activity-regulated growth
factors, which by virtue of being membrane-bound,
may permit exquisite spatial and temporal control of
neuronal growth.
cpg15 Expression in Tectal Cell
Increases Presynaptic Retinal
Axon Arbor Growth In Vivo
I. Cantallops, K. Bronson, H.T. Cline
I. Cantallops tested the effect of tectal cell overexpres-
sion of cpg15 on the development of retinotectal
axons. She showed that viral expression of cpg15 in
postsynaptic neurons increases the elaboration of
presynaptic retinal axons in vivo. These results concur
with the experiments done by E. Nedivi and G.-Y. Wu
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documenting the effects of cpg15 expression of tectal
cell dendritic arbor development. The results suggest
that CPG15 may be one of the mediators of activity-
dependent developmental plasticity.
CPG15 Promotes Maturation
of Retinotectal Synapses
K. Haas, H.T. Cline
The studies mentioned above indicate that CPG15
increases the morphological complexity of pre- and
postsynaptic neurons in the visual system. To test
whether CPG15 affects the development of electro-
physiological properties of the visual system, K. Haas
took whole-cell recordings from tectal neurons of ani-
mals infected with vaccinia virus expressing CPG15.
He found that expression of CPG15 resulted in
increased strength of glutamatergic retinotectal synap-
tic transmission. CPG15 promoted the maturation of
glutamateric synapses in immature neurons.
Expression of the truncated form of CPG15 lacking
the GPI consensus sequence reduced the strength of
synaptic transmission and prevented the normal matu-
rational program seen in glutamatergic synapses from
control animals.
Developmental Regulation of cpg15
Gene and Protein Expression
A. Javaherian, E. Nedivi, J. Jay, H.T. Cline
To continue our analysis of CPG15 function in the
developing nervous system, A. Javaherian cloned
cpg15 from Xenopus. The gene from Xenopus is high-
ly homologous to cpg15 from rat, cat, and humans.
Comparison of the gene from Xenopus with mam-
malian species will allow us to test the function of
conserved regions of the protein, under the assump-
tion that the conserved domains are required for
CPG15 function. In situ hybridization and antibody
labeling were used to determine the developmental
time course and distribution of CPG15 expression in
the tadpole nervous system. The cpg15 message is
highly expressed in retinal ganglion cells, but no other
cells in the retina; however, the protein appears to be
preferentially targeted to the axons of retinal ganglion
cells. Within the brain, the cpg15 message and protein
are widely expressed in differentiated neurons.
CPG15 protein expression is barely detectable in
brains of adult frogs, indicating that it is developmen-
tally regulated.
Analysis of Aberrant Axon
Trajectories in Homer
Expressing Neurons
I. Rajan, J. Jay, J. Newman, L Foa, H.T. Cline
[in collaboration with P. Worley, Johns Hopkins]
homer is an activity-regulated gene induced in the hip-
pocampus of rodents. To study the potential function
of Homer in developmental plasticity, J. Jay and I.
Rajan labeled the tadpole brain with antibodies against
Homer. Homer is widely expressed throughout the
developing nervous system. Injection of kainic acid,
an analog of glutamate, increased Homer expression in
tadpole brains. J. Newman and L. Foa have worked to
clone the Xenopus homolog of homer. I. Rajan used
vaccinia virus to express Homer in the brains of
Xenopus tadpoles, combined with in vivo imaging of
single neurons to test whether Homer expression mod-
ified neuronal morphological development. Axon
guidance, as opposed to synaptogenesis, has been con-
sidered activity-independent. It therefore came as a
surprise to find that expression of Homer resulted in
stereotyped errors in axon guidance in tectal neurons.
Dendrites appeared to be normal. The data suggest that
homer, an activity-regulated gene, may be involved in
the early stages of axonal guidance in Xenopus.
Homer's association with mGluR1/5a and their cou-
pling to IP3/Ca2+ signal transduction suggest potential
mechanisms by which this protein causes enhance-
ment of aberrant axon trajectories.
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SIGNAL TRANSDUCTION AND DIFFERENTIATION
G. Enikolopov J. Hemish J. Mignone R. Rajagopal
S. John N. Nakaya V. Scheinker
P. Krasnov M. Packer Y. Stasiv
T. Michurina N. Peunova
The main interest of our laboratory remains the signals
that link cell activity with cell differentiation. We
focus on the role of nitric oxide (NO), a multifunc-
tional second messenger, in tissue differentiation and
organism development. Within the last several years,
we found that NO acts as an essential negative regula-
tor of cell proliferation in developing tissue, contribut-
ing to the control of organ size. We now study the role
of NO in several systems of animal development,
focusing on the genetic and molecular interactions of
NO with the major pathways that control cell prolifer-
ation and differentiation.
Search for Genes Activated
by NO
N. Nakaya
Although the physiological function of NO in the
organism has been studied in much detail, very little is
known about the transcriptional targets of NO. We
decided to search for genes whose transcription is
affected by short- or long-term NO signaling.
We used four approaches to isolate NO-induced
genes: suppressive subtractive hybridization (SSH),
selective amplification via biotin- and restriction-medi-
ated enrichment (SABRE), immobilized cDNA arrays
of several hundred identified genes (Atlas Gene
Expression Arrays, Clontech), and arrays of 18,024
genes from the IMAGE project (Gene Discovery
Arrays, Genome Systems). Attempts with SSH and
gene arrays were particularly successful, and we have
identified more than 100 genes whose transcription
was induced or suppressed in response to NO. For
many genes, the changes were confirmed by Northern
or reverse transcriptase-polymerase chain reaction
(RT-PCR) analysis. Among these NO-dependent genes,
we found new genes and previously identified genes.
Importantly, many genes were isolated in all four
screening procedures, supporting the feasibility of this
approach. Of most importance, some NO-activated
genes fall into distinct groups, revealing signaling cas-
156
cades necessary for various physiological functions of
the cell. Although some of these groups were anticipat-
ed (stress response genes, cell-cycle-related genes,
transcription factors), some were not and provided
unforeseen insights to the nature of NO activity in the
cell (genes related to cell adhesion, G-protein signal-
ing, cytoskeleton, chemokine receptors, etc.). Thus, we
were able to consider the action of NO in terms of par-
ticular cellular functions and signaling cascades, rather
than induction of individual genes. For instance, obser-
vation of several targets of p53 induced in response to
NO gave us a direct indication to search for functional
interactions between NO and p53. Indeed, in collabora-
tion with Scott Lowe here at the Laboratory, we found
that p53-/- mouse embryonal fibroblasts do not respond
to NO by induction of these target genes and are com-
promised in their ability to stop dividing in response to
NO, that the p53 protein is accumulated in cells after
exposure to NO, and that the p53 molecule undergoes
characteristic posttranslational modifications in
response to NO. We use the results of the screen to
identify specific components of the cell cycle machin-
ery that are activated by the NO signals.
Structure and Expression of
the Xenopus NOS Gene
V. Scheinker, Y. Stasiv, N. Peunova
Using highly conserved regions from mammalian and
Drosophila nitric oxide synthase (NOS) genes as
probes, we cloned NOS cDNA from a Xenopus tad-
pole cDNA library. The nucleotide and deduced amino
acid sequences of the cloned XNOSJ gene show the
highest similarity to the neuronal isoform of mam-
malian NOS.
The deduced XN0S1 protein contains the deter-
minants which are crucial for NOS activity, including
regions for binding FMN, FAD, NADPH, tetrahydro-
biopterin, heme, and calmodulin, and a consensus site
for phosphorylation by cAMP-dependent protein
kinase. The amino terminus of XN0S1 contains a
PDZ motif which is crucial for association with PDZ
domains of other proteins. When expressed in cultured
cells, XNOS1 cDNA produced a polypeptide of the
expected size of 160 la similar to mammalian neu-
ronal NOS and NOS from the frog brain. XN0S1 gen-
erated NO with high efficiency after transfection in
cultured cells. Production of NO was dependent on the
presence of calcium, calmodulin, and NADPH and
was completely blocked by application of specific
inhibitors of NOS.
In situ hybridization with the XNOS1 probe shows
that XNOS1 RNA is present in the tadpole brain in a
distinct pattern in neuron cell bodies in the optic tec-
turn, thalamus, telencephalon, and spinal cord.
Antibody staining showed the presence of XNOS1 in
the cell bodies and processes in the tadpole brain.
Together, the gene structure, enzymatic properties, and
distribution of XN0S1 indicate that we have cloned the
ortholog of the mammalian neuronal isoform of NOS.
NO Is an Essential Negative
Regulator of Cell Proliferation
in Xenopus Brain
N. Peunova [in collaboration with H.T. Cline,
Cold Spring Harbor Laboratory]
NO can suppress DNA synthesis and cell proliferation
in cultured cells and in Drosophila imaginal discs. To
examine the role of NO in vertebrate organogenesis,
we studied the antiproliferative activity of NO syn-
thase on brain development in Xenopus laevis. We
used histochemical staining and in situ hybridization
of a cloned neuronal isoform of Xenopus NOS
(XNOS1; see previous section) to identify its expres-
sion pattern in the developing brain. We found that a
zone of NOS-positive neurons lies adjacent to the zone
of dividing neuronal precursors, suggesting that NO
may be involved in cessation of proliferation of neu-
ronal precursors. To test whether NO is essential for
cell cycle arrest in Xenopus brain development, we
introduced a polymer matrix impregnated with NOS
inhibitors into the ventricle of the tadpole brain. These
implants resulted in a dramatic increase in the number
of proliferating cells in the tectum area and a net
increase in the overall size of the tadpole brain. Using
specific antibodies as markers of neuronal develop-
ment, we found that the organization of the brain was
grossly perturbed by excess proliferation of precursors
that differentiated after NOS inhibitors were applied.
Neurons that differentiated before application of NOS
inhibitors appeared to be unaffected. Our results indi-
cate that NO is an important negative regulator of cell
proliferation during normal Xenopus tadpole brain
development.
Transgenic Mice Expressing
nNOS in the Adult Brain
M. Packer, S. John
We have developed transgenic mice overexpressing
the neuronal nitric oxide synthase (nNOS) gene under
the control of the calcium/calmodulin kinase Ike pro-
moter. This promoter gives strong expression of the
transgene from postnatal day 12 in specific regions of
the fully formed brain of the mouse. This has the
advantage that normal development of the brain will
not be potentially affected by expression of the trans-
gene. Spatial expression of the transgene is also an
advantage because we can then follow the fate of spe-
cific cell types.
Full characterization of the nine lines of transgenic
mice by PCR, RT-PCR, Northern blotting, in situ
hybridization, histochemical and immunohistochemi-
cal staining, and NOS activity assay has shown that six
of the nine lines express the nNOS transgene in the
expected areas of the brain and that this expression
continues in mice until at least 35 weeks of age.
Phenotypically, these mice appear to be normal at a
gross level.
We plan to use these mice to study the differentia-
tion process of neural progenitor cells in the adult
mouse brain. Two areas exist in the rodent brain where
neurogenesis continues into adulthood. One of these
areas, in particular, the subgranular zone of the dentate
gyrus of the hippocampus, is a region where we get
very high expression of our transgenic nNOS protein.
These mice therefore are good models to test the role
of NO in the control of proliferation and subsequent
differentiation of these cells.
NO in the Developing Brain
J. Mignone
Antiproliferative properties of NO are used by the
organism to control the cell number during differenti-
ation and development. Numerous data indicate that
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NO may have a similar role during mammalian brain
development. We want to address this question by gen-
erating transgenic mice that express NOS genes in the
developing brain. We created bicistronic constructs
which express different isoforms of NOS and reporter
genes under the control of general and neuron-specif-
ic promoters and tested their activity in cultured cells.
We are now introducing these recombinants in the
germ line and will search for changes in the prolifera-
tion patterns of neuronal precursors and distribution of
early neuronal markers.
Molecular Mechanisms of NO
Synthesis during Drosophila
Development
Y. Stasiv, R. Rajagopal [in collaboration with
M. Regulski and T. Tully, Cold Spring Harbor Laboratory]
Molecular characterization of the Drosophila NOS
locus shows that DNOS1 mRNA which encodes
Drosophila NO synthase is dispersed over a minimum
40 kb of genomic DNA and consists of at least 20
exons with translation initiation and termination in
exon 3 and exon 20, respectively. Previous studies in
mammals demonstrated that several forms of nNOS
mRNA are generated due to alternative splicing. We
found that this mechanism of NOS regulation is pres-
ent in Drosophila as well: Numerous alternatively
spliced transcripts of DNOS were identified using RT-
PCR and screening of cDNA libraries. In one of the
alternatively spliced transcripts, one of the introns is
not spliced out. This introduces a premature stop
codon, and as a result, this transcript encodes a trun-
cated protein DNOS4 with a unique carboxyl termi-
nus. This protein lacks important domains and does
not produce NO. However, it strongly inhibits DNOS1
activity in cotransfection experiments. One possibility
is that it disrupts homodimerization of DNOS1 which
is crucial for its enzymatic activity. The truncated pro-
tein forms homodimers in yeast two-hybrid system,
and we are now testing to determine whether it can
form heterodimers with DNOS1 protein. Our results
suggest that DNOS4 may code for a natural negative
regulator of DNOS1 activity and that it can be used as
a dominant negative regulator of DNOS1 when intro-
duced to the Drosophila germ line. We have generated
transgenic flies expressing DNOS4 under an eye-spe-
cific promoter to test this hypothesis.
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Protein Targeting to
Neuronal Cell Terminals
P. Krasnov
Synaptic vesicle biogenesis requires precise targeting
of constituent proteins to the axon terminal. We
searched for the targeting signals that determine deliv-
ery of synaptotagmin, a major synaptic vesicle pro-
tein, to the neurite terminal in neuronal cells. Using
deletion and point mutagenesis of the synaptotagmin
molecule, we identified a targeting signal in the car-
boxy-terminal domain that is necessary for the accu-
mulation of synaptotagmin at the neurite terminal and
found two amino acid residues which are indispens-
able for the correct targeting. When possible confor-
mations of the synaptotagmin carboxy-terminal
domain were modeled using the Macromodel program
(P. Nestler and P. Krasnov), the crucial residues fell
within the loop of a highly stable hairpin formed by
the adjacent acidic and basic residues, suggesting that
these residues may represent points of contact between
the synaptotagmin molecule and proteins that deter-
mine its distribution in the neuronal cell. Using affin-
ity chromatography, we isolated a protein that binds to
the targeting signal. We identified it by microsequenc-
ing (R. Kobayashi and P. Krasnov) and are currently
testing whether it interacts with the synaptotagmin
molecule in neuronal cells in vivo.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN
CENTRAL SYNAPSES
R. Malinow N. Dawkins
A. Barria
J. Esteban
Y. Hayashi
F. Kamenetz
Z. Mainen S. Shi
M. Maletic-Savatic S. Zaman
A. Piccini N. Yamashita (visiting Japanese
J.-C. Poncer medical student)
We address issues directed toward an understanding of
learning and memory by studying the physiology of
synapses. We study synaptic transmission and plasticity
in rodent brain slices which are complex enough to show
glimpses of emergent properties, as well as simple
enough to allow hard-nosed biophysical scrutiny. To
monitor and perturb the function of synapses, we use a
combination of electrophysiology, microscopic imaging,
and transfection techniques. This allows us to examine
the cell biological basis for changes in electrophysiolog-
ical function. It is our philosophy that synapses have key
properties whose understanding will provide insight into
phenomena at higher levels of complexity.
Delivery of Glutamate Receptors
to Synapses during Development
J. Esteban [in collaboration with R. Petralia
and R. Wenthold, National Institutes of Health]
The synapses we study (which are similar to and serve
as a model for most excitatory synapses in the vertebrate
brain) use glutamate as the neurotransmitter and have
two types of postsynaptic glutamate-sensitive receptors:
a-amino-3-hydroxy-5-methyl-4-isoxazole proprionate
(AMPA) type and N- methyl -n- aspartate (NMDA) type.
Roughly speaking, AMPA receptors (AMPA-Rs) trans-
mit all presynaptic release events, whereas NMDA
receptors (NMDA-Rs) require intense activity and trig-
ger plasticity. We have used immunogold electron
microscopy to test the hypotheses that (1) there are
synapses containing NMDA-Rs and no AMPA-Rs, (2)
such synapses are more prevalent early in development,
and (3) there is an increase in AMPA-R-containing
synapses with no change in the NMDA-Rs.
Since immunogold electron microscopy allows
accurate quantification and precise anatomical localiza-
tion of the proteins in question, these methods are opti-
mal for the questions addressed. We find that a large
fraction of synapses contain NMDA-R immunoreactiv-
ity with no AMPA-R immunoreactivity. These are like-
ly to correspond to the pure NMDA responses detected
electrophysiologically by our laboratory (Liao et al.,
Nature 375: 400 [19951), and at present by several other
laboratories, in various preparations, including the cere-
bral cortex, spinal cord, and optic tectum. As the physi-
ology predicts, the prevalence of these synapses con-
taining only NMDA-R protein decreases during devel-
opment. These results provide a molecular basis for the
physiological observation of "silent synapses": synaptic
responses mediated purely by NMDA-Rs. Their
increased prevalence early in development likely
reflects exuberant synaptogenesis during this period.
Since synaptogenesis has a large random component, it
makes sense that such synapses would have only
NMDA-Rs which do not transmit information if such
synapses fire in isolation, but will transmit if such
synapses fire in unison with other synapses.
Delivery of Glutamate Receptors to
Synapses during Long-term Potentiation
Y. Hayashi
Having seen that delivery of AMPA-R occurs during
development (see above), we wanted to test if long-
term potentiation (LTP) can be expressed by the rapid
delivery of AMPA-Rs from regions not accessible by
the transmitter (either intracellular storage or extrasy-
naptic dendritic surfaces) to the synaptic surface (a
process we term AMPA-fication). One method to test
this possibility is to acutely overexpress GluRl in hip-
pocampal slice neruons. We find that such overexpres-
sion produces significant amounts of AMPA-Rs with
only G1uRI. Such AMPA-Rs have an electrophysio-
logical fingerprint different from that of endogenous
AMPA-Rs, which generally contain some G1uR2;
namely, homomeric G1uR1 receptors show inward rec-
tification, whereas endogenous receptors do not. Thus,
we can infect neurons in hippocampal slices using a
Sindbis virus that expresses GluR1-EGFP (enhanced
green fluorescent protein). In infected cells, we moni-
tor transmission onto two synaptic pathways. In one
pathway, we induce LTP and are now testing if this
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potentiated pathway has greater rectification than the
control pathway. If this is so, it will indicate that newly
synthesized recombinant receptor has been rapidly
delivered to potentiated synapses.
Dendritic Trafficking, Clustering,
and Synaptic Delivery of AMPA-Rs
in Hippocampal Neurons
S. Shi, Y. Hayashi, J. Esteban [in collaboration
with K. Svoboda, Cold Spring Harbor Laboratory,
and R. Petralia and R. Wenthold, National
Institutes of Health]
To monitor directly changes in AMPA -R distribution in
living neurons, the AMPA-R subunit GIuR1 was tagged
with green fluorescent protein (GFP). This protein
(G1uR1 -GFP) is functional and was transiently
expressed in hippocampal CAl neurons. In dendrites
visualized with two-photon laser scanning microscopy
or electron microscopy, most of the GluRl-GFP is intra-
cellular, mimicking endogenous GluR1 distribution.
Tetanic synaptic stimulation induces a rapid delivery of
tagged receptors into dendritic spines as well as clusters
in dendrites. These postsynaptic trafficking events
require synaptic NMDA-R activation and may con-
tribute to the enhanced AMPA-R-mediated transmis-
sion observed during LTP and activity-dependent
synaptic maturation.
Role of CaMKII in Receptor Trafficking
A. Piccini, Y, Hayashi, S. Shi
Considerable evidence indicates that calcium-calmod-
ulin kinase II (CaMKII) activation mediates the genera-
tion of LTP. To examine the effect of increased CaMKII
activity on AMPA-R trafficking, we have generated a
Sindbis expression vector with an internal ribosome
entry site (IRES) sequence able to express two proteins.
These proteins are GluR1 -GFP and tCaMKII, the latter
being the constitutively active catalytic domain of
CaMKII. Extracts from neurons expressing this con-
struct show an increase in constitutive (calcium-inde-
pendent) CaMKII activity. AMPA-R-mediated synaptic
transmission onto such infected cells shows an increased
amount of rectification, indicating that CaMKII activity
induces a delivery of recombinant GluRl-GFP to
synapses. These results provide direct evidence for the
view that LTP is due, at least in part, to an increased
delivery of AMPA-Rs to synapses.
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Role of Candidate Plasticity
Genes in Synaptic Maturation
R. Malinow [in collaboration with K. Haas, E. Nedivi,
and H. Cline, Cold Spring Harbor Laboratory]
cpg-15 is a gene showing increased expression follow-
ing activity protocols that induce plasticity. Exogenous
expression of this gene promotes growth of dendritic
arbors in Xenopus optic tectum. We are testing the
effect of this gene expression on synaptic transmission,
as well as testing the view that the protein promotes
maturation (AMPA-fication) of immature synapses in
immature cells and promotes growth of immature
(silent) synapses in mature cells. Preliminary electro-
physiological results support this view.
Silent Synapses: Calcium
Imaging Analysis
Z. Mainen [in collaboration with K. Svoboda,
Cold Spring Harbor Laboratory]
We and others have observed electrophyisological
responses mediated purely by action on NMDA-Rs.
One interpretation is that there are synapses that have
only NMDA-Rs (see above). Another interpretation is
that a sufficient amount of transmitter can leak out of
synapses to activate only NMDA-Rs on nearby
synapses. The higher affinity of NMDA-Rs for gluta-
mate, compared to that of AMPA-Rs, makes this sce-
nario plausible. To examine the biophysical basis for
pure NMDA responses, we are monitoring the sto-
chastic responses of single synapses that are posi-
tioned next to each other. If there is transmitter leak-
age, nearby synapses should respond synchronously. If
there is no leakage, synapses should respond indepen-
dently. Our data from such cases indicate that synaps-
es function independently, with no detectable spillover.
This provides direct evidence that transmission in the
central nervous system occurs as a point-to-point
process and argues against transmitter spillover being
responsible for pure NMDA responses.
Interactions between Short-term
and Long-term Plasticity
J. -C. Poncer
If synapses are activated twice within approximately
100 msec, the second response is generally different in
amplitude from the first. At some synapses, the second
response is larger (paired-pulse facilitation), whereas at
other synapses, the second response is smaller (paired-
pulse depression). This short-term plasticity has been
studied extensively at a number of synapses and likely
reflects properties of the presynaptic transmitter release
and recycling machinery. There have been reports that
such short-term plasticity changes during LTP. Does
this indicate that LTP produces changes in presynaptic
function? We find that changes in short-term plasticity
during LTP can be explained by recruitment of previ-
ously silent synapses. This recruitment may occur by
addition of AMPA-Rs to synapses containing only
NMDA-Rs. Such functional recruitment of synapses
has an impact on the information processing properties
of transmission.
Plasticity of NMDA-R-mediated
Synaptic Transmission
A. Barria
Tetanic stimulation of synapses leads to an increase in
AMPA-R function, at least in part due to a rapid delivery
of receptors to synapses. In addition, under certain con-
ditions, an increase can be seen in NMDA-R-mediated
transmission. We wish to test the hypothesis that this is
due to the formation of new synapses containing only
NMDA-Rs. We are testing this possibility in a number of
ways, using electrophysiological imaging and molecular
biological and pharmacological methods.
Electrophysiology of Transgenic
Mice Carrying Mutated Presenilin-1
S. Zaman, F. Kamenetz [in collaboration with S. Sisodia,
A. Parent, and D. Borchelt, Johns Hopkins University]
Mutations in presenilin-1 (PS-1) are responsible for
approximately 50% of cases of familial Alzheimer's dis-
ease. Little is known regarding the cellular distribution
and function of PS-1. We have recently found that calci-
um-triggered processes (e.g., short- and long-term
potentiation) are enhanced in transgenic mice expressing
mutant PS-1, consistent with the view that PS-1 controls
calcium homeostasis. Furthermore, we are able to nor-
malize this abnormality with a benzodiazepine. Of inter-
est, these drugs have recently been associated with a
decreased incidence of Alzeheimer's disease in a clinical
study. We are now examining the subcellular distribution
of PS-1 in neurons, measuring calcium homeostasis in
neurons expressing mutant PS-1, and examining if ben-
zodiazepines can normalize the increased secretion of
AD seen in tissue-expressing mutant PS-1.
In conclusion, we are continuing to elucidate the
basic mechanisms involved in central synaptic trans-
mission. Such an understanding is necessary to derive
a mechanistic flowchart of plastic processes. We also
continue to probe the role of different molecules,
including CaMKII and PS-1, in activity-induced and
developmental synaptic plasticity.
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THE BIOLOGY OF LEARNING AND MEMORY
A.J. Silva 0. Carvalho Y. Elgersma P.W. Frank land
P. Chen N.B. Fedorov J.H. Kogan
J. Coblentz E. Friedman M. Ohno
Our laboratory is studying the biology of learning and
memory. We are interested in the molecular, cellular, and
circuit processes that underlie the storage and recall of
information. To accomplish this, we are using a variety
of techniques including transgenic manipulations, phar-
macology, in vitro and in vivo electrophysiology, neu-
roanatomical lesions, and behavioral analysis. The focus
of our studies has been on hippocampus-dependent
learning and memory. Our results implicate a variety of
hippocampal mechanisms in learning and memory,
including long-term potentiation, short-term plasticity,
and the slow after-hyperpolarization. For example, we
have found mutations that affect the induction of long-
term changes in synaptic function and learning, and oth-
ers that affect the stability of these synaptic changes and
memory (but not learning). Our laboratory is also inter-
ested in applying these findings to the development of
treatments for learning and memory disorders, such as
those observed with aging and in neurofibromatosis type
I (NF1). Below we describe in more detail studies car-
ried out during this last year in our laboratory.
PHARMACOLOGICAL AND GENETIC RESCUE
OF THE LEARNING DEFICITS CAUSED BY THE
NF1 HETEROZYGOUS MUTATION IN MICE
Specific learning disabilities are the most common
neurological complication in children with neurofi-
bromatosis type 1 (NF1). The complexity of these cog-
nitive deficits, and the difficulty of pursuing their
study in patients, motivated us to study an animal
model of this disease. We have previously shown that
mice with the same mutation that causes NF1 in
humans (Nfl mice) have learning deficits that resem-
ble in important ways the deficits observed in some
NF1 patients. As with NF1 patients, the learning and
memory deficits of the Nfl mice are restricted to spe-
cific types of learning, they do not affect all individu-
als, they can be compensated for with extra help and
training, and they do not involve deficits in simple
forms of learning
The advantage of having an animal model for NF1
is that these animals can be used to search for a cure
for this disease. We started by testing the hypothesis
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that the deficits that cause tumors in NF1 patients are
also responsible for their learning disabilities.
Previous studies suggested that abnormally high activ-
ity of the Ras protein may result in tumor formation,
since one of the functions of neurofibromin, the pro-
tein disrupted in NF 1 patients, is to increase the inac-
tivation of Ras. Our behavioral studies indicate that
just as with tumors, the learning disabilities associated
with NF1 may be due to increased Ras activity.
Remarkably, our results also showed that treating the
Nfl mice with a drug that decreases Ras function (far-
nesyl transferase inhibitor or FTI) also rescues their
learning deficits. We have also been able to rescue the
learning deficits of these mutant mice by deleting an
allele of one of the ras genes expressed in the brain
(N-ras). These findings support the hypothesis that the
learning deficits associated with NF1 are caused by
excessive Ras activity. This is an important first step
toward the development of a cure for NF1, because we
have a molecular clue for the cause of the disease.
INDUCIBLE AND REGION-RESTRICTED
TRANSGENIC SYSTEMS: THE
LBD-ESTROGEN FUSION SYSTEM
Protein kinases and transcription factors can be regulat-
ed in a hormone-dependent manner when fused to the
ligand binding-domain of steroid receptors (LBD).
Proteins fused with LBD are probably kept inactive due
to sterical hindrance by Hsp90 proteins bound to the
LBD in the absence of hormone. Simplicity is the main
advantage of this posttranscriptional approach to regu-
late protein activity. Only one DNA vector is required
for the expression of a LBD fusion protein. In contrast
to transcriptional control systems (Tet-based), this
approach allows the activation of a protein rapidly by
the release of preformed molecules from Hsp90 protein
inhibition. Until recently, the LBD-fusion protein
approach was restricted to applications in cell lines,
since natural steroids, which activate the wild-type
LBDs, can be excluded in vitro but not in vivo experi-
ments. However, we have used instead a mutant LBD of
the estrogen receptor (LBDm) which is not activated by
endogenous estrogen. We have applied this system to
regulate the function of a mutant CREB (cAMP-respon-
sive element binding) protein that interferes with
endogenous CREB function. The CREBm/LBDm pro-
tein is expressed in the brain of the transgenic mice and
activated by tamoxifen, the ligand for LBDm. Our
results so far indicate that the injection of tamoxifen
impairs long-term memory for contextual conditioning
and for social recognition in the CREBm/LBDm trans-
genic mice, but not in wild-type controls.
PHARMACOLOGICAL INDUCTION
OF MUTANT PHENOTYPES
To date, the genetics community has generated target-
ed alleles for more than 2500 genes. Even though this
is a valuable resource, many of these mutations affect
function both during development and in the adult. In
the last year, our laboratory has developed a strategy
that may allow inducible manipulation of the effects of
many of these mutations. We introduced a strategy in
which pharmacology is used to induce the effects of
targeted mutations. For example, mice heterozygous
for a null mutation of a cAMP-dependent transcription
factor (CREB"°-) showed normal contextual memory.
However, antagonists of adenylyl cyclase-linked
receptors, at concentrations that did not affect memo-
ry in wild-type littermates, revealed a specific long-
term memory deficit in these mutants. Importantly,
these antagonists did not disrupt memory in mice with
a heterozygous point mutation (T286A) in the a calci-
um/calmodulin-dependent kinase II gene. Instead, a
behaviorally ineffective dose of an NMDA receptor
antagonist in wild type blocked short- and long-term
memory in the kinase mutants. These results demon-
strate that pharmacological manipulations can be used
to reveal the effects of mutations in mice in a tempo-
rally controlled manner.
THE KV01.1 POTASSIUM CHANNEL MUTATION
RESCUES THE HIPPOCAMPAL-DEPENDENT
LEARNING DEFICITS ASSOCIATED WITH
AGING IN MICE
Normal aging is associated with cognitive decline
unrelated to diseases such as Alzheimer's. Increases in
the slow after-hyperpolarization (sAHP) of aged neu-
rons have been proposed to contribute to this cognitive
decline. In the last year, we showed that in aged mice,
a targeted mutation of the modulatory potassium chan-
nel subunit KA31.1 decreases the sAHP of hippocam-
pal CA1 neurons and improves learning and memory
in three hippocampus-dependent tasks: contextual
conditioning, spatial learning, and the social transmis-
sion of food preferences. Importantly, young mutants
do not show this improvement. Our results demon-
strate that modulation of potassium channel function
can improve learning and memory specifically in aged
mice, and they support the hypothesis that increases in
the sAHP contribute to age-related learning and mem-
ory deficits.
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NEOCORTICAL CIRCUITRY AND ITS PLASTICITY
K. Svoboda B. Burbach E. Nimchinsky
B. Lendvai P. O'Brien
Z. Mainen B. Sabatini
M. Maravall E. Stern
The neocortex underlies most cognitive functions in
mammals. Even though these functions can be
extremely diverse, the anatomy underlying these func-
tions is relatively well conserved. Neocortical tissue is
dauntingly complex: 1 pi contains nearly 1 million
neurons and more than 1 billion synapses. A single
neuron connects to thousands of other neurons. This
awesome network underlies our perception of the
world. To begin to unravel neocortical function, we are
studying how the basic units of this network, namely,
neurons and synapses (the connections between neu-
rons), work within the intact network.
We use sensitive tools to monitor neuronal function
in intact tissue. Two-photon laser scanning microscopy
(TPLSM) allows us to keep track of neuronal excitabil-
ity at the level of single synapses by measuring intra-
cellular calcium levels at high resolution. Optical stim-
ulation by the uncaging of neurotransmitters allows us
to excite subcellular structures with great spatial and
temporal control. Intracellular electrical recordings
using sharp and whole-cell electrodes allow us to mon-
itor the electrical membrane potential and synaptic cur-
rents of neurons. We have also begun to use powerful
molecular tools that allow us to perturb signal trans-
duction cascades in neurons in very specific ways.
Neurons in juvenile and adult cortex can be infected
with viruses or transfected with the gene gun to intro-
duce virtually any transgene of interest.
Our efforts so far have been focused on the func-
tion and plasticity of the hardware of the neocortex.
Despite the complexity of neocortical tissue, there is
some reason to hope that in the foreseeable future
(even perhaps our grandchildren's lifetime), it will be
possible to understand how neocortical neural net-
works perform computations. This hope is mainly
based on the realization that the neocortex is built up
of repeating elemental functional modules, containing
relatively few types of neurons and synapses. Thus, it
could be that the neocortex is decomposable into a
simpler problem, namely, understanding the function
of the elemental module. Despite some growing pains,
we were able to make progress on a number of fronts
during the last year.
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Dendritic Morphogenesis
Induced by Synaptic Activity
in Brain Slices
E. Nimchinsky [in collaboration with
M. Maletic-Savatic and R. Malinow,
Cold Spring Harbor Laboratory]
Coordinated patterns of activity help to organize neur-
al circuits throughout the brain. Relatively little is
known about the role of activity in the development of
mammalian dendritic morphology. Dendrites, the input
side of neurons, develop in a stereotypical sequence:
Early after birth, the relatively smooth dendrites of
neonates sprout numerous thin filopodia-like protru-
sions that are later replaced by dendritic spines as the
brain matures. Recent studies in cultures from hip-
pocampal area CAl have shown that dendritic protru-
sions, including filopodia and spines, are structurally
dynamic, perhaps powered by actin motility. These
observations led to the hypothesis that dendritic filopo-
dia are crucial in establishing synaptic connections dur-
ing development, paving the way for the development
of mature spines. Activity-dependent dendritic mor-
phogenesis could therefore underlie Hebbian plasticity
during development. We used vital imaging of den-
drites in living brain slices to directly study dendritic
morphogenesis evoked by synaptic activity.
A small number of CAI pyramidal neurons were
infected in cultured hippocampal slices with a neu-
rotropic recombinant Sindbis virus expressing enhanced
green fluorescent protein (EGFP). Visualized with a
TPLSM, infected neurons showed bright homogeneous
fluorescence throughout their dendritic and axonal
arbors, revealing detailed morphology with numerous
dendritic protrusions. Small dendritic segments labeled
with EGFP could be imaged repeatedly at high resolu-
tion for hours without signs of photobleaching or photo-
toxicity. Time-lapse imaging of dendritic segments
showed that dendritic morphology is dynamic on time
scales of minutes to hours. Protrusions appeared and dis-
appeared or changed shape.
High-frequency focal synaptic stimulation induced
a period (-45 minutes) of enhanced growth of small
filopodia-like protrusions (<5 lam). Synaptically
evoked growth was long-lasting, localized to dendritic
regions close (<50 gm) to the stimulating electrode,
and was prevented by blockade of NMDA (N-methyl-
D-aspartic acid) receptors (NMDA-R). Thus, synaptic
activation can produce rapid, input-specific changes in
dendritic structure. Such persistent structural changes
could contribute to the development of neural circuit-
ry. We are now attempting to show that new dendritic
filopodia in fact make synapses.
Optical Studies of Single Synapses
Z. Mainen, M. Maravall, B. Sabatini [in collaboration
with R. Malinow, Cold Spring Harbor Laboratory]
Does the release of a single vesicle saturate synaptic
glutamate receptors? The answer to this simple ques-
tion is central to an understanding of transmission at
central nervous system synapses, as receptor occupan-
cy determines how a sequence of closely spaced action
potentials at the presynaptic terminal is transformed
into a postsynaptic signal by the synapse: Is the
process linear or nonlinear? Moreover, determining
the degree of receptor occupancy will shed light on the
mechanisms that determine quantal size, synaptic
noise, and synaptic plasticity.
In general, the number of neurotransmitter (gluta-
mate) molecules released from a vesicle greatly
exceeds the number of postsynaptic receptors.
Although experiments using a variety of electrophysi-
ological methods have addressed the issue of receptor
saturation, the results have been extremely controver-
sial due to complexities in the interpretation of these
indirect experiments. We used 2-photon imaging to
measure NMDA-R-mediated [Ca"] transients in sin-
gle dendritic spines of CAl pyramidal neurons in hip-
pocampal slices. This approach can be used to dis-
criminate failure and success of transmitter release at
an individual synapse and to quantify the amount of
NMDA-R activation following release (Fig. 1). We
tested for saturation of NMDA-Rs by comparing
responses evoked by single stimuli with those evoked
by pairs of stimuli separated by a short interval. We
find that a single release event does not saturate
synaptic NMDA-Rs; we calculate that a second release
occurring 10 msec later produces more than 80% of
the first response. These results suggest that NMDA-
Rs are essentially linear detectors of glutamate release.
Synaptic NMDA-R [Ca"] transients in individual
spines are therefore sensitive to both the number of
quanta released by a burst of action potentials and the
changes in the concentration profile of glutamate in
the synaptic cleft.
Spread of Excitation in
Individual Axons
K. Svoboda [in collaboration with
L. Cox, SUNY, Stony Brook]
Axons, the output side of neurons, are normally con-
sidered to reliably transmit action potentials through-
out their arbors, delivering impulses to presynaptic ter-
minals. However, this view was established many
years ago in the reflex arc. Essentially nothing is
known about the reliability of action potential propa-
gation in the profusely branching axons of the neocor-
tex. We used whole-cell recordings to fill individual
neocortical pyramidal neurons in brain slices with the
[Ca"] indicator and to elicit somatic action potentials.
We then measured action-potential-associated [Cal
transients in presynaptic terminals distal and proximal
to the soma. Under a variety of conditions, we find
that action potentials reliably invade the axonal arbors
of neocortical pyramidal neurons, with no sign of
branchpoint failures.
Modulation of Dendritic
Excitation in Neocortex In Vivo
E. Stern, K. Svoboda
In vitro experiments, employing electrophysiological
recording and optical imaging of Ca" ion concentration
([Cal), have provided increasing evidence that Na'
action potentials can, under appropriate conditions,
propagate somatofugally into the dendritic tree of corti-
cal pyramidal neurons. Because action potentials can
open voltage-sensitive Ca" channels (VSCCs) and
relieve the Mr block of NMDA-Rs, they could play an
important part in the control of long-term synaptic plas-
ticity (LTP) and learning and memory. But despite the
convenience of the brain slice preparation for studying
dendrites, it has become clear that dendritic excitability
depends on a variety of factors that are hard to repro-
duce in vitro. We applied in vivo TPLSM imaging
together with sharp electrode intracellular recordings to
study dendritic excitability and its modulation in vivo.
165
BC
15
0 500 1000
Time (ms)
1IL
25 50 75 100
APE
FIGURE 1 Probabilistic synaptic activation of NMDA-Rs monitored using TPLSM to image spine [Cal transients. (4,
Top) TPLSM image (single section) of a spiny tertiary apical dendritic branch of a CA1 pyramidal neuron. An active spine
(box in inset) is indicated. (Bottom) Time sequence of frames showing [Cal-associated fluorescence transients dur-
ing synaptic activation of one synapse. The stimulus is delivered at the beginning of frame 5 (star). The time (in mil-
liseconds) at the beginning of each frame is shown at its top right. (8) Sample fluorescence transients from the same
spine. (C) Histogram of [Cal transient amplitudes. Black bars are classified as release failures; gray bars are classified
as nonfailures (Z.F. Mainen et al. 1999).
We find that in layer 2/3 pyramids in the barrel cor-
tex in vivo, sodium action-potential-evoked [Cal tran-
sients are limited to dendritic regions close to the soma.
By directly recording from dendrites, we show that dis-
tal dendrites of layer 2/3 cells are electrically excitable
in vivo and capable of generating large [Cal transients.
In addition, we observe a strong attenuation and broad-
ening of Nay action potentials with distance from the
soma. These results demonstrate that the restricted pat-
tern of dendritic [Cal transients we observe is due to a
suppression of Na* action potential propagation into
dendrites. Furthermore, we find that stimulation of sub-
cortical activating systems by tail pinch can enhance
sensory-stimulus-induced dendritic [Cal transients,
consistent with the importance of these activating sys-
tems in neocortical plasticity and learning. In the next
year, we plan to investigate the effects of activity in neu-
romodulatory systems that are activated during attentive
behaviors, such as Raphe and Nucleus Basalis, on den-
dritic excitability.
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Molecular Basis of Neocortical Plasticity
B. Burbach, K. Svoboda [in collaboration with E. Nedivi,
Massachusetts Institute of Technology]
The rodent somatosensory cortex contains a map of the
facial whiskers (barrel cortex) that can be visualized
using simple stains. The neuronal responses in each bar-
rel-column are dominated by a single principal whisker
(PW), with some surrounding contributions from neigh-
boring whiskers. Whisker deprivation changes the
responses in the whisker map. For example, trimming all
but one whisker leads to potentiation of the spared
whisker response and depression of the deprived whisker
response in the deprived columns. These effects occur
mostly in superficial layers over time scales of days.
Is experience-dependent plasticity in the adult neo-
cortex associated with dendritic morphogenesis? One
approach to address this question is to induce plasticity
in the barrel cortex by whisker trimming and to look for
up-regulation of genes that are known to regulate den-
dritic morphology in other systems. One such gene,
cpg15, has been shown to regulate dendritic growth in
the developing retinotectal system in the tadpole. To
induce plasticity, all but the D1 vibrissa were removed
unilaterally in awake, adolescent mice (age -4-5
weeks) for a period from 3 hours to 7 days. We subse-
quently measured the spatial and temporal distribution
of cpg15 expression by in situ hybridization. Induction
of experience-dependent plasticity is associated with a
transient change in the expression pattern of cpg15.
We find that (1) the barrel-column corresponding
to the spared whisker (D1) shows enhanced cpg15
expression, (2) the barrel-columns corresponding to
the deprived whiskers show reduced cpg15 expression,
(3) changes in cpg15 mRNA level first appear in layer
4, peak at about 12 hours, and then decline rapidly. In
layer 2/3, changes in cpg15 expression appear later,
peak at approximately 24 hours, and persist for days.
These findings suggest that experience-dependent
plasticity is associated with morphological rearrange-
ments in dendrites.
Morphological Basis of
Experience-dependent
Plasticity In Vivo
B. Lendvai, B. Burbach, K. Svoboda
During the last year, we have developed a method to
measure the dynamics of dendrites and their spines in
vivo using a combination of TPLSM and viral trans-
fection of neurons with the gene for EGFP. This
method allows us to characterize dendritic and spine
morphology and dynamics with micrometer-level spa-
tial resolution and high temporal resolution (approxi-
mately seconds). Most of our experiments were done
in rats between postnatal days 8 and 27. The goal of
our initial study was to characterize spine dynamics
and morphology as a function of developmental age
and to look at the effects of sensory experience on
spine dynamics. Very little is known about dendritic
dynamics in this system. In addition, these data are
crucial to characterize the morphological effects of
mutations (such as knockouts of theFMR1 gene) that
are thought to affect dendritic motility. Consistent with
our brain slice experiments, spines and dendrites of
neocortical pyramidal cells of layer 2/3 rapidly
changed shape. Perhaps most exciting, we were able to
modulate dendritic dynamics by changing sensory
experience. For example, clipping the rat's whiskers
for 2 days prior to imaging drastically reduced den-
dritic dynamics.
Instrumentation
K. Svoboda, P. O'Brien
Our instrumentation efforts during the last year have
focused on getting several imaging/electrophysiology
rigs up and running. First, we built a microscope that
is optimized for TPLSM imaging together with intra-
cellular recording in the intact brain. This microscope
implements a new hanging design that allows place-
ment of instruments and manipulators all around the
preparation. Signal collection is optimized to allow
imaging as deep in the brain as possible. We think that
this instrument will allow in vivo cellular physiology
at an unprecedented level or precision. Second, we
adapted a commercial confocal microscope (generous-
ly donated by Olympus) for multiphoton multicolor
imaging of GFP and its variants in brain slices. Third,
we produced essentially a replica of our first instru-
ment for brain slice physiology and imaging in brain
slices. The major difference is that we developed an
A/D board that allows us to acquire multiple fluores-
cence wavelengths simultaneously.
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MOLECULAR NEUROBIOLOGY OF LEARNING AND
MEMORY IN DROSOPHILA
T. Tully C. Alexander J. Dubnau R. Jones M. Saitoe
T. Bridges (URP) R. Gasperini H. Li J. Salvatore
J. Christensen T. Gill J. Medal le P. Smith
J. Connolly S. Gossweiler S. Pinto K. Velinzon
J. DeZazzo L. Grady M. Rahimzadeh S. Xia
J. Di Leo M. Hannan M. Regulski L. Zhang
Two components of our efforts this year have been
factory-like. With the successful implementation of
RoboTrainers, our "Hartford screen" for new mutants
that disrupt learning/memory would be admired by
Henry Ford himself. "Hartford" now functions well as
a "high-throughput" behavioral screen. With Helicon
Therapeutics, we have begun to screen the Roche
library of 160,000 drug compounds for their abilities
to enhance long-term memory (LTM) formation.
Initial experiments have yielded promising results.
Together, these brute-force projects will ensure the
continued contribution of Drosophila to our under-
standing of human cognitive dysfunction.
Molecular Search for
CREB-dependent
LTM Genes
T. Tully, J. Dubnau, J. Medalle, S. Gossweiler,
J. Salvatore, T. Gill [in collaboration with
Helicon Therapeutics, Inc.]
Our collaborations with Helicon Therapeutics, Inc.
have afforded us access to Affymetrix DNA chip tech-
nology. Roche/Affymetrix has produced a Drosophila
chip for our group that contains all 1500 known,
cloned genes, approximately 10% of the fly genome.
To these chips, we have hybridized probes derived
from RNA transcripts expressed in adult fly heads 24
hours after they were subjected to one of two training
protocols: spaced training (which induces CREB-
dependent LTM), massed training (which produces
learning and early memory levels similar to those pro-
duced by spaced training but which does not induce
CREB-dependent memory). In this manner, candidate
memory genes (CMGs) are sought that are differen-
tially expressed during LTM formation. Preliminary
experiments indicate that the signal to noise of such
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differentially expressed genes is at the limit of detec-
tion, often only a twofold effect. Hence, we have been
forced to apply basic statistical methods to detect
these weak signals more reliably.
By increasing the sample size of chips hybridized
to particular probes and by transforming the raw data,
we were able to apply parametric statistics to detect
differential transcript levels. From this first time
point during LTM formation, we have identified 66
CMGs, 75% of which also show signal differences in
follow-up Northern blot analyses. These results
demonstrate the first functional genomic response to
LTM formation.
Identification of New Genes
Involved with Associative
Learning
T. Tully, S. Pinto, J. Christensen, T. Bridges,
J. DeZazzo, K. Velinzon, M. Saitoe, P. Smith,
M. Rahimzadeh, C. Alexander, M. Hannan,
H. Li, L. Zhang, L. Grady [in collaboration with
M. Ramaswami, University of Arizona, and with
A. Dutta, Brigham and Women's Hospital and
Harvard Medical School]
After cloning the latheo transcription unit and identi-
fying a human homolog, we submitted the information
into the public database. This contribution precipitated
the identification of one function of latheo. A. Dutta's
group at Brigham and Women's Hospital discovered
that human LAT (HsLAT) appears to participate in the
origin recognition complex (ORC) during DNA repli-
cation. Given this observation, they want to show that
DrosophilaLAT (DmLAT) associates with DmORC2.
We showed that latheo null mutants die as pupae,
because normal cell proliferation stops during the third
instar stage and adult tissues fail to develop.
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FIGURE 1 linotte mutants produce a defect in paired-pulse
facilitation at the larval neuromuscular junction. (Closed circles)
to' mutants; (open squares) wild-type third instar larvae.
Strikingly, these phenotypic defects are similar to those
produced by lethal mutations of DmORC2.
Our attempts to identify the biochemical nature of
linotte remain elusive. Toward that end, however, we
have begun to study synaptic function at the larval
neuromuscular junction (lnmj) in linotte mutants, as
we have in the past for latheo. Interestingly, linotte
mutants produce functional defects in synaptic plastic-
ity (see Fig. 1), which are rescued inducibly by an hs-
lio+ transgene.
In collaboration with M. Ramaswami's group, we
also have identified a defect at the lnmj in nalyot
mutants. This time, however, the defect does not lie in
synaptic function but rather in synaptic structure.
Synaptic contacts onto the muscle are modulated in
direct correspondence to levels of expression of the
nalyot gene (which itself corresponds to Adfl). To the
extent that Adfl- dependent synaptogenesis has a role
in adult behavioral plasticity, we presently will evalu-
ate LTM formation in Adfl transgenic flies. Such
experiments on emc transgenic flies, for instance, sug-
gest no role for this negative regulator of transcription
(which was identified as golovan mutants) in adult
memory formation.
Finally, our new Hartford mutagenesis is progress-
ing well. With the development and installation of the
RoboTrainers, we already have screened about 2500
P-element transposant lines for possible defects in 1-
day memory retention. At this rate, we expect to iden-
tify up to a dozen new learning/memory mutants by
the end of next year.
Characterization of Extant Mutants
T. Tully, M. Regulski, J. DeZazzo, S. Xia
After teaming up with U. Heberlein's group (now at
University of California, San Francisco) to show that
amnesiac mutants disrupt via cAMP signaling the sen-
sitivity of adults to ethanol, we turned our efforts
toward a rescue of amnesiac's memory defect with
amn+ transgenes. In this, we succeeded. Surprisingly,
however, we found that expression of amn+ during
development is sufficient to rescue the adult memory
defect. This observation differs from that for alcohol
sensitivity, where expression of amn' in the adult is
sufficient to rescue the phenotypic defect. Given the
fact that amnesiac is known to encode a precursor pro-
tein for one or more neuropeptides, these results sug-
gest multiple (pleiotropic) roles for amnesiac in neu-
rodevelopment and function-a now recurring theme
in Drosophila neurogenetics.
We refuse to give up on our attempts to show a role
for nitric oxide (NO) in fruit fly memory formation. To
date, our attempts to modulate NO synthase (NOS)
function via genetic methods have failed. Hence, we
turned our attention (temporarily) to more traditional
pharmacology. We have developed a reliable enzymat-
ic assay of NOS activity that can be used on adult head
homogenates. With this assay, we have determined the
concentrations of NOS antagonists that are sufficient,
when fed to flies, to inhibit NOS activity in the brains
by more than 90%. With this knowledge, we now are
prepared to return to behavioral evaluations of NO
during memory formation.
The Virus Hypothesis
Our entire group [in collaboration with
P. Wendel in B. Stillman's group and
T. Howard in the EM facility]
To a moderate degree, our behavioral experiments
have been hampered by a general degradation of the
health of our fly colony. This pathology first revealed
itself as a significant reduction in the longevity of
adult flies. Moreover, adult flies that were still alive 7
days after training (which is when we prefer to mea-
sure LTM) appeared sluggish, thereby producing a
general reduction in performance in our memory
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assays. More seriously, the inducible effects on learn-
ing/memory of four of our transgenic lines (hs-CREB-
a, hs-CREB-b, hs-lio, and hs-lat) disappeared.
In response to this unanticipated problem, we ini-
tially spent several months systematically investigat-
ing which of dozens of variables (technical skills of
new experimenters, mechanics of RoboTrainers, odor
qualities, food qualities, etc.) might be responsible for
this health problem. In the end, our usual culprits were
not implicated, thereby forcing us to do some serious
biological detective work. Antibiotics, fungicides
(which normally are in our food anyway), and antipar-
asitics did not improve the health of our fly cultures.
We noticed, however, a high incidence of dead "black
pupae" in our culture bottles. Perusal of the literature
suggested that this might be caused by a viral infection
and that bleaching fly eggs might kill such virus.
Accordingly, an initial bleaching of eggs temporarily
reduced the incidence of black pupae but did not yield
the return of our transgenic effects.
In the meantime, we searched outside sources to
no avail for a wild-type strain that was not infected.
These stocks either arrived at CSHL with a viral infec-
tion or they were infected rapidly once here. Sensitized
to our dilemna, other fly behaviorists now also have
noticed black pupae in their stocks, and the presence
of such is coincident with reduced performance levels
in their (different) learning assays.
We have focused on the behavioral evaluation of
transgenes, the expression of which is driven by pro-
moters other than heat shock. We previously had pub-
lished on the abolition of olfactory learning by over-
expressing a dominant-negative G protein via a yeast
GAL4-driven promoter. In infected flies, this transgene
still works to block olfactory learning. We constructed
a la( transgene, the expression of which was con-
trolled by its own 5 genomic regulatory region. In
infected flies, the learning defect of lat mutants is res-
cued by this "genomic" transgene, in contrast to our
recent attempts to rescue the learning defect with the
inducible hs -lat' transgene. Taken together, these
results suggest that the putative viral infection affects
transiently expressed transgenic transcripts more than
chronically expressed transgenic constructs.
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Further search of the literature turned our attention
to a family of RNA viruses that suppress host transla-
tion. In particular, infections by the Drosophila C
virus (DCV) strain block translation of heat shock pro-
teins in response to heat shock, precisely the cellular
mechanism through which hs-driven transgenes are
expressed. Fortunately, DCV has recently been cloned
by P. Christian's group in Australia. Subsequent elec-
tron microscopic studies detected the presence of
DCV in infected cultured fly cells (morphologically
confirmed by P. Christian), and reverse transcrip-
tase-polymerase chain reaction (RT-PCR) detected
DCV in infected fly stocks.
Currently, we are using our RT-PCR protocol to
evaluate the effectiveness of egg bleaching in eradicat-
ing DCV from infected stocks. From this, we have
established that published egg-bleaching protocols are
insufficient to kill all DCV, thereby leading to an even-
tual return of the virus in bleached stocks. Once an
effective way to disinfect our stocks is worked out, we
finally will be able to do the most definitive experi-
ment: We will infect a transgenic stock (CREB, lio or
lat) with DCV or not (sham-infection) and determine
whether the behavioral effects of transgenic expres-
sion are blocked specifically by the presence of virus.
Such a demonstration will presage the return of our
beloved behavioral productivity.
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LONG-TERM MEMORY FORMATION IN DROSOPHILA
J. Yin M. Cowan J. Horiuchi Z. Lin M. Tello
E. Drier W. Jiang J. Nagel P. Wu
E. Friedman S. Kourpanidies M. Stebbins H. Zhou
R. Filipkowski K. La Vine
Subcellular Localization of
dCREB2 Proteins
M. Tel lo, M. Belvin, H. Zhou, M. Cowan
When Drosophila head extracts are biochemically frac-
tionated, both endogenous and transgenic dCREB2 pro-
teins partition differentially between the nuclear and
cytoplasmic fractions. The dCREB2-b isoform, whose
induction totally blocks the formation of long-term
memory (LTM), contains a nearly consensus nuclear
localization signal (NLS) in its basic region. This iso-
form, whether endogenous or transgenic, always
appears to be greatly enriched in the cytoplasmic frac-
tion. In contrast, the dCREB2-a isoform, which also
contains the identical NLS, is more enriched in the
nuclear fraction. A similar pattern of distribution is seen
when the two proteins are induced in yeast. Tissue
immunocytochemistry on adult photoreceptor cells
shows an enrichment for induced dCREB2-b in the
cytoplasm relative to that of dCREB2-a.
We are currently trying to determine whether a
mutant dCREB2-b protein that contains a mutant
NLS, and is totally cytoplasmic, can still block LTM
formation. Cell-based studies are under way to deter-
mine if the NLS sequence is necessary and sufficient
for nuclear localization. We are also trying to deter-
mine which sequences in dCREB2-b are required for
cytoplasmic partitioning, in anticipation of determin-
ing if the protein can mask its own NLS or is being
tethered in the cytoplasm by another protein.
Characterization of S162, a Mutation
in the dCREB2 Gene
M. Belvin, H. Zhou, M. Tello
S162 is a recessive, hemizygous, larval lethal mutation
that co-maps genetically and cytologically to 17A-B
on the X chromosome. Mutant escaper males normal-
ly survive at less than 0.5% frequency. When the
dCREB2-b transgene is crossed into the mutant back-
ground, rescued males survive at about 0.5% of the
normal frequency, and a daily heat shock induction of
the transgene during development results in about
50% survival. Western blot analysis of proteins from
escaper males shows that the predominant dCREB2
doublet, which is normally approximately 40-45 kD in
size, appears smaller (33-37 kD). We are currently try-
ing to isolate and characterize the mutant proteins, as
well as to locate and sequence the chromosomal muta-
tions.
S162 escaper males have a shortened circadian
locomotor period of about 22.8 hours (as compared
with the normal 24 hours). When Per protein is over-
produced by mutation, it results in a shorter locomotor
period. Consistent with these observations, the Per
protein is overproduced in the 5162 mutant back-
ground. A molecular understanding of how dCREB2
regulates per transcription may lead to a better func-
tional picture of the 5162 mutation in terms of its
effect on the activator/blocker ratio.
dCREB2 Is a Component of
the Circadian Clock
M. Belvin, H. Zhou
Transgenic flies that contain CRE-TATA-luciferase
reporters show circadian rhythmicity in reporter activ-
ity, with two peaks every 24-hour period. This activi-
ty is regulated by the dCREB2 gene, since it is abol-
ished in the 5162 mutant background. The reporter is
also CRE-dependent, since mutations in the consen-
sus CRE sites destroy cyclical transcription. Thus,
these reporter flies reflect dCREB2 activity. Although
dCREB2 activity cycles with two peaks in reporter
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activity across a 24-hour period, there is no detectable
cycling of any dCREB2 proteins, nor is there any
cycling of (the fly equivalent to) Ser-133 phosphory-
lation. We also do not detect any change in the cyto-
plasmic localization of dCREB2-b across a circadian
cycle.
The dCREB2 gene directly affects the circadian
clock. 5162 mutant flies have a shortened locomotor
period (22.8 hours), which can be rescued by induc-
tion of a dCREB2-d transgene. dCREB2 also affects
per expression. When per reporter flies are examined
in the 5162 backgroud, they show diminished cycling.
A per transcriptional fusion shows stronger effects
than a per promoter and protein fusion, consistent with
the interpretation that there are transcriptional and
posttranscriptional mechanisms that contribute to Per
cycling. When Per protein is examined in the 5162
background, it has an altered cycling pattern, with less
degradation of Per during the trough periods (morn-
ing). Paradoxically, there is also an apparent increase
in Per protein, although the per reporters show
decreased transcription in 5162, suggesting that a
posttranscriptional compensatory mechanism exists.
Since per also affects the dCREB2 reporters, these two
genes, per and dCREB2, affect each other, forming a
complex feedback loop.
scs and scs" Function
as Insulators
M. Belvin, J. Wallach, H. Zhou
We have made a series of insulated and uninsulated
CRE-TATA-/acZ and 3xCRE-TATA-luciferase trans-
genic reporter flies. Quantitatively, the insulated trans-
genic reporters cluster much more closely as a group
with respect to their levels of luciferase activity, when
compared with the uninsulated lines. In addition, on
average, the uninsulated lines have lower levels of
expression. Therefore, scs and scs' are capable of pro-
tecting transgenes from the effects of random inser-
tion, which tend to decrease expression. Since the
lines all show circadian rhythmicity in their transcrip-
tional activity, insulators do not disrupt transcriptional
regulation of the intervening DNA. Spatially, all of the
lacZ lines have similar patterns of expression in the
adult head. As the number of CRE sites increases,
insulated lines tend to show staining in new areas of
the adult head, in addition to retaining the basal pattern
of staining.
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Role of Phosphorylation in
Controlling dCREB2 Activity
W. Jiang, J. Horiuchi, H. Zhou
CREB family molecules from the honeybee, Aplysia,
Drosophila, chicken, mouse, rat, and humans show a
high degree at conservation in eight putative phosphor-
ylation sites. We are interested in the possible roles
these sites have in dCREB2 function. One important
role to which some of these sites contribute is DNA
binding. Both in vivo and in vitro, we detect effects of
phosphorylation on the binding properties of the pro-
teins. We are currently trying to determine which phys-
iologies affect which sites, as well as what signaling
pathways are involved. Ultimately, we are interested in
how phosphorylation and dephosphorylation are modu-
lated during neuronal activity and memory formation,
and how these different sites affect biochemical and cel-
lular properties of the dCREB2 proteins. We anticipate
that these posttranslational events are directly related to
behavioral properties of long-term memory formation,
such as the requirement for repetitive training trials and
the need for rest intervals (spaced training).
Subcellular Ablation of Protein Activity
E. Drier
We are interested in further extending spatial (anatomi-
cal) and temporal inhibition of protein function by teth-
ering dominant-negative molecules to certain parts of
cells. Our approaches will be initially tested in flies
using Gal4 to spatially (anatomically) limit expression of
the inhibiting molecules. We will then integrate these
methods with the tetracycline system, allowing temporal
control of induction. These approaches will ultimately
be applied to the study of molecules whose subcellular
location, and movement, is postulated to be important
for the processes of learning and memory formation.
LTM Formation in Flies
E. Drier, M. Cowan [in collaboration with
T. Tully, Cold Spring Harbor Laboratory]
We are continuing to characterize the viral infection of
our flies, which is one of the likely sources of our
behavioral problems. Reverse transcriptase-poly-
merase chain reaction (RT-PCR) analysis, combined
with amplification of virus in cell culture, shows that
we have an infection of at least the DCV virus.
Western blot analysis indicates that badly infected fly
stocks show dramatic decreases in heat-shock-
inducible transgene expression. "Koch's" postulates
type experiments show that transmission of the virus-
containing supernatant is lethal and likely to cause
behavioral defecits, especially for long-term memory
formation. We have developed methodology for keep-
ing viral titers very low, and these flies seem to exhib-
it dCREB2 transgene-responsive effects on long-term
memory formation (blocking and enhancement).
Amplifying RNA for
Analysis
J. Horiuchi [in collaboration with R. Malinow,
Cold Spring Harbor Laboratory]
We are investigating the feasibility of amplifying
small amounts of RNA for subsequent analysis using
microarray techniques. Claims have been made that
various PCR- and in-vitro-transcription-based tech-
niques can amplify with little bias. We are using RNA
isolated from hippocampal slices as a test case for var-
ious approaches.
Microarray Analysis
of Gene Expression
during Mouse Memory
Formation
R. Filipkowski, S. Kourpanidies, J. Nagel,
E. Freedman [in collaboration with T. Tully,
Cold Spring Harbor Laboratory]
Mice are trained in a variety of behavioral tasks (fear
conditioning, the Morris Water Maze, the acoustic
startle response) that produce long-lasting memory.
These mice and a closely matched behavioral control
(where the mice are subjected to the same stimuli,
but do not produce long-lasting memory) are used as
sources of RNA for complex probe preparations and
microarray analysis. Much of the difficulty with this
type of analysis is obtaining the proper control
group.
Transgenic Reporter Mice
R. Filipkowski, J. Nagel, S. Kourpanidies,
E. Friedman, J. Wallach [in collaboration with
K. Svoboda, Cold Spring Harbor Laboratory], P. Wu
Transgenic CRE- TATA -lacZ reporter mice have been
analyzed for changes in gene expression in response to
a variety of behavioral tasks. Tissue histochemistry has
been used to examine appropriate brain tissue sections
from mice which have long-lasting memory of cued
and contextual fear conditioning and conditioned taste
aversion. No training-induced changes in histochemi-
cal staining have been detected. Because of the high
background staining in this mouse line, we have made
new transgenic reporter lines that contain a destabilized
enhanced green fluorescent protein (EGFP) reporter
moiety. If any of the new lines are promising, we will
eventually use fiber-optic-based techniques to try to
image changes in gene expression in vivo. Finally, we
are beginning to generate transgenic mice for use in
molecular and behavioral analysis.
Tetracycline-inducible
Gene Expression
M. Stebbins, Z. Lin, W. Jiang, P. Wu
We are continuing to characterize our modified tetracy-
cline-inducible system. In Drosophila, both the "tet on"
(add drug to induce target gene expression) and the "tet
off" (withdraw drug) systems appear to work quite
well. When the trans-activator protein is driven by the
ubiquitously expressed actin promoter, inducible gene
expression can be detected on Western blots. The trans-
activator can also be driven using the Gal4 system,
allowing spatially delimited expression of the trans-
activator. Target gene induction is very robust with the
"tet off" system and quite good with the "tet on" sys-
tem. We are evaluating whether the target protein is
appropriately spatially limited in its expression pattern.
This would mean that spatial and temporal induction of
target genes can be achieved in Drosophila.
In mice, despite detectable "tet on" trans-activator
expression in the hippocampus and cortex, target gene
induction is poor. We are comparing the fly and mouse
systems to understand what is responsible for the func-
tional differences. Candidate factors include differ-
ences in the degradation pattern of the trans-activator
protein and competition for target site binding by
endogenous proteins.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong N. Wright Y. Wang J. Tong
F. Hannan J. An K. Weinreich
H.-F. Guo
We are interested in the neural basis of learning and
memory, and our research is currently following two
paths. First, we have developed the first preparation that
enables optical recordings of neural activity from the
living Drosophila brain, which has allowed us to inves-
tigate problems related to sensory representation, per-
ception, and learning. Second, we are establishing
Drosophila models for studying genes involved in
human neuro-disorders that impair learning and memo-
ry. In particular, we are investigating functions of the
neurofibromatosis 1 (NF1) gene and All peptides. NF1
mutations cause a neurogenetic disorder identified by
neurofibromas and other symptoms including learning
defects. Accumulation of insoluble All has been sug-
gested as a key event in the pathogenesis of Alzheimer's
disease. This approach, on the one hand, serves as a new
way to identify biochemical cascades underlying learn-
ing and memory in Drosophila. On the other hand, it
may also provide insights into pathogenesis of the dis-
eases. The specific projects are described below.
Role of the NPI-regulated
Rutabaga-encoded Adenylyl Cyclase
Pathway in Drosophila Learning
H.-F. Guo, J. Tong, F. Hannan
The tumor suppressor gene Nfl encodes a large protein
containing a fragment homologous to Ras-specific
GTPase-activating proteins (Ras -GAPS), which inhibit
Ras activity. In addition to neurofibromas and other
symptoms, about 40% of children with NF1 exhibit
specific learning defects. Similarly, tumorigenesis and
learning defects have also been reported in the mouse
Nfl knockout mutant. To gain insights into how NF1
affects learning in human patients and mouse mutants,
we examined the performance of Drosophila NF1
mutants in a classical conditioning task.
Drosophila NF1 is highly conserved since 60% of
its 2803 amino acids are identical to human NFL In
addition to functioning as a Ras-GAP, substantial but
indirect evidence obtained from our previous studies
of two Drosophila NF1 mutant phenotypes of a defec-
tive neuropeptide response and small body size have
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suggested that NF1 regulates activation of rutabaga
(rut)-encoded adenylyl cyclase (AC). Because rut was
isolated as a learning and short-term memory mutant
(8,9), we were led to pursue the hypothesis that NF1
may affect learning by its control of the activation of
Rut-AC/cAMP pathway.
Two mutant alleles showed learning and short-term
memory defects. We demonstrated that this deficit does
not arise from a developmental abnormality and that
NF1 is so crucial to learning that the performance of
NF1 mutants is improved in proportion to the amount
of NF1 expressed by acute induction of the transgene
(Fig. 1). Further behavioral analysis implies that NF1
affects the learning process via its control of the Rut-
AC/cAMP signaling pathway. Direct evidence from
biochemical assays shows, for the first time, that G-
protein-stimulated adenylyl cyclase activity consists of
two components, i.e., NF1-dependent and NF1-inde-
pendent. The NF1-dependent activity is largely mediat-
ed via the rut-encoded adenylyl cyclase (Fig. 2).
Age-dependent Learning Defect Induced
by Induced Expression of Af342
J. Tong, H.-F. Guo, F. Hannan, K. Weinreich
Alzheimer's disease (AD) is characterized by amyloid
plaques, neurofibrillary tangles, dementia, and age-
dependent memory loss. Although pathogenic mecha-
nisms remain to be fully established, a widely support-
ed hypothesis is that extracellular deposition of A1342
and A1343 derived from 13-amyloid precursor proteins
(APPs) in senile plaques may be a critical pathogenic
event. Expression of A1342 or mutant APPs that elevate
production of A1342 in transgenic mice has been asso-
ciated with some AD neuropathogenic features
(Games et al., 1995; Hisao et al., 1996). Yet events
downstream from Al deposition that lead to neurode-
generation and impaired memory remain elusive. If
flies can provide an AD model, it will greatly facilitate
the testing of hypotheses, discovery of down- stream
molecules, and screening for drugs because of the
short life span and genetic tools available in flies. Our
preliminary results indicate that induced expression of
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FIGURE 1 Rescue of NF1 learning defect by inducible expression
of the normal NF1 gene. (4) Effects of heat shock on learning per-
formance. The heatshock (hs) treatment that was used to induce
expression of the NF1 transgene (see B) did not affect learning in
the controls (K33) and mutant (NF1P2). In addition, learning was
also not affected by induced overexpression of the NF1 transgene
in the control background (hsNF1/+; K33). (B) Rescue of the learn-
ing defect by induced expression of the NF1 transgene. At room
temperature, a substantial improvement of learning performance
was observed in hsNF1/+; NF1P2 probably due to leaky expression
of hsNF1. Thus, flies were shifted from room temperature to 18°C
for overnight to minimize the leaky expression of the transgene. In
the first group, the flies were moved from 18°C to 25°C or 30°C for
2 hr before the learning test. The higher temperature produced a
better learning score (p <0.05, Turkey Kramer HSD). In the second
group, flies were shifted from 18°C to 25°C for 0, 2, 4, 6, and 8 hr,
respectively. Signtficant differences began to show after flies were
shifted to 25°C for 2 hr (p <0.05 compared to that of 18°C). The
numbers of performance indices (Rs) for each group are indicated
on top of the error bars.
human A1342 in flies caused an age-dependent decline
in learning ability.
APP is a type I integral membrane glycoprotein that
is subject to alternative proteolytic pathways. Although
conserved structurally, the physiological function of
APP remains to be identified. A13 peptides are generat-
ed by endoproteolytic cleavage of APP by 13- and y-sec-
retase activities. About 90% of secreted Al3 peptides are
soluble A1340, whereas about 10% are A!342 and A1343
which are highly fibrillogenic, readily aggregated, and
neurotoxic (Price and Sisodia 1998). It is the deposition
of A1342 and Al343 in senile plaques that has been impli-
cated in AD pathogenesis. A1342 secretion and deposi-
tion have been observed in Caenorhabditis elegans
expressing a minigene in which an A1342 fragment with
an artificial stop codon is linked to an artificial signal
peptide. We have made transgenic flies carrying this
minigene under the control of a heat shock promoter
(hs-A1342). Induced expression of A1342 did not reduce
learning and memory scores in young flies (2-4-day-
old adult flies) (not shown), but drastically reduced
learning scores in older flies (30 days old, maximum life
span under these conditions is about 50-60 days) (Fig.
3). We are examining whether other AD neuropatho-
genic features can be observed in these flies.
Ensemble Coding and Odor Perception:
Ca" Imaging of Odor-evoked Neural
Activity in the MB of the Living Drosophila
Y. Wang, N. Wright, J. An, H.-F. Guo
Drosophila has been a powerful genetic model for dis-
secting the molecular basis of learning and memory, but
it has fallen short for studying the physiology of learning
and memory because of the small size of the brain and
central nervous system (CNS) neurons. It has long been
our intention to find a preparation that will allow us to
directly examine the Drosophila CNS. In this study,
neural-activity-dependent changes in intracellular
concentrations were taken as an indicator of neural activ-
ity, which has been successfully used in studying odor-
induced responses in the honeybee antennal lobe and
zebrafish olfactory bulb. The recording of Ca-HP imaging
in fact turns the small size ofDrosophila into an advan-
tage because we can take a close look at the whole mush-
room body (MB), a brain region essential for olfactory
learning in flies. We show here that in combination with
mutant analyses, Ca'' imaging of the living Drosophila
MB, the secondary relay of the olfactory CNS, provides
an ideal model for visualizing ensemble coding and
revealing its biological significance because of its simple
structure and because ensemble coding has a more cen-
tral role at this high level of the CNS. It is demonstrated
that the quality and intensity of an odor are represented
not by simple amplitude of neural activity, but by a spe-
cific pattern of highly distributed neural activity. For the
first time, this study demonstrates that the spatial repre-
sentation of neural activity can be disrupted by mutations
without affecting the overall activity level, but in close
association with a behavioral defect. It is suggested that
the odorant and concentration-specific activity pattern
observed in the MB encodes attractiveness of an odor.
On the basis of this understanding of olfactory coding in
175
A
1000
900
9 800
700
a r 600
81 503
403
MO
100
- o-- ,c33
k33+GTPTS
500
r
6:1
8T 100
0 , 104 104 10. 104 104 104 104 104 10' 104 10' 104
[Ca.] M [Ca.] M
FIGURE 2 Biochemical assay of the NF1 effect on AC activity (4) Reduction in GTPyS-stimulated AC activity in NF1 mutants. The procedure for
the AC assay was modified to amplify the NF1 effect. To minimize variation, each experiment provided one set of results including all data points
presented in Fig. 34. Each data point (mean ± sem.) is averaged from four independent experiments. To be comparable to the rescuing experi-
ment, all flies were subjected to heat shock treatment (for 2 hr at 35°C and 1 hr rest at room temperature). All curves have the same scales as
indicated. (8) Diminished NF1 effect on AC activity in the nit mutant background. To be comparable, flies were also subjected the same heat
shock treatment as those in A. Each data point (mean ± S.E.M., the error bar may not be seen in some data points because it is smaller than the
square symbol) is averaged from three independent experiments. The scale is the same for all curves as well as the same as that used inA.
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MB, we are beginning to investigate how such coding is PUBLICATIONS
modified during olfactory learning and hope to gain
insights into the neural basis of learning.
Two-hybrid Screening of
NF1 Targets That Mediate the
NF1-dependent cAMP Pathway
F. Hannan
Because a yeast homolog of NF1, IRA, has been pro-
posed to bind to the yeast adenylyl cyclase and Ras to
mediate Ras-dependent cAMP synthesis, as well as indi-
cations from electrophysiological data that NF1 may reg-
ulate activation of rut-encoded adenylyl cyclase, we
examined the possibility that the NF1 protein binds to
Rut-AC by yeast two-hybrid analysis. Various combina-
tions of fragments of the coding region of the two genes
were cloned into vectors to test their interactions, but
none were found to give a positive result. Thus, we turned
to the second scenario in which NF1 may interact with
adenylyl cyclase via an intermediate. We are now prepar-
ing to use the yeast two-hybrid system for screening
potential targets of NF I from a fly cDNA library.
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FIGURE 3 Age-dependent learning defect in Ar342 transgenic flies.
Impaired learning in old A15 and A30 flies (two independently isolated
heat shock promoter -controlled A)342 transgenic lies). The test was
taken at day 30. n 35 for each genotype.
COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent research
by outstanding young scientists who, during their graduate studies, displayed exceptional promise of
becoming leading scientists of the future. The purpose of this program is to provide an opportunity for
these young scientists to work independently at the Laboratory for a period of up to 3 years on pro-
jects of their own choice. Fellows are provided with a salary, research support, and technical assis-
tance so that they can accomplish their goals free from other distractions. The interaction among
research groups at the Laboratory and the program of courses and meetings on diverse topics in mol-
ecular biology contribute to a research environment that is ideal for innovative science by these
Fellows.
Previous Cold Spring Harbor Fellows, Dr. Adrian Krainer (1987), Dr. Ueli Grossniklaus (1994), and
Dr. Scott W. Lowe (1995), are currently members of the faculty at the Laboratory. Dr. David Barford
(1991) left in 1994 to go to Oxford University (Laboratory of Molecular Biophysics) as a university lec-
turer. Dr. Eric Richards (1989) is currently Assistant Professor of Biology at Washington University. Dr.
Carol Greider (1988) left after 9 years at the Laboratory to accept a position as Associate Professor in
the Department of Molecular Biology and Genetics at Johns Hopkins University School of Medicine.
Dr. Marja Timmermans joined us from Yale University in 1998.
PLANT DEVELOPMENTAL GENETICS
M. Timmermans P. Vahab
Research in our laboratory is aimed at understanding
the molecular basis of axis specification and pattern
formation during lateral organ development in plants.
Organogenesis in higher plants continues beyond the
period of embryogenesis, and lateral organs of the
shoot develop progressively from small groups of stem
cells named meristems. A family of homeobox genes,
the Knox genes, is expressed in the shoot apical meris-
tern and is required for the self-maintenance of the tis-
sue. Lateral organs such as leaves are initiated by the
recruitment of founder cells, which is facilitated by the
down-regulation of Knotted] (Kn1) homeobox gene
expression in a subset of cells within the meristem.
During or soon after initiation, developmental axes are
specified in the new primordium, which ultimately
results in the differentiation of specific cell types in
the appropriate positions. Signals from the meristem
are thought to be required for the correct orientation of
the new primordium relative to the main body axis.
However, the genetic basis of initiation and patterning
of lateral organs in plants is still largely unknown.
We are using transposable elements to generate
mutants that affect axis specification and pattern for-
mation during lateral organ development in maize. In
particular, we are analyzing the roles of two genes:
Leafbladeless 1 (Lb11) and Rough sheath2 (Rs2). A
better understanding of the function of these and other
genes involved in the early patterning steps during lat-
eral organ formation will provide new insights into
fundamental concepts of plant development. In addi-
tion, these studies may facilitate the manipulation of
plant architecture, which has become increasingly
more important for aspects of crop yield such as shade
tolerance.
Leafbladelessl IS REQUIRED FOR DORSOVENTRALITY
OF LATERAL ORGANS
Normal maize leaves develop as flattened, dorsoven-
tral organs with distinct cell types on the adaxial/dor-
sal and abaxial/ventral sides. We have shown that
recessive mutations in the lbll gene result in a loss of
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adaxial cell types. The most extreme lbll mutant phe-
notype is the formation of radially symmetric, abaxi-
alized leaves. Less severe phenotypes include the for-
mation of ectopic blade tissue at the boundaries
between abaxialized sectors on the adaxial leaf sur-
face. Leaf-like lateral organs of the inflorescences and
flowers show similar phenotypes. Because lbll is a
recessive mutation, these observations are consistent
with a role for Lbll in establishing or maintaining
adaxial cell identity in the leaf and other dorsoventral
lateral organs. These observations also suggest that
lateral growth of the organ occurs at the boundary
between adaxial and abaxial domains.
Dorsoventrality of the maize leaf is in part estab-
lished during leaf initiation by the lateral recruitment
of founder cells. Immunolocalization using a KN1-
specific antibody on transverse sections of wild-type
and lbll mutant apices showed that the number of
founder cells incorporated into lbll leaf primordia is
strongly reduced. Lbll and adaxial/abaxial axis speci-
fication are thus required for the lateral propagation of
leaf founder cell recruitment, and Lbll has a direct or
indirect role in the down-regulation of the homeobox
gene, Knl. Our results are consistent with earlier sur-
gical experiments which suggested that signals derived
from the shoot apical meristem are needed to establish
adaxial/abaxial asymmetry within lateral organs.
We are currently in the process of cloning the Lbll
gene and are isolating additional mutant alleles of lbll.
Phenotypic and restriction-fragment-length polymor-
phism linkage analysis placed the lbll locus in close
proximity to a classical leaf mutant, ragged seedlingl
(rgdl). Subsequent allelism tests showed that rgdl is a
severe allele of lbll. The rgdl mutation frequently
results in embryo lethality and causes segregation dis-
tortion, suggesting that it affects gametophyte develop-
ment. Several potential additional mutant lbll alleles
have been obtained from ethylmethanesulfonate
(EMS)-mutagenized families. The availability of mul-
tiple Ibll alleles will be important to confirm the
cloning of Lbll and to fully analyze the effect of loss of
adaxial cell identity on the different aspects of maize
development.
Rough sheath2 REPRESSES Knox
HOMEOBOX GENES IN LATERAL ORGANS
As mentioned above, the Knox homeobox gene family
is normally expressed in shoot meristems and is
required for their indeterminate growth. The Knox
gene products are absent in normal leaf and floral pri-
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mordia. In maize, several dominant mutants have been
isolated that result in the ectopic expression of indi-
vidual Knox genes in developing leaf primordia. These
mutations interfere with cell differentiation along the
proximodistal axis, resulting in the distal displacement
of sheath and auricle tissues into the distal blade
region of the leaf.
The recessive leaf mutant rs2 exhibits phenotypes
that resemble the phenotypes of the dominant knox
mutants. We showed that in the rs2 mutant, KNOX
proteins are expressed not only in the meristem, but
also in leaf primordia. Depending on the severity of
the mutant phenotype, the number of founder cells
recruited into rs2 mutant leaves was also reduced.
Both observations suggest that Rs2 is a negative regu-
lator of Knox gene expression. Rs2 thus plays an
important part in the transition from the indeterminate
growth of the meristem to the determinate growth of
lateral organs.
We cloned the Rs2 gene that encodes a Myb
domain protein with a novel DNA-binding motif. In
wild-type apices, Rs2 is expressed in young leaf pri-
mordia in a pattern that is consistent with the rs2
mutant phenotype. Comparison of the Rs2 and Knl
expression patterns in wild-type vegetative and floral
apices showed that these two genes are expressed in
mutually exclusive domains. However, the down-regu-
lation of Knl during leaf initiation preceded the onset
of Rs2 expression, suggesting that Rs2 may not act to
down-regulate Knox gene expression, but rather to
maintain the Knox genes in an "off" state. The pattern
of ectopic KNOX accumulation in rs2 mutants is con-
sistent with this interpretation. Ectopic KNOX protein
accumulation in rs2 mutant leaves occurs in a subset
of the normal Rs2-expressing cells. Furthermore,
KNOX proteins accumulated in patches with sharp
lateral boundaries, suggesting that rs2 leaves are clon-
al mosaics of Knox' and Knox-- sectors. This variegat-
ed accumulation of KNOX proteins in rs2 mutants
suggests the Rs2 represses Knox expression through
epigenetic means.
Rs2 is the maize homolog of the Antirrhinum
Phantastica (Phan) gene (Waites et al., Cell 93: 779
[1998]). We showed that a Knox-like homeobox gene
from Antirrhinum is similarly misregulated in phan
mutants, suggesting that Phan and Rs2 have ortholo-
gous functions. Like rs2 mutants, mutations in the
Phan gene cause patterning defects along the proxi-
modistal axis in leaves and other lateral organs (Fig.
1). However, unlike rs2, phan mutants exhibit adaxi-
al/abaxial polarity defects. KNOX proteins delay the
transition from cell proliferation to differentiation.
FIGURE 1 Mutations in the maize Rs2 gene alter the pattern of cell differentiation along the
proximodistal axis. The maize leaf consists of proximal sheath and distal blade tissue,
which are separated by the auricle and ligule. The ligule is an epidermal fringe that devel-
ops on the adaxial leaf surface at the sharp boundary between sheath and blade. In the rs2
mutant, sectors of sheath and auricle tissue are displaced into the distal blade region (A)
and ectopic ligular fringes develop along the sectors of displaced sheath tissue (8). (S)
Sheath; (A) auricle.
Our analysis suggests that the spatial pattern of this
transition in leaves differs among plant species result-
ing in different leaf morphologies. In maize, this pat-
tern occurs along the proximodistal axis, such that
ectopic Knox expression results in a distal displace-
ment of proximal features. The development of abaxi-
al features on the adaxial leaf surface of phan mutant
leaves suggests that this transition in Antirrhinum is
deferred along both the proximodistal and adaxial/
abaxial axes.
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On September 18, 1998, Cold Spring Harbor Laboratory became a degree-granting institution for the
first time in its history. On that day, the Laboratory received authority from the Board of Regents of the
New York State Education Department to grant the Doctor of Philosophy (Ph.D.) and Master of
Science (M.S.) degrees in the biological sciences.
It is an exciting time to establish a new doctoral program in the biological sciences. The pace of
discovery in the biological sciences is breathtaking. It is hard to imagine that less than 50 years ago,
the structure of DNA was unknown and that within the next decade, we will know the complete
sequence of the human genome. Almost daily, scientists report new discoveries and developments in
the biological sciences that have a profound influence on society. The Laboratory's new doctoral pro-
gram will train biologists for this new era in biology.
Since its inception in 1890, Cold Spring Harbor Laboratory has been an institution of higher learn-
ing and for more than 25 years has been involved in graduate education leading to the Ph.D. degree.
Graduate students from institutions with Ph.D. degree-granting authority, most notably the State University
of New York (SUN`l) at Stony Brook, perform their doctoral research at Cold Spring Harbor Laboratory.
Until this year, however, the Laboratory has had no graduate degree-granting program of its own.
The Laboratory is an exciting place for a doctoral program in the biological sciences. Its special
environment provides a unique venue for an innovative and stimulating program. Its international fac-
ulty provides a global view of graduate education in the biological sciences. And its maverick tradition
inspires a new type of doctoral program.
Establishing a Graduate School
The establishment of a graduate school at the Laboratory was the culmination of nearly three years of
effort, which began in November 1995 when the Board of Trustees initiated a study into the desirabil-
ity and feasibility of a graduate school at the Laboratory. During an exploratory period, there were
numerous discussions among the Laboratory trustees and staff and with other institutions to fully
explore the concept of establishing a graduate school at the Laboratory. Encouraged by the discus-
sions, in June 1997 the Board of Trustees authorized the Laboratory to apply to the New York State
Education Department for the authority to grant the Ph.D. degree in the biological sciences.
A coordinated effort to prepare for a Ph.D. program at the Laboratory began. Working in concert
with the New York State Education Department, a timetable was established by which the Laboratory
could begin accepting students for the fall 1999. During the fall 1997, a curriculum was developed
through weekly meetings of interested staff members, and the goals of the Ph.D. curriculum were
established. We set out six ambitious goals.
to offer a doctoral education that takes approximately four years. In the context of a well-designed
program, we believe that students need no longer than four years to develop the skills necessary
to become successful biologists.
to provide extensive guidance, which we will provide in part through a "two-tier" mentoring pro-
gram of research and academic mentors.
to focus course instruction on teaching students how to think about biology independently and
critically.
to provide a broad education in the biological sciences and to demonstrate to students how dis-
coveries in seemingly unrelated fields influence one another.
to offer students an outstanding research experience while emphasizing that learning is a lifelong
process that goes hand in hand with research.
to educate biologists who can communicate effectively with nonscientists.
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The doctoral program that we developed to meet these goals is intense and is designed for stu-
dents with exceptional ability and a deep commitment to their graduate education.
In April 1998, our proposed program was evaluated by a New York State-endorsed review com-
mittee. The committee was chaired by Dr. Keith Yamamoto (University of California, San Francisco) and
included Mr. William T. Golden (Chairman Emeritus of the American Museum of Natural History in New
York City), Dr. Irwin B. Levitan (Brandeis University), Dr. Joachim Messing (Rutgers University), Dr.
Barbara J. Meyer (University of California, Berkeley), and Dr. Frank Solomon (Massachusetts Institute
of Technology). The reviewers were enthusiastic about the proposed program but cautioned the
Laboratory that it would have to take great care in implementing the new innovative and intense pro-
gram to ensure that the students were not overwhelmed.
During preparation of the Ph.D. program, we paid special attention to ensure that there would be
no adverse impact on SUNY Stony Brook or our current shared Ph.D. programs with SUNY Stony
Brook. Currently, 90% of the graduate students at Cold Spring Harbor Laboratory belong to a gradu-
ate program at SUNY Stony Brook, and these SUNY Stony Brook students form an important element
of the educational and research environment at the Laboratory. Furthermore, byestablishing a gradu-
ate school, the Laboratory is eager to enhance-not detract from-the environment for research in the
biological sciences on Long Island. As a result of discussions with SUNY Stony Brook, a mechanism
for coordinated recruitment of students to both institutions was established.
In June 1998, the State Education Department distributed an abstract of the Laboratory's proposal
for degree-granting status to all higher education institutions on Long Island and all Ph.D. degree-grant-
ing institutions in the biological sciences in New York State. The State invitedrepresentatives of these
institutions to comment on the plan. The responses to the proposal reflected strong support, particu-
larly from our two neighboring institutions: SUNY Stony Brook and the Picower Institute. The response
helped ensure approval of the proposal by the Board of Regents in September.
While the proposal was in the final stages of approval, the Laboratory initiated a capital campaign
to raise an endowment for the School. Encouraged by the response of benefactors, it was agreed at
the Laboratory's Board of Trustees meeting on November 7 to matriculate a first classof five students
in the fall 1999, and to begin recruitment of that first class.
An Innovative Ph.D. Program
Advances in biology depend on multidisciplinary approaches, in which knowledge and technology from
diverse areas intersect to inspire new discoveries. Today, however, the breadth of accumulated knowl-
edge about biology is immense-far more extensive than any individual can assimilate. Thus, the
Laboratory's doctoral curriculum has been designed to train self-reliant students who, under their own
guidance, can acquire and assimilate the knowledge their research or career demands require.
The curriculum takes advantage of the unique and flexible environment of Cold Spring Harbor
Laboratory. The first year of the curriculum assumes an innovative format, in whichstudents progress
rapidly from course instruction to doctoral research. The year begins with a 14-week fall course term.
The curriculum used in the fall course term provides intense instruction in a series of integrated cours-
es. Students participate in three core courses-Scientific Reasoning and Logic, Scientific Exposition
and Ethics, and Research Topics-which span the length of the fall term. In parallel, students partici-
pate in three, tandem four-week lecture courses in specialized disciplines. The courses will be taught
by a teaching faculty, consisting of self-selected research and nonresearch faculty.
During the fall term, students are free of research responsibilities, which allows them to devote their
full attention to intensive course instruction and seminars. During the subsequent winter and spring,
students participate in three six-week-long laboratory rotations, a week-long Topics in Biology course,
and teaching high school students at the DNA Learning Center. In May, students select a research
mentor and prepare for the Ph.D. qualifying exam that takes place in June. After the requirements of
the qualifying exam have been satisfied, students focus on their doctoral research.
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The Laboratory is committed to the success of its graduate students. To promote a high level of
student achievement, the faculty and administration will take an active role in mentoring and supervis-
ing the students. A special feature of the curriculum is the "two-tier" mentoring program, which involves
an academic mentor and a research mentor for each student. At matriculation, each student will be
assigned a faculty member as an academic mentor. The academic mentor follows the student's aca-
demic and research progress and provides advice for the duration of the student's tenure in the grad-
uate program. After the laboratory rotations, each student chooses a research mentor. The research
mentor is the doctoral thesis research advisor, who supervises the student's independent laboratory
research. By providing both academic and research mentors, the School of Biological Sciences pro-
vides each student with advice from faculty who hold different views and can offer unique and in-depth
evaluations of the student.
After the first year, students focus on laboratory research. Nevertheless, course instruction, in the
form of the annual Topics in Biology course, and annual participation in the Laboratory's postgraduate
courses (of the student's choosing) continues. Approximately six to nine months before defending the
research thesis, students will prepare and defend a postdoctoral research proposal. For those students
who plan to continue in research, this proposal will outline a postdoctoral research program, which will
aid students in the preparation of postdoctoral fellowship applications. For students who do not plan
to continue in scientific research, the proposal will describe their future plans and how they plan to use
their doctoral education after receiving the Ph.D. degree.
An Exciting and Intensive Graduate Program
The Cold Spring Harbor Laboratory School of Biological Sciences is designed to provide an exciting
and intensive educational experience. Course work is concentrated in, but not limited to, the fall term
of the first year. Students are expected to begin full-time laboratory research within ten months and to
complete the doctoral degree within approximately four years. The program has been designed for
outstanding, self-motivated students. To provide each student with the individual attention necessary
to ensure success in the program, we intend to keep class sizes small. In April of this year, we learned
that six outstanding students from across the country and around the world-the founding class-will
be joining us this fall to begin this exciting new adventure. We look forward to the beginning of the
School with great excitement...and a proper touch of apprehension!
A New Name
As the initiative to establish a graduate school came to fruition, the Laboratory's administration and
Board of Trustees strongly agreed that it would be appropriate to name the unique, new educational
program for long-term Laboratory director and now president Jim Watson. Jim was asked, and reluc-
tantly approved, and an application for the formal name change was submitted to New York State. On
February 3, 1999, the New York State Board of Regents granted Cold Spring Harbor Laboratory
authority to change the name of the graduate program to Cold Spring Harbor Laboratory Watson
School of Biological Sciences in recognition of its president James D. Watson. It is fitting that, after all
that Jim Watson has done for the biological sciences, for education, and for Cold Spring Harbor
Laboratory, the new school is named in his honor.
May 1999
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ACADEMIC AFFAIRS
The academic program at Cold Spring Harbor serves to communicate new discoveries, concepts, and
methodologies to an international community of scientists from universities, medical schools, research
institutes, and industry. A broad-ranging series of postgraduate laboratory and lecture courses, work-
shops, and large meetings now extend almost year round. In addition, a summer research program for
undergraduates enables college students to work in the laboratories of Laboratory scientists.
The courses and workshops serve a unique function, emphasizing the state-of-the art method-
ologies that may be applied immediately to the students' own research. Lectures and discussions serve
to set the experiments in the context of the field and its most recent scientific advances. The courses
are of relatively short duration so that senior scientists as well as junior faculty, postdoctoral fellows, and
graduate students can attend. All of the courses are oversubscribed, which is a tribute to the skills and
talents of the instructors as well as the timeliness of the courses. The meetings held this year enabled
scientists to present their latest results in a broad range of areas in molecular biology, genomics, and
neurobiology. A key feature of most meetings is that talks are selected by the organizers from submit-
ted abstracts, allowing junior as well as senior scientists to present innovative work. This year, more
than 7000 scientists came to the Laboratory, including instructors, lecturers, and students in the cours-
es as well as meeting participants.
This year, 20 molecular genetics, genomics, structure, and neurobiology laboratory courses were
held. These were taught in the Howard Hughes Medical Institute (HHMI) teaching laboratories in the
Beckman Neuroscience Center and the Delbruck Laboratory. In addition, five neurobiology lecture and
workshop courses were held at the Banbury Center. Course instructors, assistants, lecturers, and stu-
dents are listed in the following pages. The instructors, who come from universities and research insti-
tutes around the world to teach at Cold Spring Harbor, are really the key to the high quality and suc-
cess of the courses. It is their creativity and skill that make the program so effective.
Each year, some scientists who have taught in the courses for several years retire. We are sorry to
see them go, but we know that we can count on them to return to give advice and lectures in future
years. This year, they include Michael Carey, an instructor in the Eukaryotic Gene Expression course;
Eric Lam and Jane Glazebrook who taught the Arabidopsis Molecular Genetics course; Dan
Gottschling, a Yeast Genetics course instructor; Tito Serafini who taught the course on Molecular
Cloning of Neural Genes; Nipam Patel and Michael Dickenson, instructors in the Neurobiology of
Drosophila course; and instructors John Caldwell, Rock Levinson, and Robert Maue, who taught the
course on Integrated Approaches to Ion Channel Biology.
The courses are supported by, and would not be possible without, a series of grants from federal
and private sources. The summer molecular genetics courses have been supported for many years by
grants from the National Institutes of Health (NIH) and the National Science Foundation (NSF). A grant
from the National Institute of Mental Health supports several of the neurobiology courses. A large and
most valuable education grant from HHMI has provided stable support for the neurobiology program
and has allowed the Laboratory to begin and support a variety of new courses. We are also pleased to
acknowledge an award from the Esther and Joseph A. Klingenstein Fund for the support of neurobiol-
ogy courses and funds from the Grass Foundation for scholarships for students in neurobiology cours-
es. In addition, the Laboratory receives valuable support from many companies that donate supplies
and lend equipment for the courses.
Eighteen meetings were held at the Laboratory this year. Several new meetings took place as well
as many old favorites that recur on a biannual basis. Organizers and meeting chairs are listed on the
following pages, and we are, as always, most grateful for their efforts. New meetings this year includ-
ed: The Genetics of Aging organized by Judith Campisi, Lenny Guarente, and Cal Harley; Axon
Guidance and Neural Plasticity, organized by Corey Goodman, Carla Schatz, and Marc Tessier-Levigne;
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Gametogenesis, organized by Brigid Hogan and Allan Spradling; and Dynamic Organization of Nuclear
Function, organized by Robert Goldman, John Newport, Pam Silver, and David Spector. A special win-
ter meeting on Pathways to Cancer, organized by Ed Harlow, Bruce Stillman, and Jan Witkowski, took
place in March. Several returning meetings continue to serve the scientific community and were, in fact,
oversubscribed. These included Zebrafish Development and Genetics; Genome Mapping, Sequencing
and Biology; Retroviruses; Cancer Genetics and Tumor Suppressor Genes; Mouse Molecular
Genetics; and Translational Control. We expect these meetings to be held again in 2 years.
The Symposium continues to be the centerpiece of the Laboratory's meeting program. The meet-
ing this year on Mechanisms of Transcription was organized and is discussed below by Bruce Stillman.
It brought together a large and animated crowd of scientists to discuss their latest research.
This year, two technology conferences, The Arabidopsis Genome: From Sequence to Function
and Conditional Genetics Technologies in the Mouse, were held outside of the regular meetings sched-
ule. These biotechnology conferences, now in their third successful year, will continue in the future. All
organizers and contributors to the meetings are listed on the following pages. The sources of support
for these meetings come from the Laboratory's Corporate Sponsor program, NIH, NSF, DOE, and var-
ious corporations and foundations. Grants helped scientists at all stages of their careers to attend the
conferences.
While graduate students, postdoctoral fellows, and faculty participate in the courses and meet-
ings, the Undergraduate Research Program (URP) provides an opportunity for college undergraduates
to spend 10 weeks at the Laboratory during the summer. The program, headed by Michael Hengartner,
allows students to do research in the laboratories of staff scientists.
The large numbers of courses and meetings proceed with skill and efficiency, thanks to the col-
laborative efforts of a large number of people at the Laboratory. The staff of the Meetings and Courses
Office coordinates the arrangements for all of the visiting scientists. This enormous job, which seems
to grow every year, is carried out not only with extreme efficiency, but with patience and tact as well.
The staff includes Micki McBride (the Course Registrar), Nancy Weeks (Head Concierge), Diane Tighe,
Marge Stellabotte, Andrea Stephenson, Drew Mendelson, Mary Smith, and Michael Glaessgen, Donna
Dykeman, Andrea Newell, as well as Herb Parsons, Ed Campodonico, Bill Dickerson, and the part-
time audiovisual staff. Staff from several other departments are crucial to the success of the meetings
and courses including Cliff Sutkevich and his staff who set up and maintain course equipment; and
Wendy Crowley, the Education Grants Manager. We especially want to acknowledge the splendid work
of Edie Kappenberg, the course coordinator, who left the Laboratory this year. We are most pleased
that Barbara Zane, a former buyer in the Purchasing Office, has returned to the Laboratory to take over
the position of course coordinator.
Terri Grodzicker
Assistant Director for Academic Affairs
David Stewart
Director of Meetings and Courses
190
63rd COLD SPRING HARBOR SYMPOSIUM
ON QUANTITATIVE BIOLOGY
Mechanisms of Transcription
June 3-8 437 participants
ARRANGED BY Bruce Stillman, Cold Spring Harbor Laboratory
The field of gene transcription intertwines with many other areas of modern biological research because
of its fundamental significance. It has been some time since a Cold Spring Harbor Laboratory
Symposium focused solely on this important topic, in part because transcription is usually included in
all Symposia in one form or another. But because of the significant advances that have occurred dur-
ing the last few years in our understanding of how genes are transcribed, it seemed appropriate to hold
a meeting on this topic again. The dramatic advances made in this field over the last 20 years have led
to the identification of a vast set of basal transcription factors in eukaryotes. Moreover, this field has
encompassed the exciting progress in related areas such as structural biology and chromatin structure
and function.
Nearly 40 years have passed since the discovery of the first RNA polymerase by Sam Weiss. Many
previous Cold Spring Harbor Laboratory Symposia have incorporated aspects of gene transcription
and gene regulation into the program, as this topic in many ways represents the core of biology. Most
noteworthy here was the famous 1977 Symposium on Chromatin, where the fundamental under-
standing of gene structure in eukaryotes was overturned. Today, we are in the midst of a very stimu-
lating era that is focused on understanding the mechanisms of gene transcription and, at this
Symposium, we listened to 67 talks, and studied posters, that reflected this excitement.
It is also most fitting that a Symposium on gene transcription be held this year as we celebrated
the 30th year that Jim Watson has worked at the Laboratory, first as Director for 25 years and now as
President. At the beginning of this meeting, I presented to Jim, on behalf of the Laboratory, a gold
model of the DNA double helix. Five years ago, Jim presented the twin of this golden helix to Francis
A. Krainer, J.D. Watson, L. Miller, T. Maniatis, B. Stillman
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Crick at a Cold Spring Harbor meeting on the occasion of the 40th anniversary of their discovery of the
structure of DNA. What better occasion to make this presentation to Jim than when many of his for-
mer students and colleagues were present? Prior to his coming to Cold Spring Harbor, Jim's labora-
tory at Harvard had made some of the key contributions to the early work on the mechanisms of gene
transcription, including the discovery of a factor.
One of the many responsibilities of the Director is to organize the annual Symposium and this Jim
did for many years. The first Symposium he organized, in 1970, was appropriately enough on
"Transcription of Genetic Material." It celebrated, among other things, the discovery 2 years before of
the a factor for RNA polymerase in bacteria. At that meeting, David Baltimore also presented the excit-
ing news of reverse transcriptase.
Jim noted in his foreword to the Symposium volume of that year: "The final result was a compro-
mise between a desire to hear everyone with relevant data and the need to restrict the talks to a num-
ber ingestible within a week's time." In this respect, nothing has changed in the last 28 years. It was
necessary to make the usual hard choices in selecting speakers. For the organization of this meeting,
my colleagues Winship Herr, Nouria Hernandez, Bob Tjian, Carol Gross, Rich Losick, and a number of
others provided valuable advice.
The Symposium started with a fascinating first night of introductory talks from Carol Gross, Robert
Tjian, Tom Maniatis, and David Allis. Bob Roeder, who has made many seminal contributions to the
biochemistry of transcription, presented this year's Reginald Harris Lecture. The Dorcas Cummings
Lecture for our friends and neighbors was this year given by Ronald Evans, who gave a spectacular
and fascinating assessment of obesity, "The Molecular Biology of Fat: Weighing the Risks." The formal
scientific program consisted of 67 oral presentations and a record 155 poster presentations, and the
meeting attracted 437 participants. I thank Rich Losick for agreeing to summarize the meeting and
writing such a marvelous and thoughtful summary, matching the great summaries of previous
Symposia.
We were particularly fortunate this year to have Lewis Miller as an artist in residence during the
meeting. Lewis, who hails form Melbourne, Australia, won the prestigious Archibald Portrait Prize in
1998. He sketched many of the Symposium participants, and Blackford Hall is now graced with some
of these marvelous portraits.
Essential funds to run this meeting were obtained from the National Cancer Institute, a branch of the
National Institutes of Health. In addition, financial help from the Corporate Sponsors of our meetings pro-
gram is essential for these Symposia to remain a success and we are most grateful for their continued sup-
port. These sponsors are Amgen Inc., BASF Bioresearch Corporation, Bayer Corporation, Bristol-Myers
Squibb Company, Chiron Corporation, Chugai Research Institute for Molecular Medicine, Inc., Diagnostic
Products Corporation, Forest Laboratories, Inc., Genentech, Inc., Genetics Institute, Hoechst Marion
K. Yamamoto
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J. Roberts, T. Steitz
T. Grodzicker, R. Losick, S. Gottesman R. Evans, R. Roeder
Roussel, Hoffmann-La Roche Inc., Johnson & Johnson, Kyowa Hakko Kogyo Co., Ltd., Eli Lilly and
Company, Merck Genome Research Institute, Novartis Pharma Research, Novo Nordisk Biotech,
Inc./ZymoGenetics, Inc., OSI Pharmaceuticals, Inc., Pall Corporation, Parke-Davis Pharmaceutical
Research, The Perkin-Elmer Corporation, Applied Biosystems Division, Pfizer Inc., Pharmacia & Upjohn,
Inc., Research Genetics, Inc., Schering-Plough Corporation, SmithKline Beecham Pharmaceuticals,
Wyeth-Ayerst Research, and the Zeneca Group PLC. Plant Corporate Associates include American
Cyanamid Company, Monsanto Company, Pioneer Hi-Bred International, Inc., and Westvaco Corporation.
We also thank our Foundation Associate, The Albert B. Sabin Vaccine Institute at Georgetown University,
and our Corporate Contributors, Genome Systems, Lexicon Genetics, and Qiagen, Inc.
PROGRAM
Welcoming Remarks: Bruce Stillman
Introduction
Chairperson: W. Herr, Cold Spring Harbor Laboratory
Activation
Chairperson: P. Sharp, Massachusetts Institute of Technology,
Cambridge
Promoter Recognition
Chairperson: L. Rothman-Denes, University of Chicago,
Illinois
Repression Mechanisms
Chairperson: T Maniatis, Harvard University, Cambridge,
Massachusetts
Reginald G. Harris Lecture: "Transcriptional Regulation
through General and Gene-specific Coactivators"
Speaker: R.G. Roeder, Rockefeller University, New York
Core Factors
Chairperson: R. Burgess, University of Wisconsin, Madison
Polymerase and Promoter Clearance
Chairperson: J. Kadonaga, University of California, San
Diego
Chromosome Structure and Transcription
Chairperson: C. Wu, National Cancer Institute, Bethesda,
Maryland
Remodeling Chromatin
Chairperson: R. Tjian, University of California, Berkeley
Regulation
Chairperson: G. Felsenfeld, NIDDK, National Institutes of
Health, Bethesda, Maryland
Dorcas Cummings Lecture: "The Molecular Biology of Fat:
Weighing the Risks"
Speaker: R. Evans, Howard Hughes Medical Institute, The
Salk Institute, San Diego, California
More Regulation, Initiation, and Elongation
Chairperson: K. Yamamoto, University of California, San
Francisco
Starting and Stopping
Chairperson: J. Conaway, Oklahoma Medical Research
Foundation, Oklahoma City
Summary: R. Losick, Harvard University Cambridge,
Massachusetts
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SPECIAL CONFERENCES
Breakthrough! How News Influences Health Perception and
Behavior
February 27-March 1 133 participants
ARRANGED BY Susan Cooper, Trudeau Institute, New York
Eric Rosenthal, Fox Chase Cancer Center
Dianne Shaw, University of North Carolina
Jan Witkowski, Cold Spring Harbor Laboratory
Laurie Young, University of Arizona
This unique weekend workshop examined what shapes the presentation and dissemination of research
findings and how this affects public expectations about health and science. The workshop aimed to
generate a dialogue between scientists, journalists, and communicators and to explore how scientific
news is communicated and reported. With more than 130 participants, and 35 oral presentations, the
workshop provided a thought-provoking opportunity to address these issues.
Speakers included editors (Richard Horton/The Lancet, Marcia Angell/New England Journal of
Medicine, Ellis Rubinstein/Science), journalists (Bob Bazell/NBC, Joe Pa Ica/NPR, Victor Cohn/Washington
Post, Gina Kolata/New York Times, Richard Saltus/Boston Globe) and scientists (Richard Klausner /National
Cancer Institute, Frank Rauscher III/The Wistar Institute, Carol Greider/Johns Hopkins School of Medicine).
In particular, the organizers chose to focus primarily on cancer, with
sessions devoted to the National Cancer Act 25 years on, mammogra-
phy screening, genetic testing (using BRCA-1 as an example), clinical tri-
als, and complementary/ alternative therapies, although a fascinating
session was included to examine how the cloning of Dolly was reported
and perceived. All in all, this workshop was considered to be an out-
standing success in many ways and should lay the foundation for special
workshops of this type in the future.
This meeting was supported in part by the National Cancer Institute,
a branch of the National Institutes of Health, and Cold Spring Harbor
Laboratory.
S. Cooper, J. Witkowski
PROGRAM
National Cancer Act
Moderator: V DeVita, Yale Cancer Center
Mammography Screening
Moderator: R. Horton, The Lancet
Genetic Testing: BRCA-1 as a Case Study
Moderator: E. Rubinstein, Editor, Science
The Cloning Story
Moderator: R. Cook-Deegan, National Academy of Sciences
Clinical Trials
Moderator: M. Angell, New England Journal of Medicine
Complementary Therapies
Moderator: Z. Hall, University of California, San Francisco
Summary and Conclusion
Moderator: S. Cooper, Trudeau Institute
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E. Rosenthal, D. Shaw, L. Young
Pathways to Cancer
March 11-14 154 participants
ARRANGED BY Ed Harlow, Massachusetts General Hospital
Bruce Stillman, Cold Spring Harbor Laboratory
Jan Witkowski, Cold Spring Harbor Laboratory
The year 1998 marked three important anniversaries: 50 years ago Jim Watson came to Cold Spring
Harbor Laboratory; 30 years ago he became Director; and 30 years ago was the beginning of the DNA
Tumor Virus Program. A special meeting-appropriately on cancer research-was held in Grace
Auditorium to celebrate these anniversaries. The Pathways to Cancer meeting examined both the mol-
ecular mechanisms that lead to cancers and the molecular events underlying particular types of can-
cer. Many of the world's leading cancer researchers took part, and Ed Scolnick, President of Merck
Research Laboratories, gave the keynote address on "Cancer through a Therapeutic Looking Glass."
PROGRAM
Introduction: A Brief Description of CSHL and Cancer
Research
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
Control of Cancer Cell Proliferation
Chairperson: E. Harlow, Massachusetts General Hospital,
Charlestown
Cancer Genetic Pathways
Chairperson: G. Rubin, University of California, Berkeley
Signaling Pathways in Cancer
Chairperson: J. Witkowski, Cold Spring Harbor Laboratory
Cancer Cell Growth Controls
Chairperson: S. Courtneidge, Sugen, Inc., Redwood City
California
Cancer Pathways from Cell to Clinic
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
Concluding Remarks: James D. Watson, Cold Spring Harbor
Laboratory
H. Varmus, B. Stillman, G. Rubin
E. Harlow, R. Jain R. Nusse, B. Ponder, A. Pawson
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SPRING MEETINGS
Genetics of Aging
April 2-5 179 participants
ARRANGED BY Judith Campisi, University of California, Berkeley
Leonard Guarente, Massachusetts Institute of Technology
Calvin Harley, Geron Corporation
This was the first meeting anywhere devoted solely to the genetics and molecular biology of aging.
Approximately 180 participants heard plenary presentations on topics including aging in model sys-
tems, DNA helicases and aging, senescence of cultured mammalian cells, telomere shortening in mam-
malian cells, and genomics of aging. The talks centered on new molecular and genetic approaches to
studying aging that promise to elucidate basic underlying mechanisms in model systems and, ulti-
mately, in humans. Notable advances were reported in studies of yeast, C. elegans, and cultured fibro-
blasts. The meeting led to the view that the pace of aging research is accelerating and will provide excit-
ing new insights in the near term.
This meeting was funded in part by the National Institute of Aging, a branch of the National
Institutes of Health. Contributions from the Corporate Sponsors, Plant Corporate Associates, and
Foundations provided core support for this meeting.
W. Herr, L. Guarente
PROGRAM
Model Systems
Chairperson: C. Kenyon, University of California, San
Francisco
Wrn-like Genes
Chairperson: L. Guarente, Massachusetts Institute of
Technology Cambridge
Short Talks from Abstracts
Chairpersons: J. Campisi, Lawrence Berkeley National
Laboratory California; W. Funk, Geron Corporation, Menlo
Park, California; L. Guarente, Massachusetts Institute of
Technology Cambridge; C. Harley, Geron Corporation,
Menlo Park, California
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C. Dennis, C. Harley
Telomeres and Telomerase
Chairperson: T. de Lange, Rockefeller University, New York,
New York
Cell Senescence and Telomeres
Chairperson: C. Harley, Geron Corporation, Menlo Park,
California
Cell Senescence and Gene Expression
Chairperson: J. Campisi, Lawrence Berkeley National
Laboratory California
Impact of Genomics and Human Genetics on Aging Research
Chairperson: M. Rose, University of California, Irvine
Zebrafish Development and Genetics
April 29-May 3 438 participants
ARRANGED BY Marie-Andree Akimenko, University of Ottawa
Jose Antonio Campos-Ortega, University of Koln
John Postlethwait, University of Oregon
Eric Weinberg, University of Pennsylvania
Stephen Wilson, Kings College London
This third Cold Spring Harbor Laboratory meeting featured more than 300 platform talks and poster
presentations, which covered many of the most interesting areas of current zebrafish research. Exciting
sessions were held on Early Development and Dorsoventral Patterning (including maternal control),
Organizing the Axis (including reports of cloning of a number of key genes identified in chemical muta-
genesis screens), Mesoderm and Endoderm Patterning, Neural Patterning, Axonal Pathfinding,
Organogenesis and Histogenesis, Genomics, and Innovative Methods. Progress was reported in using
insertional mutagenesis to carry out mutant screens, in the development of transposon tagging meth-
ods, and in genomic analysis of the zebrafish genome. The information presented confirmed the great
L. Zon, T, Zhong
W. Driever, N. Hopkins
C. Nislein-Vollard
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promise of the zebrafish as a model vertebrate for the study of developmental and physiological
processes. The meeting clearly indicated that molecular characterization of genes first identified from
zebrafish mutant screens is adding greatly to our knowledge of vertebrate development.
This meeting was funded in part by the National Institute of Child Health and Human Sciences;
National Institute of Environmental Health Sciences; National Institute on Deafness and Other
Communication Disorders; National Institute of Neurological Disorders and Stroke; National Institute of
Diabetes and Digestive and Kidney Diseases; National Human Genome Research Institute; and the
National Center for Research Resources (all branches of the National Institutes of Health); and the
National Science Foundation. Contributions from the Corporate Sponsors, Plant Corporate
Associates, Foundations, and Technical Contributors provided core support for this meeting.
PROGRAM
Early Development and Dorsoventral Patterning
Chairperson: F. Rosa, Ecole Norma le Superieure, Pan's, France
Organizing the Axis
Chairperson: L. Solnica-Krezel, Vanderbilt University
Nashville, Tennessee
Mesoderm and Endoderm Patterning
Chairperson: M. Halpern, Carnegie Institution of Washington,
Baltimore, Maryland
Neural Patterning I
Chairperson: C. Beatty, Ohio State University Columbus
Neural Patterning II
Chairperson: M. Cooper, University of Washington, Seattle
Axonal Pathfinding
Chairperson: F. Bonhoeffer, Max-Planck-Institut fur
Entwicklungsbiologie, Tubingen, Germany
Sensory Systems, Neural Crest and Head
Chairpersons: T. Whitfield, University of Sheffield, United
Kingdom; D. Raible, University of Washington, Seattle
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Organogenesis and Histogenesis I
Chairperson: D. Stainier, University of California, San
Francisco
Organogenesis and Histogenesis II
Chairperson: A. Shima, University of Tokyo, Japan
Keynote Speaker
Chairperson: J. Rossant, Samuel Lunenfeld Research
Institute
Genomics
Chairperson: P. Hefter, Max- Planck -lnstitut far
Entwicklungsbiologie, Tubingen, Germany
Innovative Methods
Chairperson: P. Hackett, University of Minnesota, St. Paul
Molecular Chaperones and the Heat Shock Response
May 6-10 400 participants
ARRANGED BY Carol Gross, University of California, San Francisco
Arthur Horwich, HHMI/Yale School of Medicine
Susan Lindquist, University of Chicago
The meeting featured advances in three major areas: structure and mechanism of action of molecular
chaperones; mechanisms of induction of the stress response; and nature and mechanism of protein
misfolding in disease. In the first area, further advances in understanding the mechanism of action of
Hsp20, Hsp60, Hsp70, Hsp90, and Hsp100 class chaperones were presented. A highlight in this area
was a first look at high resolution at a small heat shock protein, a hollow "soccer ball" with windows,
that likely captures non-native proteins at its surface during heat shock. In the area of stress response,
further advances in understanding the heat shock transcription factor were reported. Evidence for a role
of Hsp90 as a thermometer sensing cytosolic stress was presented. There were also several exciting
talks summarizing the rapid progress in understanding the unfolded response of the ER, by which mis-
C. Gross, P. Walter
M.-J. Gething, E. Craig I. Yahara, S. Lindquist
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folded proteins in this compartment signal to the nucleus to induce a collective of ER chaperones and
other components that likely serve a protection function. The topic of protein misfolding in disease was
inaugurated with two dedicated sessions, including reports on amyloid formation in Alzheimer's dis-
ease, Lowey body formation in Parkinson's disease, nuclear aggregate formation in polyglutamine
repeat disease (Huntington), and amyloid formation in prion disease and in transthyretin polyneuropa-
thy. The interactions of chaperones both with amyloidogenic protein in prion disease in yeast and with
mutant CFTR in the ER and cytoplasm were also discussed.
This meeting was funded in part by the National Institute of Neurological Disorders and Stroke, a
branch of the National Institutes of Health; Affinity Bioreagents, Inc.; Alzheimer's Association; Bristol-
Myers Squibb Company; Cystic Fibrosis Foundation; Medical and Biological Laboratories Company,
Ltd.; Merck Research Laboratories; and Stress Gen Biotechnologies Corporation. Contributions from
the Corporate Sponsors, Plant Corporate Associates, and Foundations provided core support for this
meeting.
PROGRAM
Diseases of Protein Misfolding
Chairperson: S. Radford, University of Leeds, United Kingdom
Regulation of the Heat Shock Response
Chairperson: C. Wu, NCI, National Institutes of Health,
Bethesda, Maryland
Chaperone Structure and Function I
Chairperson: L. Gierasch, University of Massachusetts,
Amherst
Cell Biology and Proteolysis
Chairperson: E. Vierling, University of Arizona, Tuscon
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Cell Biology
Chairperson: I. Yahara, The Tokyo Metropolitan Institute of
Medical Science, Japan
Chaperones in Disease
Chairperson: R. Kaufman, University of Michigan Medical
Center, Ann Arbor
Chaperone Structure and Function II
Chairperson: B. Bukau, Albert-Ludwigs Uniyersitat Freiburg,
Germany
Genome Mapping, Sequencing, and Biology
May 13-17 453 participants
ARRANGED BY Mark Boguski, National Center for Biotechnology Information
Richard Gibbs, Baylor College of Medicine
Stephen Brown, MRC Mouse Genome Centre
This meeting marked the 11th annual gathering of genome scientists in this setting. The past 10 years
have seen remarkable progress in the mapping and sequencing of the genomes of many "model
organisms," and there is now strong confidence that the human genome sequence is an attainable
goal. Phrases such as "functional genomics" and "post-genome biology" have become common
terms. In the light of this emerging shift of emphasis, the new organizers chose to modify the name of
the annual meeting to reflect these changes, by the inclusion of the term "biology." More than 450 peo-
ple from around the world attended the meeting, with 254 abstracts presented describing a broad
array of topics relating to the analysis of genomes from a number of different organisms.
E. Landes, R. Gibbs S. Brown, M. Bucan
S. Brenner, M. Smith
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The session topics includes areas such as biological insights from phylo-genomics, mapping
methods and technologies, functional genomics, computational genomics, and 21st century genetics.
This year's poster session featured progress on sequencing the human genome. Once again, projec-
tion-style, interactive computer demonstrations in Grace Auditorium effectively highlighted the critical
new bioinformatics tools being developed for storing, organizing, and analyzing genomic maps and
sequences. There was also a panel discussion on the genome ELSI (Ethical, Legal, and Social
Implications) program, chaired by Francis Collins, Director of the National Human Genome Research
Institute, which included a timely presentation on the ethical and scientific issues relating to the appli-
cation of single nucleotide polymorphisms (SNPs).
The major themes of the meeting related to the gathering pace of human genomic sequencing and
the increasing number of approaches being developed for using sequence data to perform important
biologic studies. Specific presentations continued to report major achievements in the sequencing of
microbial genomes, the development of new sequencing technologies, and the use of microarrays for
performing genome analysis. The now traditional Saturday afternoon keynote talk was delivered by
Harold Varmus, Nobel Laureate and Director of the National Institutes of Health.
With the anticipated achievements in the next decade, future genome meetings at Cold Spring
Harbor should continue to serve as the premiere showcase for the Human Genome Project and
genome research.
This meeting was funded in part by the National Human Genome Research Institute, a branch of
the National Institutes of Health. Contributions from the Corporate Sponsors, Plant Corporate
Associates, and Foundations provided core support for this meeting.
PROGRAM
Phylo-Genomics
Chairpersons: C. Fraser, The Institute for Genomic Research,
Rockville, Maryland; H. Jacob, Medical College of
Wisconsin, Milwaukee
Computational Genomics
Chairpersons: D. Lipman, NCBI, National Institutes of Health,
Bethesda, Maryland; G.Duyk, Millenium Pharmaceuticals,
Cambridge, Massachusetts
Computer Demonstrations I
Chairperson: 0. Lichtarge, Baylor College of Medicine,
Houston, Texas
Mapping
Chairpersons: J. MacPherson, Washington University School
of Medicine, St. Louis, Missouri; L. Stubbs, Lawrence
Livermore National Laboratory California
Large-scale Sequencing Poster Symposium
Chairperson: E. Green, NHGRI, National Institutes of Health,
Bethesda, Maryland
Computer Demonstrations II
Chairperson: J. Zhang, NCBI, National Institutes of Health,
Bethesda, Maryland
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ELSI Panel Discussion
Chairperson: F. Collins, NHGRI, National Institutes of Health,
Bethesda, Maryland
Functional Genomics I
Chairpersons: V. Cheung, University of Pennsylvania,
Philadelphia; L. Stadt, NCI, National Institutes of Health,
Bethesda, Maryland
Functional Genomics II
Chairpersons: M. Bucan, University of Pennsylvania,
Philadelphia; E. Rubin, Lawrence Berkeley National
Laboratory California
Computer Demonstrations III
Chairperson: R. McCombie, Cold Spring Harbor Laboratory
Keynote Speaker
Chairperson: H. Varmus, National Institutes of Health
21st Century Genetics
Chairpersons: A. Chakrayarti, Case Western Reserve
University Cleveland, Ohio; M. Meisler, University of
Michigan, Ann Arbor
The Cell Cycle
May 20-24 342 participants
ARRANGED BY Fred Cross, Rockefeller University
Jim Roberts, Fred Hutchinson Cancer Research Center
The fifth biannual Cell Cycle meeting was held this year at Cold Spring Harbor. This conference is inter-
nationally recognized for its ability to bring together scientists who study cell cycle regulation in eukary-
otes ranging from yeast to humans. Diverse themes from previous years received continued attention:
the interaction of cell cycle control with developmental and cancer biology; mechanisms of CDK acti-
vation by cyclins and by activating phosphorylation; the key role of proteolysis in regulating cell cycle
transitions; and the mechanisms of action of cell cycle checkpoints. Research in proteolysis for both
Gi/S and G2/M regulation in particular continues to receive intense focus, with much progress report-
ed. There was a high level of new interest in the long-standing problem of regulation of DNA replica-
tion in the cell cycle, its onset, and its restriction to once per cell cycle. This problem was examined
from the perspective of regulation of nuclear transport and binding to origins of key activators of DNA
replication in yeast, flies, and mammalian cells in culture. There was also an extension of previous con-
cepts derived from yeast studies to metazoans in the examination of the coordination between growth
and cell cycle progression in mammals and in flies.
As in other years, scientists studying cell cycle regulation in yeast, Xenopus, Drosophila, and mam-
mals were well represented. Once again the striking phylogenetic conservation of cell cycle regulatory
mechanisms was readily evident.
The cell cycle conference brought together 342 scientists for talks and the presentation of posters.
It was another landmark meeting for the cell cycle field, and the participants all continued to look for-
ward to equally exciting meetings in future years.
This meeting was funded in part by the National Cancer Institute, National Institute of Aging, and
the National Institute of Child Health and Human Development, all branches of the National Institutes
of Health, and the National Science Foundation. Contributions from the Corporate Sponsors, Plant
Corporate Associates, and Foundations provided core support for this meeting.
J. Roberts, C. Sherr R Oliver, M. Fero
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F. Cross, T. Grodzicker
PROGRAM
Keynote Address
Speaker: B. Stillman, Cold Spring Harbor Laboratory
Replication I
Chairperson: J. Diffley, ICRF Clare Hall Laboratories, South
Mimms, United Kingdom
CDK Regulation
Chairperson: J. Ruderman, Harvard Medical School, Boston,
Massachusetts
Cell Cycle Control I
Chairperson: C. Sherr, Howard Hughes Medical Institute,
St. Jude Children's Research Hospital, Memphis,
Tennessee
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Cell Cycle Control II
Chairperson: L.-H. Tsai, Howard Hughes Medical Institute,
Harvard Medical Institute, Boston, Massachusetts
Replication II
Chairperson: T. Orr-Weaver, Whitehead Institute/MIT,
Cambridge, Massachusetts
Development
Chairperson: B. Edgar, Fred Hutchinson Cancer Research
Center, Seattle, Washington
Mitosis
Chairperson: B. Dunphy, Howard Hughes Medical Institute,
California Institute of Technology, Pasadena
Telomeres/Senescence/Cancer/Checkpoints
Chairperson: T. de Lange, Rockefeller University, New York
Retroviruses
May 26-31 439 participants
ARRANGED BY Paul Jolicoeur, Clinical Research Institute of Montreal
Michael Emerman, Fred Hutchinson Cancer Research Center
The annual Retrovirus meeting is the major international meeting to discuss fundamental aspects of
retrovirus biology. It has become a comprehensive meeting in which the replication and pathogenesis
of many different viruses (including HIV) can be compared. New information was forthcoming from
many different levels. For example, a session on viral assembly presented progress on determination
of the structure of these viruses and on the pathways in which the structures are assembled. New data
were also presented on the means by which viruses enter cells and what steps are limiting in this
process. Two new sessions were also added this year to discuss the burgeoning amount of informa-
tion on how the virus usurps cellular processes to transport viral RNA and proteins and how the virus
redirects trafficking of cellular proteins. Participants also learned how cellular proteins may affect inte-
gration of the viral DNA and about determinants of pathogenesis and viral transcription.
Contributions from the Corporate Sponsors, Plant Corporate Associates, and Foundations pro-
vided core support for this meeting.
PROGRAM
Early Events
Chairpersons: J. Cunningham, Harvard Medical School,
Boston, Massachusetts; M. Roth, UMDNJ-Robert Wood
Johnson Medical School, Piscataway
Integration
Chairpersons: A. Skalka, Fox Chase Cancer Center,
Philadelphia, Pennsylvania; R. Bushman, Salk Institute, La
Jolla, California
Evolution/Recombination/RT
Chairpersons: J. Levin, National Institutes of Health, Bethesda,
Maryland; S. Hughes, National Cancer Institute, Frederick,
Maryland
Pathogenesis
Chairpersons: S. Ross, University of Pennsylvania,
Philadelphia; H. Fan, University of California, Irvine
Transcriptional and Posttranscriptional Regulation
Chairpersons: A. Rice, Baylor College of Medicine, Houston,
Texas; K.-T. Jeang, National Institutes of Health, Bethesda,
Maryland
Host-Cell Interactions and New Viruses
Chairpersons: S. Marriot, Baylor College of Medicine,
Houston, Texas; Y. Ikawa, Tokyo Medical and Dental
University Japan
Assembly
Chairpersons: J. Wills, Pennsylvania State University Hershey;
P. Boulanger, Montpellier School of Medicine, France
J. Cunningham, P. Jolicoeur
Trafficking I
Chairpersons: M. Malim, University of Pennsylvania,
Philadelphia; E. Hunter, University of Alabama,
Birmingham
Trafficking II
Chairperson: R. Swanstrom, University of North Carolina,
Chapel Hill
Packaging and Anti-Virals
Chairpersons: W.-S. Hu, West Virginia University
Morgantown; V. Vogt, Comet University Ithaca, New York
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FALL MEETINGS
Cancer Genetics and Tumor Suppressor Genes
August 19-23 431 participants
ARRANGED BY Terri Grodzicker, Cold Spring Harbor Laboratory
Doug Hanahan, University of California, San Francisco
Ed Harlow, Massachusetts General Hospital
David Livingston, Dana Farber Cancer Institute
Carol Prives, Columbia University
Bert Vogelstein, Johns Hopkins University
This second Cancer Genetics and Tumor Suppressor Genes meeting allowed scientists in different dis-
ciplines to discuss their latest results on different aspects of cancer cell biology and to have extensive
crosstalk concerning ideas and methodologies. The conference was oversubscribed, with more than
450 scientists meeting to present more than 320 talks and posters. Launched by a keynote address
by Harold Varmus, Director of the National Institutes of Health, the meeting presented an extensive
range of work: from location and nature of mutations in different tumors to properties of the p53 tumor
B. Stillman, P. Howley, C. Thompson
S. Lowe, P. Branton
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T. Jacks, H. Varmus
suppressor gene. Many talks dealt with growth control of cancer cells, and areas that received much
attention included control of the cell cycle, apoptosis, signaling transduction pathways, DNA repair, and
transcriptional regulation of and by tumor suppressor genes. Animal models have provided much infor-
mation about tumorigenesis, and more than one session dealt with knockout and transgenic mouse
models. The wide range of studies in this area was emphasized by presentations that dealt with tumor
progression, angiogenesis, and metastasis. This meeting continued to be enthusiastically supported
and all sessions found the lecture and poster halls packed with extensive discussions and exchanges
of information. A new feature this year was a session called "NCI Listens," chaired by David Livingston.
NCI staff and scientists who served on institute panels answered questions from the audience regard-
ing NCI grants, policy, and future directions.
This meeting was funded in part by the National Cancer Institute, a branch of the National
Institutes of Health. Contributions from the Corporate Sponsors, Plant Corporate Associates,
Foundations, and Corporate Contributors provided core support for this meeting.
PROGRAM
Keynote Address
Speaker: H. Varmus, National Institutes of Health, Bethesda,
Maryland
Mouse Models I
Chairperson: D. Hanahan, University of California, San
Francisco
Signal Transduction
Chairpersons: A. Levine, Princeton University, New Jersey;
G. Vande Woude, NCI-Frederick Cancer Research and
Development Center, Maryland
Apoptosis
Chairpersons: M. Oren, Weizmann Institute of Science,
Rehovot, Israel; C. Thompson, University of Chicago, Illinois
Genetics/Genomics
Chairpersons: L. Strong, University of Texas, Houston;
B. Vogelstein, Johns Hopkins University Oncology Center,
Baltimore, Maryland
National Cancer Institute Panel
"NCI Listens"
Introduction
Speaker: D. Livingston, Dana-Farber Cancer Institute,
Boston, Massachusetts
Transcription Regulation
Chairpersons: T. Tlsty, University of California, San Francisco;
P. Howley, Harvard Medical School, Boston, Massachu-
setts
Repair/Cell Cycle
Chairpersons: M. Kastan, Johns Hopkins University School of
Medicine, Baltimore, Maryland; C. Harris, NCI, National
Institutes of Health, Bethesda, Maryland
Mouse Models II
Chairpersons: A. Berns, The Netherlands Cancer Institute,
Amsterdam; T. Jacks, Massachusetts Institute of
Technology, Cambridge
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Molecular Genetics of Bacteria and Phages
August 25-30 212 participants
ARRANGED BY: Richard Gourse, University of Wisconsin, Madison
Allan Grossman, Massachusetts Institute of Technology
Marjorie Russel, Rockfeller University
The Molecufar Genetics of Bacteria and Phages meeting continued to re-invent itself this year, keeping up
with changing times. Initiated as a forum for bacteriophage X and T4 genetics; it expanded to include other
phages and then the molecular genetics of their bacterial host, Escherichia coli. Now, many other bacteria
and even archaebacterial phages are discussed, providing insights into previously unanswerable questions.
Surprising results were reported on the topology and dynamic properties of bacterial chromosomes-
experiments assessing the frequency with which distant sites on the chromosome "touch" one another led
to the conclusion that knots and tangles in DNA restrict the movement of supercoil domains; spectacular
images of living Bacillus subtilis cells suggest that DNA polymerase is fixed (to the membrane?) and replicat-
ing DNA threads its way through this key enzyme. A refined picture of the geometry of the transcription com-
plex emerged from cleverly conceived fusion proteins, sophisticated imaging techniques, and novel chemical
cleavage tags. New ways of thinking about populations were discussed-how bacterial pathogens (and the
phage of pathogens!) interact with and compromise eukaryotic cells, what genes determine biofilm formation,
how bacteria respond to and evolve in unusual environments, and the beginnings of a holistic description of
how phage X makes an appropriate binary "decision."
This meeting was funded in part by the National Science Foundation. Contributions from the Corporate Sponsors,
Plant Corporate Associates, Foundations, and Corporate Contributors provided core support for this meeting.
B. Landrick, P. Model, M. Russel
PROGRAM
Bacterial Genome I
Chairperson: J. Roth, University of Utah, Salt Lake City
Bacterial Genome II
Chairperson: R Model, Rockefeller University New York
Structure of the Transcription Complex
Chairperson: S. Darst, Rockefeller University New York
Transcriptional Control
Chairperson: L. Rothman-Denes, University of Chicago, Illinois
Posttranscriptional Control
Speaker: S. Gottesman, National Cancer Institute, Bethesda,
Maryland
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A. Grossman, P. Higgens
Signaling and Global Circuits
Speaker: D. Dubnau, New York Public Health Research
Institute, New York
Heat Shock/Stress Response
Speaker: T. Yura, HSP Research Institute, Kyoto, Japan
Cell Cycle and Cell Division
Speaker: A. Wright, Tufts University School of Medicine,
Boston, Massachusetts
Pathogens and Bacteria-Host Interactions
Speaker: H. Shuman, Columbia University New York
Cell Surfaces, Import, and Export
Speaker: R. Young, Texas A &M University College Station
Mouse Molecular Genetics
September 2-6 441 participants
ARRANGED BY Allan Bradley, Baylor College of Medicine/HHMI
Rosa Beddington, National Institute for Medical Research, United Kingdom
Maja Bucan, University of Pennsylvania
Richard Harvey, Walter & Eliza Hall Institute of Medical Research, Australia
This meeting held every other year at Cold Spring Harbor attracted the usual large group of researchers
from across the globe. A significant fraction of scientists who apparently had not yet reached satura-
tion from the conditional knockout workshop (which was scheduled immediately before) stayed on for
the second meeting refreshed by a free afternoon with BBB (Beach, Barbecue, and Beer).
The Mouse Molecular Genetics meeting brings together a vast cadre of scientists with very diverse
backgrounds who are linked by the common thread of working with mouse mutants. Consequently, the
scope of the biology presented at the meeting is enormous, covering topics from early developmental
decisions in gastrulating embryos to the sleep patterns of mice.
Following a historically successful format, the meeting was organized into eight sessions each
arranged so that a session begins and ends with an invited senior researcher. Between these more in-
depth talks (which are selected to be of general interest), 8-9 speakers per session were selected from
the abstracts for more concise presentations. The meeting also included the presentation of several
R. Beddington, M. Shen
R. Behringer
A. Bradley
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hundred posters in two afternoon sessions. In an attempt to highlight some of the contemporary
approaches, an "ENU workshop" was arranged where several groups who are doing mutagenesis in
the mouse came and presented their approaches. Although concurrent with one of the poster ses-
sions, this workshop was very well attended.
The mouse meeting has evolved over the years to have a stronger genetic and genomics empha-
sis and this year invited presentations included detailed presentations on the state of the mouse EST
database, the importance of genetic background, and a very entertaining introduction on how to ana-
lyze mouse behavior.
The meeting exemplified some of the special characteristics of the mouse genetics community-
sharing of unpublished data and reagents (including mice). Inevitably, this meeting is also a mouse dat-
ing service! Mice described in the meeting have found their way to new homes to mate with other
mutants to prove (or disprove) hypotheses developed during interactions at Cold Spring Harbor.
This meeting was funded in part by the National Institute of Child Health and Development, the
National Human Genome Research Institute, the National Institute of Mental Health, and the National
Cancer Institute, all branches of the National Institutes of Health; and the National Science Foundation.
Contributions from the Corporate Sponsors, Plant Corporate Associates, Foundations, and Corporate
Contributors provided core support for this meeting.
PROGRAM
Genetics I Tumorigenesis
Chairperson: L Silver, Princeton University, New Jersey Chairperson: T. Van Dyke, University of North Carolina,
Chapel Hill
Genomics
Chairperson: K. Moore, Millennium Pharmaceuticals,
Cambridge, Massachusetts
Signals and Receptors
Chairperson: P. Beachy, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Organogenesis
Chairperson: R. Lovell-Badge, MRC National Institute for
Medical Research, London, United Kingdom
ENU Workshop
Chairperson: S. Brown, Medical Research Council, Harwell,
United Kingdom
210
Genetics II
Chairperson: T. Magnuson, Case Western Reserve
University, Cleveland, Ohio
Patterning
Chairperson: R. Beddington, National Institute for Medical
Research, London, United Kingdom
Neural Development
Chairperson: A. Joyner, New York University Medical Center
Translational Control
September 9-13 445 participants
ARRANGED BY Lynne Maquat, Roswell Park Cancer Institute
Michael Mathews, University of Medicine and Dentistry of New Jersey
Peter Sarnow, Stanford University School of Medicine
The 1998 Translational Control meeting featured eight platform and three poster sessions that covered
337 published abstracts.
Highlights of the session on Factors and Mechanisms included the macromolecular organization
of the yeast and mammalian translation initiation factor elF3 complex (Hershey and Hinnebusch labs),
interactions of elF5 with elF2 and its role in formation of 40S preinitiation complexes (Maitra and
Hinnebusch labs), and the surprising role of factors elF1 and elF1A in the positioning of 48S complex-
es at the initiator AUG codon (Pestova and Hellen).
The highlight of the Development session was a talk by Joel Richter demonstrating that visual
experience (i.e., light-induced synaptic activation) is accompanied by the polyadenylation of a-Ca"-
calmodulin-dependent protein kinase li a mRNA in rodent brain. Polyadenylation was shown to be
mediated by the binding of cytoplasmic polyadenylation element binding protein (CPEB) to the two
CPEs within the mRNA 3' UTR. Other talks focused on how 3' UTR-binding proteins, including Bicoid
in Drosophila (Niessing lab), CPEB and the p82 masking factor in Xenopus oocytes (Wormington lab),
and Pumilio in Drosophila (Williamson and Lehmann labs), repress or activate mRNA translation. Protein
binding to 3' UTR sequences can also affect mRNA stability (Goodwin lab), and protein binding to either
5' or 3' UTR RNA was shown to regulate RNA localization and, in some cases, translation (Standart lab,
Nielsen lab). Notably, a report from the Wolfe lab demonstrated that the presence of an intron near the
5' end of H1 transcripts relieves translational silencing of the resulting mRNA in Xenopus oocytes.
The UTR Functions session featured talks from the Hohn and Schneider labs that pointed to a role
of RNA hairpin structures and base pair complementarity to 18S rRNA in the translational initiation
mechanism of ribosome shunting. Most of the remaining talks further substantiated the finding that the
5' and 3' ends in mRNA can interact to regulate translation initiation (Millard, Tahara, Benchimol, Allen,
and Browing labs).
The RNA Turnover session consisted of four talks on nonsense-mediated mRNA decay (NMD) in
either S. cerevisiae (Peitz lab, Jacobson lab) or mammalian cells (Maquat lab and Kulozik lab), five talks
M. Mathews, W. Merrick R. Kaufman, L. Maquat
that described AU-rich element (ARE)-directed effects on mRNA half-life (Brewer lab, Shyu lab,
Schneider lab, Wilusz lab, and Kiledjian lab), and presentations on proteins that affect parathyroid
mRNA stability (Haveh-Many lab), decapping (Parker lab), or mRNA degradation via poly(A) binding
(Sachs lab). The session included evidence for both yeast and mammalian cells that NMD, which
appears to involve cytoplasmic translation, requires earlier nuclear processes (Peitz, Maquat, and
Kulozik labs). Also noteworthy was the first report of ARE-mediated mRNA decay in vitro and use of in
vitro decay to demonstrate that ELAV proteins stabilize ARE-containing mRNAs ( Wilusz lab).
The IRES Elements session reported on factors that regulate viral (Hellen, Siddiqui, Jackson labs)
and cellular (Sarnow, Elroy-Stein labs) IRESs. Microarray display techniques were employed to demon-
strate that cap-independent translation is more prevalent than previously anticipated (Sarnow lab). An
interesting story was presented by Andino, who reported that the switch from translation to replication
in the polioviral genome is regulated by viral factors that displace IRES-interacting factors, resulting in
a stop of translation and commencement of viral replication.
Highlights of the Ends and Means session included the description of structures of eIF4E (Burley
lab) and elF4E binding proteins (Fletcher lab). Regulation of eIF4E by phosphorylation (Sonenberg lab),
and sequestration of elF4G by HSP70 during heat shock (Schneider lab) were additional exciting top-
ics in this session.
The Kinases session concentrated primarily on PKR, the double-stranded RNA-dependent protein
kinase. Talks on PKR dealt with a characterization of negative sequences within the amino-terminal
region of the protein (Wek lab), associations of PKR with nuclear factor 90 and RNA helicase A
(Mathews lab), the role of PKR in apoptosis (Kaufman lab), and the inhibition of PKR by either the E2
envelope protein (Hinnebusch and Lai labs) or the nonstructural 5A protein (Katze lab) of interferon-
resistant hepatitis C viruses. Among other presentations was an impressive description of how phos-
phorylated elF2a binds the regulatory subcomplex of eIF2B and inhibits a productive interaction with
the catalytic subcomplex, thereby inhibiting translation by inhibiting guanine nucleotide exchange
(Hinnebusch lab).
The last session, Elongation and Termination, highlighted the regulation of translation by upstream
open reading frames (Morris, Geballe, and Sachs labs). In addition, new insights into the mechanism
of translational frameshifting were provided (Farabaugh and Atkins labs).
This meeting was funded in part by RiboGene Inc.; Irvine Scientific; and Promega Corporation.
Contributions from the Corporate Sponsors, Plant Corporate Associates, Foundations, and Corporate
Contributors provided core support for this meeting.
PROGRAM
Factors and Mechanisms
Chairperson: T Dever, NICHD, National Institutes of Health,
Bethesda, Maryland
Development
Chairperson: B. Goodwin, Northwestern University Medical
School, Chicago, Illinois
UTR Functions
Chairperson: D. Morris, University of Washington, Seattle
RNA Turnover
Chairperson: S. Peitz, University of Medicine and Dentistry of
New Jersey Piscataway
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IRES Elements
Chairperson: A-C. Prats, INSERM, Toulouse, France
Ends and Means
Chairperson: A. Sachs, University of California, Berkeley
Kinases
Chairperson: S. Morley, University of Sussex, United Kingdom
Elongation and Termination
Chairperson: E. Goldman, UMDNJ-New Jersey Medical
School, Newark
Axon Guidance and Neural Plasticity
September 16-20 365 participants
ARRANGED BY Corey Goodman, University of California, Berkeley
Carla Shatz, University of California, Berkeley
Marc Tessier-Lavigne, University of California/HHMI
The remarkable feats of information processing performed by the human brain are determined by the intricate net-
work of connections between nerve cells (or neurons). The magnitude of the task involved in wiring the nervous sys-
tem is staggering. In adult humans, each of over a trillion neurons makes connections with, on average, over a thou-
sand target cells in an intricate circuit whose precise pattern is essential for the proper functioning of the nervous sys-
tem. How can this pattern be generated during embryogenesis with the necessary precision and reliability? Neuronal
connections form when each developing neuron sends out an axon, tipped by a growth cone, which migrates
through the embryonic environment to its synaptic targets, guided by attractive and repulsive proteins that instruct it
to migrate in particular directions. Once in their appropriate target regions, axons must seek out particular target cells
with which to form synaptic connections. These connections are then further refined, through the making and break-
ing of synaptic contacts, under the control of specific patterns of electrical activity in the neurons and targets, until a
highly tuned circuit is established.
In the past decade, our understanding of
the mechanisms that control axon growth and
guidance, synaptogenesis, and the remodel-
ing of neural circuits during development, has
progressed rapidly from phenomenology to
the identification of specific molecular control
mechanisms. Progress has been assisted by
the finding that these mechanisms are highly
conserved across evolution, so that both bio-
chemical approaches in vertebrates and
genetic approaches in invertebrates (and
increasingly, in vertebrates as well) have led to
mutually reinforcing discoveries that have
helped fuel further advances.
As the pace of discovery has quickened,
the field has grown enormously, making it B. Stillman, J. Witkowski, C. Goodman
T. Grodzicker, C. Bargmann J. Kupa, M. Emerson, J. Flanagan
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more difficult for scientists to keep abreast of new developments. It therefore seemed desirable to start
a new biennial CSH conference series on "Axon Guidance and Developmental Plasticity of the Nervous
System", modeled after the very successful CSH conferences on Drosophila and Zebrafish
Developmental Biology. The meeting had an open registration. It was divided into sessions devoted to
particular stages in the assembly of the nervous system, with speakers chosen from among the par-
ticipants submitting abstracts by session chairs who are leaders in the field. Other abstracts were pre-
sented as posters.
The response of the field was one of overwhelming enthusiasm. Despite a late start in organiza-
tion and advertising, and the fact that many scientists in the field already had plans to attend the annu-
al Society for Neuroscience meeting in Los Angeles just a few weeks later, there were 365 registrants,
231 of whom submitted abstracts. 64 abstracts were selected for talks, in eight sessions. Senior
researchers, starting Assistant Professors, postdoctoral fellows, and graduate students were are well
represented. All the major areas of research in the field were covered, as were all of the major
approaches (cellular, physiological, anatomical, biochemical, and genetic). In addition, a keynote
address was given by Dr. Gerry Fischbach, the new director of the National Institutes of Neurological
Diseases and Stroke, who outlined a vision for the field of Neuroscience, and of Developmental
Neurobiology in general. The meeting provided an important clearing house for ideas and approaches,
and helped scientists in the field get the most up-to-date information, as well as enabling them to meet,
to network, and to establish collaborations. From the uniformly enthusiastic comments of the partici-
pants, the intensity of the oral and poster sessions, and the large crowds that stayed up late every night
at the bar to discuss science further, the meeting was deemed a great success. It was therefore decid-
ed therefore to hold the meeting every two years, alternating every other year with an EMBO meeting
in Europe on the same topic.
Contributions from the Corporate Sponsors, Plant Corporate Associates, Foundations, and
Corporate Contributors provided core support for this meeting.
PROGRAM
Migration and Guidance I
Chairpersons: L. Landmesser, Case Western Reserve
University Cleveland, Ohio; J. Kuwada, University of
Michigan, Ann Arbor
Migration and Guidance II
Chairpersons: C. Bargmann, HHMI, University of California,
San Francisco; M.B. Hatten, Rockefeller University New
York
Migration and Guidance III
Chairpersons: J. Raper, University of Pennsylvania School of
Medicine, Philadelphia; J. Culotti, Samuel Lunenfeld
Research Institute, Toronto, Canada
Signal Transduction
Chairpersons: L. Zipursky, HHMI, University of California, Los
Angeles; M.-M. Poo, University of California, San Diego
Topographic Mapping
Chairpersons: J. Flanagan, Harvard Medical School, Boston,
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Massachusetts; F. Bonhoeffer, Max-Planck-Thstitut fur
Entwicklungsbiologie, Mbingen, Germany
Targeting and Synaptogenesis
Chairpersons: D. O'Leary, Salk Institute, La Jolla, California;
S. Burden, New York University Medical Center
Developmental Plasticity I
Chairpersons: J. Lichtman, Washington University School of
Medicine, St. Louis, Missouri; H. Cline, Cold Spring Harbor
Laboratory
Keynote Address: Growth and regeneration and NINDS
Speaker: G. Fischbach, Harvard Medical School
Developmental Plasticity II
Chairpersons: L. Katz, HHMI, Duke University Medical Center,
Durham, North Carolina; T. Bonhoeffer, Max-Planck
Institute of Neurobiology Mitnchen, Germany
Gene Therapy
September 23-27 385 Participants
ARRANGED BY Theodore Friedmann, University of California, San Diego
Margaret Liu, Chiron Corporation
Richard Mulligan, HHMI/Children's Hospital/Harvard University
Gary Nabel, University of Michigan
This was the fourth in the Laboratory's series of bi-yearly meetings on Gene Therapy. There has been
an explosion of interest and progress in the field and a growing conviction that truly beneficial clinical
applications of gene transfer technologies will soon appear. Of the many meetings on gene therapy,
this meeting remains the only one with an abstract-driven format and therefore continues to be the
most accessible to the broad gene therapy community, including students, fellows, and junior and
senior investigators. Several sessions focused on developments in vector design, including adenoviral,
adeno-associated viral, retroviral, and nonviral vectors, whereas other sessions examined emerging
G. Brownlee, T. Friedmann J. Wilson, J. Leiden
P. Johnson, G. Nabel
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technologies, the immune system, and disease models including cancer, cardiovascular diseases, and
AIDS. While results and progress in a number of ongoing clinical trials were presented at the latest
meeting, the program of the meeting emphasized the molecular genetics and cell biology issues under-
lying approaches to human gene therapy. The organizers are convinced that interest and progress in
human gene therapy will grow enormously in the very near future and that further meetings at Cold
Spring Harbor will continue to satisfy an important need in the scientific and medical communities.
This meeting was funded in part by the National Institute of Child Health and Human Development,
a branch of the National Institutes of Health. Contributions from the Corporate Sponsors, Plant
Corporate Associates, Foundations, and Corporate Contributors provided core support for this meet-
ing.
PROGRAM
Viral Vectors I: Adenovirus
Chairpersons: R. Mulligan, HHMI, Children's Hospital, Harvard
Medical School, Boston, Massachusetts; J. Leiden,
University of Chicago, Illinois
Viral Vectors II: AAV; Nonviral Vectors
Chairpersons: J. Samulski, University of North Carolina,
Chapel Hill; M. Cotten, Research Institute of Molecular
Pathology, Vienna, Austria
Retrovirus and Lentivirus Vectors
Chairpersons: T. Friedmann, University of California, San
Diego; L. Leinwand, University of Colorado, Boulder
The Immune System
Chairpersons: J. Wilson, University of Pennsylvania,
Philadelphia; M. Liu, Chiron Corporation, Emeryville,
California
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Emerging Technologies
Chairpersons: I. Verma, Salk Institute, La Jolla, California;
P. Davis, Case Western Reserve University Cleveland, Ohio
Disease Models I: Cancer, Cardiovascular System
Chairpersons: J. Folkman, Children's Hospital, Boston,
Massachusetts; S. Woo, Mt. Sinai School of Medicine, New
York
Disease Models II: Infectious Disease (AIDS),
Hematopoietic System
Chairpersons: G. Nebel, HHMI, University of Michigan, Ann
Arbor; R.M. Blaese, NHGRI, National Institutes of Health,
Bethesda, Maryland
Other Disease Models
Chairpersons: D. Curiel, University of Alabama, Birmingham;
G. Brownlee, University of Oxford, United Kingdom
Gametogenesis
October 1-4 151 participants
ARRANGED BY Brigid Hogan, Vanderbilt University Medical School/HHMI
Allan Spradling, Carnegie Institution of Washington
An essential requirement for sexual reproduction is the germ line-the immortal cell lineage that gener-
ates the male and female gametes. During the past few years, it has become apparent that many of the
fundamental developmental mechanisms required for the establishment and function of germ cells have
been conserved during evolution. The Gametogenesis meeting was organized with the goal of bringing
together researchers who study germ line development in both vertebrate and invertebrate systems, as
well as plants, so that recent exciting advances in one field could cross-fertilize the other. During the
course of the meeting, investigators using Drosophila and C. elegans reported the identification of new
genes required for germ cell specification, meiosis, and germ cell migration. At least one of these, a
mouse homolog of the Drosophila vasa gene, was shown to be required for spermatogenesis in mice.
In addition, germ cells in the mouse ovary appear to be arranged into cysts resembling those in the
Drosophila ovary. The highlight of the meeting was a talk given by R. Yanagimachi, who discussed initi-
ation of mouse embryonic development in unorthodox ways, including nuclear transfer in eggs (cloning).
Following Dr. Yanagimachi's talk, a lively public forum, chaired by A. McLaren, was held on the ethics and
potential medical benefits of cloning mammals. The impact of basic research on human reproduction
was also discussed in relation to the genetics of human infertility. The next Gametogenesis meeting will
be held in the year 2000 with G. Seydoux and C. Wylie serving as the organizers.
This meeting was funded in part by the National Institute of Child Health and Human Development,
a branch of the National Institutes of Health; the National Science Foundation; the Lalor Foundation;
and the March of Dimes. Contributions from the Corporate Sponsors, Plant Corporate Associates,
Foundations, and Corporate Contributors provided core support for this meeting.
PROGRAM
Germ Cell Specification
Chairperson: A. Mahowald, University of Chicago, Illinois
Germ Cell Proliferation and Migration
Chairperson: A. McLaren, University of Cambridge, United
Kingdom
Meiosis I
Chairperson: J. Kimble, University of Wisconsin, Madison
Germ-line-Soma Interactions I
Chairperson: B. Hogan, Vanderbilt Medical Center; Nashville,
Tennessee
Germ-line-Soma Interactions II
Chairperson: M. Matzuk, Baylor College of Medicine, Houston,
Texas
Gamete Development
Chairperson: L. Cooley, Yale University School of Medicine,
New Haven, Connecticut
PUBLIC FORUM-CLONING MAMMALS
Meiosis II
Chairperson: S. Roeder, Yale University School of Medicine,
New Haven, Connecticut
A. McLaren, M. Renfree
S. Wasserman, T. Schupback
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Dynamic Organization of Nuclear Function
October 7-11 386 Participants
ARRANGED BY Robert Goldman, Northwestern University
John Newport, University of California, San Diego
Pamela Silver, Dana Farber Cancer Institute/Harvard University
David Spector, Cold Spring Harbor Laboratory
The Dynamic Organization of Nuclear Function meeting was a successful gathering of researchers from
disparate fields to discuss nuclear structure, its functions, and how both change over time. The open-
ing session focused on the nuclear envelope and lamina, and Jan Ellenberg showed a movie revealing
the dynamics of the nuclear envelope during the cell cycle by following the movement of GFP-tagged
components of the nucleus. The Nuclear Import/Export session illustrated the complexity of transport
of macromolecules across the nuclear envelope, which involves many different receptors, cargoes, and
pathways. Elena Conti from the Kuriyan lab presented the X-ray crystal structure of the import recep-
tor, Karyopherin a, both free and bound to an NLS peptide. The interactions between the a receptor
and its peptide cargo as seen in the crystal structure suggest a mode for recognition of any NLS bear-
ing import substrate. The idea that the GTPase Ran may not provide the energy for transport but
M. Paddy, A. Belmont
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instead may function to load and unload cargo was presented by Karsten Weis in a poster. In the DNA
Replication session, John Newport presented evidence that DNA replication does not require the
nuclear envelope or nuclear lamina and that initiation of ORC-dependent replication does not appear
to require a unique origin sequence. The RNA Processing and Dynamics session focused on the inter-
play between the events leading up to the production of mature RNA and its subsequent movement
out of the nucleus. Joan Politz of the Singer lab presented a new method for following RNA movement
within the nucleus of living cells. Melissa Moore discussed preliminary results which suggest that decay
of mRNAs containing premature stop codons may occur in the nucleus rather than in the cytoplasm.
The meeting closed with a session that focused on connections between nuclear structure and dis-
ease. Norma Neff presented data that correlated the activity of the ssDNA helicase BLM, which is
absent from cells of Bloom syndrome patients, with its nuclear localization. The variety of subjects and
detailed discussions at this meeting offered a comprehensive view of the importance of the dynamic
organization of nuclear function.
Contributions from the Corporate Sponsors, Plant Corporate Associates, Foundations, and
Corporate Contributers provided core support for this meeting.
PROGRAM
Nuclear Envelope/Lamina
Chairperson: U. Aebi, University of Basel, Switzerland
Nuclear Import/Export
Chairperson: D. Forbes, University of California, San Diego
Nucleoli and Other Inclusions
Chairperson: J. Gall, Carnegie Institution of Washington,
Baltimore, Maryland
Genome Organization
Chairperson: A. Belmont, University of Illinois, Urbana
DNA Replication and Repair
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
Transcription
Chairperson: A. Greenleaf, Duke University Medical Center,
Durham, North Carolina
RNA Processing and Dynamics
Chairperson: C. Guthrie, University of California, San
Francisco
Nuclear Structure and Disease
Chairperson: G. Dreyfuss, University of Pennsylvania School
of Medicine, Philadelphia
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SPECIAL WORKSHOP ON
EMERGING TECHNOLOGIES
Conditional Genetic Technologies in the Mouse
August 31-September 2 362 participants
ARRANGED BY Allan Bradley, HHMI/Baylor College of Medicine, Houston
Klaus Rajewsky, Institute for Genetics, Weyertal, Germany
Janet Rossant, Mt. Sinai Hospital, Toronto, Canada
This new workshop represents the first in a series to address emerging technologies in cancer
research. The timing of the workshop was arranged to allow interested participants to attend both
workshop and meeting, with a picnic on the beach to wind down between events.
The primary goal of this workshop was to bring together a diverse group of scientists interested in
new genome alteration approaches in the mouse, including the key developers of these emerging tech-
nologies, researchers who have begun to apply and assess these new approaches, and parties inter-
ested in using and extending the technologies. The workshop encouraged an in-depth and unvarnished
explanation of technologies such as Cre-Lox, tetracycline-based strategies, hormone-modulated sys-
tems, ligand-induced dimerization strategies, insect hormone-based systems, adenovirus-mediated
gene transfer, and other trans-activating systems, including discussion of real-world experiences in
diverse systems and second-generation developments. The schedule included 34 oral presentations
and 66 posters focused on all the latest technology and methodology available for controlling gene acti-
vation and inactivation in transgenic mice.
In an interesting experiment, the talks (but not the discussions that followed) were recorded and
made available on a subscription basis as slide-and-audio presentations over the World Wide Web to
anyone with an Internet connection and reasonably up-to-date computer. The experimental Web site
(www.leadingstrand.org) has netted more than 175 subscribers and will remain available until
September 1999. It is hoped that this workshop on conditional genetic technologies will become a
model for future workshops intended to focus on the enabling technologies underlying new trends in
cancer research.
G. Schoetz, M. Mayford
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This meeting was funded in part by the National Cancer Institute, a branch of the National Institutes
of Health. Contributions from the Corporate Sponsors, Plant Corporate Associates, Foundations, and
Corporate Contributors provided core support for this meeting.
PROGRAM
Site-specific Recombination: Tools of the Trade
Chairperson: K. Rajewsky, University of Cologne, Germany
Inducible Systems
Chairperson: H. Bujard, University of Heidelberg, Germany
Inducible Recombination
Chairperson: B. Sauer, NIDDKD, National Institutes of Health,
Bethesda, Maryland
Genomic Engineering: New Developments
Chairperson: A. Bradley, Howard Hughes Medical Institute,
Baylor College of Medicine, Houston, Texas
Final Discussion
Chairperson: J. Rossant, Samuel Lunenfeld Research Institute,
Toronto, Canada
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WINTER BIOTECHNOLOGY CONFERENCE
The Arabidopsis Genome: A Model for Crop Plants
December 3-6 122 participants
ARRANGED BY R. Martienssen, Cold Spring Harbor Laboratory
M. Bevan, John Innes Center, United Kingdom
This meeting was the second in a series of biotechnology symposia aimed at bringing together those
groups sequencing and interpreting the sequence of Arabidopsis thaliana with those attempting to
determine the biological function of plant genes and other chromosomal sequences. Steven Tanks ley
opened the meeting with a fascinating overview of the impact plant genomics is beginning to have upon
the identification and use of economically valuable traits for crop improvement. This was immediately
followed by a session on crop plant genomics, illustrating how comparative approaches are yielding
information on traits in crops such as maize, sorghum, rice, and legumes. The following two sessions
revealed the current status of Arabidopsis sequencing, the development of accessible databases, the
progress being made in mapping (including the first Arabidopsis SNP map), and the analysis of chro-
mosome structure in plants. Further sessions on functional genomics highlighted approaches to the
S. Rounsley, M. Anderson, J. Jones
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identification of gene function, including multiple insertional mutagenesis strategies, and gave a fore-
taste of how these strategies will be used to identify biological function on a large scale. A final session
on gene expression and bioinformatics highlighted novel means to catalog, assemble, interpret, and
disseminate this vast flood of new data. The need to simultaneously examine gene function and
expression in a systematic way was emphasized in a large number of the presentations. In all, the
meeting included 39 oral presentations, 13 posters, and additionally, a number of posters were pre-
sented by the sequencing consortium on current progress in Arabidopsis genome sequencing, which
is likely to be completed within the next 2 years. In light of the probable completion of the genome, the
third conference on this topic is planned to be held at the end of the year 2000.
This meeting was funded in part by Cereon Genomics Inc. (a division of Monsanto); De Kalb
Genetics Corporation, Keygene N.V.; Novartis Crop Protection, Inc., and Pioneer Hi-Bred International,
Inc. Contributions from the Corporate Sponsors, Plant Corporate Associates, Foundations, and
Corporate Contributors provided core support for this meeting.
PROGRAM
Keynote Address
Chairperson: S.D. Tanks ley, Cornell University Ithaca, New York
Crop Plant Genomics
Chairperson: R. Michelmore, University of California, Davis
Progress in Arabidopsis Genome Sequencing and Database
Development
Chairperson: J. Ecker, University of Pennsylvania, Philadelphia
Mapping and Chromosome Structure
Chairperson: D. Preuss, University of Chicago, Illinois
Functional Genomics I
Chairperson: J. Jones, John Innes Centre, Norwich, United
Kingdom
Functional Genomics II: Applications
Chairperson: M. Sussman, University of Wisconsin, Madison
Gene Expression and Informatics
Chairperson: M. Bevan, John Innes Centre, Norwich, United
Kingdom
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POSTGRADUATE COURSES
The summer program of Postgraduate Courses at Cold Spring Harbor Laboratory is aimed at meeting
the special need for training in interdisciplinary subjects that are either so new or so specialized that
they are not adequately treated by universities. Our aim is to provide intensive study in the most recent
developments and techniques in these subjects and to prepare students to enter directly into research
in a particular area. To ensure up-to-date coverage of current research work, we bring together a work-
shop staff from many laboratories around the world and supplement this staff with a series of seminar
speakers.
Advanced Molecular Cytogenetics
March 4-10
INSTRUCTORS Ried, Thomas, M.D., National Institutes of Heath
Schrock, Eve lin, M.D., National Institutes of Health
ASSISTANTS Janisch, Catherine, Applied Spectral Imaging
Padilla-Nash, Hesed, National Institutes of Health
This course focused on advanced molecular cytogenetic methodologies for the visualization of chro-
mosome aberrations. Emphasis was placed on applications of spectral karyotyping (SKY) for the
refinement of clinical and tumorcytogenetic diagnostics. In addition, the students covered comparative
genomic hybridization (CGH) and novel sensitive methods for visualization of FISH experiments (tyre-
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mides). Methodologies, technologies, and scientific expertise for the microscopic visualization of chro-
mosomal alterations were provided. The course was designed for cytogeneticists who use chromo-
some analytical methods in diagnostics and basic research and for the molecular biologists who intend
to employ advanced molecular cytogenetic methods in mammalian chromosome analysis. Among the
methods presented were the preparation of tagged DNA probes, FISH and multicolor detection meth-
ods, quantitative digital image analysis, spectral imaging, and data interpretation. Students were
encouraged to bring their own samples of human or mouse origin for SKY and CGH analysis. State-
of-the-art microscopic and imaging equipment was available to gain hands-on experience. The labo-
ratory portion of the course was supplemented by invited lectures by Drs. David H. Ledbetter, Janet D.
Rowley, Jeffrey M. Trent, and David C. Ward, who presented updates in the field of molecular cytoge-
netic research and diagnostics.
PARTICIPANTS
Adeyinka, A., B.S., Lund University Hospital, Sweden
Barch, M., B.S., M.S., University of Louisville, Kentucky
Burki, N., B.S., M.D., Yale University, New Haven, Connecticut
Capua, E., B.S., North York General Hospital, Canada
Davidson, J., B.S., University of Cambridge, United Kingdom
Exeler, J.R., B.S., Ph.D., University of Munster, Germany
Forus, A., B.S., M.S., Ph.D., Norwegian Radium Hospital,
Norway
Kahkonen, M., Ph.D., Tampere University Hospital, Finland
SEMINARS
Garini, Y., Applied Spectral Imaging, Carlsbad, California.
Spectral imaging.
Hohman, B., Carl Zeiss, Inc., Thornwood, New York.
Fluorescence microscopy.
Ledbetter, D., University of Chicago, Chicago, Illinois. Current
status and future prospect of FISH in the clinical laboratory.
Moens, P., NEN Life Science Products, Inc., Boston,
Massachusetts. Tyramide signal amplification.
Piper, J. VYSIS, Inc., Downers Grove, Illinois. Software for
comparative genomic hybridization.
Lau, C., Ph.D., M.D., Baylor College of Medicine
Lytle, C., B.S., Genzyme Genetics, New Mexico
Montgomery, K., B.S, Ph.D., University of New Mexico
Nordgren, A., M.D., Karolinska Institute, Sweden
Rao, VK., B.S., M.D., National Cancer Institute
Roque, L, B.S., Portuguese Cancer Institute, Portugal
Wong, N., B.S., M.S., Ph.D., Chinese University of Hong
Kong, China
Zou, Y, B.S, M.D., Ph.D., Medical College of Virginia
Ried, T, National Institutes of Health, Bethesda, Maryland.
Cancer cytogenetics revisited: Comparative genomic
hybridization and spectral karyotyping.
Rowley, J., University of Chicago Medical Center, Chicago,
Illinois. Chromosome translocations: Dangerous liasions.
Trent, J., National Institutes of Health, Bethesda, Maryland.
Applications of new genomic technologies in cancer
research: Microarrays and microdissection.
Ward, D., Yale University School of Medicine, New Haven,
Connecticut. Padlock probes and rolling-circle amplification.
225
Advanced Genome Sequence Analysis
March 18-31
INSTRUCTORS Chen, El !son, Ph.D., PE Applied Biosystems, Inc.
Gibbs, Richard, Ph.D., Baylor College of Medicine
McCombie, W. Richard, Ph.D., Cold Spring Harbor Laboratory
Mardis, Elaine, Ph.D., Washington University School of Medicine
Muzny, Donna, Ph.D., Baylor College of Medicine
Wilson, Richard, Ph.D., Washington University School of Medicine
Zuo, Lin, M.D., AxyS Pharmaceuticals Inc.
ASSISTANTS Bentley, Kimberly, Case Western Reserve University
Dedhia, Nei lay, Cold Spring Harbor Laboratory
De la Bastide, Melissa, Cold Spring Harbor Laboratory
Fitzgerald, Michael, Genome Therapeutics Corporation
Galvin, Margaret, AxyS Pharmaceuticals Inc.
Gnoj, Lidia, Cold Spring Harbor Laboratory
Greco, Tracie, Washington University School of Medicine
Habermann, Kristina, Cold Spring Harbor Laboratory
Huang, Emily, Cold Spring Harbor Laboratory
Johnson, Doug, Washington University School of Medicine
Ma, Peter, PE Applied Biosystems, Inc.
Parnell, Larry, Cold Spring Harbor Laboratory
Schutz, Kristin, Cold Spring Harbor Laboratory
The purpose of this course was to teach students the range of techniques and project management
skills required to carry out a large-scale sequencing project. The course provided a 2-week, extensive
laboratory experience in which the students worked as a team to carry out a large-scale sequencing
226
project. Recent advances in the automation of DNA sequencing have opened new possibilities for the
analysis of complex genomes at the DNA sequence level. This course provided intensive training in this
rapidly evolving field. The course emphasized techniques and strategies for using automated
sequences to sequence large, contiguous genomic regions. Students carried out all of the steps in the
sequencing process from preparing cosmid DNA to computer analysis of the finished sequence.
Topics included subclone library generation, large-scale template purification, sequencing reactions,
gel analysis on automated sequencers, sequence assembly, gap filling, and conflict resolution.
Students worked in groups of four to sequence and analyze a large region of genomic DNA. A 143-kb
human BAC clone containing two chemokine receptor genes was sequenced and analyzed. Through
this process, the students were trained in crucial project and data management techniques. A series
of lecturers discussed their applications of these techniques as well as alternate strategies for high-
speed automated DNA sequencing and analysis. This year, the course introduced new material in the
analysis phase. Students had an opportunity to use laboratory methods to confirm findings predicted
from the genomic sequence data. The analysis phase also included the use of DNA sequencing tech-
nology for polymorphism and mutation detection.
PARTICIPANTS
Bashkin, J., B.S. Ph.D., Molecular Dynamics, Sunnyvale,
California
Battistutti, W., C.V.M., D.V.M., National Institute of Sera and
Vaccines, Vienna, Austria
Blair, M., B.S., Ph.D., Cornell University, Ithaca, New York
Bruce, D., B.S., Los Alamos National Laboratory, New
Mexico
Eley, G., B.S., Mayo Foundation, Rochester, Minnesota
Frazer, K., BA., Ph.D., Lawrence Berkeley National
Laboratory, Berkeley, California
Gardmo, C., M.S., Karolinska Institute, Huddinge, Sweden
Hinkle, G., B.A. Ph.D., Marine Biological Laboratory/University
of Massachusetts, Woods Hole
SEMINARS
Chen, E., Applied Biosystems, Inc., Foster City, California.
Ordered-shotgun sequencing.
Fraser, C., National Institutes of Health, Bethesda, Maryland.
Microbial genome sequencing.
Kwok, P.-Y., Washington University School of Medicine, St.
Louis, Missouri. Single nucleotide polymorphisms.
Mardis, E., Washington University School of Medicine, St.
Louis, Missouri. Technology development at large scale
sequencing centers.
McPherson, J., Washington University School of Medicine, St.
Louis, Missouri. Physical mapping of the human genome.
Lee, R., B.S., M.S., Hoechst Marion Roussel, Inc.,
Bridgewater, New Jersey
Li, L., B.S. Ph.D., University of Texas, Houston
Lovitt, C., B.S., SmithKline Beecham Pharmaceuticals, King
of Prussia, Pennsylvania
Ok lu, R., B.S., University of Cambridge, Cambridge, United
Kingdom
Penuela, S., B.S., University of Minnesota, St. Paul
Rath, RC., B.S., Ph.D., Jawaharlal Nehru University, New
Delhi, India
Rode, C., B.A., M.S., University of Michigan, Ann Arbor
Shan, Y., B.S., Hua Zhong Agricultural University, Wu Han,
China
Meldrum, D., University of Washington, Seattle. New
sequencing technologies.
Miller, W., Pennsylvania State University, University Park.
Comparative genomics of the human and mouse.
Schwartz, D., New York University, New York. Optical mapping.
Stein, L., Cold Spring Harbor Laboratory. Genome informatics
resources on the Internet.
Watson, J., Cold Spring Harbor Laboratory. History of the
Human Genome Project.
Wilson, R., Washington University School of Medicine, St.
Louis, Missouri. The C. elegans genome project.
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Protein Purification and Characterization
April 15-28
INSTRUCTORS Burgess, Richard, Ph.D., University of Wisconsin, Madison
Courey, Albert, Ph.D., University of California, Los Angeles
Lin, Sue-Hwa, Ph.D., University of Texas/MD Anderson Cancer Center, Houston
Mische, Sheenah, Ph.D, Rockefeller University
ASSISTANTS Arthur, Terry, University of Wisconsin, Madison
Chen, Guoqing, University of California, Los Angeles
Earley, Karen, University of Texas/MD Anderson Cancer Center
Thompson, Nancy, University of Wisconsin, Madison
Fernandez, Joseph, Rockefeller University
Tantingco, Vicky, University of Texas/MD Anderson Cancer Center
Weinberg, Catherine, Rockefeller University
This course was intended for scientists who are not familiar with techniques of protein isolation and
characterization. It was a rigorous program that included laboratory work all day and a lecture with dis-
cussion session every evening. Each student became familiar with each of the major techniques in pro-
tein purification by actually performing four separate isolations including (1) a regulatory protein from
muscle tissue; (2) a sequence-specific, DNA-binding protein; (3) a recombinant protein overexpressed
in E. coli; and (4) a membrane-bound receptor. A variety of bulk fractionation, electrophoretic, and
chromatographic techniques were employed including precipitation by salts, pH, and ionic polymers;
ion exchange, gel filtration, hydrophobic interaction, and reverse-phase chromatography; lectin affinity,
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ligand affinity, oligonucleotide affinity, and immunoaffinity chromatography; polyacrylamide gel elec-
trophoresis and electroblotting; and high-performance liquid chromatography. Procedures were pre-
sented for solubilizing proteins from inclusion bodies and refolding them into active monomeric forms.
Methods of protein characterization were utilized including immunological and biochemical assays,
peptide mapping, amino acid analysis, protein sequencing, and mass spectrometry. Emphasis was
placed on strategies of protein purification and characterization using both classical and modern tech-
niques and equipment. Guest lecturers discussed protein structure and function, methodologies for
protein purification and characterization, and applications of protein biochemistry to cell molecular and
developmental biology.
PARTICIPANTS
Bartsch, S., Ph.D., Columbia University, New York
Belostotsky, D., Ph.D., State University of New York, Albany
Byrne, M., Ph.D., Cold Spring Harbor Laboratory
Cinar, B., M.S., D.V.M., University of Virginia, Charlottesville
De Las Penas, A., Ph.D., University of Virginia,
Charlottesville
Ehsani, N., Ph.D., University of Helsinki, Finland
Ferreira, J., M.D., University of Lisbon, Portugal
Hua, V., Ph.D., Massachusetts Institute of Technology/HHMI,
Cambridge
SEMINARS
Burgess, R., University of Wisconsin, Madison. Overview of
protein purification, immunoaffinity purification. Biochemical
studies of RNA polymerase/sigma factor interactions.
Collier, J., Harvard Medical School, Boston, Massachu-
setts. Membrane translocation by diphtheria and anthrax
toxins.
Courey, A., University of California, Los Angeles. Protein-pro-
tein interactions in dorsaVventral pattern formation in
Drosophila.
Eisenberg, D., University of California, Los Angeles. Domain
swapping and protein-protein interactions.
Lieberthal, W., M.D., Boston University Medical Center,
Massachusetts
Maiorella, B., Ph.D., Chiron Corporation, Emeryville, California
McDermott, B., M.A., Columbia University, New York
Merchant, J., M.D., Ph.D., University of Michigan, Ann Arbor
Merrick, A., Ph.D., National Institutes of Health, Research
Triangle Park, North Carolina
Stuckey, J., Ph.D, University of Michigan, Ann Arbor
Szigyarto, C., B.S., Stockholm University, Sweden
Teixeira, M.T., B.S., Institut Pasteur, Paris, France
Graves, B., University of Utah, Salt Lake City. Structural
analysis of autoinhibition of transcription factor ETS1.
Guidotti, G., Harvard University, Boston, Massachusetts.
Membrane proteins and extracellular ATP.
Lin, S.-H., University of Texas/M.D. Anderson Cancer Center,
Houston. Role of cell adhesion molecule (C-CAM) in
prostate cancer.
Mische, S., Rockefeller University, New York. Microanalytical
protein preparation and characterization.
Stillman, B., Cold Spring Harbor Laboratory. Biochemical
approach to understanding replication of the eukaryotic cell.
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Early Development of Xenopus laevis
April 19-28
INSTRUCTORS Krieg, Paul, Ph.D., University of Texas, Austin
Moody, Sally, Ph.D, George Washington University Medical Center
ASSISTANTS Cleaver, Ondine, University of Texas, Austin
Kenyon, Kristy, George Washington University Medical Center
Kroll, Kristen, Harvard University, Boston
Zorn, Aaron, Wellcome/CRC Institute, Cambridge, United Kingdom
This course provided extensive laboratory exposure to the biology, manipulation, and use of embryos
from the frog, Xenopus laevis. This course was suited both for investigators who had no experience
with Xenopus and for those who worked with Xenopus and wished to learn new techniques. All stu-
dents had current training in molecular biology and some knowledge of developmental biology. The
course consisted of intensive laboratory sessions, supplemented by daily lectures and demonstrations
from experts in both experimental and molecular embryology. Areas covered included (1) care of adults
and embryo isolation; (2) stages of embryonic development and anatomy; (3) whole-mount in situ
hybridization and immunocytochemistry; (4) microinjection of eggs and oocytes, including lineage trac-
ers, DNA constructs, mRNA, and antisense oligonucleotides; (5) micromanipulation of embryos, includ-
ing explant and transplantation assays; (6) preparation of transgenic embryos; and (7) use of Xenopus
tropicalis as a genetic model.
PARTICIPANTS
Bogdan, S., B.S., University of Essen Medical School,
Germany
Frommer, G., B.S. Ph.D., University of Tubingen, Germany
Gross, S., B.A., Ph.D., University of Colorado School of
Medicine/HHMI, Denver
Henrich, T., B.S., Max-Planck Institute, Goettingen, Germany
Hutcheson, D., B.A., University of Utah, Salt Lake City
Meijer, H., M.S., Utrecht University, The Netherlands
Ohan, N., B.S., Ph.D., Ottawa Civic Hospital/Loeb Research
Institute, Ontario, Canada
Poage, R., B.S. Ph.D., University of Pittsburgh, Pennsylvania
Radcliffe, M., B.S., Ph.D., University College London, United
Kingdom
SEMINARS
Christian, J., Oregon Health Sciences University, Portland.
Posttranscriptional regulation of BMP activity during verte-
brate embryonic patterning.
Dawid, I., National Institutes of Health, Bethesda, Maryland.
Some aspects of organizer function in Xenopus.
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Rollins-Smith, L., B.A., Ph.D., Vanderbilt University,
Tennessee
Saulnier, D., B.S., Swiss Federal Institute of Technology,
Zurich, Switzerland
Singhatat, V., B.S., Ohio State University College of
Pharmacy, Columbus
Stancheva, I., M.S., Ph.D., University of Edinburgh, Scotland,
United Kingdom
Wheeler, G., B.S., Ph.D., University of Dundee, United
Kingdom
Woda, J., BA., Harvard Medical School, Cambridge,
Massachusetts
Grainger, R., University of Virginia, Charlottesville. Lens deter-
mination.
Heasman, J., University of Minnesota School of Medi-
cine, Minneapolis. Maternal control of cell fates in the
blastula.
Keller, R., University of Virginia, Charlottesville. Xenopus gas-
trulation.
King, M.L., University of Miami Medical School, Florida. RNA
localization in the Xenopus oocyte.
Klymkowsky, M., University of Colorado, Boulder.
Plakoglobin, the other ARM of vertebrates: Its role in cell
adhesion and signaling.
Kroll, K., Harvard University, Boston, Massachusetts. An
introduction to transgenesis in Xenopus.
Krieg, P., University of Texas, Austin. Development of the car-
diovascular system.
Moody, S., George Washington University Medical Center,
Washington, D.C. Cell-cell interactions and ancestry influ-
ence the fate to become retina.
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Arabidopsis Molecular Genetics
June 3-23
INSTRUCTORS Barton, Katherine, Ph.D., University of Wisconsin, Madison
Glazebrook, Jane, Ph.D., University of Maryland, College Park
Lam, Eric, Ph.D., Rutgers University, New Brunswick, New Jersey
ASSISTANTS Long, Jeff, University of Wisconsin, Madison
Pontier, Dominique, Rutgers University, New Brunswick, New Jersey
Zhou, Nan, University of Maryland, College Park
This course provided an intensive overview of topics in plant growth and development, focusing on
molecular genetic approaches to understanding plant biology. It emphasized recent results from
Arabidopsis thaliana and other model plants and provided an introduction to current methods used in
Arabidopsis research. It was designed for scientists with experience in molecular techniques or in plant
biology who wish to work with Arabidopsis. The course consisted of a vigorous lecture series, a hands-
on laboratory, and informal discussions. Discussions of important topics in plant research were pre-
sented by the instructors and by invited speakers. These seminars included plant anatomy; plant
development (including development of flowers, roots, meristems, embryos and the epidermis); per-
ception of light and photomorphogenesis; responses to pathogens and to other environmental stress-
es; synthesis and function of secondary metabolites and hormones; macromolecular transport; and the
role of ion channels in plant cell physiology. Lectures describing bioinformatics tools available to the
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Arabidopsis community and the potential of the Arabidopsis genome project for accelerating
Arabidopsis research were also included. Speakers provided overviews of their fields, followed by in-
depth discussions of their own work. The laboratory sessions provided an introduction to important
techniques currently used in Arabidopsis research. These included studies of Arabidopsis develop-
ment, mutant analysis, studies of epidermal features, in situ detection of RNA, histochemical staining,
transient gene expression, detection and analysis of plant pathogens, applications of green fluorescent
protein fusions, techniques commonly used in genetic and physical mapping, and map-based cloning.
PARTICIPANTS
Alvarez, M., M.S., Ph.D., National University Cordoba,
Argentina
Boch, J., B.S., Ph.D., Washington University, St. Louis,
Missouri
Chalivendra, S., M.S., Ph.D., University of Illinois, Urbana
Destefano, L., B.S., Ph.D., Institute of Paper Science and
Technology, Atlanta, Georgia
Hagenblad, J., M.S., Lund University, Sweden
Harmer, S., B.A., University of California, San Francisco
Hay, A., B.S., University of California, Berkeley
Hillebrand, H., M.S., Ph.D., Ruhr-Universitat Bochum,
Germany
SEMINARS
Assmann, S., Pennsylvania State University, University Park.
Patch-clamping ion channels and transport.
Barton, K., University of Wisconsin, Madison. Development of
leaf or embryo.
Bleecker, T, University of Wisconsin, Madison. Ethylene/
auxin signaling.
Briggs, W., Carnegie Institution of Washington, Stanford,
California. Light perception.
Britt, A., University of California, Davis. DNA repair.
Chapple, C., Purdue University, West Lafayette, Indiana.
Secondary metabolism.
Cherry, M., Stanford University, California. Arabidopsis
resources AtDB.
Citovsky, V., State University of New York, Stony Brook.
Macromolecular trafficking.
Clark, S., University of Michigan, Ann Arbor. Organ formation.
Crosby, B., National Research Council of Canada, Saskatoon.
Protein interaction and floral morphogenesis.
Deng ler, N., University of Toronto, Canada. Plant anatomy.
Glazebrook, J., University of Maryland, College Park. Map-
based cloning strategies.
Haughn, G., University of British Columbia, Vancouver,
Canada. Seed and ovule development.
Kadalayil, L, M.S., Ph.D., Stockholm University, Sweden
Leader, D., B.S., Ph.D., Zeneca Plant Science, Berkshire,
United Kingdom
Maloof, J., B.A., University of California, San Francisco
Matteucci, A., B.S., Ph.D, National Institute of Nutrition,
Rome, Italy
Rajasekhar, V. B.S., Ph.D., Samuel Roberts Nobel
Foundation, Ardmore, Oklahoma
Reynaga-Pena, C., B.S., Ph.D., University of California,
Riverside
Shimizu, K., B.S., Kyoto University, Japan
Xiao, Y., B.S., M.S., Iowa State University, Ames
Last, R., Boyce Thompson Institute for Plant Research/
Cornell University, Ithaca, New York. Plant stress responses.
Ma, H., Cold Spring Harbor Laboratory. Molecular analysis of
plant development.
Martienssen, R., Cold Spring Harbor Laboratory. Enhancer
traps in Arabidopsis.
Preuss, D., University of Chicago, Illinois. Male gametophyte
development and fertilization.
Richards, E., Washington University, St. Louis, Missouri.
Genome organization and epigenetics. Programmed cell
death.
Rounsley, S., The Institute for Genomic Research, Rockville,
Maryland. Computer lab.
Schifelbein, J., University of Michigan, Ann Arbor. Root devel-
opment.
Sederoff, R., North Carolina State University, Raleigh. Tree
genetics.
Theologis, A., Plant Gene Expression Center, Albany,
California. Arabidopsis genome project.
Weigel, D., Salk Institute, La Jolla, California. Floral develop-
ment: Evolution meets function.
Wessler, S., University of Georgia, Athens. Transposons and
genome evolution.
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Genetic Epidemiological Studies of Complex Diseases
June 10-16
INSTRUCTORS Risch, Neil, Ph.D., Stanford University
Squires-Wheeler, Elizabeth, Ph.D., Columbia University College of Physicians & Surgeons
This lecture course considered the difficulties in studying the genetic basis of complex disorders, such
as diabetes, Alzheimer's disease, schizophrenia, and epilepsy, with a particular emphasis on neu-
ropsychiatric conditions. Discussed were genetic-epidemiologic study designs, including family, twin,
and adoption studies and the mode of inheritance analyses, and their role in setting the framework for
understanding the genetic and nongenetic components of a disease.
A major focus was the identification of specific gene effects using both linkage and association
analysis. The efficiency and robustness of different designs for such analysis were discussed, and how
evidence from genetic-epidemiologic studies informs both the design and interpretation of molecular
genetic studies was considered. Recent discoveries of genes for both Mendelian and non-Mendelian
diseases guided the discussion of the various methodologic issues.
PARTICIPANTS
Andersson, C., B.M., M.D., Karolinska Hospital, Stockholm,
Sweden
Bergen, A., B.A., Ph.D., National Institutes of Health,
Rockville, Maryland
Bradley, M., M.D., Karolinska Institute, Stockholm, Sweden
Burk, M., M.D., Albert Einstein College of Medicine, Bronx,
New York
Dahlman, Ingrid, M.D., Karolinska Institute, Stockholm,
Sweden
Ferrence, B., M.S, M.D., Yale University School of Medicine,
New Haven, Connecticut
Gaffney, P., B.S., M.D., University of Minnesota, Minneapolis
of British Columbia/Jack Bell
Research Center, Vancouver, Canada
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lacoviello, L., M.D., Consorzio Mario Negri Sud, Santa Maria
Imbaro, Italy
Kanes, S., M.D., Ph.D., Yale University, New Haven,
Connecticut
Lee, Y.-A., B.S., M.D., Max Delbriick Center for Molecular
Medicine, Berlin, Germany
Lin, J.P., M.D., Ph.D., National Institutes of Health, Bethesda,
Maryland
Neul, J., M.D., Ph.D., University of Chicago, Illinois
Post, W., B.A., M.D., Johns Hopkins University Hospital,
Baltimore, Maryland
Ritter, D., M.D., D.M.S., St.Louis University Medical Center,
St. Louis, Missouri
SEMINARS
Bressman, S., Beth Israel Medical Center, New York.
Dystonia.
Keats, B., Louisiana State University Medical Center, New
Orleans. Linkage analysis I.
Merikangas, K., Yale University, New Haven, Connecticut.
Further issues in genetic epidemiology.
Ott, J., Rockefeller University, New York. Linkage analysis II.
Ottman, R., Columbia University, New York. First principles of
genetic epidemiology.
Rossing, MA., B.S., D.V.M., Ph.D., Fred Hutchinson Cancer
Research Center, Seattle, Washington
Silver, J., B.S., Ph.D., New York University Medical
School/North Shore Hospital, Manhasset, New York
Tseng, T.-L., B.S., M.S., State University of New York, Stony
Brook
Verheyen, G., B.S., Ph.D., University of Antwerp, Wilrijk,
Belgium
Wijemga, C., B.S., Ph.D., Utrecht University, The Netherlands
Wilbur, V., B.S., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Wong, G., B.S., Ph.D., University of Washington, Seattle
Zwaigenbaum, L., M.D., McGill University, Montreal, Canada
Risch, N., Stanford University, Stanford, California. Biometrical
genetics: Twin and adoption designs.
Sandkuijl, L., Leiden University, The Netherlands. Linkage dis-
equilibrium in founder populations. Bipolar disorder.
Spielman, R., University of Pennsylvania School of Medicine,
Philadelphia. Association studies: Candidate genes, transmis-
sion disequilibrium test, genome mismatch scanning. Diabetes.
Risch N., Stanford University, Stanford, California. Multiple
sclerosis.
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Advanced Bacterial Genetics
June 10-30
INSTRUCTORS Bass ler, Bonnie, Ph.D., Princeton University
Manoil, Colin, Ph.D., University of Washington, Seattle
Slauch, James, Ph.D., University of Illinois, Champaign-Urbana
ASSISTANTS Cosma, Christine, University of Washington, Seattle
Freeman, Jeremy, Princeton University
Janakiraman, Anuradha, University of Illinois, Champaign-Urbana
The laboratory course presented logic and methods used in the genetic dissection of complex biolog-
ical processes in bacteria. The methods presented included mutagenesis using transposons, mutator
strains, and chemical and physical mutagens; mapping mutations using genetic and physical tech-
niques; generation and analysis of gene fusions; molecular cloning; PCR; Southern blot analysis; epi-
tope insertion mutagenesis; and site-directed mutagenesis. A key component of the course was the
use of sophisticated genetic methods in the analysis of pathogenic and "undomesticated" bacteria.
Invited lecturers described the use of genetic approaches to study biological processes in a variety of
bacteria.
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PARTICIPANTS
Agrawal, R., M.S., Ph.D., New York State Department of
Health, Albany
Boehm, A., B.S., University of Konstanz, Germany
Ciampi, S., B.S., Ph.D., University of Bari, Italy
Dixon, T., B.S., Duke University Medical Center, Durham,
North Carolina
Folkesson, A., M.S., Karolinska Institute, Stockholm, Sweden
Fox, J., B.A. Ph.D., Tufts University School of Medicine,
Boston, Massachusetts
Hochkoeppler, A., B.S., Ph.D., University of Bologna, Italy
Karkhoff-Schweizer, R.A., B.S.,B.A., Ph.D., Colorado State
University, Fort Collins
Membrillo-Hernandez, J., B.S., Ph.D., Harvard Medical
SEMINARS
Brown, S., Copenhagen University, Denmark. Genetic analy-
sis of the biological-inorganic interface.
Gottesman, S., National Cancer Institute, Bethesda,
Maryland. Two levels of posttranscriptional control of the
stationary phase a factor, RpoS.
Hultgren, S., Washington University School of Medicine, St. Louis,
Missouri. The link between pills biogenesis and pathogenesis.
Kaplan, H., University of Texas, Houston. Sensing and inte-
gration of multiple signals during Myxococcus multicellular
development.
School, Boston, Massachusetts
Nechaev, S., M.S., State University of New Jersey/Rutgers
State University, Piscataway
Rabus, R., B.S. Ph.D., University of California, San Diego
Tear le, R., B.S., Ph.D., BresaGen Ltd., Thebarton SA, Australia
Tegmark-Wisell, K, M.D., Karolinska Institute, Stockholm, Sweden
Tersteegen, A., B.S., M.S., Max-Planck Institute, Marburg,
Germany
Viboud, G., B.S., Ph.D., National Institute of Infectious
Diseases, Buenos Aires, Argentina
Winrow, MA., B.S., M.S., Ph.D., Elizabeth City State
University, North Carolina
Ma loy, S., University of Illinois, Urbana. Regulation of gene
expression by membrane sequestration.
Silhavy, T., Princeton University, New Jersey. Parallel path-
ways perceive periplasmic problems.
Stewart, V, Cornell University, Ithaca, New York. Indirect inference.
Storz, G., National Insitutes of Health, Bethesda, Maryland.
Regulation of the E coil response to oxidative stress.
Taylor, R., Dartmouth University, Hanover, New Hampshire.
Genetic approaches to understanding the virulence mecha-
nisms of Vibrio cholerae.
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Integrated Approaches to Ion Channel Biology
June 10-30
INSTRUCTORS Coldwell, John, Ph.D., University, of Colorado Health Sciences Center, Denver
Levinson, Rock, Ph.D., University of Colorado Health Sciences Center, Denver
Maue, Robert, Ph.D., Dartmouth Medical School, Hanover
ASSISTANT Whisenand, Teri, University of Colorado Health Sciences Center, Denver
This intensive laboratory/lecture course introduced students to the multidisciplinary use of molecular
biological, biochemical, immunological, and electrophysiological approaches to the study of ion chan-
nels. The laboratory focused on the cellular regulation of channel expression and function. Hands-on
exercises included characterization of regulatory elements that control transcription of channel genes,
identification of ion channel isoform transcripts and proteins, visualization of channel distributions, and
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the biophysical analysis of channel isoform function in excitable cells and tissues and in exogenous
expression systems. Specific techniques employed included PCR, Western blot, transient transfection
and expression, immunocytochemistry, and patch-clamp analysis of ionic currents. Lectures covered
the techniques employed while providing broad exposure to current issues surrounding ion channel
mechanisms and cellular expression. This course was intended for advanced students with specific
plans to apply the techniques taught to a defined problem, and students were encouraged to bring
their preparation to the course for preliminary studies.
PARTICIPANTS
Baruscott, M., B.S., Universita Deg li Studi Di Milano, Milano, Italy
Decker, K., B.S., Justus Liebig University, Giessen, Germany
Donohoe, P., M.S., Ph.D., University of California, San
Francisco
Fraser, H., B.S., University of Alberta, Edmonton, Canada
Kuusinen, A., M.S., University of Helsinki, Finland
Sadreyev, R., B.S., Moscow State University, Russia
Spura, A., B.S., Brown University, Providence, Rhode Island
SEMINARS
Caldwell, J., University of Colorado Health Sciences Center,
Denver. NaCh6: An abundant CNS and PNS voltage-gated
sodium channel.
Froehner, S., University of North Carolina, Chapel Hill.
Localization of ion channels and receptors at synapses.
Gardner, P., University of Texas Health Science Center, San
Antonio. Regulation of neuronal nicotinic acetylcholine
receptor gene expression.
Lilly, W., Hopkins Marine Station, Stanford University, Pacific
Grove, California. Expression of sodium and potassium
channel isoforms in squid neurons.
Henderson, L., Dartmouth Medical School, Hanover, New
Hampshire. Pumping ions: Steroids, sex, and the GABAA
receptor.
Isom, L., University of Michigan School of Medicine, Ann
Arbor. Regulation of sodium channel density and localization
by auxiliary /3 subunits.
Levinson, R., University of Colorado Health Sciences Center,
Denver. Selective expression and localization of sodium
channel isoforms in the peripheral nervous system.
Lewis, R., Stanford University School of Medicine, California.
Tonini, R., B.S., M.S., University of Milan, Italy
Townsend, TM., B.S., Ph.D., Yale University, New Haven,
Connecticut
Vernon, J., B.S., University of Cambridge, United Kindgom
Xu, X.Z.S., B.S., M.S., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Yellow ley, C., B.S., Ph.D., Pennsylvania State University
College of Medicine, Hershey
Local calcium domains and the regulation of store-operated
calcium channels.
Mandel, G., State University of New York, Stony Brook.
Regulation of sodium channels: How to quiet your nerves.
Maue, R., Dartmouth Medical School, Hanover, New
Hampshire. Molecular analysis of neuronal sodium channel
expression.
O'Dowd, D., University of California, Irvine. Analysis of ion
channel gene expression by single-cell RT-PCR.
Ribera, A., University of Colorado Health Science Center,
Denver. Study of development of electrical excitability using
both forward and reverse genetics.
Salkoff, L., Washington University School of Medicine, St.
Louis, Missouri, Impact of genome sequencing projects on
potassium channel biology.
Sargent, P., University of California, San Francisco. Location
and functional role of nicotinic receptors in a purportedly sim-
ple neuronal system: The vertebrate autonomic ganglion.
Snutch, T., University of British Columbia, Vancouver,
Canada. Molecular determinants of calcium channel modu-
lation: From worms to mammals.
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Computational Neuroscience: Vision
June 18-July 1
INSTRUCTORS Heeger, David, Ph.D., Stanford University
Shad len, Michael, Ph.D.,University of Washington, Seattle
Simoncelli, Eero, Ph.D., New York University
ASSISTANTS Horwitz, Gregory, Stanford University
Wichmann, Felix, Oxford University, Oxford, United Kingdom
Computational approaches to neuroscience have produced important advances in our understanding
of neural processing. Prominent successes have come in areas where strong inputs from neurobio-
logical, behavioral, and computational approaches can interact. Through a combination of lectures and
hands-on experience with a computer laboratory, this intensive course examined several areas, includ-
ing feature extraction, motion analysis, binocular stereopsis, color vision, higher-level visual processing,
visual neural networks, and oculomotor function. The theme was that an understanding of the com-
putational problems, the constraints on solutions to these problems, and the range of possible solu-
tions can help guide research in neuroscience. Students had experience in neurobiological or compu-
tational approaches to visual processing. Some background in mathematics was beneficial.
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PARTICPANTS
Alliston, E., B.S., New York University, New York
Bailey, D., B.S., M.S., University of Washington, Seattle
Barberini, C., B.S., Stanford University, California
Bridge, H., University of Oxford, United Kingdom
Brown, M., B.A., New York University, New York
Cai, R., B.S., Ph.D., University of California, Los Angeles
Chukoskie, L., B.A., New York University, New York
Cook, E., B.S., Ph.D., Baylor College of Medicine, Houston,
Texas
Gardner, J., B.S., University of California, Berkeley
Hol, K., M.S., University of TObingen, Germany
Loeffler, G., B.S., M.S., Glasgow Caledonian University,
United Kingdom
McMahon, M., B.S., MA., University of California, San Diego
Oomes, A., M.S. University of Nijmegen, The Netherlands
SEMINARS
Adelson, T., Massachusetts Institute of Technology,
Cambridge. Elements of early vision.
Brainard, D., University of California, Santa Barbara. Color,
trichromacy, and color spaces. Color appearance and color
constancy.
Chichilnisky, E.J., The Salk Institute, San Diego, California.
Color appearance and color constancy. White noise analy-
sis of retinal ganglion cell receptive.
Dacey, D., University of Washington, Seattle. Retina:
Anatomy and physiology of various types of bipolar, hori-
zontal, amacrine, and ganglion cells.
Glimcher, P., New York University, New York. Models of VOR
and OKN eye movements.
Graham, N., Columbia University, New York. Pattern detec-
tion and texture discrimination.
Groh, J., Dartmouth College, Hanover, New Hampshire. MT
and pursuit eye movements/Models of saccadic eye move-
ments.
Heeger, D., Stanford University, California. Linear systems,
convolution, and Fourier transform. Signal detection theory.
Models of V1 physiology, orientation, direction, and dispar-
Prince, S., B.S., University of Oxford, United Kingdom
Rees, G., B.A., University College London, United Kingdom
Rieger, J., B.A., Max-Planck Institute, Tithingen, Germany
Roitman, J., B.S., University of Washington, Seattle
Rossi, A., B.A., Ph.D., National Institutes of Health, Bethesda,
Maryland
Stanley, G., B.E., Ph.D., University of California, Berkeley
Sun, H., B.S., M.S., University of Chicago, Illinois
Tsai, J., B.S., M.S., Cornell University Medical College, Ithaca,
New York
Turner, J., BA., Ph.D., Rutgers University, Newark, New
Jersey
Wainwright, M., B.M., Harvard University, Cambridge,
Massachusetts
Walker, G., B.S., University of California, Berkeley
ity selectivity, contrast normalization control. Multiscale/
pyramid/wavelet image transforms as models of neural
image representations. Neural codes, noise, and the statis-
tics of cortical spike trains. Linking brain and behavior with
fMRI.
Maunsell, J., Baylor College of Medicine, Houston, Texas.
Attention physiology.
Movshon, T, New York University, New York. LGN-V1 physi-
ology. Extrastriate and MT physiology.
Palmer, J., University of Washington, Seattle. Attention psy-
chophysics.
Schall, J., Vanderbilt University, Nashville, Tennessee. Frontal
eye fields and the neural basis of saccade target selection.
Shad len, M., University of Washington, Seattle. MT and the
neural basis of visual motion discrimination. Decisions, LIP,
and frontal cortex.
Simoncelli, E., New York University, New York. Linear sys-
tems, convolution, and Fourier transform. Statistics of nat-
ural images. Model of MT physiology.
Welch, L., Brown University, Providence, Rhode Island. Visual
motion perception and psychophysics.
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Molecular Cloning of Neural Genes
July 3-23
INSTRUCTORS Darnell, Robert, M.D., Ph.D., Rockefeller University
Du lac, Catherine, Ph.D., Harvard University
Lai, Cary, Ph.D., Scripps Research Institute
Rupp, Fabio, Ph.D., John Hopkins University
Serafini, Tito, Ph.D., University of California
CO-INSTRUCTORS Amrein, Hubi, Columbia University
Lavery, Daniel, Glaxo Wellcome Experimental Research, Lausanne, Switzerland
ASSISTANTS Dredge, Kate, Rockefeller University
Herrada, Gilles, Harvard University
Jensen, Kirk, Rockefeller University
Okano, James, Rockefeller University
This intensive laboratory and lecture course teaches neuroscientists current approaches to molecular
neurobiology. The course consisted of daily laboratory exercises, detailed discussions on the practice
of molecular neurobiology, with an emphasis on modern approaches to cloning and analyzing the
expression of neural genes, and a series of evening research seminars by invited speakers. This lec-
ture series examined the ways in which molecular techniques studied in the laboratory have been suc-
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cessfully applied to the study of neural genes, including expression cloning, single-cell cloning, sub-
tractive cDNA cloning strategies, and genetic and mechanistic studies of neurologic disease, acquisi-
tion of cell identity, and axon guidance in the developing nervous system.
The focus of the laboratory portion of the course was to introduce different approaches to generat-
ing cDNA libraries and analyzing gene expression that are of particular interest to neurobiologists.
Students learned to generate and examine cDNA libraries from large regions of the nervous system (e.g.,
mouse cerebellum and forebrain), from several hundreds to thousands of cells (embryonic tissue, spe-
cific nuclei) and from single neurons. Specific methods taught included the isolation and characteriza-
tion of poly(A)+ RNA; construction and screening of cDNA libraries; expression cloning; analysis of cDNA
clones, including phagemid rescue, restriction analysis, Southern blotting, ligations, transformation, and
subcloning; PCR analysis including oligonucleotide design and PCR cloning; and an exploration of
advanced cloning techniques including single-cell library synthesis and PCR-based subtraction cloning
technique, SABRE. Gene expression studies included Northern blot analysis and mammalian cell trans-
fection, including use of a biolistic gene gun.
PARTICIPANTS
Altemus, M., BA., M.D., Cornell University, New York
Anton, E., B.A., Ph.D., Yale University, New Haven,
Connecticut
Barnes, G., B.S., M.D., Ph.D., Duke University Medical
Center, Durham, North Carolina
Cohen, E., BA., Ph.D., Yale University, New Haven,
Connecticut
Couillard-Despres, S., B.S., Montreal General Hospital,
Montreal, Canada
Dunaevsky, A., B.A., M.A., Ph.D., Columbia University, New
York
Ebersole, T., B.S., University of Notre Dame, Indiana
Grabham, P., B.S., Ph.D., Columbia University, New York
SEMINARS
Darnell, R., Rockefeller University, New York. Cloning neuron-
specific genes with neurologic disease antisera.
Du lac, C., Harvard University, Cambridge, Massachu-
setts. Molecular biology of pheromone perception in
mammals.
Edwards, R., University of California, San Francisco. Neurotrans-
mitter transporters and the regulation of neurotransmitter
release.
Hernmati-Brivanlou, A., Rockefeller University, New York. In
vivo systems for expression cloning in vertebrates.
Huganir, R., Johns Hopkins University, Baltimore, Maryland.
Molecular studies of synaptic transmission.
Lavery, D., Glaxo Wellcome, Lausanne, Switzerland.
Approaches to cloning of differentially expressed genes.
Kavalali, E., B.S., Ph.D., Stanford University School of
Medicine, California
Khakh, B., B.S, Ph.D., California Institute of Technology,
Pasadena
Kossel, A., B.S., Ph.D., Max-Planck Institute, Munich, Germany
Svoboda, K., B.A., Ph.D., Cold Spring Harbor Laboratory
Thallmair, M., B.S., M.S., University of Zurich, Switzerland
Wenner, P., B.S., Ph.D., National Institutes of Health,
Bethesda, Maryland
Williams, J., B.A., Ph.D., Massachusetts General Hospital,
Boston
Zhong, H., B.S., Johns Hopkins University, Baltimore,
Maryland
Lemke, G., Salk Institute, La Jolla, California. Neuregulins in
development.
Serafini, T., University of California, Berkeley. In vitro analysis
of axon guidance and targeting.
Stein, L., Cold Spring Harbor Laboratory. Sequence analysis
on the Web.
Streittmatter, S., Yale University, New Haven, Connecticut.
Transduction of inhibitory guidance signals by the axonal
growth cone.
Walsh, C., Harvard University/Beth Israel Hospital, Boston,
Massachusetts. Genes that regulate cortical control mecha-
nisms.
Worley, P., Johns Hopkins University, Baltimore, Maryland.
Novel brain IEGs: Insights into synaptic plasticity.
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Neurobiology of Drosophila
July 3-23
INSTRUCTORS Dickinson, Michael, Ph.D., University of California, Berkeley
Patel, Nipam, Ph.D., University of Chicago
Taylor, Barbara, Ph.D., Oregon State University, Corvallis
ASSISTANTS Davis, Gregory, University of Chicago
Song, Ho Juhn, Oregon State University, Corvallis
This laboratory/lecture course was intended for researchers at all levels who want to use Drosophila as
an experimental system for studying behavior, physiology, and development. Daily seminars introduced
students to a variety of research topics and developed those topics by including recent experimental
contributions and outstanding questions in the field. Guest lecturers brought original preparations for
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viewing and discussion and/or direct laboratory exercises and experiments in their area of interest. The
course provided students with hands-on experience using a variety of experimental preparations
employed in the investigation of current neurobiological questions. The lectures and laboratories
focused on both the development of the nervous system and its role in controlling larval and adult
behaviors. In addition to an exposure to the molecular genetic approaches available in Drosophila, stu-
dents learned a variety of techniques including embryo in situ hybridization, labeling of identified neu-
rons, electrophysiological recording from nerves and muscles, and the analysis of larval and adult
behavior. Collectively, the course provided a comprehensive and practical introduction to modern
experimental methods for studying the Drosophila nervous system. The specific topics included neu-
rogenesis, axon pathfinding, synaptogenesis, membrane excitability, learning and memory, biological
rhythms, courtship, neural circuits, and walking and flight behaviors.
PARTICIPANTS
Beckstead, R., B.S., Baylor College of Medicine, Houston,
Texas
Butler, A., BA., Michigan State University, East Lansing
Chodagam, S., B.S., TATA Institute of Fundmental Research,
Mumbai, Maharashtra, India
Gregor, I., M.S., Oxford University, Oxford, United Kingdom
Hayward, N., B.S., Cambridge University, United Kingdom
Higashi, C., B.S., University of Tokyo, Japan
SEMINARS
Brand, A., University of Cambridge, United Kingdom. Neural
cell fate determination.
Dickinson, M., University of California, Berkeley. Muscle func-
tion and flight.
Fortini, M., University of Pennsylvania, Philadelphia. Early neu-
rogenesis.
Hall, J., Brandeis University, Waltham, Massachusetts.
Behavioral mutants and genetics, an overview.
Kernan, M., State University of New York, Stony Brook.
Mechanosensory systems.
Meinertzhagen, I., Dalhousie University, Halifax, Nova Scotia.
Synaptic plasticity and the adult visual system.
O'Dowd, D., University of California, Irvine. Ion channels and
neuronal diversity.
Patel, N., University of Chicago, Illinois. Embryogenesis and
early pattern formation.
Ramaswami, M., University of Arizona, Tucson. Exocytosis
and neuromuscular function.
Restifo, L., University of Arizona, Tucson. Metamorphosis and
adult development.
Park, J., B.S., Ph.D., Brandeis University, Waltham,
Massachusetts
Riedl, C., B.S., York University, Ontario, Canada
Strigini, M., M.S., EMBL, Heidelberg, Germany
Tong, J., B.S., Cold Spring Harbor Laboratory
Voelkner, M., B.S., Max-Planck Institute, Frankfurt, Germany
Wildemann, B., B.S., Freie University Berlin, Germany
Sink, H., New York University, New York. Axonal pathfind-
ing.
Sokolowski, M., York University, Ontario, Canada. Larval
behaviors.
Strauss, R., Max-Planck Institute, Tubingen, Germany.
Central processing centers and walking.
Sun, X.J., Cross Cancer Institute, Edmonton, Canada.
Synaptic plasticity and the adult visual system.
Taghert, P., Washington University School of Medicine, St.
Louis, Missouri. Neuropeptide signals: Regulators of devel-
opment and behavior.
Taylor, B., Oregon State University, Corvallis. Sex differences
and reproductive behaviors.
Tully, T, Cold Spring Harbor Laboratory. Learning and
memory.
Treisman, J., N.Y. Medical Center/Skirball Institute of
Molecular Medicine, New York. Visual system develop-
ment.
Zhong, Y., Cold Spring Harbor Laboratory. Neuronal plas-
ticity.
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Brain Development and Function
July 7-20
INSTRUCTORS McKay, Ronald, Ph.D., National Institutes of Health
Schuman, Erin, Ph.D., California Institute of Technology
This advanced lecture and discussion course was on the development and function of the nervous sys-
tem. Eighteen participants with diverse geographical and intellectual backgrounds met for 2 weeks with
leading neuroscience researchers. The lectures provided both a comprehensive introduction as well as
a detailed presentation of current research. There were many opportunities for discussion among the
students and lecturers. The following topics were discussed: axon guidance and recognition,
cytoskeleton and protein trafficking, neurotransmitter release, organization of synaptic structures, visu-
al system development, structural plasticity, hippocampal function, olfactory signaling and coding, and
modulatory brain systems.
PARTICIPANTS
Diaz, E., B.A., Stanford University, Stanford
Furuyashiki, T, M.D., Kyoto University, Japan
Huber, A., B.S., M.S., University of Zurich, Switzerland
Karam, S., B.S., M.S., University of Washington, Seattle
Kools, R, B.S., Ph.D., University of Gent, Belgium
Malyala, A., B.A., M.A., George Washington University,
Washington, D.C.
Metta, G., M.S., University of Genova, Italy
Muehlner, U., B.S., Research Institute of Molecular Path-
ology, Vienna, Austria
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Nagano, T., M.D., Ph.D., Niigata University, Japan
Raab-Graham, K., B.A., Ph.D., University of California, Santa
Barbara
Smidt, M., M.D., Ph.D., Rudolf Magnus Institute for
Neuroscience Utrecht, The Netherlands
Widenfalk, J., M.D., Ph.D., Karolinska Institute, Stockholm,
Sweden
Wilson, S., B.S., Ph.D., National Cancer Institute, Frederick,
Maryland
SEMINARS
Adolphs, R., University of Iowa College of Medicine, Iowa
City. Lesion studies of human cortex.
Craig, A.M., University of Illinois, Urbana. Cell biology of
synaptic structures.
Davis, G., University of California, Berkeley. Axon guidance
and control of neuromuscular function.
Davis, M., Yale University, New Haven, Connecticut. Anxiety
and fear.
Eichenbaum, H., Boston University, Massachusetts.
Relational functions in hippocampus.
Feller, M., National Institutes of Health, Bethesda, Maryland.
Retinal development.
Ginty, D., Johns Hopkins University, Baltimore, Maryland.
Signal pathways in neurons.
Harris, K., Harvard University, Boston, Massachusetts.
Organization of synaptic structures.
Huganir, R., Johns Hopkins University, Baltimore,
Maryland. Molecular biology and function of glutamate
receptors.
Kolodkin, A., Johns Hopkins University, Baltimore, Maryland.
Axon guidance and recognition I.
Lichtman, J., Washington University, St. Louis, Missouri.
Synaptic competition at the neuromuscular junction.
Lippincott Schwartz, J., National Institutes of Health,
Wulf, P., B.A., Swiss Federal Institute of Technology, Zurich,
Switzerland
Yamaguchi, M., Ph.D., RIKEN Brain Research Institute, Wako
Saitama, Japan
Yu, X., B.A., MRC Laboratory of Molecular Biology,
Cambridge, United Kingdom
Zhang, K., M.D., Helsinki University, Finland
Zhong, Z.-W., B.S., Ph.D., Laval University, Quebec, Canada
Bethesda, Maryland. Membrane dynamics.
Lurent, G., California Institute of Technology, Pasadena. Spike
coding.
McKay, R., National Institutes of Health, Bethesda, Maryland.
Stem and progenitor cells.
Mitchison, T, Harvard University, Boston, Massachusetts.
The neuronal cytoskeleton.
Muller, R., SUNY Health Science Center, Brooklyn, New York.
Hippocampal place cells.
Ngai, J., University of California, Berkeley. Olfaction.
Posner, M., University of Oregon, Eugene. Imaging human
brain function.
Reichardt, L., University of California, San Francisco.
Neurotrophin in development.
Ryan, T., Cornell University, Ithaca, New York. Synaptic vesi-
cle recycling.
Schuman, E., California Institute of Technology, Pasadena.
Synaptic modulation.
Serafini, T, University of California, Berkeley. Axon guidance
and recognition II.
Wong, R., Washington University, St. Louis, Missouri. Visual
system, structure, and plasticity.
Yuste, R., Columbia University, New York. Imaging neuronal
function.
247
Molecular Embryology of the Mouse
June 10-30
INSTRUCTORS Koopman, Peter, Ph.D., University of Queensland, Australia
Magnuson, Terry, Ph.D., Case Western Reserve University
CO-INSTRUCTORS Nagy, Andras, Ph.D., Samuel Lunenfeld Research Institute/Mount Sinai Hospital, Ontario, Canada
Tam, Patrick, Ph.D., Children's Medical Research Institute, Sydney, Australia
ASSISTANTS Bowles, Josephine, University of Queensland, Australia
Bultman, Scott, Case Western Reserve University
This intensive course was designed for biologists interested in broadening their expertise to the study
of mouse embryonic development. Laboratory components provided an introduction into the technical
aspects of working with and analyzing mouse embryos, and lectures provided the conceptual basis for
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current research. The procedures described included isolation and culture of pre- and postimplantation
embryos, in situ hybridization to whole mounts of embryos, LacZ staining, skeletal preparation, mak-
ing aggregation chimeras, establishment, culture, and genetic manipulation of embryonic stem cell
lines, electrofusion, microinjection of DNA into pronuclei, microinjection of embryonic stem cells into
blastocysts, and surgical transfer of manipulated embryos into oviducts and uteri of host mice.
PARTICIPANTS
Allen, A., B.S., Ohio State University, Columbus
Begue-Kirn, C., M.S., Ph.D, University of Texas/M.D.
Anderson Cancer Center, Houston
Beverdam, A., M.S., Netherlands Institute for Developmental
Biology, Utrecht, The Netherlands
Casey, B., BA., M.D., Baylor College of Medicine, Houston,
Texas
Cunningham, S., B.S., Ph.D., University of Warwick,
Coventry, United Kingdom
Hietanen, K., M.S., University of Helsinki, Finland
Hornyak, T., B.A., M.D., Ph.D., New York University Medical
Center, New York
SEMINARS
Behringer, R., The University of Texas/M.D. Anderson Cancer
Center, Houston. Genetic regulation of mammalian embryo-
genesis. Transgenic mice in biomedical research.
Bradley A., Baylor College of Medicine, Houston. Introduction
to ES cells. Screening the genome for tumor suppressor
genes.
Eppig, J., The Jackson Laboratory, Bar Harbor, Maine. The
mouse and the Web: Exploring information resources.
Hogan, B., Vanderbilt University Medical School, Nashville,
Tennessee. Role of BMPs and Forkhead genes in cell-cell
interactions during mouse development.
Joyner, A., N.Y. Medical Center/Skirball Institute of
Biomolecular Medicine, New York. Genetic analysis of
mid/hindbrain patterning and the Shh pathway in mice.
Koopman, P., The University of Queensland, Australia. Sex
determination. Sox9 and the development of the skeleton.
Jenkins, N., National Cancer Institute, Frederick, Maryland.
Molecular genetic analysis of mouse coat color mutations
provides new insight into intracellular vesicle transport.
Jessell, T., Columbia University, New York. Inductive signals,
transcriptional responses, and the control of neuronal iden-
tity in the vertebrate CNS.
Krumlauf, R., National Institute for Medical Research,
London, United Kingdom. Patterning mechanisms in the
vertebrate hindbrain.
Lovell-Badge, R., National Institute for Medical Research,
London, United Kingdom. Functional analysis of mouse
sex-determining genes. Sox genes in early development of
the nervous system.
Magnuson, T., Case Western Reserve University, Cleveland,
Ohio. Genetic approaches to mouse development.
Mann, J., Beckman Research Institute/City of Hope Medical
Center, Duarte, California. Imprinting and its role in development.
Jungbluth, S., B.S., Ph.D., United Medical and Dental
School/Guy's Hospital, London, United Kingdom
Mirotsou, M., B.S., University College London Medical
School, London, United Kingdom
Salisbury, J., B.S., Ph.D., Mayo Clinic, Rochester, Minnesota
Schneider, R., BA., M.S., Duke University, Durham, North
Carolina
Smith, K., B.S., University of Virginia, Charlottesville
Vasioukhin, V., B.S., Ph.D., University of Chicago, Illinois
Yang, T, BA., Ph.D., University of Florida College of
Medicine, Gainesville
Martin, G., University of California, San Francisco. Vertebrate
limb development. Multiple uses of Cre recombinase to
study mouse development.
McLaren, A., Wellcome/CRC Institute, Cambridge, United
Kingdom. Origin and development of germ cells. Mouse
reproductive cycle and husbandry.
McMahon, A., Harvard University, Cambridge,
Massachusetts. Signaling pathways in vertebrate limb mor-
phogenesis. Manipulating gene expression in utero.
Mobraaten, L., The Jackson Laboratory, Bar Harbor, Maine.
Embryo and gamete cryopreservation.
Nagy, A., Mount Sinai Hospital, Ontario, Canada. Applications
of gene knockout technology in mice.
Olson, E., University of Texas/Hamon Center for Basic Cancer
Research, Dallas. Molecular control of cardiac development
and disease.
Papaioannou, G., Columbia University, New York. Chimeras in
experimental embryology. T-box genes in mouse develop-
ment.
Solter, D., Max-Planck Institute of Immunobiology, Freiberg,
Germany. Preimplantation development overview from egg
to blastocyst: Hard road to follow.
Soriano, P., Fred Hutchinson Cancer Research Center,
Seattle, Washington. Insertional mutagenesis. Growth factor
signaling during mouse development.
Tam, P., Children's Medical Research Institute, Wentworthville,
Australia. Postimplantation development overview.
Gastrulation, staging, landmarks of development. Functional
analysis of the mouse organizer.
Wilkinson, D., National Institute for Medical Research,
London, United Kingdom. In situ hybridization: Methods
and research applications. Segmentation of the hindbrain
and neural crest.
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Molecular Mechanisms of Human Neurological Diseases
July 23-29
INSTRUCTORS Gandy, Sam, M.D., Ph.D., New York University, Orangeburg
Sisodia, Sangram, Ph.D., University of Chicago
How and why do neurons die in specific acute or chronic human neurological disorders? What are the
molecular and biochemical manifestations of specific genetic lesions in specific neurodegenerative dis-
orders? Do different pathological deaths share common mechanisms? What practical treatments can
be contemplated? This lecture course explored possible answers to these important questions. Recent
advances in neurogenetics and in molecular and cell biology have begun to shed light on the mecha-
nisms that underlie nervous system injury in disease states such as Alzheimer's disease, amyotrophic
lateral sclerosis, prion diseases, Huntington's disease, epilepsy, and stroke. Taking advantage of small
class size and extensive discussion, invited faculty lecturers examined critical issues in their areas of
expertise. Overview was provided, and course participants did not need to have familiarity with neuro-
logical diseases. A basic introduction to central and peripheral neurons system structure and biology
(including developments) was provided. The course focused principally on the specific hypotheses and
approaches driving current research. Emphasis was placed on the highly dynamic interface between
basic and clinical investigation, including the interdependence of clinical research and disease model
development, and the value of disease research in understanding the function of the normal nervous
system.
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PARTICIPANTS
Auburger, G., B.S., M.D., National Human Genome
Research Institute, Bethesda, Maryland
Beagles, K., B.S., University of Kentucky, Lexington
De Feo, P., B.A., M.S., Zeneca Pharmaceuticals, Wilmington,
Delaware
Gaspar, C., B.S., Ph.D., Montreal General Hospital Research
Institute, Canada
Goto, J., B.S., University of California, Los Angeles
Heyes, M., B.S, Ph.D., National Institutes of Mental Health,
Bethesda, Maryland
Hotvedt, C., B.S., M.A., Ketchum Public Relations, New
York
Kolmerer, B., B.S., Ph.D., Schering AG, Berlin, Germany
Kubota, K., B.A., Ph.D., Yamanouchi Pharmaceutical Co.,
Ibaraki, Japan
Lin-Chao, S., M.S., Ph.D., Academia Sinica, Taiwan,
Republic of China
SEMINARS
Aguzzi, A., University Hospital of Zurich, Switzerland. Prion
diseases.
Catteno, E., University of Milan, Italy. Molecular biology of
neurogenesis.
Ehrlich, M., New York University, New York. Molecular biolo-
gy of neurogenesis.
Fischbeck, K., National Institutes of Health, NINDS,
Bethesda, Maryland. Neurobiology and pathology of hered-
itary peripheral neuropathies.
Gandy, S., New York University, Orangeburg. Molecular
pathology of familial Alzheimer's disease.
Griffin, J., Johns Hopkins University, Baltimore, Maryland.
Structure and pathobiology of the PNS.
Lee, V., University of Pennsylvania School of Medicine,
Philadelphia. Intracellular fibrous structures as a common
feature of some neurodegenerative disease.
MacDonald, M., Massachusetts General Hospital, Charles-
town. Huntington's disease and triple repeat disorders.
McNamara, J., Duke University Medical School, Durham, North
Carolina. Neurobiology and pathology of the epilepsies.
Malyala, A., B.A., M.A., Ph.D., George Washington
University, Washington, D.C.
Orth, M., M.D., Ph.D., Otto Von Guericke University,
Magdeburg, Germany
Pitossi, F., M.S., Ph.D., University of Buenos Aires, Argentina
Pramatarova, A., B.S., Ph.D., Montreal General Hospital
Research Institute, Canada
Sacrestano, D., B.S., Rockefeller University, New York
Shan ley, J., B.S., Zeneca Pharmaceuticals, Wilmington,
Delaware
Terai, K., B.A., M.S., Ph.D., Yamanouchi Pharmaceutical Co.,
Ibaraki, Japan
Vincenz, C., B.S., Ph.D., University of Michigan, Ann Arbor
Zacco, A., B.S., Zeneca Pharmaceuticals, Wilmington,
Delaware
Zhong, Z., B.S., Ph.D., R.W. Johnson Parmaceutical
Research Institute, Raritan, New Jersey
Nixon, R., New York University, Orangeburg. Approaching
sporadic Alzheimer's disease.
Orr, H., University of Minnesota, Minneapolis. Hereditary atax-
ias, DRPLA, and other triplet diseases.
Price, D., Johns Hopkins University School of Medicine,
Baltimore, Maryland. Approaches to modelling late-onset
human neurodegeneration.
Rothman, S., St. Louis Children's Hospital, St. Louis,
Missouri. Pathobiology of hypoxic-ischemic neural injury.
Rothstein, J., Johns Hopkins University School of Medicine,
Baltimore, Maryland. Molecular biology of motor neuron dis-
ease.
Salzer, J., New York University, New York, Molecular cell biol-
ogy of myelin.
Sisodia, S., University of Chicago, Illinois. Molecular patholo-
gy of familial Alzheimer's disease.
Snider, W., Washington University School of Medicine, St.
Louis, Missouri. Neurobiology of neurotrophins.
Walsh, C., Harvard Medical School, Boston, Massachusetts.
Cerebral cortical development and dysgenesis.
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Eukaryotic Gene Expression
July 28-August 17
INSTRUCTORS Carey, Michael, Ph.D., University of California, Los Angeles
Gill, Grace, Ph.D., Harvard Medical School
Gilmour, David, Ph.D., Pennsylvania State University, University Park
Goodrich, James, Ph.D., University of Colorado, Boulder
ASSISTANTS Auerbach, Scott, Pennsylvania State University, University Park
Johnson, Barbra, Harvard Medical School
Klube, Shelley, University of Colorado, Boulder
Mitsouras, Katherine, University of California, Los Angeles
This course was designed for students, postdocs, and professors who had recently ventured into the
dynamic area of gene regulation. The course focused on state-of-the-art strategies and techniques
employed in the field including in vitro transcription with cell-free extracts and transfection of mam-
malian tissue culture cells. Analytical techniques for measuring gene expression included primer exten-
sion and enzymatic analyses of reporter proteins. An emphasis was placed on biochemical studies of
protein-DNA and protein-protein interactions. A site-specific transcription factor was expressed in E.
coil and purified by affinity chromatography. A detailed characterization of the DNA-binding properties
of the protein was carried out using electrophoretic mobility shift, DNase I footprinting, and methylation
interference assays. Students also learned strategies and techniques for executing a structure-function
study by generating site-directed mutants in the transcription factor and analyzing them both bio-
chemically and by computer modeling. The factor was subjected to affinity chromatography to under-
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stand how it interacts with the general transcription machinery. Over the past few years, the gene reg-
ulation field has begun to emphasize the importance of in vivo approaches to studying protein-DNA
and protein-protein interactions. Students were exposed to in vivo footprinting, mapping of DNase-1-
hypersensitive sites and the yeast two-hybrid methodologies. Experience with basic recombinant DNA
techniques was a prerequisite for admission to this course. Lectures by the instructors covered the
current status of the gene expression field, theoretical aspects of the methodology, and broader issues
regarding strategies for investigating the regulation of gene expression in eukaryotes. Guest lecturers
discussed contemporary problems in eukaryotic molecular biology and technical approaches to their
solution.
PARTICIPANTS
Andrew, S., B.S., Kolling Institute of Medical Research,
Sydney, Australia
Del Mar Pena, L., B.S., Northwestern University of Medical
School, Chicago, Illinois
Frank, R., B.A., M.D., Memorial Sloan Kettering Cancer
Center, New York
Germain, S., B.S., M.S., Ph.D., INSERM, College de France,
Paris, France
Le Saux, A., D.E.A., Ph.D., Max-Planck Institute, Koln,
Germany
McDonald, M., B.S., Brandeis University, Waltham,
Massachusetts
SEMINARS
Bentley, D., Amgen Institute/University of Toronto, Ontario,
Canada. Transcription elongation complexes.
Berger, S., Wistar Institute, Philadelphia, Pennsylvania.
Histone acetylases.
Burley, S./Roeder, R., Rockefeller University, New York. X-ray
crystallographic studies of eukaryotic transcription factors.
Carey, M., University of California, Los Angeles. Biochemical
mechanisms of gene activation.
Ebright, R., Rutgers University, New Brunswick, New Jersey.
Protein-DNA interactions in eukaryotic transcription initia-
tion.
Gill, G., Harvard Medical School, Boston, Massachusetts. A
transcriptional repressor that antagonizes E1A-mediated
activation.
Gilmour, D., Pennsylvania State University, University Park. In
vivo and in vitro analysis of the hsp70 promoter of
Drosophila.
Goodrich, J., University of Colorado, Boulder. RNA poly-
merase II transcriptional regulation.
Haykinson, M., University of California, Los Angeles.
Computer modeling and simulation of transcription
factor-DNA interactions.
McLellan, A., B.S., University of Cambridge, United Kingdom
Monteiro, A., B.S., Ph.D., Rockefeller University, New York
Rodzik, S., B.S., North Carolina State University, Raleigh
Rosonina, E., B.S., University of Toronto, Ontario, Canada
Shieh, P., B.A., M.A., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Skopicki, H., B.A., M.D., Ph.D., Columbia University College
for Physicians & Surgeons, New York
Theuns, J., B.S., University of Antwerp, Belgium
Tienhaara, A., M.D., Ph.D., University of Turku, Finland
Worley, T., B.A., Ph.D., University of Texas, Dallas
Yeung, F., B.S., University of Virginia, Charlottesville
Lees, J., Massachusetts Institute of Technology, Cambridge.
Role of the E2F transcription factors in cell cycle control.
Lis, J., Cornell University, Ithaca, New York. Multiple mecha-
nisms of transcriptional regulation.
Maniatis, T., Harvard University, Cambridge, Massachusetts.
The IFN-13 enhanceosome.
Ptashne, M., Memorial Sloan Kettering Cancer Center, New
York. The recruitment model for gene activation.
Roeder, R., Rockefeller University, New York. Role of general
and gene-specific cofactors in transcriptional regulation.
Shi, Y., Harvard Medical School, Boston, Massachusetts.
Function and mechanism of action of a CBP/p300 homolog
in C. elegans.
Smale, S., University of California/HHMI, Los Angeles.
Transcriptional regulation in the immune system.
Struhl, K., Harvard University, Boston, Massachusetts.
Molecular mechanisms of yeast transcriptional regulation.
Workman, J., Pennsylvania State University, University Park.
Multiprotein complexes that regulate transcription by modi-
fying chromatin structure.
Zaret, K., Brown University, Providence, Rhode Island. Specifying
tissues and gene expression patterns in development.
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Imaging Structure and Function in the Nervous System
July 28-August 17
INSTRUCTORS Denk, Winfried, Ph.D., Lucent Technologies Bell Labs, Murrary Hill, New Jersey
Halpain, Shelley, Ph.D., Scripps Research Institute
Kay, Steve, Ph.D., Scripps Research Institute
ASSISTANTS Graber, Simone, Scripps Research Institute
Helmchen, Fritjof, Lucent Technologies Bell Labs, Murrary Hill, New Jersey
Ozer, Rachel, Scripps Research Institute
Advances in light microscopy, digital image processing, and the development of a variety of powerful
fluorescent probes present expanding opportunities for visualizing and measuring the structure and
function of neurons, synapses, and networks in the brain. This intensive laboratory and lecture course
provided participants with the theoretical and practical knowledge to utilize emerging imaging tech-
nologies. The primary emphasis of the course was on vital light microscopy. Students learned the prin-
ciples of light microscopy, as well as the use of different types of electronic cameras, laser-scanning
systems, functional fluorophores, delivery techniques (such as microinjection), and digital image-pro-
cessing software. The synergistic combination of different imaging modalities, such as fluorescence
and infrared differential interference contrast combined with different functional probes, such as calci-
um-sensitive probes, voltage-sensitive dyes, photo-activated ("caged") compounds, and exocytosis
tracers, with electrophysiological techniques was emphasized. Particular weight was given to multi-
photon laser-scanning microscopy and to newly available biological fluorophores such as green fluo-
rescent protein (GFP) and its variants and derivatives. A variety of neural systems were used, including
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living animals, brain slices (e.g., hippocampus, cerebellum, and neocortex), and cultured cells.
Applicants had a strong background in the neurosciences or in cell biology.
PARTICIPANTS
Aakalu, G., B.A., California Institute of Technology, Pasadena
Arnth-Jensen, N., B.S., University of Oxford, United Kingdom
Bausch, S., B.A., Ph.D., Duke University Medical Center,
Durham, North Carolina
Brecht, M., B.S., Ph.D., Max-Planck Institute for Brain
Research, Frankfurt, Germany
Cochilla, A., B.S., Ph.D., University of Colorado Medical
School, Denver
Di Cristo, G., B.S., Scuola Norma le Superiore di Pisa, Italy
Ehrlich, I., B.S., M.S., University of Frankfurt, Germany
SEMINARS
Betz, W., University of Colorado, Denver. Vesicle release with
FM -143.
Block, S., Princeton University, New Jersey. Optical tweezers
and applications.
Bonhoeffer, T., Max-Planck Institute for Neurobiology,
Munich, Germany. Intrinsic imaging.
Brand, A., Cambridge University, United Kingdom. GFP in
Drosophila development.
Cline, H., Cold Spring Harbor Laboratory. In vivo imaging of
CNS neuronal development.
Cohen, L., Yale University, New Haven, Connecticut. Voltage-
sensitive dyes, diode arrays.
Day, R., University of Virginia Health Science Center,
Charlottesville. Application lecture: GFP, BFP as
genetically encoded fluorophores. Application lecture:
FRET.
Denk, W., Lucent Technologies Bell Labs, Murray Hill, New
Jersey. Basic Microscopy I. Basic Microscopy II.
Dodt, H.-U., Max-Planck Institute, Munich, Germany.
Contrast methods in tramsmitted-light microscopy I.
Contrast methods II.
Fetcho, J., Cold Spring Harbor Laboratory. Functional imag-
ing of neural circuits in living zebrafish.
Forscher, P., Yale University, New Haven, Connecticut.
Imaging structural dynamics using video-enhanced DIC.
Neuronal growth cone dynamics.
Halpain, S., The Scripps Research Institute, La Jolla,
California. Tissue fixation and staining. Neuronal tissue
preparations for light microscopy.
Harris, K., Children's Hospital/Harvard University, Boston,
Massachusetts. Electron microscopy and synapse struc-
ture/function
Helmchen, F., Bell Laboratories, Murray Hill, New Jersey.
Fundamentals of electrophysiological recording and calcium
imaging in neurons.
Huang, J., B.S., Ph.D., Massachusetts Institute of
Technology, Cambridge
Kaksonen, M., M.S., University of Helsinki, Finland
Kim, S., B.A., University of Texas Health Science Center,
Houston
Mermelstein, P., B.S., Ph.D., Stanford University, California
Nascimento, A., B.S., M.S., Ph.D., University of Sao Paulo,
Brazil
Spors, H., M.D., Max-Planck Institute, Heidelberg, Germany
Zhang, L., B.S., M.S., University of California, San Diego
Hess, G., Cornell University, Ithaca, New York. Caged neuro-
transmitters.
Hockerberger, P., Northwestern University, Chicago, Illinois.
Basic photochemistry and phototoxicity.
Katz, L., Duke University, Durham, North Carolina. Mapping
circuits with caged compounds. Biolistic gene transfer.
Kleinfeld, D., University of California, La Jolla. Imaging cere-
bral blood flow in vivo.
Konnerth, A., University of Saarlandes, Germany. Functional
imaging, Ca++ channels.
Lanni, F., Carnegie Mellon University, Pittsburgh,
Pennsylvania. Standing wave microscopy.
Lictman, J., Washington University, St. Louis, Missouri.
Confocal microscopy I. Confocal microscopy II and long-
term time lapse studies in vivo.
Matus, A., Friedrich Miescher Institute, Basel, Switzerland.
Use of GFP-fusion proteins to study neuronal cytoskeleton
in vivo.
Piston, D., Vanderbilt University, Nashville, Tennessee. Two-
photon imaging of GFP to study insulin action.
Stelzer, E., European Molecular Biology Laboratory,
Heidelberg, Germany. Image deconvolution. Theta/4PI
imaging.
Svoboda, K., Cold Spring Harbor Laboratory. In vivo two-
photon/GFP.
Tsien, R., University of California, San Diego. Development
and use of fluorescent indicators to study second messen-
gers. GFP and its cousins-the next generation of fluores-
cent indicators for in vivo imaging.
Watt, W., Cornell University, Ithaca, New York. Three-pro-
ton/multi-photon autofluorescence.
White, J., University of Wisconsin, Madison. Multi-photon
imaging in particular of developing animals development.
Yuste, R., Columbia University, New York. Two-photon imag-
ing of synapse dynamics.
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Yeast Genetics
July 28-August 17
INSTRUCTORS Dawson, Dean, Ph.D., Tufts University
Gottschling, Daniel, Ph.D., Fred Hutchinson Cancer Research Center
Stearns, Timothy, Ph.D., Stanford University
ASSISTANTS Byrnes, Micheal, Stanford University
Kemp, Benedict, Tufts University
Stel !wagon, Anne, Fred Hutchinson Cancer Research Center
The major laboratory techniques used in the genetic analysis of yeast were studied, including the iso-
lation and characterization of mutants, tetrad analysis, complementation, and mitotic recombination.
Micromanipulation used in tetrad analysis was carried out by all students. Molecular genetic tech-
niques, including yeast transformation, gene replacement, analysis of gene fusions, and generation of
mutations in cloned genes, were studied. Indirect immunofluorescence experiments were done to
identify the nucleus, microtubules, and other cellular components. Lectures on fundamental aspects of
yeast genetics were presented along with seminars given by outside speakers on topics of current
interest.
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PARTICIPANTS
Adler, E., B.A., Ph.D., University of California, San Diego
Basu, S., B.S., University of Medicine and Dentistry of New
Jersey, Piscataway
Beletskii, A., M.S., Wayne State University, Detroit, Michigan
Carbrey, J., B.S., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Carmel-Harel, 0., M.A., Ph.D., National Institutes of Health,
Bethesda, Maryland
Collins, J., B.S., Brandeis University, Natick, Massachusetts
Couvreur, M., M.S., Catholic University, Leuven, Belgium
Fries, B., M.D., Albert Einstein College of Medicine, Bronx,
New York
Frosco, M.B., B.S., M.D., Bristol Myers Squibb Pharmaceu-
SEMINARS
Burke, D., University of Virginia, Charlottesville. DNA damage
and the cell cycle.
Chant, J., Harvard University, Cambridge, Massachusetts.
Cell polarity.
Cyert, M., Stanford University, California. Role of calcineurin in
yeast.
Drubin, D., University of California, Berkeley. The actin
cytoskeleton.
Futcher, B., Cold Spring Harbor Laboratory. The cell-cycle-
regulated genes of yeast.
Haber, J., Brandeis University, Waltham, Massachusetts.
Recombination and chromosome mechanics.
Hinnebusch, A., National Institutes of Health, Bethesda,
Maryland. Translational control.
Hicke, L., Northwestern University, Evanston, Illinois.
Ubiquitination and endocytosis.
tical Research Institute, Wallingford, Connecticut
Li, Y.-C., B.S., Ph.D., Baylor College of Medicine, Houston,
Texas
Mirels, L., B.A., M.D., Stanford University Medical Center,
California
Mori llon, A., B.S., M.S., CNRS, French Research Council,
Paris, France
Nicholas, D., B.S., University of Idaho, Moscow
Shen, X., B.S., Ph.D., National Institutes of Health, Bethesda,
Maryland
Sjostrom, I., M.S., University of Gothenburg, Sweden
Ungermann, C., M.S., Ph.D., Dartmouth Medical School,
Hanover, New Hampshire
Hoyt, A., Johns Hopkins University, Baltimore, Maryland.
Meiotic checkpoints.
Kaiser, C., Massachusetts Institute of Technology,
Cambridge. Protein sorting and transport.
Koshland, D., Carnegie Institute of Washington, Baltimore,
Maryland. Sister chromatid cohesion and chromosome
condensation.
Michaelis, S., Johns Hopkins University, Baltimore, Maryland.
Pheromone response and production.
Mitchell, A., Columbia University, New York. Meiotic regulation.
Silver, P., Dana Farber Cancer Institute, Boston,
Massachusetts. Nuclear targeting.
Rose, M., Princeton University, New Jersey. Nuclear fusion
and fission.
Tyers, M., Samuel Lunenfeld Research Institute, Ontario,
Canada. Ubiquitin and cell cycle regulation.
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Advanced Drosophila Genetics
July 30-August 12
INSTRUCTORS Ashburner, Michael, Ph.D., University of Cambridge, United Kingdom
Hawley, R. Scott, Ph.D., University of California, Davis
This intensive seminar course provided an introduction to the theory and practice of methods used to
manipulate the Drosophila genome. It was suitable for graduate students and researchers with some
experience with Drosophila who were interested in expanding their knowledge of the wide range of
genetic techniques now available for use with this organism. Topics covered included chromosome
mechanics, the design and execution of genetic screens, and the use of transposable elements as
genetic tools.
PARTICIPANTS
Ballard, J.W., B.S., Ph.D., The Reid Museum, Chicago, Illinois
Baum, B., B.A., Ph.D., Harvard Medical School, HHMI,
Boston, Massachusetts
Camonis, J., M.D., Ph.D., CNRS, Institute Curie, Paris,
France
Chavez, V., B.S., Ph.D., University of Minnesota, Minneapolis
Dobie, K., B.S, Ph.D., The Salk Institute, La Jolla, California
Gur, D., B.S., Hebrew University, Jerusalem, Israel
Hendengren, M., M.S., Stockholm University, Sweden
Huang, A., B.A., University of California, Berkeley
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Johnson, M., B.S., M.S., Harvard Medical School, Boston,
Massachusetts
Lincecum, J, B.A., Ph.D., Harvard Medical School, Boston,
Massachusetts
Onfelt, T., M.S., Stockholm University, Sweden
Page, S., B.S., Ph.D., University of California, Davis
Parnell, T., B.S., University of Iowa, Iowa City
Renaud, 0., B.S., M.S., IGBMC, Illkirch France
Robert, V, B.S., CNRS, GSM., Gif Sur Yvette, France
Shimmi, 0., B.S., Ph.D., University of Minnesota, Minneapolis
Song, Z., B.S., Ph.D., Massachusetts Institute of Technology,
SEMINARS
Ashburner, M., University of Cambridge, United Kingdom.
Introduction to Drosophila biology, phylogeny. Fly base: Where
to find information. Chromosomes, cytogenetics, chromo-
some abberations, mapping (genetic and cytogenetic).
Cherbas, P., Indiana University, Bloomington. Somatic cell
genetics.
Cline, T., University of California, Berkeley. Alternative to brute
force: Selective and sensitized genetic screens, and their
use in the genetic dissection of Drosophila sex determina-
tion.
Ganetzky, B., University of Wisconsin, Madison.
Neurogenetics.
Golic, K., University of Utah, Salt Lake City. Mosaic systems:
FRT/FLP.
Hall, J., Brandies University, Waltham, Massachusetts.
Genetic analyses of behavior.
Cambridge
Tickoo, S., B.S., M.S., Tata Institute of Fundamental
Research, India
Vandaele, C., M.S., University of Claude Bernard Lyon I,
Villeurbanne, France
Wayson, S., B.S., University of California, Davis
Wu, X., B.S., New York University, New York
Zarnescu, D., M.S., Pennsylvania State University, University
Park
Zhang, Y., B.A., Ph.D., University of Utah, Salt Lake City
Hawley, S., University of California, Davis. Genetics of meio-
sis; methods of study an exploitation; distributive pairing.
Lehman, R., New York University Medical Center/Skirball
Institute, New York. Genetics screens for mutations affecting
embryogenesis (including maternal effect mutations); meth-
ods for their analysis.
Karpen, G., The Salk Institute, La Jolla, California. cis and
trans regulators of chromosome inheritance in Drosophila.
Roth, P., EMBL, Heidelberg, Germany. P-element technolo-
gies.
Rubin, G., University of California, Berkeley. The fly genome.
Spradling, A., Carnegie Institute of Washington, Baltimore,
Maryland. P-element technologies.
Sullivan, W., University of California, San Francisco. Crosses
and columns: Complementary approaches for analyzing the
embryonic cytoskeleton.
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Advanced In Situ Hybridization and Immunocytochemistry
October 14-27
INSTRUCTORS Ochs, Robert, Ph.D., Scripps Research Institute
Murray, John, M.D., Ph.D., University of Pennsylvania
Spector, David, Ph.D., Cold Spring Harbor Laboratory
Ried, Thomas, Ph.D., National Institutes of Health
Schrock, Eve lin, Ph.D., National Institutes of Health
ASSISTANTS Howard, Tamara, Cold Spring Harbor Laboratory
Quin lin, Margot, University of Pennsylvania
This course focused on specialized techniques in microscopy related to localizing DNA and RNA
sequences and proteins in cells for microscopic examination. It emphasized the use of the latest equip-
ment and techniques in epifluorescence microscopy, confocal laser scanning microscopy, electron
microscopy, and digital image processing. The aims of the course were designed to provide state-of-
the-art technology and scientific expertise in the use of microscopic applications to address basic
questions in genome organization and cellular and molecular biology. The course was designed for the
molecular biologist who is in need of microscopic approaches and for the cell biologist who is not famil-
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iar with the practical application of the advanced techniques presented in the course. Among the meth-
ods presented were the preparation of tagged nucleic acid probes, fixation methods, detection of mul-
tiple DNA sequences in single nuclei or chromosome spreads, comparative genomic hybridization,
spectral karyotyping, cellular localization of RNA, use of a variety of reporter molecules and nonanti-
body fluorescent tags, indirect antibody labeling, detection of multiple proteins in a single cell, and
immunoelectron microscopy. In each method, several experimental protocols were presented, allow-
ing the students to assess the relative merits of each and to relate them to their own research. Students
were encouraged to bring nucleic acid or antibody probes to the course which were used in addition
to those provided by the instructors. The laboratory portion of the course was supplemented by invit-
ed lecturers who gave up-to-the-minute reports on current methods and research using the techniques
that were presented in the course.
PARTICIPANTS
Andresen, V., B.S., University of Bergen, Norway
Anneser, J., M.D., University of Munich, Germany
Binnie, A., B.S., Sir William Dunn School of Pathology,
Oxford, United Kingdom
Bjork, P. B.S., Stockholm University, Sweden
Boorer, K., B.S., Ph.D., VivoRX Inc., Santa Monica, California
Chamberlin, M., B.A., Ph.D., Pioneer Hi-Bred International,
Johnston, Iowa
Duca, K., B.S, Ph.D., University of Wisconsin, Madison
Dunn, D., B.S., M.S., University of Western Australia,
Perth
SEMINARS
Deerinck, T., University of California, San Diego. Electron
microscopy as a tool in cell and molecular biology.
Hell, S., Max-Planck, Gottingen, Germany. 4 Pi microscopy.
Huang, S., Northwestern University Medical School, Chicago,
Illinois. RNA in situ hybridization.
Lippincott-Schwartz, J., National Institutes of Health,
Bethesda, Maryland. GFP and FRAP analysis.
Murray, J., University of Pennsylvania, Philadelphia. Basic
introduction to light and fluorescence microscopy. Principles
of confocal microscopy and deconvolution techniques.
Pinkel, D., University of California, San Francisco. Filters and
Ermakova, 0., B.S., M.S., Albert Einstein College of
Medicine, New York
Fuchs, J., B.S., Ph.D., University of Vienna, Austria
Kosak, S., BA., Ph.D., University of Chicago, Illinois
Montagna, C., B.S., Ph.D., Consiglio Nazionale Delle
Richerche, Milan, Italy
Oklu, R., B.S., University of Cambridge, United Kingdom
Seandel, M., B.A., State University of New York, Stony Brook
Thomas, J., B.A., M.D., Vanderbilt University, Nashville,
Tennessee
Van Tine, B., B.S., University of Alabama, Birmingham
fluorochromes for fluorescence microscopy.
Ried, T., National Institutes of Health, Bethesda, Maryland.
CGH and SKY.
Rieder, C., New York State Department of Health, Albany.
Mitosis.
Singer, R., Albert Einstein College of Medicine, New York.
Cytoplasmic organization of mRNA.
Spector, D., Cold Spring Harbor Laboratory. Immunocyto-
chemistry.
Svoboda, K., Cold Spring Harbor Laboratory. 2-Photon
microscopy.
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Macromolecular Crystallography
October 14-27
INSTRUCTORS Furey, William, Ph.D., V.A. Medical Center, Pittsburgh, Pennsylvania
Gilliland, Gary, Ph.D., National Institute of Standards and Techniques, Rockville, Maryland
McPherson, Alexander, Ph.D., University of California, Riverside
Pflugrath, James, Ph.D., Molecular Structure Corporation, The Woodlands, Texas
ASSISTANT Chu, Seung, National Institute of Standards and Techniques, Rockville, Maryland
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through other
methods. This "intensive" laboratory/computational course focused on the major techniques used to
determine the three-dimensional structures of macromolecules. It was designed for scientists with a
working knowledge of protein structure and function, but who were new to macromolecular crystal-
lography. Topics covered included crystallization (proteins, nucleic acids, and complexes), crystal char-
acterization, X-ray sources and optics, synchrotrons, crystal freezing, data collection, data reduction,
multiple isomorphous replacement, multiwavelength anomalous diffraction phase determination, sol-
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vent flattening, molecular replacement and averaging, electron density interpretation, structure refine-
ment, molecular graphics, noncrystallographic summary, simulated annealing, and coordinate despo-
sition. Participants learned through extensive hands-on experiments. They crystallized and determined
a protein structure, with lectures on the theory and informal discussions behind the techniques.
PARTICIPANTS
Brunskill, A., B.S., Rutgers University, Newark, New Jersey
Buckler, D., BA., Ph.D., University of Dentistry and Medicine
of New Jersey, Piscataway
Conn, G., B.S., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Di Marco, S., B.S., Ph.D., Institute of Molecular Biology
Research, Pomezia, Italy
Fu, D,X., B.A., Ph.D., University of California, San Francisco
Grollman, A., BA., M.D., State University of New York, Stony
Brook
Handel, T., B.S., Ph.D., University of California, Berkeley
Kostyukova, A., B.S., Ph.D., Matsushita Electric Industrial
Co., Ltd., Kyoto, Japan
Lin, S.-X., B.S., Ph.D., Laval University Medical Center,
SEMINARS
Berman, H., Rutgers University, Piscataway, New Jersey.
DNA: Relationship of structure to function.
Bounre, P., University of California, San Diego. 3-D compari-
son methods: Theory and practice.
Brunger, A., Yale University, New Haven, Connecticut.
Structural insights into synaptic vesicle fusion.
De La Fortelle, E., MRC Laboratory of Molecular Biology,
Cambridge, United Kingdom. SHARP.
Fitzgerald, P. Merck Research Laboratories, Rahway, New
Jersey. Metalo-13-lactamase as a target for structure-based
drug design.
Ginell, S., Argonne National Laboratory, Illinois. Cryo-crystal-
lography and the "immortal crystal."
Gilliland, G., National Institutes of Standards and Technology,
Rockville, Maryland. Crystal structure of E. coli uracil DNA
glycosylase and its complexes with uracil and glycerol:
Quebec, Canada
O'Neill, J., B.A., Fred Hutchinson Cancer Research Center,
Seattle, Washington
Podell, E., B.A., M.S., University of Colorado, Boulder
Schwartz, J.C., B.S., Albert Einstein College of Medicine,
New York
Walke, S., B.S., Medical Research Council Laboratory of
Molecular Biology, Cambridge, United Kingdom
Wilson, N., BA., Ph.D., National Jewish Medical and
Research Center, Denver, Colorado
Wucherpfennig, K., B.S., M.D., Ph.D., Dana Farber Cancer
Institute, Boston, Massachusetts
Yaffe, M., B.S., Ph.D., M.D., Harvard Medial School, Boston,
Massachusetts
Structure and glycosylase mechanism revisited.
Hendrickson, W., Columbia University, New York. MAD phas-
ing. HIV gp120.
Howell, PL., Hospital for Sick Children, Ontario, Canada.
Desperately seeking selenium: The structure determination
of S-adenosyl-homocysteine.
Kjeldgaard, M., Aarhus University, Denmark. The EF-Tu:tRNA
complex.
Lee Mor, J.-T, Cold Spring Harbor Laboratory. Bleomycin
hydrolase: Intriguing structure, enigmatic activities, and links
to diseases.
Perrakis, A., Grenoble, Germany. WARP.
Tronrud, D., University of Oregon, Eugene. Macromolecular
refinement: Past, present, and future.
Xu, R., Cold Spring Harbor Laboratory. A novel structure of
human mitochondrial protein p32.
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Positional Cloning: Contig to Candidate Gene
October 14-27
INSTRUCTORS Jacob, Howard, Ph.D., Medical College of Wisconsin, Milwaukee
Silverman, Gary, M.D., Ph.D., Harvard University
Spencer, Forrest, Ph.D., Johns Hopkins University School of Medicine
CO-INSTRUCTORS Church, Deanna, Samuel Lunenfeld Research Institute, Toronto, Canada
Parimoo, Satish, Johnson & Johnson, Skillman, New Jersey
ASSISTANTS Brown lie, Alison, Harvard University
Kwitek-Black, Anne, Medical College of Wisconsin, Milwaukee
This laboratory-based course was designed for investigators using genetic and physical mapping tools
or functional assays to isolate genes of interest, with emphasis placed on those procedures used to
isolate and evaluate a candidate gene after it has been localized genetically. Principal procedures
included physical mapping by contig construction using YACs and BACs/PACs, STS-content map-
ping, DNA fingerprinting, pulsed-field gel electrophoresis, and end sequence rescue. Additional proce-
dures illustrating the use of yeast as a host organism for YAC analysis and manipulation were covered,
including YAC transfer between yeast strains to facilitate isolation of pure clone DNA, the generation of
high-density physical maps using a YAC fragmentation strategy, and the introduction of mammalian
selectable markers or specific mutations into YACs. Techniques for preparing large-insert DNA for
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transfer into ES or other cell lines via lipofection, spheroplast fusion, or pronuclear injection were includ-
ed. Gene identification from large cloned DNA segments was accomplished by laboratory exercises in
cDNA selection and/or exon trapping. Candidate gene evaluation through computer-based sessions
designed to access data and applications available on the World Wide Web were emphasized, includ-
ing map, similarity, and expression profile information. Studies in mutational analysis for identifying the
gene of interest were discussed in depth. The laboratory-based component of the course was sup-
plemented by lectures by invited speakers who are prominent investigators and utilized many of the
procedures taught in the course. All participants presented their own research topics, which were used
as the basis for structured discussions of how to apply current technologies to specific research pro-
jects.
PARTICIPANTS
Attie, A., B.S., Ph.D., University of Wisconsin, Madison
Ayele, M., B.S., M.S., Texas Technical University, Lubbock
Baranzini, S., B.S., M.S., Ph.D., University of California, San
Francisco
Berghmans, S., D.V.M., University of Liege, Belgium
Budiman, M., B.S., Clemson University, South Carolina
Feuerman, M., B.A., Ph.D., State University of New York,
Brooklyn
Gardner, K., B.F.A., M.D., University of Pittsburgh,
Pennsylvania
Hornum, L., M.S., Ph.D., Hagedorn Research Institute,
Gentofte, Denmark
SEMINARS
Baxevanis, A., National Institutes of Health, Bethesda,
Maryland. Computational analysis I: Alignment tools
and assigning function to candidate proteins.
Computational analysis II: Gene finding in genomic
sequence.
Birren, B., Whitehead Institute/Massachusetts Institute of
Technology, Cambridge. BAC and methods of library
screening. Map building.
Church, D., Mount Sinai Hospital, Toronto, Canada.
Functional genomics: Generating a biological map of the
mouse genome.
Dietz, H., Johns Hopkins University, Baltimore, Maryland.
Mutational screening.
Green, E., National Institutes of Health, Bethesda, Maryland.
Mapping and sequencing a human chromosome: How and
why.
Jacob, H., Medical College of Wisconsin, Madison.
Lan, H., B.S, Ph.D., University of Wisconsin, Madison
Maumenee, I., B.S., M.D., Johns Hopkins University,
Baltimore, Maryland
Pegoraro, E., B.S., M.D., University of Padova, Italy
Roth, S., M.S., University of Helsinki, Finland
Saitta, F., B.S., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Villafuerte, S., M.S., Ph.D., University of Antwerp, Belgium
Winkler, S., B.S., EMBL, Heidelberg, Germany
Wise, R., B.S., Ph.D., United States Department of
Agriculture, Ames, Iowa
Comparative mapping to facilitate positional cloning.
Parimoo, S., Johnson & Johnson, Skillman, New Jersey.
Postional cloning of hair follicle genes.
Roe, B., University of Oklahoma, Norman. The Human
Genome Project: So many bases, so little time-A view
from the trenches.
Spencer, F., Johns Hopkins University, Baltimore, Maryland.
Genome fidelity: View from a model system.
Stein, L., Cold Spring Harbor Laboratory. Map building.
Trask, B., University of Washington, Seattle. Genomic insights
through cytogenetics.
Reeves, R., Johns Hopkins University, Baltimore, Maryland.
Comparative genomic strategies in the investigation of com-
plex genetic traits.
Silverman, G., Harvard Medical School, Boston,
Massachusetts. Now that I found it, what does it do?
Functional analysis of single genes.
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Caenorhabditis elegans
November 11-24
INSTRUCTORS Hengartner, Michael, Ph.D., Cold Spring Harbor Laboratory
Jorgensen, Erik, Ph.D., University of Utah, Salt Lake City
Plasterk, Ronald, Ph.D., Netherlands Cancer Institute, Amsterdam
ASSISTANTS Harris, Todd, University of Utah, Salt Lake City
Korswagen, Hendrik, Netherlands Cancer Institute, Amsterdam
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans genome pro-
ject. The course was suited both for those who have a current training in molecular biology and some
knowledge of genetics, but have no experience with C. elegans, as well as students with some prior
worm experience who wished to expand their repertoire of expertise. The following topics were cov-
ered both in the laboratory and by lectures from experts in the field: worm pushing, C. elegans data-
bases and worm bioinformatics, anatomy and development, forward genetics, chemical and transpo-
son mutagenesis, generation of transgenic animals, expression pattern analysis, reverse genetics, con-
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struction and screening of deletion libraries, and RNA inactivation. The course was designed to impart
sufficient training to students in the most important attributes of the C. elegans system to enablestu-
dents to embark on their own research projects after returning to their home institutions.
PARTICIPANTS
Berezikov, E., M.S., Novosibirsk State University, Russia
Calvo, D., B.S., Ph.D., Harvard Medical School, Boston,
Massachusetts
Graves, B., B.A., Ph.D., University of Utah, Salt Lake
City
Hagen, F., B.S, Ph.D., University of Rochester, New York
Herlitze, S., B.S., Ph.D., University of Tubingen, Germany
Herr, W., B.A., Ph.D., Cold Spring Harbor Laboratory
Lamphear, B., B.S., Ph.D., Louisiana State University,
Shreveport
Nass, R., B.A., B.S., Ph.D., Vanderbilt University, Nashville,
Tennessee
Peraus, G., B.S., Ph.D., Hoechst Marion Roussel AG,
Germany
SEMINARS
Blumenthal, T, University of Colorado Medical Center,
Denver. Splicing-Worm biochemistry.
Chalfie, M., Columbia University, New York. Mechano-sensa-
tion-Use of GFP for reporters.
Durbin, R., Wellcome Trust, Sanger Center, Cambridge,
United Kingdom. The C. elegans genome-AceDB.
Hengartner, M., Cold Spring Harbor Laboratory. Programmed
cell death-Suppression genetics.
Jorgensen, E., University of Utah, Salt Lake City. Synaptic
transmission-Nomenclature, forward genetics.
Kemphues, K., Cornell University, Ithaca, New York. Early
embryonic development-RNA inhibition.
Silverman, G., B.A., M.D., Ph.D., Harvard University, Boston,
Massachusetts
Trupp, M., B.S., Ph.D., Karolinska Institute, Stockholm,
Sweden
Van Gi 1st, M., B.S., Ph.D., University of California, San
Francisco
Vietor, I., Ph.D., I.M.R, Research Institute of Molecular
Pathology, Vienna, Austria
Walker, A., B.S., Ph.D., Harvard University, Boston,
Massachusetts
Westerlaken, J., M.S., University of Nijmegen, The
Netherlands
Zhang, Z., B.M., Ph.D., Harvard University, Boston,
Massachusetts
Meyer, B., University of California, Berkeley. Sex determination/
Dosage compensation -Transgenics.
Okkema, P., University of Illiniois, Chicago. Muscle develop-
ment/gene expression-Reporter gene constructs, ectopic
expression.
Plasterk, R., Netherlands Cancer Center, Amsterdam, The
Netherlands. G proteins in C. elegans-Reverse genet-
ics.
Ruvkun, G., Harvard Medical School, Boston,
Massachusetts. Dauer formation, genome analysis.
Seydoux, G., Johns Hopkins University, Baltimore, Maryland.
Regulation of gene expression-In situ hybridization.
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Computational Genomics
November 5-10
INSTRUCTORS Pearson, William, Ph.D., University of Virginia, Charlottesville
Smith, Randall, Ph.D., SmithKline Pharmaceuticals
ASSISTANT Retief, Jacques, University of Virginia, Charlottesville
This course presented a comprehensive overview of the theory and practice of computational meth-
ods for gene identification and characterization from DNA sequence data. The course focused on
approaches of extracting the maximum amount of information from protein and DNA sequence simi-
larity through sequence database searches, statistical analysis, and multiple sequence alignment.
Additional topics included gene recognition (exon/intron prediction), identifying signals in unaligned
sequences, and integration of genetic and sequence information in biological databases. The course
combined lectures with hands-on exercises; students were encouraged to pose challenging sequence
analysis problems using their own data. The course was taught using Windows NT and Macintosh
workstations connected to the World Wide Web and Unix server. Participants were expected to be
comfortable using the Unix operating system, programs, and a Unix text editor (programming knowl-
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edge was not required). The course was ideal for biologists seeking advanced training in biological
sequence analysis, computer core directors, and staff for molecular biology or genetics resources and
for scientists in other disciplines, such as computer scientists, who wished to survey current research
problems in biological sequence analysis.
PARTICIPANTS
Bongcam, R., B.S., Ph.D., Uppsala University, Sweden
Cabot, E., B.A., Ph.D., Genetics Computer Group, Inc.,
Madison, Wisconsin
Chen, R., B.S., M.S., Allergan, Inc., Irvine, California
Christoffels, A., B.S., M.S., University of Western Cape, Cape
Town, South Africa
Cusick, M., B.S., Ph.D., Wadsworth Center, Albany, New
York
Dwyer, R., B.A., M.S., Ph.D., North Carolina State University,
Raleigh
Fink, L., B.S., University of California, San Diego
Gardiner, K., B.S., Ph.D., Eleanor Roosevelt Institute, Denver,
Colorado
GuhuThakurta, D., M.S., Johns Hopkins University, Baltimore,
Maryland
Hazard, E.S. III, B.S., M.S., Ph.D., Medical University of
South Carolina, Charleston
Knowlton, R., B.A., Ph.D., SmithKline Beecham Pharmaceu-
ticals, King of Prussia, Pennsylvania
Long, M., B.S., Ph.D., University of Chicago, Illinois
SEMINARS
Altschul, S., National Institutes of Health, Bethesda, Maryland.
Statistics of sequence similarity scores. Identifying distant
relationships with BLAST2 and PSI-BLAST. Statistic of pat-
terns and profiles.
Eddy, S., Washington University, St. Louis, Missouri. Blocks,
motifs, domains, and other databases. Multiple sequence
comparison with hidden markov models.
Henikoff, S., Fred Hutchinson Cancer Research Center,
Seattle, Washington. Using BLOCKS to identify very distant
relationships.
Neuwald, A., Cold Spring Harbor Laboratory. Exploiting
domains.
Lopez, L., B.S., Ph.D., University of Sao Paolo, Brazil
Metz, T., B.S., M.S, Ph.D., GSF National Research Center,
Neuherberg, Germany
Morley, M., B.A., M.S., Children's Hospital of Philadelphia,
Pennsylvania
Nachman, I., B.S., Ph.D., Compugen, Petach Tikva, Israel
Person, C., M.S., Lexicon Genetics, Inc., The Woodlands,
Texas
Radelof, U., B.S., Max-Planck Institute, Berlin, Germany
Raumann, B., B.A., Ph.D., University of California, San
Francisco
Sasinowski, M., B.S., Ph.D., Clemson University Genomics
Institute, South Carolina
Schaid, D., B.S., Ph.D., Mayo Clinic, Rochester, Minnesota
Snyder, E., B.A., Ph.D., Genomica Corporation, Boulder,
Colorado
Waters, E., B.A., Ph.D., Marquette University, Milwaukee,
Wisconsin
Wintero, A.K., M.S., Ph.D., The Royal Veterinary & Agricul-
tural University, Frederiksberg, Denmark
Pearson, W., University of Virginia, Charlottesville.
Introduction and overview. Protein evolution- biology.
Algorithms for pairwise sequence comparison.
Smith, R., SmithKline Beecham Pharmaceuticals, King of
Prussia, Pennsylvania. Introduction to multiple sequence
comparison.
Stormo, G., University of Colorado, Boulder. Identifying sites
in unaligned sequences. New approaches to discovering
features in biological sequences. Eukaryotic gene identifica-
tion.
Zhang, M., Cold Spring Harbor Laboratory. Computing on
yeast promoters.
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Phage Display of Combinatorial Antibody Libraries
November 11-24
INSTRUCTORS Barbas, Carlos, Ph.D., Scripps Research Institute
Siegel, Donald, M.D., Ph.D., University of Pennsylvania Medical Center, Philadelphia
Silverman, Gregg, M.D., University of California, San Diego
ASSISTANTS Carey, Stephen, University of California, San Diego
Fuller, Roberta, Scripps Research Institute
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for the
rapid production of antibodies from immune and nonimmune sources. This laboratory/lecture course
focused on the construction of combinatorial antibody libraries expressed on the surface of phage and
selection of desired antibodies from the library. Students learned the theoretical and practical aspects
of constructing combinatorial libraries from immune and nonimmune sources as well as the construc-
tion of synthetic antibody libraries. Antibodies were selected from the library by panning. Production,
purification, and characterization of Fab fragments expressed in E. coli were covered. The lecture was
series-presented by a number of invited speakers, who emphasized PCR amplification of immunoglob-
ulin genes, the biology of filamentous phage, and the utility of surface-expression libraries, expression
of antibodies in E. coli and mammalian cells, antibody structure and function, catalytic antibodies, the
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whole biology of antibody activity, and recent results on the use of antibodies in therapy. The theory
and practical implications for selection from phage-displayed libraries of random peptides, cDNA prod-
ucts, and semisynthetic proteins were also explored.
PARTICIPANTS
Balyasnikova, I., M.S., Ph.D., University of Illinois, Chicago
Bubis, M., B.S., M.S., Ph.D., Weizmann Institute of Science,
Rehovot, Israel
Di Donato, J., B.A., Ph.D., Lerner Research Institute,
Cleveland, Ohio
Dincq, S., M.S., University of Leuven, Belgium
Engel, A., B.S., Ph.D., Roche Diagnostics, Penzberg,
Germany
Fernsten, P. B.S., Ph.D., Wyeth-Lederle Vaccines and
Pediatrics, West Henrietta, New York
Goodyear, C., B.S., Glasgow Caledonian University, United
Kingdom
Martin, G., B.S., M.S., Ph.D., Hoechst Marion Roussel, Inc.,
Bridgewater, New Jersey
SEMINARS
Barbas, C., Scripps Research Institute, La Jolla, California.
Phage display of antibodies and zinc finger proteins.
Kelsoe, G., Duke University, Durham, North Carolina. B-cell
development: Phenotype, anatomy location, and diversifica-
tion of the antibody gene repertoire.
Lowman, H., Genetech, Inc., San Francisco, California.
Extending antibody contacts to VEGF by phage display.
Nest ler, R, Cold Spring Harbor Laboratory. Encoded combi-
natorial libraries: Chemistry and beyond.
Pasqualini, R., La Jolla Cancer Research, California. In vivo
panning.
Moeck, G., B.S., Ph.D., Universite Paris-Sud, France, Orsay,
France
Pupo-Antunez, M., B.S., M.S., Pedro Kouri Tropical Medicine
Institute, Havana, Cuba
Raats, J., M.S., Ph.D., University of Nijmegen, The
Netherlands
Reiersen, H., B.S., M.S., University of Bath, United Kingdom
Rookey, K., B.S., M.S., Scriptgen Pharmaceuticals, Waltham,
Massachusetts
Thaler, D., B.A., Ph.D., Rockefeller University, New York
Wachtel, M., B.A., Ph.D., United States Department of
Agriculture, Albany, California
Zhang, X.K., B.S., Ph.D., Medical University of South
Carolina, Charleston
Scott, J., Simon Fraser University, British Columbia, Canada.
Phage display of peptides.
Siegel, D., University of Pennsylvania Medical Center,
Philadelphia. Cell surface selection of combinatorial Fab
libraries.
Silverman, G., University of California, San Diego. Repertoire
cloning of SLE autoantibodies.
Webster, R., Duke University, Durham, North Carolina. The
biology of filamentous phage.
Wilson, I., Scripps Research Institute, La Jolla, California.
Structural biology of the immune system.
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Mouse Behavorial Anaylsis
December 2-15
INSTRUCTORS Gallagher, Michela, Ph.D., Johns Hopkins University, Baltimore
Silva, Alcino, Ph.D., University of California, Los Angeles
ASSISTANTS Bourtchuladze, Roussudan, Columbia University
Han, Jung-Soo, Johns Hopkins University, Baltimore
Kogan, Jeff, University of California, Los Angeles
Wolfer, David, University of Zurich, Switzerland
This course was intended to provide a theoretical and experimental introduction to behavioral analysis
in the mouse, with a focus on learning and memory. It was especially designed for geneticists, molec-
ular biologists, pharmacologists, and electrophysiologists with a need for a hands-on introduction to
behavioral analysis of the mouse. Additionally, the course covered the principles of using mutant mice
in behavioral studies, as well as the issues involved in integrating behavioral, neuroanatomical, neuro-
physiological, and molecular findings. Among the methods presented were the water maze, cued and
contextual fear conditioning, natural/ethologically relevant learning, the rotor-rod, and other activity
tests. In addition, there were demonstrations of several aspects of in vitro and in vivo electrophysiolo-
gy (fields and whole-cell recordings of synaptic plasticity and hippocampal place cell recordings).
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PARTICIPANTS
Anokhin, K., M.D., Ph.D., Institute of Normal Physiology,
Moscow, Russia
Bartsch, D., B.S., Ph.D., Columbia University, New York
Berke, J., B.A., Ph.D., National Institutes of Health,
Bethesda, Maryland
Bito, H., B.A., M.D., Ph.D., Kyoto University, Japan
Boulter, J., B.A., Ph.D., University of California, Los Angeles
De Lacalle, S., M.D., Ph.D., Beth Israel Deaconess Medical
Center, Boston, Massachusetts
SEMINARS
Alcino, S., University of California, San Francisco.
Introduction-Orientation.
Basbaum, A., University of California, San Francisco. The
neurobiology of pain and its control.
Burwell, R., Brown University, Providence, Rhode Island.
CorticaVhippocampal anatomy.
Davis, M., Emory University, Atlanta, Georgia. Neural system
involved in fear and anxiety.
Dudai, Y., Weizmann Institute of Science, Rehovot, Israel.
Chemical senses and ecological behaviors in rodents:
Paradigms for the analysis of normal and abnormal learning.
Interim reevaluation of the contribution of neurogenetics to
the analysis of learning and memory.
Eichenbaum, H., Boston University, Massachusetts.
Hippocampal place cells: Space and more. The nature of
hippocampal memory representation.
Holland, P., Duke University, Durham, North Carolina.
Behavioral analysis of learning and memory.
Gallagher, M., Johns Hopkins University, Baltimore, Maryland.
The aging brain.
Hsiao, K., BA, M.D., Ph.D., University of Minnesota, Minneapolis
Huang, T.-T, B.S., Ph.D., University of California, San
Francisco
Huynh, D., B.S., Ph.D., Cedars-Sinai Medical Center, Los
Angeles, California
Martinez, A., B.S., Ph.D., University of Texas, San Antonio
Simpson, E., B.S., Ph.D., The Jackson Laboratory, Bar
Harbor, Maine
Wetsel, W., BA., Ph.D., Duke University, Durham, North Carolina
Laroche, S., CNRS-Universite Paris-SUD, Orsay, France. A
molecular biological approach to synaptic plasticity and
learning.
McClelland, J., Carnegie Mellon Institute, Pittsburgh,
Pennsylvania. Why there am complementary learning systems
in hippocampus and neocortex: Insights from the success
and failures of connectionist models of learning and memory.
Muller, R., State University of New York, Brooklyn. Site visit.
Squire, L., University of California, San Diego. The measurement
of mammalian memory functions: Lessons from humans.
Price, D., Johns Hopkins University, Baltimore, Maryland.
Transgenic models of neurodegenerative disease.
Thompson, R., University of Southern California, Los Angeles.
Genetic approaches to mechanisms of cerebellar-depen-
dent memory.
Wilson, M., Massachusetts Institute of Technology,
Cambridge. Rodent hippocampal function.
Wolfer, D., University of Zurich, Switzerland. Meta-analysis of
behavior in large numbers of mutant and wild-type mice:
Conclusions concerning genetic background.
The Laboratory would like to acknowledge the generosity of the following companies who loaned equipment and reagents to the carious courses:
5 Prime-3 Prime Diagnostic Instruments, Inc. LiCor, Inc. PerSeptive Biosystems
Access Graphics Diruscio & Associates Life Technologies, Inc. Pfanstiehl Laboratories, Inc.
ALA Scientific Instruments, Inc. Drummond Scientific Company Ludl Electronic Products Photometrics, Inc.
American Laser Corporation DuPont NEN Luigs & Neumann Pierce
Amersham Life Science Dynal MatTek Corporation Polyfiltronics
Incorporated Dynex Med Associates Princeton Separations
Arnersham Pharmada Biotech, Inc. E-Y Laboratories Media Cybernetics Promega Corporation
Amresco E-Y Laboratories, Inc. Medical Systems Corporation Qiagen Inc.
Applied Precision Eastman Kodak Company Meta Systems Robbins Scientific Corporation
Applied Scientific Instrumentation,
Inc.
Epicentre Technologies
Eppendorf Scientific
Micro Video Instruments
Millipore
Savant Instruments
Scanalytics Inc.
Applied Spectral Imaging Ericomp MJ Research, Inc./ Schleicher & Schuell
Atto Instruments Fine Science Tools Modulation Optics, Inc. Seikagaku America, Inc.
Axon Instruments Fisher Scientific Molecular Dynamics Sherwood-Davis & Geck
Bachem Biosciences FMC Corporation Molecular Probes Shimadzu
Beckman-BREA Fostec Inc. Nalge Labware Sigma-Aldrich
Becton Dickinson Labware Fotodyne Nalge Nunc International Sony Medical Systems
Bio-101 General Valve Narishige International USA, Inc. Sooner Scientific, Inc.
Bio-Rad Laboratories Gibco/Ufe Technologies NEN Life Science Products Sorenson
Bioptechs Hamamatsu Photonic Systems New England Biolabs Spectra-Physics Lasers, Inc.
Boehdnger Mannheim Corp. Hampton Research Nikon Stoelting Co.
Burleigh Instruments, Inc. Havard Apparatus Inc. Novagen Stratagene
Carl Zeiss Hewlett Packard Novex Sutter Instruments
CBS Scientific Hoeffer Pharmacia Ocean Optics Techne, Inc.
Cell & Molecular Technologies,
Inc.
HVS Image Ltd.
lnovision
Olympus America, Inc.
Omega Optical
Technical Manufacturing Corp.
Tektronix
Chroma Technology Corporation Instrutech Operon Technologies Inc. Tropix
Clontech Laboratories, Inc. lnvitrogen Corporation Optronics Engineering Upstate Biotechnology Inc.
Codonics Inc. Jackson lmmunoresearch Laboratories Orinvchm Packard Instruments Vector Laboratories
Coherent Laser Jouan, Inc. Owl Scientific, Inc. Vorhies Technologies, Inc.
Cooke Corporation Kopf Instruments Packard Instruments VWR Scientific Products
Cora Styles Lecroy PE Biosystems Vysis
Corning Costar Corporation Lei., Inc. Perceptive Biosystems Wallac, Inc.
Corning Inc. Lexicon Genetics Incorporated Perkin-Elmer Applied Biosystems Warner Instruments
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SEMINARS
Invited Speaker Program
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present
their latest findings on a weekly basis. These seminars keep the CSHL staff current on the latest
developments and broaden their perspectives. Graduate students and postdoctoral fellows meet
with the seminar speakers for lunch immediately after the seminar, allowing an opportunity for the
exchange of ideas in an informal setting.
January
Dr. Gary Karpen, Salk Institute. Are centromere identity and
function determined by an epigenetic mechanism? (Host:
Tatsuya Hirano)
Dr. Daniel Leahy, Department of Biophysics and Biophysical
Chemistry, Johns Hopkins University. Structure and function
of the developmental signaling molecule hedgehog. (Host:
Leemor Joshua-Tor)
Dr. Gary Stormo, University of Colorado, Boulder. Specificity in
protein/DNA interactions: Experimental and computational
approaches. (Host: Michael Zhang)
Dr. Barbara Meyer, HHMI/University of California, Berkeley. Sex
determination and X-chromosome dosage compensation in
C. elegans. (Host: Tatsuya Hirano)
February
Dr. Tak Mak, Ontario Cancer Institute, Canada. Three dead
mice, see how they run. (Host: Scott Lowe)
Dr. Barry Gumbiner, Memorial Sloan Kettering Cancer Center.
Signaling and morphogenesis mediated by cadherins and
catenins. (Host: David Helfman)
Dr. Denise Montell, Johns Hopkins University School of
Medicine. Molecular genetics of cell migration in Drosophila.
(Host: Tim Tully)
Dr. Phil Green, University of Washington, Seattle. Assembly of
genome sequences and ESTs. (Host: Michael Zhang)
March
Dr. Stephen Johnston, University of Texas, Southwestern Medical
Center. Genetic to genomic immunization: A technological
approach to making vaccines. (Host: Leemor Joshua-Tor)
Dr. Peter Kim, HHMI/MIT/VVhitehead Institute. Invasion of cells
by viruses. (Host: James Moore)
Dr. Michael Greenberg, Harvard Medical School, Division of
Neuroscience. Signal transduction pathways that regulate
differentiation and survival in the developing nervous system.
(Host: Hollis Cline)
Dr. William Bialek, NEC Research Institute, Princeton, New
Jersey. What do neurons compute? Low-dimensional fea-
tures in complex signals. (Host: Karel Svoboda)
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April
Dr. Gerald Joyce, Scripps Research Institute. Order from ran-
domness in the in vitro evolution of a DNA enzyme. (Host:
Adrian Krainer)
Dr. Lewis C. Cant ley, Harvard Medical School. Structural basis
for specificity in signal transduction. (Host: Michael Wig ler)
Dr. Mark Peifer, University of North Carolina, Chapel Hill. Cell
adhesion, signal transduction, and cancer: The Armadillo
connection. (Hosts: Nick Tonks/David Helfman)
Dr. Xiaodong Wang, University of Texas, Southwestern Medical
Institute. Biochemical studies of apoptosis: Putting a colorful
puzzle together. (Host: Yuri Lazebnik)
October
Dr. Robert Pruitt, Harvard University. Regulating cellular inter-
actions by modifying extracellular properties. (Host: Ueli
Grossniklaus)
Dr. Richard Roberts, New England Biolabs. The real world of
restriction enzymes or why I love bugs. (Host: Adrian Krainer)
November
Dr. Robert Darnell, Rockefeller University. Functional studies of
neuron-specific paraneoplastic disease antigens. (Host: Karel
Svoboda)
Dr. Roland Somogyi, Incyte Pharmaceuticals, Inc. Inference of
genetic programs in CNS development and injury. (Host:
Michael Zhang)
December
Dr. Alan Weiner, Yale University. Role of p53 and CSB proteins
in virally induced chromosome fragility. (Host: Nouria
Hernandez)
Dr. Gabriel Nunez, University of Michigan, Regulation of pro-
grammed cell death. (Host: Michael Hengartner)
Dr. Steven Smith, State University of New York, Stony Brook.
How light activates rhodopsin: Structural insights into the
mechanism of a G-protein-coupled receptor. (Host: Winship
Herr)
In-House Seminar Program
Cold Spring Harbor In-House Seminars were initiated to provide a semiformal avenue for communica-
tion between the various research groups at the Laboratory. They are particularly useful for research
personnel who have recently joined the Laboratory. The seminars also afford a necessary opportunity
for the graduate students and postgraduate staff to develop their skills in organizing, presenting, and
defending their research.
January
Mark Settles (Martienssen Lab): Analogies in protein transloca-
tion: What maize can tell us about E. coli.
Tom Misteli (Spector Lab): Pre-mRNA splicing in the nuclear
landscape.
Qiong Liu (Hengartner Lab): Potential signal transduction pro-
tein CED-6 is required for engulfment of apoptotic cells in C.
elegans.
Meena Selvakumar (Helfman Lab): Regulation of alternative
RNA splicing via exon sequences.
February
Yi Liu (Herr Lab): The HSV VP16 associated protein HCF has
a conserved function in cell proliferation control.
Jean-Philippe Vielle-Calzada (Grossniklaus Lab): Confessions
of a botanical voyeur: Altering the sexual life of Arabidopsis.
Dick McCombie: Our first megabase: How we got there and
what we found.
Lee Zou (Stillman Lab): One step closer to initiation: The story
of CDC45.
March
Michael Gutch (Tonks Lab): A genetic analysis of protein tyro-
sine phosphatase function and signal transduction in C. e /e-
gans.
Karel Svoboda: Imaging neuronal function.
Hollis Cline: Imaging mechanisms of neuronal plasticity in vivo.
April
Rui-Ming Xu: The crystal structure of a human mitochondrial
protein.
Gregory Hannon: myc activates telomerase.
Masaaki Hamaguchi: RICH: Looking for the gene.
Ethan Ford (Hernandez Lab): How do transcriptional activa-
tors function? Oct-1 as a model.
October
Marcia Belvin (Yin Lab): Role of the dCREB2 transcription fac-
tor in circadian rhythms in Drosophila.
Andy Neuwald: Sequence-based prediction of protein struc-
ture and function: Chaperone-like ATPases related to the 5'
subunit of DNA polymerase III.
Ana Losada (Hirano Lab): Cohesins: Protein complexes hold-
ing sister chromatids together.
November
Bill Tansey: Myc: Dead at 30 (minutes).
Michael Myers (Tonks Lab): PTEN: Sometimes taking it off is
better than putting it on.
December
Yalin Wang (Zhong Lab): Calcium imaging of olfactory
responses in the mushroom body of adult Drosophila.
Michael Greenberg (Skowronski Lab): Nef uses different
strategies to down-regulate surface expression of CD4 and
MHC class I molecules.
Tracy Kuhlman (Hernandez Lab): The general transcription
factors in snRNA transcription: Making sense of the alpha-
bet soup.
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UNDERGRADUATE RESEARCH
Program Director: Michael Hengartner
Program Assistant: Jane Reader
An important aspect of the summer program at the Laboratory is the participation of college under-
graduate students in active research projects under the supervision of full-time laboratory staff mem-
bers. The program was initiated in 1959. Since that year, 508 students have participated in the course,
and many have gone on to productive careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental princi-
ples of biology; (2) an increased awareness of experimental approaches to science; (3) a deeper under-
standing of the major issues in the fields of biochemistry, genetics, and molecular and cellular biology;
and (4) a personal acquaintance with research, research workers, and centers for study. The following
students, selected from 459 applicants, took part in the program:
Thomas Bridges, Gonville and Caius College, Cambridge
University
Advisor: Timothy Tully
Sponsor: Burroughs Wellcome
The cloning of the human homolog of the Drosophila learning
gene linotte.
Brian Chan, Harvard University
Advisor: Michael Zhang
Sponsor: National Science Foundation
Computational analysis of intronic elements involved in alter-
native splicing.
Curtis Robert Chong, Harvard University
Advisor: Leemor Joshua-Tor
Advisor: National Science Foundation
Crystal structure of o-cysteine bound to carboxypeptidase A
at 1.75 A resolution.
Serafin Colmenares III, University of Hawaii at Manoa
Advisors: Nouria Hernandez and Shannon Pendergrast
Sponsor: Frederica von Stade
Structure-function analysis of the FBI-1 zinc finger domain.
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Ruth Cosgrove, New Hall, Cambridge University
Advisor: David Spector
Sponsor: Burroughs Wellcome
Visualization of RNA in the living cell.
Justin Cross, Queens' College, University of Cambridge
Advisor: Linda Van Aelst
Sponsor: Burroughs Welcome
The functional characterization of AF-6, a Ras-binding protein.
Wilson W. Cui, University of California, San Diego
Advisor: Peter Nest ler
Sponsor: Olney Fund
Detection by fluorescence of protease substrate specificity
using an encoded combinatorial library.
Rachel Dodes, College of Agriculture and Life Sciences,
Cornell University
Advisors: Michael Hengartner and Mona Spector
Sponsor: National Science Foundation
Toward determining function of CED-9 interacting proteins in
Caenorhabditis elegans.
Maitreya Dunham, Massachusetts Institute of Technology
Advisor: Robert Martienssen
Sponsor: National Science Foundation
Molecular genetics of asymmetric leaves 1 in Arabidopsis
thaliana.
Kristina Gremski, Yale University
Advisor: Ueli Grossniklaus
Sponsor: Garfield Fund
tlazolteotl: A mutation affecting ovule development and
female fertility in Arabidopsis thaliana.
Kristin Hendren, Duke University
Advisor: Rui-Ming Xu
Sponsor: Jephson Educational Trust
Purification and crystallization studies of the human cell cycle
protein hCDC34.
Zainab Khalfan, Cedar Crest College
Advisor: David Jackson
Sponsor: Dr. H. Bentley Glass
Determination of cell-to-cell trafficking of the maize KNOT-
TED-1 protein via grafting.
Shujin Luo, College of Life Sciences, Peking University
Advisor: Hong Ma
Sponsor: Emanuel Ax
Isolation of genes expressed in flower development using
enhancer trap and gene trap.
Todd Morgan, Harvard University
Advisor: Bruce Stillman
Sponsor: Burroughs Wellcome
Human CDC45: The homolog of a yeast replication origin protein.
Jason Moss, Duke University
Advisor: Ryuji Kobayashi
Sponsor: Burroughs Wellcome
Improved techniques for MALDI-MS analysis of large pro-
teins.
Masafumi Muratani, University of Tsukuba
Advisor: William Tansey
Sponsor: Read Fellowship
Transcriptional activation domains that signal protein destruc-
tion.
Sabine Nicoleau, Wesleyan University
Advisor: Winship Herr
Sponsor: National Science Foundation
The protein interactions that occur with a specific region of a
nuclear host-cell factor called HCF.
Audra Norris, Reed College
Advisor: W. Richard McCombie
Sponsors: Libby Internship, Bliss Memorial Fund
Sequence analysis of maize ESTs.
Rithwick Rajagopal, Cornell University
Advisor: Grigori Enikolopov
Sponsor: National Science Foundation
Mapping Drosophila nitric oxide synthase using the yeast
two-hybrid system.
Matthew S. Robbins, Yale University
Advisor: Gregory Hannon
Sponsor: Burroughs Wellcome
Identification of secreted proteins overexpressed in human
breast cancer using a secretion trap screen.
Patrice Saunders, Howard University
Advisor: David Helfman
Sponsor: National Science Foundation
Adhesion-dependent signaling transduction: Normal versus
transformed cells.
Markus Seeliger, Universitaet Hannover
Advisor: Yuri Lazebnik
Sponsor: Shakespeare Fund
Studies on protein-protein interactions of caspase 9.
Eva M. Smietana, Indiana University-Purdue University at
Indianapolis
Advisor: Scott Lowe
Sponsor: National Science Foundation
Genetic and biochemical analysis of c-Myc-induced apopto-
sis in primary mouse embryonic fibroblasts.
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NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to
acquire a greater knowledge and understanding of their environment. Through a series of specialized
field courses, younger students can engage in introductory programs, such as Nature Bugs, Nature
Detectives, and Nature Discovery, and older students can enroll in more advanced programs, such as
Marine Biology and Nature Photography.
During the summer of 1998, a total of 355 students participated in 28 courses within the program.
The classes were held outdoors, weather permitting, at the West Side School. The Laboratory has
equipped and maintains classroom and laboratory facilities as well as a darkroom at West Side School.
This facility is used as a base for the students' exploration of the local environment. Field classes are
held on Laboratory grounds, St. John's Preserve, Fire Island National Seashore, Caumsett State Park,
the Cold Spring Harbor Fish Hatchery and Aquarium, as well as other local preserves and sanctuar-
ies.
In addition to the three 2-week sessions, the Adventure Education course meets on two Fridays for
trips. The students go on a three-masted schooner to navigate and explore the waters of Long Island
Sound and on a 12-mile canoe trip on the Nissequogue River.
PROGRAM DIRECTOR
William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR
Amy Stiso, Cold Spring Harbor Laboratory
INSTRUCTORS
Alison Forte, B.S. in Marine Science, University of Rhode Island
Donna Pandaliano, M.S., Science Teacher, Valley Stream School District
Linda Payoski, M.S., Science Teacher, Uniondale School District
Marjorie Pizza, M.S., Science Teacher, Locust Valley School District
Brian Withers, Fine Arts Teacher, New York City School System
COURSES
Nature Bugs
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BANBURY CENTER
DIRECTOR'S REPORT
This was the 22nd year in which scientists from all over the world made their way to the beautiful estate
that Charles Robertson so generously gave to Cold Spring Harbor Laboratory. And this year they made
their way here in record numbers to participate in a record number of meetings. The Center was also
used for meetings by Laboratory scientists and local community groups as well as for courses, so that
no fewer than 40 events took place here.
Summary of Meetings and Participants
This was, indeed, a record year of 19 science meetings, 8 meetings for Laboratory-related purposes,
8 occasions when the Center was used for special meetings by local community groups, and the annu-
al 5 neurobiology courses. There were 601 participants in the science meetings alone, of whom 474
were from the United States. Although, as usual, California, Maryland, Massachusetts, and New York
accounted for more than 50% of these scientists, participants were drawn from no fewer than 36
states; 75 scientists came from Europe and our most distant visitors were from Japan and Australia.
The Corporate Sponsors sent 75 scientists to the Center, and 41 scientists from other companies were
invited participants.
Human Genetic Disorders
We continue to hold meetings dealing with human genetic disorders and disorders in which there is
likely to be a strong genetic component. Three of these meetings were designed to review critically
specific research and provide guidance on what should be done next. Superoxide Dismutase and
Motor Neuron Disease examined what is known of the role of superoxide dismutase in cells, its mech-
anism of action, and how it relates to cell death, and, most importantly, how useful the various animal
models of ALS are for understanding the pathology of ALS and for testing therapeutic agents.
Therapeutic agents are not yet available for the treatment of Duchenne muscular dystrophy but
major research is under way to exploit the fact that the muscle protein utrophin may be able to sub-
stitute for the dystrophin that is missing or nonfunctional in Duchenne muscular dystrophy. The key is
to find a small molecule that will turn on the utrophin gene and that can be administered easily to
patients. In Muscle Gene Regulation and Its Therapeutic Potential-the second in a series of meetings
on this subject-we brought together experts from around the world to discuss what is known about
the control of muscle gene expression. We were looking for common or special mechanisms that might
provide clues as to how to turn on the utrophin gene and what sorts of molecules might work.
The third of these meetings-Critical Issues in Marfan Research-dealt with a very important strate-
gic issue in all cases where advances have been made in the understanding of the genetic basis of a
human disorder, namely, how to use that genetic knowledge to benefit patients. Thus, this meeting dis-
cussed not only continuing laboratory research, especially in mouse models, but also what clinically
based research is needed and how new information can be used for diagnosis. Finally, there was dis-
cussion of research priorities and how collaborations might be set up to promote research.
Two other meetings in this group covered disorders where there is considerable molecular knowl-
edge of both the genes involved and the systems affected. Because of this, researchers in these fields
can begin to make rational, data-based choices of possible therapeutics. The Molecular Basis of
Asthma: Fundamental Processes with Potential Genetic and Therapeutic Targets was particularly inter-
esting in beginning to integrate all that is known about immunological mechanisms in asthma with the
knowledge coming from the genetic analysis of the components of these systems.
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Robertson House provides housing accommodations at Banbury Center.
The Molecular Physiology of Weight Regulation and Obesity meeting was equally interesting and
exciting. Energy regulation has long been a field of research in physiology, but a revolution occurred
some years ago when the first gene involved in obesity-leptin-was cloned. This has led to a remark-
able synthesis of findings in genetics, endocrinology, and neuroendocrinology. The workshop explored
what is known of leptin and its neuroendocrine control as well as the role of other molecules such as
those derived from POMC (pro-opiomelanocortin).
Horse Genetics
At the same time that sequencing the human genome is forging ahead, programs have been estab-
lished to do the same with animals of agricultural importance. The targeted livestock include cattle,
sheep, chickens, and pigs, but one livestock animal that has not received the largesse of substantial
funding is the horse. This is unfortunate not least because horses are interesting genetic animals in their
own right and, through the horse-racing industry, an important economic force. The Banbury Center
meeting on horse genetics was inspired by the claim that thoroughbred performance has not improved
in recent years and that this failure may have a genetic basis. However, Horse Genomics and the
Genetics of Factors Affecting Horse Performance went far beyond that one topic: It provided an occa-
sion for evaluating the current state of horse genetics, for establishing collaborations, and for deter-
mined discussions on the future of horse genomics.
Genomics
Complete genome sequences are known for many bacteria, for parasites and yeast, and even for
Caenorhabditis elegans, a multicellular organism. But all these millions of nucleotides are of little use
unless we can identify the genes they contain and find out what the genes do. We held three techni-
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cal meetings dealing with these questions, and the first was Full-length cDNA Cloning: A Workshop on
Problems and Solutions. cDNA clones are made from mRNA that carries information from genes to
sites of protein synthesis. They are very useful, representing as they do just genes without all of the
sequences in chromosomal DNA that do not code for protein. Unfortunately, it is not easy to make
complete cDNA clones or to make copies of all the mRNAs in a cell. Participants critically reviewed the
current status of cDNA cloning and tried to identify new strategies for improving cloning. There was
also a very interesting discussion of intellectual property rights that affect this work.
Finding human disease genes using mapping techniques has been very successful for disorders where
one gene is involved. But it becomes increasingly difficult to do such mapping when several or even many
genes may contribute to a disorder. Large-scale Discovery and Genetic Applications of SNPs was an in-
depth look at single nucleotide polymorphisms, a relatively new tool for doing such mapping. Enthusiasts
believe that SNPs will make it possible to find genes involved in complicated disorders, and although there
have been some successes (e.g., in diabetes), much still needs to understood about how many SNPs will
be needed, how they are to be found, and the theoretical basis for their use.
Finally, finding all of the genes in an organism will be of little use unless we can determine what they
do. This has become a critical issue for those organisms for which the complete sequence is known
(e.g., yeast). Beyond identifying the functions of genes, we also need to know how sets of genes inter-
act in the life of the cell. Techniques are being developed to do this and The Genome and Experimental
Biology reviewed a wide variety of approaches, especially those based on chip technology. One con-
sequence of genomic-based research is that data are going to be produced at a very high rate. There
was discussion of how to cope with this flood of information, which became very lively when it turned
to the physicists' strategy of E-mail publishing.
Infectious Diseases
Banbury Center has long had an interest in Lyme disease and in the use of vaccines to combat infec-
tious diseases. Our series of Lyme disease meetings shows how research in this area has changed-
we now have the complete genomic sequence of Borrelia burgdorferi. The meeting this year dealt with
a more prosaic topic but one of tremendous importance-Laboratory Methods for the Diagnosis of
Lyme Disease. The meeting reviewed the various tests currently being used, including those based on
immunological methods and those based on detecting spirochete DNA or RNA. In addition, there was
considerable discussion of factors affecting the reliability of these tests. The meeting concluded with
an overview of the key issues and how they might be tackled.
The goal of the Albert B. Sabin Vaccine Institute is to promote the use of vaccines. One obstacle in
doing this-a problem common to many fields-is the difficulty of moving from research findings to
applications in the "real world." Here, economic, social, and political factors come into play in ways not
so evident in the laboratory. From Bench to Bedside: A Colloquium on Translational Vaccine Control
was a case-based review of these problems and drew on a wide variety of vaccine developments,
including vaccines directed against measles, influenza, viral hepatitis, Lyme disease, and even cancer.
Coping with Stress
It is not only human beings that feel stress. In fact, our cells lead very stressful lives and a complex
metabolic system has evolved to help them cope. Integrating Cellular Stress Responses reviewed how
cells detect and respond to a variety of stresses: heat, starvation, hypoxia, and poisoning by heavy
metals, for example. The participants discussed the extent to which these challenges initiate the same
or similar responses and how these responses evolved. Here is a case where the chip technology
referred to above can be used to monitor all the changes in gene expression that go on in a yeast cell
when it is stressed.
Our experience with boiling eggs demonstrates the effect of heat on proteins: It produces irre-
versible changes. And yet there are bacteria and other organisms that flourish in the boiling hot springs
of Yellowstone Park or around the "black smoker" vents in the deepest oceans. How they are able to
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survive there was the topic of Biochemistry at 100°C: How Are Enzymes and Their Substrates
Stabilized? The participants came from a wide variety of backgrounds including chemistry, biophysics,
biochemistry, and evolutionary biology. The former dealt with the mechanisms by which life goes on at
these high temperatures and the latter discussed the controversial questions of whether these organ-
isms are "primitive" and what they can tell us about the origins of life. We were honored to have Stanley
Miller, who carried out seminal experiments on the origin of life more than 40 years ago, participate in
the meeting.
The Art of Science-State and Federal Judges
The Federal Judicial Center serves as the agency for research and continuing education for judges in
the federal court system. In addition, its Interjudicial Affairs Office is charged with serving as an infor-
mation clearinghouse for the Center's research and education programs with state judicial systems.
These two functions come together in the Basic Issues in Science seminars that we hold here at
Banbury Center. These are not intended to give specific information on scientific issues as they come
before the courts, but rather to give state and federal judges a flavor of how scientists think and carry
out their research. Thus, our program includes history and philosophy of science, as well as an edu-
cation in genetics. We try also to cover contemporary issues-this year, for example, Lee Silver came
to Banbury to discuss human cloning.
Genetics Learning on the Web
Banbury Center and the DNA Learning Center are collaborating on a very exciting project to provide a
genetics text for the lay public and high school students on the World Wide Web. Although many
examples of genetics sites exist on the Web, Dave Mick los and I believe that none of them provides
the information at the appropriate level or in a manner that does not intimidate. The Josiah Macy, Jr.
Foundation agreed and has provided funding to support the project. Part of this funding is for work-
shops at Banbury Center to explore how such a site might be designed and made and to assess our
progress. Thus, the meeting Genes, Teens, and the World Wide Web brought together science edu-
cators, Web designers, science writers, and Web scientists. We were especially pleased that Bruce
Alberts, President of the National Academy of Sciences, was able to participate. He has made improv-
ing science education a major goal of the Academy.
Eugenics Source Materials on the Web
Banbury Center is also collaborating with the DNA Learning Center on another project exploiting the
power of the Web to deliver information and materials that would otherwise be inaccessible. Our pro-
ject, funded by the National Human Genome Research Institute, will make available to teachers,
researchers, and the general public up to 1000 images on eugenics. This material is currently stored
in archives in academic institutions and only a very small amount has been published in books and
journals. An advisory group is helping us prepare this site and providing us with guidance about how
to annotate and provide context for the materials. It is a very mixed group, including historians, geneti-
cists, and ethicists. The group met here in September to review what we had collected and to discuss
the guidelines for display. For example, should all names and other identifiers be removed? Can this
be done without compromising the data? We will now go on to produce some sample pages for fur-
ther review.
The J.P. Morgan/Cold Spring Harbor Laboratory Executives' Seminar
When this series of meetings began in 1986, there can have been no expectation of their remarkable
success. Indeed, this year, the acceptance rate was so high that we became worried that our partici-
pants would be flowing out of the door. The meeting was remarkable also for the range of physical
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dimensions covered. Entitled Imaging from Molecules to Brains, we began with atomic force
microscopy of molecules, moved through X-ray crystallography and tracking molecules in cells, to
imaging the living human brain at work on various tasks. The topic was chosen in part because of the
Laboratory's increasing interest in imaging, and Leemor Joshua-Tor, David Spector, and Karel Svoboda
described their work. We are very grateful to David Deming and J.P. Morgan for their continuing sup-
port of this extraordinary event.
Other Meetings
On several occasions, scientists from the Laboratory used the Center for small meetings. In addition,
we are happy to make the Center available on a limited basis for use by local community groups, as
the pressure of our schedule permits. In 1998, such groups included the Lloyd Harbor Conservation
Board, Holiday House, and Huntington Hospital Board of Trustees.
Funding
The Corporate Sponsor Program, now in its 15th year, continues to provide funding for six Banbury
Center meetings. The participating companies make good use of their spaces at Banbury Center,
sending 46 scientists to our meetings. Foundation support of meetings was especially strong in 1998
with no fewer than eight foundations coming to Banbury: the ALS Foundation, the William Theodore
Dens low Foundation, the Dorothy Russell Havermeyer Foundation, the National Marian Foundation,
the Merck Genome Research Institute, the Oxnard Foundation, the Albert B. Sabin Vaccine Institute,
Shriners Hospitals for Children, and the Swartz Initiative for Computational Neuroscience. Federal fund-
ing came from the Federal Judicial Center; the National Heart, Lung, and Blood Institute; the National
Human Genome Research Institute; and the National Institute of Allergy and Infectious Diseases.
Company support for Banbury Center meetings comes for specific meetings as well as through the
Banbury Conference Center
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Corporate Sponsor Program. In 1998, Glaxo Wellcome, Inc.; Immunetics; Research Genetics, Inc.;
SmithKline Beecham Pharmaceuticals; and Tularik Inc. provided funding for meetings.
Other News
The most significant change to Banbury Center is the addition of the Meier House to the estate.
Immediately across from the Conference Room, this house belonged to Dr. Walter and Mrs. Anne
Meier, who was one of the daughters of Charles and Marie Robertson. The house has been refurbished
and will provide extra accommodation for our participants. This means that the capacity of the
Conference Room is now matched by the accommodation in Sammis Hall and Robertson and Meier
Houses and we will not need to ferry people to and from the main Laboratory campus.
A very welcome improvement in 1998 was the upgrade of our Internet connection to a T1 line. The
Web has become our primary source of information, and although 10 years ago, the fax machine rev-
olutionized communications with organizers and participants, the impact of E-mail is far, far greater. The
increased speed of the T1 line is much appreciated by participants as well, especially for genomics-
related meetings where Internet access is a sine qua non of research and presentations.
Acknowledgments
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MEETINGS
Neurocomputational Strategies: From Synapses to Behavior
February 1-4
FUNDED BY The Swartz Initiative for Computational Neuroscience
ARRANGED BY R. Malinow, Cold Spring Harbor Laboratory
T. Sejnowski, The Salk Institute for Biological Studies
SESSION 1: Cellular and Molecular Mechanisms Underlying Synaptic Signaling,
Synaptic Plasticity, and Axonal Pathfinding
Chairperson: T. Sejnowski, The Salk Institute for Biological Studies, San Diego,
California
M. Poo, University of California, San Diego, La Jolla: Long- R. Malinow, Cold Spring Harbor Laboratory: Silent synapses
range propagation of LTP and LTD in neural networks. in plasticity.
G.J. Goodhill, Georgetown University Medical Center, Z.F. Mainen, Cold Spring Harbor Laboratory: Increase in func-
Washington, D.C.: Theoretical modeling of axon guid- tional AMPA receptors during LTP.
ance. T. Bonhoeffer, Max-Planck Institute for Psychiatry, Munchen,
D. Willshaw, University of Edinburgh, Scotland: Competitive Germany: Specificity of synaptic enhancement in the hip-
influences in the development of nerve connections. pocampus.
SESSION 2: Spike Coding in Axons and Spike Decoding in Dendrites
Chairperson: R. Malinow, Cold Spring Harbor Laboratory
M. Wilson, University of California, Davis: The smallest unit of Dendritic computations.
synaptic transmission. G.M. Shepherd, Yale University School of Medicine, New
K. Svoboda, Cold Spring Harbor Laboratory: Dendritic func- Haven, Connecticut: Action potential propagation in den-
tion in neocortex in vivo. drites-Its significance for information processing in the
F. Gabbiani, California Institute of Technology, Pasadena: olfactory system.
Multiplying with neurons. I. Segev, Hebrew University, Jerusalem, Israel: The noisy
D. Johnston, Baylor College of Medicine, Houston, Texas: neuron.
P. Konig, T Sejnowski, N. Kopell, A. Destexhe, K. Svoboda
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SESSION 3: Thalamocortical Interactions and Short-term Synaptic
Plasticity
Chairperson: R.E. Shrock, State University of New York, Stony Brook
S.M. Sherman, State University of New York, Stony Brook: Haven, Connecticut: Network and computational implica-
Functional organization of thalamus and thalamocortical tions of short- and long-term changes in thalamic and corti-
interactions. cal activity.
A. Destexhe, Laval University, Quebec, Canada: How corti- M.V. Tsodyks, Weizmann Institute of Science, Rehovot,
cothalatic feedback and intrathalatic inhibition cooperate to Israel: Dynamics of neocortical circuits-Models and exper-
synchronize oscillations over large cortical territories. iments.
P.R. Adams, State University of New York, Stony Brook: The L.F. Abbott, Brandeis University, Waltham, Massachusetts:
thalamocortical algorithm. The role of short-term synaptic plasticity in cortical process-
D.A. McCormick, Yale University School of Medicine, New ing.
SESSION 4: Mechanisms for Response Properties and Synchronization of
Cortical Neurons
Chairperson: P.R. Adams, State University of New York, Stony Brook
D.L. Ferster, Northwestern University, Evanston, Illinois: R.D. Traub, Birmingham University School of Medicine,
Assembly of receptive fields in cat visual cortex. United Kingdom: Synaptic plasticity induced by 40 Hz oscil-
K.D. Miller, University of California, San Francisco: Ocularly lations.
matched, contrast-invariant orientation tuning in cat V-I: N. Kopell, Boston University, Massachusetts: Mechanisms for
Development and mature circuitry. synchronization (and desynchronization) in networks of neu-
G.G. Turrigiano, Brandeis University, Waltham, Massa- rons.
chusetts: Activity-dependent scaling of synaptic strengths R.E. Shrock, State University of New York, Stony Brook:
in neocortical networks. Synaptic plasticity in neural networks modeling brain func-
R Konig, Institute for Neuroinformatics, Zurich, Switzerland: tion.
Is synchronization of neuronal activity relevant for behavior?
SESSION 5: Neural Assemblies and Neural Population Codes
Chairperson: L.F. Abbott, Brandeis University, Waltham, Massachusetts
D. Horn, Tel Aviv University, Israel: Memory maintenance via W.B. Kristan, University of California, San Diego: Population
neuronal regulation. codes for directed behaviors in simple nervous systems.
D.W. Tank, Bell Laboratories, Lucent Technologies, Murray T Sejnowski, The Salk Institute for Biological Studies, San
Hill, New Jersey: Cellular and circuit mechanisms of persis- Diego, California: Limits on the accuracy of population
tent neural activity. codes.
SESSION 6: Whither Computational Neuroscience?
Discussion Leader: T. Sejnowski, The Salk Institute for Biological Studies, San
Diego, California
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Superoxide Dismutase and Motor Neuron Disease
February 22-25
FUNDED BY Amyotrophic Lateral Sclerosis Association
ARRANGED BY R.H. Brown, Massachusetts General Hospital
R. Horvitz, Massachusetts Institute of Technology
SESSION 1: Superoxide Dismutase-Structure and Related Issues
Chairperson: R.H. Brown, Massachusetts General Hospital, Charlestown
R.N. Brown, Massachusetts General Hospital, Charlestown: P.J. Hart, University of California, Los Angeles: Atomic struc-
Introduction to ALS and SOD1-VVT and mutant. ture of human SOD and effect of FALS mutations on this
I. Fridovich, Duke University Medical Center, Durham, North structure.
Carolina: A superoxide-dependent proxidase activity of the V.S. Culotta, Johns Hopkins University, School of Hygiene
H480 valiant. and Public Health, Baltimore, Maryland: The role of copper
L.J. Hayward, Massachusetts General Hospital-East, Boston: chaperone for superoxide dismutase.
Introduction to ALS and SOD1-VVT and mutant.
SESSION 2: Superoxide Dismutase-Catalytic and Noncatalytic Mechanisms
Chairperson: J.S. Valentine, University of California, Los Angeles
J.S. Valentine, University of California, Los Angeles: M.F. Beal, Massachusetts General Hospital, Boston:
The abnormal copper chemistry of ALS-mutant Oxidative pathology in ALS.
CuZnSODs. C. Kunst, Eleanor Roosevelt Institute, Denver, Colorado:
E.R. Stadtman, National Heart, Lung, and Blood Institute, Aberrant protein binding.
NIH, Bethesda, Maryland: Increased peroxidation. A.L. Goldberg, Harvard Medical School, Boston,
Institute, NIH, Massachusetts: Selective degradation of abnormal
Bethesda, Maryland: Increased peroxidation. teins-Proteasome inhibitors and protection against cell
J.P. Crow, University of Alabama at Birmingham: Aberrant damage.
metal binding by SOD mutants and possible functional con- K.J. Davies, University of Southern California, Los Angeles:
sequences. Protein aggregation/recycling.
R. Brown, R. Horvitz
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SESSION 3: Superoxide Dismutase-Cell Death Activation
Chairperson: H.R. Horvitz, HHMI, Massachusetts Institute of Technology, Cambridge
H.R. Horvitz, HHMI, Massachusetts Institute of Technology,
Cambridge: Overview of programmed cell death.
C.M. Troy, College of Physicians & Surgeons of Columbia
University, New York: Caspase specificity in different models
of neuronal cell death.
R.P. Roos, University of Chicago, Illinois: Mechanisms of
FALS-associated neuronal death and rescue.
D.A. Figlewicz, University of Rochester Medical Center, New
York: Pathways of cell death in mutantSOD-expressing
spinal motor neurons.
R.M. Friedlander, Massachusetts General Hospital, Boston:
Mechanisms and modulation of the ICE cell death cascade.
S. Przedborski, Columbia University, New York:
(1) Programmed cell death. (2) Oxidative stress.
D.E. Bredesen, The Burnham Research Institute, La Jolla,
California: Protein abnormalities in motor neuron diseases.
SESSION 4: Animal Models for ALS and Other Neurodegenerative Diseases
Chairperson: D. Cleveland, University of California, San Diego, La Jolla
M. Gurney, Pharmacia and Upjohn, Kalamazoo, Michigan: neurodegenerative disorders.
Excess in vivo free radical production in FALS transgenic J.P. Phillips, University of Guelph, Ontario, Canada:
mice. Targeted expression of normal and FALS human SOD in
D. Cleveland, University of California, San Diego, La Jolla: motor neurons of wild-type and SOD-Null mutants of
Mechanism of FALS-linked SOD1 mutant-mediated disease Drosophila.
in mice. S.W. Davies, University College London, United Kingdom:
D.L. Price, The Johns Hopkins University School of Neuronal intranuclear inclusions and trinucleotide repeat
Medicine, Baltimore, Maryland: Models of ALS and other disease.
SESSION 5: Non-SOD1 ALS and Other Neurodegenerative Diseases
Chairperson: K.H. Fischbeck, University of Pennsylvania Medical School,
Philadelphia
R.H. Brown, Massachusetts General Hospital, Charlestown:
Other ALS genes.
K.H. Fischbeck, University of Pennsylvania Medical School,
Philadelphia: Spinal and bulbar muscular atrophy
(Kennedy's disease).
A.H.M. Burghes, Ohio State University, Columbus: Spinal
muscular atrophy/SMN.
SESSION 6: General discussion: Future Research
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Participants during meeting break.
Horse Genomics and the Genetics of Factors Affecting
Horse Performance
March 8-11
FUNDED BY The Dorothy Russell Havemeyer Foundation, Inc.
ARRANGED BY D. Antczak, Cornell University
E. Bailey, University of Kentucky
SESSION 1: Background
Chairperson: W.R. Allen, University of Cambridge, United
Kingdom
D.F. Antczak, Cornell University, Ithaca, New York and E.F.
Bailey, University of Kentucky, Lexington: Introduction.
E.G. Cothran, University of Kentucky, Lexington: Genetic vari-
ability in the horse.
SESSION 2: Determinants of Performance
Chairperson: E.F. Bailey, University of Kentucky, Lexington
J.R. Rooney, Queenstown, Maryland: Structural and function-
al conformation and lameness.
S.G. Kemerling, Louisiana State University, Baton Rouge:
Equine performance: Tests and targets.
T. Ivers, Equine Racing Systems, Inc. Washougal,
Washington: Nongenetic factors in racehorse performance.
SESSION 3: Performance: What It Is: How To Measure It
Chairperson: D.F. Antczak, Cornell University, Ithaca, New
York
E.P. Cunningham, Trinity College, Dublin, Ireland: Estimates of
heritability and genetic gain in thoroughbreds.
COMMENTARIES
J. Leimbach, West Chester, Pennsylvania: Signs of inbreeding
depression in the thoroughbred. Pedigree analysis. Mapping
on full-sibling horse reference families.
A. Porter, Alan Porter Pedigree Research, Lynbrook, New York:
The way the racing/breeding community recognizes the lead-
ing performers (the social divide-stakes winners and the
rest).
J. Witkowski, E. Bailey, D. Antczak
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SESSION 4: Horse Genomics
A. Chakravarti, Case Western Reserve University,
Cleveland, Ohio: Problems and strategies of complex trait
analysis.
A.T. Bowling, University of California, Davis: Synteny map.
M. Binns, Animal Health Trust, Suffolk, United Kingdom:
Mapping on full-sibling horse reference families.
SESSION 5: Horse Genetics
Chairperson: S.J. O'Brien, National Cancer Institute, Frederick,
D.F. Antczak, Cornell University, Ithaca, New York: The mater-
nal grandsire effect: Does it exist, and could it be caused by
genomic imprinting.
E.P. Cunningham, Trinity College, Dublin, Ireland: Inbreeding
and fertility in thoroughbreds.
S. Ohno, City of Hope, Duarte, California: The rule of mito-
chondria) inheritance dictates Eclipse and Matchem (two
foundation sires of the racing thoroughbred) shared the
SESSION 6: Genetics In Other Species
Chairperson: S. Ohno, City of Hope, Duarte, California
S.J. O'Brien, National Cancer Institute, Frederick, Maryland:
Comparative genomics in mammals.
S.C. Heath, Rockefeller University, New York: Linkage
SESSION 7: Future Developments-Scientific and Policy
Discussion Leaders: D.F. Antczak, Cornell University,
Ithaca, New York, and E.F. Bailey, University of Kentucky,
Lexington
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E.F. Bailey, University of Kentucky, Lexington: Status of the
International Gene Mapping Workshop for the Horse:
Completion of Phase I.
L.C. Skow, Texas A&M University College of Veterinary
Medicine, College Station: Development of anchored type II
markers in the horse map.
Maryland
identical mitochondria] sequence.
S. Valberg, University of Minnesota, St. Paul: Clinical applica-
tion of equine genetics to neuromuscular disorders.
J. Mickelson, University of Minnesota, St. Paul: Genetic basis
of the overo lethal white foal syndrome.
L.D. Van Vleck, University of Nebraska, Lincoln: Issues
involved with improving quantitative traits such as racing
ability.
analysis for large complex pedigrees.
M. Neff, University of California, Berkeley: From cottage
industry to community: Canine molecular genetics.
Presentation during a meeting.
Full-length cDNA Cloning: A Workshop on Problems and Solutions
March 22-25
FUNDED BY The Merck Genome Research Institute, National Cancer
Institute, and Research Genetics, Inc.
ARRANGED BY M.B. Soares, University of Iowa
P. Carninci, RIKEN, Ibaraki, Japan
SESSION 1: Meeting Overview and Discussion of Issues
M.B. Soares, University of Iowa, Iowa City: Meeting overview.
SESSION 2: Quality Assessment of Full-length cDNA Libraries
Chairperson: P. Carninci, RIKEN, Ibaraki, Japan
C. Auffray, Genetique Moleculaire et Biologie du Develop-
ment, Villejuif, France: Generating and analyzing full-length
cDNA clones for muscle and brain-specific transcripts.
R.A. Gibbs, Baylor College of Medicine, Houston, Texas:
SESSION 3: Synthesis and Selection of Full-length cDNAs I
Chairperson: W. Szybalski, University of Wisconsin Medical Sc
M.B. Soares, University of Iowa, Iowa City: Introductory
overview.
J. Jessee, Life Technologies, Inc., Rockville, Maryland: New
reverse transcriptases for cDNA synthesis.
P. Carninci, RIKEN, Ibaraki, Japan: First-strand synthesis of
cDNAs by thermoactivated reverse transcriptase.
C. Schneider, National Laboratory CIB, Trieste, Italy:
Strategies to select full-length cDNA copies for cloning.
J. Pelletier, McGill University, Montreal, Canada: Affinity selec-
tion of full-length cDNA: RNA product.
P. Carninci, RIKEN, Ibaraki, Japan: Full-length cDNA selection
by biotinylated cap trapper.
M. Lovett, University of Texas Southwestern Medical Center,
Dallas: CAP trapping as a full-length cDNA methodology.
Sequencing and sequence analysis of full-length cDNAs.
M.A. Marra, Washington University School of Medicine, St.
Louis, Missouri: Sequencing and sequence analysis of full-
length cDNAs.
hool, Madison
S. Sugano, The University of Tokyo, Japan: Oligo-capping
method and its use in construction of full-length cDNA
libraries.
S. Kato, Sagami Chemical Research Center, Sagamihara-shi,
Japan: Synthesis of full-length cDNA using a DNA-RNA
oligo capping method.
N. Nomura, Kazusa DNA Research Institute, Chiba, Japan:
Complete sequencing of 610 human nearly full-length cDNA
clones which correspond to long transcripts.
D.B. Krizman, National Cancer Institute, Bethesda,
Maryland: Analysis of transcript size from various sources
of RNA.
G.G. Lennon, Gene Logic, Inc. Columbia, Maryland:
Imagene: Clustering of ESTs and full-length clones.
C. Schneider, M. Soares
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SESSION 4: Synthesis and Selection of Full-length cDNAs II
Chairperson: S. Weissman, Yale University School of Medicine, New Haven, Connecticut
L. Stubbs, Lawrence Livermore National Laboratory,
California: Constructing libraries with large inserts using
size-selected mouse cDNA.
M.B. Soares, University of Iowa, Iowa City: cDNA synthesis
and cloning from size-fractionated mRNA.
SESSION 5: Critical Issues Pertaining to Cloning and Amplification of Full-length
cDNAs: From Single Cells to Bulk Tissues I
Chairperson: S. Weissman, Yale University School of Medicine, New Haven, Connecticut
W. Szybalski, University of Wisconsin Medical School,
Madison: Introductory overview.
K.W. Beisel, Boys Town National Research Hospital, Omaha,
Nebraska: Construction of cDNA libraries from single cells.
D.B. Krizman, National Cancer Institute, Bethesda, Maryland:
Construction of cDNA libraries from a few thousand cells
derived from microdissected tissues.
M. McClelland, Sidney Kimmel Cancer Center, San Diego,
California: Critical issues pertaining to PCR amplification of
full-length cDNAs.
F.S. Hagen, Icogen Corporation, Redmond, Washington: Full-
length representative cDNA libraries.
M. Metzker, Merck Genome Research Institute, West Point,
Pennsylvania: Full-length cloning and sequencing at Merck.
SESSION 6: Critical Issues Pertaining to Cloning and Amplification of Full-length
cDNAs: From Single Cells to Bulk Tissues II
Chairperson: R.A. Gibbs, Baylor College of Medicine, Houston, Texas
W. Szybalski, University of Wisconsin Medical School,
Madison: Development of conditionally amplifiable pBAC
vectors for cloning of full-length cDNAs.
M.B. Soares, University of Iowa, Iowa City: Full-length nor-
malized libraries. Are they needed? Can they be construct-
ed with existing methods?
V. Prasad, Albert Einstein College of Medicine, Bronx, New
York: Factors affecting processivity and fidelity of RT.
S. Weissman, Yale University School of Medicine, New
Haven, Connecticut: cDNA display from small numbers of
hematopoietic cells.
S. Wiemann, German Cancer Research Center,
Heidelberg: Identification and characterization of full-
length cDNA.
SESSION 7: Toward the Development of a Unigene Set of Full-length cDNAs
Chairperson: R.A. Gibbs, Baylor College of Medicine, Houston, Texas
J.R. Hudson, Research Genetics, Inc., Huntsville, Alabama:
Clone distribution, availability, and intellectual property.
SESSION 8: Revisiting the Critical Issues: Critical Overview, Coordination, and
Future Planning
Chairperson: M. Boguski, National Center for Biotechnology Information, NLM,
Bethesda, Maryland
S. Weissman, Yale University School of Medicine, New
Haven, Connecticut: A critical overview.
M.J. Finley Austin, Merck Genome Research Institute, West
Point, Pennsylvania: Coordination among different public
and private institutions.
R.L. Strausberg, National Cancer Institute, Bethesda,
Maryland: The Cancer Genome Anatomy Project:
Round Table Discussion on Funding Interests/Opportunities
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Coordination challenges. What have we learned from CGAP
that could facilitate this project?
E.A. Feingold, National Human Genome Research Institute,
Bethesda, Maryland: Role of NHGRI.
N. Nomura, Kazusa DNA Research Institute, Japan: Proposal
for cDNA symposiums in Kazusa.
The Molecular Basis of Asthma: Fundamental Processes
with Potential Genetic and Therapeutic Targets
March 29-April 1
FUNDED BY The William Theodore Dens low Foundation,
with additional support from the National Heart,
Lung, and Blood Institute, NIH, Tularik, Inc.,
and private contributions
ARRANGED BY J.M. Drazen, Brigham and Women's Hospital
S.B. Liggett, University of Cincinnati College of Medicine
Goals of Conference:
S.B. Liggett, University of Cincinnati College of Medicine
SESSION 1: Interlukin 5
Chairperson: C.J. Sanderson, TVVV Telethon Institute for Child Health Research,
Perth, Australia
J. Tavernier, University of Gent Faculty of Medicine, Belgium:
Expression and activation of the IL-5 receptor: The close
relationship between agonism and antagonism.
A.E.I. Proudfoot, Glaxo Wellcome Research & Development
SA, Geneva, Switzerland: Structure-function studies of the
IL-5/IL-5R interaction.
P.S. Foster, John Curtin School of Medical Research,
Canberra, Australia: IL-5 and allergic airways disease as
assessed in IL-5 knockout mice.
C.J. Sanderson, TVW Telethon Institute For Child Health
Research, Perth, Australia: IL-5 production.
R.W. Egan, Schering-Plough Research Institute, Kenilworth,
Biology of IL-5 blockade.
P. Foster, M. Rothenberg, L. Gbencher
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SESSION 2: IL-4 and the TH2 Phenotype-basic Immunobiology
Chairperson: L.H. Glimcher, Harvard School of Public Health, Boston, Massachusetts
L.H. Glimcher, Harvard School of Public Health, Boston,
Massachusetts: Transcriptional regulation of IL-4 gene
expression.
W.E. Paul, National Institutes of Health, Bethesda, Mary-
land: IL-4 signaling mechanisms with regard to TH com-
mitment.
R.M. Locks ley, University of California, San Francisco: In vivo
SESSION 3: Polymorphisms of Target Genes in Asthma
Chairperson: S.B. Liggett, University of Cincinnati College of
N.J. Schork, Case Western Reserve University, Cleveland,
Ohio: Analysis of target gene variations in complex dis-
eases.
M.T. Boyce-Jacino, Molecular Tool, Inc., Baltimore, Maryland:
Methods of rapid detection of polymorphisms.
J.M. Drazen, Brigham and Women's Hospital, Boston,
origins of TH2 cells in murine parasitic infestation.
R.L. Coffman, DNAX Research Institute of Molecular and
Cellular Biology, Palo Alto, California: T cell development in
murine models of allergic disease.
G.K. Khurana Hershey, Children's Hospital Medical Center,
Cincinnati, Ohio: Biology of the R576 IL-4 receptor allele: A
gain-of-function variant.
Medicine, Ohio
Massachusetts: Genetic variants of 5-liponrgenase.
S.M. Prescott, University of Utah, Salt Lake City:
Platelet activating factor acetylhydrolase gene varia-
tion.
S.B. Liggett, University of Cincinnati College of Medicine,
Ohio: Polymorphisms of the f3-adrenergic receptor.
SESSION 4: Chemokines
Chairperson: J. Oppenheim, NCI-Frederick Cancer Research and Development
Center, Maryland
T.J. Williams, National Heart and Lung Institute, London,
United Kingdom: Regulation of eotaxin.
M.E. Rothenberg, Children's Hospital Medical Center,
Cincinnati, Ohio: Control of eosinophil trafficking by
chemokines.
D.M. Center, Boston University School of Medicine,
Massachusetts: Regulation of CD4ii T-cell accumulation and
activation in the lung by IL-16.
J.A. Elias, Yale University School of Medicine, New Haven,
Connecticut: Transgenic modeling: Lessons from IL-11 and
IL-16 mice.
N.W. Lukacs, University of Michigan Medical School, Ann
Arbor: Role of chemokines on leukocyte recruitment, airway
reactivity and lymphokine profiles.
J. Oppenheim, NCI-Frederick Cancer Research and
Development Center, Maryland: Chemokine-induced neu-
trophil release of immunoadjuvants: Defensins and cathep-
sin G.
SESSION 5: IgE Function and Regulation
Chairperson: S.J. Galli, Beth Israel Deaconess Medical Center, Boston,
Massachusetts
S.J. Galli, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Role of mast cells and IgE- and Fa RI-
dependent amplification and positive feedback mecha-
nisms.
J.V. Ravetch, The Rockefeller University, New York: FCaRII-
dependent regulation of the allergic response.
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K.J. Moore, Millennium Pharmaceuticals Inc., Cambridge,
Massachusetts: Analysis of the defective IgE response in a
mouse inbred strain.
J.-P. Kinet, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Positive and negative regulation of signaling
via the Fa RI.
Critical Issues in Marfan Research
April 17-19
FUNDED BY National Marian Foundation, with additional support
from Shriners Hospitals for Children
ARRANGED BY P. Byers, University of Washington School of Medicine
R.B. Devereux, New York Hospital/Cornell Medical Center
H.C. Dietz, The Johns Hopkins Hospital
Uta Francke, HHMI, Stanford University Medical Center
R.E. Pyeritz, Allegheny University of the Health Sciences
F. Ramirez, Mount Sinai School of Medicine
L.Y. Sakai, Shriners Hospital for Children
SESSION 1: Clinical Research in Marian Syndrome and Related Disorders
Chairperson: R.E. Pyeritz, Allegheny University of the Health Sciences,
Pittsburgh, Pennsylvania
R.E. Pyeritz, Allegheny University of the Health Sciences,
Pittsburgh, Pennsylvania: Introduction and overview.
Brief Reports
D.M. Alcorn, Stanford University Medical Center, California
A.C. Braverman, Washington University School of Medicine,
St. Louis, Missouri
P. Byers, University of Washington School of Medicine,
Seattle
SESSION 2: Lessons from Animal Models
Chairperson: F. Ramirez, Mount Sinai School of Medicine, New
F. Ramirez, Mount Sinai School of Medicine, New York:
Introduction.
N.C. Dietz, The Johns Hopkins Hospital, Baltimore, Maryland:
Vascular pathogenesis of MFS and mice.
S.D. Shapiro, Washington University School of Medicine, St.
Louis, Missouri: Metalloproteinases which degrade elastic fibers.
N.C. Dietz, The Johns Hopkins Hospital, Baltimore,
Maryland
D.M. Milewicz, University of Texas Medical School at Houston
S.D. Shapiro, Washington University School of Medicine, St.
Louis, Missouri
York
P. Carmeliet, KU Leuven, Belgium: Proteinases and aneurysm
formation.
N.C. Dietz, The Johns Hopkins Hospital, Baltimore, Maryland:
Phenotypic variability in MFS and mice.
R. Akhurst, Onyx Pharmaceuticals, Richmond, California:
Identification of modifiers in mice.
R Byers, R. Akhurst, D. Rifkin, L. Sakai
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SESSION 3: Molecular Diagnostics and Databases
A. Diagnostic Issues-Clinical
All participants: Revisit the clinical diagnostic criteria for
MFS-experience using the Ghent criteria.
R. Pyeritz, D.M. Milewicz, P. Byers, H.C. Dietz: Define
MFS/CCA overlap syndromes.
All participants: Clinical subtypes or continuum?
B. Diagnostic Issues-Laboratory
M. Godfrey, University of Nebraska Medical Center, Omaha,
N.C. Dietz: Immunofluorescence with FBN1 antibodies.
D.M. Milewicz: .Cys pulse-chase studies.
All participants: MFAPS, LTBPS screening methods.
C. Boileau, N.C. Dietz, R. Pyeritz: FBN1.
D.M. Milewicz: FBN2.
M. Godfrey: LTBP2.
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C. Database Issues
R Byers, R. Pyeritz: NMF-supported clinical database.
C. Boileau, INSERM-Clinique Maurice Lamy, Paris, France:
Marfan database.
N.C. Dietz: Consortium database.
D. Discussion of Research Priorities and Possible
Collaborations
SESSION 4: Summaries and General Discussion
Chairperson: P. Byers, University of Washington School of
Medicine, Seattle
R.E. Pyeritz, Allegheny University of the Health Sciences,
Pittsburgh, Pennsylvania
F. Ramirez, Mount Sinai School of Medicine, New York
General Discussion
Moderator: P. Byers, University of Washington School of
Medicine, Seattle
Coffee break
Muscle Gene Regulation and Its Therapeutic Potential
April 26-29
FUNDED BY Oxnard Foundation
ARRANGED BY K.E. Davies, University of Oxford
S.D. Hauschka, University of Washington
D. Helfman, Cold Spring Harbor Laboratory
P.W.J. Rigby, MRC National Institute for Medical Research
SESSION 1: Muscle Transcription
Chairperson: P.W.J. Rigby, MRC National Institute for Medical Research,
London, United Kingdom
K.E. Davies, University of Oxford, United Kingdom:
Introduction to Utrophin Project.
J.D. Haley, OSI Pharmaceuticals, Inc. Uniondale, New York:
Searching for small molecules to regulate gene expres-
sion.
W. Herr, Cold Spring Harbor Laboratory: Introduction to
SESSION 2: Muscle Gene Regulation I
Chairperson: K.E. Davies, University of Oxford, United Kingdom
M. Buckingham, Institut Pasteur, Paris, France: Myf -5.
P.W.J. Rigby, MRC National Institute for Medical Research,
London, United Kingdom: Regulation of Myf -5.
H.H. Arnold, University of Braunschweig, Germany: Control of
the Myr-5 gene.
S.F. Konieczny, Purdue University, West Lafayette, Indiana:
general transcription factors.
0. Pourquie, Developmental Biology Institute of Marseilles,
France: Evidence for a molecular clock linked to somitogen-
esis.
C.P. Emerson, University of Pennsylvania School of Medicine,
Philadelphia: Developmental regulation of MyoD.
Positive and negative regulators of myogenesis.
L. Kedes, University of Southern California, Los
Angeles: and acetylation control of
MyoD activity.
M. Buckingham, Institut Pasteur, Paris, France: Attaining in
vivo levels of muscle gene transcription.
blIP..."--.71111111r"".".7
J. Rafael, K. Davies
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SESSION 3: Muscle Gene Regulation II
Chairperson: S.D. Hauschka, University of Washington, Seattle
S.J. Tapscott, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Expression of genes in native chro-
matin in skeletal muscle cells.
C.P. Ordahl, University of California, San Francisco:
Transcriptional repression and activation via MCAT ele-
ments.
P. Maim, INSERM, Paris, France: Characterization of MEF3
proteins and their role in controlling muscle gene expression.
SESSION 4: Muscle Gene Regulation III
Chairperson: D. Helfman, Cold Spring Harbor Laboratory
S.D. Hauschka, University of Washington, Seattle: Are there
new muscle gene control elements and transcription factors
still to be discovered?
R.J. Schwartz, Baylor College of Medicine, Houston, Texas:
Regulation of muscle gene activity.
M. Antoniou, UMDS, Guy's Hospital, London, United
Kingdom: The value of locus control regions in integrating
and nonintegrating gene therapy vectors.
N. Rosenthal, Massachusetts General Hospital-East,
Charlestown: The molecular basis of muscle cell diversity.
M.A. Rudnicki, McMaster University, Ontario, Canada:
Regulations of myogenic determination and differentia-
tion.
J. Robbins, Children's Hospital Research Foundation,
Cincinnati, Ohio: Control of muscle protein levels during
transgenic overexpression.
L. Schaeffer, Pasteur Institute, Paris, France: Implication of a
multisubunit Ets-related transcription factor in synaptic
expression of the nicotinic acetylcholine receptor.
S. Burden, Skirball Institute, New York University Medical
Center: Neuregulin-activated gene expression.
A. Buonanno, National Institute of Child Health and Human
Development, Bethesda, Maryland: Activity-dependent and
fiber-type-specific regulation of muscle genes.
SESSION 5: Implications for Therapies
Chairperson: T.A. Partridge, Imperial College School of Medicine, London,
United Kingdom
B. Jasmin, University of Ottawa, Ontario, Canada: Regulation
of utrophin gene expression in skeletal muscle cells.
J.M. Tinsley, University of Oxford, United Kingdom: Multifunc-
tional analysis of utrophin transgenes in mouse models.
J.M. Leiden, The University of Chicago, Illinois: Gene transfer
into skeletal and cardiac muscle in vivo.
G. Cossu, University of Rome La Sapienza, Italy: Nonsomitic
myogenic progenitors.
J.S. Chamberlain, University of Michigan Medical School, Ann
Arbor: Development of muscle-specific adenoviral vectors.
Roundup/General Discussion
Moderator: T.A. Partridge, Imperial College School of
Medicine, London, United Kingdom
Cocktails at Robinson House
Laboratory Methods for the Diagnosis of Lyme Disease
August 30-September 2
FUNDED BY National Institute of Allergy and Infectious Diseases, NIH,
Centers for Disease Control and Prevention, and ORD, with
additional support from Immunetics and SmithKline
Beecham Pharmaceuticals
ARRANGED BY P. Baker, National Institute of Allergy and Infectious Diseases, NIH
SESSION 1: ELISA and Western Blot Assays
Chairperson: B.J. Luft, State University of New York, Stony
Brook
A.C. Steam, New England Medical Center, Boston,
Massachusetts: Prospective evaluation of two-tiered testing
in early Lyme disease.
M. Aguero-Rosenfeld, Westchester County Medical Center,
Valhalla, New York: Critique of recommended two-tiered
testing.
M.E. Schriefer, Centers for Disease Control and Prevention,
Ft. Collins, Colorado: Can two-tiered testing do any better?
J. Glass, Brook Biotechnologies, Inc., Stony Brook, New
York: Use of recombinant antigens in diagnosis.
A. de Silva, Yale University School of Medicine, New Haven,
Connecticut: Differential Borrelia burgdorferi gene expres-
sion: Applications in serodiagnosis.
B.J.B. Johnson, Centers for Disease Control and Prevention,
Fort Collins, Colorado: Evaluation of recombinant antigens.
A.E. Levin, Immunetics, Inc., Cambridge, Massachusetts:
Neural network interpretation of Lyme Western blots:
Human versus Deep Green.
F.C. Cabello, Viro Dynamics, New York: Potential use of
BmpC, a Borrelia burgdorferi protein of the 39 kD family, as
a reagent in diagnosis of Lyme disease.
SESSION 2: Nucleic-acid-based Approaches and
Applications I
Chairperson: J.L. Goodman, University of Minnesota,
Minneapolis
J.L. Goodman, University of Minnesota, Minneapolis: PCR in
Borrelia burgdorferi infection: Principles, practice, and criti-
cal review.
G.P. Wormser, Westchester County Medical Center, Valhalla,
New York: PCR and the culturing of Borrelia burgdorferi.
SESSION 3: Nucleic-acid-based Approaches and
Applications II
Chairperson: J.L. Goodman, University of Minnesota,
Minneapolis
I. Schwartz, New York Medical College, Valhalla, New York:
Mining the Borrelia burgdorferi genome sequence for
improved diagnostic targets.
A.C. Steere, New England Medical Center, Boston,
Massachusetts: New strategies for improved diagnosis.
SESSION 4: Other Approaches for Diagnosis
Co-Chairpersons: A.G. Barbour, University of California,
Irvine and A.G. Steere, New England Medical Center,
Boston, Massachusetts
E.A. Davidson, Georgetown University School of Medicine,
Washington, D.C.: Rapid detection and early diagnosis.
M.S. Klempner, Tufts-New England Medical Center, Boston,
Massachusetts: Matrix metalloproteinases in the cere-
brospinal fluid of patients with Lyme disease.
P.K. Coyle, State University of New York, Stony Brook:
Antigen-capture and immune.
S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark:
Immune complex analysis for the diagnosis of early and
active Lyme disease.
A.G. Barbour, University of California, Irvine: Bacteriocidal
assays.
S. Lesley, Promega Corporation, Madison, Wisconsin: Use of
phage display to isolate biotinylated detection reagents.
SESSION 5: Evaluating the Influence of Coinfection and
Other Factors
Co-Chairpersons: G.P. Wormser, Westchester County
Medical Center, Valhalla, New York and A. Weinstein,
George Washington University Medical Center, Washington,
D.C.
G.P. Wormser, Westchester County Medical Center, Valhalla,
New York: Addressing coinfection.
J.W. IJdo, Yale University School of Medicine, New Haven,
Connecticut: Serologic diagnosis of human granulocytic
ehrlichiosis.
D.T. Dennis, Centers for Disease Control and Prevention, Ft.
Collins, Colorado: Evaluating testing in primary care prac-
tice.
R.R. Porwancher, Infectious Disease Consultants, P.C.,
Trenton, New Jersey: A probabilistic approach to the diag-
nosis of Lyme disease.
SESSION 6: Overview and Panel Discussion
Chairperson: D.J. Gubler, Centers for Disease Control and
Prevention, Ft. Collins, Colorado
Panel Members: J.L. Goodman, G.P. Wormser,
Barbour, B.J. Luft, A.C. Steere
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Image Archive on the American Eugenics Movement
Editorial Advisory Panel Workshop
September 20-22
FUNDED BY National Human Genome Research Institute, NIH
ARRANGED BY D. Mick los, DNA Learning Center, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Introduction and Overview
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory, and J.A. Witkowski, Banbury Center, Cold Spring
Harbor Laboratory: Introduction-Description of the project
and summary of what has been done, review of the functions
of the EAP as defined in the grant application, and review of
important issues as identified by the NIH Review Panels.
SESSION 2: Round Table Discussion
An opportunity for each participant to raise other issues
based on their professional and personal perspectives and
making a list of key points to be kept in mind during the
meeting.
SESSION 3: "Focus" Talks
M.L. Levitt, The American Philosophical Society, Philadelphia,
Pennsylvania: The American Philosophical Society and the
Project.
E.J.Thompson, National Human Genome Research Institute,
Bethesda, Maryland: Privacy and confidentiality-A view
from NHGRI.
R Reilly, Shriver Center for Mental Retardation, Waltham,
Massachusetts: Privacy and confidentiality-A geneticist's
view.
H. Friedlander, Brooklyn College/City University of New York,
Brooklyn: A historian's view.
SESSION 4: Review Selected Images
Examine selected images in the light of the morning's discus-
sions, with particular reference to: themes, keywords, priva-
cy, context.
Tour of Laboratory and DNA Learning Center; Review Macy
Foundation DNA from the Beginning Project
SESSION 5: Review Images
Examine as many examples as possible, with particular refer-
ence to interest, coverage of themes, technical quality.
SESSION 6: Summary
An opportunity for critical review of the meeting, suggestions for
the next stage of the project, date and goals of next meeting.
Gathering outside the Banbury Conference Center.
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Y Chromosome in Disease and Evolution
October 13-16
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY H. Cooke, University of Edinburgh
SESSION 1
J.A. Marshall Graves, La Trobe University, Melbourne,
Australia: Evolution of the mammalian Y chromosome, sper-
matogenesis and sex determining genes.
D.S. Guttman, University of Chicago, Illinois: An X-linked gene
with a degenerate Y-linked homolog in the dioecious plant
Silene latifolic.
SESSION 2
P.S. Burgoyne, National Institute for Medical Research,
London, United Kingdom: The multiple-copy Y-gene families
Rbm and Ssty in the mouse.
Y.-F.C. Lau, University of California, San Francisco: Expres-
sion of Y chromosome genes in human prostate cancers.
W.R. Rice, University of California, Santa Cruz: Evolutionary
SESSION 3
G.A. Rappold, Institute of Human Genetics, Heidelberg,
Germany: SHOX-A pseudoautosomal gene involved in
growth and development.
W. Schempp, Universitat Freiburg, Germany: Fiber-FISH map-
ping of DAZ, RBM, and CDY gene family members within
deletion interval 6 of the human Y chromosome.
M. Mitchell, INSERM, Marseilles, France: The organization of
genes on the mouse Y chromosome.
J. Schmidtke, Institute of Human Genetics, Hannover,
Germany: Evolution of TSPY and related genes.
S.C. Maxson, University of Connecticut, Storrs: The mouse Y
chromosome and behavior.
decay of the Y sex chromosome.
B. Charlesworth, University of Edinburgh, United Kingdom:
The population genetics of Y chromosome evolution.
D.C. Page, HHMI, Whitehead Institute for Medical Research,
Cambridge, Massachusetts: The fall and rise of the human
Y chromosome.
W.-H. Li, University of Texas, Houston: Male-driven evolution
of DNA sequences in mammals.
H. Cooke, University of Edinburgh, United Kingdom: Lack of
detectable differences in function between DAZ and Dazl.
M.F. Hammer, University of Arizona, Tucson: Evolutionary his-
tory of the human Y chromosome.
P. Burgoyne, S. Maxson, E. Simpson
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SESSION 4
M.A. Job ling, University of Leicester, United Kingdom:
Identification and dating of Y chromosomal lineages, and
the influence of selection on Y haplotypes.
E.E. Eichler, Case Western Reserve University, Cleveland,
Ohio: Pericentromeric gene duplications and the complex
architecture of the human genome.
B.D. McKee, University of Tennessee, Knoxville: Role
of gene conversion in maintenance of sequence
homogeneity in Su (Ste) and rDNA clusters of D. mel-
SESSION 5
E.M. Simpson, The Jackson Laboratory, Bar Harbor, Maine:
Toward a physical map of the mouse Y chromosome:
Enrichment, sizing, and cloning by bivariate flow cytome-
try.
D. Vollrath, Stanford University, California: DNA sequence
diversity of the human Y chromosome.
S.R. Haynes, National Institute of Child Health and Human
Development, NIH, Bethesda, Maryland: Rb97D, a
Drosophila RNA-binding protein that associates with a
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anogaster X and Y chromosomes.
S. Henikoff, HHMI, Fred Hutchinson Cancer Research
Center, Seattle, Washington: Evolution and utility of satel-
lite repeats.
P.A. Underhill, Stanford University, California: Y chromosome
SNP halotype diversity.
C.E. Bishop, Baylor College of Medicine, Houston, Texas:
Sequencing the mouse Y chromosome.
specific region of the Y chromosome in spermatocytes.
M. Steinemann, Henrich Heine Universitat Dusseldorf,
Germany: Drosophila miranda: A model system for Y
chromosome evolution and differential gene activity.
P.H. Yen, University of California, Los Angeles, Torrance:
Deletion interval 6 of the human Y chromosome:
Spermatogenesis genes and large repeats.
J.A. Marshall Graves, La Trobe University, Melbourne,
Australia: Meeting overview.
Participants outdoors discussing the meeting during a break.
The Molecular Physiology of Weight Regulation and Obesity
October 18-21
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY R. Cone, Oregon Health Sciences University
J.S. Flier, Beth Israel Deaconess Medical Center
Goals of the Conference:
J.S. Flier, Beth Israel Deaconess Medical Center, Boston, Massachusetts
SESSION 1: Leptin
Chairperson: R. Cone, Oregon Health Sciences University,
Portland
J.M. Friedman, HHMI, The Rockefeller University, New York:
Leptin and the neural circuits regulating weight.
J.S. Flier, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Leptin and the regulation of neuroendocrine
function.
R.A. Steiner, University of Washington, Seattle: Leptin as a
neuroendocrine signal to the reproductive system.
J.L. Cameron, Oregon Regional Primate Research Center,
Beaverton: Neural control of food intake in nonhuman pri-
mates: Comparison with rodent species.
M.W. Schwartz, Puget Sound VA Health Care System,
Seattle, Washington: Leptin, hypothalamic neuropeptides,
and energy homeostasis.
SESSION 2: Central Regulation of Energy Balance I
Chairperson: M.W. Schwartz, Puget Sound VA Health Care System, Seattle,
Washington
J.K. Elmquist, Beth Israel Deaconess Medical Center,
Boston, Massachusetts: Linking mediobasal and lateral
hypothalamic feeding centers in the rodent and human
brain.
R. Palmiter, HHMI, University of Washington, Seattle: Role of
NPY and dopamine in regulation of feeding behavior.
G. Barsh, Stanford University School of Medicine,
California: Genetics and biochemistry of endogenous
M. Yanagiswa
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melanocortin receptor antagonists.
K.L. Stark, Amgen, Inc., Thousand Oaks, California: AGRP
and the control of feeding.
SESSION 3: Central Regulation of Energy Balance II
Chairperson: L. Van der Ploeg, Merck Research Laboratories,
Jersey
R. Cone, Oregon Health Sciences University, Portland:
Melanocortins and energy balance.
K. Gudmundsson, Children's Hospital, Boston, Massachu-
setts: CRH-leptin interactions.
P.J. Larsen, Novo-Nordisk, Maalov, Denmark: Hypothalamic
CART: A new anorectic peptide regulated by leptin.
B.E. Levin, VA Medical Center, East Orange, New Jersey:
Neuropeptides and the defense of body weight set-point in
diet-induced obesity.
Rahway, New
SESSION 4: GLP-1/Energy Expenditure
Chairperson: J.M. Friedman, HHMI, The Rockefeller University,
S. Bloom, Hammersmith Hospital, London, United Kingdom:
GLP-1 and body weight regulation.
D. Drucker, The Toronto Hospital, Canada: Essential neuroen-
docrine role of GLP-1 in vivo.
M.L. Reitman, National Institutes of Health, Bethesda,
Maryland: Role of adipose tissue in metabolic regulation:
SESSION 5: Genetics of Obesity
Chairperson: J.S. Flier, Beth Israel Deaconess Medical Center,
Massachusetts
J. Naggert, The Jackson Laboratory, Bar Harbor, Maine: Fat
and tub.
R.L. Leibel, Columbia University, New York: Molecular physiol-
ogy of human obesity.
C. Bouchard, Laval University, Ste-Foy, Quebec, Canada:
Genetics of human obesity.
A.G. Comuzzie, Southwest Foundation for Biomedical
E. Maratos-Flier, Jos lin Diabetes Center, Harvard Medical
School, Boston, Massachusetts: Melanin concentrating hor-
mone.
M. Yanagisawa, HHMI, University of Texas Southwestern
Medical Center, Dallas: Orexins: Novel lateral hypothalamic
neuropeptides that regulate feeding behavior.
New York
Lessons from a no-fat mouse.
B. Spiegelman, Dana-Farber Cancer Institute, Boston,
Massachusetts: PGC1: A transcriptional regulator of energy
dissipation.
G.S. McKnight, University of Washington, Seattle: Role of
PKA IIB isoform in weight regulation.
Boston,
Research, San Antonio, Texas: Genome scanning for obesi-
ty genes in humans.
S. O'Rahilly, Addenbrooke's Hospital, Cambridge,
United Kingdom: Genetics of early-onset obesity in
humans.
A. Gruters- Kieslich, Humboldt University, Berlin, Germany:
POMC defects in human obesity.
J.P. Morgan & Co. Incorporated/Cold Spring Harbor Laboratory
Executive Conference on Imaging: From Molecules to Brains
October 23-25
ARRANGED BY J.D. Watson, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1
J.D. Watson, Cold Spring Harbor Laboratory: Welcoming
remarks.
C. Bustamante, University of California, Berkeley: Seeing mol-
ecules-The scanning force microscope in biology.
SESSION 2
P. Sigler, HHMI, Yale University, New Haven,
Connecticut: Proofreading and editing protein fold-
ing-Imaging the final step in gene expression.
R. Tsien, HHMI, University of California, San Diego: Fluorescent
sensors of intracellular signal transduction-Applications to
pharmaceutical screening.
M. Ellisman, National Center for Microscopy and Imaging
Research, University of California, San Diego: Cellular and
subcellular components of nervous systems-3-D
microscopy.
SESSION 3
B. Stillman, Cold Spring Harbor Laboratory: Introduction-
Imaging at Cold Spring Harbor Laboratory
K. Svoboda, Cold Spring Harbor Laboratory: Two-photon
Imaging.
D. Spector, Cold Spring Harbor Laboratory: Imaging RNA
processing in cells.
SESSION 4
B. Rosen, MGHG-NMR Center, Harvard Medical School,
Cambridge, Massachusetts: Functional imaging of the
working brain.
J. Gabrieli, Stanford University, California: Imaging memory in
the brain.
J.D. Watson, Cold Spring Harbor Laboratory: Closing
remarks.
H. Solomon, C. Bustamante
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The Art of Judging: Perspectives of Science
October 27-30
FUNDED BY
ARRANGED BY
SESSION 1
The Federal Judicial Center, Judiciary Leadership Development
Council, and Cold Spring Harbor Laboratory
J.G. Apple, Federal Judicial Center, Washington, D.C.
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D. Mick los, DNA Learning Center, Cold Spring Harbor
Laboratory: Cold Spring Harbor Laboratory and its place in
science.
SESSION 2
J. Maienschein, Arizona State University, Tempe: From Darwin
to Dolly: Developments in the biological sciences in the 20th
century.
L. Silver, Princeton University, New Jersey: Cloning: The bio-
logical and social implications of new science.
SESSION 3
D. Wilkinson, Princeton University,
inhospitable universe.
S. Feinberg, Carnegie Mellon University, Pittsburgh,
Pennsylvania: Statistics and probabilities in science.
SESSION 4
D. Wilkinson, Princeton University, New Jersey: New con-
cepts of the universe.
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SESSION 5
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: A look at the past.
J.A. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory: DNA and the Human Genome Project.
Visit to DNA Learning Center and Cold Spring Harbor
Laboratory
Tour Leader: J. Kruper, DNA Learning Center, Cold Spring
Harbor Laboratory
SESSION 6
P. Reilly, Shriver Center for Mental Retardation, Waltham,
Massachusetts: Social implications of genetic research.
SESSION 7
R. Shapiro, New York University, New York: Origins of life.
M. Gallo, Robert Wood Johnson Medical School, Piscataway,
New Jersey: Toxicology, the environment, and risk assess-
ment.
SESSION 8
J. Horgan, Scientific American, Washington, D.C.: Science in
the 21st century.
Overhead slide projection presentation.
Integrating Cellular Stress Responses
November 1-4
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY M.-J.H. Gething, University of Melbourne
R.I. Morimoto, Northwestern University
SESSION 1
Chairperson: N.C. Jones, Imperial Cancer Research Fund, Lon
R.I. Morimoto, Northwestern University, Evanston, Illinois:
Introduction
J.A. King, Massachusetts Institute of Technology, Cambridge:
How protein folding fails at higher temperatures.
T Baker, Massachusetts Institute of Technology, Cambridge:
Specificity determinants in the Clp/Hsp100 protein family.
R.I. Morimoto, Northwestern University, Evanston, Illinois:
SESSION 2
Chairperson: J.A. King, Massachusetts Institute of Technology,
S. Hultgren, Washington University, St. Louis, Missouri: Link
between pilus biogenesis, pathogenesis, and host respons-
es.
M.-J.H. Gething, University of Melbourne, Victoria, Australia:
Unfolded protein and inositol starvation responses:
don, United Kingdom
Protein homeostasis and the heat shock response.
J. Bardwell, University of Michigan, Ann Arbor: Heat shock
proteins, beyond the chaperone paradigm.
P. Spellman, Stanford University School of Medicine,
California: Examination of stress responses in yeast using
DNA microarrays.
Cambridge
Modulation by the cell integrity MAPK pathway.
N.C. Jones, Imperial Cancer Research Fund, London, United
Kingdom: Gene regulation by stress-activated map kinases.
D. Ron, The Skirball Institute of Biomolecular Medicine, New
York: CHOP and the ER stress response.
SESSION 3
Chairperson: D.R. Green, La Jolla Institute for Allergy and Immunology,
California
U. Jakob, University of Michigan, Ann Arbor: Hsp33-A
Redox-regulated molecular chaperone.
G.L. Semenza, Johns Hopkins Hospital, Baltimore, Maryland:
Regulation of oxygen homeostasis by hypoxia-inducible fac-
tor 1.
C. Prives, Columbia University, New York: Signaling to the
p53 tumor suppressor protein.
SESSION 4
Chairperson: C. Prives, Columbia University, New York
D. Ingber, Children's Hospital Medical Center, Boston,
Massachusetts: Cellular signal integrations.
D.L. Levens, National Cancer Institute, Bethesda, Maryland:
How does DNA sense stress?
D.R. Green, La Jolla Institute for Allergy and Immunology,
T.V. O'Halloran, Northwestern University, Evanston, Illinois:
Managing heavy metal stress: Copper and zinc trafficking
pathways.
W. Schaffner, Universitat Zurich, Switzerland: MTF-1, a mam-
malian zinc finger transcription factor, is required for correct
response to heavy metal and oxidative stress.
California: The apoptotic response to stress.
G.I. Evan, Imperial Cancer Research Fund, London, United
Kingdom: Cytokines and oncogenes: Decisions for growth
control.
SESSION 5
Chairperson: T. Baker, Massachusetts Institute of Technology, Cambridge
M.E. Feder, University of Chicago, Illinois: Organismal and
evolutionary limits to inducible responses.
S.L. Rutherford, HHMI, University of Chicago, Illinois: Hsp90
as a capacitor of evolution.
M.-J.H. Gething, University of Melbourne, Victoria, Australia:
Closing comments and summary.
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Large-scale Discovery and Genetic Applications of SNPs
November 10-13
FUNDED BY Glaxo Wellcome Inc. and the National Human Genome
ARRANGED BY A. Chakravarti, Case Western Reserve University
E. Lander, Whitehead Institute for Biomedical Research
SESSION 1: Genomic Variation
Chairperson: A. Chakravarti, Case Western Reserve University,
A. Chakravarti, Case Western Reserve University, Cleveland,
Ohio: Introduction.
C.H. Langley, University of California, Davis: Lessons from
SNP association studies in Drosophila.
M.E. Kreitman, University of Chicago, Illinois: Toward a DNA
polymorphism database.
C.F. Aquadro, Cornell University, Ithaca, New York: DNA
Research Institute, NIH
Cleveland, Ohio
diversity and rates of recombination across the human
genome.
R. Harding, John Radcliffe Hospital, Oxford, United Kingdom:
Patterns of nucleotide diversity, recombination, and linkage
disequilibrium in the beta-globin gene.
A.G. Clark, Pennsylvania State University, University Park: Fine-
scale structure of linkage disequilibrium in LPL, ACE, and ApoE.
SESSION 2: Genome-wide Mapping and Association Studies
Chairperson: E.S. Lander, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts
D. Cohen, Genset SA, Paris, France and Nicholas Schork,
Case Western Reserve University, Cleveland, Ohio.
L. Kruglyak, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Prospects for the use of SNPs in
whole-genome linkage disequilibrium mapping.
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A. Chakravarti, Case Western Reserve University, Cleveland,
Ohio: Quantitating genome sharing using SNPs.
A.J. Brookes, University of Uppsala, Sweden: Association
study design based on SNPs: Optimizing chances of suc-
cess.
D. Cox, A. Roses, J. Witkowski
SESSION 3: Current Status of SNP Discovery
Chairperson: D. Nickerson, University of Washington, Seattle
D.G. Wang, Bristol-Myers Squibb, Princeton, New Jersey:
Large-scale identification, mapping, and genotyping of sin-
gle-nucleotide polymorphisms.
P.-Y. Kwok, Washington University School of Medicine, St.
Louis, Missouri: Strategies for SNP discovery and testing.
E. Lai, Glaxo Wellcome Inc., Research Triangle Park, North
SESSION 4: Future Technologies for SNP Discovery
Chairperson: D.R. Cox, Stanford University School of Medicine,
L Fors, Third Wave Technologies, Inc., Madison, Wisconsin:
Scalable, high-throughput technology for SNP analysis
directly from genomic DNA.
U. Landegren, University of Uppsala, Sweden: Strategies for
high-throughput SNP analysis.
L.M. Smith, University of Wisconsin, Madison: Mass spectro-
metric analysis of genetic variations.
SESSION 5: Intellectual Property Issues
Chairperson: A.R. Williamson, London, United Kingdom
A.R. Williamson, London, United Kingdom: Introduction.
M. Freire, National Institutes of Health, Rockville, Maryland:
NIH perspective on ESTs and SNPs intellectual property.
D.R. Cox, Stanford University School of Medicine, California:
A high-resolution SNP map of the Human Genome.
R. Eisenberg, University of Michigan Law School, Ann Arbor:
Competition between public and private research funding
for SNP discovery.
SESSION 6: General Discussion and Summing Up
Chairpersons: A. Chakravarti, Case Western Reserve
University, Cleveland, Ohio and E.S. Lander, Whitehead
Institute for Biomedical Research, Cambridge,
Massachusetts
Carolina: Large-scale SNP identification.
J. Hacia, National Human Genome Research Institute, NIH,
Bethesda, Maryland: Evolutionary sequence analysis of
human SNP sites.
P.J. Oefner, Stanford University, California: Geographic distrib-
ution and frequency of SNPs.
California
M.P. Weiner, Glaxo Wellcome, Inc., Research Triangle
Park, North Carolina: SNP analysis using mobile solid
support.
R. Lipshutz, Affymetrix, Santa Clara, California: Chips and
SNPs.
C. Tynan, PE-Applied Biosystems, Foster City, California:
High-density Taq Man arrays and "Zip Chips."
Coffee break
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Genes, Teens, and the World Wide Web
November 22-24
FUNDED BY The Josiah Macy, Jr. Foundation
ARRANGED BY J. Kruper, DNA Learning Center, Cold Spring Harbor Laboratory
D. Mick los, DNA Lea-ning Center, Cold Spring Harbor Laboratory
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Opening Remarks and Keynote Address I
J.D. Watson, Cold Spring Harbor Laboratory: Thirty years of
biology publishing.
A. Kay, Walt Disney Imagineering, Glendale, California:
Helping children learn.
SESSION 2: The Web in Biology Education and Publishing
N. Campbell, University of California, Riverside: The biology
place: Using the Web to build investigative learning commu-
nities.
L.J. Chaput, Cogito Learning Media, Inc., San Francisco,
California: Making cutting edge science accessible
to students.
SESSION 3: Keynote Address II
B.M. Alberts, National Academy of Sciences, Washington,
D.C.: Why it's important to communicate biology.
V.L. Ward, Genentech Access Excellence, South San
Francisco, California: Preparing teachers for genomic
biology.
R.J. Semper, The Exploratorium, San Francisco, California:
Live@the Exploratorium: Communicating scientific discovery
through webcasting.
SESSION 4: How Do We and How Should We Use the Web to Learn?
C. Marshall, Xerox Palo Alto Research Center, California: A
reader's-eye view of the Web: Hypertext, annotation, collab-
oration, and the real world.
T.M. Kahn, Design Worlds for Learning, Inc., San Jose,
California: Building virtual learning communities.
SESSION 5: Emerging Technologies and Opportunities
J. McEntyre, National Center for Biotechnology Information,
NIH, Bethesda, Maryland: The Human Genome Project and
opportunities to integrate research into education.
J. Kruper, DNA Learning Center, Cold Spring Harbor
Laboratory: DNA from the beginning.
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P. Greenspun, Massachusetts Institute of Technology,
Cambridge: Building scalable online communities.
B. Berenfeld, The Concord Consortium, Massachusetts:
Authentic science for kids: The global laboratory curricu-
lum.
K. Jones, Magnet Interactive Studios, Washington, D.C.:
PBS online: Bringing educational programming to the digi-
tal age.
T Hass, Applications Development for Internet2, Ann Arbor,
Michigan: High bandwidth and opportunities for learning.
The Genome and Experimental Biology
December 1-4
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY P.O. Brown, Stanford University
G.M. Rubin, University of California
SESSION 1: How Has the Genome Sequence Changed the Way We
Look At Yeast?
G.N. Giaever, Stanford University School of Medicine, R.A. Young, Whitehead Institute for Biomedical Research,
California: Drug-induced haploinsufficiency, drug target Cambridge, Massachusetts: Dissecting the regulatory cir-
identification. cuitry of the yeast genome.
P. Spellman, Stanford University Medical Center, California: M. Martin, Rosetta Inpharmatics, Kirkland, Washington:
Identification of cell-cycle-regulated genes in yeast. Genomics and drug discovery.
SESSION 2: Comprehensive Genetic Surveys and Screens-Methods and
Models
G.M. Rubin, University of California, Berkeley: Using genetics
to analyze gene function in Drosophila.
E.H. Ruley, Vanderbilt Medical Center, Nashville, Tennessee:
Genetic analysis of cultured cells and mice by tagged
sequence mutagenesis.
B.J. Wold, California Institute of Technology, Pasadena:
Challenges for functional genomics in the mouse: Single cell
expression states and dispersed cis-regulatory elements.
L.I. Zon, HHMI, Children's Hospital, Boston, Massachusetts:
Zebrafish genetics and human disease.
SESSION 3: Dealing with a Flood of Data: Understanding, Integrating, Publishing
M.B. Eisen, Stanford University School of Medicine,
California: Exploring gene expression space.
D.J. Lipman, National Library of Medicine, Bethesda,
Maryland: Computing discoveries in biology.
P.H. Ginsparg, Los Alamos National Laboratory, New Mexico:
Knowledge network for physics?
M. Ashburner, European Bioinformatics Institute, Cambridge,
United Kingdom: Integrating information across organ-
isms-On the representation of information concerning
gene functions in databases.
P. Brown, L. Zon, J.D. Watson
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SESSION 4: Experimental Approaches with a "Genomic" Style
0. Kallioniemi, National Human Genome Research Institute,
NIH, Bethesda, Maryland: Tissue microarrays for high-
throughput molecular profiling.
M. Wig ler, Cold Spring Harbor Laboratory: Representational
approaches to genomic analysis.
J.S. Minden, Carnegie Mellon University, Pittsburgh,
Pennsylvania: Difference gel electrophoresis: A rapid
method for identifying proteosome changes.
T.S. Heuer, Massachusetts General Hospital, Boston: Functional
screening of cDNA libraries with mRNA-protein fusions.
SESSION 5: Experimental Genomic Approaches to Understanding, Diagnosing,
and Treating Human Disease
D. Gerhold, Merck & Company, West Point, Pennsylvania: A
drug metabolism and safety gene-chip database; on silica
to in silica.
L. Staudt, National Cancer Institute, NIH, Bethesda,
Maryland: Genomic-scale views of gene expression in
normal and malignant lymphocytes using the
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Lumphochip cDNA microarray.
L.T. Williams, Chiron Corporation, Emeryville, California: A
high throughput gene expression study in cancer.
P.O. Brown, HHMI, Stanford University Medical School,
California: The DNA microarray as a vehicle for genome
exploration.
Making a presentation.
Biochemistry at 100°C: How Are Enzymes and Their Substrates
Stabilized?
December 6-9
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY M.W. Adams, University of Georgia
R.M. Kelly, North Carolina State University
Welcoming Remarks:
J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Goals of the Conference:
M.W. Adams, University of Georgia, Athens
Robert M. Kelly, North Carolina State University, Raleigh
SESSION 1: Origins, Environments and Organisms
Chairpersons: D.S. Clark, University of California, Berkeley and
University of Maryland, Baltimore
S.L. Miller, University of California, La Jolla: A cold origin for
life: Pros and cons.
J. Wiegel, University of Georgia, Athens: Thermal ranges of
microbial growth.
M.W. Adams, University of Georgia, Athens:
SESSION 2: Biochemistry
Chairperson: R. Jaenicke, University of Regensburg, Germany
H. Santos, Universidade Nova de Lisboa, Oeiras, Portugal:
Organic solutes from hyperthermophiles: Stabilizing effects
on enzymes.
J. Trent, NASA Ames Research Center, Moffett Field,
California: Role of heat-shock proteins in vivo-Do hyper-
thermophilic enzymes need chaperones?
F.B. Per ler, New England BioLabs, Inc., Beverly,
F.T. Robb,
Hyperthermophilic metabolisms and pathways: Unusual or
standard?
R.W. Kelly, North Carolina State University, Raleigh:
Carbohydrate utilization by hyperthermophiles: What do the
genome sequences tell us?
Massachusetts: Protein splicing in hyperthemophiles.
G. Antranikian, Technical University, Hamburg, Germany:
Hydrolytic enzymes from hyperthermophiles.
M.J. Danson, University of Bath, United Kingdom: Staying
together-The importance of subunit interactions in enzyme
hyperstability.
R. Jaenicke, F. Per ler
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SESSION 3: Protein Structure
Chairpersons: M.J. Danson, University of Bath, United Kingdom and
A. Karp lus, Cornell University, Ithaca, New York
R. Jaenicke, University of Regensburg, Germany: Stability
and folding of hyperthermophilic proteins.
F.T. Robb, University of Maryland, Baltimore: Rational
placement of mutations that enhance protein thermosta-
bility.
T. Oshima, Tokyo University of Pharmacy and Life Science,
Japan: Stabilization of mesophilic enzymes by a combination
SESSION 4: Biophysical Approaches
Chairpersons: J.N. Reeve, Ohio State University, Columbus
Universidade Nova de Lisboa, Oeiras, Portugal
M. Rossi, University of Naples, Italy: Studies on molecular
bases of the thermostability of the p-glycosidase from
Sulfolobus solfataricus.
W. Englander, University of Pennsylvania, Philadelphia:
Hydrogen exchange as a tool to assess protein stabili-
ty.
G.N. La Mar, University of California, Davis: Solution NMR
study of the novel molecular structure of the ferredoxin from
SESSION 5: Genetics/Protein-DNA Interactions/Genomics
of theoretical design and evolutionary molecular engineering.
J.G. Zeikus, Michigan State University, East Lansing:
Molecular determinants for activity and stability of xylose
isomerase, amylase, and alkaline phosphatase.
R. Sterner, University of Gottingen, Germany: How do (ba)8-
barrel enzymes protect themselves and their thermolabile
substrates at temperatures close to 100°C?
and H. Santos,
Chairperson: F.B. Per ler, New England Biolabs, Inc., Beverly
J.N. Reeve, Ohio State University, Columbus: Histone-fold
stabilization.
P. Lopez-Garcia, Universite Paris-Sud, Orsay, France: Control
of DNA superhelical changes during heat shock in hyper-
thermophilic Archaea.
K.M. Noll, University of Connecticut, Storrs: Recent develop-
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Pyrococcus furiosus.
D.S. Clark, University of California, Berkeley: Pressure stabi-
lization of proteins near 100°C: Implications for structure-
function relationships.
J.W. Shriver, Southern Illinois University School of Medicine,
Carbondale: Global analysis of the linkage of pH and salt
concentration to protein folding: Application to core packing
mutants of Sac 7d and Sso7d.
, Massachusetts
ments in genetic transfer methods in Thermotoga.
D.W. Grogan, University of Cincinnati, Ohio: Genetic process-
es in thermophilic Archaea.
H.-P. Klenk, University of Gottingen, Germany: Extreme
thermophilia: Ancient conserved feature or phylogenetic
pitfall?
Participants discussing presentation.
From Bench to Bedside: Colloquium on Translational
Vaccine Research
December 15-17
FUNDED BY The Albert B. Sabin Vaccine Institute, Inc. at
Georgetown University
ARRANGED BY H.B. Herscowitz, Georgetown University
P.K. Russell, Potomac, Maryland
Introductory Remarks:
H.R. Shepherd, The Albert B. Sabin Vaccine Institute, Inc. at
Georgetown University, Washington D.C.
P. Hotez, Yale University School of Medicine, New Haven,
Connecticut
P.K. Russell, Potomac, Maryland
SESSION 1: Historical Perspective
Chairperson: P. Hotez, Yale University School of Medicine,
New Haven, Connecticut
P. Hotez, Yale University School of Medicine, New Haven,
Connecticut: Welcoming remarks.
R. Rabinovich, National Institute of Allergy and Infectious
Diseases, NIH, Bethesda, Maryland: Setting the stage.
SESSION 2: Viral Vaccines
Chairperson: P. Hotez, Yale University School of Medicine,
New Haven, Connecticut
D.E. Griffin, Johns Hopkins School of Public Health,
Baltimore, Maryland: Issues in developing new measles
vaccines.
J.L. Gerin, Georgetown University Medical Center, Rockville,
Maryland: Vaccines for viral hepatitis.
A.R. Shaw, Merck Research Laboratories, West Point,
Pennsylvania: Development of a live oral vaccine for
rotavirus.
R.B. Belshe, St. Louis University School of Medicine,
Missouri: Efficacy of live attenuated influenza vaccine given
intranasally.
P. Hotez, J. Gerin, D. Sack
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SESSION 3: Arthropod-borne Infection Vaccines
Chairperson: P. Hotez, Yale University School of Medicine, New Haven,
Connecticut
W.R. Ballou, Walter Reed Army Institute of Research,
Washington, D.C.: Malaria vaccines: Translational obstacles.
A.C. Steere, New England Medical Center, Boston,
Massachusetts: Vaccination for Lyme disease with recombi-
nant Borre lia burgdorferi OspA with adjuvant.
S. Hoffman, Naval Institute of Medical Research, Bethesda,
Maryland: Translating genomic sequence data into vac-
SESSION 4: Bacterial Vaccines
M.M. Levine, University of Maryland School of Medicine,
Baltimore: Attenuated Salmonella typhi as live vector vac-
cines expressing foreign antigens.
SESSION 5: Cancer Vaccines and Immunomodulators
J. Schlom, National Cancer Institute, NIH, Bethesda,
Maryland: T-cell costimulation in vaccine design and devel-
opment.
R. Bucala, The Picower Institute for Medical Research,
Manhasset, New York: A novel circulating cell type with
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cines: Malaria as a model system.
N. Kanesa-Thasan, Walter Reed Army Institute of Research,
Washington, D.C.: Progress and problems in Dengue virus
vaccine development.
P. Hotez, Yale University School of Medicine, New Haven,
Connecticut: Approaches to vaccinating against Helminth
infections.
D.A. Sack, Johns Hopkins University, Baltimore, Maryland:
Formulation issues with cholera vaccine: Making efficacious
vaccines effective.
potent antigen presenting properties: basic and clinical
studies.
M.M. Levine, University of Maryland School of Medicine,
Baltimore, and P.K. Russell, Potomac, Maryland: Wrap up
and discussion.
Robertson House Library
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DNA LEARNING CENTER
David A. Mick los
Judy Cumella-Korabik
Janeen Russo
John A. Kruper
Susan Lauter
Shirley Chan
Matt Christensen
Gisella Walter
Mark Feingold
Scott Bronson
Patricia Harrison
Amanda Broege
Martha Mullally
Andrew Morotti
Laboratory President James Watson is fond of saying, "You get bigger or you get smaller." Behind this
deceptively simple adage lies the business plan for any good institution. Organizations rarely stay the
same size for very long. Those that respond to change and take advantage of new opportunities,
evolve into large ones. Those that fail to respond and adapt, shrink.
1998 was a year of remarkable change that put the DNALC solidly on the up side of that simple
equation. Income increased by 59%, from $878,400 in 1997 to $1,393,100 in 1998. In the past sev-
eral years, the DNALC has shown a deficit roughly equal to depreciation costs. However, the 1998
budget was balanced after full payment of depreciation. The greatest single source of growth in 1998
was funding from the Josiah Macy, Jr. Foundation. Other sources of strength were three major federal
grants, annual giving by the Corporate Advisory Board, and increased receipts for lab instruction.
The organization of our staff masthead is also emblematic of the year.
The DNALC staff grew from 9 to 14 positions in 1998. These were in addi-
tion to a similar number of personnel changes in the second half of 1997.
The large number of new staff members and new grant commitments dic-
tated a functional reorganization. In the past, staff functions were divided by
grade level into elementary-middle school instruction and high school-col-
lege instruction. Under the reorganization, the staff was divided into three
functional groups: Core Administration (three positions), Laboratory
Education (five positions), and Multimedia Communications (six positions).
One major effect of the reorganization was to move away from our reliance
on part-time instructors to a staff of full-time instructors. These changes
have simplified administration and increased collaboration among staff
members.
Despite an almost complete changeover in instructional staff since mid-
1997, our service to local school systems increased in 1998. Most notable
was a 34% increase in students performing labs at the DNALC. This
increase was mainly due to bringing the middle-school genetics lab into full use, with up to four class-
es per day. We had our busiest summer yet, administering 25 student workshops, including eight
minority workshops held at Stuyvesant High School and Mt. Sinai School of Medicine (Manhattan),
John E Kennedy High School (Bronx), Intermediate School 109 (Queens), and Central Islip High School
(Suffolk County). We also collaborated with Mt. Sinai School of Medicine to conduct two Gateway
Summer Teacher Institutes, drawing 100 faculty from 15 New York City high schools. With support from
Howard Hughes Medical Institute and the William Randolph Hearst Foundation, we have been making
a concerted effort to increase learning opportunities for students in New York City. Thanks primarily to
multi-year collaborations with Community School District 29 and Mt. Sinai's Gateway to Higher
Education Program, minorities comprised 35% of students participating in 1998 lab programs.
Scott Bronson assists a participant
at the new Genomic Biology &
PCR Workshop
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1997-1998
1994 1995 1996 1997 1998 Change
Student Labs (on-site) 3,961 4,682 6,088 7,105 9,540 34%
Student Labs (off-site) 1,434 2,328 5,045 7,665 8,195 7%
Teacher Labs 302 379 302 392 482 23%
Student Workshops 361 503 437 402 429 7%
Teacher Workshops 177 101 151 245 190 -22%
Lab Subtotal 6,235 7,993 12,023 15,809 18,836 19%
Student Lectures 575 520 575 407 568 40%
Exhibit/LI Discovery 9,943 10,366 10,122 11,150 12,062 8%
Total 16,753 18,879 22,720 27,366 31,466 15%
DNA from the Beginning Goes Online
By year's end, we had made a limited online release of the first installment of DNA from the Beginning,
an Internet primer on genetics funded by the Josiah Macy, Jr. Foundation. The initial release covers 14
key concepts in classical genetics, including Mendelian inheritance, the physical basis of heredity,
genetic linkage, and the beginning of human genetics. Additional releases in 1999 and 2000 will cover
concepts in molecular genetics, gene regulation, genetic manipulation, and genomic biology.
Initially, a confidential Internet address was provided for review by a select group of biology
researchers, scholars, and teachers. After incorporating reviewers' feedback, the World Wide Web
(VWWV) site was officially launched with registration on major search engines and a 4700-piece post-
card mailing that included 3000 high school teachers from our national database of leaders in genet-
ics education. We also added links to major genetics education programs, medical and genome
research centers, and genetics support groups.
The title of DNA from the Beginning (DNAFTB) can be taken as a metaphor on several levels. On a
conceptual level, DNAFTB stresses DNA as the beginning of human life and health, and as the medi-
ator of the evolution of all life. On a pedagogical level, DNAFTB builds knowledge following the histor-
ical development of genetics-from the beginning, one experiment at a time. DNAFTB is targeted at
the level of a bright teenager and is intended to provide basic information that anyone would find use-
ful in facing a "personal genetic dilemma."
DNAFTB is designed to support the learning styles of two types of Internet users: the casual brows-
er, who wants a quick synopsis of key materials, and the active learner, who wants to build a deeper
understanding. We hope that the consistent organization and novel features of the site will actually
encourage browsers to become active learners.
In contrast to books, which are organized around chapters, DNAFTB is organized around key con-
cepts. Approximately 75 concepts will form the narrative backbone of the work-a Readers' Digest of
genetics from Mendel to molecular cloning. Thus, the casual reader can take DNAFTB as a continuous
story or work to master "a concept a day." Each concept is carefully chosen to emphasize the pro-
gressive development of genetics. Concepts are presented as pure ideas and in relatively nonscientif-
ic language. In keeping with research showing that Internet users tend to skim Web pages and get con-
fused by too many "clicks," each concept is limited to a single screen containing a title, collage illus-
tration, and maximum 150 words of text.
Layered behind each concept screen are multimedia elements that allow the active learner to dis-
cover the experiments and people behind the concept:
Animations created with Macromedia Flash software illustrate exemplar experiments upon which
the concept is based, with scientists describing their own experiments in the first person.
Animation is especially effective in illustrating multistep experiments and molecular events that are
difficult to capture in static text illustrations. We believe that these animations are unique in biolo-
gy education; similar animations are the most requested and downloaded pages at our WWW
site.
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Gallery contains still images collected from primary scientific archives, often rare photographs not
found in science textbooks. The images are displayed in a linear, scrolling loop, which gives the sense
of browsing pictures on a gallery wall. Each image can be enlarged for closer inspection.
Audio/Video contains primarily short video clips from interviews with scientists and historians that
highlight the human side of discovery. Clips are served to users as "streaming video." This system
avoids long download delays by quickly delivering an initial segment, and then loading the remain-
ing footage while the scene is playing.
Bio provides details about the scientists closely associated with the concept. Biographies highlight
scientific "heroes" and attempt to reflect the person behind the science.
Links provides several jumping off points to related VWVVV sites outside of DNAFTB. Our editors
have judged each link especially relevant and appealing. A review is provided for each external
resource.
Problem provides an animated tutorial that tests comprehension, usually by means of an experiment
that builds upon experiments presented in the Animation section. Each problem presents a series
of connected investigations. At appropriate checkpoints within the problem, multiple-choice ques-
tions test for concept mastery before allowing the user to continue.
Gene the Gene is an animated cartoon character who presents entertaining facts and stimulating
thought questions that challenge users to make associations or to consult other resources.
DNAFTB incorporates a number of unique programming features. Each "page" downloaded by a
user is dynamically constructed, at the time of a user request, from individual narrative and media ele-
ments stored on the DNAFTB database server. A customized authoring shell allows the project editors
to easily edit, add, or delete elements without reconstructing or reprogramming an entire page layout.
The site's dynamic structure also makes possible a unique Relational Navigator, which allows users to
explore DNAFTB according to their own interests, in a nonlinear manner. Depending on the page from
which it is activated, the Relational Navigator draws a unique "map" of internal links to related concepts
and media elements.
Although anyone may access DNAFTB as a "guest," users are encouraged to register to take
advantage of additional features, including setting browser preferences, bookmarking pages, tracking
sections read, and searching by key words. Registered users are also provided a personalized score
sheet on Problems they have answered, which can be printed out and turned in to the classroom
teacher as a homework assignment. The registered user database also provides accurate measures of
DNAFTB site use, according to both content viewed and user demographics.
Genes, Teens, and the World Wide Web Affirms Our Methods
In preparation for the initial release of DNAFTB, in November we collaborated with our favorite Brit Jan
Witkowski to sponsor a Banbury meeting on the future of online genetics education. Genes, Teens, and
the World Wide Web drew together experts from the worlds of biological research, science publishing,
and Internet computation. The meeting was cohosted by CSHL president James Watson and Bruce
Alberts, President of the National Academy of Sciences. Keynote speaker Alan Kay, Vice President of
Walt Disney Imagineering, was a member of the Xerox Palo Alto Research Center (PARC), which invent-
ed modern personal and networked computing. Other participants included Lubert Stryer and Neil
Campbell, authors of mega-selling biochemistry and biology texts; Phillip Greenspun, who construct-
ed database-driven \NVVW sites for Fortune 500 companies; Robert Semper, Vice President of the San
Francisco Exploratorium; and Ted Hanss, Vice President of Internet II.
In many ways, discussion at the meeting affirmed our methods for online publishing. First, our home
page, Gene Almanac, was reconceived in July as "the source for timely information about genes in edu-
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(Left) Dr. Alan Kay, Walt Disney Imagineering, addresses participants of the Genes, Teens, and the World Wide Web meeting in
November. (Right) Philip Greenspun (seated), Matt Christensen, and John Kruger of the DNALC, Joe Perpich of Howard Hughes
Medical Institute, and Cathy Marshall of Xerox PARC browse DNA from the Beginning.
cation." Far from the standard organizational mouthpiece, it is a dynamic information source that
changes daily. Gene News posts four to six daily news articles generated by a customized Internet
search engine, which scans numerous national news sources, including The New York Times, Los
Angeles Times, Boston Globe, MSNBC, Fox News, and BBC Online feature articles, that highlight sci-
ence methods and people in the news, using animations and video elements to make the topics
engaging to nonscientific audiences.
Several Gene Almanac elements aim to involve students in research and build a community of
online learners. Student Allele Database and the new DNA Sequence Server allow students to use their
own DNA "fingerprints" as a starting point for online investigations. BioForms provide case studies on
DNA sequence analysis and custom interfaces that allow students to easily use statistical tools avail-
able at genome servers. Gene Talk includes bulletin boards and chat rooms, including special areas for
teacher groups trained at summer workshops.
The freshness of the Gene Almanac content is made possible because each page is "made from
scratch," drawing items and design features from a number of sources to create the page seen by a
user. Some pages draw information from databases maintained at the DNALC, and others send
requests to other VW\NV sites and package the returned information in our own forms. This sort of
dynamic page construction is common to the most advanced sites on the V\NVVV. Users seem to
appreciate the changes. Traffic at the site increased threefold during the year, to more than 18,500
unique user sessions per month, including visitors from 50 countries.
We Look Forward to a Major Addition to the DNALC
Since opening in 1988, the DNALC has been the largest provider of genetics and biotechnology labs.
Now, our new multimedia projects have made the DNALC one of the largest Internet providers of mul-
timedia learning materials for biology education. However, realistically, our current facilities will not allow
us to maintain this advantage very far into the future. In 1998, our two teaching labs were saturated,
and our super-talented Internet developers joined the rest of the staff in our dreary basement office.
So, we were buoyed by news in the spring that the Dolan Family Foundation had agreed to provide
$1 million toward construction of a 7600-square-foot BioMedia addition that will double the size of the
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DNALC. BioMedia expresses our goal to explore the creative use of computer and telecommunication
technology in modern biology education. Computer and video facilities in the addition will allow stu-
dents to move effortlessly between multimedia experiences and hands-on science in adjacent bio-
chemistry and genetics laboratories.
Centerbrook Architects and Planners, of Essex, Connecticut, are designing the addition. This firm
has done the bulk of the Laboratory's architectural design for the past 20 years and was responsible
for the DNALC's major renovation in 1993. Centerbrook received the coveted 1998 Architectural Firm
Award presented by the American Institute of Architects. So we were not surprised when architect Jim
Childress came up with a brilliantly simple solution to our problem of how to make a two-story addition
look like only one. He simply continued the ground floor partially below grade, so that the second floor
merges with the natural break in the hill behind our building. The net effect-the elevation at the back
of the facility-gives the impression of a single-story ranch house!
The centerpiece of the addition will be an octagonal computer laboratory to support hands-on
instruction in bioinformatics, explorations using interactive and virtual reality technologies, and distance
learning programs. To allow us to fully explore the "convergence" of CD/ROM, video, broadcast, and
cable media, the upper level will feature a video studio/production suite and a multimedia conference
room. A lunchroom and rest rooms are practical elements needed to deal with our ever-increasing num-
ber of young visitors. Staff offices will be located on the upper and lower levels, according to function.
The Bio Media addition, and reconstruction of existing space, will create a suite of three teaching
laboratories and a student research laboratory. Believing that sequencing will become a substantial part
of future laboratory programs, we have included a dedicated DNA sequencer in the capital budget for
the BioMedia addition. A Visible DNA Sequencing Laboratory will perform double duty as an exhibit to
showcase DNA technology and as a working laboratory. On a daily basis, high school interns will
process DNA samples submitted by high school and college classes around the nation. Visitors can
watch all phases of sequencing, culminating with a real-time output of finished sequence on a scrolling
ticker. The DNA sequences processed in the visible laboratory will be returned via the Internet to par-
ticipating schools, where they will be the starting points for a series of online exercises.
Shedding Light on an Important Lesson from the Past
Early in the year, we received a 2-year grant of $404,000 from the Ethical, Legal, Social Issues (ELSI)
Program of the National Human Genome Research Institute to establish a Digital Image Archive on the
American Eugenics Movement. We considered this award an important vote of confidence in our work,
since it is the first grant the ELSI Program has made to explore this sensitive issue.
The Archive will be drawn from the corpus of the Eugenics Record Office at Cold Spring Harbor,
which was the primary repository of American eugenical thought and activity from 1910 to 1940.
Some documents remain in the CSHL Archives, but the bulk have come to rest at the American
Philosophical Society (APS) Library in Philadelphia and the Harry Laughlin
Archives at Truman State University in Kirksville, Missouri. Nearly 700
images-toward our goal of 1000-were collected at Cold Spring Harbor
and during two trips to APS in Philadelphia. Collected items included pho-
tographs, family records, personal correspondence, quotations, clippings,
pedigrees, tables, and sample publications.
The major aim of the Digital Image Archive is to provide materials that
will stimulate independent, critical thinking about the parallels between
eugenics and modern genetics research. The Archive is intended as an
educational tool to allow individuals to learn about society's past involve-
ment in genetics by exploring primary materials that heretofore have been
inaccessible to the layperson. By basing the Archive on primary materials,
users assume the role of historian/researcher, finding materials according
to their own preferences and drawing inferences based on their own syn-
The American
Philosophical Society
Library in Philadelphia.
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thesis. By focusing primarily on visual documents, we hope to engage young people who are accus-
tomed to visual media and others who would not normally access a scholarly collection.
While we want to allow users to form their own opinions about the eugenics movement and its par-
allels to modern genetics research, we also recognize that people need to have some sense of the his-
torical, social, and ethical context in which the eugenics movement flourished. Thus, construction of
the Archive involves formal review by an Editorial Advisory Panel, which includes historians, clinical
geneticists, educators, bioethicists, philosophers of science, and healthcare advocates:
Garland E. Allen, Washington University of St. Louis
Elof Carlson, State University of New York, Stony Brook
Patricia Colbert-Cormier, NASA
Nancy L. Fisher, Washington State Department of
Social and Health Services
Henry Friedlander, Department of Justice
Daniel J. Kev les, California Institute of Technology
Philip Kitcher, University of California, San Diego
Martin L. Levitt, American Philosophical Society
Paul Lombardo, University of Virginia, Charlottesville
Nancy Press, Oregon Health Sciences University
Philip R. Reilly, Shriver Center for Mental Retardation, Inc.
Pat Ryan, Hopkins High School
Marsha Saxton, World Institute on Disability
Steven Selden, University of Maryland, College Park
G. Terry Sharrer, National Museum of American History
The first of four EAP meetings took place at CSHL Banbury Center in September. Lengthy discus-
sions resulted in a policy that takes every reasonable effort to protect people's privacy and confiden-
tiality, without sacrificing the historical integrity of documents. Panel discussion also led to development
of the site's narrative outline, consisting of 11 context topics. Several panel members took on the chal-
lenge of writing 750-1000-word "theme essays" to introduce key persons and events in the context of
social and historical events. We hope that this rigorous, participatory review process will provide a
model for other ELSI educational efforts that demand cultural, racial, and ethnic sensitivity.
Dan Kev les (gesturing,
near center) addresses
the Editorial Advisory
Panel.
(Left) Henry Friedlander,
Elizabeth Thompson, and
Jan Witkowski during a
break in the meeting.
(Right) Dave Mick los talks
with Garland Allen.
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Bringing the Human Genome Project into the Science Classroom
During the year, we continued our work to involve students and teachers in human molecular genet-
ics-through grants from the Howard Hughes Medical Institute, the National Science Foundation's
Advanced Technological Education Program, and the Department of Energy's ELSI program. We are
striving to develop a robust and accurate analog of human genome research that allows students to
use their own chromosomal and mitochondrial DNA polymorphisms as the basis of explorations into
contemporary genomic biology.
The DOE Program introduces high school biology faculty to a laboratory-based unit on human DNA
polymorphisms, which provides a uniquely personal perspective on the science and ELS! aspects of
the Human Genome Project. We conducted three training workshops, drawing a total of 65 teachers,
at the Mills Godwin Specialty Center (Richmond), Eccles Institute of Human Genetics (Salt Lake City),
and the University of Denver. Each workshop mixed theoretical, laboratory, and computer work with
practical and ethical implications. Program participants learned simplified lab techniques for amplifying
two types of chromosomal polymorphisms: an Alu insertion and a VNTR. These polymorphisms illus-
trate the use of DNA variations in disease diagnosis, forensic biology, and identity testing and provide
a starting point for discussion of the uses and potential abuses of genetic technology.
DOE workshop participants also learned how to use their Alu insertion data as an entrée to human
population genetics and evolution, using our Student Allele Database. This online facility, developed
with Howard Hughes funding, contains more than 3000 student DNA types, as well as archival data
from populations around the world. Several statistical functions are available: testing Hardy-Weinberg
equilibrium within a single population, measuring genetic distance between two populations, and com-
paring two populations using contingency Chi square. A Hardy-Weinberg simulator shows the effect of
genetic drift and gene fixation in small populations. Working with the Student Allele Database stresses
the shared ancestry of all human beings and sets the stage for further investigations of human origins
using mitochondria! DNA.
Under the NSF program, we are developing a hands-on curriculum to bring students up to the minute
with the techniques and applications of genomic biology. The curriculum merges the DNALC's content
expertise with the vocational-technical expertise of project collaborator CORD (Center for Occupational
Research and Development) of Waco, Texas. The project targets participation by leading high school
and community college faculty interested in technology education and instructional innovation.
As part of this program, we began development of a new PCR (polymerase chain reaction) experi-
ment of extraordinary promise. The object is to visualize the insertion polymorphism responsible for
wrinkled pea seeds-one of the seven original traits investigated by Gregor Mendel. This experiment
provides a bridge between the "old" classical genetics and the "new" molecular genetics, and empha-
sizes the connection between genotype and phenotype. The transposon responsible for the wrinkled
phenotype appears related to the Ac/Ds system discovered at Cold Spring Harbor Laboratory by
Barbara McClintock. Although this pea experiment illustrates a natural mutation caused by a transpo-
son, a parallel experiment shows the use of transposon mutagenesis as a research tool for exploring
the plant genome. The transposon insertion in peas is also analogous to the human Alu insertion used
in the DOE Workshop.
The most novel aspect of the NSF program is a Sequencing Service to provide low-cost sequenc-
ing of mitochondrial DNA samples. Over the past year, we have worked closely with Dick McCombie
at the Arabidopsis Genome Sequencing Center of CSHL to provide proof of concept for processing
DNA samples submitted from around the country. During each DOE workshop, teacher participants
amplified the mitochondria! control region from DNA prepared from their hair roots or cheek cells. The
amplified DNA was returned to the DNALC, where dye terminator reactions were performed; the sam-
ples were then passed to the Genome Center for sequencing. The completed sequences were then
posted at the DNALC's WWW site on the DNA Sequence Server, which currently contains 350
sequences. This process was further replicated with 60 student samples submitted, by mail, from
teachers in New York, Maryland, Utah, and Virginia.
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Bioinformatics on the World Wide Web
During the year, we developed case materials that use sequence and polymorphism data to illustrate
key principles of biology, including evolutionary relatedness and conservation of function. In addition,
we introduced several step-by-step Internet templates that allow teachers and students to analyze their
own mitochondria! DNA sequences, including similarity searches and multiple sequence alignments.
To support these investigations, we developed two novel computer tools: Bioforms and DNA
Sequence Server. Bioforms let students explore realistic, meaningful biology problems in a guided envi-
ronment. By "wrapping" difficult-to-use genome resources within an easy-to-use contextual guide, the
innovative Bioform interface lets participants easily select and submit data sets for analysis to Internet
genome servers. Results returned by the remote servers are intercepted by the Bioform data proces-
sor and reformatted to a simplified display. In this manner, Bioforms allow students to focus on the bio-
logical question at hand, rather than being overwhelmed by navigating their way through complex
research sites.
Our first Bioform allows students to solve the "mystery of the Romanovs" by using mitochondrial
DNA sequence polymorphisms to determine whether a set of bones found in a Russian mass grave
were those of the murdered Russian royal family. A second Bioform improves on an existing unit where
students' mitochondrial DNA sequences are compared with reference sequences to determine
whether Neanderthal hominids were our direct ancestors.
In contrast to the guided framework used in Bioforms, DNA Sequence Server is an open-ended
"exploratorium" that puts powerful computational biology tools in the hands of the beginning learner.
DNA Sequence Server is a full-featured database and sequence analysis application built upon
Microsoft SQL Server database technology. The application lets users access DNALC sequence data
sets, search external databases, and directly manipulate personal sequence collections. In addition,
DNA Sequence Server lets users easily analyze sequences using a number of built-in resources, includ-
ing BLAST and CLUSTALW. Additional analysis tools-including evolutionary tree drawing, restriction
mapping, and open reading frame determination-will be added over time.
Corporate Advisory Board
The Corporate Advisory Board (CAB) provides a crucial link to local businesses that serve the same
population base as the DNALC. Represented on the board are companies of all kinds-from family-
owned to multinational and from biotechnology to banking. A major goal of the Board is to raise aware-
ness of the DNALC among opinion leaders on Long Island and to involve others in our work.
Under the chairmanship of Jack Leahy, the CAB raised $200,000 in support of the DNALC and the
Partners for the Future Program, a 20% increase over 1997. Key to this huge success was the 5th
Annual Golf Tournament, held on June 18 at Piping Rock Club. Organized by John Kean, the tourna-
ment netted $125,000, a 28% increase over 1997. The tournament's founding sponsor is J.P. Morgan
& Co., Cablevision and Luitpold Pharmaceuticals, Inc. were major corporate sponsors. Other corpo-
rate sponsors were Badge Agency, Inc.; Conde Nast Publications; Festo Corporation; Kean
Development Company; KPMG Peat Marwick LLP; Motors and Armatures, Inc.; Price Waterhouse
Coopers; RMC Industrial Supply; and The Rosyln Savings Foundation.
Staff and Interns
Malissa Hewitt went on maternity leave in the summer and, after giving birth to Charles Fowler Lindsay,
decided to become a full-time mom. Melissa came to the DNALC in 1994, becoming our first full-time
staff member devoted to middle-school instruction. On short notice, she gamely stepped in to manage
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the burgeoning program in 1997 and set the stage for this year's large expansion. The DNALC will miss
her can-do attitude, and the students will miss her attentive and caring style.
Then, in the fall, we bid farewell to Assistant Director Mark Bloom, as he pre-
pared to take a new position at the Biological Sciences Curriculum Study in
Colorado Springs. Mark joined CSHL in 1987, when our educational programs
shared offices (and staff) with the Public Affairs and Development Departments.
Mark was there when we embarked on the initial renovation of the DNALC facil-
ity, and he initiated the student lab field trip program. Over the years, he per-
sonally instructed more than 1000 biology faculty at workshops sponsored by
the National Science Foundation and the Howard Hughes Medical Institute.
Students and teachers alike responded to his friendly and down-to-earth way of
presenting science. On many occasions, he helped the DNALC go through the
"eye of the needle"-a pressing grant or other crisis-to survive to become the
institution we now are. For that, we owe him a large debt of gratitude.
The departures of Malissa and Mark provided opportunities for expanded responsibility for Trisha
Harrison and Scott Bronson, who were each promoted to the rank of Education Manager. Trish main-
tained the momentum of the middle school program, while Scott assumed responsibility for managing the
laboratory program and our growing cadre of student interns. Working together, they fostered a collabo-
rative management style that has provided a common vision for our education programs at all levels.
The educational staff was bolstered by the arrival of two new laboratory instructors-Amanda
Broege and Martha Mul lally. Having come from a family of dog breeders, Amanda started her biology
degree at SUNY, Stony Brook with an eye toward a career in veterinary medicine. It is our gain that she
later decided to become NYS-certified in secondary science education. A native of Halifax, Nova
Scotia, Martha became our second Canadian staff member. While working on her bachelor's degree in
Mark Bloom in a
photo from 1989.
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biochemistry at Dalhousie University, Martha conceived of the World Weavers, a province-wide envi-
ronmental education program for precollege students.
In recognition of his leadership in establishing the BioMedia Group, John Kruper was named assis-
tant director of the DNALC. Three new staff members, programmer Matt Christensen and media
designers Gisella Walter and Mark Feingold, joined BioMedia group members Sue Lauter and Shirley
Chan. Born in Chile and raised in San Francisco, Gisella received a fine arts degree from Alfred
University. Several years in the New York art world and working as a free-lance Web designer have
made her a superb computer animator. Mark also received a fine arts degree from Alfred University, but
got his start in art as a graffiti artist on the streets of Manhattan.
The expansion of the staff put added pressures on core administrators Dave Micklos and Judy
Cumella-Korabik, so we were pleased when Janeen Russo joined the administrative group as secre-
tary. A native of Brooklyn, Janeen provides the DNALC with needed clerical and administrative support.
She assumed responsibility for scheduling and introducing Cablevision's multimedia presentation Long
Island Discovery.
An intern program funded by the Howard Hughes Medical Institute allows high school students to
assist the instructional staff in preparing the teaching laboratories and to undertake independent
research projects. The independent work allows interns to push themselves intellectually while gaining
technical expertise they can carry to the university level. Intern research projects also contribute to new
lab experiences offered as student field trips or as part of summer workshops.
Hana Mizuno, of Cold Spring Harbor High School, received highest honors in the Long Island
Science Congress, as well as a cash award from the Suffolk County Science Teachers Association, for
her work using green fluorescent protein (GFP) as a reporter molecule in subcloning experiments. Much
of her work was incorporated into a special summer workshop entitled "Green Genes" and also helped
to update lab field trips on bacterial transformation. Hana later began research on programmed cell
death (apoptosis) with CSHL scientist Yuri Lazebnik. Rachael Neumann, of Syosset High School, was
one of only six students selected to participate in the Partners for the Future Program, working under
the tutelage of CSHL scientist Grigori Enikolopov.
The instructional staff was ably assisted by veteran interns Jermel Watkins (New York Institute of
Technology), Karin Glaizer (Portiedge High School), and Gerry DeGregoris (Chaminade High School).
Salley Anne Gibney returned from her freshman year at Johns
Hopkins University to assist with the summer workshops.
Hetty Ashton, a native of Australia, visited the DNALC in July
to volunteer and partcipate in the middle school summer
workshops. Using her education background, Hetty worked
closely with the instructors and students to aptly assist in the
laboratories and activities. She has retured to Australia to pur-
sue her interest in education. In August, we bid farewell to
Trevor Sammis, who began his freshman year at the University
of Virginia at Richmond, and to Mera Goldman, who started at
Barnard College. In the fall, we welcomed newcomers Gina
Conenello (John Glenn High School), Sunjay Kelkar (Syosset
High School), Stephen Mak (Syosset High School), Laura
Roche (Cold Spring Harbor High School), and Rebecca Yee
(Huntington High School).
332
Hetty Ashton talks with a parent of a Fun
With DNA participant.
1998 Workshops, Meetings, and Collaborations
January 10
January 17
February 7
February, 18-19
March 9-11
March 20
March 26-28
April 3
April 3-5
April 10
April 16
April 21
April 22
April 23
April 23-25
April 28
May 1-3
May 5
May 8-10
May 12
May 18-19
June 4
June 9
June 10-11
June 29-July 2
June 29-July 8
June 29-July 29
July 6-10
July 6-17
July 13-17
July 20-24
July 27-31
August 3-7
August 10-14
August 17-19
Laboratory for Town of Huntington Senior Citizens Center
Laboratory for Queens Bridge to Medicine High School
Laboratory for Rampart and Sierra High Schools, Colorado Springs, Colorado
National Human Genome Research Institute ELSI Project, Eugenics Image Archive, image
collection visit to American Philosophical Society Library, Philadelphia, Pennsylvania
National Science Foundation Grant Review Site Visit, City College of San Francisco,
California
Site visit by Linda Conlon, International Center for Life, Newcastle, Great Britain
Department of Energy Workshop, The Science and Issues of Human DNA Polymorphisms,
University of Utah, Salt Lake City, Utah
Seminar at Trudeau Institute, Saranac Lake, New York
National Science Foundation Workshop, Human Genome Diversity-Student Allele Database
Workshop, Pierce College, Woodland Hills, California
Site visit by Ray Gladden and Maria Rapoza, Carolina Biological Supply Company,
Burlington, North Carolina
Site visit by National Science Foundation National Visiting Committee
Great Moments in DNA Science Honors Students Seminar, CSHL
Seminar for National Institute of Social Sciences, Harvard Club, New York, New York
Site visit by Topaz Conway, Garvan Research Foundation, Sydney, Australia
Visiting Scholar Program, Mills Godwin Specialty Center, Richmond, Virginia
Site visit by Simon Collier, University of Virginia, Charlottesville, Virginia
National Science Foundation Workshop, Human Genome Diversity-Student Allele Database
Workshop, University of Washington, Seattle, Washington
Great Moments in DNA Science Honors Students Seminar, CSHL
National Science Foundation Workshop, Human Genome Diversity-Student Allele Database
Workshop, Kingsborough Community College, Brooklyn, New York
Great Moments in DNA Science Honors Students Seminar, CSHL
Site visit by Sylvia Metcalfe, University of Melbourne, Australia
National Human Genome Research Institute ELSI Review Panel, Washington, D.C.
Site visit by June Osborn, Josiah Macy, Jr. Foundation, New York, New York
Gateway Summer Teachers Institute Reception, New York, New York
World of Enzymes Workshop, DNALC
DNA Science Minority Workshop, Central Islip, New York
Advanced DNA Science Workshop, DNALC
Gateway Summer Teachers Institute, Stuyvesant High School, New York, New York
Fun With DNA Workshop, DNALC
Fun With DNA Minority Workshop, Intermediate School 109, Queens, New York
Advanced DNA Science Minority Workshop, Central Islip, New York
Fun With DNA Minority Workshop, Intermediate School 109, Queens, New York
Green Genes Workshop, DNALC
World of Enzymes Minority Workshop, Intermediate School 109, Queens, New York
World of Enzymes Workshop, DNALC
DNA Science Minority Workshop, John F. Kennedy High School, Bronx, New York
DNA Science Workshop, DNALC
Fun With DNA Workshop, DNALC
DNA Science Workshop, DNALC
Fun With DNA Workshop, DNALC
DNA Science Minority Workshop, Stuyvesant High School, New York, New York
DNA Science Workshop, DNALC
Fun With DNA Workshop, DNALC
DNA Science Minority Workshop, Mt. Sinai School of Medicine, New York, New York
National Human Genome Research Institute ELSI Project, Eugenics Image Archive image
collection visit to American Philosophical Library Society, Philadelphia, Pennsylvania
Genomic Biology & PCR Workshop, DNALC
August 17-21 Fun With DNA Workshop, DNALC
Reading the Code of Life Workshop, DNALC
August 20-28 Advanced DNA Science Workshop, DNALC
August 24-28 World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
September 21-22 National Human Genome Research Institute ELSI Project, Eugenics Image Archive, Advisory
Panel Meeting, Banbury Center, CSHL
October 7 Site visit by Bronwyn Terrill, Museum Victoria, Australia
October 9-12 National Science Foundation ATE Project, Genomic Biology, Editorial Advisory Board
Meeting, DNALC
October 20-24 Western States Courts and Genetic Testing Conference, Snowbird, Utah
October 21-23 Howard Hughes Medical Institute Directors Meeting, Rockville, Maryland
October 29 Site visit and laboratory for participants in The Art of Judging: Perspectives of Science
Banbury Center Meeting
October 30 Mid-Atlantic Judicial Conference, Ocean City, Maryland
November 3 Laboratory for science faculty from High School for the Humanities, New York, New York
November 3 National Institutes of Health ELSI Grant Review
November 12-14 Department of Energy Workshop, The Science & Issues of Human DNA Polymorphisms,
Mills Godwin Specialty Center, Richmond, Virginia
November 20-21 National Science Foundation ATE Director's Meeting, Washington, D.C.
November 22-24 Macy Foundation Meeting, Genes, Teens, and the World Wide Web, Banbury Center, CSHL
December 3-5 Department of Energy Workshop, The Science & Issues of Human DNA Polymorphisms,
University of Denver, Colorado
Sites of Major Faculty Workshops 1985-1998
Key: High School College Middle School
ALABAMA University of Alabama, Tuscaloosa 1987-1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA Foothill College, Los Altos Hills 1997
University of California, Davis 1986
San Francisco State University 1991
University of California, Northridge 1993
Canada College, Redwood City 1997
Pierce College, Los Angeles 1998
COLORADO Colorado College, Colorado Springs 1994
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
DISTRICT OF COLUMBIA Howard University 1992,1996
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
GEORGIA Fernbank Science Center, Atlanta 1989
Morehouse College, Atlanta 1991,1996
Morehouse College, Atlanta 1997
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986,1987
University of Chicago 1992,1997
!INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-1992
St. John's College, Annapolis 1991
MASSACHUSETTS Beverly High School 1986
City Lab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Boston University 1994,1996
MICHIGAN Athens High School, Troy 1989
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990,1991
MISSOURI Washington University, St. Louis 1989
Washington University, St. Louis 1997
NEW HAMPSHIRE St. Paul's School, Concord 1986,1987
NEVADA University of Nevada, Reno 1992
NEW YORK Albany High School 1987
Bronx High School of Science 1987
Columbia University, New York 1993
Cold Spring Harbor High School 1985,1987
DeWitt Middle School, Ithaca 1991,1993
DNA Learning Center 1988-1995
DNA Learning Center 1990,1992,1995
DNA Learning Center 1990-1992
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine, New York 1997
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987-1990
Titusville Middle School, Poughkeepsie 1991,1993
Wheatley School, Old Westbury 1985
US Military Academy, West Point 1996
Stuyvesant High School, New York 1998
NORTH CAROLINA North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA School of Science and Mathematics, Oklahoma City 1994
PENNSYLVANIA Duquesne University, Pittsburgh 1988
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Germantown Academy 1988
SOUTH CAROLINA Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
WASHINGTON University of Washington, Seattle 1993, 1998
WEST VIRGINIA Bethany College 1989
WISCONSIN Marquette University, Milwaukee 1986,1987
University of Wisconsin, Madison 1988,1989
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
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1998 PUBLICATIONS
Laboratory Manuals
Detecting Genes: A Laboratory Manual
Genome Analysis, Volume 2
Bruce Birren, Eric D. Green, Sue Klapholz, Richard M. Myers,
and Jane Roskams (eds.)
Crystallization of Biological Macromolecules
Alexander McPherson
Concepts in Eukaryotic DNA Replication
Melvin L. DePamphilis (ed.)
Cloning Systems: A Laboratory Manual
Genome Analysis, Volume 3
Bruce Birren, Eric D. Green, Sue Klapholz, Richard M. Myers, Cancer Surveys Series
Harold Reithman, and Jane Roskams (eds.)
Mapping Genomes: A Laboratory Manual
Genome Analysis, Volume 4
Bruce Birren, Eric D. Green, Philip Hieter, Sue Klapholz, Richard
M. Myers, Harold Reithman, and Jane Roskams (eds.)
Using Antibodies
Ed Harlow and David Lane
CSHL Monograph Series
The Development of Human Gene Therapy
Theodore Friedmann (ed.)
The RNA World, Second Edition
Raymond F. Geste land, Thomas R. Cech, and John F. Atkins
(eds.)
General Books
Pattem Formation during Development
Cold Spring Harbor Symposia on Quantitative Biology LXII
I Wish I'd Made You Angry Earlier
Max Perutz
At the Bench: A Laboratory Navigator
Kathy Barker
The Structure and Reproduction of Corn
T.A. Kiesselbach
Vol. 31: Bladder Cancer
R.T.D. Oliver (ed.)
Vol. 32: Precancer
J. Ponten (ed.)
Journals
Genes & Development (Volume 12, 24 issues)
T. Grodzicker and N. Hastie (eds.)
Genome Research (Volume 8, 12 issues)
L. Goodman, A. Chakravarti, R. Gibbs, E. Green, R. Myers, and
M. Boguski (eds.)
Learning & Memory (Volume 5, 6 issues)
J.H. Byrne (ed.)
Slides
Cells: Basic Principles of Microscopy
David Spector and Robert Goldman (eds.)
Other
CSHL Annual Report 1997
Banbury Center Annual Report 1997
Administration and Financial Annual Report 1997
COLD SPRING HARBOR LABORATORY PRESS
The 1998 results for Cold Spring Harbor Laboratory Press owed much to the previous year's gains in
productivity through staff restructuring and investment in technology. Fourteen new books were
released, all produced digitally. All three journals were published for the first time in both electronic and
print editions and all made gains in quality, influence, advertising pages, and circulation. Financially,
there was a substantial improvement in operating margin on increased sales of $6.34 million.
Books for Scientists
The complete list of new books published is shown opposite. The most eagerly anticipated was the lab-
oratory manual Using Antibodies, by Ed Harlow and David Lane, released in December. This handsome
book with its innovative design features is an update of material from Harlow and Lane's classic man-
ual Antibodies, which has been a mainstay of our publishing program since its appearance in 1988.
Entirely rethought and rewritten in the light of a further decade's experience, this new book is essential
for molecular and cell biologists who want to use antibodies with insight as well as accuracy.
The year also saw the culmination of the series of four lab manuals entitled Genome Analysis.
Conceived when the human genome project was only just getting under way, this series was an enor-
mous undertaking, encompassing and at times overwhelming a team of 7 editors and more than 50
contributors, whose goals were continually challenged by the rapid evolution of genomic science. Now,
their efforts have created a set of techniques with lasting value as the era of mapping and sequencing
gives way to functional genomic approaches that are destined to change how experimental biology is
done.
The celebrated series of Cold Spring Harbor Laboratory monographs continued to expand with the
appearance of two new titles. The Development of Human Gene Therapy is a volume with a particu-
larly well-defined mission. Its editor, Ted Friedmann, undertook the work with the aim of celebrating the
remarkable scientific achievements that have helped found the brand-new medical discipline of gene
science. But he and the contributors have ensured that the book provides a clear-eyed view of the
improvements still required to make the technology of gene transfer stable as well as a careful and crit-
ical assessment of the medical benefits that have been achieved so far-results that have been over-
sold to an eager public. As a result, the book has provoked vigorous comment and some bruised feel-
ings.
The public became aware of another new monograph, thanks to a prominent story in the Science
section of The New York Times that spoke to continuing popular fascination with the origins of life. The
RNA World, edited by Ray Gesteland, Tom Cech, and John Atkins, is devoted to the possibility that pre-
biotic evolution depended on RNA replication, but it also provides a valuable perspective on the mod-
ern world of RNA. A second edition of one of our most successful recent books, this volume is being
appreciated by research scientists and educators alike.
Our decision last year to develop a number of books with appeal to an audience beyond profes-
sional science was vindicated with the extraordinarily warm response to the appearance of a new col-
lection of essays by the distinguished protein chemist Max Perutz. I Wish I'd Made You Angry Earlier
consists of articles written by Max at the invitation of several well-known magazines such as New York
Review of Books. Reviews of the biographies of scientists, many of whom were friends and acquain-
tances, become in Max's hands wonderful reflections on science and society as a whole, often illumi-
nated by autobiographical fragments that make fascinating reading. This essay collection has been
enthusiastically received by a scientific community which cherishes the author; but reviews in a number
of international literary magazines introduced the book to a wider public and prompted a distribution
agreement for a European edition through Oxford University Press and translation into five languages.
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Widespread praise also greeted the appearance of an introduction to bench science for neo-
phytes entitled At the Bench: A Laboratory Navigator, by Kathy Barker. Written in a light-hearted but
thoroughly practical tone, this user-friendly manual offers advice, moral support, and social etiquette
as well as detailed descriptions of basic laboratory procedures that are seldom explained clearly
enough to novices by experienced colleagues. Based on the author's own observations of life in teach-
ing and research institutions, the book has found a responsive audience in graduate students, lab tech-
nicians, and doctors rotating through research labs, as well as the senior staff who have to shepherd
them.
Our front-list was rounded out by two books notable for the beauty of their illustrations as well as
the excellence of their text. The 1997 Symposium volume, Pattern Formation during Development,
reviewed the remarkable convergence in the mechanisms of embryonic development across verte-
brate and invertebrate species, its 60 authoritative chapters embellished with the results of a battery of
new techniques for visualizing biological processes. On the other hand, an imaging technique with a
long and honorable history, X-ray crystallography, is the target of a new work by an expert in the art,
Alexander McPherson. Crystallization of Biological Macromolecules presents the physical and chemi-
cal principles of crystal growth in an approachable way with the aid of splendid photographs, helping
investigators prepare their favorite molecules for X-ray analysis.
Books for Students
As the year came to a close, a decision was made with the potential to transform the future shape of
book publishing at Cold Spring Harbor. Jim Watson has been the visionary and driving force behind
the Laboratory's role in scholarly publishing since his appointment as Director in 1968. Already a high-
ly successful author, with the pioneering textbook Molecular Biology of the Gene and the extraordinary,
best-selling memoir The Double Helix to his credit, Jim devoted part of his formidable energies to build-
ing upon the already prestigious reputation established by the annual volumes in the Symposia for
Quantitative Biology series. From his ideas and recruitment of influential editors and authors came the
beginnings of the classic monographs and lab manuals that form the mainstay of our professional pub-
lishing program today.
During the seventies and eighties, Jim and teams of talented colleagues created two additional
innovative, influential, and highly successful textbooks for undergraduate teaching, Recombinant DNA,
and Molecular Biology of the Ce//, while nurturing MBOG through several editions of increasing size and
scope as molecular biology entered the teaching mainstream. All these books were published by com-
mercial publishers with the resources to gamble on breaking new ground and the marketing muscle to
back up that investment-not the characteristics of a small publishing program at an institution such
as the Laboratory. Nevertheless, Jim never lost sight of the possibility, and appropriateness, of expand-
ing the publishing program here and bringing to the development of books for undergraduates the rep-
utation for quality and outstanding scholarship earned by the books for working scientists.
Jim's vision became a reality this year when the Trustees approved investment in the development
of a series of innovative books for teaching undergraduate biology. Half a dozen titles are proposed to
begin with, books aimed at college juniors and seniors that reflect both new facts and new approach-
es to the way research is done. The editorial development of the books will be in the hands of Cold
Spring Harbor Laboratory Press, particularly those of Alexander Gann, a writing collaborator of Mark
Ptashne's and an experienced undergraduate teacher, who joined us from the University of Lancaster
as the editor spearheading the program. But the funding and final publication of the books are planned
to be the responsibility of a separate organization set up in partnership with a commercial publisher.
Initial conversations with prospective partners have been highly encouraging. Even more gratifying has
been the reaction of prospective authors of the books concerned, who have unanimously applauded
our decision to get involved in this important aspect of teaching and are delighted to be participants.
Central to the success of the program will be the use of the newly acquired and splendidly refurbished
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Meier House at Banbury, as a writing center where authors can retreat from the pressures of other aca-
demic activities.
The prospects for this leap forward in the book publishing program are truly exciting and have a
pleasing symmetry with the Laboratory's intiation this year of its own graduate school. Our goal for the
textbook program is an ambitious combination of first-class publishing, a novel educational approach,
and substantial financial success.
Journal Publishing
The three Cold Spring Harbor journals, Genes & Development, Genome Research, and Learning &
Memory, were offered more manuscripts for publication this year and the number of pages published
by each rose substantially. Their contents diversified with the addition of short papers and regular
reviews to Genes & Development, website reviews to Genome Research, and the publication of spe-
cial issues of Learning & Memory devoted to single topics such as mushroom bodies and transgenic
techniques.
Online editions of Genes & Development and Genome Research, initiated in 1997 in a partnership
with the High Wire Press of Stanford University, were renewed for the first time. Print editions of jour-
nals have an elaborate infrastructure for such renewal, particularly at an institutional level, but sub-
scription management is one of many ways in which the business of electronic journals is still evolving,
and we were pleased when this milestone was passed with only minor difficulties.
Learning & Memory was published online for the first time in November, aided by a grant from the
Oliver S. and Jennie R. Donaldson Charitable Trust, and an electronic subscription was made available
starting January 1999. All three journals are currently offered as a combination of print and online edi-
tions, which provides users with the optimum blend of paper's portability and software's flexibility. One
of the many benefits of the collaboration with High Wire Press is our membership of the community of
publishers participating in the Stanford initiative. Respectful of the different agendas of these organiza-
tions, largely nonprofit but with often quite divergent goals, High Wire has enabled open discussion of
many publishers' experiments, so that real information is available on which to base business decisions
in this emerging marketplace. Several organizations have decided that print issues are a liability quick-
ly to be disposed of. For the moment, encouraged by our readers, we take a different view.
All three journals were buoyed by increasing subscriptions, particularly from institutions, higher
advertising sales, and increasing influence as measured by the Institute for Scientific Information. The
impact factor of Genes & Development increased to 18.86 in 1998, ranking it, as last year, in the top
ten of all primary research journals. The impact factor for Genome Research rose from 3.67 last year
to 5.42, placing it second among genome science journals. And Learning & Memory acquired an
impact factor for the first time, at 3.67, positioning it 13th among the enormous number and diversity
of neuroscience journals. This measure is likely to improve since the journal's acceptance this year for
inclusion in Med line and Index Medicus.
As always, we are grateful to the scientists who edit our journals from locations beyond Cold
Spring Harbor: Davor Solter (Freiburg) at Genes & Development; Mark Boguski (Bethesda), Aravinda
Chakravarti (Cleveland), Richard Gibbs (Houston), Eric Green (Bethesda), and Richard Myers (Palo Alto)
at Genome Research; and Jack Byrne (Houston) at Learning & Memory.
Marketing and Distribution
Marketing activities in 1998, which centered on direct mail, meeting exhibits, space advertising, and
the Web, produced increased income. A new catalog of front and mid-list titles and the fall New Book
Titles newsletter were widely circulated. Striking, large-format four-color brochures advertising the Cells
and Genome Analysis manuals successfully drew sales for these new and important titles.
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Exhibits were mounted at 14 major scientific society meetings, twice the number attended last
year. Our largest presence was at the ASCB meeting held in December, where the newly published
Using Antibodies was launched. The thriving Cold Spring Harbor meetings and courses provide further
promotional opportunities and John Coffin and Steve Hughes, two of the editors of the Retroviruses
volume, signed numerous copies of the book during the Retroviruses meeting in May.
A gratifyingly high proportion of our books received favorable reviews in prominent locations such
as Nature, Science, and the Trends journals. In addition, the 1997 title Mutants of Maize won honor-
able mention in the biological sciences category at the annual awards of the Professional and Scholarly
Publishing Division of the American Association of Publishers.
The Press website, consistently updated with new announcements and descriptions of new
releases, is a marketing channel of growing importance and has become the definitive statement of our
book program. During the year, the site was redesigned and book covers for 1998 and 1997 titles were
added. Electronic advertisements on other websites added to the online visibility of our publications.
In the Fulfillment Department, a new proprietary package for order fulfillment was fully implement-
ed and has already demonstrated its effectiveness and flexibility. It permits major improvements in the
speed and accuracy of attention to customer requirements and the subsequent analysis of sales and
costs.
Staff
The staff members of the Press as of December 1998 are listed elsewhere in this volume. Gratitude
and thanks are extended to each one of them for the hard work, commitment, and participation in the
processes of change that led to this successful year. It should be noted that we are now a truly net-
worked organization, with staff members Judy Cuddihy and Kaaren Janssen making important contri-
butions as book editors from their home offices in New Mexico and Connecticut, respectively; Ingrid
Benirschke managing many of our marketing activities from San Diego; and several freelance associ-
ates of the editorial development department telecommuting from locations as far apart as Seattle,
Washington, and Malvern, U.K.
The heart of any publishing program is the quality of its output and in this respect we are fortu-
nate to be able to work with some of the world's most outstanding scientists. But to create the vehi-
cle for that work and find an audience for it, many additional kinds of craft must be applied. For the
careful, intelligent application of this expertise, we are grateful for the leadership of the senior staff of
the Press: the editors of our journals, Terri Grodzicker at Genes & Development and Laurie Goodman
at Genome Research; Jan Argentine, Editorial Development Manager; Denise Weiss, Production
Manager; Ingrid Benirschke, Marketing Manager; Marcie Ebenstein, Advertising Manager; Nancy
Hodson, Business Manager; and Guy Keyes, Fulfillment and Distribution Manager.
John R. Inglis
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GEORGE LANE NICHOLS MEMORIAL
FINANCIAL STATEMENTS
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
December 31, 1998 and 1997
Assets: 1998 1997
Cash and cash equivalents $ 16,258,527 16,542,395
Investments 158,108,972 140,573,553
Accounts receivable:
Publications 782,598 829,653
Other 172,405 158,235
Grants receivable 2,384,707 3,038,893
Contributions receivable 2,657,748 1,707,605
Publications inventory 1,923,784 1,991,707
Prepaid expenses and other assets 1,482,543 1,377,264
Investment in employee residences 2,464,260 2,269,345
Land, buildings and equipment:
Land and land improvements 12,557,726 9,980,071
Buildings 69,897,882 66,519,640
Furniture, fixtures, and equipment 5,037,823 4,950,130
Laboratory equipment 12,626,629 12,655,257
Library books and periodicals 365,630 365,630
Construction in progress 4,256,539 626,728
104,742,229 95,097,456
Less accumulated depreciation and amortization (32,455,453) (30,500,090)
Land, buildings, and equipment, net 72,286,776 64,597,366
Total assets $ 258,522,320 233,086,016
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $ 2,809,788 2,599,761
Notes payable 276,163 645,839
Bonds payable 30,000,000 30,000,000
Deferred revenue 3,358,722 5,554,037
Total liabilities 36,444,673 38,799,637
Net assets:
Unrestricted
General operating 10,598,288 5,760,936
Designated by board for:
Research programs 1,900,000 1,150,000
Capital expenditures 1,207,889 3,709,145
Endowment 71,296,987 70,713,010
Net investment in plant 42,010,613 33,951,527
Total unrestricted 127,013,777 115,284,618
Temporarily restricted 4,185,424 4,723,413
Permanently restricted 90,878,446 74,278,348
Total net assets 222,077,647 194,286,379
Total liabilities and net assets $ 258,522,320 233,086,016
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year Ended December 31, 1998
With comparative totals for the year ended December 31, 1997
Unrestricted
Temporarily
Restricted
Permanently
Restricted
1998
Total
1997
Total
Revenue, gains, and other support:
Public support (contributions and
nongovernment grant awards) $ 9,069,659 4,155,424 9,342,949 22,568,032 14,010,944
Government grant awards 15,929,141 15,929,141 15,392,415
Indirect cost allowances 11,230,797 11,230,797 10,000,564
Other revenue:
Program fees 2,388,531 2,388,531 2,117,904
Rental income 333,196 - 333,196 389,658
Publications sales 6,341,142 6,341,142 5,237,814
Dining services 2,444,384 2,444,384 2,172,196
Rooms and apartments 1,877,794 1,877,794 1,712,294
Royalty and licensing fees 754,705 754,705 679,082
Net appreciation in fair
value of investments 4,686,928 7,257,149 11,944,077 17,183,813
Investment income
(interest and dividends) 6,053,220 - 6,053,220 5,677,213
Miscellaneous 124,984 - 124,984 167,324
Total other revenue 25,004,884 - 7,257,149 32,262,033 35,337,298
Net assets released from restrictions 4,693,413 (4,693,413) -
Total revenue, gains, and other support 65,927,894 (537,989) 16,600,098 81,990,003 74,741,221
Expenses:
Research 28,718,081 28,718,081 27,715,449
Summer programs
(meetings and courses) 7,834,447 7,834,447 6,848,437
Publications 6,219,895 6,219,895 5,400,006
Banbury Center conferences 877,834 877,834 953,562
DNA Learning Center programs 1,034,538 - 1,034,538 627,763
General and administrative 6,663,226 - - 6,663,226 6,091,915
Dining services 2,850,714 - 2,850,714 2,617,705
Total expenses 54,198,735 - 54,198,735 50,254,837
Increase (decrease) in net assets 11,729,159 (537,989) 16,600,098 27,791,268 24,486,384
Net assets at beginning of year 115,284,618 4,723,413 74,278,348 194,286,379 169,799,995
Net assets at end of year $ 127,013,777 4,185,424 90,878,446 222,077,647 194,286,379
CONSOLIDATED STATEMENTS OF CASH FLOWS
Year ended December 31, 1998 and 1997
1998 1997
Cash flows from operating activities:
Increase in net assets $ 27,791,268 24,486,384
Adjustments to reconcile increase in net assets to net
cash provided by operating activities:
Depreciation and amortization 3,443,290 3,370,584
Net appreciation in fair value of investments (11,944,077) (17,183,813)
Contributions restricted for long-term investment (10,762,186) (4,998,910)
Changes in assets and liabilities:
Decrease (increase) in accounts receivable 32,885 (306,794)
Decrease (increase) in grants receivable 654,186 (787,248)
(Increase) decrease in contributions receivable (950,143) 1,810,560
Decrease (increase) in publications inventory 67,923 (565,589)
Increase in prepaid expenses and other assets (105,279) (68,803)
Increase in accounts payable and accrued expenses 210,027 1,129,754
Decrease in deferred revenue (2,195,315) (161,473)
Net cash provided by operating activities 6,242,579 6,724,652
Cash flows from investing activities:
Capital expenditures (11,132,700) (8,316,421)
Proceeds from sales and maturities of investments 25,341,828 100,940,803
Purchases of investments (30,933,170) (100,647,823)
Net change in investments in employee residences (194,915) 101,598
Net cash used in investing activities (16,918,957) (7,921,843)
Cash flows from financing activities:
Permanently restricted contributions 9,342,949 335,498
Contributions restricted for investment in land, buildings, and equipment 1,419,237 4,663,412
Repayment of notes payable (369,676) (570,122)
Issuance of notes payable 351,000
Net cash provided by financing activities 10,392,510 4,779,788
Net (decrease) increase in cash and cash equivalents (283,868) 3,582,597
Cash and cash equivalents at beginning of year 16,542,395 12,959,798
Cash and cash equivalents at end of year $ 16,258,527 16,542,395
Supplemental disclosures:
Interest paid $ 1,254,036 1,239,341
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COMPARATIVE OPERATING HISTORY 1994-1998
(Dollars in Thousands)
1994 1995 1996 1997 1998
Revenue:
Main Lab:
Grants and contracts $ 19,293 19,653 20,879 22,743 24,025
Indirect cost reimbursement 8,460 8,881 9,704 9,910 11,054
Other 6,808 7,461 7,859 8,472 9,441
CSHL Press 4,390 5,119 4,805 5,238 6,341
Banbury Center 1,569 1,732 1,214 1,495 1,444
DNA Learning Center 824 954 754 875 1,334
Total income 41,344 43,800 45,215 48,733 53,639
Expenses:
Main Lab:
Research and training 19,293 19,653 20,879 22,743 24,025
Operation and maintenance of plant 5,141 5,266 5,446 5,274 5,549
General and administrative 2,909 3,329 3,438 3,625 3,378
Other 4,847 4,959 5,367 5,759 7,328
CSHL Press 4,309 5,079 5,032 5,320 6,141
Banbury Center 1,498 1,643 1,225 1,437 1,321
DNA Learning Center 798 958 781 887 1,228
Total expenses, excluding depreciation 38,795 40,887 42,168 45,045 48,970
Excess before depreciation, amortization,
and release of designated funds 2,549 2,913 3,047 3,688 4,669
Depreciation and amortization (2,668) (2,821) (2,988) (3,371) (3,443)
Release (designation) of funds (1) 200 - (750)
Net operating excess $ 81 92 59 317 476
The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
(1) Funds designated to underwrite future direct and indirect expenses of the neuroscience, imaging, computational neuroscience, and other research programs.
COLD SPRING HARBOR LABORATORY Corporate Contributions and
SOURCES OF REVENUE Grants
YEAR ENDED DECEMBER 31, 1998 5.0%
Auxiliary Activities
18.6
Interest and Miscellaneous
1.4%
Royalty and Licensing Fees
3.3 %
Federal Grants
35.8 %
Foundation and Private
Contributions and Grants
28.4
Endowments and Board
Designated Funds
7.5 %
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the DNA Learning Center receive a substantial
portion of their funding through grants from the Federal Government and through grants, capital gifts,
and annual contributions from private foundations, corporations, and individuals. The following section
summarizes funding that occurred during 1998.
GRANTS January 1, 1998-December 31, 1998
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 1998 Funding*
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Program Projects Dr. Herr 1/92-12101 $ 4,005,655
Dr. McCombie 9/98-7/99 1,100,000
Dr. Stillman 8/90-7/00 3,104,389
Dr. Tully 5/96-4/99 726,521
Research Support Dr. Beach 5/94-2/99 328,573
Dr. Beach 8/95-5/00 275,338
Dr. Cline 12/95-11/98 292,524
Dr. Cline 3/98-2/01 279,341
Dr. Futcher 4/93-3/01 267,507
Dr. Futcher 1/91-12/99 175,093
Dr. Hengartner 5/95-4/00 242,477
Dr. Hernandez 7/87-6/00 152,992
Dr. Herr 8/96-7/00 212,883
Dr. Hirano 5/96-4/00 214,855
Dr. Joshua-Tor 8/96-7/99 234,063
Dr. Krainer 7/89-6/02 418,728
Dr. Malinow 5/92-4/00 252,839
Dr. Malinow 4/95-2/03 357,330
Dr. Nedivi 7/97-8/98 22,393
Dr. Neuwald 10/98-8/01 360,556
Dr. Skowronski 4/98-3/03 452,942
Dr. Spector 4/95-3/99 338,280
Dr. Stillman 7/91-5/00 518,706
Dr. Svoboda 12/98-11/03 433,635
Dr. Tonks 8/91-3/01 495,885
Dr. Tonks 5/97-4/01 282,203
Dr. Tully 4/94-3/02 332,224
Dr. Tully 8/96-6/00 288,400
Dr. Tully 5/97-4/99 84,500
Dr. Van Aelst 12/97-11/01 361,040
Dr. Wig ler 7/95-4/99 1,465,194
Dr. Wig ler 7/98-4/02 949,501
Dr. Xu 12/97-11/02 285,815
Dr. Yin 9/96-8/99 275,374
Dr. Yin 10/97-9/01 100,000
Dr. Zhang 9/97-8/00 354,253
Dr. Zhong 2/96-1/00 250,385
New Grants Awarded in 1998
*Includes Direct and Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 1998 Funding'
Fellowships Dr. Dickinson 7/97-11/98 10,743
Dr. Dubnau 7/96-6/99 28,600
Dr. Haas 7/98-6/01 26,176 *
Dr. Horiuchi 10/98-9/00 26,176 *
Dr. Kogan 1/97-12/98 29,160
Dr. Nimchinsky 9/98-8/00 30,160 *
Training Support Training in Cancer Cell Biology and 7/94-2/99 176,841
Tumor Virology
Course Support Advanced Bacterial Genetics 5/93-4/99 62,089
Cancer Research Center Workshops 4/92-3/00 268,388
Neurobiology Short-term Training 5/82-4/01 143,129
Analysis of Large DNA Molecules 4/91-3/01 54,469
Computational Genomics 9/91-8/01 41,224
In Situ Hybridization and Immuno-
cytochemistry
7/98-6/03 61,929 *
Automated Genome Sequencing 4/95-3/01 77,960
Molecular Biology and Development
of Xenopus laevis
4/96-3/00 10,000
Caenorhabditis elegans 8/98-6/01 36,101 *
Meeting Support Genome Mapping and Sequencing 4/90-3/99 37,871
The Cell Cycle 4/98-3/99 11,000 *
Zebrafish Development and Genetics 4/98-3/99 18,090 *
Genetics of Aging 4/98-3/00 25,732 *
Heat Shock Proteins and Molecular 5/98-4/99 5,000 *
Chaperones
63rd Symposium: Mechanisms of 6/98-5/01 10,000 *
Transcription
Cancer Genetics and Tumor Suppressor 7/98-6/99 10,000 *
Mouse Molecular Genetics 7/98-6/99 15,000 *
Gametogenesis 7/98-6/99 6,000 *
NCI Cancer Workshop 1/98-12/98 10,075 *
Gene Therapy 8/98-7/99 24,000 *
Conditional Genetic Technologies in
the Mouse Workshop
9/98-8/99 26,000 *
Equipment Automated DNA Sequencer 5/98-5/99 128,500 *
NATIONAL SCIENCE FOUNDATION
Cooperative Agreement Drs. Martienssen/McCombie 9/96-8/99 1,335,000
Research Support Dr. Cline 9/96-8/99 108,750
Dr. Grossniklaus 8/97-7/00 125,000
Dr. Jackson 1/98-12/00 100,000 *
Dr. Ma 1/98-8/99 87,292 *
Dr. Ma 4/98-8/99 22,490
Dr. Martienssen 11/98-10/99 736,538 *
Dr. Nest ler 4/98-3/00 100,000 *
Training Support Undergraduate Research Program 6/91-5/00 50,000
Course Support Arabidopsis Molecular Genetics 6/94-5/00 60,000
Early Development of Xenopus laevis 9/98-8/02 19,311 *
Computational Neuroscience: Vision 7/98-6/99 46,710 *
*New Grants Awarded in 1998
*Includes Direct and Indirect Cost
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Grantor Program/Principal Investigator Duration of Grant 1998 Funding+
Meeting Support The Cell Cycle 4/98-3/99 4,000 *
Zebrafish Development and Genetics 2/98-3/99 9,000 *
Mouse Molecular Genetics 5/98-4/99 4,000 *
Gametogenesis 9/98-8/99 12,776 *
The Molecular Genetics of Bacteria
and Phages
9/98-8/99 5,000 *
Equipment Genomic Computing Resource 9/98-8/01 113,615 *
DEPARTMENT OF ENERGY
Research Support Dr. Martienssen 8/91-2/01 98,000
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Drs. McCombie/Martienssen 9/97-8/00 122,773
Dr. Martienssen 9/97-8/00 64,915
Drs. McCombie/Martienssen 7/98-8/01 98,456 *
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Futcher 7/97-6/00 99,802
Dr. Hannon 9/96-8/00 150,000
Dr. Hengartner 7/97-6/00 99,698
Fellowship Support Dr. Liu 12/96-11/99 39,474
J. Polyakova 7/97-6/00 20,000
Dr. Schneider 8/97-7/00 41,000
Dr. Sherlock/Donovan 7/97-6/00 41,000
MISCELLANEOUS GRANTS
Research Support
American Cancer Society Dr. Wig ler, Professorship 1986-2012 50,000
Dr. Wig ler, Supply Allowance 1986-1998 10,000
Calbiochem-Novabiochem Dr. Krainer 2/96-1/00 60,000
Corporation
Council for Tobacco Research Dr. Futcher 1/97-12/99 67,500
Dr. Skowronski 7/97-6/00 78,751
Devgen N.V. Dr. Hengartner 4/98-3/01 200,000
The Lillian Goldman Charitable Dr. Wig ler 9/98-8/99 300,000
Trust through The Breast
Cancer Research Foundation
Lita Annenberg Hazen Neurobiology Support 12/98-11/99 200,000 *
Foundation
The John A. Hartford Dr. Tully 1/97-12/99 302,082
Foundation, Inc.
Helicon Therapeutics Drs. TullyNin 9/97-8/00 1,400,000
Human Frontier Science Dr. Hirano 7/98-6/01 55,000 *
Program Dr. Svoboda 9/98-8/01 64,484 *
Huntington Breast Cancer Dr. Wig ler 10/98-9/99 25,000 *
Action Coalition
1 in 9: L.I. Breast Cancer Dr. Wig ler 1998 100,000 *
Action Coalition
*New Grants Awarded in 1998
'Includes Direct and Indirect Cost
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L.I.F.E. Dr. Wig ler 1998 4,590 "
March of Dimes Dr. Enikolopov 6/98-5/00 66,048 *
The McKnight Endowment Dr. Yin 7/96-6/99 50,000
Fund for Neuroscience
Mellam Family Foundation Dr. Tonks 12/96-11/00 50,000
Maxfield Foundation Dr. Lazebnik 12/98-11/99 5,000 *
Merck Genome Research Dr. Zhang 11/97-10/99 90,000
Institute
Monsanto, Inc.-Plant Dr. Martienssen 1/98-12/02 135,000 *
Consortium Program
NIH/The Jackson Laboratory Dr. Stein 1/98-12/98 44,253 *
Consortium Agreement
NIH/Sloan Kettering Dr. Wig ler 9/95-8/00 399,261
Consortium Agreement
NIH/Sloan Kettering Drs. TonksNan Aelst 8/97-5/01 444,152
Consortium Agreement
NIH/Nanoprobes, Inc. Dr. Spector 9/96-8/00 31,439
Consortium Agreement Dr. Spector 9/96-8/00 12,724
NIH/University of Pennsylvania Dr. Yin 10/97-9/01 100,000
Consortium Agreement
NIH/Washington University Dr. Stein 1/98-6/99 182,762 *
Consortium Agreement
N.A.T.O. Dr. Hannon 1/98-4/99 5,080 *
Novartis-Plant Consortium Dr. Martienssen 1/98-12/02 135,000 *
Program
Offin Charitable Trust Dr. Hengartner 8/98-7/99 25,000 *
Perkin Fund Dr. Zhong 6/97-5/99 25,000
Pioneer Hi-Bred International Dr. Grossniklaus 10/97-9/99 35,000
Michael Rankowitz and Shelia Dr. Zhong 4/98-3/99 25,000 *
Heffron
Roche Discovery Welwyn Dr. Stenlund 1/98-12/98 50,000 *
The Kelly Rich Rett Dr. Hatchwell 12/98-11/99 10,000 *
Research Foundation
Robin and Enrique Senior Dr. Hellman 12/97-11/99 10,000
Philanthropic Fund of The
Jewish Communal Fund
Seraph Foundation Dr. Enikolopov 12/98-11/99 27,000 *
Dr. Lazebnik 12/98-11/99 23,000 *
Lauri Strauss Leukemia Dr. Tonks 12/97-11/98 15,000
Foundation, Felix Schnyder
Memorial Fund
Alexander and Margaret Stewart Dr. Hannon 1/98-12/98 150,000 *
Trust Dr. Hengartner
Dr. Stenlund
Dr. Tonks
St. Giles Foundation Dr. Wig ler 4/98-3/00 251,000 *
Tularik, Inc. Dr. Wig ler 10/97-10/03 660,000
Westvaco-Plant Consortium Dr. Martienssen 1/98-12/02 135,000 *
Program
The Whitaker Foundation Dr. Svoboda 6/98-7/01 87,380 *
Fellowships
Academy of Finland Dr. Vaahtoka 12/97-12/98 8,368 *
Rita Allen Foundation Dr. Hengartner 9/94-8/99 30,000
American Cancer Society Dr. Kass-Eisler 11/96-10/99 28,000
Burroughs Wellcome Fund Dr. Mainen 9/97-8/99 58,300
*New Grants Awarded in 1998
'Includes Direct and Indirect Cost
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CSHL Association Dr. Ding 4/95-3/99 181,559
Dr. Fraser
Dr. Jackson
Dr. Kidner
Dr. Shen
Dr. Spillane
Dr. Tansey
European Molecular Biology Dr. Gartner 6/97-3/99 36,000
Organization
Fonds National Suiss de la Dr. Vielle-Calzada 1/98-3/00 12,000 *
Recherche Scientifique
Joseph G. Goldring Foundation Dr. Stillman 7/98-6/99 50,000
Human Frontier Science Dr. Cartegni 10/97-9/99 35,400
Program Dr. Chong 10/97-9/99 35,400
Dr. Mendez 10/97-9/99 35,400
Dr. Poncer 4/97-3/99 29,400
Dr. Soengas 6/97-6/99 35,400
IBRO Fellowship Dr. Filipowski 3/98-3/99 25,000
Dr. Lendvai 3/98-2/99 25,000
Japan Society for Promotion Dr. Hayashi 1/98-3/98 7,500
of Science Dr. Shibahara 4/97-3/99 40,000
Sidney Kimmel Foundation Dr. Lowe 7/97-6/99 100,000
Dr. Van Aelst 7/97-6/99 100,000
Esther A. and Joseph Dr. Svoboda 7/98-6/01 40,000
Klingenstein Fund, Inc.
Charles Henry Leach II Dr. Enikolopov 1/97-12/97 25,000
Foundation
Leukemia Society of America, Dr. Kimura 7/97-6/00 36,700
Inc. Dr. Pendergrast 7/98-6/01 39,700 *
Dr. Tansey 7/96-6/99 35,640
Dr. Weinreich 7/97-6/00 36,700
New Zealand Foundation for Dr. Packer 12/97-11/99 59,940
Research Science and
Technology
Pew Charitable Trust Dr. Hannon 7/97-6/01 50,000
Dr. Hirano 7/96-6/00 50,000
Dr. Lazebnik 7/95-6/99 50,000
Dr. Svoboda 7/98-6/02 50,000 *
Rotary Foundation Dr. Shibahara 9/97-9/98 19,400
Searle Scholars Program Dr. Grossniklaus 7/98-6/01 60,000 *
Andrew Seligson Memorial Dr. Fearnhead 1/97-12/98 35,000
Fellowship
Mildres Scheel-Stiftung Krebshilfe, Dr. Schmitt 2/98-2/00 26,000 *
The German Cancer Aid
Tularik, Inc. Fellowships 1/98-12/03 100,000 *
Uehara Memorial Foundation Dr. Hayashi 4/98-12/98 18,000 *
The V Foundation Dr. Van Aelst 8/97-7/99 50,000
Helen Hay Whitney Dr. Sun 1/97-12/99 30,000
Foundation
The Wellcome Trust Dr. Chew 2/98-1/99 15,000 *
Dr. Connolly 6/97-5/99 10,990
Henry Wendt Dr. Nakaya 1998 56,450
Dr. Wang
Training Support
Howard Hughes Graduate Student Support 1994-1999 28,000
Medical Institute
'New Grants Awarded in 1998
'Includes Direct and Indirect Cost
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Course Support
Applied Spectral Imaging Advanced Molecular Cytogenics 1998 10,000 *
Chroma Technology Advanced Molecular Cytogenics 1998 5,000 *
Corporation
Cyber lab, Inc. Crystallography Workshop 1998 1,000 *
Grass Foundation Scholarships 5/94-4/99 15,000
Hampton Research Corporation Crystallography Workshop 1998 500 *
Hoffmann-La Roche Inc. Crystallography Workshop 1998 400 *
Howard Hughes Medical Advanced Neurobiology Courses 1991-1999 275,000
Institute
Esther A. and Joseph Advanced Neurobiology Courses 3/98-2/99 60,000 *
Klingenstein Fund, Inc.
Labscientific, Inc. Crystallography Workshop 1998 250 *
Leica Imaging Systems, Inc. Advanced Molecular Cytogenics 1998 5,000 *
Molecular Structure Crystallography Workshop 1998 1,000 "
Corporation
Nonius Crystallography Workshop 1998 500 *
Protein Solutions, Inc. Crystallography Workshop 1998 500 *
Vysis Advanced Molecular Cytogenics 1998 5,000 *
Carl Zeiss Advanced Molecular Cytogenics 1998 5,000 *
Meeting Support
Affinity Bioreagents, Inc. Heat Shock 1998 1,000 *
Alhzeimer's Association Heat Shock 1998 2,500 *
Bedex Laboratories Vector Targeting Strategies for 1998 1,000 *
Therapeutic Gene Delivery
Bristol-Myers Squibb Co. Heat Shock 1998 500 *
Cereon Genomics The Arabidopsis Genome: From 1998 1,000 *
Model to Crops
Cystic Fibrosis Foundation Heat Shock 1998 2,000 *
De Kalb Genetics Corporation The Arabidopsis Genome: From 1998 1,500 *
Model to Crops
Gen Medicine, Inc. Vector Targetting Strategies for 1998 2,000 *
Therapeutic Gene Delivery
Gen Vec, Inc. Vector Targeting Strategies for 1998 1,000 *
Therapeutic Gene Delivery
Genzyme Vector Targeting Strategies for 1998 1,000 *
Therapeutic Gene Delivery
Glaxo Wellcome Inc. Vector Targeting Strategies for 1998 500 "
Therapeutic Gene Delivery
Irvine Scientific Translational Control 1998 3,500 *
Johnson & Johnson Vector Targeting Strategies for 1998 500 *
Corporation Therapeutic Gene Delivery
Key Gene N.V. The Arabidopsis Genome: From 1998 2,000 *
Model to Crops
Lalor Foundation Gametogenesis 1998 5,000 *
Leica Imaging Systems, Inc. Zebrafish 1998 1,200 *
Lexicon Genetics, Inc. Corporate Contribution Program 1998 3,000 *
Lilly Research Laboratories Vector Targeting Strategies for 1998 500 *
Therapeutic Gene Delivery
March of Dimes Gametogenesis 1998 6,000 *
Marine Biotech, Inc. Zebrafish 1998 1,000 *
Medical & Biological Heat Shock 1998 5,000 *
Laboratories Co., Ltd.
New Grants Awarded in 1998
*Includes Direct and Indirect Cost
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Megabios Corporation Vector Targeting Strategies for 1998 1,000 *
Therapeutic Gene Delivery
Merck Research Laboratories Heat Shock 1998 2,000 *
Novartis Crop Protection, Inc. The Arabidopsis Genome: From 1998 1,000 *
Model to Crops
Pioneer Hi-Bred International,
Inc.
The Arabidopsis Genome: From
Model to Crops
1998 500 *
Promega Corporation Translational Control 1998 1,000 *
RiboGene, Inc. Translational Control 1998 10,000 *
Selective Genetics Inc. Vector Targeting Strategies for 1998 1,000 *
Therapeutic Gene Delivery
Systemix Vector Targeting Strategies for 1998 2,000 *
Therapeutic Gene Delivery
Stress Gen Biotechnologies Heat Shock 1998 7,500 *
Corporation
Transgene S.A. Vector Targeting Strategies for 1998 1,000 *
Therapeutic Gene Delivery
Carl Zeiss Zebrafish 1998 1,200 *
Zeneca Pharmaceuticals Vector Targeting Strategies for 1998 500 *
Therapeutic Gene Delivery
'New Grants Awarded in 1998
includes Direct and Indirect Cost
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BANBURY CENTER
Grantor Program/Principal Investigator Duration of Grant 1998 Funding'
FEDERAL SUPPORT
The Federal Judicial Center,
Judiciary Leadership
Development Council
NIH-National Heart, Lung, and
Blood Institute
NIH-National Human Genome
Research Institute
NIH-National Institute of Allergy
and Infectious Diseases
NONFEDERAL SUPPORT
Meeting Support
ALS Association
The William Theodore Dens low
Foundation
Glaxo Wellcome Inc.
The Dorothy Russell
Havemeyer Foundation, Inc.
Immunetics
The Merck Genome Research
Institute, Inc.
National Marfan Foundation
Oxnard Foundation
Private Contributions
Research Genetics, Inc.
Albert B. Sabin Vaccine Institute, Inc.
at Georgetown University
Shriners Hospitals for Children
SmithKline Beecham
Pharmaceuticals
The Swartz Initiative for
Computational Neuroscience
Tularik Inc.
'New Grants Awarded in 1998
'Includes Direct and Indirect Cost
The Art of Judging: Perspectives of
Science
The Molecular Basis of Asthma:
Fundamental Processes with Potential
Genetic and Therapeutic Targets
Large-scale Discovery and Genetic
Applications of SNPs
Laboratory Methods for the Diagnosis
of Lyme Disease
1998
1998
1998
1998
$15,855 *
5,842 *
14,240 *
11,393 *
Superoxide Dismutase and Motor 1998 32,940 *
Neuron Disease
The Molecular Basis of Asthma: 1998 27,331 *
Fundamental Processes with Potential
Genetic and Therapeutic Targets
Large-scale Discovery and Genetic 1998 23,773 *
Applications of SNPs
Horse Genomics and the Genetics of 1998 25,000 *
Factors Affecting Horse Performance
Laboratory Methods for the Diagnosis 1998 5,000 *
of Lyme Disease
Full-length cDNA Cloning: A Workshop 1998 24,861 *
on Problems and Solutions
Critical Issues in Marfan Research 1998 11,563 *
Muscle Gene Regulation and Its 1998 47,826 *
Therapeutic Potential
The Molecular Basis of Asthma: 1998 2,000 *
Fundamental Processes with Potential
Genetic and Therapeutic Targets
Full-length cDNA Cloning: A Workshop 1998 2,000 *
on Problems and Solutions
From Bench to Bedside: Colloquium 1998 13,785 *
on Translational Vaccine Research
Critical Issues in Marfan Research 1998 5,000 *
Laboratory Methods for the Diagnosis 1998 5,000 *
of Lyme Disease
Neurocomputational Strategies: From 1998 40,655 *
Synapses to Behavior
The Molecular Basis of Asthma: 1998 1,000 *
Fundamental Processes with Potential
Genetic and Therapeutic Targets
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Grantor Program/Principal Investigator Duration of Grant 1998 Funding*
FEDERAL SUPPORT
NATIONAL INSTITUTES OF HEALTH Creation of a Digital Archive on the 2/98-1/00 $148,358
National Human Genome Research Institute American Eugenics Movement
NATIONAL SCIENCE FOUNDATION A Novel Mechanism for Introducing 4/95-4/98 16,245
Human Genome Research in Freshman
Biology Classes, Mark Bloom
A Partnership to Develop Advanced 8/97-7/00 138,856
Technology Units on Genomic Biology
DEPARTMENT OF ENERGY The Science and Issues of Human DNA 1/97-1/00 91,073
Polymorphisms: An ELSI Training
Program for High School Biology
Teachers
NONFEDERAL GRANTS
Hearst Foundation Genetics as a Model for Whole Learning 7/98-6/99 22,234
Howard Hughes Medical Institute Precollege Science Education Initiative
for Biomedical Research Institutions
7/94-8/99 77,169
Josiah Macy, Jr. Foundation Gene Almanac 10/97-9/00 264,418
NYS Education Department 1/98-12/98 48,954*
The following schools each awarded a grant for the Genetics as a Model for Whole Learning Program:
China Town School District 1 4,950 Mamaroneck Union Free School District 500
Community School District 29 18,400 Massapequa Union Free School District 950
East Meadow Union Free School District 3,150 Oceanside Union Free School District 1,050
Elwood Union Free School District 2,725 Plainedge Union Free School District 1,075
Friends Academy 8,024 Port Washington Union Free School District 4,875
Garden City Public School 5,725 Old Westbury School of the Holy Child 3,896
Great Neck Union Free School District 14,515 South Huntington Union Free School District 10,150
Green Vale School 3,550 St. Dominic Elementary School 3,175
Harborfields Central School District 8,800 Syosset Central School District 17,125
Jericho Union Free School District 6,700
The following schools each awarded a grant for Curriculum Study of 1,100:
Commack Union Free School District
East Meadow Union Free School District
Elwood Union Free School District
Garden City Union Free School District
Great Neck Union Free School District
Herricks Union Free School District
Island Trees Union Free School District
South Huntington Union Free School District
Syosset Central School District
West Hempstead Union Free School District
of 1,500:
Green Vale School
Hicksville Union Free School District
Plainview-Old Bethpage Central School District
'New Grants Awarded in 1998
*Includes Direct and Indirect Cost
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Locust Valley Central School District
Massapequa Union Free School District
North Shore Central School District
Oyster Bay-East Norwich Central School District
Plainedge Union Free School District
Portledge School
Port Washington Union Free School District
Roslyn Union Free School District
Sachem Central School District
We wish to express the genuine gratitude of the trustees, administration, and most especial-
ly the scientists of Cold Spring Harbor Laboratory for the generous financial support of those
persons, corporations, and foundations whose names appear on the following pages of the
Annual Report.
Richard L. Cosnotti, Chief Development Officer
Cold Spring Harbor Laboratory is a nonprofit research and educational institution chartered
by the University of the State of New York. Less than half (44.1%) of our annual support is
derived from Federal grants and contracts, and thus, we rely heavily on support from the pri-
vate sector: foundations, corporations, and individuals. Contributions from the private sector
are tax exempt under the provisions of Section 501(c)(3) of the Internal Revenue Code. In
addition, the Laboratory is designated a "public charity" and, therefore, is enabled to receive
funds resulting from the termination of "private foundations."
METHODS OF CONTRIBUTING TO COLD SPRING HARBOR LABORATORY
Gifts of Money can be made directly to Cold Spring Harbor Laboratory.
Securities: Stock certificates may be reassigned directly or transferred through your broker.
Appreciated securities should be given outright, which will avoid capital gains taxes on the
appreciated value. Securities that have decreased in value should be sold, and the proceeds
donated. In this way, a donor will receive a deduction for both the loss and the charitable
contribution.
Life Insurance: You may designate the Laboratory as the beneficiary of an existing or new
policy, or irrevocably assign ownership of the policy. There are estate tax benefits in either
case. If ownership is assigned, there is an immediate tax deduction.
Pooled Income Funds: Combine gifts from a number of donors in a pool for attractive
investment and tax purposes.
Appreciated Real Estate or Personal Property: Sizable tax benefits can result from such
donations; the Laboratory can use some in its program and can sell others.
Charitable Remainder Trusts can be structured to suit the donor's specific desires as to
extent, timing, and tax needs.
Bequests: Most wills probably need to be updated. Designating Cold Spring Harbor
Laboratory as beneficiary ensures that a bequest will be utilized as specified.
Conversion of Private Foundation to "Public" Status on Termination: This may be
done by creating a separate fund within Cold Spring Harbor Laboratory whereby the assets
of the private foundation are accounted for as a separate fund and used for the purposes
specified by the donor. Alternatively, the private foundation can be established as a sup-
porting organization of Cold Spring Harbor Laboratory.
Matching Gifts: Many employers will match gifts to Cold Spring Harbor Laboratory and/or
the Watson School of Biological Sciences. Please check with your employer to augment
your gift.
For additional information, please contact the Chief Development Officer, Cold Spring Harbor Laboratory,
One Bungtown Road, Post Office Box 100, Cold Spring Harbor, NY 11724, 516-367-8840.
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CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 1998-December 31, 1998
Contributions of $5,000 and above, exclusive of Annual Fund
In 1998, the Laboratory received significant support in the form of capital and program contributions
from individuals, foundations, and corporations.
Rita Allen Foundation, Inc.
Banbury Fund
The Breast Cancer Research Foundation
Gladys Brooks Foundation
Burroughs Wellcome Fund
The Eppley Foundation for Research
Goldring Family Foundation
The Grass Foundation
Irving A. Hansen Memorial Foundation
The John A. Hartford Foundation
Lita Annenberg Hazen Charitable Trust
The Helen Hoffritz Foundation
Huntington Breast Cancer Action Coalition
Sidney Kimmel Foundation for Cancer Research
The Esther A. and Joseph Klingenstein Fund, Inc.
Charles Henry Leach II Foundation
Marjorie A. and William L. Matheson Charitable Trust
The Maxfield Foundation
Total $2,881,806
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The Merck Genome Research Institute
Estate of Vernon Merrill
Offin Charitable Trust
1 in 9: The Long Island Breast Cancer Action Coalition
The Perkin Fund
The Pew Charitable Trusts
The William E. and Maude S. Pritchard Charitable Trust
Michael L. Rankowitz and Sheila Heffron
John R. Reese
Roche Discovery Welwyn
Mr. and Mrs. Alan Seligson
The Seraph Foundation
St. Giles Foundation
The Stone Foundation, Inc.
The V Foundation
Westvaco
The Whitaker Foundation
Helen Hay Whitney Foundation
NANCY AND EDWIN MARKS IMAGING CENTER
CAPITAL CAMPAIGN
January 1, 1998-December 31, 1998
Contributions of $20,000 and above, exclusive of Annual Fund
The Nancy and Edwin Marks Advanced Neuroscience Imaging Center will employ a revolutionary, new
imaging technique called two-photon laser optical scanning that uses tremendous pulses of light to
image individual brain cells and networks of such cells in the intact brains of living animals. In 1998, the
Laboratory received significant support from individuals, trusts, foundations, and corporations.
Arrow Electronics
Booth Ferris Foundation
Fairchild Martindale Foundation
David H. Koch Charitable Foundation
Mary D. Lindsay
Marks Family Foundation
The William E. and Maude S. Pritchard Charitable Trust
Estate of Sophie Rubinfeld
Mary G. Turner
The Weezie Foundation
Total $2,816,410
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THE SCHOOL OF BIOLOGICAL SCIENCES
CAPITAL CAMPAIGN
January 1, 1998-December 31, 1998
Contributions of $50,000 and above, exclusive of Annual Fund
The Watson School of Biological Sciences at Cold Spring Harbor Laboratory has been established for
the purpose of granting the Ph.D. degree. Students who complete this intensive, accelerated, 4 to 4.5
year doctoral degree will have a solid foundation of basic biological processes and disease mecha-
nisms to use as they enter the highly competitive research field, academia, or corporate realm. In
1998, the Laboratory received significant support from individuals, foundations, and trusts.
Dean's Chair The Lita Annenberg Foundation
Lita Annenberg Hazen Charitable Trust
Fellowships William Stamps Farish Fund
Mr. and Mrs. David L. Luke III
Mr. and Mrs. David H. Koch
Mrs. and Mrs. William R. Miller
Mr. and Mrs. Leslie C. Quick, Jr.
Founders Endowment Anonymous (provides five fellowships)
Knight House Dr. and Mrs. Mark A. Ptashne
Graduate Residence The Seraph Foundation
Total $11,954,000
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ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
The Cold Spring Harbor Laboratory Corporate Sponsor Program continues to make a very substantial
contribution to the meetings programs in Grace Auditorium on the main campus and at Banbury
Center. This funding enables us to bring specially invited speakers to the meetings; to help underwrite
the expenses of young scientists attending meetings; and to ensure that the meetings at Banbury
Center are on cutting-edge research. More than 6000 scientists attended meetings at Cold Spring
Harbor Laboratory and Banbury Center in 1998. Full details of these meetings are found elsewhere in
this Annual Report.
The members of the Program receive special privileges in acknowledgment of their contributions.
We waive all on-site fees for eight representatives of each company at our meetings. Three of these
scientists may attend meetings at Banbury Center, where attendance is otherwise only by invitation of
the organizers. Corporate Sponsors receive gratis copies of Cold Spring Harbor Laboratory Press pub-
lications including the journals Genes & Development, Learning & Memory, and Genome Research.
Special meetings held in Grace Auditorium in the Spring and Fall are also available to Corporate
Sponsor Program members.
In addition, we acknowledge our Sponsors in all relevant publications, including the abstract books
given to every participant. The names of the sponsoring companies are listed on the poster describing
each meeting. This is mailed to approximately 17,000 scientists throughout the world. There were 37
members of the Program in 1998, including virtually all of the pharmaceutical companies and major play-
ers in biotechnology. We welcomed our first Foundation contributor, Albert B. Sabin Vaccine Institute, Inc.,
at Georgetown University. We are grateful to all members of the Program for their generosity.
COLD SPRING HARBOR LABORATORY CORPORATE SPONSORS
Alafi Capital Company
Amgen Inc.
BASF Bioresearch Corporation
Bayer Corporation
Bristol-Myers Squibb Company
Chiron Corporation
Chugai Research Institute for Molecular
Medicine, Inc.
Diagnostic Products Corporation
The DuPont Merck Pharmaceuticals
Company
Forest Laboratories, Inc.
COLD SPRING HARBOR LABORATORY
PLANT CORPORATE ASSOCIATES
American Cyanamid Company
Monsanto Company
Pioneer Hi-Bred International, Inc.
Westvaco Corporation
Genentech, Inc.
Genetics Institute
Glaxo Wellcome Inc.
Hoechst Marion Roussel
Hoffmann-La Roche Inc.
Johnson & Johnson
Kyowa Hakko Kogyo Co., Ltd.
Eli Lilly and Company
Merck Research Laboratories
Novartis Pharma Research
Novo Nordisk Biotech,
Inc./ZymoGenetics, Inc.
FOUNDATIONS
Albert B. Sabin Vaccine Institute, Inc.,
at Georgetown University
Total $858,000
OSI Pharmaceuticals, Inc.
Pall Corporation
Parke-Davis Pharmaceutical Research
PE Biosystems
Pfizer Inc.
Pharmacia & Upjohn, Inc.
Research Genetics, Inc.
Schering-Plough Corporation
SmithKline Beecham Pharmaceuticals
Wyeth-Ayerst Research
Zeneca Group PLC
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DNALC Corporate Advisory Board Annual Fund
An important objective of the Corporate Advisory Board is to provide a sustainable level of annual fund-
ing for the DNA Learning Center's programs and to increase visibility in the local business community.
As a means of reaching this objective, the Board conducts an Annual Fund and an Annual Golf
Tournament with proceeds benefiting the DNA Learning Center.
Chairman: John J. Leahy, Citibank
Vice Chairman: Gary E. Frashier, OSI Pharmaceuticals, Inc.
Michael Aboff, Aboff's Inc.
Andrew D. Ackerman, Chase
Manhattan Bank
Rocco S. Barrese, Esq., Dilworth &
Barrese
Howard M. Blankman, The Blankman
Group
Jane S. Block, Pall Corporation
Thomas J. Calabrese
Edward Chernoff, Motors & Armatures,
Inc.
Paul Czeladnicki, Rivkin, Radler &
Kremer
Robert Diller, Brinkmann Instruments
Candido E. Fuentes, M.D.
ANNUAL FUND CONTRIBUTORS
CORPORATE BENEFACTORS
Contributions of $10,000 or more
Luitpold Pharmaceuticals, Inc.
Edward A Chemoff, Motors & Armatures, Inc.
Pall Family Fund
CORPORATE PATRONS
Contributions of $5,000 or more
Laurie J. Landeau, V.M.D.
Newsday
Pall Corporation
CORPORATE ASSOCIATES
Contributions of $2,500 or more
Anonymous
Citibank
Louis and Virginia Clemente Foundation, Inc.
KPMG Peat Marwick LLP
Meenan Oil Co., LP
OSI Pharmaceuticals, Inc.
CORPORATE MEMBERS
Contributions of $1,000 or more
Aboff's Inc.
Adchem Corporation
The Blankman Group
Brinkmann Instruments, Inc.
Daniel Gale Agency
Total
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Arthur D. Herman, Herman
Development Corp.
Richard Kalenka,
PricewaterhouseCoopers
John Kean III, Kean Development
Company
Laurie J. Landeau, V.M.D.
Ralf Lange, Luitpold Pharmaceuticals,
Inc.
Lilo Leeds, CMP Publications
James Mattutat, Shore Pharmaceutical
Providers, Inc.
Patricia Petersen, Daniel Gale
Agency
William Porter, U.S. Trust Company
Dilworth & Barrese
Festo Corporation
Harweb Foundation
Herman Development Corp.
Gerard and Lilo Leeds
John and Katherine Naudin Foundation
Rivkin, Radler & Kremer
William D. Roche
The Schiff Foundation
Donald J. Sutherland
Robert and Patrick Wong
FRIENDS OF THE DNALC
Contributions of $50 or more
American Biogenetic Sciences, Inc.
John W. Andrews
Anonymous
Charles A. and Elizabeth M. Beach
Carl J. Becker
George A. Bourne
Rosemary Bourne
Thomas and Marilyn Chengot
J. and L. Conenello
Mr. and Mrs. Gerald R. Davino
Gerard and Ann E. DeGregoris, Jr.
John DeLalio
Marilyn DeLalio
Dr. and Mrs. Steven Eisner
Mr. Robert and Dr. Cynthia Hoey
Beatrice W. Ingham
J. M. R. Concrete Corp.
Dr. and Mrs. Alexander Kofinas
Mr. and Mrs. Joseph Leondis
$93,525
William D. Roche, Republic New York
Securities Corp.
Wendy Vander Poel Russell, CSHL
Honorary Trustee
Horst Saalbach, Festo Corporation
Peter G. Schiff, Northwood Ventures
LLC
Charles R. Schueler, Cablevision
Systems Corp.
James D. Shaw, Newsday
Paul A. Vermylen, Jr., Meenan Oil Co., LLP
Lawrence J. Waldman, KPMG Peat
Marwick LLP
Raymond A. Walters, Ph.D. CSH Central
School District
Richard and Anita MacDougall
James E. Mattutat
Joseph P. O'Brien Agency
John G. Peterkin
Joseph C. Pickard
George A. Roche
John G. Roche
Roslyn Eye Centre
Wendy Vander Poel Russell
Alan Shamoon
Torn Singh
Lydia T. Smith
Jeff Stern
Paige C. Sutherland
Dr. and Mrs. S.V. Tanguturi
Thomson Industries, Inc.
M. & G. Tumminio
Mr. and Mrs. Joseph C. Viviani
Raymond A. Walters, Ph.D.
Windemere Development Corporation
Zurich Centre Group
OTHER CONTRIBUTORS
James R Canner
Mr. and Mrs. C. Eisler
Philip Lichtenstein
Mr. and Mrs. Anthony Sabino
MATCHING GIFT CONTRIBUTIONS
Republic New York Securities
Zurich Centre Group
FIFTH ANNUAL GOLF TOURNAMENT SPONSORS
Golf Tournament Committee
Tournament Chairman
John C. Kean, Kean Development
Company
Vice Chairmen
Vincent L. Adimando, Badge
Insurance Agency
Howard M. Blankman, Blankman
Cunningham Group
G. Morgan Browne, Cold Spring
Harbor Laboratory
Richard A. Catalano, KPMG Peat
Marwick, LLP
Edward A. Chernoff, Motors &
Armatures, Inc.
Frank J. Ciardullo, Ciardullo
Landscape and Designs, Inc.
Paul Czeladnicki, Rivkin, Radler &
Kremer
Steven Florio, Conde Nast
Publications
Arthur D. Herman, Herman
Development Company
William Keen, Cold Spring Harbor
Laboratory
John J. Leahy, Grant Thornton
James S. Margolin, Margolin &
Margolin
James E. Mattuat, Omnicare, Inc.
Patricia Petersen, Daniel Gale
Agency
Robert Ricciuti, Diamond Mortgage
James Rojas, Diamond Mortgage
John F. Romeo, Price Waterhouse
LLP
Horst Seelbach, Festo Corporation
Founding Sponsor
J.P. Morgan and Co. Inc.
Major Corporate Sponsors
Cablevision
Luitpold Pharmaceuticals, Inc.
Corporate Sponsors
Badge Agency, Inc.
Conde Nast Publications
Festo Corporation
Kean Development Company, Inc.
KPMG Peat Marwick LLP
Motors & Armatures, Inc.
Price Waterhouse LLP
The Roslyn Savings Foundation
RMC Industrial Supply
Prize Sponsor
Gracewood Properties
Auction Prize
Lufthansa
Total
Brunch Sponsor
Zeluck Brothers, Inc.
Cocktail Reception Sponsor
Centerbrook Architects and Planner
$30,000 Hole-In-One Sponsor
Badge Insurance Agency
Golf Cart Sponsor
Diamond Mortgage
Driving Range Sponsor
Chase Manhattan Bank
Refreshments Sponsor
Herman Development Company
Putting Green Sponsor
Daniel Gale Real Estate
Gold Sponsors
All-Pro Carpet Co., Inc.
Arthur Andersen LLP
Barnes & Noble Bookstores
Brinkmann Instruments, Inc.
Mr. Thomas Calabrese
Chase Manhattan Bank
Ciardullo Landscapes and Designs,
Inc.
Daniel Gale Real Estate
Dilworth & Barrese
Ferran Brothers, Inc.
Grant Thornton
J.P. Morgan & Co. Inc.
Luitpold Pharmaceuticals, Inc.
Northwood Ventures Inc.
OSI Pharmaceuticals, Inc.
Rivkin, Radler & Kremer
Sprint
U.S. Trust Company of N.Y.
Silver Sponsors
ADT Security Services
Brinkmann Instruments, Inc.
J&H Marsh & McLennan, Inc.
Omnicare, Inc.
Sprint PCS
Suffolk Bookstore, Inc.
The Hartford
Village Green Service Center
Bronze Sponsors
Aboff's Inc.
Advantage Title
Bank of Smithtown
Callan, Regenstreich, Koster &
Brady
Margolin & Margolin, Esqs.
James Van de Walle
$119,910
Commemorative Journal
Sponsors
Alarm Guard Security Services
Alarm-Tech Security Systems, Inc.
The Albicocco Family
A Partymaker
Berger's Wholesale Meats, Inc.
Blackman-Hicksville Company
D. Reis Furniture
Essig Electrical Services Inc.
Fa la Direct Marketing, Inc.
Farrell, Fritz, Caemmerer, Cleary,
Barnosky & Armentano
Farmingdale Iron Works, Inc.
Feraco, Inc.
Fisher Scientific
G.A. Feddersen, Inc.
HRH/A.D. Herman Construction Co. Inc.
Huntington Business Products Centre
Jack Berleth & Sons
Jeff's Seafood
J&M Bakery Products
L&N Prochilo, Inc.
La Forge Francaise Ltd.
Lawrence & Lawrence
New York Biotechnology
Association, Inc.
Nortech Laboratories
Oyster Bay Appliance World Inc.
Palmetto, Mollo & Company
Paul Rosenvold Inc.
Riverhead Building Supply
Roman Concrete Corp.
Sammis, Smith & Brush
Super Millwork Inc.
Sunrise Medical Laboratories
To-Jo Provisions
Tee/Green Sponsors
Alliant Foodservice, Inc.
Blankman Cunningham Group, LLC
De Lalio Sod Farms, Inc.
Dvirka & Bartilucci
Fa la Direct Marketing, Inc.
Stirling Creek Associates
Raffle Prize Contributors
Aboff's Inc.
All-Pro Carpet Co., Inc.
Aromatherapy, Cold Spring Harbor
Arthur D. Herman
Audio Command Systems
Audio Interiors
Mr. Peter Barmonde
Barney's Restaurant
Capriccio's Restaurant
Carl Zeiss Inc.
Cineplex Odeon Cinemas
Clare Rose
Coca Cola Bottling Co.
Crossroads
Total DNA Learning Center Annual Fund $213,435
Custom Shirts by Tar low
Daniel Gale Real Etate
Distinctive Products Co.
Ecco Environmental
Ecology Tree, Inc.
Enterprise Rent-A-Car
Fa la Direct Marketing
Halesite Deli
Arthur D. Herman
Huntington Business Products Centre
Huntington Indoor Tennis
Industrial Art & Sculpture
The Inn on the Harbor
Kean Development Company
Lemongrass
L&L Camera
Main Street Nursery
Mill River Inn
National Arts Club Dining Room
Newsday
Nickels North
107 Ocean Bistro
OC Tanner
Olympus America
Oyster Bay Frame Shop
Piccolo's
Rain Man Irrigation
Rivkin, Radler & Kremer
Scarsella's Florist
Sharp
Sunderland of Scotland
Spinnaker Travel
Texas Instruments
Tiffany & Co.
Trattoria Grasso, Cold Spring Harbor
Tupelo Honey
Winebow Inc., Ltd.
Zip Limousine
Other Contributors
Bumble Ingham-The Worth
Collection
CompuMail Business Services
Country Printer
Dvirka & Bartilucci
Mr. Timothy T. Kruszewski, Wallace
Business Forms
Parker, Chapin, Flattau & Klimpl
Mr. William D. Roche
Sunrise Medical Laboratories
Tony's Fish & Seafood Corp.
Vittorio Auto Body, Inc.
Roy J. Zuckerberg Family
Foundation
Beverage Donations
Arizona Beverage
Gift Bags
Torneau
Price Waterhouse
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Cold Spring Harbor Laboratory Association (CSHLA)
Officers
Vernon L. Merrill, President*
James L. Spingarn, Vice President/Acting President
Cathy Cyphers Soref, Secretary/Treasurer
Directors
W. Dillaway Ayres, Jr.
Nicholas J. Bartilucci
Trudy H. Calabrese
Mary Ann Charlston
David C. Clark
David H. Deming
Joseph T Donohue
Frances N. Elder
President's Report
Linda R. Franciscovich
Robert A. Gay
John S. Grace
Antoine C. Kemper, Jr.
E. Coe Kerr
Carol E. Large
Mary D. Lindsay
Gilbert R. Ott, Jr.
Phillip M. Satow
Jordan Saunders
Lisa Schiff
Ann C. Seifert
Cynthia R. Stebbins
Bruce Stillman, Ph.D.
Marjorie M. von Stade
James D. Watson, Ph.D.
Succeeding many years of past accomplishments, 1998 was a year of notable achievement for the
Association and also a year tinged with great sadness. On July 13, our dynamic and highly esteemed
Association president, Vernon Merrill, passed away after a long battle with breast cancer. Her death
was both a shock and an inestimable loss. Vernon's short tenure had been one of sparkling vitality-
an attribute that those of us who follow her will surely attempt to emulate. Her direction, leadership,
wisdom, and warmth will be sorely missed. Shortly after her death, the Association directors decided
to make a contribution as a Board to the Laboratory in Vernon Merrill's memory; the funds will be used
specifically for breast cancer research.
During the course of 1998, our directors and members
helped to create a memorable year. Events, lectures, and
fundraising were all very successful. The year started with
the Next Generation Initiative lecture. CSHL investigator
Nicholas Tonks, Ph.D., spoke on "Drug Tests for Cancer
and Diabetes." It was a fascinating and extremely infor-
mative talk on the great progress being made in this
important field and the considerations that such tests
have raised. Afterward, Lola and John Grace hosted a
lovely cocktail buffet.
The Association's Annual Meeting held on February 1
began with election of officers and new directors. New
directors elected were Joseph Donohue, Franny Elder,
Robert Gay, Ann Seifert, and Marjorie von Stade. The fol-
lowing talented, devoted directors retired after years of
great contributions to the Association: Holly Brooks, our
exceptional past president John P. Cleary, Laurie Nesi,
and Gerald D. Olin. Many thanks to them for their fine ser-
vice.
*deceased July 13, 1998
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Dr. Judah Folkman at 1998 CSHLA Annual
Meeting.
Co-Chair Bob Gay, CSHLA President Vernon Merrill, and Co-Chair Nancy Gay
After the meeting, Association members were treated to a not to be forgotten lecture by Dr. Judah
Folkman, Senior Associate in Surgery and Director of the Surgical Research Laboratory at Children's
Hospital and Harvard Medical School in Boston. Dr. Folkman spoke of his twenty-plus years of inves-
tigation into anti-angiogenic therapy and his recent success in tumor eradication in mice. His research
involves interrupting the growth of tumors by curtailing the blood supply through the revolutionary
application of two compounds developed in his laboratory-angiostatin and endostatin. He told the
audience that if eventual clinical trials in humans prove to be as successful as his work in mice, then
radiation and chemotherapy treatment might eventually become unneeded in the war on cancer. The
audience was awestruck, and you could literally have heard a pin drop!
On March 8, we were fortunate to have Dr. Patrick Cunningham, Professor of Animal Genetics of
Trinity College, Dublin, give a public lecture on the "Genetics of the Thoroughbred." For those who have
wondered about the role of genetics in horse breeding and performance, myself included, this lecture
was fascinating. Dr. Cunningham made a complicated subject understandable and enjoyable.
April 18 was the night of the ever-special Blue Hill Troupe. This Gilbert and Sullivan performance
was a sell-out smash hit, and the audience thoroughly enjoyed the group's repertoire, which included
selections from many operettas. This was Blue Hill Troupe's second performance at the Laboratory,
and the event, expertly chaired by Bob and Nancy Gay and their enthusiastic committee, raised a
spectacular $23,000. The money provided support for start-up costs of CSHL assistant investigator
Bill Tansey, Ph.D., who is doing research into the very important cell division cycle and its role in can-
cer.
Association director Phillip Satow hosted a very successful reception in New York City on April 22.
Both Dr. Watson and Dr. Stillman addressed the attendees.
June brought one of the biggest events of the year, the Dorcas Cummings Memorial Lecture and
its attendant dinner parties. This year's lecture on June 7 featured Dr. Ronald Evans of the Salk
Institute, who spoke on "The Molecular Biology of Fat: Weighing the Risks." All I know is that it made
me feel very guilty. I headed home for the treadmill and a more sensible diet. Actually, the genetic dis-
cussion on fat and health was fascinating and very thought-provoking. The lecture was followed by 23
very successful dinner parties for visiting scientists, CSHL staff, and many interested friends. Cynthia
Stebbins was the organizer with the adept assistance of the Association's most capable staff. The fol-
lowing individuals deserve our special thanks for hosting dinner parties:
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Mr. and Mrs. W. Dillaway Ayres, Jr.
Ms. Mary Lenore Blair
Mr. and Mrs. Thomas J. Calabrese
Mr. and Mrs. John P Cleary
Mr. and Mrs. Norris Darrell, Jr.
Mr. and Mrs. Joseph T Donohue
Mr. and Mrs. Duncan Elder
Mr. and Mrs. Robert A. Gay
Mr. and Mrs. John S. Grace
Mr and Mrs. Antdne C. Kemper, Jr
Mr. and Mrs. E. Coe Kerr
Mr. and Mrs. Townsend J. Knight
Mr. and Mrs. Robert D. Lindsay
Mr. and Mrs. David L. Luke Ill
Mr. and Mrs. Robert G. Merrill
Mr. and Mrs. Robert O'Connor
Mr. and Mrs. Gilbert R. Ott, Jr.
Mr. and Mrs. John J. Phelan
Mr. and Mrs. Whitney D. Pidot
Mr. and Mrs. Luis E. Rinaldini
Mrs. William F. Russell
Mr. and Mrs. Douglas S. Soref
Mr. and Mrs. James L Spingarn
Mr. and Mrs. James F. Stebbins
Mr. and Mrs. John C. Stevenson
Mr. and Mrs. Hugh Wallace
Mr. and Mrs. Robert P. Walton
The annual Volunteer Appreciation Reception held at the Laboratory on September 28 was occa-
sioned by an enthusiastic turnout for a pleasant evening. This event honors all those who volunteer
their time and efforts on behalf of CSHLA.
A wonderful time was had by all at Carol and Jim Large's beautiful home for the October 18 Major
Donor Cocktail Party. Carol and Jim, thanks again for your always wonderful, and delicious, hospitality.
Last but not least, through the extraordinary dedication and efforts of our board, we have exceed-
ed our 1998 Annual Appeal goal of $675,000 by raising $701,664. The number of 1998 gifts rose to
1032 (from 684 in 1997), and the number of Association members rose to 848 (from 571 in 1997).
Wonderful participation! My special thanks and deep appreciation for all the time each Association
member contributed. Those great efforts and their generosity made this year's Annual Appeal an
unqualified success.
Let us keep up the good work and growth. It can only lead to bigger, more stunning successes and
greater support for the marvelous Cold Spring Harbor Laboratory and its dedicated scientists.
February 1999 James L. Spingarn
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Members of the Cold Spring Harbor Laboratory Association
ANGELS
Contributions of $10,000 or more
The Albert C. Bostwick
Foundation
Mr. and Mrs. John P. Cleary
Mr. and Mrs. Roderick H.
Cushman
Mr. Robert B. Gardner, Jr.
Mrs. Oliver R. Grace
Mrs. George N. Lindsay
Mr. and Mrs. David L Luke III
Dr. and Mrs. Walter C. Meier
Mr. Arthur C. Merrill
The Miller Family Foundation
Mr. and Mrs. Douglas P Mortis
Dr. David B. Pall
Quick & Reilly, Inc.
The Dorothy Schiff Foundation
Dr. and Mrs. James D. Watson
BENEFACTORS
Contributions of $5,000 or more
Mr. and Mrs. Roger L Bahnik
Mr. and Mrs. Harry A. Brooks
Mr. and Mrs. G. Morgan Browne
Mr. and Mrs. Peter B. Canna II
Mr. and Mrs. Norris Darrell, Jr.
The Samuel Freeman Charitable
Trust
Mrs. Robin T. Hadley
Mrs. John H. Livingston
Mr. and Mrs. Robert L. Marcus
Samuel I. Newhouse Foundation,
Inc.
Mr. and Mrs. Gerald D. Olin
Mr. and Mrs. Edward L. Palmer
Mr. and Mrs. John J. Phelan, Jr.
The Howard Phipps Foundation
Mr. and Mrs. John R. Reese
Mr. and Mrs. Phillip M. Satow
Mr. and Mrs. James L Spingarn
The Ruth and Oliver Stanton
Foundation
Mr. and Mrs. Philip R. von Stade
The Alex J. Weinstein
Foundation, Inc.
H. G. Wellington & Co., Inc.
PATRONS
Contributions of $2,500 or more
Mr. and Mrs. W. Dillaway Ayres,
Jr.
Mr. and Mrs. Thomas M.
Bancroft, Jr.
Mr. and Mrs. Nicholas J.
Bartilucci
Cheryl and Rod Brayman
Dr. and Mrs. C. Thomas Caskey
Craigmyle Foundation
The Arthur & Barbara Crocker
Charitable Trust
Mr. and Mrs. David H. Deming
Mr. and Mrs. Edward E.
Fessenden
Mr. and Mrs. Robert A. Gay
Mr. and Mrs. Edward H. Gerry
Grey Healthcare Group
Mr. and Mrs. Barclay G. Jones
The Ada Howe Kent Foundation
Mr. and Mrs. Townsend J. Knight
Dr. Laurie J. Landeau
Mr. and Mrs. James M. Large, Jr.
Mrs. Cynthia R. Mead
Ruth Nussdorf/Quality King Dist.
Mrs. William H. Osborn
Mrs. Jessie E. Phillips
Mrs. H. Irving Pratt
Mr. and Mrs. Richardson Pratt,
Jr.
Mr. and Mrs. Lawrence J.
Schecter
Alexandra White Smith
Mr. and Mrs. Douglas S. Sorel
Mr. and Mrs. James F Stebbins
Frederick and Latta Stern
Philanthropic Fund
The Tilles Family Foundation
Mr. and Mrs. Douglas A. Warner
ASSOCIATES
Contributions of $1,000 or more
Mr. Warren S. Adams II
Mr. and Mrs. Robert F. Albertson
Mrs. Harriet W. Bailey
Mr. Robert H.B. Baldwin
Mrs. Robert H.B. Baldwin
Mr. and Mrs. David L. Banker
Mr. and Mrs. Edmund Bartlett
Mr. and Mrs. Rodney B. Berens
Mr. and Mrs. Allen L. Boorstein
Dr. and Mrs. Hans Bosch
David Botstein and Renee Fitts
Mr. Lester E. Brion, Jr.
Mr. and Mrs. F. Sedgwick
Browne
Mrs. Jackson Burke
Centerbrook Architects
Mr. and Mrs. Harry G. Charlston
Mrs. Jane H. Choate
Dr. and Mrs. Bayard D. Clarkson
Mrs. Robert L. Clarkson, Jr.
Mr. James W. Cleary
Mr. and Mrs. John H. Coleman
Cord Meyer Development
Company
The Peter 0. Crisp Fund
Dr. and Mm. Burke A. Cunha
Mr. and Mrs. Richard T Cunniff
Dr. and Mrs. Paul Cushman,
Jr.
Mr. and Mrs. George W. Cutting,
Jr.
Mr. and Mrs. Donald L. Darning
The Dess Group, Inc.
Dr. Lester Dubnick
Mr. and Mrs. William T Dunn, Jr.
Duplex Electrical Supply Corp.
Mr. and Mrs. Jam. A. Eisenman
Mr. and Mrs. Duncan Elder
Mr. and Mrs. William Everdell
Farrell, Fritz, Caemmerer, Cleary,
Barnosky & Armentano, P.C.
Mr. and Mrs. E. Maxwell Geddes,
Jr.
Mr. Jonathan Gold and Dr. Sari
H. Gold
Mr. Peter C. Gould
Mr. and Mrs. John S. Grace
Mr. and Mrs. Oliver R. Grace, Jr.
Mr. and Mrs. Austen T. Gray, Jr.
Mr. Henry U. Harris, Jr.
Mr. and Mrs. Philip R. Herzig
Mr. Lindsay C. Harkness III
Mr. and Mrs. Waldo Hutchins III
Mr. Frederic B. Ingraham
Mr. George E. Isaacs
Walter B. James Fund #2
The Howard Johnson
Foundation
Mr. Jeffrey Keller and Ms.
Dolores Fredrich
Mr. and Mrs. E. Coe Kerr
Mr. and Mrs. David M. Knott
Mr. and Mrs. Ragnar M.
Knutsen
Mr. and Mrs. Gordon E. Lamb
Mr. and Mrs. Edward M.
Lamont
Mrs. Lois A. Lenahan
Eugene and Shirley Levitt
Mrs. Henry Lewis III
Dr. Robert V Lewis
Mr. and Mrs. Robert V Lindsay
The Fay J. Lindner Foundation
Mm. Vladimir S. Littauer
Mr and Mrs. Luke D. Lynch,
Jr.
Mr. John P. Maguire
David & Hildegarde Mahoney
Foundation
Dr. Thomas Maniatis
Mr. and Mrs. Gerald M. Mayer,
Jr.
Mr. and Mrs. John E. Merow
Mr. and Mrs. Robert G. Merrill
Mr. and Mrs. Clarence F
Michalis
Leo Model Foundation, Inc.
Mr. and Mrs. Keith M. Moffat
Mr. and Mrs. Francis W. Murray
III
Mr. and Mrs. William J.
Nammack
Mr. and Mrs. Edmond J. Nouri
Mrs. Carol R. Noyes
Mr. and Mrs. Michael S.
O'Brien
Ms. Nina Ogen
Abby & George O'Neill Trust
Mr. and Mrs. George D. O'Neill
The Anthony & Claire Pace
Foundation, Inc.
Mrs. Arthur W. Page, Jr.
Dr. and Mrs. Philip F. Palmedo
Mr. and Mrs. Nicholas B.
Paumgarten
Pegalis & Wachsman, PC
Mr. and Mrs. Whitney D. Pidot
Mr. and Mrs. Robert A.
Pilkington
Mr. and Mm. Richard F Powers
III
Mrs. Frances S. Reese
Mr. and Mrs. William S.
Robertson
Mr. and Mrs. Arthur M. Rogers,
Jr.
Mr. Harold L Rosenberg and
Dr. Laurie Sayet
Mr. and Mrs. J. Wright
Rumbaugh, Jr.
Mrs. Wendy Russell
Mr. and Mrs. Peter G. Schiff
Mr. and Mrs. Thomas Seifert
Mr. and Mrs. Enrique F Senior
Mr. and Mrs. Owen T Smith
Mr. and Mrs. Peter 0. A.
Solbert
Mr. and Mrs. Paul Stallings
Dr. and Mrs. Bruce Stillman
Mrs. Richard Storrs
Mr. and Mrs. Donald Taylor
Mr. and Mm. Warren I. Titus, Jr.
Town of Brookhaven
Helene P. Victor
WLNY1V55
Mr. and Mrs. Thomas J. Walsh
Townsend Weekes and Diana
Collins
Mrs. Taggart Whipple
Mr. Gerald I. White
Mr. Mayer Wolf
FRIENDS
Contributions of $3W or more
Joan and Alan M. Ades
Albrecht, Viggiano, Zureck &
Company, P.C.
Mr. and Mm. Charles 0. Ames
Anonymous
Mr. William R. Appleby
James J. Arsenault, Medi Media
Inc.
Mrs. Jules W. Aubry
Mr. and Mrs. Edward H.
Auchinclo.
Mr. and Mrs. Richard Aurelio
Diane and Joseph Azznara
Henry and Erica Babcock
Bancker Construction Corp.
Dr. and Mm. Henry H. Bard
Dr. and Mrs. Douglas Barkin
Mrs. George DeB. Bell
Dr. and Mrs. Paul Berg
Mr. and Mrs. Rynn Berry
Dr. William Bloom
Mr. and Mrs. William Braden
Miranda Brooks
Buck Consultants, Inc.
Mr. and Mrs. Thomas J.
Calabrese, Jr.
Mr. and Mrs. Samuel R. Callaway
Mr. and Mrs. Ward C. Campbell
Mrs. Jean Cattier
Eleanor Chemick
Dr. and Mrs. Joseph B. Conolly,
Jr.
Richard L. Cosnotti and The Rev.
Sharon C. Bledsoe
Reverend Mario Costa
Mr. and Mrs. Miner D. Crary, Jr.
Mr. Robert L. Cummings III
Mr. Robert L Cummings
Mr. Theodore N. Danforth
Richard S. Davis
Mr. and Mrs. Daniel P. Davison
Mr. and Mrs. Daniel C. de Roulet
Ms. Lorinda de Roulet
Mr. and Mrs. William Tucker Dean
Elizabeth and Robert Deans
Philip F. DiLeo and Virginia K.
DiLeo
James and Sophie Donaldson
Mr. and Mrs. Joseph T Donohue
Mr. and Mrs. Chuck Dubroff
Mr. and Mrs. Anthony D. Duke,
Jr.
Mr. and Mrs. John E. Eckelberry
Julie C. Eichenberger
Mr. Martin Elias
Dr. and Mrs. Jerry L. Ellstein
Stephen Ely
Mr. and Mrs. Stephen C. Eyre
Mr. and Mm. Joel M. Fairman
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Mr. and Mrs. George J. Farrell, Jr.
Dr. and Mrs. Robert James
Feeney
Mr. J. Barry Ferguson
Mr. and Mrs. Dugald A. Fletcher
Joan F French
Mr. and Mrs. Guy A. Fritts
Clarence E. Galston
William C. Gay, Jr.
Joyce M. Goldring
Lola and Allen Goldring
Joseph L Goldstein, M.D.
Dr. and Mrs. Maurice Green
Green Point Financial
Mr. and Mrs. John P. Havens
Mr. and Mrs. Harold W. Hawkey
Mrs. Albert L. Hoffman
Mrs. Bruce Duff Hooton
Mr. and Mrs. James B. Hoover
Mr. John H. Humpstone, Jr.
Thomas lovino
Mr. and Mrs. John F. Johnston II
Kathleen and Scott Katzman
Mr. and Mrs. John M. Keese
Mr. and Mrs. Francis E. Kelly,
Jr.
Mr and Mrs. Antoine C. Kemper,
Jr.
Andrea B. and Peter D. Klein
John Kingenstein
Virginia C. Knott
Mr. and Mrs. Michael L. Kolodner
Mort and Deborah Kunst ler
Mr. and Mm. John W. Laps ley
Mr. and Mrs. Peter M. Lee
Mrs. Richard Leeds
Mr. and Mrs. Anthony V Leness
Mr. and Mrs. Thomas Leon
Liddell, Sapp, ZMey, Hill and
La Boon, L.L.P.
George N. Lindsay, Jr. and Nancy
Metz
Mr. and Mrs. Robert D. Lindsay
Mr. and Mrs. Robert V Lindsay
Muriel and Tom Losee
Mr. Henry Luce III
Mr. and Mrs. Patrick H. Mackay
Mrs. Doris Magowan
Mr. and Mrs. Norton W. Mailman
The Chase Manhattan
Foundation
Bart D. Marksohn and Jan M.
Lockett
Mr. and Mm. William H. Mathers
Mr. and Mrs. William Matheson
Mr. and Mm. Robert P May
Malcolm Scott McClintock
Mr. and Mrs. Randall P. McIntyre
Mrs. Linda H. McLaughlin
Mr. and Mrs. David B. Miller
Kay Miller
Lindley G. Miller
Mr. and Mrs. Jeffery H. Miller
Mr. and Mrs. Gordon Mills
Mrs. Gloria S. Mooney
Mr. and Mrs. John R Morgan II
Barbara Mosbacher
Mr. Charles A. Riggs and Ms.
Sheila Mahony
Larry Nathanson, M.D.
Peter and Marcy Neumann and
Family
Mr. and Mm. Adams Nickerson
Mr. and Mrs. Richard M. Nick las
Joseph R O'Brien
Mr. and Mrs. Denis J. O'Kane
Mr. and Mm. Peter O'Neill
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Innis O'Rourke, Jr.
Gilbert R. Ott, Jr.
Mrs. John H. Page
Mr. and Mrs. Walter H. Page
Mr. and Mrs. Howard Phipps, Jr.
Mr. and Mrs. Sterling Pile, Jr.
Mr. and Mrs. James Pirtle
Mr. and Mrs. Richard C. Pisan, Jr.
Ann and Graham L. Platt
Grant and Christina Porter
J.D. Posillico, Inc.
Mr. and Mm. Nicholas C. Potter
Barbara S. Powers
Dr. and Mrs. Richard M. Powers
Mr. and Mm. Clayton A. Prugh
Mr. and Mrs. Richard I. Purnell
Rita and Bill Quinlan
William Rand
Random House, Inc.
Curtis and Louise Read
Mr. and Mrs. Samuel B. Rogers
Charlotte and Bob Rubin
Richard and Pamela Rubinstein
Sabin, Bermant & Gould LLP
Mr. Henry Salzhauer
Patricia R Sands
Mr. and Mrs. R. Sheldon Scherer
Drs. Joseph and Laura Schor
Bill and Susan Sheeline
Dr. and Mm. Edward M. Shepard
Mr. and Mrs. Edward Shorn
Dr. and Mrs. Walter Shropshire,
Jr.
Mary L and Robert Sibert
Mr. and Mrs. Richard Simon, Jr.
Mr. and Mrs. Howard Simpson
Dr. Maxine F. Singer
Herbert L. Smith III
Sotheby's
Georgette A. Spingarn
Dr. and Mrs. David Stacy
Mr. and Mrs. Erwin R Staller
Mr. and Mrs. James F. Stebbins
Stebel & Paseltiner, P.C.
Drs. Joan and Thomas Steitz
Mr. and Mrs. Jeffrey Stevenson
Dr. Charles and Jame Strom
Carol and Jim Swiggett
Jill and Stuart Tane
Mrs. David S. Taylor
Anne M. Thomas
James and Mary Gay Townsend
Dr. and Mrs. Henry J. Travis
Mr. and Mrs. Stanley S. Trotman,
Jr.
U. S. Trust Company
Mr. and Mrs. Eugene D.
Wadsworth
Mrs. Em Lee Walker
Dr. and Mrs. Peter Walker
Mr. and Mrs. William E. Walsh
Mr. and Mrs. Henry G. Walter,
Jr.
Mr. and Mrs. Robert R Walton
Mr. Charles Wellington
Mr. and Mrs. John E. Welsh III
Mr. and Mrs. Douglas Williams
Ms. Natalie Wolcott Williams
Mr. and Mrs. Rivington R.
Winant
Mrs. T Scudder Winslow
Mr. and Mm. Samuel Wolcott
Mr. Hugh ler Wyatt
Diane and Bernie Yatauro
Diane and Irwin Young
Dr. Takashsi Yura
Dr. and Mm. Norton D. Zinder
BASIC MEMBERSHIP
Contributions of $50 or more
Mr. and Mrs. Thomas H.
Ackerman
Adalsan, Inc.
John L. Adams
Mr. and Mrs. Stirling S. Adams
Mr. Frank Adduci
Bruce and Betty Alberts
Dr. and Mrs. Thomas M.
Alderson
Mr. and Mm. Prescott Ammarell
Drs. H. W. and S. R. Andersen
Carl W. and Mary E. Anderson
Mr. and Mrs. J. Bryan Anthony
Mrs. S. Reed Anthony
George D. Baker
Mr. and Mrs. Benjamin H.
Balkind
Daniel R Barbiero
Mrs. Laura H. Barr
Mr. and Mm. Anthony B. Barton
Mr. and Mrs. Robert E. Benson
Mr. John Berejka and Dr. Diane
Moriarty
Dr. Barbara S. Bergman
Dr. Gergory A. Beroza
Mr. and Mrs. Ashok Bhavnani
Sheila M. Bidwell
Mr. and Mrs. William Binnian
Georgina Bissell
Mary Lenore Blair
Betsy and Jonathan Blattmachr
Dr. Gunter Blobel
Mr. and Mrs. Peter H. Blohm
Martin Blumenthal
Dorothy Blumner
Mr. George H. Bostwick, Jr.
Mari Brady
Cathy and Kevin Broderick
Mrs. Catherine D. Brown
Mr and Mrs. Douglas Brown
Betty A. Brunauer
Mrs. Julian G. Buckley
Mr. and Mrs. Robert Carson
Mr. and Mrs. Douglas T
Carpenter
Dr. and Mrs. Walter T
Carpenter
Mrs. Clifford M. Carver
Mr. and Mrs. William M. Casler
Wendy and Larry Chamberlin
Mr. and Mm. Gilbert W.
Chapman, Jr.
Chase Bank of Texas, N.A.
The Chase Manhattan Private
Bank
Dr. and Mm. Donald Chiarello
Mr. and Mrs. William H.
Chisholm
Chubb Group of Insurance
Companies
Mr. and Mrs. Henry C. Clark
Kathryn J. Clark
Waleta H. Clark
Ira Cohen
Mr. Michael Cohen
Mr. and Mm. Payson C.
Coleman
Mrs. Gertrude Coletti-Perucca
Peter B. Colgrove
Maryda S. Colovvick
Mr. Cornelius P. Connors
Mrs. Alan L. Corey, Jr.
Mr. and Mrs. Ronald M.
Craigmyle, Jr.
Mr. and Mrs. Peter 0. Crisp
Mrs. Howard H. Dana
Daniel Gale Agency, Inc.
Dr. E. William Davis
Mary and Chuck De Bare
Rick and Jenice Delano
Edward F. DelFce III
Mr. and Mm. John Deming
Mr. and Mrs. Andrew P. DeNatale
Mark and Lisa DeNatale
Robert E. DeNatale
Constance and William R.
Dens low, Jr.
Sydney Hatch Di Villarosa
Mr. and Mrs. Sidney G. Dillon
Robert Ditkoff and Andi
Emerson-Ditkoff
Mr. William Doremus
E. Richard Droesch
Don Durgin
Mm. William S. Eakins
Frederick Eberstadt
Dr. and Mrs. James D. Ebert
Michael and Clarissa Elgarten
Gretchen Elkus
Alexander T Ercklentz
Dr. and Mrs. N. Dennis Eryou
Mrs. James M. Estabrook
Frances C. Fennebresque
Mr. and Mrs. James C. Ferrer
Annette and Anthony Ferruggio
Mr. and Mm. Peter L Fetterolf
Neil Fidel, M.D.
Dr. Noah and Risa Finkel
Mr. and Mrs. William Floyd-
Jones, Jr.
Rosemary Foehl
Mr. and Mrs. Henry L Fox
Freddy and Seth French
Joan F. French
Norman Friedman
Mine B. Frisk
Mr. and Mrs. Robert Fusco
Ellen Futter and John Shutkin
Charles R. Gabalis
Mr. and Mm. Richard Gachot
Stanley C. Gale
Mr. and Mm. John W. Galston
Mr. and Mrs. M. Dozier Gardner
Helena Gaviola
Mr. and Mrs. Charles S. Gay
Dolores G. Gebhardt
Dr. Martin Gellert
Ms. Jeanne Genovese
Mr. and Mrs. Roger M. Gerber
Mr and Mrs. Henry A. Gerry
William F. Gerry
Hugh Jay Gershon
Helen and Monte Get ler
Dr. and Mrs. Stephen A.
Gettinger
Mr. and Mm. Stephen E. Gilhuley
William and Maxine Glenn
Harold Glick
Dr. and Mm. Lewis A. Goldfinger
Andrew and Susan Goldstein
Hope T Goodwin
Mr. and Mrs. Michael M.
Gottsegen
Janet and Charles Goulding
Mr. and Mrs. Edward R. Greeff
Mr. and Mrs. Stephen Ridge ly
Green
Mr. and Mrs. Scott H. Greenfield
Mr. and Mrs. Stanley Greenman
Dr. and Mrs. Raymond B. Grifiths
Ellen Grossman
Frank and Lynn Gundersen
Susan Gunduz, M.D.
John L Gwydir Company, Inc.
Employees
Mr. and Mrs. Michael J.
Hambrook
Clifford and Sherrie Hammond
Virginia H. Hanson
Louisa Hargrave
Mr and Mm. Gordon S. Hargraves
Matthew N. Harris
Dr. and Mrs. Chester Hartenstein
Mr. and Mrs. Charles L. Hatton
Thomas S. and Mary Jo
Heckman
Mr. Huy ler C. Held
Debbie and Michael Held
Mr. Anthony S. Hendrick
Jean Hermann
Larry Hertz
Catherine G. Heyes
Mr. and Mrs. Chats A Hickmann
Mr. and Mrs. Lawrence P. Hubert
Tom and Judy Hogan
Mr. and Mrs. Charles R. Holcomb
Irving and Edna Holtzman
Mary Jo and George Hossfeld
Mr. and Mrs. George H. Howard III
George H. Howard
Dr. Shiu-Lok Hu
Charles and Elizabeth Hubbard
Hubbinette-Cowell Associates,
Inc.
Philip and Gretchen Hull
Mr. and Mm. Rudolf Hunermund
Frank and Patricia Huntington
Mrs. Eugene E. Hosting
Robert Hutchings
Beatrice W. Ingham
Mr. and Mrs. Herbert S. Ingham
Dr. and Mrs. John R. Inglis
Mrs. Laura Ingraham
Institute of Ecosystem Studies
Fred and Janet Irwin
Mr. and Mrs. Howard S. Jacobs
Mr. and Mrs. Valdemar F.
Jacobsen
Mr. and Mrs. Raymond A. Jansen
Mr. and Mrs. Alen D. Jebsen
Mr. and Mrs. J. William Johnson
Ruth B. Jordan
Mrs. Gilbert W. Kahn
Howard and Sandra Kane
Ms. Bonnie J. Kansler
Yoshiro Kawano
Mrs. Norman Keith
Mr. and Mrs. Spencer Kellogg II
Thomas J. and Joan T Kelly
Mr. and Mrs. A. Claude Kemper
Arnold Keppler
Jane and Jim Keresey
Doris Ketcham
Heather M. Kirby
Mary and Gordon Kirwan
Ricahrd Kleinknecht
Richard and Constance Knies
Angela Koenig
Peter and Margot Kohler
Peggy Lehman Korn
Edward Kramer
Mr. and Mrs. Z. Jerry Kuliga
Mrs. Mitsuko T. Kurahara
William and Evelyn Kurtz
Liz and Mark Ladner
David Lamb
Betty Dods Lasek
Mr. and Mrs. Charles Lassen
Ms. Sue Lathrop
Lois K. Learned
Lorraine R Lee
Isabel and Jack Leib
Mr. and Mrs. Daniel S. Leon
Mr. and Mm. William Le Suer
Robed V Lewis, M.D.
Mr. and Mrs. Thomas K. Lieber
Dr. Irene Llovera and Mr. Candido
Uovera
Brian and Ann Lonegan
Alan J. and Joan Long
Long Island Old Car Club, Inc.
L.I. Region Homeless Carriage
Club
M.M.G. Agency Inc.
Ralph L. MacDonald, Jr.
Richard and Anita MacDougall
Mr. Wilfred G. Mackey
Mrs. Henry R. Macy
Mary Louise Magee
Mr. and Mrs. Scott Marcus
Paula Marglin
Mm. Lawrence M. Marks
Mildred Marmur
Mr. and Mrs. Henry C. Marshall, Jr.
Ernst Mayr
Mr. and Mrs. Gregory McMahon
Charles McCurdy and Lisa
Maddox
Mrs. Martha Mc Duffie
Diane McGaw
D. McIlvaine
Robert M. McLane
Jeanne L. McRoberts
Mrs. Bayard H. Megear
Ronald Menzin, M.D.
Carolyn and Norman Mernoff
Elizabeth Meyer
Richard W. Meyer
Mr. and Mm. William A. Milanese
William H. Miller
Ms. Mary Misiorek
Carolyn R. Moomaw
Marjorie K. Moore
Richard Moore
Claire and Joe Moosbrugger
Mr. and Mrs. John W. Morrison
Gisela Mosig
Mr. and Mrs. Brent M. Mowery, Jr.
The Mobile Press Register, Inc.
Theresa Mall Mullarkey
Mr. and Mm. G. Robert Muller
Mrs. Alfred E. Munier
Mrs. George Murnane, Jr.
Mr. and Mrs. Yale Murov
Mr. and Mrs. Vincent R. Nesi
Mr. and Mrs. Barry R Newburger
Benny K.C. Ng, M.D.
Mrs. William S. Niven
Ann L. Nolte
North Country Garden Club
North Side Sunshine Fund
Mr. and Mrs. David C. Noyes
John and Theresa O'Brien
Mr. and Mrs. Matthew M.
O'Connell
Robert and Noelle O'Connor
Mr and Mrs. Frank J. Olt, Jr.
Martha M. Osterhus
Samuel D. Parkinson
Mr. and Mrs. Scott L. Paterson
Paul and Cecily Pennoyer
Mr. and Mrs. John R. Pflug
J. Gardiner Pieper
Judge and Mrs. Thomas C. Platt
Sarah Plimpton
Mr. and Mm. Martin M. Pollak
Mr. and Mm. Edward Everett
Post
Mr. and Mm. R. Scott Powers
Mr. and Mm. Michael S. Press
Mr. and Mrs. Millard B. Prisant
Sherry T Pryor
Mr. and Mrs. Preston V
Pumphrey
Mr. and Mrs. John J. Randall IV
Edward R. Raskin, D.D.S.
Mr. and Mrs. Daren A. Rathkopf
Miss Sandra Read
Jacqueline and Mark Rechler
Geraldyn L. Redmond
Mr. Arthur G. Reid
Mr. Cornelius J. Reid, Jr.
Robert J. Reidy
Mm. Ewing W. Reilley
Mr. and Mrs. Charles J. Reina
Dr and Mm. Robert M. Reiss
Mr. Bernard J. Reverdin
Mr. and Mm. James A.
Reynolds
The Richard Foundation
Mr. and Mm. Bernard Richards
Elizabeth L. Ricks
Mr and Mm. Joseph M. Rizza,
Francis and Patricia Roberts
Linda L. Roll
Sarane H. Ross
Harriet and Stanley Roth
Jerry and Brigitte Rounds
Robert and Lois Rubenstein
Cynthia F Rupp
Leon A. Rushmore
Charlene Russert
Mr. Robert Sabin
Selig D. Sacks
Dr Marilyn Moffat Salant
Caroline W. Salas
Mrs. Harold P. Salembier
Dr. Kay Hutchins Sato
Phyllis Satz
Paul Scherer & Company LLP
Mr. and Mrs. T.V. Shiavoni
Harvey A. Schneier, M.D.
Mr. and Mrs. Richard R.
Schnier, Jr.
Mr. and Mrs. William J. Scholan
Jane R. Schreuder
Carol and Norm Schulman
Melinda Straus Schwartz
Mr. and Mrs. John E.
Schwadzberg
Mr. and Mrs. Steven
Schwartzreich
Mr. and Mrs. Alfred J. Seaman
Mr. and Mm. Frederick E.
Seymour
Ellen and Dan Shapiro
Gloria and Marvin J. Shads
Lisa and David Simek
Hope G. Simpson
Mr John D. Simpson
William C. Simpson
Bernard and Natalie Sklar
Mr. and Mrs. Alexander B.
Slater
Mr. and Mrs. John E. Slater
Mr. and Mrs. Alexander J.
Smith
C. Arthur Smith, Jr.
Mr. and Mrs. John C. Smith
Mr. and Mrs. William S. Smoot
Drs. Carl and Madelon Soloway
James and Joan Sommermeyer
Stephen W. Spencer
Spinnaker Travel
John and Margaret Starkes
Mr. Lawrence Starr
Judith Steers
Mr. and Mrs. B. Albert Stern, Jr.
Mr. William M. Stiger
Barbara H. Stout
Laura and Brian Swiggett
Judith and Irwin Tautleff
Missie and Zack Taylor
Mr. and Mrs. John W. Taylor
Mr. Jon L Ten Haagen
Dudley B. Tenney
The Chase Manhattan Private
Bank
The Mobile Press Register, Inc.
The Richard Foundation
Mr. and Mrs. Edward M. Thomas
Mr George M. Thomas
Charles 0. Thompson
Mr. and Mrs. Henry B. Thompson
Mr. and Mm. William D.
Thompson
Three Harbors Garden Club
Stanford W. Ting
Alexander C. Tomlinson
Elizabeth and David Townsend
Mr. and Mrs. Bronson Trevor
Edward D. Truslow
Mrs. Mary G. Turner
Mr. and Mrs. Cornelius M. Ulman
Mr. and Mrs. Stephen van R.
Ulman
Mr. Nicholas Valkenburg
Mrs. B.F. VanderPoel
Dr. and Mrs. Thornton Vandersall
Paul and Robin Vermylen
Mr. and Mm. Nildaus Vetsch
Anna Glen Vietor
Mr. and Mrs. Colton R Wagner
Mrs. Sherwood Waldron
Mr. and Mrs. Robert Walker
The Hugh Wallace Family
Dr. Heidi Wang
Mr. Jin Wang
Cathie B. Wardell
Charles W.B. Wardell, Jr.
Mrs. David E. Warden
Lewis and Lisa Warren
Mr. and Mrs. Kenneth W.
Washburn
Mr. and Mrs. Richard K. Webel
Mrs. Bradford G. Weekes
Mr. and Mrs. L.B. Wehle, Jr.
Mr. and Mm. Gary Wehren
Mr. and Mrs. Richard Weir, III
Mr and Mrs. W. Perry Welch
Edward C.R. Whitcraft
Mrs. John R. Wierdsma
Mrs. John C. Wilmerding
Catherine Bostwick Wilson
Dr. and Mrs. Philip D. Wilson, Jr.
Roy L. Wilson
Eckard Wimmer, Ph.D.
Dr. Jan and Rona Witkowski
Mr and Mm. Frederick C. Wttsdl,
Sam and Nora Wolcott
Mr. and Mrs. Bertrand Wolff
Mrs. Ethel M. Woolverton
Mm. Gordon R. Wright
Dr. Keith R. Yamamoto
Drs. Moshe and Josette Yaniv
YPO ETA Forum Education
Fund
Bob and Melissa Zakarian
Ms. Joan C. Zulch
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CSHLA CORPORATE AND FOUNDATION MATCHING CONTRIBUTIONS AND OTHER GIFTS
The Bristol-Myers Squibb Foundation, Inc.
W. P. Carey Foundation, Inc.
Citicorp Foundation
Computer Associates International, Inc.
Corning Incorporated Foundation
Florence Corporation
The Fluor Foundation
GE Fund
CSHLA Annual Fund
Greenpoint Financial
The John A. Hartford Foundation, Inc.
Kemper National Insurance Companies
J.P. Morgan Charitable Trust
Morgan Stanley Dean Witter & Co.
Newsweek
Old Westbury Gardens
CSHLA Membership (848) and Other Support
Angels, Benefactors, Patrons, Associates
Friends and Basic Members
Other
Total $701,514.77
$567,191.52
133,092.00
1,231.25
MEMORIAL AND GIFT IN HONOR CONTRIBUTORS
Adalsan, Inc.
Mr. John L. Adams
Mr. Frank Adduci
Mr. and Mrs. Charles 0. Ames
Dr. and Mrs. C. E. Anagnostopoulos
Mr. David T. Andrews
Mrs. S. Reed Anthony
Mr. and Mrs. Edward H. Auchincloss
Mr. George D. Baker
Dr. and Mrs. Henry H. Bard
Mr. and Mrs. Edmund Bartlett
Mr. and Mrs. Rynn Berry
Mrs. Georgina M. Bissell
Dr. Gunter Blobel
Mr. and Mrs. James C. Bostwick
Ms. Mari Brady
Mr. and Mrs. Kevin P. Broderick
Mrs. Helen M. Brooks
Mrs. Anne C. Brown
Mrs. Linda H. Calabrese
Dr. C. Thomas Caskey
Chase Bank of Texas, N.A.
The Chase Manhattan Private Bank
Mrs. Thomas H. Choate
Chubb Group of Insurance Companies
Ms. Kathryn J. Clark
Dr. Bayard D. Clarkson
Mrs. Waleta H. Clark
John P. Cleary, Esq.
Mr. Ira Cohen
Mr. Michael Cohen
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Mr. and Mrs. C. Payson Coleman
Mrs. Gertrude Coletti-Perucca
Dr. and Mrs. Joseph Conolly, Jr.
Mrs. Susan L. Cooper
Mrs. Alan L. Corey, Jr.
Mr. and Mrs. Robert M. Craigmyle, Jr.
The Peter Crisp Fund
Mr. Raymond V. Damadian
Mr. Charles A. De Bare
Mm. Vincent de Roulet
Mrs. Robert B. Deans, Jr.
Mr. and Mrs. Donald L. Deming
Mr. Sydney Hatch Di Villarosa
Mr. Sidney G. Dillon
Mr. and Mrs. Charles F. Dolan
Mr. and Mrs. William T. Dunn, Jr.
Mr. David L. Einsidler
Mr. Stephen Ely
Mr. Alexander T. Ercklentz
Mr. and Mrs. William Everdell
Mr. and Mrs. James C. Ferrer
Mr. Anthony C. Ferruggio
Mr. and Mrs. Dugald A. Fletcher
Ms. Meryl B. Fordin
Mrs. Ann Kerr Franklin
The Samuel Freeman Charitable Trust
Mr. and Mrs. Seth B. French, Jr.
Mr. and Mrs. Raymond French
Mr. Norman Friedman
Mrs. Arline B. Frish
Daniel Gale Agency, Inc.
Oppenheimer Funds, Inc.
The Pechter Foundation
Pfizer Inc.
Phelps Dodge Foundation
The Prudential Foundation Matching Gifts
H. G. Wellington & Co., Inc.
Union Pacific Corporation
Mr. and Mrs. M. Dozier Gardner
Ms. Helena Gaviola
Ms. Dolores G. Gebhardt
Mr. Henry A. Gerry
Mrs. Martha Farish Gerry
Mr. and Mrs. Stephen E. Gilhuley
Mr. and Mrs. Allen A. Goldring
Dr. and Mrs. Andrew Goldstein
Mr. Peter C. Gould
Mr. and Mrs. Austen T. Gray, Jr.
Mr. and Mrs. Frank Gundersen
John L. Gwydir Company, Inc. Employees
Mr. Gordon S. Hargraves
Mr. and Mrs. David Harrison
Mr. and Mrs. Thomas S. Heckman
Miss Jean E. Hermann
Mrs. L. Shepley Hermann
Mrs. Frederick L. Heyes
Mrs. Bruce Duff Hooton
Ms. Jean L. Houghton
Mr. and Mrs. Michael J. Hrinyak
Mr. and Mrs. Waldo Hutchins III
The George E. Isaacs Foundation
Ms. Susan B. Jaye
Mr. and Mrs. Allen D. Jebsen
Mr. and Mrs. Francis E. Kelly, Jr.
Kemper National Insurance Companies
Mr. and Mrs. James F. Keresey
Mr. C. Gordon Kirwan
Mr. and Richard A. Knies
Ms. Virginia Commander Knott
John Kuriyan, Ph.D.
Mr. William Kurtz
Mr. Mark R Ladner
Mrs. Carol E. Large
Mr. Joel Lehman
Mr. and Mrs. John H. Leib
Mrs. Lois A. Lenahan
Liddell, Sapp, Zivley, Hill & La Boon,
L.L.P.
Mrs. Mary D. Lindsay
Long Island Old Car Club
Long Island Region Horse less Carriage
Club
M.M.G. Agency Inc.
Mr. Ralph L. MacDonald, Jr.
Mrs. Robert A. Magowan
David & Hildegarde Mahoney
Foundation
Mr. and Mrs. William L. Matheson
Mrs. Rachel May
Ms. Elizabeth M. McIntosh
Mr. Robert M. McLane
Mrs. Linda H. McLaughlin
Mrs. Jeanne L. McRoberts
Dr. Lorne Mendell
Mr. Donald G. Meyer
Mr. Richard W. Meyer
Mr. Lindley G. Miller
Mr. William R. Miller
Mr. and Mrs. Gordon Mills
The Mobile Press Register, Inc.
Mr. and Mrs. James D. Mooney, Jr.
Ms. Marjorie K. Moore
Mr. and Mrs. John W. Morrison
Ms. Mary R. Moser
Mr. and Mrs. Francis W. Murray III
Samuel I. Newhouse Foundation, Inc.
Mr. and Mrs. Richard M. Nick las
IN MEMORY OF
Barbara Altman
Morris Fensterstock
Dorothy Kornfeld
Helen M. Kraft
William Leibfried
Vernon L. Merrill
George Mutterperl
Martha Papalcure
North Side Sunshine Fund
Mr. and Mrs. Edmond J. Nouri
Mr. and Mrs. John P O'Brien
Mr. and Mrs. George D. O'Neill
Mrs. William Osborn
Mr. and Mrs. John B. Pace
Mr. and Mrs. Edward L. Palmer
Mr. John J. Phelan, Jr.
Mr. and Mrs. J. Gardiner Pieper
Mr. and Mrs. Sterling Pile, Jr.
Mr. and Mrs. James J. Pirtle, Jr.
Mr. and Mrs. Grant A. Porter
Mrs. Barbara Powers
Mr. and Mrs. Tom Press
Mrs. Sherry T Pryor
Dr. Mark Ptashne
Mr. and Mrs. Richard I. Purnell
Mrs. Barbara B. Ramsey
Mr. and Mrs. William Rand
Random House, Inc.
Miss Sandra Read
Mr. John R. Reese
Mr. and Mrs. Cornelius J. Reid, Jr.
Mr. and Mrs. James A. Reynolds
Mr. William S. Robertson
Mrs. Linda L. Roll
Mrs. Sarane H. Ross
Mr. and Mrs. Robert Rubenstein
Ms. Cynthia Foy Rupp
Mrs. Wendy Russell
Mr. and Mrs. Charles Sabin
Mr. Thomas A. Saunders III
Sabin, Bermant & Gould LLP
Paul Scherer & Company LLP
Mr. and Mrs. Norman Schulman
Ms. Melinda Straus Schwartz
Mr. and Mrs. William C. Simpson
Mrs. Hope G. Simpson
Helen Roppelt
Joseph Rosenberg
Pearl Sale
Adelaide Simpson
Rose Stetson
Marvin Thomas Hower
Robert Wagner
Memorials and In Honor Totals
Mr. John E. Slater
Mr. and Mrs. Herbert L. Smith III
Ms. Margaret O'Brien Smith
Mrs. Cathy Syphers Soref
Sotheby's
Mr. Stephen W. Spencer
Mr. and Mrs. James L. Spingarn
Mr. John Starkes
Mrs. Cynthia R. Stebbins
Ms. Judith Steers
Joan Steitz, Ph.D.
Mr. and Mrs. Jeffrey T Stevenson
Dr. Bruce Stillman
Missy and Zach Taylor
Mr. Donald Taylor
Mr. Jon L. Ten Haagen
Mr. and Mrs. Warren I. Titus, Jr.
Mr. and Mrs. Bronson Trevor
U. S. Trust Company
Mr. and Mrs. Colton P Wagner
Mrs. Sherwood Waldron
The Hugh Wallace Family
Mr. and Mrs. Henry G. Walter, Jr.
Mrs. Cathie B. Wardell
Mr. and Mrs. Kenneth W. Washburn
Dr. James D. Watson
Mrs. Bradford G. Weekes
Mr. and Mrs. Gary Wehren
H. G. Wellington & Co., Inc.
Mr. and Mrs. Caleb Whitaker
Mrs. John R. Wierdsma
Mr. and Mrs. Clarence Wilson
Eckard Wimmer, Ph.D.
Mrs. Eunice Johnson Winslow
Mr. and Mrs. Samuel H. Wolcott III
Mrs. Gordon R. Wright
Mr. and Mrs. John Yaworski
YPO ETA Forum Education Fund
IN HONOR OF
Allen A. Goldring
Ralph Guild
Mr. and Mrs. Frank Hain
Louis Lester
$49,421.39
David L. Luke Ill
Leslie C. Quick, Jr.
James D. Watson
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President's Council
The President's Council was formed five years ago in an effort to bring together a small group of indi-
viduals interested in science and the work at Cold Spring Harbor Laboratory. Members of the
President's Council contribute $25,000 or more in any given year in support of the research and edu-
cational programs of the Laboratory. This funding is critical to the Laboratory's continued initiative to
attract top young scientists fresh from their Ph.D. or M.D. studies. These fellowships support new
researchers who have already demonstrated a capacity to pursue their own high-level, independent
research, rather than assisting in the laboratory of an established scientist.
A major feature of the Council is an annual meeting for this select group of leaders from business,
research, and biotechnology. The Council's 1998 meeting, held May 15-16, focused on the topic of
human evolution and began with lunch on Friday at the President's House and was followed by an
afternoon lecture by Dr. Karel Svoboda on imaging neuronal function on the intact brain. The keynote
speaker, Dr. Roger Lewin, a collaborator with Richard Leakey, addressed the issue of what archaeol-
ogy is able to tell us about evolution. The speakers on Saturday were Dr. Sean Carroll from the
University of Wisconsin, Dr. Mark Stoneking from Pennsylvania State University, and Dr. Michael
Hammer from the University of Arizona. These presentations evoked interesting insights as well as
provocative discussions. The following are members of the 1998 President's Council.
Abraham Appel, Appel Consultants, Inc.
Peter Bloom, General Atlantic Partners, LLC
James T. Conneen, A.T. Hudson & Co.
Theodore N. Danforth, Oxford Bioscience
Michel David-Weill, Lazard Freres & Co.
Stefan Englehorn
Leo A. Guthart, ADEMCO
Charles E. Harris, Harris & Harris Group, Inc.
Walter B. Kissinger, WBK Associates
Total $258,750
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Thomas J. McGrath, Simpson Thacher &
Bartlett
Donald A. Pels, Pelsco, Inc.
George B. Rathmann, ICOS Corporation
Hubert J.P. Schoemaker, Centocor, Inc.
James H. Simons, Renaissance
Technologies Corporation
Sigi Ziering, Diagnostic Products Corporation
The Harbor Society
One of the most personal, and meaningful, ways of saying, "I believe in what the Laboratory does" is
to make a Planned Gift. A Planned Gift can take many forms: a bequest in your will, a charitable remain-
der trust, a gift of real estate, securities, life insurance, retirement plan, or other assets.
The Harbor Society is a distinguished group of individuals, currently numbering 44, who have made
Planned Gifts to the Laboratory and have given us permission to list their names. In 1998, several more
individuals pledged their support to Cold Spring Harbor Laboratory, either with a new gift or by adding
to an existing gift.
CONTRIBUTORS
Anonymous Sam and Ann Parkinson
Jim and Jan Eisenman John and Joyce Phelan
Lois Learned John and Hope Reese
Ed and Betty Palmer
Undergraduate Research Program/Partners for the Future
The Undergraduate Research Program introduces college students to the skills they need to become
research scientists. Approximately 20 participants work under the guidance of staff scientists for 10
weeks each summer on projects of mutual interest. The Partners for the Future Program teaches the
principles and methods of basic scientific research to six Long Island high school seniors, who work
with a scientist 10 hours per week after school, from October through March.
CONTRIBUTORS ENDOWMENTS
Cornelius N. Bliss Memorial Fund
Dorcas Cummings Memorial Lecture
Reverend Linda P. Hancock
Jephson Educational Trust
Joan P. Tilney
Total $113,930
Burroughs Wellcome Fund
Garfield Fellowship Emanuel Ax Fund
H. Bentley Glass Fellowship
Libby Fellowship
Olney Fund
Joan Redmond Read Fund
William Shakespeare Fellowship
Frederica von Stade Fund
Total All Annual Funds $19,797,596.00
373
LABORATORY STAFF
James D. Watson, President
Bruce W. Stillman, Director
Winship Herr, Asst. Director/Dean, Watson School
of Biological Sciences
G. Morgan Browne, Administrative Director
W. Dillaway Ayres, Jr., Assoc. Administrative Director
John P. Maroney, Asst. Administrative Director
William D. Keen, Comptroller
Terri I. Grodzicker, Asst. Director for Academic
Affairs
Jan A. Witkowski, Director of Banbury Center
David A. Mick los, Director of DNA Learning Center
John R. Inglis, Executive Director of CSHL Press
David J. Stewart, Director of Meetings and Courses
FACULTY
Investigators
Hollis Cline
David Helfman
Nouria Hernandez*
Adrian Krainer
Roberto Malinow
Robert Martienssen
David Spector
Nicholas Tonks
Timothy Tully
Michael Wig ler
Associate Investigators
Grigori Enikolopov
Bruce Futcher
Michael Hengartner
Tatsuya Hirano
Ryuji Kobayashi
Yuri Lazebnik
Scott Lowe
W. Richard McCombie
Jacek Skowronski
Arne Stenlund
Linda Van Aelst
Yi Zhong
Assistant Investigators
Shivinder Grewal
Ueli Grossniklaus
Masaaki Hamaguchi
Gregory Hannon
David Jackson
Leemor Joshua-Tor
H. Peter Nest ler
Andrew Neuwald
Lincoln Stein
Karel Svoboda
William Tansey
Rui Ming Xu
Chi-Ping (Jerry) Yin
Michael Zhang
CSHL Fellow
Marja Timmermans
Research Investigators
Nei lay Dedhia
Robert Lucito
Natalia Peunova
Andrew Reiner
Clifford Yen
Adjunct Investigator
David Beach
Adjunct Associate
Investigator
Scott Powers
Adjunct Assistant
Investigator
Craig Ogata"
Visiting Scientists
Jiaxin An
Sham Chew
Tatyana Michurina
Jyoti Raychaudhuri
Vladimir Scheinker
lmran Siddiqi
Toshiro Tsukamoto
Senior Fellows
Douglas Conklin
Edward Stern
Postdoctoral Fellows
Andres Barria-Roman
Christine Berthier
Guy Birkenmeier
Benjamin Bottner
Katherine Braun
Mary Byrne
Isabel Cantallops
Luca Cartegni
James Chong
John Connolly
Robert Del Vecchio
Serge Desnoyers
James Dezazzo
Dennis Dong
Joseph Donovan
Eric Drier
Joshua Dubnau
Nicholas Edgington
Viola Ellison
Jose Esteban
Howard Fearnhead
Gerardo Ferbeyre
Francisco Ferrezuelo
Robert Filipkowski
Lisa Foa
Andrew Fraser
Anton Gartner
Michael Greenberg
Andrew Groover
Hui-Fu Guo
Kurt Haas
Frances Hannan
Michelle Hastings
Mariko Hayashi
Yasunori Hayashi
Andreas Herbst
Sangeet Honey
Junjiro Horiuchi
Ilya loschikhes
Nobuhiro Kashige
Alyson Kass-Eisler
Catherine Kidner
Keiji Kimura
Peter Krasnov
Balazs Lendvai
Wen-Chuan (Athena) Lin
Zhixin Lin
Dehua Liu
Hong-Xiang Liu
Qiong Liu
Ana Losada
Zachary Mainen
Mireya Marin
Juan Mendez
Thomas Misteli
Vivek Mittar
Michael Murray
Michael Myers
Naoki Nakaya
Esther Nimchinsky
Paul O'Farrell
Michael Packer
Helena Palka
Laurence Parnell
Shannon Pendergrast
Antonella Piccini
Jean-Christophe Poncer
Pablo Rabinowicz
Baskar Ramamurthy
Michael Regulski
Edward Ruthazer
Minoru Saito
Noriko Saitoh
Cyril Sanders
Clemens Schmitt
Arndt Schmitz
Lidia Serina
Andrew (Mark) Settles
Yu Shen
Keiichi Shibahara
Kaetrin Simpson
Wun Chey Sin
Maria Soengas
Mona Spector
Charles Spillane
Yuri Stasiv
Peiqing Sun
Jack Tabaska
*Funding provided by Howard Hughes Medical Institute
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Anne Vaahtokari
Daan van Aalten
Daniel Vaughn
Jean-Philippe Vie Ile-
Calzada
Erik Vollbrecht
Jing (Jenny) Wang
Yalin Wang
Michael Weinreich
Shouzhen Xia
Tomoki Yokochi
Shahid Zaman
Lifang Zhang
Shaohui Zhang
Zhiguo Zhang
Xinyang Zhao*
Xuemei Zhao
Jianlong (Jim) Zhou
Jian Zhu
Dong-Jing Zou
Graduate Students
Robert Babb
Kenneth Chang
Grace Chen
Jeffrey Christensen
Elisa de Stanchina
Yi Chieh (Nancy) Du
Lavina Faleiro
Eric Gillitzer
Eve-Ellen Govek
Tina Gumienny
Jill Hemish
Brian Hill
Daniel Hoeppner
Ashkan Javaherian
Jianzhong Jiang
Flavio Kamenetz
So Young Kim
Tracy Kuhlman
Arlinda Lee
So Young Lee
Zheng Li
Miguel Maravall
Michele Mc Donough
Troy Messick
John Mignone
Stuart Milstein
Paul Mintz
James Moore
Shirly Pinto
Julia Polyakova
Alex Rai
Patrick Reilly
Jose Rodriguez*
Ahmed Samatar
Andrew Samuelson
Laura Schramm
Setareh Sepehri
Hang Shi
Songhai Shi
Michael Stebbins
Javor Stolarov
Tomasz (Tomek) Swigut
Marcela Tello-Ruiz
Suzanne Tharin
Jiayuan (James) Tong
Beth Trumbull
Tzu-Ling Tseng
Thomas Tubon
Thomas Volpe
Joseph West
Herman Wijnen
Joanna Wysocka
Xiaohong (Helena) Yang
Ming Ming Zhao
Jun Zhu
Lee Zou
Research Programmers
John Healy
Zhanna loschikhes
Aleksandar Poleksic
Research Associates
Carmelita Bautista
Robert Gasperini
Lisa Manche
Linda Rodgers
Lab Facility Managers
Diane Esposito
Timothy Mulligan
Spencer Teplin
Ming Wang
Regina Whitaker
Laboratory Manager
Martha Daddario
Secretaries
Sadie Arana
Patricia Bird
Idee Mallardi
Carol Marcincuk
Barbara Matusik
Lorraine Mclnerny
Jane Reader
Judith Smith
Madeline Wisnewski
Research Assistants
Robin Holden
Indraneil Mahapatra
Laboratory Technicians
Caroline Alexander
Joan Alexander
Juana Arroyo
Deborah Aufiero
Kimberly Bronson
Anthony Bug lino
Barry Burbach
Eileen Cahill
Xiocun (Joan) Chen
Jodi Coblentz
Alison Coluccio
Maureen Cowan
Catherine Cronin
Nancy Dawkins-Pisani
Melissa de la Bastide
Joseph Di Leo
Ping Dong
Margaret Falkowski
Eugenia Friedman
Scott Gossweiler
Kristina Habermann
Michiko Hirano
Tamara Howard
Emily Huang
Wei Jiang
Santosh John
Rachel Jones
Susan Kourpanidis
Robert Krimper
Hui Li
Jianping Liu
Anthony Matero
Mila McCurrach
Robert McGuirk
Joshua Nagel
Lidia Nascimento
Aigoul Nourjanova
Peter O'Brien
Andrew O'Shaughnessy
Ximena Opitz-Araya
Ronnie Packer
Kimberly Pennino
Nora Poppito
Raymond Preston
Lori Pyzocha
Michael Riggs
Milka Rodriguez
Julie Rosenbaum
Simone Salghetti
Kristin Schutz
Lei-Hoon See
Ravi Shah
Monica Shekher
Nadim Shohdy
Joseph Simorowski
Patrick Smith
Lori Spiegel
l'kyori Swaby
Julie Thomas
Jennifer Troge
Philip Vahab
Klara Velinzon
Marie Vil
Kimberly Wanat
Kimberly Weinreich
Patricia Wendel
Jeanne Wiggins
Priscilla Wu
Cristina Yordan
Zhuang Yuan
Li Zhang
Ying Zhang
Hong Zhou
Media Makers/
Laboratory Aides
Esteban Araya
June Blanchford
Sabrina Boettcher
Patricia Brady
Jack Brodsky
Florinda Chaves
Rodney Chisum
Janice Douglas
Salvador Henriquez
Robin Kirchner
Vincent Meschan
Rulan Shen
Margaret Wallace
Xiu-Xia Zhang
Howard Hughes Medical
Institute Employees
Support Staff
Beicong Ma
Carol Sekunda
Yu ling Sun
DEPARTMENTS
Art
Michael Ockler
James Duffy
Irwin Mend linger
Philip Renna
Information Services
Gerald Latter
James Bense
Derek Johnson
Ardavan Kanani
*Funding provided by Howard Hughes Medical Institute
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Matthew Labush Marketing
Robert Pace
Barbara Peters
Salvatore Serafino
John Uhl
Lee Wilbur Advertising Sales
Ingrid Benirschke
Cynthia Weidman
CSHL Press
Acquisition
Elizabeth Powers
Books: Editorial
Janet Argentine
Mary Cozza
Judith Cuddihy
Maryliz Dickerson
Joan Ebert
Kaaren Janssen
Inez Sialiano
Journals: Editorial
Laurie Goodman
Margaret Calicchia
Kimberly Gavin
Valerie Pakaluk
Production
Denise Weiss
Patricia Barker
Dorothy Brown
Daniel de Bruin
Nadine Dumser
Barbara Elliott
Cynthia Grimm
Kristin Kraus
Laura Mintz
Susan Schaefer
Marcie Ebenstein
Public Affairs
Deborah Barnes
Margot Bennett
Marlena Emmons
Wendy Goldstein
Lynn Hardin
Laura Hundt
Development
Richard Cosnotti
Gordon Hargraves
Kelly MacKay
Katherine Ruffolo
Julie Sutherland
Kathleen Waisane
Cathie Wardell
Library
Margaret Henderson
Ellen de Bruin
Laura Hyman
Leigh Johnson
Wanda Stolen
Claudia Zago
Accounting
Jennifer Blovsky
Guy Cozza
Mary Ellen Goldstein
Elizabeth Janow
Patricia Maroney
Fulfillment/Distribution Alison McDermott
Carlos Mendez
Mary Ann Miceli
Elizabeth Panagot
Lan Russo
Amy Stiso
Patricia Urena
Noreen Vance
Barbara Wang
Guy Keyes
Kathleen Cirone
Gabriella Horvath
Jacqueline Matura
Michael Mclnerny
Llywelyn Passmore
Sharon Story
Joanne Thomas
Finance
Nancy Hodson
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Grants
Susan Schutz
Sharon Bense
Wendy Crowley
Maureen Davies
Carol DuPree
Patricia Kurfess
William Mahoney
Dee McKeon
Human Resources
Cheryl Sinclair
Marjorie Berko
Jan Eisenman
Kim Gronachan
Barbara Purcell
Merilyn Simkins
Anastasia Velar-Stephen
Food Service
James Hope
Jaime Bonilla
Francis Bowdren
Guiditta Carino
William Carmona
Michael Corral
Joan Doxey
Julie Ehrlich
Lesley Finnegan
Barbara Gordon
Jennifer Gordon
Oscar Lastra
Jesus Magana
Thomas Mcllvaine
Maureen Morrow
Ronald Padden
Jorge Ramirez
Mauricio Rodriguez
Susana Roman
David Sarinick
Cathy Van Deurs
Leslie Wenzel
Clarke Williams
Javier Zepeda
Meetings/Courses
Edward Campodonico
William Dickerson
Donna Dykeman
Michael Glaessgen
Michela McBride
Andrew Mendelsohn
Andrea Newell
James (Herb) Parsons
Mary Smith
Margaret Stellabotte
Andrea Stephenson
Diane Tighe
Nancy Weeks
Barbara Zane
Purchasing
Philip Lembo
Margaret Brock
Carol Brower
Lorraine Byers
Susan De Angelo
Bruce Fahlbusch
Patricia Hinton-Stenko
Christopher Oravitz
Susan Rose
Leonard Sposato
Central Administration
Maureen Berejka
Barry Braunstein
Carol Dempster
Delia King
Roberta Salant
Banbury Center
Katya Davey
Eleanor Sidorenko
Beatrice To liver
DNA Learning Center
Joan Alexander
Amanda Broege
Scott Bronson
Shirley Chan
Matthew Christensen
Judy Cumella-Korabik
Patricia Harrison
Malissa Hewitt
John Kruper
Susan Lauter
Michele McDonough
Vivek Mittal
Andrew Morotti
Martha Mullally
Janeen Russo
Joel Stern
James Tong
Thomas Volpe
Gisella Walter
Facilities
Arthur Brings
Christopher Hubert
Jack Richards
Peter Stahl
Leslie Allen
Margaret Chellis
Marlene Rubino
Frank Russo
Charles Schneider
Carpentry and Painting
Peter Schwind
Edwin Bennett
Michael Demers
Paul Edwards
John Meyer
Joseph Pirnak
Wilson Ramones
Benjamin Veneable
Harry Wozniak
Custodial/Housekeeping
Steven Tang
Dessie Carter
Ming-Kai Chan
Joseph Houser
Louis Hunter
Susanne MacPherson
Patricia McAdams
Dora Merlino
Guido Mosquera
Maria Mosquera
Mary Muno
Wayne Pay
Ronald Romani
Claudia Schmid
Danuta Slodkowska
Yew Teo
Curtis Williams
Electrical
Louis Jagoda
Jeffrey Goldblum
Environmental Health and
Safety
Randal Jones
John Pisciotta
Equipment Design
Fabrication and Repair
Cliff Sutkevich
Robert Eifert
George Newell
James Robey
Grounds
Daniel Miller
Drew Corner
Joseph Ellis
Lawrence Giordano
Jeffrey Haefling
Edward Haab
Christopher McEvoy
Jose Perez
Andrew Sauer
Stanley Schwarz
Nelson Zepeda
Harris Research Support
Facility
Lisa Bianco
Kelly Brings
Jodi Coblentz
Charlene De Poto
Christine Maurel
Halina Swidzinski
Ryszard Swidzinski
Mechanical Services
Robert Collins
Russell Allen
Greg Beal
William Bishop
Robert Dickerson
Paul Draser
Jeffrey Klaverweiden
Lane Smith
Security
Robert Gensel
Frank Carberry
Randy Wilfong
Shipping and Receiving
Daniel Jusino
Renee Le Strange
Joseph Marcel lo
Charles Ranaudo
Research Staff Departures
during 1998
Faculty
Hong Ma
Akila Mayeda
El ly Nedivi
Alcino Silva
Shou Waga
Visiting Scientists
Yoshitaka Azumi
Eli Hatchwell
Mirjana Maletic-Savatic
Keiko Mizuno
Mariko Nakamura
Zuoping Xie
Postdoctoral Fellows
Marcia Belvin
Anton Bennett
Mark Curtis
Pedro De Campos-Lima
Jeffrey Dickinson
Jianzhong Ding
Andrea Doseff
Ype Elgersma
Nikolai Federov
Paul Frank land
Fei Gao
Andrew Garton
Karl Giese
Cameron Gray
Michael Gutch
Ronald (Bill) Henry
Craig Hinkley
Jeffrey Kogan
Chun Liang
Ruiping Liu
Yu Liu
Martin Lock
Hiroyasu Onaka
Masuo Ono
Indrani Rajan
Brandt Schneider
Gavin Sherlock
Hue Tu
Alain Verreault
Jonathan Wallach
Yixing Wang
Yung-Chih (Judy) Wang
Nicholas Wright
Ming Yang
Graduate Students
Ofelia Carvalho
Degui (Charlie) Chen
Pin (Adele) Chen
Ethan Ford
Richard Freiman
Anthony (John) lafrate
Kenneth La Montagne
Debra Morrison
Peter Rubinelli
Meenakshi Selvakumar
Rachel Wallace-Brodeur
Qiang Wu
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